data_2jqj_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2jqj _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.703 0.287 . . . . 0.0 110.471 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.8 t -64.46 130.71 44.78 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.91 0.386 . . . . 0.0 111.036 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.12 -47.0 0.64 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.77 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -138.83 -178.84 16.7 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.357 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.429 ' CD2' ' HA ' ' A' ' 49' ' ' GLU . 49.4 m80 -147.02 162.36 38.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.865 0.364 . . . . 0.0 110.919 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -127.07 119.7 27.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.754 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.5 t -97.53 122.96 49.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.104 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -89.99 126.48 35.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.884 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -90.62 106.82 18.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.53 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 20.8 mt -124.09 140.65 35.25 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.934 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.53 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 57.2 Cg_endo -73.86 87.99 1.1 Allowed 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.162 1.908 . . . . 0.0 111.983 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 137.79 -12.08 3.68 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.386 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.1 pttp 178.2 173.51 0.63 Allowed 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 120.727 0.299 . . . . 0.0 110.689 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -135.7 160.68 37.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.048 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.61 134.08 33.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.947 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.04 127.7 56.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.82 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 30.6 t -119.48 130.79 73.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.182 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.429 ' HA ' ' CD2' ' A' ' 36' ' ' HIS . 3.3 pm0 -81.6 136.6 35.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.734 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.7 tt -116.02 132.11 66.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.338 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -97.05 168.09 10.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.999 -179.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -92.63 66.16 4.43 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.079 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.602 ' C ' ' H ' ' A' ' 55' ' ' VAL . 0.1 OUTLIER -90.37 13.26 15.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.016 -179.253 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.434 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 0.7 OUTLIER 69.28 -34.6 0.28 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -179.524 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.602 ' H ' ' C ' ' A' ' 53' ' ' ARG . 62.3 t -137.28 124.09 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-O 120.948 0.404 . . . . 0.0 111.343 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.429 ' HB ' ' HB2' ' A' ' 80' ' ' PHE . 15.9 m -111.04 128.8 55.98 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.624 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.74 138.67 40.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.908 0.385 . . . . 0.0 111.043 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.427 HD11 ' CD2' ' A' ' 80' ' ' PHE . 4.7 mp -126.64 117.98 49.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.033 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 176.68 -160.73 28.29 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.667 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.426 ' N ' HG23 ' A' ' 73' ' ' ILE . 5.2 ttp180 -83.39 -29.82 27.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.726 0.298 . . . . 0.0 110.979 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.2 t -58.09 129.32 41.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.968 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.42 -22.64 67.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.022 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 6.3 m -69.89 -27.58 64.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.004 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 97.5 m -57.16 151.61 15.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.82 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.411 ' HB3' ' CG2' ' A' ' 56' ' ' THR . 63.9 t0 -61.31 -43.96 98.01 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.884 0.374 . . . . 0.0 110.603 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.8 t -125.03 114.92 42.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.093 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 19.6 tt -93.75 107.4 19.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.026 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.405 ' CD1' ' CD1' ' A' ' 73' ' ' ILE . 18.0 mt -65.36 -177.97 0.46 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.928 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.9 p -123.39 65.05 1.0 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.238 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.87 141.1 40.67 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.606 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.22 -19.22 50.72 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.605 2.203 . . . . 0.0 112.911 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -133.86 34.78 3.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.794 0.331 . . . . 0.0 111.31 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.426 HG23 ' N ' ' A' ' 60' ' ' ARG . 3.2 tp -71.86 128.7 35.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.165 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.4 m -59.92 133.35 56.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.212 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 86.7 m -64.46 -44.03 92.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.802 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.456 ' O ' ' C ' ' A' ' 77' ' ' HIS . 34.9 m-85 -99.68 13.9 31.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.405 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.456 ' C ' ' O ' ' A' ' 76' ' ' PHE . 1.8 t-160 -19.0 -69.94 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.737 -1.12 . . . . 0.0 112.771 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.422 ' HB1' ' CE1' ' A' ' 127' ' ' PHE . . . -153.78 164.08 38.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.986 0.422 . . . . 0.0 111.731 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.15 138.96 50.91 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.737 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.429 ' HB2' ' HB ' ' A' ' 56' ' ' THR . 38.3 m-85 -119.53 131.07 55.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.55 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.434 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 9.0 m-70 -94.77 115.84 28.0 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.139 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.08 109.81 21.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.796 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.0 pp -120.1 140.07 51.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.048 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -117.44 128.11 54.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.878 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.3 ttm -135.65 151.4 50.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.892 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -106.52 121.01 43.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.947 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.5 p -126.92 121.44 58.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.929 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.8 t0 75.18 -58.0 0.58 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.062 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -173.17 -40.61 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.842 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -89.54 132.92 34.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.773 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.01 131.0 35.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.929 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -113.49 143.49 44.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.821 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -113.99 142.79 45.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.983 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 tp -131.91 136.19 47.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.739 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.427 HD13 ' CE1' ' A' ' 135' ' ' PHE . 3.4 mp -114.7 140.95 33.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.125 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -117.54 133.54 55.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.785 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.414 ' HB ' ' HB3' ' A' ' 117' ' ' TYR . 7.7 t -96.36 127.34 48.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.238 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 9.9 mt -130.09 139.14 52.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.962 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -114.19 129.92 56.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.979 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.11 31.42 0.76 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.86 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.3 m -135.11 -178.74 5.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.881 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.02 37.68 3.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.882 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -101.13 -30.11 11.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.2 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 115.27 106.26 2.58 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.441 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.423 ' CG2' ' CE1' ' A' ' 127' ' ' PHE . 89.4 m -122.34 123.26 40.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.843 0.354 . . . . 0.0 110.948 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -121.0 115.0 22.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.855 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.8 tp -110.56 137.29 43.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.506 0.67 . . . . 0.0 111.318 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 59.84 31.54 20.81 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.75 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.63 9.32 69.3 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.893 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -134.13 151.97 51.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.843 0.354 . . . . 0.0 110.838 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 30.4 ttp180 -74.73 140.54 44.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.908 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.98 133.68 40.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.915 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.8 m -112.08 -34.3 2.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.128 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 44.1 mttp -100.34 -178.16 3.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.895 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.6 mttp -121.17 32.08 6.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.85 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -154.23 56.17 0.71 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.989 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.414 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 1.8 t80 -84.15 139.25 32.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.815 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.2 tp -98.53 118.89 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.217 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 9.2 tt -103.08 136.74 42.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.007 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 9.0 mttt -130.54 178.08 6.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.751 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.414 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 28.5 p30 -53.1 148.07 8.69 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.089 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.65 37.48 92.5 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.507 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.91 131.5 53.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.77 0.319 . . . . 0.0 110.87 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -97.99 125.54 42.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.837 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.411 HG21 ' CE2' ' A' ' 127' ' ' PHE . 2.9 mp -121.96 135.53 61.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.14 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.9 t -120.85 126.34 75.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.977 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.433 ' HB3' ' CE1' ' A' ' 77' ' ' HIS . 44.8 m-85 -123.39 124.93 44.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.955 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 85.88 -6.16 81.76 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.864 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 77.74 27.8 0.58 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.93 0.395 . . . . 0.0 110.492 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 82.5 p -153.13 -46.36 0.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.797 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 60.1 m -80.37 108.29 13.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.861 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 48.3 t -124.0 125.61 44.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.927 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -138.03 155.0 49.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.813 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.5 tt -108.29 130.02 55.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.79 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.427 ' CE1' HD13 ' A' ' 95' ' ' ILE . 30.2 t80 -99.68 141.58 32.3 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 122.025 0.917 . . . . 0.0 111.712 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 12.8 tttm -154.47 155.09 34.28 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 113.853 -1.521 . . . . 0.0 110.726 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.414 ' CE2' ' HB3' ' A' ' 121' ' ' ASN . 3.4 m-85 -81.62 139.51 34.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.958 0.409 . . . . 0.0 110.793 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.466 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.03 -179.914 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.433 ' N ' HG21 ' A' ' 51' ' ' THR . 0.9 OUTLIER . . . . . 0 N--CA 1.457 -0.109 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.8 t -59.89 144.79 47.91 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.816 0.341 . . . . 0.0 111.114 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 tp -157.49 -67.35 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.968 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -118.98 165.25 13.03 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.526 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.447 ' CE1' ' CB ' ' A' ' 138' ' ' ALA . 32.0 m80 -136.83 161.12 36.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.848 0.356 . . . . 0.0 111.078 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.9 mt -120.58 111.08 17.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.669 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.6 t -96.02 121.76 46.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.02 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -90.17 113.91 25.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.882 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.74 106.81 14.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.814 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.514 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 22.0 mt -124.2 140.44 34.92 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.847 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.514 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 57.8 Cg_endo -74.29 86.42 1.31 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.186 1.924 . . . . 0.0 111.955 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 115.6 23.74 4.28 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.256 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 176.92 -168.36 0.06 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.738 0.304 . . . . 0.0 110.593 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -177.47 152.39 0.83 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.886 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -137.97 130.81 29.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.087 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.3 tttt -113.07 134.84 54.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.905 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 37.5 t -121.62 151.02 24.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.202 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -100.82 133.62 45.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.789 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.1 mm -116.07 129.51 72.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.173 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.433 HG21 ' N ' ' A' ' 32' ' ' THR . 2.0 p -106.08 167.99 9.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.96 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.416 ' HA ' ' CD2' ' A' ' 82' ' ' LEU . 6.9 m-80 -85.1 63.67 8.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.168 0.508 . . . . 0.0 110.256 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.61 ' C ' ' H ' ' A' ' 55' ' ' VAL . 23.2 ttt-85 -87.3 2.76 49.25 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.914 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.402 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 0.7 OUTLIER 71.68 -34.63 0.3 Allowed 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -178.573 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.61 ' H ' ' C ' ' A' ' 53' ' ' ARG . 75.6 t -137.22 136.06 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.473 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.465 ' N ' ' O ' ' A' ' 80' ' ' PHE . 18.8 m -125.12 129.68 50.67 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.957 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.81 136.12 44.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.911 0.386 . . . . 0.0 110.846 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.41 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 36.6 mt -125.68 128.4 72.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.983 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 168.91 -143.95 8.4 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.222 -0.99 . . . . 0.0 113.353 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.487 ' HB2' ' CG2' ' A' ' 73' ' ' ILE . 5.8 ttp-105 -96.9 -40.55 8.85 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.904 0.383 . . . . 0.0 111.145 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' SER . . . . . 0.42 ' HB3' ' CG2' ' A' ' 75' ' ' THR . 4.7 p -53.91 127.27 25.54 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.309 -179.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 28.6 ptt85 -59.84 -20.12 55.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.024 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.77 -27.06 64.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.558 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 60.3 m -56.99 149.08 19.66 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.411 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.402 ' HB3' ' CG2' ' A' ' 56' ' ' THR . 7.9 t0 -61.36 -44.71 96.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.947 0.403 . . . . 0.0 110.794 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 58' ' ' ILE . 56.0 t -125.21 133.17 70.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.551 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.4 pt -100.62 112.6 33.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.349 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.4 mt -78.72 -88.22 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.006 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 30.9 t -108.22 -108.65 0.32 Allowed 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.544 ' CB ' ' HD3' ' A' ' 71' ' ' PRO . 0.0 OUTLIER 169.27 -60.86 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.198 0 N-CA-C 111.574 0.212 . . . . 0.0 111.574 179.25 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.544 ' HD3' ' CB ' ' A' ' 70' ' ' GLU . 25.6 Cg_exo -62.39 -40.05 42.3 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 121.955 1.77 . . . . 0.0 113.061 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -121.74 25.26 9.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.676 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.487 ' CG2' ' HB2' ' A' ' 60' ' ' ARG . 5.0 tp -106.77 121.48 59.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.178 0.513 . . . . 0.0 111.102 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.433 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 0.7 OUTLIER -69.7 137.47 52.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.457 -179.298 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.42 ' CG2' ' HB3' ' A' ' 61' ' ' SER . 27.6 m -57.66 -43.99 85.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.942 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.47 ' O ' ' C ' ' A' ' 77' ' ' HIS . 2.9 m-85 -100.85 14.19 32.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.662 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.47 ' C ' ' O ' ' A' ' 76' ' ' PHE . 2.0 t-160 -18.92 -69.09 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.883 -1.053 . . . . 0.0 112.814 -179.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -155.57 164.07 39.14 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.929 0.395 . . . . 0.0 111.643 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 56' ' ' THR . 0.2 OUTLIER -125.95 138.99 53.8 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.848 179.802 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.465 ' O ' ' N ' ' A' ' 56' ' ' THR . 2.6 m-85 -119.58 131.07 55.42 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.86 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.402 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 15.2 m-70 -97.29 116.3 29.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.81 0.338 . . . . 0.0 111.384 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.425 ' CD1' ' O ' ' A' ' 51' ' ' THR . 6.0 tt -106.82 109.93 21.96 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.058 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.8 mp -119.26 139.94 51.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.812 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -123.88 139.06 54.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.117 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -155.03 132.81 11.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.927 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.6 p-10 -107.04 128.73 54.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.914 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.8 m -130.8 139.12 51.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.201 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 68.43 -67.99 0.19 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.137 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -178.1 38.16 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.839 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -148.14 -177.93 6.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.669 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -121.37 127.94 51.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.94 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.13 110.88 20.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.738 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 -114.04 129.06 56.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.079 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.83 136.22 52.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.655 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.421 HD13 ' CE1' ' A' ' 135' ' ' PHE . 4.2 mp -113.78 141.01 31.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.11 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -119.72 143.95 47.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.793 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.409 HG22 ' CZ ' ' A' ' 80' ' ' PHE . 16.8 t -109.88 129.93 63.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.208 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 24.0 mm -124.27 124.15 67.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.054 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.86 131.37 48.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.994 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -93.72 10.54 32.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.325 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.4 m 59.83 64.1 1.35 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.868 0.366 . . . . 0.0 110.88 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -161.38 132.2 5.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.941 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 70.23 5.8 5.49 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.988 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 61.76 130.87 0.01 OUTLIER Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.766 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.449 ' CG2' ' CE1' ' A' ' 127' ' ' PHE . 95.8 m -132.04 125.86 32.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.791 0.329 . . . . 0.0 110.814 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -117.62 123.92 47.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.92 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.3 tp -122.08 137.2 56.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.511 0.672 . . . . 0.0 111.152 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 62.4 29.04 17.15 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.881 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.7 9.44 69.83 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.911 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -134.0 152.03 51.69 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.748 0.308 . . . . 0.0 110.839 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 8.1 mtp-105 -68.5 142.64 55.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.852 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.3 tp -77.48 140.28 39.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.953 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 19.3 m -126.05 -44.58 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.077 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.71 -178.64 0.97 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.897 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.03 -29.04 8.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.902 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -122.66 83.86 2.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.884 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -82.3 139.18 34.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.808 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.2 tp -98.51 121.61 49.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.969 0.414 . . . . 0.0 111.395 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.8 tp -103.07 134.0 47.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.894 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 2.4 mttp -129.19 178.12 6.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.858 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.448 ' HB2' ' CE2' ' A' ' 137' ' ' TYR . 3.6 t30 -54.89 144.93 21.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.223 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 64.55 44.68 94.77 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.379 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -117.04 122.36 43.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.762 0.315 . . . . 0.0 111.089 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 78.1 mtt180 -89.89 133.05 34.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.718 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.413 HG22 ' CE2' ' A' ' 127' ' ' PHE . 2.9 mp -126.67 132.35 70.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.251 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.9 t -118.33 126.15 74.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.958 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.449 ' CE1' ' CG2' ' A' ' 105' ' ' THR . 45.2 m-85 -122.74 144.23 49.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.075 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 81.56 -67.09 3.7 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.391 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 170.51 -33.91 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.773 0.321 . . . . 0.0 111.036 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 9.6 p -116.41 -37.49 3.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.413 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 48.6 m -55.15 103.95 0.11 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.977 0.418 . . . . 0.0 111.184 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 44.3 t -124.62 124.54 42.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.035 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 24.8 p90 -142.08 156.12 45.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.919 0.39 . . . . 0.0 110.998 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -111.78 140.02 46.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.864 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.421 ' CE1' HD13 ' A' ' 95' ' ' ILE . 20.0 t80 -100.46 141.27 33.55 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.924 0.869 . . . . 0.0 111.695 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 8.6 mtmt -154.78 157.11 37.46 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 113.864 -1.516 . . . . 0.0 110.95 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.448 ' CE2' ' HB2' ' A' ' 121' ' ' ASN . 4.8 m-85 -86.02 139.61 31.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.928 0.394 . . . . 0.0 110.616 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.447 ' CB ' ' CE1' ' A' ' 36' ' ' HIS . . . . . . . . 0 C--N 1.324 -0.507 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.06 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.052 0 CA-C-O 120.796 0.331 . . . . 0.0 110.648 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.8 t -67.36 122.86 18.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.999 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.0 tp -133.29 -62.39 0.79 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.675 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.5 162.77 12.26 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.298 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.414 ' CD2' ' HG3' ' A' ' 49' ' ' GLU . 27.3 m80 -132.24 160.38 36.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.961 0.41 . . . . 0.0 111.185 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.9 mt -127.11 118.72 24.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.845 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.5 t -100.36 121.85 51.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.129 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -89.7 125.27 35.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.888 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.7 mp -86.74 106.97 18.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.877 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.519 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 1.7 mt -124.11 141.39 37.07 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.63 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.519 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 56.2 Cg_endo -72.14 -8.33 22.64 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.171 1.914 . . . . 0.0 112.489 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -109.29 -14.2 15.31 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.555 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 175.97 -165.84 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.705 0.288 . . . . 0.0 110.744 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -137.99 132.42 32.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.923 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -108.13 133.59 52.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.1 tttm -113.06 122.93 49.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.942 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 18.6 t -111.56 151.16 13.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.997 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.414 ' HG3' ' CD2' ' A' ' 36' ' ' HIS . 0.3 OUTLIER -104.85 119.42 38.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.063 -179.878 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 27.3 mm -98.37 132.09 44.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.829 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -103.2 168.03 9.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.063 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 14.3 p30 -97.68 73.64 2.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.435 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.629 ' C ' ' H ' ' A' ' 55' ' ' VAL . 6.1 ptp180 -103.47 16.9 25.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.614 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.412 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 13.7 m120 68.49 -29.16 0.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.629 ' H ' ' C ' ' A' ' 53' ' ' ARG . 59.4 t -137.38 131.3 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-O 121.072 0.463 . . . . 0.0 111.623 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.447 ' N ' ' O ' ' A' ' 80' ' ' PHE . 45.7 m -125.29 125.86 44.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.688 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.401 ' HB ' ' HA ' ' A' ' 64' ' ' CYS . 0.1 OUTLIER -103.67 130.76 51.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.986 0.422 . . . . 0.0 111.183 -179.64 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.2 mp -112.23 117.17 54.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.789 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 172.56 -141.92 6.51 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.357 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.526 ' HB3' ' HA ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -111.47 -23.17 10.9 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.696 0.284 . . . . 0.0 111.233 179.891 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -51.88 126.06 17.03 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.8 0.334 . . . . 0.0 111.072 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.22 -28.61 59.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.049 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.27 -22.45 59.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.113 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.401 ' HA ' ' HB ' ' A' ' 57' ' ' THR . 94.2 m -55.76 168.14 0.47 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.982 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -89.24 -51.37 5.61 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.863 0.363 . . . . 0.0 110.893 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.22 132.02 51.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.029 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.4 pt -108.16 128.96 63.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.357 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.3 mp -114.3 -152.32 0.5 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.304 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.575 ' O ' ' CB ' ' A' ' 70' ' ' GLU . 0.5 OUTLIER -42.08 -58.45 2.1 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.506 0.193 . . . . 0.0 110.753 179.779 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.688 ' HB3' ' HD3' ' A' ' 71' ' ' PRO . 0.7 OUTLIER 110.42 -56.04 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.585 0 C-N-CA 123.594 0.758 . . . . 0.0 112.209 178.708 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.688 ' HD3' ' HB3' ' A' ' 70' ' ' GLU . 16.9 Cg_exo -67.22 -40.08 11.94 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.177 1.918 . . . . 0.0 112.899 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -107.06 23.92 13.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.828 0.347 . . . . 0.0 111.016 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.8 tp -115.94 127.9 73.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.103 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 54.7 m -67.48 131.76 46.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.902 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 85.1 m -58.75 -33.12 69.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.574 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.442 ' O ' ' C ' ' A' ' 77' ' ' HIS . 0.1 OUTLIER -112.19 13.96 20.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.537 179.859 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.442 ' C ' ' O ' ' A' ' 76' ' ' PHE . 1.0 OUTLIER -22.03 -69.61 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.748 -1.115 . . . . 0.0 112.576 -179.339 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -159.33 164.06 35.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.101 0.477 . . . . 0.0 111.936 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -123.74 140.23 53.2 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.405 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.447 ' O ' ' N ' ' A' ' 56' ' ' THR . 2.3 m-85 -119.38 131.16 55.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.866 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.412 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 4.4 m-70 -95.28 116.26 28.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.82 0.343 . . . . 0.0 111.082 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.64 109.62 21.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.853 179.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.1 mp -122.32 140.15 52.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.978 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -111.92 121.02 43.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.834 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -132.37 130.09 40.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.929 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -107.06 128.56 54.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.936 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.6 t -129.83 136.08 59.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.953 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.0 t0 71.98 -60.67 0.52 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.982 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -176.09 -39.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.767 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -81.03 131.85 35.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.731 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -82.96 128.14 34.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.032 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -112.98 143.1 44.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.783 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 27.0 m120 -114.01 129.56 56.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.051 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.9 mt -120.62 142.36 49.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.703 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.456 HG13 ' CE1' ' A' ' 135' ' ' PHE . 10.7 mm -124.26 141.17 45.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.245 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -113.8 138.54 50.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.743 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.4 t -109.63 120.85 61.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.311 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 13.9 mt -130.15 120.94 50.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.88 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -115.32 126.12 54.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.957 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.05 28.38 5.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.056 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 58.11 106.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.05 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.21 -76.08 0.28 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.893 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -125.02 27.87 6.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.254 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 66.79 128.14 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.597 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.4 HG22 ' CD1' ' A' ' 127' ' ' PHE . 63.1 m -131.29 123.02 27.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.821 0.343 . . . . 0.0 110.751 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.42 ' CE2' ' HG3' ' A' ' 111' ' ' ARG . 62.2 m-85 -120.02 114.97 22.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.93 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.4 HD13 ' CE2' ' A' ' 117' ' ' TYR . 2.1 pp -109.48 131.19 61.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.118 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 59.59 31.75 21.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.968 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.63 13.05 74.5 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.96 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -129.12 132.36 47.36 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.845 0.355 . . . . 0.0 110.895 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.42 ' HG3' ' CE2' ' A' ' 106' ' ' PHE . 5.4 ttt180 -68.41 142.99 55.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.92 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.47 132.74 35.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.851 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 14.7 p -144.06 32.62 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.081 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 4.1 mptt -131.12 138.18 49.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.843 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.08 -40.05 86.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.896 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -126.31 78.43 1.77 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.939 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.4 ' CE2' HD13 ' A' ' 107' ' ' ILE . 31.9 t80 -84.05 139.07 32.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.819 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.5 tp -98.52 119.94 47.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.011 0.434 . . . . 0.0 111.289 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.436 ' HB3' ' HB ' ' A' ' 95' ' ' ILE . 3.1 tt -103.18 142.37 34.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.014 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 6.3 mttt -125.42 178.03 5.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.072 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.448 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 7.9 p30 -62.73 146.86 51.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.173 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 68.92 51.86 27.0 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.342 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . 0.401 ' HB2' ' CD2' ' A' ' 119' ' ' LEU . 0.7 OUTLIER -127.61 124.31 37.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.843 0.354 . . . . 0.0 111.191 -179.752 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -84.7 132.3 34.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.707 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.443 ' CD1' ' CE2' ' A' ' 133' ' ' PHE . 22.5 pt -129.56 128.4 65.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.212 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.6 t -113.56 129.63 69.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.0 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.4 ' CD1' HG22 ' A' ' 105' ' ' THR . 5.5 m-85 -116.77 111.96 20.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.004 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 104.76 -75.55 0.25 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.479 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 5.6 tttt 179.42 -38.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.769 0.319 . . . . 0.0 110.989 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 12.0 p -104.51 -40.59 5.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.287 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 22.0 m -57.93 107.04 0.42 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.842 0.353 . . . . 0.0 111.079 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 29.7 t -124.21 119.92 30.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.788 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.446 ' CD1' ' N ' ' A' ' 133' ' ' PHE . 1.1 p90 -141.9 150.32 41.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.091 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.22 140.13 43.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.777 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.456 ' CE1' HG13 ' A' ' 95' ' ' ILE . 12.3 t80 -102.25 141.26 35.38 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 121.893 0.854 . . . . 0.0 111.664 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.449 ' N ' ' CD1' ' A' ' 135' ' ' PHE . 7.2 mttp -154.68 155.4 34.55 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 113.829 -1.532 . . . . 0.0 111.128 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.448 ' CE2' ' HB3' ' A' ' 121' ' ' ASN . 8.7 m-85 -86.16 140.0 30.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.003 0.43 . . . . 0.0 110.638 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.407 ' HB2' ' CE1' ' A' ' 36' ' ' HIS . . . . . . . . 0 C--N 1.324 -0.509 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.123 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.842 0.353 . . . . 0.0 110.675 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.8 t -72.27 120.57 18.07 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.977 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.7 tt -119.81 -40.5 2.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.893 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -149.25 -169.6 15.95 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.49 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 51.1 m80 -146.96 160.65 42.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.774 0.321 . . . . 0.0 110.919 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.4 mp -127.1 119.33 26.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.799 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.4 t -98.28 121.76 49.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.179 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -89.93 119.16 30.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.844 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -75.37 106.88 7.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.915 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.418 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 18.9 mt -124.11 138.75 31.27 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.847 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.418 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 86.6 Cg_exo -44.46 -28.76 2.78 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.48 2.12 . . . . 0.0 112.441 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -111.18 -143.4 9.37 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.268 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.0 mtpt -53.89 113.77 1.33 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.83 0.347 . . . . 0.0 111.134 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -59.93 168.02 1.99 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.955 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -135.66 125.01 24.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.015 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.01 134.28 54.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.92 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.8 t -125.42 139.42 51.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.122 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -80.31 139.67 36.5 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.748 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.2 tt -116.01 130.86 70.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.895 0.378 . . . . 0.0 111.398 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.77 168.11 10.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.6 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -110.76 73.16 0.81 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.677 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.637 ' C ' ' H ' ' A' ' 55' ' ' VAL . 0.1 OUTLIER -98.65 23.36 8.76 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.115 -179.788 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 69.83 -28.3 0.17 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.637 ' H ' ' C ' ' A' ' 53' ' ' ARG . 58.6 t -137.29 134.18 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-O 121.111 0.481 . . . . 0.0 111.506 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.463 ' N ' ' O ' ' A' ' 80' ' ' PHE . 18.0 m -125.45 125.9 44.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.372 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.4 ' HB ' ' HA ' ' A' ' 64' ' ' CYS . 0.0 OUTLIER -103.78 133.24 49.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.956 0.408 . . . . 0.0 111.213 -179.444 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.417 HD13 ' CD1' ' A' ' 80' ' ' PHE . 3.9 mp -118.35 116.73 52.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.896 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.42 -142.37 6.58 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.657 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.423 ' HB2' ' CG2' ' A' ' 73' ' ' ILE . 11.7 ttp180 -103.76 -30.94 10.08 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.777 0.322 . . . . 0.0 110.947 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -49.17 124.46 9.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.241 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 47.6 mtm180 -57.04 -30.32 64.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.904 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.4 m -69.99 -21.96 63.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.081 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.4 ' HA ' ' HB ' ' A' ' 57' ' ' THR . 86.5 m -55.8 166.17 0.77 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.995 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -83.58 -48.13 10.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.816 0.341 . . . . 0.0 111.033 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 58' ' ' ILE . 21.3 t -124.93 125.43 69.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.515 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.6 pt -98.28 131.04 46.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.786 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.437 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 19.9 mt -118.25 105.17 11.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.263 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.57 ' O ' ' CB ' ' A' ' 70' ' ' GLU . 0.6 OUTLIER 68.75 -70.27 0.14 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.571 179.991 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.57 ' CB ' ' O ' ' A' ' 69' ' ' SER . 31.1 mt-10 112.18 -60.71 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.84 0 C-N-CA 123.992 0.917 . . . . 0.0 112.336 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.556 ' HD2' ' C ' ' A' ' 69' ' ' SER . 38.1 Cg_endo -66.74 -14.15 42.73 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.123 1.882 . . . . 0.0 113.367 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -129.18 25.72 5.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.66 0.267 . . . . 0.0 111.269 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.437 ' HB ' ' O ' ' A' ' 68' ' ' LEU . 4.9 tp -119.89 150.61 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-O 120.943 0.402 . . . . 0.0 111.566 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.45 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 45.0 t -94.88 129.38 41.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.063 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 58.0 m -53.7 -33.39 55.33 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.157 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -112.3 14.0 20.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.167 0.508 . . . . 0.0 111.838 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.45 ' HB2' ' O ' ' A' ' 74' ' ' SER . 2.0 t-160 -29.17 -70.38 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.901 -1.045 . . . . 0.0 112.617 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -154.96 164.15 39.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.08 0.467 . . . . 0.0 112.126 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -127.79 139.23 52.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.206 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.463 ' O ' ' N ' ' A' ' 56' ' ' THR . 5.5 m-85 -119.42 131.33 55.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.984 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -94.59 116.39 28.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.972 0.415 . . . . 0.0 110.964 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -106.47 109.72 21.72 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.775 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.9 tp -120.79 140.0 52.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.065 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -107.63 126.36 52.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.745 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -126.09 143.09 51.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.984 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -95.84 116.91 29.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.895 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.6 t -138.71 121.05 17.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.073 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 62.11 -176.59 0.13 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.825 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 22.7 t30 -50.7 -31.13 15.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.257 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -94.46 -177.53 4.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.922 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -115.67 128.66 56.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.849 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.19 123.2 43.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.923 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -113.51 138.26 50.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.745 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.07 134.22 45.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.95 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.417 HD11 ' CE1' ' A' ' 135' ' ' PHE . 3.6 mp -115.45 141.11 33.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.976 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -113.91 137.66 51.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.844 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.419 HG21 ' CE2' ' A' ' 80' ' ' PHE . 12.1 t -105.78 126.36 61.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.222 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 33.9 mt -129.95 120.99 51.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.984 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.76 139.01 54.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.951 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.3 mmtm -99.92 6.27 45.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.332 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.6 m 58.08 101.83 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.75 0.31 . . . . 0.0 111.014 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 14.3 ttt180 -149.23 -63.72 0.23 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.889 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -96.2 -45.61 6.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.235 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 132.96 106.08 0.97 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.554 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.9 m -118.52 126.36 51.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.835 0.35 . . . . 0.0 110.949 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.417 ' CE2' ' HB2' ' A' ' 111' ' ' ARG . 19.3 m-85 -120.83 121.26 37.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.882 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.3 tp -108.51 137.29 40.97 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 CA-C-O 121.522 0.677 . . . . 0.0 111.193 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 61.71 28.05 17.26 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.825 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.69 9.55 69.99 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.947 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -134.1 152.0 51.64 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.804 0.335 . . . . 0.0 110.862 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.417 ' HB2' ' CE2' ' A' ' 106' ' ' PHE . 0.6 OUTLIER -71.77 133.02 45.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.954 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.9 pp -88.57 134.62 33.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.924 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 13.0 m -110.52 -30.22 2.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.224 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.2 153.97 31.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.983 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.62 -36.3 16.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.895 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -102.93 74.62 1.33 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.917 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -83.72 139.04 32.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.815 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.6 tp -98.63 118.99 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.148 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.1 tt -103.04 135.88 43.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.056 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -131.07 178.12 6.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.743 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.436 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 4.5 p-10 -52.95 143.77 16.34 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.091 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 68.51 44.04 74.48 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.475 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -112.85 121.19 43.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.806 0.336 . . . . 0.0 110.916 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -90.51 119.03 30.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.871 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.6 mt -114.94 132.07 65.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.061 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 29.6 t -116.57 131.84 67.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.174 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -118.57 133.63 55.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.975 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 80.19 -66.19 3.67 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.446 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 170.38 -33.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.814 0.34 . . . . 0.0 110.998 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.3 p -107.19 -42.76 4.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.287 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 59.5 m -56.4 104.78 0.16 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.874 0.369 . . . . 0.0 111.194 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.42 125.01 43.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.922 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.43 ' CD1' ' N ' ' A' ' 133' ' ' PHE . 2.1 p90 -142.15 156.12 45.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.93 0.395 . . . . 0.0 111.091 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.6 tt -116.25 138.97 50.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.645 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.417 ' CE1' HD11 ' A' ' 95' ' ' ILE . 25.4 t80 -103.38 141.4 36.01 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 122.029 0.919 . . . . 0.0 111.875 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 11.4 mtmt -154.67 143.8 21.09 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 113.787 -1.552 . . . . 0.0 110.74 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.436 ' CE2' ' HB3' ' A' ' 121' ' ' ASN . 4.0 m-85 -72.86 139.72 47.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.002 0.43 . . . . 0.0 110.72 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.462 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.092 -179.97 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.68 0.276 . . . . 0.0 110.743 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 10.6 t -69.7 114.9 8.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.58 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.1 tp -118.16 -41.95 2.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.28 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -148.53 -167.92 14.07 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.233 -0.984 . . . . 0.0 113.056 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.422 ' CD2' ' HG3' ' A' ' 49' ' ' GLU . 46.1 m80 -144.58 161.04 40.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.862 0.363 . . . . 0.0 110.683 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 23.5 mt -127.11 112.85 15.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.666 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.5 t -95.92 121.77 46.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.135 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -90.23 125.96 35.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.933 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.8 mp -106.1 106.81 17.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.802 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.8 mm -124.03 138.17 30.2 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.086 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -55.78 87.11 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.4 2.067 . . . . 0.0 112.205 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 139.51 -22.55 2.86 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.662 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.9 mtpt 177.01 164.03 0.49 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.861 0.363 . . . . 0.0 110.814 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -122.61 -178.19 3.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.906 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.53 134.93 16.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.882 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -109.03 122.7 47.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.854 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.3 t -122.47 151.12 26.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.211 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.422 ' HG3' ' CD2' ' A' ' 36' ' ' HIS . 0.4 OUTLIER -94.69 130.65 41.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.602 179.852 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.1 tt -116.1 128.88 73.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.084 0.469 . . . . 0.0 111.578 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.79 168.12 10.69 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.196 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . 0.526 ' HA ' ' HB3' ' A' ' 82' ' ' LEU . 56.5 m-80 -68.51 -89.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.333 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.598 ' C ' ' H ' ' A' ' 55' ' ' VAL . 12.9 ttt-85 72.79 -1.09 3.12 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 179.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.404 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 1.3 m-20 70.33 -34.06 0.28 Allowed 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.096 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.598 ' H ' ' C ' ' A' ' 53' ' ' ARG . 64.1 t -137.04 134.84 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 CA-C-O 121.012 0.434 . . . . 0.0 110.949 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.467 ' N ' ' O ' ' A' ' 80' ' ' PHE . 50.6 m -125.28 132.17 52.96 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.061 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.405 ' HB ' ' CB ' ' A' ' 64' ' ' CYS . 0.0 OUTLIER -104.33 143.84 32.44 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.843 0.354 . . . . 0.0 111.231 -179.786 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.8 mp -130.76 126.72 60.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.083 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 164.98 -139.28 5.73 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.667 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.41 ' HB2' ' CG2' ' A' ' 73' ' ' ILE . 10.6 ttp180 -106.85 -26.59 11.18 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.749 0.309 . . . . 0.0 110.969 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.12 136.5 29.68 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.24 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.74 -31.89 72.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.915 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 46.2 p -69.95 -23.91 63.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.942 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.405 ' CB ' ' HB ' ' A' ' 57' ' ' THR . 96.4 m -56.64 171.87 0.29 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.944 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.414 ' HB2' HG23 ' A' ' 56' ' ' THR . 0.7 OUTLIER -85.07 -68.16 0.75 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.002 0.429 . . . . 0.0 110.885 179.813 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.2 t -105.95 115.31 47.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.899 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.4 pt -91.94 104.97 16.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.553 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.435 ' O ' ' O ' ' A' ' 69' ' ' SER . 1.8 mp -66.85 -155.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.837 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.482 ' O ' ' CB ' ' A' ' 70' ' ' GLU . 19.1 p -41.81 -96.43 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 117.592 0.178 . . . . 0.0 111.193 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.519 ' CB ' ' HD3' ' A' ' 71' ' ' PRO . 1.5 mt-10 159.19 -60.93 0.0 OUTLIER Pre-proline 0 N--CA 1.466 0.366 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.519 ' HD3' ' CB ' ' A' ' 70' ' ' GLU . 36.4 Cg_exo -57.4 -40.31 82.47 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.206 1.937 . . . . 0.0 113.241 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -116.53 28.86 8.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.698 0.285 . . . . 0.0 111.313 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.429 HD11 ' CD2' ' A' ' 68' ' ' LEU . 4.9 tp -110.6 126.74 67.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.99 0.424 . . . . 0.0 111.293 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 1.5 m -79.03 134.66 36.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.194 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 72.0 m -61.03 -29.16 69.56 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.02 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.431 ' O ' ' C ' ' A' ' 77' ' ' HIS . 0.3 OUTLIER -106.91 14.02 27.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.237 0.541 . . . . 0.0 111.598 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.458 ' CE1' ' HB3' ' A' ' 127' ' ' PHE . 1.4 t-160 -24.41 -71.11 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.759 -1.109 . . . . 0.0 112.747 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -163.43 164.12 24.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.062 0.458 . . . . 0.0 112.019 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -124.35 140.88 52.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.342 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.467 ' O ' ' N ' ' A' ' 56' ' ' THR . 3.2 m-85 -119.22 131.15 55.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.751 0.31 . . . . 0.0 110.863 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -94.82 116.47 28.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.909 0.385 . . . . 0.0 111.038 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.526 ' HB3' ' HA ' ' A' ' 52' ' ' ASN . 0.1 OUTLIER -106.41 109.55 21.51 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.107 179.866 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.23 130.62 53.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.814 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 5.7 tm0? -107.0 128.12 54.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.925 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 9.4 ttt -152.03 143.15 23.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.928 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -99.89 131.13 46.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.852 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 19.8 t -137.01 134.46 47.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.112 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 61.11 39.83 15.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.833 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 62.26 32.67 17.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.856 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -145.68 157.09 43.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.882 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -82.98 127.92 33.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.905 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -117.01 117.44 29.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.008 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -105.42 119.96 40.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.766 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.4 mt -118.2 125.65 50.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.077 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.403 HG13 ' CE1' ' A' ' 135' ' ' PHE . 11.7 mm -115.0 133.3 61.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.013 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -113.94 143.49 44.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.635 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.433 HG13 ' CE1' ' A' ' 80' ' ' PHE . 18.0 t -109.12 132.63 56.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.381 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.422 HG22 HD11 ' A' ' 98' ' ' ILE . 25.3 mm -130.05 120.93 50.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.029 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -102.23 127.05 49.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.964 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.4 mmtp -140.69 31.54 1.85 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.886 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.6 m -123.92 178.35 5.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.953 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -121.95 31.25 6.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.951 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -103.58 -56.29 2.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.186 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 138.05 120.78 1.9 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.514 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.8 m -125.59 122.95 37.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.813 0.34 . . . . 0.0 110.911 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -116.31 129.15 56.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.848 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.1 tp -123.08 137.24 57.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.445 0.641 . . . . 0.0 111.378 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 61.86 29.71 17.98 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.838 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.64 12.98 74.49 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.87 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 73.3 m-80 -133.47 152.01 51.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.798 0.332 . . . . 0.0 110.849 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.0 143.05 55.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.932 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.46 126.31 33.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.865 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.2 p -112.16 -40.81 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.113 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.6 tptp -76.56 163.71 26.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.968 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.68 -29.25 18.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.902 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -121.13 82.06 1.87 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.018 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -84.09 139.21 32.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.673 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.407 ' O ' ' CG2' ' A' ' 118' ' ' ILE . 8.7 tp -98.52 118.52 45.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.435 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.0 tt -103.2 143.93 31.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.841 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.3 mmtt -127.51 178.01 6.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.851 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.439 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 11.7 p-10 -59.94 148.07 36.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.973 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 64.05 43.71 96.92 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.413 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -114.69 130.74 56.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.774 0.321 . . . . 0.0 111.069 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.2 mmm-85 -83.87 130.77 34.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.712 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.43 ' HB ' ' CE1' ' A' ' 133' ' ' PHE . 2.7 mt -126.8 128.14 70.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.356 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 40.6 t -122.76 124.01 69.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.734 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.458 ' HB3' ' CE1' ' A' ' 77' ' ' HIS . 3.3 m-85 -113.47 145.98 40.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.969 0.414 . . . . 0.0 111.306 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 70.6 -65.17 0.82 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.435 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 173.83 -50.18 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.853 0.358 . . . . 0.0 110.859 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 89.1 p -96.15 -36.15 11.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.203 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 24.7 m -57.66 104.49 0.19 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.003 0.43 . . . . 0.0 111.124 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.41 124.14 41.69 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.951 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.43 ' CE1' ' HB ' ' A' ' 125' ' ' ILE . 8.4 p90 -142.13 153.64 44.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.966 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.0 tt -112.22 133.93 54.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.766 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.403 ' CE1' HG13 ' A' ' 95' ' ' ILE . 48.0 t80 -106.42 141.4 37.79 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 121.958 0.885 . . . . 0.0 111.802 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.55 157.44 38.29 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 113.928 -1.487 . . . . 0.0 111.119 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.439 ' CE2' ' HB3' ' A' ' 121' ' ' ASN . 6.7 m-85 -86.0 139.87 30.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.761 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.564 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.125 179.972 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.414 ' N ' HG23 ' A' ' 51' ' ' THR . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.776 0.322 . . . . 0.0 110.692 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 4.4 t -62.05 138.43 58.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.07 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.1 tp -142.54 -47.83 0.34 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.708 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -137.63 -174.68 13.47 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.287 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.402 ' NE2' ' CG ' ' A' ' 49' ' ' GLU . 50.5 m80 -144.83 163.76 33.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.893 0.378 . . . . 0.0 111.031 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.0 mt -126.59 131.05 51.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.683 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.1 t -105.33 121.92 58.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.094 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.401 ' N ' ' OD1' ' A' ' 39' ' ' ASN . 1.1 m-20 -89.99 126.01 35.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.794 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.94 106.54 18.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.88 0.371 . . . . 0.0 110.782 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.529 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 4.3 mp -124.49 141.06 36.68 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.906 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.529 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 58.9 Cg_endo -74.44 83.31 1.72 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.102 1.868 . . . . 0.0 111.978 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 143.33 -14.3 2.29 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.531 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.02 176.18 0.92 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 120.716 0.293 . . . . 0.0 110.672 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -132.73 160.62 36.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.141 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -137.78 130.27 29.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.814 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 33.6 tttt -106.21 127.28 53.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.007 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 23.5 t -117.47 147.73 20.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.083 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.402 ' CG ' ' NE2' ' A' ' 36' ' ' HIS . 3.4 mt-10 -97.26 135.72 38.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.844 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.1 tt -115.25 132.15 65.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.093 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.414 HG23 ' N ' ' A' ' 32' ' ' THR . 0.7 OUTLIER -106.46 168.46 9.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.253 -179.653 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -85.07 68.93 10.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.153 0.502 . . . . 0.0 110.511 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.602 ' C ' ' H ' ' A' ' 55' ' ' VAL . 19.3 ttt-85 -87.77 4.45 44.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.814 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.498 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 10.3 m120 69.0 -35.08 0.29 Allowed 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -178.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.602 ' H ' ' C ' ' A' ' 53' ' ' ARG . 70.5 t -137.27 135.23 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.599 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.467 ' N ' ' O ' ' A' ' 80' ' ' PHE . 53.4 m -125.15 126.52 45.4 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.023 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.73 131.05 51.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.964 0.411 . . . . 0.0 110.732 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.452 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 5.0 mp -119.77 118.91 58.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.929 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 172.46 -137.18 4.1 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.449 -0.881 . . . . 0.0 113.201 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.461 ' HD2' ' O ' ' A' ' 70' ' ' GLU . 11.2 ttt-85 -103.29 -38.13 7.36 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.815 0.34 . . . . 0.0 111.103 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -45.8 127.52 8.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.583 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.8 -29.1 69.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.737 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 94.2 p -69.93 -23.67 63.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.826 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 87.9 m -53.3 158.15 1.73 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.87 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -74.09 -47.62 35.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.847 0.356 . . . . 0.0 111.008 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 58' ' ' ILE . 20.8 t -125.08 133.27 69.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.559 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 4.7 pt -100.24 118.93 47.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.603 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.434 ' HG ' ' CZ ' ' A' ' 133' ' ' PHE . 2.3 mp -84.83 -86.67 0.13 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.784 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 38.9 m -107.7 -109.77 0.31 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.596 ' CB ' ' HD3' ' A' ' 71' ' ' PRO . 0.1 OUTLIER 168.34 -63.49 0.0 OUTLIER Pre-proline 0 CA--C 1.529 0.157 0 O-C-N 122.375 -0.203 . . . . 0.0 111.541 178.862 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.596 ' HD3' ' CB ' ' A' ' 70' ' ' GLU . 21.5 Cg_exo -64.74 -22.14 64.28 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 121.977 1.785 . . . . 0.0 112.867 -179.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -136.32 22.07 3.2 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.684 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.46 ' CG2' ' HB2' ' A' ' 60' ' ' ARG . 4.7 tp -105.68 121.25 57.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.06 0.457 . . . . 0.0 110.957 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.8 m -65.24 133.08 50.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.484 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 77.8 m -58.73 -35.34 72.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.974 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.43 ' O ' ' C ' ' A' ' 77' ' ' HIS . 0.2 OUTLIER -112.01 14.14 20.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.225 0.536 . . . . 0.0 111.361 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.43 ' C ' ' O ' ' A' ' 76' ' ' PHE . 14.8 t60 -24.88 -69.14 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.648 -179.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -149.77 163.96 36.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.07 0.462 . . . . 0.0 112.056 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -129.01 137.98 51.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.462 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.467 ' O ' ' N ' ' A' ' 56' ' ' THR . 2.0 m-85 -119.57 125.98 50.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.848 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.406 ' CD2' HD12 ' A' ' 98' ' ' ILE . 10.1 m-70 -94.84 116.19 28.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.913 0.387 . . . . 0.0 111.294 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.64 109.5 21.44 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.714 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.9 tp -122.49 140.2 53.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.2 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -122.82 120.95 35.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.807 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -115.47 126.58 54.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.985 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -107.07 117.56 34.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.904 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 25.3 t -133.54 125.08 49.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.015 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.5 t70 70.61 -61.55 0.47 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.048 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -176.54 -39.64 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.845 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -89.48 101.28 13.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.68 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -82.93 145.44 29.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.051 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 2.8 ttp-105 -113.1 141.13 47.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.808 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -107.35 129.92 54.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.029 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.7 133.9 50.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.718 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.8 mp -117.48 140.77 39.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.22 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -117.82 125.82 51.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.825 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.422 HG21 ' CZ ' ' A' ' 80' ' ' PHE . 18.0 t -96.34 131.48 43.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.131 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.406 HD12 ' CD2' ' A' ' 81' ' ' HIS . 32.4 mt -123.0 120.95 61.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.03 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.48 117.88 26.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.93 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.04 30.06 1.82 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.885 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 18.5 m -96.04 177.71 5.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.825 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.9 29.58 1.87 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.093 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 34.7 p-10 -135.18 -44.85 0.71 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.964 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 157.33 117.01 0.52 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.739 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.401 HG23 ' CD1' ' A' ' 127' ' ' PHE . 62.5 m -132.04 122.75 25.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.734 0.302 . . . . 0.0 110.79 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -121.21 139.07 53.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.188 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.3 tp -122.79 137.34 56.62 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 CA-C-O 121.443 0.639 . . . . 0.0 111.196 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 60.52 30.0 19.43 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.65 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.69 12.67 74.36 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.843 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -134.14 152.03 51.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.819 0.342 . . . . 0.0 110.769 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.83 143.09 44.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.872 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.2 mp -74.74 131.33 40.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.942 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.3 p -114.73 -37.09 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.07 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 9.9 tttt -115.38 149.77 37.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.871 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.3 165.94 21.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.027 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 27.5 t70 62.48 64.73 0.91 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.988 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -84.04 138.47 33.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.846 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.4 tp -98.7 120.28 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.226 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.7 tt -103.07 139.06 39.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.992 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 13.0 mmtp -129.84 178.17 6.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.74 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.446 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 4.8 p-10 -53.41 148.0 9.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.153 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 64.08 37.5 94.68 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.565 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -109.81 127.85 54.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.821 0.343 . . . . 0.0 110.96 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 54.2 mtt180 -93.6 132.69 37.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.858 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.42 122.0 68.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.087 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 46.7 t -112.71 123.9 68.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.771 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.401 ' CD1' HG23 ' A' ' 105' ' ' THR . 68.5 m-85 -120.38 148.03 44.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.951 0.405 . . . . 0.0 111.211 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 73.79 -65.84 1.78 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.348 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 175.35 -50.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.807 0.337 . . . . 0.0 111.022 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.06 -33.13 9.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.681 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 21.6 m -55.74 105.46 0.18 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.884 0.373 . . . . 0.0 110.98 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 13.7 p -124.22 136.76 54.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.918 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.434 ' CZ ' ' HG ' ' A' ' 68' ' ' LEU . 15.5 m-85 -142.25 156.21 45.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.151 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.8 tt -121.66 116.1 23.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.711 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -94.7 141.56 28.47 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 122.054 0.931 . . . . 0.0 111.895 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 6.8 tttt -154.62 160.4 41.43 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 113.781 -1.554 . . . . 0.0 110.85 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.446 ' CE2' ' HB3' ' A' ' 121' ' ' ASN . 3.7 m-85 -86.07 139.98 30.66 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.051 0.453 . . . . 0.0 110.681 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.535 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.058 179.987 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.868 0.366 . . . . 0.0 110.517 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 40.6 t -59.84 120.17 9.08 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.158 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -117.04 -34.97 4.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.705 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -168.54 -177.9 39.84 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.274 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 23.2 m80 -138.08 166.05 25.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.084 0.468 . . . . 0.0 111.138 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.1 mt -127.28 114.73 18.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.614 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 20.0 t -95.92 121.59 46.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.129 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -90.37 142.04 28.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.939 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.6 mt -107.43 106.49 16.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.681 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.9 mt -124.39 138.67 31.41 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.983 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_exo -52.12 -25.39 22.82 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.475 2.117 . . . . 0.0 112.516 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -85.52 -34.01 15.04 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.736 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 177.15 -174.28 0.12 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.835 0.35 . . . . 0.0 110.948 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -107.92 157.53 18.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.918 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -135.41 120.26 18.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.954 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.7 mmtp -100.72 128.2 46.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.882 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.1 t -122.4 139.71 48.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.156 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -92.43 127.42 37.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.724 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 15.9 tt -116.05 132.08 66.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.04 0.448 . . . . 0.0 111.468 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.81 167.87 10.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.454 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -61.14 -92.18 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.684 -0.235 . . . . 0.0 110.387 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.584 ' C ' ' H ' ' A' ' 55' ' ' VAL . 8.0 ttt180 75.2 -5.77 2.1 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 179.15 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.413 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 7.9 t-20 71.03 -32.97 0.26 Allowed 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.786 -0.365 . . . . 0.0 110.199 -179.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.584 ' H ' ' C ' ' A' ' 53' ' ' ARG . 61.6 t -135.82 138.33 47.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 CA-C-O 120.926 0.393 . . . . 0.0 110.931 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.455 ' N ' ' O ' ' A' ' 80' ' ' PHE . 94.0 m -125.38 130.5 52.04 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.579 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.413 ' O ' ' N ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -104.01 139.76 38.69 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.821 0.343 . . . . 0.0 111.025 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 4.7 mp -132.2 130.87 60.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.335 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.35 -135.31 3.99 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.971 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.472 ' HB2' ' CG2' ' A' ' 73' ' ' ILE . 7.5 ttt-85 -100.59 -40.9 7.18 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 120.855 0.36 . . . . 0.0 110.918 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -44.83 118.82 1.73 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.446 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 15.9 mtt85 -57.42 -27.42 62.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.884 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.7 m -69.82 -25.62 63.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.778 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 89.8 m -54.73 166.6 0.46 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.78 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' A' ' 57' ' ' THR . 0.6 OUTLIER -73.52 -58.33 3.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.875 0.369 . . . . 0.0 111.117 -179.945 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 58' ' ' ILE . 21.2 t -121.51 125.36 73.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.647 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.3 pt -95.81 118.19 41.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.567 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.457 ' HB2' HG12 ' A' ' 73' ' ' ILE . 9.1 mt -77.01 -91.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.686 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.46 ' O ' ' CB ' ' A' ' 70' ' ' GLU . 1.3 p -101.42 -102.11 0.26 Allowed 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.57 ' CB ' ' HD3' ' A' ' 71' ' ' PRO . 3.6 mt-10 162.4 -63.96 0.0 OUTLIER Pre-proline 0 CA--C 1.531 0.228 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.57 ' HD3' ' CB ' ' A' ' 70' ' ' GLU . 46.8 Cg_exo -56.09 -40.13 86.86 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.107 1.871 . . . . 0.0 113.355 -178.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -124.19 25.67 7.72 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.472 ' CG2' ' HB2' ' A' ' 60' ' ' ARG . 3.1 tp -104.31 121.93 56.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.137 0.494 . . . . 0.0 111.223 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.6 m -62.9 136.31 57.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.285 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 65.8 m -64.4 -40.57 96.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.806 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.452 ' O ' ' C ' ' A' ' 77' ' ' HIS . 3.5 m-85 -99.24 13.86 31.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.232 0.539 . . . . 0.0 111.448 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.452 ' C ' ' O ' ' A' ' 76' ' ' PHE . 1.0 OUTLIER -20.6 -69.8 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.705 -1.134 . . . . 0.0 112.76 -179.346 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -156.64 164.05 38.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.214 0.53 . . . . 0.0 112.099 -179.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -129.52 133.78 47.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.085 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.455 ' O ' ' N ' ' A' ' 56' ' ' THR . 5.1 m-85 -119.2 131.22 55.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.975 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.413 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 8.1 m-70 -94.67 116.33 28.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.991 0.424 . . . . 0.0 110.906 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.43 109.65 21.63 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.058 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.31 137.56 54.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.794 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -109.64 129.2 55.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.868 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.88 141.22 34.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.948 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.8 p-10 -106.95 115.95 31.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.856 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.0 m -124.95 117.41 50.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.3 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.7 t0 58.35 77.51 0.29 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.081 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 63.18 -80.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.994 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -63.67 151.72 41.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.917 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -118.63 136.72 53.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.96 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.7 mtp180 -112.64 149.74 32.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.997 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -112.12 125.61 54.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.716 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.3 mp -107.78 127.29 53.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.927 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.1 mp -118.09 137.41 52.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.076 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -114.01 144.09 43.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.041 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.419 HG12 ' CE1' ' A' ' 80' ' ' PHE . 14.1 t -106.45 127.13 62.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.253 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 11.9 mt -130.03 120.91 50.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.851 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -100.14 136.5 39.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.021 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.7 mmtt -133.47 30.55 3.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.913 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.7 m -160.68 150.78 17.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.841 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -102.21 44.76 0.99 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.954 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -83.65 -31.71 26.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.242 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 121.33 89.21 1.03 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.51 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 67.4 m -112.36 126.09 54.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.9 0.381 . . . . 0.0 110.912 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -121.03 118.31 29.49 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.956 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.7 tp -115.49 137.33 49.41 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-O 121.551 0.691 . . . . 0.0 111.255 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 59.98 28.09 17.57 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.838 -1.073 . . . . 0.0 110.931 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.74 9.89 70.82 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.878 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -134.04 152.0 51.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.823 0.344 . . . . 0.0 110.854 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.04 136.74 43.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.894 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.91 144.96 52.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.866 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.2 p -141.11 56.13 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.106 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -177.25 -176.4 0.64 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.835 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.41 25.84 9.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.024 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -166.46 72.9 0.15 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.778 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -84.14 139.4 32.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.833 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 7.8 tp -98.51 117.62 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-O 120.984 0.421 . . . . 0.0 111.242 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.417 HD22 ' CD2' ' A' ' 135' ' ' PHE . 0.5 OUTLIER -103.1 132.54 49.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.035 -179.834 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -130.84 178.09 6.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.799 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.423 ' HB2' ' CE2' ' A' ' 137' ' ' TYR . 0.3 OUTLIER -54.81 141.32 33.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.061 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 71.8 53.04 10.16 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.5 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -129.14 127.12 40.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.895 0.378 . . . . 0.0 111.009 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -91.13 124.38 35.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.747 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.2 mp -115.0 131.57 66.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.283 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.7 t -122.71 128.14 75.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.943 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.43 ' CD2' HD11 ' A' ' 68' ' ' LEU . 44.5 m-85 -121.77 118.22 28.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.983 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 86.63 -8.17 76.39 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.84 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 76.74 27.98 0.72 Allowed 'General case' 0 CA--C 1.522 -0.11 0 CA-C-O 120.939 0.4 . . . . 0.0 110.243 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.2 p -138.13 -48.24 0.54 Allowed 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.94 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 1.8 m -88.41 112.04 22.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.865 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 23.0 t -120.08 123.35 43.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.036 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.431 ' CE1' HD21 ' A' ' 68' ' ' LEU . 3.1 p90 -142.16 156.22 45.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.118 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 7.1 tt -108.07 138.79 43.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.706 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.417 ' CD2' HD22 ' A' ' 119' ' ' LEU . 56.5 t80 -105.18 141.57 36.49 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.992 0.901 . . . . 0.0 111.938 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.43 155.11 34.37 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 113.846 -1.525 . . . . 0.0 110.747 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.423 ' CE2' ' HB2' ' A' ' 121' ' ' ASN . 1.1 m-85 -85.06 139.74 31.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.945 0.403 . . . . 0.0 110.847 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.47 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.065 -179.942 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.726 0.298 . . . . 0.0 110.635 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 13.2 t -76.43 114.86 15.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.901 0.382 . . . . 0.0 111.071 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.19 -35.8 3.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.889 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -141.03 -177.81 16.67 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.565 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.421 ' CD2' ' HG2' ' A' ' 49' ' ' GLU . 31.9 m80 -142.13 157.87 44.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.836 0.35 . . . . 0.0 110.832 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.0 pp -127.08 123.05 35.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.722 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.3 t -105.89 121.93 58.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.197 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -86.3 115.16 23.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.751 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 45.1 mt -83.87 106.87 15.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.986 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.538 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 4.4 mt -124.25 141.5 37.55 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.806 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.538 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 57.5 Cg_endo -73.66 84.91 1.36 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.253 1.968 . . . . 0.0 112.018 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 141.34 -14.04 2.76 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.41 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -179.03 173.68 1.15 Allowed 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 120.767 0.317 . . . . 0.0 110.628 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -139.04 160.76 39.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.075 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -141.5 123.35 15.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.959 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.406 ' HE2' ' CD2' ' A' ' 36' ' ' HIS . 28.4 tttt -110.68 126.17 54.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.819 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 38.5 t -124.05 144.67 33.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.235 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.421 ' HG2' ' CD2' ' A' ' 36' ' ' HIS . 48.0 mt-10 -80.87 135.64 35.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.546 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.9 tt -111.65 131.99 61.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.043 0.449 . . . . 0.0 111.444 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -102.7 168.02 9.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.465 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -68.43 -91.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.611 ' C ' ' H ' ' A' ' 55' ' ' VAL . 5.8 ttt85 69.75 -2.48 1.97 Allowed 'General case' 0 C--O 1.231 0.126 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 178.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 70.29 -32.21 0.23 Allowed 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 -179.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.611 ' H ' ' C ' ' A' ' 53' ' ' ARG . 81.6 t -136.99 143.25 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.822 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.451 ' N ' ' O ' ' A' ' 80' ' ' PHE . 9.2 m -125.49 131.2 52.87 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.458 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 65' ' ' ASP . 0.1 OUTLIER -103.98 137.46 41.93 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.908 0.385 . . . . 0.0 111.087 -179.862 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.424 HD11 ' CD1' ' A' ' 80' ' ' PHE . 3.4 mp -132.1 128.47 59.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.096 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 168.9 -135.27 3.53 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.754 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.438 ' HB3' HG21 ' A' ' 73' ' ' ILE . 14.8 ptt85 -108.11 -29.4 8.97 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.663 0.268 . . . . 0.0 111.022 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.8 t -57.46 121.73 10.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.831 0.348 . . . . 0.0 110.816 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.68 -25.36 39.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.07 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.97 -24.63 63.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.0 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 87.7 m -58.22 166.47 1.62 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.038 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.446 ' N ' ' O ' ' A' ' 57' ' ' THR . 0.5 OUTLIER -71.01 -57.1 4.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.003 0.43 . . . . 0.0 110.832 179.742 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.0 t -125.2 133.3 69.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.67 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.6 pt -101.72 125.32 55.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.722 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.3 mp -93.28 -85.98 0.26 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.944 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.401 ' O ' ' CB ' ' A' ' 70' ' ' GLU . 10.0 t -98.33 -101.93 0.21 Allowed 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.531 ' CB ' ' CD ' ' A' ' 71' ' ' PRO . 0.1 OUTLIER 167.21 -70.2 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.189 0 CA-C-O 120.528 0.204 . . . . 0.0 111.299 179.369 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.531 ' CD ' ' CB ' ' A' ' 70' ' ' GLU . 47.0 Cg_endo -67.86 -38.19 13.95 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.56 2.173 . . . . 0.0 113.579 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -105.71 10.51 32.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.757 0.313 . . . . 0.0 111.226 -179.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.449 ' O ' ' CG2' ' A' ' 73' ' ' ILE . 2.9 tp -105.88 117.29 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-O 121.016 0.436 . . . . 0.0 110.612 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 0.3 OUTLIER -67.22 135.97 54.26 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.16 -179.163 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 64.1 m -49.33 -44.02 44.09 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.826 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.448 ' O ' ' C ' ' A' ' 77' ' ' HIS . 5.7 p90 -106.85 14.1 27.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.22 0.533 . . . . 0.0 111.327 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.448 ' C ' ' O ' ' A' ' 76' ' ' PHE . 3.9 t-160 -20.2 -58.51 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.609 -1.178 . . . . 0.0 112.826 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.431 ' CB ' ' CZ ' ' A' ' 127' ' ' PHE . . . -150.63 157.89 43.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.97 0.414 . . . . 0.0 111.583 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -133.06 133.49 43.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.684 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.451 ' O ' ' N ' ' A' ' 56' ' ' THR . 5.0 m-85 -119.3 131.33 55.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.608 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -94.41 116.43 28.79 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.985 0.421 . . . . 0.0 111.092 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.8 tt -106.49 109.88 21.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.814 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -121.6 137.4 54.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.895 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -108.93 136.91 47.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.856 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -126.88 131.77 51.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.869 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -88.54 120.17 29.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.904 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.5 t -139.96 139.13 37.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.065 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -50.1 132.86 23.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.078 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 35.6 m120 62.47 99.35 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.792 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 63.16 133.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.999 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -82.93 158.71 22.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.897 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.91 111.82 20.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.974 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -113.34 138.92 49.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.837 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.9 mp -130.03 137.17 50.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.995 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.8 mp -119.59 139.02 48.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.078 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -116.88 144.13 44.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.688 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.422 HG23 ' CD2' ' A' ' 80' ' ' PHE . 16.4 t -116.2 132.15 66.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.271 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.432 HG23 HD13 ' A' ' 98' ' ' ILE . 20.5 mm -127.11 131.06 71.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.119 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -90.22 128.35 36.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.861 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.5 mmmt -119.93 -35.36 3.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.278 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.8 m -78.07 -44.84 25.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.117 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.51 21.54 10.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.904 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -85.95 -30.51 22.73 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.855 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 167.36 73.37 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.506 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.423 HG23 ' CE1' ' A' ' 127' ' ' PHE . 62.0 m -104.72 122.76 46.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.888 0.375 . . . . 0.0 110.869 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -121.14 119.29 31.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.874 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.9 tp -118.09 137.29 52.52 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 CA-C-O 121.524 0.678 . . . . 0.0 111.202 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 60.15 27.29 16.75 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.818 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.75 9.86 70.81 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.818 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -134.03 152.02 51.67 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.749 0.309 . . . . 0.0 110.958 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 30.1 mtm180 -65.1 142.97 58.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.902 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.1 pp -99.17 129.57 45.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.898 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.6 m -111.85 -30.79 2.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.189 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 16.9 mtmt -80.64 142.22 34.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.937 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.73 -32.75 53.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.875 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -105.64 75.04 1.11 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.927 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -80.75 139.03 36.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.822 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.6 tp -98.54 119.06 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.37 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.6 tt -103.0 138.51 39.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.982 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.02 178.11 7.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.862 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.438 ' HB2' ' CE2' ' A' ' 137' ' ' TYR . 2.0 t30 -55.31 142.06 33.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.084 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 68.08 48.62 52.47 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.406 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -123.44 124.24 42.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.843 0.354 . . . . 0.0 111.072 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 48.6 ttt-85 -90.22 122.19 32.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.801 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.444 ' CG2' ' CE2' ' A' ' 133' ' ' PHE . 0.5 OUTLIER -120.63 136.41 57.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.933 0.397 . . . . 0.0 111.317 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.4 t -124.09 133.95 67.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.815 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.431 ' CZ ' ' CB ' ' A' ' 78' ' ' ALA . 9.7 m-85 -124.85 138.42 54.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.955 0.407 . . . . 0.0 111.142 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 86.77 -69.83 3.03 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.343 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 176.67 -39.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.729 0.3 . . . . 0.0 111.076 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.38 -40.21 4.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.804 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 33.6 m -53.92 103.95 0.09 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.071 0.462 . . . . 0.0 111.268 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 5.6 p -124.6 129.34 50.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.902 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.457 ' CD1' ' N ' ' A' ' 133' ' ' PHE . 1.3 p90 -142.16 156.08 45.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.058 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.5 tt -115.11 136.16 53.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.83 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -105.67 141.56 36.92 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.95 0.881 . . . . 0.0 111.774 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -154.31 159.67 41.35 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 113.828 -1.533 . . . . 0.0 110.756 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.438 ' CE2' ' HB2' ' A' ' 121' ' ' ASN . 4.5 m-85 -85.29 140.11 31.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.059 0.457 . . . . 0.0 110.618 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.405 ' HB1' ' CE1' ' A' ' 36' ' ' HIS . . . . . . . . 0 C--N 1.323 -0.573 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.191 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.082 0 CA-C-O 120.823 0.344 . . . . 0.0 110.73 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.8 t -59.81 145.07 46.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.117 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.3 tt -152.2 -44.98 0.1 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.945 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -157.72 172.82 35.04 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.445 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.423 ' CE1' ' HB2' ' A' ' 138' ' ' ALA . 32.1 m80 -133.47 161.19 35.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.008 0.432 . . . . 0.0 111.208 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.43 HD11 ' CE1' ' A' ' 133' ' ' PHE . 57.9 mt -127.19 107.92 10.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.596 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.2 t -96.78 121.74 47.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.825 0.345 . . . . 0.0 111.366 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -90.16 119.44 30.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.836 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.5 mt -79.26 106.8 11.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.898 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.4 mt -124.27 139.27 32.45 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.914 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -50.11 91.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.41 2.074 . . . . 0.0 112.286 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 116.03 -105.6 1.42 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.263 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.85 -168.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.791 0.329 . . . . 0.0 111.023 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -155.5 141.7 18.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.985 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -110.46 120.17 41.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.82 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.57 126.14 54.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.993 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.7 t -117.21 143.99 26.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.975 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -93.7 131.16 39.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.925 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 30.5 mm -111.33 122.38 65.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.002 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -102.48 168.2 9.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.899 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 17.2 p30 -93.19 71.38 4.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.704 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.626 ' C ' ' H ' ' A' ' 55' ' ' VAL . 2.6 ptp180 -98.35 15.62 24.09 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.618 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 68.97 -29.26 0.17 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.706 0.289 . . . . 0.0 110.333 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.626 ' H ' ' C ' ' A' ' 53' ' ' ARG . 59.3 t -137.09 134.64 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 CA-C-O 121.193 0.52 . . . . 0.0 111.548 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.463 ' N ' ' O ' ' A' ' 80' ' ' PHE . 39.7 m -125.06 122.53 37.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.756 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.88 133.84 48.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.901 0.382 . . . . 0.0 111.038 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.4 mp -119.11 116.52 51.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.721 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 174.72 -146.09 8.32 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.571 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.507 ' HB3' ' HA ' ' A' ' 70' ' ' GLU . 9.4 ptt180 -100.21 -27.67 13.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.702 0.287 . . . . 0.0 111.102 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.06 121.4 7.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.911 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.7 ptt85 -54.96 -28.78 54.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.067 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.91 -24.99 63.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.836 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 99.8 m -55.36 158.8 3.0 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.001 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -76.3 -52.89 9.05 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.905 0.383 . . . . 0.0 110.943 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.6 t -101.64 129.83 52.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.253 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 14.6 pt -99.82 125.84 53.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.158 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.405 ' O ' ' C ' ' A' ' 69' ' ' SER . 3.3 mp -113.71 -163.69 0.88 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.249 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.596 ' O ' ' CB ' ' A' ' 70' ' ' GLU . 1.2 m -35.56 -58.46 0.59 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.574 0.226 . . . . 0.0 110.975 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.596 ' CB ' ' O ' ' A' ' 69' ' ' SER . 9.0 tm-20 109.84 -61.74 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.529 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.702 178.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.556 ' HD2' ' C ' ' A' ' 69' ' ' SER . 44.0 Cg_endo -67.75 -33.51 27.26 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 121.888 1.726 . . . . 0.0 113.199 -179.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -112.04 21.56 15.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.701 0.286 . . . . 0.0 111.301 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.423 HG23 ' HB3' ' A' ' 60' ' ' ARG . 4.8 tp -117.8 128.85 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-O 120.916 0.388 . . . . 0.0 111.147 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.8 m -63.55 132.78 52.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.057 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.8 m -59.81 -33.48 71.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.897 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.448 ' O ' ' C ' ' A' ' 77' ' ' HIS . 14.9 m-85 -112.1 13.88 20.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.474 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.448 ' C ' ' O ' ' A' ' 76' ' ' PHE . 2.1 t-160 -21.62 -69.49 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.726 -1.125 . . . . 0.0 112.574 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -153.06 159.68 42.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.125 0.488 . . . . 0.0 112.045 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -126.53 134.2 50.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.41 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.463 ' O ' ' N ' ' A' ' 56' ' ' THR . 7.5 m-85 -119.4 131.45 55.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.888 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 9.9 m-70 -94.63 116.37 28.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.917 0.389 . . . . 0.0 111.011 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 12.8 tp -106.47 109.69 21.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.915 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.1 140.08 52.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -116.3 125.13 51.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.864 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 32.6 tpp -138.84 133.39 31.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.912 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -107.04 133.66 51.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.93 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.5 t -135.8 134.19 51.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.002 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.8 t70 75.04 -58.24 0.58 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.021 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -176.31 -39.02 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.894 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -86.63 146.11 26.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.775 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -97.07 137.84 35.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.032 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.2 mtm-85 -114.3 144.8 42.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.873 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -114.08 121.34 43.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.854 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.8 tt -115.72 132.84 56.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.877 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.424 HD13 ' CE1' ' A' ' 135' ' ' PHE . 3.2 mp -122.27 140.99 44.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.146 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -113.94 144.0 43.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.823 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.414 HG13 ' CZ ' ' A' ' 80' ' ' PHE . 22.7 t -109.15 122.91 64.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.193 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 25.1 mt -130.1 122.32 53.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.089 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -107.71 138.6 43.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.863 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.9 mmtp -92.65 -6.02 50.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.414 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.8 m 63.05 44.37 5.92 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.882 0.372 . . . . 0.0 110.877 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -95.32 -45.84 6.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.86 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -123.99 -43.59 2.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.244 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 136.34 110.61 1.04 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.504 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 35.8 m -114.39 123.13 48.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.721 0.296 . . . . 0.0 110.942 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.419 ' CE2' ' HB2' ' A' ' 111' ' ' ARG . 6.2 m-85 -121.04 120.34 35.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.808 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.8 tp -102.75 137.24 31.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.493 0.663 . . . . 0.0 111.263 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 61.65 30.55 18.6 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.79 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.67 11.32 72.84 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.849 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -134.01 150.58 51.24 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.782 0.325 . . . . 0.0 110.877 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.419 ' HB2' ' CE2' ' A' ' 106' ' ' PHE . 57.4 ttt-85 -74.97 137.89 41.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.902 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.58 134.86 40.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.882 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 15.0 p -107.46 -37.27 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.186 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.1 tttp -61.39 151.52 32.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.874 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.14 30.91 3.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.888 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -169.76 60.25 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.783 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -73.25 136.46 44.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.746 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.441 ' C ' ' CD1' ' A' ' 118' ' ' ILE . 0.0 OUTLIER -98.83 116.71 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.817 -179.887 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.8 tt -101.41 145.87 28.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.977 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 8.4 mmmt -133.51 178.06 7.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.807 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.429 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 12.6 p30 -56.19 141.65 40.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.081 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 70.11 46.45 50.93 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.523 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -120.29 120.78 37.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.768 0.318 . . . . 0.0 110.945 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.19 124.47 31.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.811 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.456 ' CG2' ' CE1' ' A' ' 127' ' ' PHE . 1.2 mp -121.49 135.16 62.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.111 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.9 t -115.84 125.42 72.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.069 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.513 ' CE1' ' CZ ' ' A' ' 133' ' ' PHE . 67.4 m-85 -116.51 113.45 22.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.014 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 86.92 -8.63 75.35 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.918 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 6.0 tttm 78.82 28.54 0.41 Allowed 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.869 0.366 . . . . 0.0 110.477 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.37 -47.57 0.34 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.929 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 18.7 m -96.11 109.99 22.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.871 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -122.07 126.63 48.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.946 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.513 ' CZ ' ' CE1' ' A' ' 127' ' ' PHE . 13.5 p90 -139.22 155.93 47.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.886 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.6 tp -105.35 136.21 45.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.97 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.424 ' CE1' HD13 ' A' ' 95' ' ' ILE . 24.7 t80 -96.53 141.54 29.69 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 121.971 0.891 . . . . 0.0 111.604 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 29.3 mttp -154.57 153.11 30.88 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 113.885 -1.507 . . . . 0.0 110.867 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.429 ' CE2' ' HB3' ' A' ' 121' ' ' ASN . 3.7 m-85 -79.26 139.68 37.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.94 0.4 . . . . 0.0 110.696 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.423 ' HB2' ' CE1' ' A' ' 36' ' ' HIS . . . . . . . . 0 C--N 1.324 -0.524 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.173 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.458 -0.07 0 CA-C-O 120.72 0.295 . . . . 0.0 110.573 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 2.0 t -59.95 127.57 32.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.971 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -128.91 -44.1 1.33 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.713 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -157.33 -165.21 14.74 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.43 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 52.9 m80 -146.18 163.9 33.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.87 0.367 . . . . 0.0 111.065 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.7 mp -126.81 119.97 28.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.644 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.4 t -96.12 121.92 47.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.209 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.417 ' HA ' ' CD1' ' A' ' 133' ' ' PHE . 4.3 m-20 -89.39 113.98 25.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.767 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.1 mt -88.59 106.51 18.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.996 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.54 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 1.7 mp -124.5 140.73 35.93 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.509 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.54 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 53.1 Cg_endo -72.24 80.86 1.54 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.003 1.802 . . . . 0.0 112.011 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 145.16 -14.47 1.89 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.686 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.4 tptm -178.34 164.28 1.71 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.806 0.336 . . . . 0.0 110.863 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -125.56 164.99 19.34 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.053 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -150.34 124.92 9.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.911 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.5 mtpt -102.41 134.66 45.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.879 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.7 t -121.71 150.18 24.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.112 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -94.93 132.4 39.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.808 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.0 tt -115.98 132.14 66.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.212 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.98 168.1 10.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.925 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -102.72 74.97 1.38 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.444 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.64 ' C ' ' H ' ' A' ' 55' ' ' VAL . 0.7 OUTLIER -99.04 23.19 9.31 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.526 -179.601 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.54 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 1.6 m-20 67.53 -28.91 0.14 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.487 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.64 ' H ' ' C ' ' A' ' 53' ' ' ARG . 60.2 t -137.76 136.56 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 CA-C-O 120.964 0.412 . . . . 0.0 111.749 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.428 ' HB ' ' HB2' ' A' ' 80' ' ' PHE . 99.5 m -125.51 129.9 50.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.062 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.456 ' O ' ' N ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -104.0 138.82 39.99 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.954 0.407 . . . . 0.0 111.529 -179.448 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.406 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 4.6 mp -132.52 135.19 58.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.093 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 157.12 -137.36 5.36 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.305 -0.95 . . . . 0.0 113.227 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.472 ' HB2' ' CG2' ' A' ' 73' ' ' ILE . 21.3 ttp180 -94.89 -49.24 5.66 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.753 0.311 . . . . 0.0 111.22 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -43.71 117.02 1.06 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.497 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.1 mtt85 -57.37 -23.3 48.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.015 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.78 -24.19 63.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.76 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 96.4 m -57.42 168.25 0.83 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.824 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' A' ' 57' ' ' THR . 0.5 OUTLIER -69.85 -56.62 6.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.952 0.406 . . . . 0.0 110.778 179.827 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 58' ' ' ILE . 21.3 t -125.2 132.95 70.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.594 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 7.9 pt -102.8 128.05 55.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.816 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.19 -71.35 0.6 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.781 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.441 ' HB3' ' HB ' ' A' ' 73' ' ' ILE . 12.8 t -121.3 -111.67 0.33 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.076 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.448 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . 9.7 tt0 170.63 -64.15 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.264 0 O-C-N 122.298 -0.251 . . . . 0.0 111.575 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.448 ' CD ' ' HB3' ' A' ' 70' ' ' GLU . 25.2 Cg_endo -62.0 -40.05 46.05 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.35 2.033 . . . . 0.0 113.28 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -122.49 28.87 7.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.569 0.223 . . . . 0.0 111.503 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.472 ' CG2' ' HB2' ' A' ' 60' ' ' ARG . 4.4 tp -110.8 125.94 68.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.971 0.415 . . . . 0.0 111.116 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -59.48 134.01 56.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.484 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 36.2 m -65.91 -44.21 85.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.856 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.448 ' O ' ' C ' ' A' ' 77' ' ' HIS . 2.1 m-85 -100.27 13.73 33.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.27 0.557 . . . . 0.0 111.153 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.459 ' CE1' ' HB3' ' A' ' 127' ' ' PHE . 0.4 OUTLIER -15.51 -71.39 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.403 -1.271 . . . . 0.0 113.175 -179.338 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.423 ' HB3' ' CE1' ' A' ' 127' ' ' PHE . . . -153.75 164.08 38.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.225 0.536 . . . . 0.0 112.293 -179.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -132.5 132.64 42.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.962 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.428 ' HB2' ' HB ' ' A' ' 56' ' ' THR . 3.9 m-85 -119.39 131.08 55.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.781 0.324 . . . . 0.0 110.96 -179.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.54 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 24.8 m-70 -95.89 116.81 29.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.245 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.2 mp -106.3 109.37 21.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.669 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -122.58 140.19 53.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.032 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -104.21 120.95 42.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.754 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -119.68 142.62 48.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.0 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -107.13 124.89 50.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.902 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 4.0 m -121.88 132.48 70.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.149 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 68.45 -65.58 0.26 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.059 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 179.82 39.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.818 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -145.94 -177.29 5.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.695 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.29 129.12 55.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.999 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.4 mtm180 -116.32 150.21 38.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.85 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -114.03 123.67 50.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.944 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.8 mp -130.05 123.84 31.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.825 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.3 mp -116.25 141.07 35.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.057 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -114.03 144.06 43.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.862 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.419 HG22 ' CE2' ' A' ' 80' ' ' PHE . 18.1 t -115.36 126.09 72.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.23 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.3 mp -127.99 135.57 62.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.071 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -107.55 120.23 41.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.822 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.45 32.38 2.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.006 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 21.8 m -126.85 178.78 5.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.898 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.1 ptp85 -127.55 39.13 3.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.922 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -106.67 -60.62 1.64 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.228 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 145.06 103.36 0.4 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.539 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.464 ' CG2' ' CE1' ' A' ' 127' ' ' PHE . 85.5 m -117.95 124.92 49.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.861 0.362 . . . . 0.0 110.979 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' A' ' 106' ' ' PHE . 5.0 m-85 -121.03 123.71 43.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.829 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.0 tp -109.95 137.29 42.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.464 0.649 . . . . 0.0 111.391 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 60.66 29.59 19.12 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.817 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.63 11.38 72.75 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.834 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -134.02 152.06 51.69 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.759 0.314 . . . . 0.0 110.877 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -63.53 142.96 58.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.964 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -83.95 133.11 34.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.769 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.8 p -120.62 -42.8 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.149 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.92 147.46 47.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.794 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.89 -37.38 48.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.795 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -111.36 77.79 1.07 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.862 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -80.05 135.95 36.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.867 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.7 tp -98.73 122.28 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.289 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.8 tt -103.06 132.78 49.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.879 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.78 178.07 5.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.838 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.418 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 8.2 p30 -60.41 138.55 57.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.07 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 74.76 56.0 5.14 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.595 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -130.96 132.91 45.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.794 0.33 . . . . 0.0 110.981 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.15 132.68 34.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.877 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 21.1 mm -117.64 121.77 68.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.166 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 59.0 t -115.13 128.35 72.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.66 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.464 ' CE1' ' CG2' ' A' ' 105' ' ' THR . 15.1 m-85 -132.08 111.88 11.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.923 0.392 . . . . 0.0 111.659 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' A' ' 129' ' ' LYS . . . 108.91 -81.9 0.29 Allowed Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.206 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 128' ' ' GLY . 14.1 tttp 172.22 37.03 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.887 0.375 . . . . 0.0 110.664 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 24.9 p 178.83 -48.82 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.95 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 77.6 m -56.7 104.7 0.16 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.887 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.3 111.94 16.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.149 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.417 ' CD1' ' HA ' ' A' ' 39' ' ' ASN . 3.0 m-85 -120.45 156.07 32.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.864 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 6.0 tt -111.74 140.1 46.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.944 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -116.33 141.76 47.73 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.885 0.85 . . . . 0.0 111.733 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -154.44 159.74 41.23 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.06 -1.427 . . . . 0.0 111.022 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.418 ' CE2' ' HB3' ' A' ' 121' ' ' ASN . 3.3 m-85 -84.25 140.25 31.8 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.057 0.456 . . . . 0.0 110.741 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.537 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.165 179.968 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.46 0.027 0 CA-C-O 120.801 0.334 . . . . 0.0 110.731 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 2.1 t -67.01 143.89 56.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.942 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.5 tp -156.21 -67.65 0.11 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.902 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -114.13 167.09 12.23 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.446 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.418 ' CD2' ' HG3' ' A' ' 49' ' ' GLU . 33.4 m80 -136.19 160.67 37.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.907 0.384 . . . . 0.0 111.017 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 97.8 mt -127.23 117.96 23.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.709 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.4 t -101.8 121.59 52.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.205 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -90.26 136.97 32.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.891 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.8 mt -108.36 106.56 16.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.974 0.416 . . . . 0.0 110.848 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.541 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 4.1 mt -124.4 141.25 37.09 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.857 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.541 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 56.9 Cg_endo -73.36 81.46 1.77 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.172 1.915 . . . . 0.0 112.041 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 148.93 -18.78 1.23 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.403 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 11.9 ttmm -177.65 165.0 2.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.709 0.29 . . . . 0.0 110.655 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -122.11 149.76 43.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.028 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -121.43 134.05 55.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.74 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.95 124.88 53.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.137 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 31.6 t -120.15 150.52 22.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.998 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.418 ' HG3' ' CD2' ' A' ' 36' ' ' HIS . 0.0 OUTLIER -103.01 142.07 34.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.037 -179.867 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.1 mm -115.38 122.68 69.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.839 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.87 168.16 10.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.144 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -100.11 73.87 1.74 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.593 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.624 ' C ' ' H ' ' A' ' 55' ' ' VAL . 4.0 ptp180 -107.05 22.04 16.61 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.437 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.49 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 30.6 m-80 67.1 -27.9 0.13 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.659 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.624 ' H ' ' C ' ' A' ' 53' ' ' ARG . 61.6 t -137.72 137.67 45.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 CA-C-O 121.006 0.431 . . . . 0.0 111.96 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.504 ' HB ' ' HB2' ' A' ' 80' ' ' PHE . 0.4 OUTLIER -125.36 128.28 47.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.72 178.911 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.464 ' O ' ' N ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -104.06 136.22 44.11 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.976 0.417 . . . . 0.0 111.488 -179.463 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.414 HD11 ' CD2' ' A' ' 80' ' ' PHE . 4.4 mp -132.2 127.17 57.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.974 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 164.08 -142.13 7.59 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.074 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.421 ' N ' HG21 ' A' ' 73' ' ' ILE . 14.3 ttp180 -88.65 -43.19 11.51 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.811 0.339 . . . . 0.0 111.027 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -45.93 115.09 0.89 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.461 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.04 -27.41 61.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.942 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.2 m -70.03 -24.71 63.32 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.814 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.414 ' CB ' ' HB ' ' A' ' 57' ' ' THR . 98.7 m -53.08 167.93 0.15 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.76 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.464 ' N ' ' O ' ' A' ' 57' ' ' THR . 0.6 OUTLIER -69.5 -53.88 16.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.922 0.391 . . . . 0.0 111.038 179.943 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 22.1 t -125.05 125.69 69.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.517 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.3 pt -99.65 131.06 47.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.504 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.4 mp -100.89 -100.33 0.25 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.344 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.2 p -92.14 -103.9 0.11 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 121.224 -0.19 . . . . 0.0 110.724 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.448 ' CB ' ' CD ' ' A' ' 71' ' ' PRO . 3.0 mt-10 167.17 -64.78 0.0 OUTLIER Pre-proline 0 CA--C 1.529 0.136 0 CA-C-O 120.68 0.276 . . . . 0.0 111.145 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.448 ' CD ' ' CB ' ' A' ' 70' ' ' GLU . 28.9 Cg_endo -62.89 -37.49 54.26 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.359 2.039 . . . . 0.0 112.56 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -112.04 17.06 19.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.276 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.421 HG21 ' N ' ' A' ' 60' ' ' ARG . 4.5 tp -108.79 127.48 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 CA-C-O 120.925 0.393 . . . . 0.0 111.093 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.42 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 0.9 OUTLIER -83.79 133.67 34.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.367 -179.578 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 57.3 m -57.94 -30.74 66.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.078 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.414 ' O ' ' C ' ' A' ' 77' ' ' HIS . 39.6 m-85 -110.27 13.97 22.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.237 0.541 . . . . 0.0 111.536 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.429 ' CE1' ' HB3' ' A' ' 127' ' ' PHE . 0.1 OUTLIER -25.94 -64.75 0.06 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.779 -1.1 . . . . 0.0 112.702 -179.277 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.423 ' HB1' ' CE1' ' A' ' 127' ' ' PHE . . . -157.66 163.98 37.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.116 0.484 . . . . 0.0 112.027 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 56' ' ' THR . 0.8 OUTLIER -134.81 141.4 46.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.319 179.405 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.504 ' HB2' ' HB ' ' A' ' 56' ' ' THR . 47.0 m-85 -119.44 131.51 55.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.942 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.49 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 4.1 m-70 -94.63 116.53 28.87 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.832 0.349 . . . . 0.0 110.756 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.28 109.89 21.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.03 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.07 133.86 55.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.705 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -101.69 128.82 47.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.917 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.7 ttt -141.45 111.97 7.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.864 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -79.03 116.02 19.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.953 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.5 t -140.0 114.3 6.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.072 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 60.83 -165.83 0.21 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.79 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -48.92 132.4 18.49 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.281 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 61.11 155.04 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.904 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -85.98 139.78 30.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.953 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 80.1 mtt180 -109.92 122.64 48.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.865 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -113.04 146.73 38.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.84 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.2 mt -128.81 140.04 51.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.927 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.1 mp -120.97 138.48 51.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.06 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -113.94 143.31 44.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.021 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.418 HG13 ' CE1' ' A' ' 80' ' ' PHE . 3.9 t -104.41 135.08 43.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.173 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 22.6 mt -129.86 146.33 34.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.18 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -119.74 123.49 43.88 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.902 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.67 -41.7 1.98 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.119 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.2 m -71.56 157.76 37.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.065 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.43 29.01 8.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.844 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -86.97 -42.2 13.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.227 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 136.48 100.58 0.58 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.671 -0.775 . . . . 0.0 112.595 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 93.7 m -109.4 123.37 49.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.8 0.333 . . . . 0.0 110.735 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.416 ' CE1' ' HB3' ' A' ' 111' ' ' ARG . 47.2 m-85 -120.87 115.06 22.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.932 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.6 tp -118.31 137.26 52.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.428 0.632 . . . . 0.0 111.196 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 61.77 32.2 18.26 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.798 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.76 10.9 72.78 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.859 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -134.05 151.96 51.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.743 0.306 . . . . 0.0 110.851 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.416 ' HB3' ' CE1' ' A' ' 106' ' ' PHE . 6.6 ptm180 -70.95 139.05 50.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.894 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -85.49 129.3 34.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.88 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.2 p -125.58 -44.65 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.11 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -66.23 172.83 3.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.908 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -119.03 31.38 6.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.931 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -162.23 57.86 0.24 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.801 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.98 139.09 38.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.84 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.404 ' O ' ' CG2' ' A' ' 118' ' ' ILE . 7.8 tp -98.59 117.31 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-O 121.004 0.43 . . . . 0.0 111.228 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.425 HD22 ' CD2' ' A' ' 135' ' ' PHE . 7.6 tt -103.07 131.23 50.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.057 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.26 178.03 6.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.781 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.457 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 5.0 p-10 -57.72 141.29 49.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.966 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 74.86 47.66 13.77 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.311 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -123.46 131.34 53.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.795 0.331 . . . . 0.0 111.081 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.74 122.6 41.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.65 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.424 HG22 ' CZ ' ' A' ' 127' ' ' PHE . 1.7 mp -114.97 133.56 60.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.314 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.2 t -124.02 123.81 67.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.968 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.429 ' HB3' ' CE1' ' A' ' 77' ' ' HIS . 23.5 m-85 -116.27 111.92 20.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.85 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . 0.402 ' O ' ' CB ' ' A' ' 129' ' ' LYS . . . 88.61 -15.31 57.45 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.88 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . 0.402 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 10.9 tttt 79.32 30.65 0.3 Allowed 'General case' 0 CA--C 1.522 -0.109 0 CA-C-O 121.002 0.43 . . . . 0.0 110.378 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 15.3 p -128.22 -50.07 1.31 Allowed 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.99 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 7.0 m -109.59 112.58 24.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.977 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -116.8 131.06 57.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.931 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -141.25 156.04 45.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.074 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 7.7 tt -107.74 140.05 41.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.8 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.425 ' CD2' HD22 ' A' ' 119' ' ' LEU . 87.7 t80 -101.57 141.56 34.25 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 122.002 0.906 . . . . 0.0 111.933 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt -154.37 145.87 23.13 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 113.748 -1.569 . . . . 0.0 110.707 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.457 ' CE2' ' HB3' ' A' ' 121' ' ' ASN . 4.4 m-85 -73.62 139.75 45.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.992 0.425 . . . . 0.0 110.736 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.416 ' HB2' ' CE1' ' A' ' 36' ' ' HIS . . . . . . . . 0 C--N 1.325 -0.482 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.045 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.1 m . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.719 0.295 . . . . 0.0 110.725 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 44.9 t -59.92 137.23 58.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.882 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.4 tt -130.21 -44.98 1.13 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.971 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -157.67 -167.89 19.3 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.567 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 54.2 m80 -147.0 164.06 34.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.841 0.353 . . . . 0.0 110.911 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.42 ' HB3' ' CD2' ' A' ' 133' ' ' PHE . 2.4 mp -127.03 108.0 10.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.809 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.5 t -97.96 121.96 49.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.163 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -90.06 117.06 28.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.785 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.4 mt -81.14 106.53 13.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.831 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.53 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 4.8 mt -124.25 140.83 35.85 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.917 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.53 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 58.0 Cg_endo -74.43 81.82 1.99 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.161 1.908 . . . . 0.0 111.867 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 145.02 -14.19 1.92 Allowed Glycine 0 CA--C 1.52 0.382 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.483 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -179.0 173.8 1.14 Allowed 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 120.774 0.321 . . . . 0.0 110.604 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -132.75 156.32 47.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.098 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -135.37 112.17 10.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.804 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.63 132.29 51.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.02 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.1 t -121.09 151.1 24.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.014 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -94.87 131.41 40.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.807 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.6 tt -116.05 124.67 72.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.248 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.93 168.14 9.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.959 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -80.32 66.36 5.8 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.173 0.511 . . . . 0.0 110.313 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.599 ' C ' ' H ' ' A' ' 55' ' ' VAL . 8.8 ttt85 -79.48 1.55 25.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.796 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 72.12 -36.55 0.36 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -178.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.599 ' H ' ' C ' ' A' ' 53' ' ' ARG . 66.5 t -137.36 132.75 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.781 179.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.435 ' HB ' ' HB2' ' A' ' 80' ' ' PHE . 21.7 m -125.22 124.32 41.46 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.917 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.65 132.37 49.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.876 0.369 . . . . 0.0 110.777 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.435 HG21 HD11 ' A' ' 58' ' ' ILE . 34.6 mt -115.19 120.37 64.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.286 -179.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 170.71 -134.09 3.01 Favored Glycine 0 C--N 1.331 0.259 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.235 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.574 ' HB3' ' HA ' ' A' ' 70' ' ' GLU . 0.2 OUTLIER -118.76 -21.96 7.61 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.585 0.231 . . . . 0.0 111.305 179.806 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -52.01 126.48 18.54 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.864 0.364 . . . . 0.0 110.96 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.4 mmm180 -55.05 -26.25 36.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.104 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.0 m -77.3 -22.68 51.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.12 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 98.5 m -54.71 162.26 1.26 Allowed 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.151 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.414 ' HB3' ' CG2' ' A' ' 56' ' ' THR . 12.9 t0 -83.69 -49.0 9.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.128 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 58' ' ' ILE . 26.7 t -123.77 116.85 49.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.371 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 16.5 pt -100.76 127.8 53.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.975 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.417 HD12 ' CE1' ' A' ' 133' ' ' PHE . 3.8 mm? -98.18 -92.21 0.25 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.697 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.411 ' O ' ' CB ' ' A' ' 70' ' ' GLU . 48.0 m -87.58 -108.01 0.07 Allowed 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.574 ' HA ' ' HB3' ' A' ' 60' ' ' ARG . 1.0 OUTLIER 167.48 -64.51 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.275 0 N-CA-C 111.644 0.238 . . . . 0.0 111.644 178.871 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.573 ' HD3' ' HB3' ' A' ' 70' ' ' GLU . 15.9 Cg_exo -67.61 -40.28 10.47 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.123 1.882 . . . . 0.0 112.998 -179.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -109.22 21.29 17.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.303 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.476 ' CG2' ' HB3' ' A' ' 60' ' ' ARG . 4.8 tp -112.26 120.62 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-O 120.905 0.384 . . . . 0.0 110.817 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.426 ' HB2' ' CG ' ' A' ' 77' ' ' HIS . 0.5 OUTLIER -57.92 131.48 50.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.075 -179.527 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.5 m -59.12 -44.01 91.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.688 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.473 ' O ' ' C ' ' A' ' 77' ' ' HIS . 1.6 m-85 -105.62 13.75 29.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.184 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.473 ' C ' ' O ' ' A' ' 76' ' ' PHE . 0.2 OUTLIER -15.0 -70.18 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.618 -1.174 . . . . 0.0 112.763 -179.479 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -151.21 153.3 34.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.065 0.459 . . . . 0.0 111.937 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -117.21 133.8 55.56 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.255 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.435 ' HB2' ' HB ' ' A' ' 56' ' ' THR . 8.2 m-85 -119.45 131.11 55.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.142 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.418 ' CD2' HD13 ' A' ' 98' ' ' ILE . 17.7 m-70 -94.88 116.67 29.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.857 0.361 . . . . 0.0 111.107 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.34 109.62 21.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.69 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.6 tt -122.19 139.38 53.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.125 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -129.1 131.89 47.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.724 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.15 148.48 40.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.078 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -107.09 125.76 51.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.779 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.5 t -139.96 126.33 22.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.158 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 58.82 42.21 20.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.987 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 62.04 29.11 17.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.949 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -139.45 130.91 27.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.814 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 20.8 mm100 -85.58 132.26 34.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.971 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -111.7 124.65 52.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.794 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -103.81 122.56 45.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.021 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.8 mt -132.08 122.96 26.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.727 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.2 mm -113.16 137.25 46.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.02 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.01 135.35 54.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.821 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.414 HG11 ' CZ ' ' A' ' 80' ' ' PHE . 18.7 t -112.82 128.55 69.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.195 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.418 HD13 ' CD2' ' A' ' 81' ' ' HIS . 7.5 mt -129.64 120.97 51.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.004 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -102.32 134.01 46.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.937 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.6 pttp -149.73 32.17 0.7 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.835 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.8 m -119.94 -178.0 3.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.01 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.35 38.1 2.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.876 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -105.53 -38.32 6.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.278 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 131.95 98.5 0.73 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.521 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.418 HG23 ' CE1' ' A' ' 127' ' ' PHE . 71.0 m -117.54 124.13 47.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.846 0.355 . . . . 0.0 110.835 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -120.98 121.79 38.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.956 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.2 tp -120.57 137.1 55.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.414 0.626 . . . . 0.0 111.282 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 9.9 m120 56.56 31.45 19.08 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.892 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.69 13.05 74.73 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.875 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 24.7 p30 -134.08 150.34 51.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.785 0.326 . . . . 0.0 110.912 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 3.7 ttm180 -62.83 141.82 58.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.983 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.1 tt -100.06 125.7 46.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.831 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.0 p -149.94 49.62 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.128 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.46 -177.47 3.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.827 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.3 mtpt -111.56 -33.75 6.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.908 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -137.59 76.8 1.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.97 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -84.0 136.38 34.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.768 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.407 ' O ' ' CG2' ' A' ' 118' ' ' ILE . 8.8 tp -98.64 118.95 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.261 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.4 tt -103.09 145.59 29.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.928 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 13.6 mttt -132.1 178.06 7.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.84 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.411 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 15.5 p30 -58.25 138.81 56.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.0 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 78.13 58.04 3.28 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.523 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -134.22 126.57 30.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.798 0.332 . . . . 0.0 110.889 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 7.9 ttm180 -93.3 127.64 38.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.846 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.418 HG23 ' CE2' ' A' ' 127' ' ' PHE . 1.7 mp -121.67 134.23 65.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.188 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.7 t -124.12 123.92 67.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.946 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.429 ' HB3' ' CE1' ' A' ' 77' ' ' HIS . 79.7 m-85 -113.98 111.89 22.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.002 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 84.04 -10.27 61.05 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.846 -0.692 . . . . 0.0 113.057 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 77.28 30.02 0.54 Allowed 'General case' 0 CA--C 1.522 -0.133 0 CA-C-O 120.985 0.421 . . . . 0.0 110.273 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 26.9 p -125.84 -44.06 1.81 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.99 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 1.8 m -118.6 116.92 27.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.032 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 77.2 p -124.06 130.66 52.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.795 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.42 ' CD2' ' HB3' ' A' ' 37' ' ' LEU . 8.8 p90 -141.98 156.01 45.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.023 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.2 tp -105.79 130.88 53.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.785 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -94.31 141.44 28.57 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.886 0.85 . . . . 0.0 111.729 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.3 tttp -154.7 149.85 26.99 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 113.938 -1.483 . . . . 0.0 111.041 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.411 ' CE2' ' HB3' ' A' ' 121' ' ' ASN . 5.6 m-85 -76.25 140.09 41.43 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.987 0.422 . . . . 0.0 110.645 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.519 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.043 -179.869 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.833 0.349 . . . . 0.0 110.435 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 51.3 t -59.83 145.19 46.41 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.367 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.6 tp -150.72 -44.22 0.12 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.665 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -153.03 -175.57 24.61 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.041 -0.599 . . . . 0.0 112.127 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.415 ' CE1' ' HG3' ' A' ' 49' ' ' GLU . 40.4 m80 -147.01 166.06 27.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.012 0.434 . . . . 0.0 111.221 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.7 mp -127.07 136.01 51.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.59 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.7 t -101.66 123.61 54.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.125 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -90.15 120.91 31.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.779 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.3 mt -97.86 107.73 20.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.965 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.415 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 3.3 mp -116.82 138.77 24.93 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.757 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.415 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 91.5 Cg_exo -44.42 -27.67 2.21 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.623 2.215 . . . . 0.0 112.708 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -149.22 45.32 0.7 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.601 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 20.8 tptt -179.86 164.15 1.17 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.792 0.329 . . . . 0.0 111.01 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -146.92 134.39 20.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.634 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -129.62 145.51 51.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.157 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.0 133.24 55.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.739 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.1 t -121.97 149.25 25.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.941 0.4 . . . . 0.0 111.237 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.415 ' HG3' ' CE1' ' A' ' 36' ' ' HIS . 48.6 tt0 -107.97 128.53 54.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.655 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.2 tt -105.92 132.03 53.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.264 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -98.55 168.42 10.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.044 -179.707 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -86.09 62.94 7.75 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.198 0.523 . . . . 0.0 110.17 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.611 ' C ' ' H ' ' A' ' 55' ' ' VAL . 23.5 ttt-85 -82.83 1.78 37.44 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.005 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 71.93 -33.62 0.27 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -178.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.611 ' H ' ' C ' ' A' ' 53' ' ' ARG . 74.0 t -136.79 141.33 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.428 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.44 ' N ' ' O ' ' A' ' 80' ' ' PHE . 51.0 m -125.18 126.79 45.79 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.336 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.79 139.1 39.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.823 0.344 . . . . 0.0 110.517 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.5 mp -130.8 132.66 63.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.063 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 164.89 -151.9 21.16 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.472 -0.871 . . . . 0.0 113.09 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.427 ' HB2' ' CG2' ' A' ' 73' ' ' ILE . 14.7 ttp180 -86.2 -45.43 11.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.76 0.314 . . . . 0.0 111.25 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 11.5 p -52.05 128.72 25.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.358 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.98 -16.49 61.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.141 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.72 -26.62 64.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.817 0.342 . . . . 0.0 110.708 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 83.1 m -59.85 156.32 14.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.627 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -62.07 -46.3 89.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.913 0.387 . . . . 0.0 110.495 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.9 t -125.18 132.98 70.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.316 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.4 mt -104.35 115.2 45.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.025 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.427 HD13 ' CD2' ' A' ' 127' ' ' PHE . 14.5 mt -87.22 -134.92 0.08 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.517 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.444 ' O ' ' CB ' ' A' ' 70' ' ' GLU . 17.4 m -57.04 -105.99 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 O-C-N 122.404 -0.185 . . . . 0.0 110.941 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.444 ' CB ' ' O ' ' A' ' 69' ' ' SER . 2.9 mt-10 163.72 -62.64 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.264 0 CA-C-O 120.597 0.236 . . . . 0.0 111.398 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.429 ' CD ' ' CB ' ' A' ' 70' ' ' GLU . 19.7 Cg_endo -58.93 -39.98 75.96 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.661 2.24 . . . . 0.0 113.009 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -118.55 27.12 9.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.682 0.277 . . . . 0.0 111.538 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.427 ' CG2' ' HB2' ' A' ' 60' ' ' ARG . 4.8 tp -109.7 127.65 66.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.96 0.409 . . . . 0.0 111.606 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.17 134.17 45.55 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.045 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 87.6 m -50.73 -44.06 58.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.271 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.494 ' O ' ' C ' ' A' ' 77' ' ' HIS . 12.1 p90 -106.69 13.86 27.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.081 0.467 . . . . 0.0 111.677 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.494 ' C ' ' O ' ' A' ' 76' ' ' PHE . 4.2 t60 -6.38 -69.09 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.671 -1.15 . . . . 0.0 112.979 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -152.81 164.05 38.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.951 0.405 . . . . 0.0 111.632 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -130.09 128.97 42.95 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.864 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.44 ' O ' ' N ' ' A' ' 56' ' ' THR . 5.6 m-85 -119.44 131.15 55.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.719 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -94.72 116.34 28.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.964 0.412 . . . . 0.0 111.266 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 22.3 tp -106.74 109.73 21.71 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.849 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.22 140.09 53.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.012 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.4 tm0? -106.03 137.18 44.39 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.759 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 7.6 mtt -107.03 136.76 46.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.841 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -97.87 116.48 30.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.035 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 17.5 t -139.97 139.15 37.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.943 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -48.36 -51.61 25.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.188 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -53.66 -65.74 0.51 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.163 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -162.67 163.11 27.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.826 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.0 128.0 34.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.913 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.3 mmm180 -108.1 129.69 55.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.82 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -114.07 120.0 39.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.01 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.2 mt -115.55 130.1 56.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.752 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.422 HD13 ' CE1' ' A' ' 135' ' ' PHE . 3.7 mp -114.66 136.04 52.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.275 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -114.28 138.76 50.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.731 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.428 ' CG1' ' CZ ' ' A' ' 80' ' ' PHE . 17.4 t -101.02 134.95 39.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.274 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 32.4 mt -129.3 134.96 62.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.071 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -105.55 118.86 37.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.849 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.3 mtpp -133.17 31.11 3.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.922 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.2 m -144.03 174.67 10.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.881 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.94 30.44 4.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.894 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -85.32 -34.46 21.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.142 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 120.94 88.79 1.04 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.527 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 75.6 m -107.12 126.98 53.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.903 0.382 . . . . 0.0 110.946 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -120.93 117.85 28.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.904 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.6 tp -113.01 137.23 46.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.449 0.643 . . . . 0.0 111.297 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 62.94 27.69 16.05 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.933 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.74 12.77 74.66 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.811 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -134.02 152.05 51.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.82 0.343 . . . . 0.0 110.903 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.0 ttp180 -73.61 129.79 38.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.85 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.6 pp -88.52 144.82 26.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.993 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 14.2 m -143.46 32.21 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.112 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -147.43 149.39 32.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.881 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.6 mtmm -98.63 34.84 1.94 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.942 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -152.76 50.27 0.74 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.972 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -83.89 136.63 34.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.843 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.9 tp -98.56 117.27 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-O 120.983 0.42 . . . . 0.0 111.216 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 10.0 tt -103.16 135.52 44.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.024 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 35.7 mttt -131.99 178.03 7.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.765 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.432 ' HB3' ' CD2' ' A' ' 137' ' ' TYR . 9.9 p-10 -62.15 142.86 57.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.871 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 72.67 42.41 47.15 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.5 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -118.08 127.3 53.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.8 0.333 . . . . 0.0 110.932 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.57 118.5 23.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.837 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.9 mt -114.93 122.68 69.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.206 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 24.7 t -118.48 128.22 75.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.96 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.427 ' CD2' HD13 ' A' ' 68' ' ' LEU . 49.1 m-85 -111.4 137.16 49.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.963 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 74.48 -65.85 2.03 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.351 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 174.94 -50.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.812 0.339 . . . . 0.0 110.95 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.2 p -91.33 -42.74 10.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.253 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . 0.403 ' HB3' ' CZ ' ' A' ' 133' ' ' PHE . 25.9 m -54.93 108.17 0.37 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.121 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 41.5 t -123.76 129.97 51.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.856 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.408 ' CZ ' HD23 ' A' ' 68' ' ' LEU . 1.5 m-85 -141.98 154.24 44.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.797 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.02 139.82 51.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.937 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.422 ' CE1' HD13 ' A' ' 95' ' ' ILE . 28.3 t80 -112.37 141.48 46.05 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.964 0.887 . . . . 0.0 111.859 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.65 159.02 40.53 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 113.853 -1.522 . . . . 0.0 110.761 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.432 ' CD2' ' HB3' ' A' ' 121' ' ' ASN . 3.6 m-85 -86.05 139.72 30.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.933 0.397 . . . . 0.0 110.763 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.504 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.083 -179.875 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.409 ' N ' HG22 ' A' ' 51' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.456 -0.13 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.8 t -59.71 144.89 46.87 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.101 0.477 . . . . 0.0 111.341 -179.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -151.52 -45.04 0.11 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.338 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -147.36 157.61 27.45 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.926 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.429 ' CE1' ' HB3' ' A' ' 138' ' ' ALA . 51.8 m80 -119.83 160.4 22.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.99 0.424 . . . . 0.0 111.295 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 59.2 mt -127.09 112.77 15.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.607 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.2 t -99.71 121.74 50.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.133 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -90.19 114.87 26.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.763 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 32.0 mt -88.21 106.85 18.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.84 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.4 mt -124.11 139.27 32.29 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.08 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.34 92.86 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.377 2.051 . . . . 0.0 112.251 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.71 34.21 10.42 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.364 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -179.94 150.55 0.39 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.806 0.336 . . . . 0.0 110.859 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -151.22 152.0 32.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.991 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -143.6 126.22 15.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.739 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.0 ttpt -104.65 126.07 51.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.929 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.0 t -111.6 150.8 13.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.104 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.409 ' HG3' ' CD2' ' A' ' 36' ' ' HIS . 0.4 OUTLIER -100.46 119.95 39.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.97 -179.891 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 31.0 mm -96.12 132.09 41.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.07 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.409 HG22 ' N ' ' A' ' 32' ' ' THR . 1.1 p -110.0 168.51 9.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.788 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -81.32 60.43 4.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.149 0.5 . . . . 0.0 110.291 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.612 ' C ' ' H ' ' A' ' 55' ' ' VAL . 20.0 ttt-85 -82.86 1.38 39.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.757 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.401 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 11.9 m-20 71.54 -33.28 0.27 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -178.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.612 ' H ' ' C ' ' A' ' 53' ' ' ARG . 78.8 t -137.19 140.75 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.58 179.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.461 ' N ' ' O ' ' A' ' 80' ' ' PHE . 30.5 m -125.29 128.33 48.08 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.054 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.405 ' HB ' ' HA ' ' A' ' 64' ' ' CYS . 0.0 OUTLIER -103.91 130.69 51.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.809 0.338 . . . . 0.0 110.768 -179.986 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.7 mp -124.06 120.94 60.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.09 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 171.35 -143.11 7.41 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.735 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.414 ' HB2' ' CG2' ' A' ' 73' ' ' ILE . 11.8 ttp180 -95.18 -32.34 13.1 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.803 0.335 . . . . 0.0 111.093 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -48.79 133.91 16.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.331 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 48.6 mtp85 -67.12 -31.14 71.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.741 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -70.98 -22.83 62.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.039 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.405 ' HA ' ' HB ' ' A' ' 57' ' ' THR . 66.9 m -52.1 146.62 8.57 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.88 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.401 ' HB3' ' CG2' ' A' ' 56' ' ' THR . 63.6 t0 -61.07 -43.82 98.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.876 0.37 . . . . 0.0 110.727 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 23.0 t -125.17 132.95 70.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.357 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 6.7 pt -109.86 127.16 66.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.856 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.0 mt -103.67 -132.76 0.3 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.881 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.405 ' O ' ' CB ' ' A' ' 70' ' ' GLU . 29.4 t -57.67 -105.67 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 O-C-N 122.336 -0.227 . . . . 0.0 111.002 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.448 ' CB ' ' CD ' ' A' ' 71' ' ' PRO . 2.7 mt-10 167.02 -64.37 0.0 OUTLIER Pre-proline 0 N--CA 1.463 0.207 0 CA-C-O 120.605 0.24 . . . . 0.0 111.213 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.448 ' CD ' ' CB ' ' A' ' 70' ' ' GLU . 21.5 Cg_endo -61.04 -40.08 54.78 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.6 2.2 . . . . 0.0 112.673 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -110.34 20.81 17.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.307 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.414 ' CG2' ' HB2' ' A' ' 60' ' ' ARG . 4.7 tp -109.39 121.8 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-O 121.114 0.483 . . . . 0.0 111.098 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 45.1 t -83.4 136.23 34.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.357 -179.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 63.6 m -61.24 -30.01 70.18 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.988 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.406 ' O ' ' C ' ' A' ' 77' ' ' HIS . 12.2 m-85 -103.92 14.23 31.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.731 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.41 ' HB2' ' O ' ' A' ' 74' ' ' SER . 0.1 OUTLIER -29.81 -72.95 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.348 -179.232 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.424 ' HB3' ' CE2' ' A' ' 127' ' ' PHE . . . -156.48 164.1 38.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.979 0.419 . . . . 0.0 111.821 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.23 136.05 49.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.651 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.461 ' O ' ' N ' ' A' ' 56' ' ' THR . 9.3 m-85 -119.3 127.88 53.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.64 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.401 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 9.0 m-70 -94.88 116.41 28.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.975 0.416 . . . . 0.0 111.53 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.68 109.74 21.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.551 179.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.18 140.08 53.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.207 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -102.4 122.38 44.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.67 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.31 113.43 20.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.15 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -107.09 121.54 44.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.816 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 11.4 p -139.98 120.1 13.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.26 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 57.99 65.53 1.28 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.001 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.8 t30 66.66 -73.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.998 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -60.47 122.63 15.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.864 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -111.17 129.14 56.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.919 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -106.64 135.52 48.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.942 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -99.97 131.29 46.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.903 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -121.93 128.42 51.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.814 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.5 mp -112.97 141.13 29.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.076 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -113.99 143.93 43.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.769 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.443 ' CG2' ' CE2' ' A' ' 80' ' ' PHE . 12.0 t -107.01 126.67 63.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.153 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.9 mp -128.23 120.97 54.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.02 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -114.17 138.75 50.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.941 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.21 -11.05 19.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.208 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.0 m 65.67 102.39 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.825 0.345 . . . . 0.0 110.913 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 12.6 mmp_? -128.1 -69.04 0.74 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.865 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 35.7 p-10 -110.97 -32.65 6.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.868 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 147.42 100.94 0.26 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.466 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -119.83 123.92 44.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.769 0.319 . . . . 0.0 110.93 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . 0.414 ' CE2' ' HG3' ' A' ' 111' ' ' ARG . 4.7 m-85 -121.15 138.12 54.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.849 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.4 tp -121.68 137.3 55.77 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-O 121.59 0.71 . . . . 0.0 111.367 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 60.05 30.41 19.9 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.69 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.8 13.03 75.1 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.782 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -129.53 152.05 49.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.946 0.403 . . . . 0.0 111.048 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . 0.414 ' HG3' ' CE2' ' A' ' 106' ' ' PHE . 30.5 ttt180 -75.02 143.46 43.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.939 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -69.71 138.25 52.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.024 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.8 m -134.39 -46.14 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.05 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -88.34 162.98 16.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.925 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.16 31.93 5.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.912 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -161.81 65.66 0.25 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.904 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -84.1 139.11 32.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.8 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.4 tp -98.58 121.42 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.221 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.4 tp -103.14 132.75 49.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.902 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -126.38 178.03 6.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.79 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.44 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 7.1 p30 -63.05 143.13 58.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.9 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 69.37 50.36 33.03 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.535 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -117.73 142.24 47.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.767 0.318 . . . . 0.0 111.025 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 61.9 mtt85 -100.94 127.14 47.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.83 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.409 ' HB ' ' CE2' ' A' ' 133' ' ' PHE . 1.6 mp -123.37 136.91 58.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.185 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 38.1 t -124.01 124.05 68.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.92 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.424 ' CE2' ' HB3' ' A' ' 78' ' ' ALA . 3.3 m-85 -111.8 133.03 54.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.09 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 82.36 -67.55 3.68 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.419 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.35 -41.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.772 0.32 . . . . 0.0 111.118 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.81 -41.98 4.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.701 -179.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 29.1 m -51.98 105.65 0.12 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.934 0.397 . . . . 0.0 111.231 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 32.4 p -124.36 134.72 53.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.909 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.409 ' CE2' ' HB ' ' A' ' 125' ' ' ILE . 6.8 p90 -141.97 155.03 45.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.01 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.3 tp -112.64 138.38 49.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.777 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -108.15 141.48 39.81 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 122.005 0.907 . . . . 0.0 111.802 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 9.2 ptpt -154.59 154.13 32.53 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 113.883 -1.508 . . . . 0.0 110.873 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.44 ' CE2' ' HB3' ' A' ' 121' ' ' ASN . 0.8 OUTLIER -86.0 139.6 31.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.913 0.387 . . . . 0.0 110.734 179.643 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . 0.429 ' HB3' ' CE1' ' A' ' 36' ' ' HIS . . . . . . . . 0 C--N 1.325 -0.484 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.121 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' THR . . . . . 0.401 ' N ' HG21 ' A' ' 51' ' ' THR . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.778 0.323 . . . . 0.0 110.613 . . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 49.7 t -59.88 145.02 47.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.094 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.4 tt -150.96 -46.68 0.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.844 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -151.16 -176.95 24.52 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.473 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 40.9 m80 -147.08 157.89 43.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.872 0.368 . . . . 0.0 111.041 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.02 129.42 48.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.716 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.3 t -109.03 122.0 63.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.224 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -90.01 119.89 30.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.805 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 66.3 mt -75.68 108.69 8.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.887 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 14.4 mt -122.24 138.52 29.13 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -46.94 -27.95 6.49 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.568 2.178 . . . . 0.0 112.529 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -114.15 -125.55 4.18 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.413 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -53.89 138.31 36.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.795 0.331 . . . . 0.0 111.129 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -82.12 150.52 27.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.833 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -117.01 110.51 18.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.025 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -113.04 121.0 43.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.842 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.8 t -124.53 151.06 29.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.153 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -100.26 142.15 32.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.786 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 6.1 tt -116.03 132.21 66.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.373 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.401 HG21 ' N ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -97.59 168.08 10.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.819 -179.848 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -85.01 62.71 7.68 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.134 0.492 . . . . 0.0 110.238 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.597 ' C ' ' H ' ' A' ' 55' ' ' VAL . 22.3 ttt-85 -81.24 2.75 26.55 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.051 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 72.06 -35.24 0.32 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 -178.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.597 ' H ' ' C ' ' A' ' 53' ' ' ARG . 73.5 t -137.18 138.43 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.424 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.467 ' N ' ' O ' ' A' ' 80' ' ' PHE . 96.9 m -125.2 129.66 50.54 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.587 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.418 ' O ' ' N ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -103.98 140.72 37.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.897 0.379 . . . . 0.0 110.954 -179.825 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.404 HD12 ' CE2' ' A' ' 127' ' ' PHE . 9.6 mt -132.05 123.41 50.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.964 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 171.78 -148.46 10.96 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.717 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.431 ' HB2' ' CG2' ' A' ' 73' ' ' ILE . 9.4 tpt85 -93.55 -33.11 13.88 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.754 0.311 . . . . 0.0 111.083 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.5 t -53.61 139.98 30.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.133 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.17 -25.41 61.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.119 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 63.6 p -69.81 -24.69 63.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.99 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 93.3 m -59.1 163.94 3.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.873 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' A' ' 57' ' ' THR . 0.9 OUTLIER -72.16 -59.18 2.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.033 0.444 . . . . 0.0 110.692 179.807 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.8 t -109.64 122.01 63.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.111 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.1 pt -98.4 105.11 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.917 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -64.94 -25.92 68.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.92 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 49.1 m 62.63 26.68 15.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.98 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.412 ' CB ' ' HB ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -85.37 148.52 49.91 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.707 179.837 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.04 -14.05 42.12 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.678 2.252 . . . . 0.0 113.061 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -135.17 23.27 3.51 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.431 ' CG2' ' HB2' ' A' ' 60' ' ' ARG . 5.2 tp -77.33 120.37 27.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.979 0.418 . . . . 0.0 110.996 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 47.0 t -62.39 133.99 55.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.311 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 94.3 m -57.94 -31.76 67.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.733 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.465 ' O ' ' C ' ' A' ' 77' ' ' HIS . 13.5 m-85 -110.36 13.9 22.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.48 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.465 ' C ' ' O ' ' A' ' 76' ' ' PHE . 1.9 t60 -18.93 -67.69 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.708 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -156.34 162.29 40.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.0 0.428 . . . . 0.0 111.982 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -128.55 132.56 48.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.385 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.467 ' O ' ' N ' ' A' ' 56' ' ' THR . 6.0 m-85 -119.28 129.39 54.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.838 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -94.88 116.19 28.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.855 0.36 . . . . 0.0 111.348 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 7.1 tt -106.85 109.88 21.9 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.714 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.28 139.93 52.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.933 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -107.31 133.29 52.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.871 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -140.18 140.7 35.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.881 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -97.33 119.68 36.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.897 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.4 t -135.74 114.53 15.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.205 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 59.59 78.1 0.28 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.944 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 64.08 -79.25 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.03 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -69.59 159.53 33.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.914 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -111.91 140.63 46.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.921 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -104.05 148.42 26.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.824 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.42 ' HB2' ' CD1' ' A' ' 137' ' ' TYR . 14.3 m120 -114.01 120.03 39.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.99 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -105.37 127.52 53.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.766 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 26.7 mm -113.1 141.12 29.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.182 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -115.83 144.09 44.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.672 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.418 HG23 ' CE2' ' A' ' 80' ' ' PHE . 22.0 t -112.32 134.3 55.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.228 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 27.7 mt -130.01 129.87 65.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.1 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -98.22 125.04 43.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.866 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 26.9 mmtp -147.42 31.37 0.9 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.893 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.1 m -105.42 171.68 7.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.878 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 21.1 mtt85 -110.36 -31.53 7.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.884 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -69.07 -73.31 0.15 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.235 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 176.36 135.41 2.14 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.672 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 88.2 m -131.82 122.96 26.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.773 0.321 . . . . 0.0 110.536 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -120.37 130.91 54.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.042 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.2 tp -123.02 137.35 56.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.49 0.662 . . . . 0.0 111.216 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 62.75 28.8 16.65 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.823 -1.08 . . . . 0.0 110.776 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.81 6.0 62.38 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.925 -0.655 . . . . 0.0 113.073 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -134.21 144.26 48.34 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.788 0.328 . . . . 0.0 110.825 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.3 ttm180 -70.32 128.94 37.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.818 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.26 139.2 41.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.98 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 30.6 m -111.78 -34.85 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.028 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -105.99 166.0 10.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.84 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.43 171.47 8.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.939 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.9 t70 62.65 56.23 2.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.023 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -79.0 137.58 37.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.745 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.5 tp -98.65 119.62 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-O 121.013 0.435 . . . . 0.0 111.418 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.9 tt -103.19 132.62 49.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.849 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 29.5 mttt -114.63 178.09 4.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.443 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 5.6 p-10 -56.23 136.69 52.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.019 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 69.47 51.36 26.72 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.3 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -111.64 129.55 56.05 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.789 0.328 . . . . 0.0 111.028 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 11.7 ttm-85 -88.23 123.96 33.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.829 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.428 ' HB ' ' CZ ' ' A' ' 133' ' ' PHE . 2.1 mp -123.07 130.43 74.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.159 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 43.7 t -124.03 134.09 67.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.179 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.404 ' CE2' HD12 ' A' ' 58' ' ' ILE . 8.6 m-85 -115.78 139.32 50.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.92 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 71.29 -64.63 1.01 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.477 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 15.0 mttt 170.34 -37.24 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.755 0.312 . . . . 0.0 111.011 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 23.8 p -99.89 -43.55 6.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.406 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 76.5 m -53.17 104.47 0.1 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.936 0.398 . . . . 0.0 111.311 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.56 127.71 47.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.963 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.428 ' CZ ' ' HB ' ' A' ' 125' ' ' ILE . 4.0 p90 -142.14 156.26 45.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.966 0.412 . . . . 0.0 111.283 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -116.33 120.3 38.44 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.625 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -97.93 141.66 30.63 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.978 0.894 . . . . 0.0 111.976 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.35 147.09 24.27 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 113.807 -1.542 . . . . 0.0 110.828 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.443 ' CE2' ' HB3' ' A' ' 121' ' ' ASN . 10.1 m-85 -76.56 140.01 40.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.037 0.446 . . . . 0.0 110.812 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.542 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.14 -179.992 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.457 -0.093 0 CA-C-O 120.721 0.296 . . . . 0.0 110.776 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 52.4 t -61.82 137.5 58.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.855 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.3 tt -142.93 -50.44 0.35 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.969 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -140.3 -177.35 15.87 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.544 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 47.5 m80 -144.69 161.02 40.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.899 0.38 . . . . 0.0 110.987 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.422 HD23 ' CD1' ' A' ' 133' ' ' PHE . 4.0 mt -121.94 121.02 36.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.637 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.3 t -96.04 121.89 47.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.345 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.16 131.79 35.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.425 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.9 mp -113.38 106.83 15.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.935 0.398 . . . . 0.0 111.21 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.402 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 22.0 mt -124.15 138.33 30.59 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.887 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.402 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 83.0 Cg_exo -45.38 -28.8 4.17 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.478 2.119 . . . . 0.0 112.639 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -85.02 -30.12 26.67 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.406 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 174.88 -169.54 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.879 0.371 . . . . 0.0 110.969 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -129.37 -178.53 4.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.946 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -162.52 151.09 14.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.975 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.7 tttt -113.01 131.53 55.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.008 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.1 t -119.1 147.48 22.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.135 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -100.16 128.54 46.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.859 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.427 ' O ' HG21 ' A' ' 50' ' ' ILE . 15.3 tt -115.93 132.3 65.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.247 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.99 168.11 10.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.884 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -102.33 75.56 1.49 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.43 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.644 ' C ' ' H ' ' A' ' 55' ' ' VAL . 1.6 ptp85 -101.05 23.59 10.56 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.39 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 68.59 -28.31 0.15 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.717 0.294 . . . . 0.0 110.216 -179.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.644 ' H ' ' C ' ' A' ' 53' ' ' ARG . 65.3 t -137.27 139.73 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 CA-C-O 121.087 0.47 . . . . 0.0 111.352 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.446 ' N ' ' O ' ' A' ' 80' ' ' PHE . 38.5 m -125.28 125.47 43.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.046 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.88 137.24 42.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.801 0.334 . . . . 0.0 110.806 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.2 mp -128.53 121.28 54.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.98 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 172.68 -151.8 15.03 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.656 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.42 ' HB2' ' CG2' ' A' ' 73' ' ' ILE . 6.3 ttp180 -87.67 -31.26 19.84 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.775 0.321 . . . . 0.0 110.974 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.53 127.54 30.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.226 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.81 -25.53 68.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.915 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 91.0 p -69.87 -25.48 63.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.927 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 88.8 m -56.11 153.49 9.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.87 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -62.7 -45.93 90.49 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.988 0.423 . . . . 0.0 110.664 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.5 t -120.31 129.16 75.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.947 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 31.2 mt -102.6 104.87 17.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.241 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.413 ' O ' ' O ' ' A' ' 69' ' ' SER . 1.3 tp -77.67 -154.58 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.132 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.471 ' O ' ' CB ' ' A' ' 70' ' ' GLU . 26.9 m -44.14 -97.79 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 111.262 0.097 . . . . 0.0 111.262 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.471 ' CB ' ' O ' ' A' ' 69' ' ' SER . 2.5 mt-10 158.81 -65.12 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.446 0 CA-C-O 120.704 0.287 . . . . 0.0 111.427 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.462 ' CD ' ' CB ' ' A' ' 70' ' ' GLU . 12.0 Cg_endo -55.93 -40.05 87.44 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.705 2.27 . . . . 0.0 113.146 -178.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -117.97 28.4 8.42 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.663 0.245 . . . . 0.0 111.663 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.42 ' CG2' ' HB2' ' A' ' 60' ' ' ARG . 4.9 tp -112.64 125.37 69.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.046 0.45 . . . . 0.0 111.459 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.424 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 57.3 m -76.87 137.71 39.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.186 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 52.8 m -60.09 -40.96 91.42 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.09 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.45 ' O ' ' C ' ' A' ' 77' ' ' HIS . 14.0 m-85 -99.46 14.13 30.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.088 0.47 . . . . 0.0 111.922 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.45 ' C ' ' O ' ' A' ' 76' ' ' PHE . 0.8 OUTLIER -22.74 -69.38 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.598 -179.361 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -154.61 164.1 39.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.054 0.455 . . . . 0.0 111.837 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -131.8 130.36 41.69 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.457 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.454 ' CZ ' ' CG1' ' A' ' 97' ' ' VAL . 7.3 m-85 -119.47 131.56 55.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.949 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 9.6 m170 -94.3 116.41 28.79 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.937 0.399 . . . . 0.0 111.075 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.9 tt -106.44 109.96 22.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.913 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.1 mp -117.85 139.22 51.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.009 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -126.57 128.74 47.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.905 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.09 146.15 38.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.913 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -104.66 115.92 31.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.85 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.4 m -122.96 110.95 27.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.262 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 57.63 82.68 0.12 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.109 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 62.47 -79.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.094 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -58.99 170.53 0.83 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.941 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -126.7 140.46 52.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.919 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.32 119.37 39.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.844 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -108.6 123.75 49.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.805 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.6 mt -125.68 132.6 52.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.981 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.0 mp -114.87 141.02 33.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.026 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -113.97 144.07 43.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.998 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.454 ' CG1' ' CZ ' ' A' ' 80' ' ' PHE . 18.2 t -110.48 127.73 67.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.136 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 33.1 mt -130.01 121.0 50.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.146 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -113.84 117.36 31.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.786 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.26 24.56 10.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.099 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 46.5 m 63.19 142.57 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.888 0.375 . . . . 0.0 110.939 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 6.4 tpt180 -178.71 -68.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.721 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -123.32 -31.01 3.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.249 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 128.82 120.46 2.27 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.281 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.451 ' CG2' ' CE1' ' A' ' 127' ' ' PHE . 90.6 m -123.27 128.47 50.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.847 0.355 . . . . 0.0 111.063 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -120.98 114.99 22.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.766 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.2 tp -120.51 137.25 54.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.522 0.677 . . . . 0.0 111.496 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 59.18 28.16 17.38 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.05 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.71 13.07 74.79 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.952 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -133.17 150.13 52.02 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.835 0.35 . . . . 0.0 110.948 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 19.3 ttt-85 -74.96 142.35 43.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.92 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.88 127.86 35.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.847 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.7 p -117.82 -40.07 2.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.155 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 4.4 mmmt -84.18 173.74 10.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.823 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.5 ptpt -121.2 32.86 5.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.818 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -145.94 49.55 1.2 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.9 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -81.56 138.11 35.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.796 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.8 tp -98.56 118.93 45.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.195 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.9 tt -103.1 136.21 43.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.015 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.9 mtmt -125.65 178.06 5.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.789 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.431 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 4.7 p30 -59.53 137.74 57.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.004 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 74.2 55.57 5.64 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.444 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -117.31 139.29 51.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.925 0.393 . . . . 0.0 110.849 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.1 ttt180 -103.18 123.62 47.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.855 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.443 ' CG2' ' CE2' ' A' ' 127' ' ' PHE . 1.4 mp -126.75 135.7 62.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.184 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.4 t -120.63 125.09 73.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.058 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.451 ' CE1' ' CG2' ' A' ' 105' ' ' THR . 90.1 m-85 -120.61 130.61 54.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.114 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 84.07 -6.0 77.26 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.899 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 12.2 mtpt 77.2 28.78 0.6 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.911 0.386 . . . . 0.0 110.525 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.29 -45.08 0.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.073 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 99.6 m -77.37 107.75 10.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.804 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 47.3 t -124.07 126.32 46.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.971 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.422 ' CD1' HD23 ' A' ' 37' ' ' LEU . 12.9 p90 -142.05 155.51 45.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.926 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.47 140.05 39.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.773 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -103.52 141.66 35.62 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 121.924 0.868 . . . . 0.0 111.809 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.8 tttt -154.26 147.69 25.03 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 113.953 -1.476 . . . . 0.0 110.932 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.467 ' CD1' ' N ' ' A' ' 137' ' ' TYR . 0.8 OUTLIER -79.88 139.73 37.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.712 179.729 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.476 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.141 -179.836 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.456 -0.135 0 CA-C-O 120.737 0.303 . . . . 0.0 110.648 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 53.6 t -59.96 134.77 57.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.842 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.7 tt -133.79 -46.11 0.8 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.987 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -156.85 -176.66 29.17 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.594 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -142.29 166.05 25.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.87 0.366 . . . . 0.0 110.901 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.8 mt -127.19 110.21 12.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.862 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.2 t -102.23 121.77 53.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.136 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -90.08 123.78 34.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.863 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.8 mt -83.8 106.68 15.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.82 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.5 mt -124.16 138.01 30.03 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.925 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -46.99 -27.76 6.36 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.454 2.103 . . . . 0.0 112.531 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -133.22 107.36 0.68 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.483 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 36.7 mttt 63.16 129.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.796 0.332 . . . . 0.0 110.916 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -95.64 170.22 9.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.929 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -126.32 121.94 34.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.897 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -102.97 129.07 49.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.936 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.2 t -121.6 130.71 74.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.065 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.12 124.2 32.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.935 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.9 tt -116.02 132.14 66.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.138 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.76 168.39 9.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.245 -179.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 16.8 p30 -82.26 68.3 8.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.342 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.599 ' C ' ' H ' ' A' ' 55' ' ' VAL . 23.5 ttt-85 -83.01 6.58 18.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.041 -179.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.469 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 2.2 t30 71.43 -38.45 0.42 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -178.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.599 ' H ' ' C ' ' A' ' 53' ' ' ARG . 75.6 t -137.64 133.49 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.531 179.153 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.449 ' N ' ' O ' ' A' ' 80' ' ' PHE . 33.0 m -125.24 131.25 53.16 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.178 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.404 ' HB ' ' HA ' ' A' ' 64' ' ' CYS . 0.0 OUTLIER -103.91 133.86 48.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.892 0.377 . . . . 0.0 111.037 -179.874 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.9 mp -118.22 123.58 71.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.201 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 166.98 -130.08 2.05 Favored Glycine 0 C--N 1.331 0.267 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.275 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.498 ' HB3' ' HA ' ' A' ' 70' ' ' GLU . 7.2 ptt180 -122.23 -25.96 4.77 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.55 0.214 . . . . 0.0 111.288 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -48.53 125.38 9.71 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.881 0.372 . . . . 0.0 110.999 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.97 -25.47 29.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.163 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 41.1 p -78.23 -23.42 47.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.993 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . 0.404 ' HA ' ' HB ' ' A' ' 57' ' ' THR . 93.8 m -57.16 169.27 0.59 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.967 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.401 ' CG ' ' HA ' ' A' ' 56' ' ' THR . 1.6 m-20 -85.91 -68.31 0.74 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.984 0.421 . . . . 0.0 110.909 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.7 t -101.99 133.05 46.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.085 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 15.7 pt -112.78 127.82 69.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.161 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.4 mt -94.04 -84.28 0.32 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.487 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.412 ' O ' ' CB ' ' A' ' 70' ' ' GLU . 10.8 t -102.55 -104.52 0.27 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.138 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.628 ' CB ' ' HD3' ' A' ' 71' ' ' PRO . 0.0 OUTLIER 166.76 -64.66 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.19 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 178.937 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.628 ' HD3' ' CB ' ' A' ' 70' ' ' GLU . 15.6 Cg_exo -67.84 -40.23 9.97 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.299 1.999 . . . . 0.0 113.519 -179.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -110.55 16.06 21.72 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -179.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.493 ' CG2' ' HB3' ' A' ' 60' ' ' ARG . 3.6 tp -107.15 124.72 63.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.865 0.364 . . . . 0.0 110.773 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.5 m -57.47 131.52 50.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.408 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 35.2 m -63.69 -39.96 95.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.436 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.465 ' O ' ' C ' ' A' ' 77' ' ' HIS . 4.4 m-85 -104.99 13.74 30.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.164 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.488 ' CD2' ' CD1' ' A' ' 127' ' ' PHE . 1.5 t60 -16.65 -69.1 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.582 -1.19 . . . . 0.0 112.708 -179.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.422 ' HB3' ' CZ ' ' A' ' 127' ' ' PHE . . . -158.88 164.1 35.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.916 0.389 . . . . 0.0 111.611 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -124.0 140.36 53.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.872 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.449 ' O ' ' N ' ' A' ' 56' ' ' THR . 4.8 m-85 -119.54 131.06 55.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.542 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.469 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 21.1 m-70 -102.91 116.11 31.9 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.691 -0.403 . . . . 0.0 111.674 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . 0.401 ' CD1' ' OG1' ' A' ' 56' ' ' THR . 0.2 OUTLIER -107.06 109.84 21.8 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.635 179.116 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.2 mt -120.67 140.05 52.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.992 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -109.49 125.76 52.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.768 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 11.1 mtp -129.62 148.53 51.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.952 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -107.07 119.92 40.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.856 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.4 t -129.44 110.96 21.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.138 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.8 t70 58.67 68.52 0.82 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.934 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 68.26 -68.36 0.17 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.951 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -64.57 146.93 53.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.865 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.91 128.04 54.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.985 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -98.54 144.68 27.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.832 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -109.14 127.01 53.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.988 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.1 mt -123.41 129.19 50.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.691 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.456 HD12 HG21 ' A' ' 95' ' ' ILE . 30.6 mm -117.93 138.01 50.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.903 0.383 . . . . 0.0 111.284 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -113.9 144.08 43.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.745 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.423 ' CG1' ' CE1' ' A' ' 80' ' ' PHE . 18.2 t -114.65 134.8 56.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.178 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 25.4 mm -121.04 121.01 63.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.03 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -97.75 123.71 41.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.941 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.98 -26.36 31.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.97 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.4 m 65.28 99.02 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.909 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.68 -42.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.888 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -104.26 -55.66 2.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.228 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 143.6 106.65 0.56 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.501 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.416 HG23 ' CD1' ' A' ' 127' ' ' PHE . 90.9 m -118.39 126.86 52.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.71 0.29 . . . . 0.0 110.898 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -120.93 115.03 22.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.921 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . 0.416 HG12 ' CZ ' ' A' ' 117' ' ' TYR . 2.5 tp -114.16 137.36 47.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.464 0.649 . . . . 0.0 111.21 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 63.09 29.05 16.26 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.826 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.78 7.98 66.93 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.974 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -134.17 144.14 48.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.758 0.313 . . . . 0.0 110.856 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.4 ttp180 -70.51 128.99 38.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.81 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.2 137.97 31.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.917 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.2 m -121.51 -42.08 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.1 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.4 mttm -65.37 -174.55 0.19 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.852 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.0 tttt -124.0 171.15 9.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.803 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.5 t70 60.48 63.42 1.36 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.872 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . 0.416 ' CZ ' HG12 ' A' ' 107' ' ' ILE . 10.7 t80 -84.2 139.13 32.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.785 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.4 tp -98.37 118.5 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.253 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.461 HD12 ' CD1' ' A' ' 135' ' ' PHE . 3.2 tm? -100.84 120.0 39.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.767 -179.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.7 178.07 4.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.882 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.441 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 17.8 p30 -60.06 135.79 57.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.017 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 75.04 56.32 4.86 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.582 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -123.09 135.06 54.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.845 0.355 . . . . 0.0 111.04 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.47 117.33 33.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.825 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 5.1 mt -115.0 133.21 61.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.114 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.4 t -124.09 127.69 73.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.072 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.488 ' CD1' ' CD2' ' A' ' 77' ' ' HIS . 4.8 m-85 -116.66 126.19 52.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.042 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 92.87 -71.09 1.51 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.36 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 174.55 -43.57 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.788 0.328 . . . . 0.0 111.171 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.0 p -98.08 -41.91 7.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.545 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 25.3 m -54.13 106.17 0.18 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.955 0.407 . . . . 0.0 111.222 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 13.9 p -124.38 122.54 37.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.773 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -142.04 156.23 45.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.034 0.445 . . . . 0.0 111.276 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.1 tp -114.37 134.44 54.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.66 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.461 ' CD1' HD12 ' A' ' 119' ' ' LEU . 14.5 t80 -98.2 141.17 31.44 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 121.929 0.871 . . . . 0.0 111.754 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . 0.428 ' N ' ' CD1' ' A' ' 135' ' ' PHE . 9.6 tptt -154.86 154.71 33.14 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 113.878 -1.51 . . . . 0.0 111.128 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.441 ' CE2' ' HB3' ' A' ' 121' ' ' ASN . 13.2 m-85 -86.13 140.15 30.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.623 179.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.542 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.124 -179.83 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.692 0.282 . . . . 0.0 110.705 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 52.6 t -64.66 144.79 56.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.954 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.2 tp -155.33 -46.32 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.705 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -154.67 169.69 32.94 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.229 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 27.2 m80 -131.52 163.62 27.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.948 0.404 . . . . 0.0 110.946 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 19.1 mt -127.06 111.07 13.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.801 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.4 t -95.92 121.88 46.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.119 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -89.17 120.88 30.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.912 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.0 mp -79.71 107.05 12.18 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.888 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.7 mt -123.98 138.39 30.52 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.856 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -47.59 -27.47 7.73 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.494 2.129 . . . . 0.0 112.429 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.96 -126.09 2.99 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.465 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.9 mttt -53.1 101.72 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.824 0.345 . . . . 0.0 111.134 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -65.36 172.27 3.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.844 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -133.61 131.1 39.23 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.906 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.07 127.36 56.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.863 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.6 t -119.94 150.98 22.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.14 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -103.44 138.16 40.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.863 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 26.2 mm -116.08 126.67 73.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.328 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.3 168.13 10.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.74 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 26.4 p30 -100.25 66.8 1.32 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.008 0.432 . . . . 0.0 110.762 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.622 ' C ' ' H ' ' A' ' 55' ' ' VAL . 0.6 OUTLIER -97.73 21.65 10.16 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.374 179.993 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.418 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 0.6 OUTLIER 68.23 -27.87 0.14 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.485 -179.726 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.622 ' H ' ' C ' ' A' ' 53' ' ' ARG . 62.9 t -137.31 139.31 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 CA-C-O 121.075 0.465 . . . . 0.0 111.826 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.443 ' HB ' ' HB2' ' A' ' 80' ' ' PHE . 0.4 OUTLIER -125.24 128.05 47.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.005 179.338 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.459 ' O ' ' N ' ' A' ' 65' ' ' ASP . 0.1 OUTLIER -103.95 138.93 39.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.971 0.415 . . . . 0.0 111.417 -179.519 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 32.8 mt -132.3 131.24 60.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.13 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 162.78 -146.67 12.09 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.264 -0.969 . . . . 0.0 113.283 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.441 ' HB2' ' CG2' ' A' ' 73' ' ' ILE . 4.1 ttp-105 -87.59 -44.54 11.17 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.83 0.348 . . . . 0.0 111.392 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 33.2 t -50.51 122.15 6.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.483 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 -60.43 -20.28 59.21 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.905 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 16.3 m -69.75 -27.43 64.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.698 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 84.4 m -56.33 164.67 1.27 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.671 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' A' ' 57' ' ' THR . 0.6 OUTLIER -66.94 -52.86 37.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.979 0.418 . . . . 0.0 110.802 179.827 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.3 t -125.12 126.79 71.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.508 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.8 mp -97.51 119.71 45.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.498 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . 0.424 HD13 ' CD2' ' A' ' 127' ' ' PHE . 19.4 mt -83.4 -86.61 0.11 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.078 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 34.4 m -108.66 -109.88 0.32 Allowed 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 110.251 -0.278 . . . . 0.0 110.251 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.576 ' CB ' ' HD3' ' A' ' 71' ' ' PRO . 0.2 OUTLIER 169.66 -63.11 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.192 0 CA-C-O 120.496 0.188 . . . . 0.0 111.412 179.414 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.576 ' HD3' ' CB ' ' A' ' 70' ' ' GLU . 37.2 Cg_exo -60.29 -40.19 61.15 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.043 1.829 . . . . 0.0 112.899 -179.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -115.13 12.73 16.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.587 -179.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.441 ' CG2' ' HB2' ' A' ' 60' ' ' ARG . 2.6 tp -104.55 133.32 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-O 120.831 0.348 . . . . 0.0 110.975 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.467 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 4.1 p -98.82 131.76 44.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.546 -179.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 19.6 m -53.48 -30.17 39.69 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.159 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -93.92 14.12 20.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.018 -179.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.467 ' HB2' ' O ' ' A' ' 74' ' ' SER . 1.4 t-160 -34.51 -66.65 0.16 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.07 -179.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.406 ' HB2' ' CE2' ' A' ' 127' ' ' PHE . . . -161.62 163.24 30.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.097 0.475 . . . . 0.0 111.765 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -129.47 135.16 48.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.237 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.449 ' CZ ' ' CG1' ' A' ' 97' ' ' VAL . 6.3 m-85 -119.34 131.46 55.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.999 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.418 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 11.9 m170 -94.69 116.45 28.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.954 0.407 . . . . 0.0 110.928 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.6 tp -106.45 109.95 22.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.948 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.2 tp -118.57 140.09 50.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.89 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.4 tm0? -100.4 132.0 46.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.937 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.3 130.1 56.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.85 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -95.12 130.77 41.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.964 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.4 t -140.09 138.8 37.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.135 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.35 67.38 0.33 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.797 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 173.4 -52.67 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.748 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -153.03 172.24 17.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -94.78 127.94 41.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.942 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -101.12 125.4 47.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.869 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . 0.419 ' HB2' ' CE1' ' A' ' 137' ' ' TYR . 24.4 m120 -112.77 125.08 53.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.994 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.3 tp -122.52 129.3 51.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.694 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.429 HD13 ' CE1' ' A' ' 135' ' ' PHE . 3.2 mp -122.96 141.01 44.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.204 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -116.53 144.01 44.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.827 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.449 ' CG1' ' CZ ' ' A' ' 80' ' ' PHE . 22.0 t -112.17 124.63 69.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.193 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . 0.413 HD11 ' CD2' ' A' ' 81' ' ' HIS . 20.4 mt -130.01 124.95 59.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.071 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -114.03 127.83 56.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.946 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.71 -7.47 59.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.372 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 21.6 m 64.25 79.02 0.27 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.779 0.324 . . . . 0.0 110.884 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.43 -39.95 3.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.919 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -133.19 -46.02 0.84 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.192 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 145.47 103.16 0.38 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.406 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 28.0 m -113.46 131.57 55.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.788 0.328 . . . . 0.0 110.92 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -116.49 117.71 30.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.871 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.0 tp -112.5 137.32 45.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.424 0.631 . . . . 0.0 111.281 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 62.15 27.66 16.65 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.942 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.59 10.22 70.74 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.94 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -133.99 151.34 51.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.775 0.321 . . . . 0.0 110.957 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.58 130.0 40.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.859 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 7.0 tt -70.19 139.28 52.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.818 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.8 p -121.98 -44.66 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.077 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.61 167.45 16.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.946 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -108.85 28.52 8.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.942 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -158.62 62.45 0.43 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.005 0.431 . . . . 0.0 110.8 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -84.06 139.11 32.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.803 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.6 tp -98.48 120.14 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-O 121.01 0.433 . . . . 0.0 111.408 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.6 tt -103.1 142.21 34.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.923 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 9.6 mmtp -129.76 178.13 6.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.817 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.446 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 9.2 p30 -56.35 144.44 30.55 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.083 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.51 45.49 89.65 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.42 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -112.37 133.59 54.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.91 0.386 . . . . 0.0 110.973 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.42 130.77 37.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.819 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.8 mp -129.83 121.92 53.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.255 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 39.2 t -113.13 130.55 66.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.033 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.427 ' HB3' ' CE1' ' A' ' 77' ' ' HIS . 3.3 m-85 -114.61 141.39 47.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.071 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 71.59 -64.67 1.11 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.49 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 169.91 -38.2 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.884 0.373 . . . . 0.0 110.963 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 82.7 p -101.75 -39.97 7.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.041 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 57.1 m -57.17 106.38 0.31 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.998 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.3 m -124.21 123.7 40.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.889 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -142.09 156.01 45.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.111 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.4 tt -117.89 140.02 50.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.717 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.429 ' CE1' HD13 ' A' ' 95' ' ' ILE . 20.3 t80 -104.94 141.39 36.64 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.945 0.879 . . . . 0.0 111.935 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -154.73 159.35 40.63 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 113.711 -1.586 . . . . 0.0 110.591 179.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.446 ' CE2' ' HB3' ' A' ' 121' ' ' ASN . 2.5 m-85 -83.83 139.81 32.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.021 0.438 . . . . 0.0 110.697 179.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.441 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.131 179.965 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.797 0.332 . . . . 0.0 110.554 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.8 t -60.71 145.05 50.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.063 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.6 mt -147.76 -53.68 0.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.908 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -140.65 -175.28 14.48 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.564 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 50.4 m80 -146.07 166.05 27.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.904 0.383 . . . . 0.0 110.936 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.7 mp -125.69 107.85 10.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.539 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.6 t -96.13 121.98 47.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.167 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -89.98 113.98 25.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.86 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -87.65 106.75 18.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.878 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.533 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 18.9 mt -124.17 141.0 36.12 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.835 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.533 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 50.2 Cg_endo -72.59 83.95 1.26 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.078 1.852 . . . . 0.0 111.967 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 118.0 25.98 2.88 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.372 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 170.58 155.31 0.06 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.691 0.282 . . . . 0.0 110.555 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -142.47 151.91 42.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.975 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -140.29 128.79 22.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.176 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.04 131.24 55.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.806 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.8 t -125.46 151.02 31.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.29 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -104.24 132.92 49.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.626 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.425 ' O ' HG23 ' A' ' 50' ' ' ILE . 2.3 tt -116.07 132.02 66.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.01 0.433 . . . . 0.0 111.492 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.01 168.05 9.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.033 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -76.28 63.39 1.91 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.307 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.57 ' C ' ' H ' ' A' ' 55' ' ' VAL . 11.1 ttt-85 -80.88 0.12 36.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.013 -179.42 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . 0.437 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 8.3 m120 71.51 -35.88 0.34 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -178.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.57 ' H ' ' C ' ' A' ' 53' ' ' ARG . 68.0 t -137.37 134.14 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.061 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.445 ' N ' ' O ' ' A' ' 80' ' ' PHE . 51.8 m -125.29 124.19 41.08 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.893 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.66 127.34 51.12 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.952 0.406 . . . . 0.0 111.11 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.433 HD13 ' CD1' ' A' ' 80' ' ' PHE . 4.6 mp -107.98 117.74 54.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.003 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 172.95 -144.96 8.14 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.405 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.3 ttm105 -111.15 -19.93 12.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.715 0.293 . . . . 0.0 111.245 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.27 151.67 2.03 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.895 0.379 . . . . 0.0 111.141 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -72.91 -38.74 66.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.93 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 6.0 m -70.1 -19.62 63.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.209 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 48.8 m -53.91 149.25 9.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.028 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -75.16 -53.68 8.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.904 0.383 . . . . 0.0 110.836 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.5 t -114.83 116.99 54.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.216 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 20.0 pt -99.15 131.05 47.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.061 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.0 mp -86.45 -175.93 5.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.911 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.2 t -118.34 34.61 5.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.98 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -109.68 118.51 50.12 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.667 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -57.74 -16.11 23.79 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.566 2.177 . . . . 0.0 112.804 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -119.8 36.61 4.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.765 0.317 . . . . 0.0 111.029 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.421 HD13 ' CE1' ' A' ' 77' ' ' HIS . 7.3 tp -82.45 147.7 5.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.27 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.405 ' HB3' ' CG ' ' A' ' 77' ' ' HIS . 2.5 t -77.17 129.91 36.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.103 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.8 m -65.37 -39.21 92.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.726 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.434 ' O ' ' C ' ' A' ' 77' ' ' HIS . 1.1 m-85 -103.8 13.94 31.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.295 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.434 ' C ' ' O ' ' A' ' 76' ' ' PHE . 0.3 OUTLIER -22.31 -71.87 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.647 -1.161 . . . . 0.0 112.595 -179.349 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -158.6 164.03 36.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.074 0.464 . . . . 0.0 111.928 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -129.09 136.49 50.3 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.471 179.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.448 ' CZ ' ' CG1' ' A' ' 97' ' ' VAL . 6.1 m-85 -119.54 131.17 55.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.887 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . 0.437 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 6.3 m-70 -94.87 116.38 28.64 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.89 0.376 . . . . 0.0 111.049 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -106.51 109.58 21.54 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.711 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.4 mp -122.2 140.14 52.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.166 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.0 tm0? -108.97 133.34 53.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.892 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -141.89 122.69 14.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.939 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -97.05 116.1 28.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.944 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 4.2 m -119.68 110.92 30.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.243 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 59.25 72.82 0.51 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.004 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 66.08 -74.54 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.042 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -52.85 144.41 14.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.152 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -108.83 130.95 55.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.94 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -116.5 125.61 52.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.796 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -106.98 135.37 48.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.939 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.66 139.62 53.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.773 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.0 mp -127.79 138.29 55.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.205 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -113.88 140.62 48.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.772 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.448 ' CG1' ' CZ ' ' A' ' 80' ' ' PHE . 16.9 t -103.99 121.99 56.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.156 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 28.6 mt -114.21 124.2 70.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.046 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -87.78 138.23 31.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.941 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.1 -25.68 14.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.013 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.1 m 65.47 81.37 0.21 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.943 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -137.07 -47.07 0.58 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.883 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -124.74 -48.83 1.77 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.157 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 154.32 129.39 1.29 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.547 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.453 ' CG2' ' CE1' ' A' ' 127' ' ' PHE . 1.7 m -131.94 123.7 27.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.758 0.314 . . . . 0.0 110.954 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -121.16 123.28 41.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.809 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.9 tp -119.01 137.32 53.36 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-O 121.426 0.631 . . . . 0.0 111.337 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 62.38 27.97 16.62 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.859 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.66 9.82 70.33 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.971 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -133.99 152.04 51.69 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.825 0.345 . . . . 0.0 110.859 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.02 129.21 39.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.88 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.1 pp -71.44 140.13 49.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.954 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.0 m -135.02 31.41 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.171 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 23.9 mmtt -145.93 149.09 33.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.931 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 17.9 ttpp -98.77 31.13 3.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.813 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -166.57 66.93 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.862 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -82.81 139.03 33.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.941 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.482 HD12 HG21 ' A' ' 118' ' ' ILE . 0.0 OUTLIER -98.73 117.61 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.749 -179.841 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.7 tt -103.0 136.89 41.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.186 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 3.1 mmmm -136.14 178.15 7.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.764 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.433 ' HB3' ' CZ ' ' A' ' 137' ' ' TYR . 12.7 p30 -55.48 139.31 44.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.034 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 71.27 52.93 11.36 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.479 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -124.8 125.25 43.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.794 0.33 . . . . 0.0 110.974 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 11.2 mtp180 -93.67 131.81 38.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.818 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . 0.412 ' HB ' ' CE1' ' A' ' 133' ' ' PHE . 2.7 mt -125.74 137.95 56.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.123 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 22.9 t -120.36 123.98 71.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.065 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.453 ' CE1' ' CG2' ' A' ' 105' ' ' THR . 3.6 m-85 -119.22 128.97 54.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.139 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 80.97 -3.38 76.42 Favored Glycine 0 CA--C 1.518 0.252 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.072 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 8.6 tttt 76.31 24.5 1.09 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.861 0.362 . . . . 0.0 110.511 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.88 -52.63 0.13 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.012 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 91.1 m -77.48 107.76 10.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.671 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 79.8 p -121.99 133.33 54.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.992 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.412 ' CE1' ' HB ' ' A' ' 125' ' ' ILE . 2.8 p90 -142.01 155.69 45.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.905 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 7.9 tt -112.35 139.98 47.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.774 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -101.5 141.5 34.28 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.944 0.878 . . . . 0.0 111.838 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.31 154.11 32.82 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 113.864 -1.516 . . . . 0.0 110.784 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.479 ' CD1' ' N ' ' A' ' 137' ' ' TYR . 0.6 OUTLIER -85.53 139.72 31.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.992 0.425 . . . . 0.0 110.752 179.74 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.414 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.097 -179.918 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.4 m . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.842 0.353 . . . . 0.0 110.749 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.8 t -60.07 135.21 57.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.868 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.9 tp -136.65 -63.61 0.61 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.97 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -139.6 178.25 19.82 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.498 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 31.0 m80 -133.52 166.0 23.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.788 0.328 . . . . 0.0 110.911 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 18.9 mt -126.5 113.71 17.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.96 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.5 t -96.24 121.89 47.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.948 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -90.0 113.85 25.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.892 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.9 mt -77.76 106.75 9.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.785 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.513 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 1.6 mp -124.15 140.26 34.47 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.97 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' PRO . . . . . 0.513 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 67.9 Cg_endo -76.13 83.84 1.92 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.304 2.003 . . . . 0.0 112.029 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 115.62 24.04 4.18 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.382 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -179.5 166.96 1.45 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.794 0.33 . . . . 0.0 110.612 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -144.41 128.27 17.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.045 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -116.17 118.82 33.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.835 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -108.82 124.83 51.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.909 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.2 t -120.36 137.64 53.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.096 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.75 132.84 34.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.84 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.4 mm -108.76 116.25 51.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.264 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.88 167.77 10.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.66 179.729 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -61.68 -95.65 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.324 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ARG . . . . . 0.594 ' C ' ' H ' ' A' ' 55' ' ' VAL . 3.9 ttt-85 70.79 -4.41 1.71 Allowed 'General case' 0 C--O 1.232 0.15 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 179.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 70.24 -32.93 0.25 Allowed 'General case' 0 C--N 1.331 -0.226 0 O-C-N 122.156 -0.34 . . . . 0.0 110.247 -179.035 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' VAL . . . . . 0.594 ' H ' ' C ' ' A' ' 53' ' ' ARG . 65.7 t -136.72 140.72 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-O 121.082 0.468 . . . . 0.0 111.055 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . 0.46 ' N ' ' O ' ' A' ' 80' ' ' PHE . 14.2 m -125.35 130.19 51.44 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.101 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.98 135.48 45.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.818 0.342 . . . . 0.0 110.684 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ILE . . . . . 0.428 ' CD1' ' CD1' ' A' ' 80' ' ' PHE . 5.9 mt -128.5 124.07 61.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.342 -179.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 166.55 -134.48 3.29 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.47 -0.872 . . . . 0.0 113.068 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ARG . . . . . 0.462 ' HB2' ' CG2' ' A' ' 73' ' ' ILE . 8.2 ttp180 -99.99 -40.12 7.8 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.886 0.374 . . . . 0.0 111.158 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -46.18 118.11 1.79 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.481 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.85 -28.37 56.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.76 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -69.93 -22.96 63.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.88 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 86.8 m -54.33 154.27 4.69 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.774 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.438 ' HB3' ' CG2' ' A' ' 56' ' ' THR . 64.1 t0 -65.88 -46.25 79.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.823 0.344 . . . . 0.0 110.957 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 58' ' ' ILE . 21.3 t -125.18 133.24 69.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.436 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.8 pt -106.16 122.43 59.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.69 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -94.15 -88.35 0.24 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.94 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 28.0 t -104.79 -115.64 0.23 Allowed 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.513 ' CB ' ' HD3' ' A' ' 71' ' ' PRO . 3.4 tt0 171.79 -62.1 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.327 0 O-C-N 122.372 -0.205 . . . . 0.0 111.117 179.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' PRO . . . . . 0.513 ' HD3' ' CB ' ' A' ' 70' ' ' GLU . 38.8 Cg_exo -59.44 -40.17 69.49 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 121.924 1.749 . . . . 0.0 112.86 -179.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -118.73 19.85 13.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.507 -179.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.462 ' CG2' ' HB2' ' A' ' 60' ' ' ARG . 4.6 tp -103.97 122.2 56.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.078 0.466 . . . . 0.0 110.942 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' SER . . . . . 0.416 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 2.6 p -71.81 134.87 46.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.406 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.4 m -61.99 -30.35 70.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.716 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' PHE . . . . . 0.422 ' O ' ' C ' ' A' ' 77' ' ' HIS . 0.4 OUTLIER -108.77 14.08 24.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.514 -179.939 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' HIS . . . . . 0.504 ' CD2' ' CD1' ' A' ' 127' ' ' PHE . 1.1 t60 -25.68 -68.73 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.796 -1.093 . . . . 0.0 112.668 -179.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . 0.446 ' CB ' ' CZ ' ' A' ' 127' ' ' PHE . . . -157.09 164.1 38.25 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.017 0.437 . . . . 0.0 111.647 -179.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -131.67 137.95 48.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.822 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' PHE . . . . . 0.46 ' O ' ' N ' ' A' ' 56' ' ' THR . 7.0 m-85 -119.28 130.14 55.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.534 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -94.78 116.17 28.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.802 0.334 . . . . 0.0 111.14 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 11.1 tp -106.54 109.49 21.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.718 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.46 140.23 52.97 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.035 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -98.45 134.89 40.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.682 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.02 122.94 47.45 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.984 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -96.97 119.53 35.61 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.002 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.4 t -140.05 139.15 37.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.098 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -48.59 -56.44 8.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.198 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 -51.08 -75.11 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.152 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -147.65 155.27 41.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.801 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -82.92 127.93 33.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.967 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.04 134.93 54.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.984 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 20.1 m-20 -111.43 140.62 45.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.733 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.6 tp -132.02 139.47 48.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.054 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ILE . . . . . 0.42 HD11 ' CE1' ' A' ' 135' ' ' PHE . 2.6 mp -125.02 134.31 67.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.049 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -114.04 144.01 43.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.817 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' VAL . . . . . 0.457 ' CG1' ' CZ ' ' A' ' 80' ' ' PHE . 16.3 t -108.78 131.61 58.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.187 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.8 mp -130.05 121.31 51.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.985 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 21.1 p30 -84.88 139.09 32.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.93 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -143.6 30.48 1.35 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.959 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.6 m -153.97 152.2 30.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.829 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 11.7 mmt180 -106.18 34.6 3.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.987 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -89.19 -31.22 18.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.207 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 121.19 115.99 2.43 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.452 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' THR . . . . . 0.463 ' CG2' ' CE1' ' A' ' 127' ' ' PHE . 99.5 m -131.72 128.45 38.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.811 0.338 . . . . 0.0 110.886 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -121.05 114.96 22.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.746 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.8 tp -111.56 137.29 44.74 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 CA-C-O 121.435 0.636 . . . . 0.0 111.342 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 61.93 26.53 16.05 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.739 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.72 8.95 69.01 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.858 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 51.9 m-80 -134.11 151.99 51.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.792 0.33 . . . . 0.0 110.901 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 10.5 mtm105 -74.96 132.82 41.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.739 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.05 143.5 30.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.95 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 14.5 p -128.75 14.56 2.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.39 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -121.85 -178.56 3.87 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.806 0.336 . . . . 0.0 110.768 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.3 mttt -110.2 -29.64 8.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.95 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -112.63 78.87 1.16 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.899 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -80.79 139.33 36.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.903 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . 0.409 ' O ' ' CG2' ' A' ' 118' ' ' ILE . 7.5 tp -98.46 115.98 40.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.035 0.445 . . . . 0.0 111.241 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.12 132.85 49.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.964 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 19.4 mttm -135.99 178.23 7.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.76 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ASN . . . . . 0.46 ' ND2' ' CD2' ' A' ' 137' ' ' TYR . 3.2 t-20 -50.93 139.99 16.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.176 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 70.75 51.46 19.78 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.497 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.46 130.07 53.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.918 0.39 . . . . 0.0 110.952 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.4 ttm-85 -98.15 124.11 42.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.918 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.9 mp -115.53 134.71 57.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.17 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 29.2 t -124.1 133.95 67.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.104 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' PHE . . . . . 0.504 ' CD1' ' CD2' ' A' ' 77' ' ' HIS . 7.5 m-85 -131.84 134.33 45.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.055 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 81.02 -2.23 81.72 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.95 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 2.8 mtpp 75.47 27.77 1.02 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.914 0.388 . . . . 0.0 110.424 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 63.9 p -154.01 -60.03 0.13 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.834 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 55.6 m -61.91 109.05 1.14 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.727 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.0 p -120.51 128.0 52.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.004 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' PHE . . . . . 0.435 ' CD1' ' N ' ' A' ' 133' ' ' PHE . 2.1 p90 -142.06 155.99 45.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.953 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.9 tt -113.37 140.11 48.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.834 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . 0.42 ' CE1' HD11 ' A' ' 95' ' ' ILE . 26.4 t80 -104.54 141.48 36.32 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.984 0.897 . . . . 0.0 111.81 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 8.7 pttt -154.71 158.97 40.37 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 113.914 -1.494 . . . . 0.0 110.867 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' TYR . . . . . 0.46 ' CD2' ' ND2' ' A' ' 121' ' ' ASN . 3.2 m-85 -86.07 139.74 30.87 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.716 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.483 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.22 179.958 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 120.81 0.338 . . . . 0.0 111.266 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -87.13 -32.57 19.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.809 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -91.42 124.58 35.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.894 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -116.3 166.23 12.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.864 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.5 164.89 18.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.935 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 60.16 -179.09 0.1 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.914 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -80.2 143.53 33.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.811 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.2 mtpt -115.93 148.78 42.06 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.966 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.77 144.19 53.17 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.552 2.168 . . . . 0.0 112.326 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 37.7 p -121.37 -52.71 2.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.804 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.1 m -105.56 -33.09 8.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.837 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.22 130.03 35.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.864 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.425 ' N ' HG22 ' A' ' 51' ' ' THR . 3.0 m-85 -57.88 -99.26 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.993 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.59 128.94 22.5 Favored 'General case' 0 C--N 1.334 -0.075 0 CA-C-O 120.703 0.287 . . . . 0.0 110.471 179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.8 t -64.46 130.71 44.78 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.91 0.386 . . . . 0.0 111.036 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.12 -47.0 0.64 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.77 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -138.83 -178.84 16.7 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.357 179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.429 ' CD2' ' HA ' ' A' ' 49' ' ' GLU . 49.4 m80 -147.02 162.36 38.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.865 0.364 . . . . 0.0 110.919 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -127.07 119.7 27.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.754 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.5 t -97.53 122.96 49.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.104 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -89.99 126.48 35.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.884 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -90.62 106.82 18.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.53 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 20.8 mt -124.09 140.65 35.25 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.934 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.53 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 57.2 Cg_endo -73.86 87.99 1.1 Allowed 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.162 1.908 . . . . 0.0 111.983 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 137.79 -12.08 3.68 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.386 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.1 pttp 178.2 173.51 0.63 Allowed 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 120.727 0.299 . . . . 0.0 110.689 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -135.7 160.68 37.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.048 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.61 134.08 33.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.947 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.04 127.7 56.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.82 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 30.6 t -119.48 130.79 73.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.182 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.429 ' HA ' ' CD2' ' A' ' 36' ' ' HIS . 3.3 pm0 -81.6 136.6 35.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.734 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 16.7 tt -116.02 132.11 66.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.338 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.425 HG22 ' N ' ' A' ' 31' ' ' TYR . 0.7 OUTLIER -97.05 168.09 10.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.999 -179.682 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 7.0 p30 -92.63 66.16 4.43 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.079 179.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.602 ' C ' ' H ' ' A' ' 55' ' ' VAL . 0.1 OUTLIER -90.37 13.26 15.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.016 -179.253 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.434 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 0.7 OUTLIER 69.28 -34.6 0.28 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -179.524 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.602 ' H ' ' C ' ' A' ' 53' ' ' ARG . 62.3 t -137.28 124.09 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-O 120.948 0.404 . . . . 0.0 111.343 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.429 ' HB ' ' HB2' ' A' ' 80' ' ' PHE . 15.9 m -111.04 128.8 55.98 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.624 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.74 138.67 40.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.908 0.385 . . . . 0.0 111.043 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.427 HD11 ' CD2' ' A' ' 80' ' ' PHE . 4.7 mp -126.64 117.98 49.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.033 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 176.68 -160.73 28.29 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.667 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.426 ' N ' HG23 ' A' ' 73' ' ' ILE . 5.2 ttp180 -83.39 -29.82 27.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.726 0.298 . . . . 0.0 110.979 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 7.2 t -58.09 129.32 41.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.968 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.42 -22.64 67.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.022 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 6.3 m -69.89 -27.58 64.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.004 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 97.5 m -57.16 151.61 15.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.82 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.411 ' HB3' ' CG2' ' A' ' 56' ' ' THR . 63.9 t0 -61.31 -43.96 98.01 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.884 0.374 . . . . 0.0 110.603 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.8 t -125.03 114.92 42.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.093 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 19.6 tt -93.75 107.4 19.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.026 179.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.405 ' CD1' ' CD1' ' A' ' 73' ' ' ILE . 18.0 mt -65.36 -177.97 0.46 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.928 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.9 p -123.39 65.05 1.0 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.238 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.87 141.1 40.67 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.606 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.22 -19.22 50.72 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.605 2.203 . . . . 0.0 112.911 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -133.86 34.78 3.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.794 0.331 . . . . 0.0 111.31 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.426 HG23 ' N ' ' A' ' 60' ' ' ARG . 3.2 tp -71.86 128.7 35.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.165 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.4 m -59.92 133.35 56.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.212 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 86.7 m -64.46 -44.03 92.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.802 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.456 ' O ' ' C ' ' A' ' 77' ' ' HIS . 34.9 m-85 -99.68 13.9 31.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.405 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.456 ' C ' ' O ' ' A' ' 76' ' ' PHE . 1.8 t-160 -19.0 -69.94 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.737 -1.12 . . . . 0.0 112.771 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.422 ' HB1' ' CE1' ' A' ' 127' ' ' PHE . . . -153.78 164.08 38.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.986 0.422 . . . . 0.0 111.731 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.15 138.96 50.91 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.737 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.429 ' HB2' ' HB ' ' A' ' 56' ' ' THR . 38.3 m-85 -119.53 131.07 55.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.55 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.434 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 9.0 m-70 -94.77 115.84 28.0 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.139 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.08 109.81 21.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.796 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.0 pp -120.1 140.07 51.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.048 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -117.44 128.11 54.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.878 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.3 ttm -135.65 151.4 50.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.892 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -106.52 121.01 43.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.947 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 10.5 p -126.92 121.44 58.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.929 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.8 t0 75.18 -58.0 0.58 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.062 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -173.17 -40.61 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.842 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -89.54 132.92 34.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.773 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.01 131.0 35.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.929 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -113.49 143.49 44.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.821 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -113.99 142.79 45.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.983 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.5 tp -131.91 136.19 47.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.739 179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.427 HD13 ' CE1' ' A' ' 135' ' ' PHE . 3.4 mp -114.7 140.95 33.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.125 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -117.54 133.54 55.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.785 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.414 ' HB ' ' HB3' ' A' ' 117' ' ' TYR . 7.7 t -96.36 127.34 48.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.238 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 9.9 mt -130.09 139.14 52.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.962 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -114.19 129.92 56.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.979 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.11 31.42 0.76 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.86 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.3 m -135.11 -178.74 5.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.881 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.02 37.68 3.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.882 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -101.13 -30.11 11.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.2 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 115.27 106.26 2.58 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.441 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.423 ' CG2' ' CE1' ' A' ' 127' ' ' PHE . 89.4 m -122.34 123.26 40.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.843 0.354 . . . . 0.0 110.948 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -121.0 115.0 22.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.855 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.8 tp -110.56 137.29 43.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.506 0.67 . . . . 0.0 111.318 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 59.84 31.54 20.81 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.75 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.63 9.32 69.3 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.893 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -134.13 151.97 51.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.843 0.354 . . . . 0.0 110.838 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 30.4 ttp180 -74.73 140.54 44.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.908 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.98 133.68 40.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.915 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.8 m -112.08 -34.3 2.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.128 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 44.1 mttp -100.34 -178.16 3.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.895 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.6 mttp -121.17 32.08 6.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.85 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -154.23 56.17 0.71 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.989 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.414 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 1.8 t80 -84.15 139.25 32.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.815 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.2 tp -98.53 118.89 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.217 -179.673 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 9.2 tt -103.08 136.74 42.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.007 -179.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 9.0 mttt -130.54 178.08 6.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.751 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.414 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 28.5 p30 -53.1 148.07 8.69 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.089 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 66.65 37.48 92.5 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.507 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.91 131.5 53.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.77 0.319 . . . . 0.0 110.87 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -97.99 125.54 42.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.837 -179.99 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.411 HG21 ' CE2' ' A' ' 127' ' ' PHE . 2.9 mp -121.96 135.53 61.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.14 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.9 t -120.85 126.34 75.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.977 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.433 ' HB3' ' CE1' ' A' ' 77' ' ' HIS . 44.8 m-85 -123.39 124.93 44.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.955 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 85.88 -6.16 81.76 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.864 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 77.74 27.8 0.58 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.93 0.395 . . . . 0.0 110.492 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 82.5 p -153.13 -46.36 0.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.797 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 60.1 m -80.37 108.29 13.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.861 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 48.3 t -124.0 125.61 44.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.927 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -138.03 155.0 49.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.813 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.5 tt -108.29 130.02 55.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.79 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.427 ' CE1' HD13 ' A' ' 95' ' ' ILE . 30.2 t80 -99.68 141.58 32.3 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 122.025 0.917 . . . . 0.0 111.712 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 12.8 tttm -154.47 155.09 34.28 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 113.853 -1.521 . . . . 0.0 110.726 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.414 ' CE2' ' HB3' ' A' ' 121' ' ' ASN . 3.4 m-85 -81.62 139.51 34.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.958 0.409 . . . . 0.0 110.793 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -120.39 68.69 0.85 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.03 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.4 -49.15 67.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.92 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.58 -45.15 1.49 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.951 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 1.1 m 60.81 107.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.826 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.7 m -102.82 129.38 49.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.874 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.4 p -151.07 38.13 0.65 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.911 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.74 104.06 8.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.865 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.459 ' CG2' ' H ' ' A' ' 146' ' ' GLU . 3.2 mm -110.66 -143.75 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.175 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.459 ' H ' ' CG2' ' A' ' 145' ' ' ILE . 0.6 OUTLIER -132.2 -46.43 0.92 Allowed 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.885 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -129.65 95.11 3.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.87 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.48 143.79 31.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.846 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.91 80.07 5.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.879 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -176.69 130.68 0.19 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.949 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.28 129.46 37.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.89 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 29.9 m -130.76 119.89 46.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.128 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 33.4 t -128.5 157.36 41.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.915 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 10.3 p -111.32 -34.51 6.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.922 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -93.83 175.08 6.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.883 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 4.0 t -132.47 154.09 50.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.899 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 2.6 mtp85 59.91 31.77 20.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.799 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.35 162.32 41.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.95 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 8.4 t80 . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.913 179.985 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.4 mtmt . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.813 0.34 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 24.7 ptt85 -129.56 106.46 8.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.921 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -138.04 148.12 44.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.912 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -157.83 162.05 38.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.856 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.8 mmm180 -107.7 149.54 28.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.807 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.5 m -98.56 32.81 2.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.968 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -162.58 152.13 15.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.892 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.6 mttp -95.78 110.85 53.61 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.847 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.3 141.14 50.78 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.384 2.056 . . . . 0.0 112.34 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -107.9 158.58 17.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.918 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -166.01 -174.13 2.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.898 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 65.77 98.7 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.081 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.458 ' HB2' ' HB ' ' A' ' 51' ' ' THR . 1.9 m-85 -52.6 -94.53 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.007 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.433 ' N ' HG21 ' A' ' 51' ' ' THR . 0.9 OUTLIER -140.31 128.63 22.54 Favored 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 179.552 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.8 t -59.89 144.79 47.91 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.816 0.341 . . . . 0.0 111.114 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.1 tp -157.49 -67.35 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.968 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -118.98 165.25 13.03 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.526 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.447 ' CE1' ' CB ' ' A' ' 138' ' ' ALA . 32.0 m80 -136.83 161.12 36.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.848 0.356 . . . . 0.0 111.078 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.9 mt -120.58 111.08 17.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.669 179.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.6 t -96.02 121.76 46.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.02 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -90.17 113.91 25.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.882 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.74 106.81 14.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.814 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.514 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 22.0 mt -124.2 140.44 34.92 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.847 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.514 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 57.8 Cg_endo -74.29 86.42 1.31 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.186 1.924 . . . . 0.0 111.955 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 115.6 23.74 4.28 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.256 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 176.92 -168.36 0.06 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.738 0.304 . . . . 0.0 110.593 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -177.47 152.39 0.83 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.886 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -137.97 130.81 29.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.087 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.3 tttt -113.07 134.84 54.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.905 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 37.5 t -121.62 151.02 24.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.202 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -100.82 133.62 45.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.789 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.1 mm -116.07 129.51 72.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.173 -179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.458 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 2.0 p -106.08 167.99 9.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.96 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.416 ' HA ' ' CD2' ' A' ' 82' ' ' LEU . 6.9 m-80 -85.1 63.67 8.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.168 0.508 . . . . 0.0 110.256 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.61 ' C ' ' H ' ' A' ' 55' ' ' VAL . 23.2 ttt-85 -87.3 2.76 49.25 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.914 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.402 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 0.7 OUTLIER 71.68 -34.63 0.3 Allowed 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -178.573 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.61 ' H ' ' C ' ' A' ' 53' ' ' ARG . 75.6 t -137.22 136.06 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.473 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.465 ' N ' ' O ' ' A' ' 80' ' ' PHE . 18.8 m -125.12 129.68 50.67 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.957 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.81 136.12 44.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.911 0.386 . . . . 0.0 110.846 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.41 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 36.6 mt -125.68 128.4 72.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.983 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 168.91 -143.95 8.4 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.222 -0.99 . . . . 0.0 113.353 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.487 ' HB2' ' CG2' ' A' ' 73' ' ' ILE . 5.8 ttp-105 -96.9 -40.55 8.85 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.904 0.383 . . . . 0.0 111.145 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' SER . . . . . 0.42 ' HB3' ' CG2' ' A' ' 75' ' ' THR . 4.7 p -53.91 127.27 25.54 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.309 -179.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 28.6 ptt85 -59.84 -20.12 55.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.024 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.77 -27.06 64.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.558 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 60.3 m -56.99 149.08 19.66 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.411 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.402 ' HB3' ' CG2' ' A' ' 56' ' ' THR . 7.9 t0 -61.36 -44.71 96.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.947 0.403 . . . . 0.0 110.794 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 58' ' ' ILE . 56.0 t -125.21 133.17 70.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.551 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.4 pt -100.62 112.6 33.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.349 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 6.4 mt -78.72 -88.22 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.006 -179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 30.9 t -108.22 -108.65 0.32 Allowed 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.544 ' CB ' ' HD3' ' A' ' 71' ' ' PRO . 0.0 OUTLIER 169.27 -60.86 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.198 0 N-CA-C 111.574 0.212 . . . . 0.0 111.574 179.25 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.544 ' HD3' ' CB ' ' A' ' 70' ' ' GLU . 25.6 Cg_exo -62.39 -40.05 42.3 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 121.955 1.77 . . . . 0.0 113.061 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -121.74 25.26 9.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.676 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.487 ' CG2' ' HB2' ' A' ' 60' ' ' ARG . 5.0 tp -106.77 121.48 59.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.178 0.513 . . . . 0.0 111.102 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.433 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 0.7 OUTLIER -69.7 137.47 52.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.457 -179.298 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.42 ' CG2' ' HB3' ' A' ' 61' ' ' SER . 27.6 m -57.66 -43.99 85.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.942 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.47 ' O ' ' C ' ' A' ' 77' ' ' HIS . 2.9 m-85 -100.85 14.19 32.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.662 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.47 ' C ' ' O ' ' A' ' 76' ' ' PHE . 2.0 t-160 -18.92 -69.09 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.883 -1.053 . . . . 0.0 112.814 -179.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -155.57 164.07 39.14 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.929 0.395 . . . . 0.0 111.643 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.407 ' HA ' ' O ' ' A' ' 56' ' ' THR . 0.2 OUTLIER -125.95 138.99 53.8 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.848 179.802 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.465 ' O ' ' N ' ' A' ' 56' ' ' THR . 2.6 m-85 -119.58 131.07 55.42 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.86 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.402 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 15.2 m-70 -97.29 116.3 29.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.81 0.338 . . . . 0.0 111.384 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.425 ' CD1' ' O ' ' A' ' 51' ' ' THR . 6.0 tt -106.82 109.93 21.96 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.058 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.8 mp -119.26 139.94 51.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.812 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -123.88 139.06 54.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.117 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -155.03 132.81 11.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.927 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.6 p-10 -107.04 128.73 54.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.914 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.8 m -130.8 139.12 51.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.201 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 68.43 -67.99 0.19 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.137 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -178.1 38.16 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.839 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -148.14 -177.93 6.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.669 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -121.37 127.94 51.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.94 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.13 110.88 20.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.738 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 17.5 m-80 -114.04 129.06 56.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.079 -179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.83 136.22 52.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.655 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.421 HD13 ' CE1' ' A' ' 135' ' ' PHE . 4.2 mp -113.78 141.01 31.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.11 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -119.72 143.95 47.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.793 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.409 HG22 ' CZ ' ' A' ' 80' ' ' PHE . 16.8 t -109.88 129.93 63.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.208 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 24.0 mm -124.27 124.15 67.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.054 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.86 131.37 48.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.994 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -93.72 10.54 32.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.325 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.4 m 59.83 64.1 1.35 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.868 0.366 . . . . 0.0 110.88 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -161.38 132.2 5.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.941 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 70.23 5.8 5.49 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.988 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 61.76 130.87 0.01 OUTLIER Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.766 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.449 ' CG2' ' CE1' ' A' ' 127' ' ' PHE . 95.8 m -132.04 125.86 32.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.791 0.329 . . . . 0.0 110.814 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -117.62 123.92 47.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.92 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.3 tp -122.08 137.2 56.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.511 0.672 . . . . 0.0 111.152 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 62.4 29.04 17.15 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.881 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.7 9.44 69.83 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.911 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -134.0 152.03 51.69 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.748 0.308 . . . . 0.0 110.839 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 8.1 mtp-105 -68.5 142.64 55.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.852 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.3 tp -77.48 140.28 39.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.953 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 19.3 m -126.05 -44.58 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.077 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.71 -178.64 0.97 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.897 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.03 -29.04 8.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.902 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -122.66 83.86 2.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.884 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -82.3 139.18 34.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.808 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.2 tp -98.51 121.61 49.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.969 0.414 . . . . 0.0 111.395 -179.549 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.8 tp -103.07 134.0 47.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.894 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 2.4 mttp -129.19 178.12 6.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.858 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.448 ' HB2' ' CE2' ' A' ' 137' ' ' TYR . 3.6 t30 -54.89 144.93 21.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.223 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 64.55 44.68 94.77 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.379 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -117.04 122.36 43.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.762 0.315 . . . . 0.0 111.089 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 78.1 mtt180 -89.89 133.05 34.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.718 179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.413 HG22 ' CE2' ' A' ' 127' ' ' PHE . 2.9 mp -126.67 132.35 70.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.251 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.9 t -118.33 126.15 74.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.958 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.449 ' CE1' ' CG2' ' A' ' 105' ' ' THR . 45.2 m-85 -122.74 144.23 49.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.075 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 81.56 -67.09 3.7 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.391 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 170.51 -33.91 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.773 0.321 . . . . 0.0 111.036 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 9.6 p -116.41 -37.49 3.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.413 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 48.6 m -55.15 103.95 0.11 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.977 0.418 . . . . 0.0 111.184 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 44.3 t -124.62 124.54 42.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.035 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 24.8 p90 -142.08 156.12 45.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.919 0.39 . . . . 0.0 110.998 179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -111.78 140.02 46.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.864 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.421 ' CE1' HD13 ' A' ' 95' ' ' ILE . 20.0 t80 -100.46 141.27 33.55 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.924 0.869 . . . . 0.0 111.695 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 8.6 mtmt -154.78 157.11 37.46 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 113.864 -1.516 . . . . 0.0 110.95 179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.448 ' CE2' ' HB2' ' A' ' 121' ' ' ASN . 4.8 m-85 -86.02 139.61 31.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.928 0.394 . . . . 0.0 110.616 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.447 ' CB ' ' CE1' ' A' ' 36' ' ' HIS . . . -105.15 101.41 10.97 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.06 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 3.5 m -62.13 107.15 0.83 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.903 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 6.0 p -169.77 139.05 1.9 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.825 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.55 87.9 1.74 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.936 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.5 m -128.48 -67.63 0.79 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.895 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 11.3 p 54.52 -169.79 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.978 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -154.5 96.35 1.89 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.866 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.477 ' CG2' ' H ' ' A' ' 146' ' ' GLU . 0.7 OUTLIER -110.27 -143.67 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.477 ' H ' ' CG2' ' A' ' 145' ' ' ILE . 0.3 OUTLIER -135.26 121.26 19.91 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.858 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -96.44 142.18 28.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.896 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -100.43 162.94 12.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.922 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -156.62 -62.52 0.1 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.967 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 60.31 31.18 20.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.898 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.92 99.24 0.46 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.863 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 14.8 m -128.41 34.05 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.133 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.6 t -172.45 -63.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.935 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 2.2 m 60.9 31.35 19.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.857 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -161.11 104.09 1.3 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.924 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.93 176.15 5.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.938 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 14.3 ttt85 -130.08 -58.76 1.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.898 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.29 86.72 2.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.895 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.883 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.8 mttt . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.758 0.313 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.5 mtt-85 -76.01 116.13 16.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.913 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 61.32 170.69 0.11 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.987 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 63.28 143.74 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.884 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -150.38 157.15 42.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.821 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -175.68 -179.54 1.24 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.967 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -116.34 106.45 13.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.925 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.417 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.2 OUTLIER -77.15 -62.48 0.59 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.014 -179.842 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.417 ' CD ' ' CB ' ' A' ' 26' ' ' LYS . 55.7 Cg_endo -70.21 159.05 54.43 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.48 2.12 . . . . 0.0 112.362 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 61.57 49.33 5.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.919 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.4 t -116.51 85.28 2.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.91 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -59.9 176.42 0.3 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.926 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.419 ' CD2' ' HB3' ' A' ' 53' ' ' ARG . 10.6 m-85 -80.15 -101.63 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.936 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.46 128.95 22.72 Favored 'General case' 0 C--N 1.334 -0.085 0 CA-C-O 120.796 0.331 . . . . 0.0 110.648 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.8 t -67.36 122.86 18.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.999 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.0 tp -133.29 -62.39 0.79 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.675 179.872 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.5 162.77 12.26 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.298 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.414 ' CD2' ' HG3' ' A' ' 49' ' ' GLU . 27.3 m80 -132.24 160.38 36.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.961 0.41 . . . . 0.0 111.185 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 78.9 mt -127.11 118.72 24.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.845 179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.5 t -100.36 121.85 51.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.129 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -89.7 125.27 35.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.888 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.7 mp -86.74 106.97 18.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.877 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.519 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 1.7 mt -124.11 141.39 37.07 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.63 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.519 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 56.2 Cg_endo -72.14 -8.33 22.64 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.171 1.914 . . . . 0.0 112.489 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -109.29 -14.2 15.31 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.555 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 175.97 -165.84 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.705 0.288 . . . . 0.0 110.744 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -137.99 132.42 32.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.923 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -108.13 133.59 52.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.1 tttm -113.06 122.93 49.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.942 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 18.6 t -111.56 151.16 13.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.997 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.414 ' HG3' ' CD2' ' A' ' 36' ' ' HIS . 0.3 OUTLIER -104.85 119.42 38.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.063 -179.878 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 27.3 mm -98.37 132.09 44.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.829 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -103.2 168.03 9.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.063 -179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 14.3 p30 -97.68 73.64 2.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.435 179.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.629 ' C ' ' H ' ' A' ' 55' ' ' VAL . 6.1 ptp180 -103.47 16.9 25.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.614 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.412 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 13.7 m120 68.49 -29.16 0.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.629 ' H ' ' C ' ' A' ' 53' ' ' ARG . 59.4 t -137.38 131.3 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-O 121.072 0.463 . . . . 0.0 111.623 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.447 ' N ' ' O ' ' A' ' 80' ' ' PHE . 45.7 m -125.29 125.86 44.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.688 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.401 ' HB ' ' HA ' ' A' ' 64' ' ' CYS . 0.1 OUTLIER -103.67 130.76 51.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.986 0.422 . . . . 0.0 111.183 -179.64 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 5.2 mp -112.23 117.17 54.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.789 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 172.56 -141.92 6.51 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.357 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.526 ' HB3' ' HA ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -111.47 -23.17 10.9 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.696 0.284 . . . . 0.0 111.233 179.891 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -51.88 126.06 17.03 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.8 0.334 . . . . 0.0 111.072 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.22 -28.61 59.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.049 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.27 -22.45 59.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.113 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.401 ' HA ' ' HB ' ' A' ' 57' ' ' THR . 94.2 m -55.76 168.14 0.47 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.982 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -89.24 -51.37 5.61 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.863 0.363 . . . . 0.0 110.893 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.6 t -104.22 132.02 51.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.029 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.4 pt -108.16 128.96 63.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.357 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.3 mp -114.3 -152.32 0.5 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.304 179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.575 ' O ' ' CB ' ' A' ' 70' ' ' GLU . 0.5 OUTLIER -42.08 -58.45 2.1 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.506 0.193 . . . . 0.0 110.753 179.779 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.688 ' HB3' ' HD3' ' A' ' 71' ' ' PRO . 0.7 OUTLIER 110.42 -56.04 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.585 0 C-N-CA 123.594 0.758 . . . . 0.0 112.209 178.708 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.688 ' HD3' ' HB3' ' A' ' 70' ' ' GLU . 16.9 Cg_exo -67.22 -40.08 11.94 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.177 1.918 . . . . 0.0 112.899 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -107.06 23.92 13.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.828 0.347 . . . . 0.0 111.016 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.8 tp -115.94 127.9 73.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.103 -179.731 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 54.7 m -67.48 131.76 46.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.902 -179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 85.1 m -58.75 -33.12 69.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.574 179.824 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.442 ' O ' ' C ' ' A' ' 77' ' ' HIS . 0.1 OUTLIER -112.19 13.96 20.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.537 179.859 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.442 ' C ' ' O ' ' A' ' 76' ' ' PHE . 1.0 OUTLIER -22.03 -69.61 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.748 -1.115 . . . . 0.0 112.576 -179.339 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -159.33 164.06 35.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.101 0.477 . . . . 0.0 111.936 -179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -123.74 140.23 53.2 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.405 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.447 ' O ' ' N ' ' A' ' 56' ' ' THR . 2.3 m-85 -119.38 131.16 55.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.866 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.412 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 4.4 m-70 -95.28 116.26 28.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.82 0.343 . . . . 0.0 111.082 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.64 109.62 21.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.853 179.588 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 7.1 mp -122.32 140.15 52.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.978 179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -111.92 121.02 43.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.834 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -132.37 130.09 40.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.929 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -107.06 128.56 54.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.936 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.6 t -129.83 136.08 59.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.953 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.0 t0 71.98 -60.67 0.52 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.982 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -176.09 -39.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.767 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -81.03 131.85 35.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.731 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -82.96 128.14 34.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.032 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -112.98 143.1 44.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.783 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 27.0 m120 -114.01 129.56 56.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.051 -179.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.9 mt -120.62 142.36 49.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.703 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.456 HG13 ' CE1' ' A' ' 135' ' ' PHE . 10.7 mm -124.26 141.17 45.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.245 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -113.8 138.54 50.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.743 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . . . . . . . . . 21.4 t -109.63 120.85 61.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.311 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 13.9 mt -130.15 120.94 50.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.88 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -115.32 126.12 54.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.957 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.05 28.38 5.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.056 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 58.11 106.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.05 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.21 -76.08 0.28 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.893 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -125.02 27.87 6.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.254 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 66.79 128.14 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.597 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.4 HG22 ' CD1' ' A' ' 127' ' ' PHE . 63.1 m -131.29 123.02 27.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.821 0.343 . . . . 0.0 110.751 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.42 ' CE2' ' HG3' ' A' ' 111' ' ' ARG . 62.2 m-85 -120.02 114.97 22.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.93 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.4 HD13 ' CE2' ' A' ' 117' ' ' TYR . 2.1 pp -109.48 131.19 61.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.118 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 59.59 31.75 21.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.968 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.63 13.05 74.5 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.96 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -129.12 132.36 47.36 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.845 0.355 . . . . 0.0 110.895 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.42 ' HG3' ' CE2' ' A' ' 106' ' ' PHE . 5.4 ttt180 -68.41 142.99 55.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.92 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -81.47 132.74 35.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.851 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 14.7 p -144.06 32.62 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.081 179.991 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 4.1 mptt -131.12 138.18 49.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.843 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.08 -40.05 86.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.896 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -126.31 78.43 1.77 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.939 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.4 ' CE2' HD13 ' A' ' 107' ' ' ILE . 31.9 t80 -84.05 139.07 32.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.819 179.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.5 tp -98.52 119.94 47.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.011 0.434 . . . . 0.0 111.289 -179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.436 ' HB3' ' HB ' ' A' ' 95' ' ' ILE . 3.1 tt -103.18 142.37 34.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.014 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 6.3 mttt -125.42 178.03 5.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.072 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.448 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 7.9 p30 -62.73 146.86 51.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.173 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 68.92 51.86 27.0 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.342 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . 0.401 ' HB2' ' CD2' ' A' ' 119' ' ' LEU . 0.7 OUTLIER -127.61 124.31 37.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.843 0.354 . . . . 0.0 111.191 -179.752 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 24.8 ttm180 -84.7 132.3 34.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.707 179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.443 ' CD1' ' CE2' ' A' ' 133' ' ' PHE . 22.5 pt -129.56 128.4 65.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.212 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.6 t -113.56 129.63 69.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.0 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.4 ' CD1' HG22 ' A' ' 105' ' ' THR . 5.5 m-85 -116.77 111.96 20.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.004 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 104.76 -75.55 0.25 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.479 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 5.6 tttt 179.42 -38.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.769 0.319 . . . . 0.0 110.989 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 12.0 p -104.51 -40.59 5.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.287 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 22.0 m -57.93 107.04 0.42 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.842 0.353 . . . . 0.0 111.079 -179.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 29.7 t -124.21 119.92 30.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.788 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.446 ' CD1' ' N ' ' A' ' 133' ' ' PHE . 1.1 p90 -141.9 150.32 41.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.091 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.22 140.13 43.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.777 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.456 ' CE1' HG13 ' A' ' 95' ' ' ILE . 12.3 t80 -102.25 141.26 35.38 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 121.893 0.854 . . . . 0.0 111.664 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.449 ' N ' ' CD1' ' A' ' 135' ' ' PHE . 7.2 mttp -154.68 155.4 34.55 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 113.829 -1.532 . . . . 0.0 111.128 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.448 ' CE2' ' HB3' ' A' ' 121' ' ' ASN . 8.7 m-85 -86.16 140.0 30.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.003 0.43 . . . . 0.0 110.638 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.407 ' HB2' ' CE1' ' A' ' 36' ' ' HIS . . . -127.24 70.71 1.31 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.123 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 3.2 m -93.29 -52.0 4.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.866 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.0 t -111.57 149.12 31.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.857 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.09 96.92 1.88 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.946 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.3 m -124.8 -44.62 1.94 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.881 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.9 m -136.9 88.63 2.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.922 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -154.29 31.17 0.43 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.894 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.8 mt -111.06 24.99 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 CA-C-O 121.611 0.72 . . . . 0.0 111.308 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -125.14 172.13 9.74 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.902 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -95.31 145.15 25.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.914 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -76.02 125.44 29.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.93 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -105.63 32.66 4.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.912 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -120.63 -48.15 2.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.877 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -88.69 -60.15 2.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.881 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.5 t -84.01 147.46 5.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.039 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 80.2 p -155.87 97.81 1.85 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.929 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 18.0 m -119.65 88.81 3.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.86 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -149.13 110.72 4.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.859 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 4.3 t -136.23 36.17 2.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.859 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -106.23 130.28 54.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.929 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 29.7 t -91.64 96.76 10.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.971 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 10.6 t80 . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.295 -0.86 . . . . 0.0 110.844 -179.973 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.3 mmtp . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.756 0.312 . . . . 0.0 111.254 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.38 31.73 4.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.842 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -112.28 -36.76 5.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.857 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.46 137.46 34.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.846 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -131.25 -59.65 0.97 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.877 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -119.4 137.73 53.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.907 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -81.18 -35.75 31.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.878 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.3 mttp -107.92 104.86 54.82 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.894 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -68.17 141.51 52.6 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.353 2.036 . . . . 0.0 112.364 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.7 m -105.48 165.67 10.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.965 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.06 160.18 21.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.927 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -144.6 130.44 19.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.811 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.409 ' CD1' ' HG2' ' A' ' 53' ' ' ARG . 4.6 m-85 -70.08 -100.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.938 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -140.48 137.34 33.8 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.842 0.353 . . . . 0.0 110.675 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.8 t -72.27 120.57 18.07 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.977 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.7 tt -119.81 -40.5 2.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.893 179.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -149.25 -169.6 15.95 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.49 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 51.1 m80 -146.96 160.65 42.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.774 0.321 . . . . 0.0 110.919 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.4 mp -127.1 119.33 26.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.799 179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.4 t -98.28 121.76 49.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.179 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -89.93 119.16 30.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.844 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -75.37 106.88 7.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.915 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.418 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 18.9 mt -124.11 138.75 31.27 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.847 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.418 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 86.6 Cg_exo -44.46 -28.76 2.78 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.48 2.12 . . . . 0.0 112.441 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -111.18 -143.4 9.37 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.268 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.0 mtpt -53.89 113.77 1.33 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.83 0.347 . . . . 0.0 111.134 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -59.93 168.02 1.99 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.955 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -135.66 125.01 24.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.015 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.01 134.28 54.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.92 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.8 t -125.42 139.42 51.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.122 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -80.31 139.67 36.5 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.748 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.2 tt -116.01 130.86 70.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.895 0.378 . . . . 0.0 111.398 -179.775 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -96.77 168.11 10.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.6 179.733 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -110.76 73.16 0.81 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.677 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.637 ' C ' ' H ' ' A' ' 55' ' ' VAL . 0.1 OUTLIER -98.65 23.36 8.76 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.115 -179.788 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 69.83 -28.3 0.17 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.637 ' H ' ' C ' ' A' ' 53' ' ' ARG . 58.6 t -137.29 134.18 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-O 121.111 0.481 . . . . 0.0 111.506 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.463 ' N ' ' O ' ' A' ' 80' ' ' PHE . 18.0 m -125.45 125.9 44.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.372 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.4 ' HB ' ' HA ' ' A' ' 64' ' ' CYS . 0.0 OUTLIER -103.78 133.24 49.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.956 0.408 . . . . 0.0 111.213 -179.444 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.417 HD13 ' CD1' ' A' ' 80' ' ' PHE . 3.9 mp -118.35 116.73 52.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.896 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 173.42 -142.37 6.58 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.657 -179.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.423 ' HB2' ' CG2' ' A' ' 73' ' ' ILE . 11.7 ttp180 -103.76 -30.94 10.08 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.777 0.322 . . . . 0.0 110.947 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -49.17 124.46 9.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.241 -179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 47.6 mtm180 -57.04 -30.32 64.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.904 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.4 m -69.99 -21.96 63.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.081 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.4 ' HA ' ' HB ' ' A' ' 57' ' ' THR . 86.5 m -55.8 166.17 0.77 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.995 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.7 t70 -83.58 -48.13 10.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.816 0.341 . . . . 0.0 111.033 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 58' ' ' ILE . 21.3 t -124.93 125.43 69.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.515 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.6 pt -98.28 131.04 46.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.786 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.437 ' O ' ' HB ' ' A' ' 73' ' ' ILE . 19.9 mt -118.25 105.17 11.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.263 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.57 ' O ' ' CB ' ' A' ' 70' ' ' GLU . 0.6 OUTLIER 68.75 -70.27 0.14 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.571 179.991 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.57 ' CB ' ' O ' ' A' ' 69' ' ' SER . 31.1 mt-10 112.18 -60.71 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.84 0 C-N-CA 123.992 0.917 . . . . 0.0 112.336 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.556 ' HD2' ' C ' ' A' ' 69' ' ' SER . 38.1 Cg_endo -66.74 -14.15 42.73 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.123 1.882 . . . . 0.0 113.367 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -129.18 25.72 5.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.66 0.267 . . . . 0.0 111.269 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.437 ' HB ' ' O ' ' A' ' 68' ' ' LEU . 4.9 tp -119.89 150.61 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-O 120.943 0.402 . . . . 0.0 111.566 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.45 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 45.0 t -94.88 129.38 41.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.063 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 58.0 m -53.7 -33.39 55.33 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.157 179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -112.3 14.0 20.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.167 0.508 . . . . 0.0 111.838 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.45 ' HB2' ' O ' ' A' ' 74' ' ' SER . 2.0 t-160 -29.17 -70.38 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.901 -1.045 . . . . 0.0 112.617 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -154.96 164.15 39.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.08 0.467 . . . . 0.0 112.126 -179.34 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -127.79 139.23 52.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.206 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.463 ' O ' ' N ' ' A' ' 56' ' ' THR . 5.5 m-85 -119.42 131.33 55.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.984 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -94.59 116.39 28.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.972 0.415 . . . . 0.0 110.964 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 4.2 mm? -106.47 109.72 21.72 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.775 179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.9 tp -120.79 140.0 52.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.065 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -107.63 126.36 52.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.745 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -126.09 143.09 51.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.984 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -95.84 116.91 29.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.895 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.6 t -138.71 121.05 17.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.073 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 62.11 -176.59 0.13 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.825 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 22.7 t30 -50.7 -31.13 15.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.257 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -94.46 -177.53 4.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.922 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -115.67 128.66 56.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.849 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.19 123.2 43.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.923 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -113.51 138.26 50.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.745 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -132.07 134.22 45.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.95 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.417 HD11 ' CE1' ' A' ' 135' ' ' PHE . 3.6 mp -115.45 141.11 33.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.976 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -113.91 137.66 51.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.844 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.419 HG21 ' CE2' ' A' ' 80' ' ' PHE . 12.1 t -105.78 126.36 61.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.222 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 33.9 mt -129.95 120.99 51.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.984 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.76 139.01 54.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.951 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.3 mmtm -99.92 6.27 45.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.332 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.6 m 58.08 101.83 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.75 0.31 . . . . 0.0 111.014 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 14.3 ttt180 -149.23 -63.72 0.23 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.889 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -96.2 -45.61 6.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.235 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 132.96 106.08 0.97 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.554 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.9 m -118.52 126.36 51.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.835 0.35 . . . . 0.0 110.949 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.417 ' CE2' ' HB2' ' A' ' 111' ' ' ARG . 19.3 m-85 -120.83 121.26 37.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.882 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.3 tp -108.51 137.29 40.97 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 CA-C-O 121.522 0.677 . . . . 0.0 111.193 179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 61.71 28.05 17.26 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.825 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.69 9.55 69.99 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.947 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -134.1 152.0 51.64 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.804 0.335 . . . . 0.0 110.862 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.417 ' HB2' ' CE2' ' A' ' 106' ' ' PHE . 0.6 OUTLIER -71.77 133.02 45.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.954 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.9 pp -88.57 134.62 33.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.924 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 13.0 m -110.52 -30.22 2.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.224 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.2 153.97 31.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.983 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.62 -36.3 16.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.895 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -102.93 74.62 1.33 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.917 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -83.72 139.04 32.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.815 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.6 tp -98.63 118.99 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.148 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.1 tt -103.04 135.88 43.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.056 -179.653 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -131.07 178.12 6.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.743 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.436 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 4.5 p-10 -52.95 143.77 16.34 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.091 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 68.51 44.04 74.48 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.475 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -112.85 121.19 43.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.806 0.336 . . . . 0.0 110.916 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.5 mpt_? -90.51 119.03 30.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.871 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.6 mt -114.94 132.07 65.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.061 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 29.6 t -116.57 131.84 67.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.174 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -118.57 133.63 55.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.975 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 80.19 -66.19 3.67 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.446 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 170.38 -33.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.814 0.34 . . . . 0.0 110.998 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.3 p -107.19 -42.76 4.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.287 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 59.5 m -56.4 104.78 0.16 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.874 0.369 . . . . 0.0 111.194 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.42 125.01 43.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.922 179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.43 ' CD1' ' N ' ' A' ' 133' ' ' PHE . 2.1 p90 -142.15 156.12 45.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.93 0.395 . . . . 0.0 111.091 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 9.6 tt -116.25 138.97 50.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.645 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.417 ' CE1' HD11 ' A' ' 95' ' ' ILE . 25.4 t80 -103.38 141.4 36.01 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 122.029 0.919 . . . . 0.0 111.875 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 11.4 mtmt -154.67 143.8 21.09 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 113.787 -1.552 . . . . 0.0 110.74 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.436 ' CE2' ' HB3' ' A' ' 121' ' ' ASN . 4.0 m-85 -72.86 139.72 47.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.002 0.43 . . . . 0.0 110.72 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -119.69 103.47 9.42 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.092 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 35.7 p -87.95 163.65 16.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.951 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.3 m -111.22 -34.42 6.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.66 133.29 17.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.825 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.4 t -117.98 -41.55 2.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.888 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 40.8 p -94.69 179.26 5.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.907 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -132.18 128.82 38.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.854 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.46 ' CG2' ' H ' ' A' ' 146' ' ' GLU . 2.4 mt -110.4 -143.39 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.098 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.46 ' H ' ' CG2' ' A' ' 145' ' ' ILE . 0.0 OUTLIER -152.96 34.31 0.48 Allowed 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.913 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 36.3 m120 61.68 56.1 2.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.904 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -95.88 109.71 22.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.848 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -106.22 31.63 5.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.947 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.16 87.26 4.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.86 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 17.9 mttp -77.32 93.03 3.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.971 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 5.7 m -120.0 -41.66 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.056 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.9 p -96.49 105.11 17.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.854 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 79.7 p -171.0 165.65 7.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.884 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 60.74 31.7 20.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.816 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 8.9 m -119.74 -66.9 1.02 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.82 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.38 84.27 0.91 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.847 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.8 p -167.98 145.84 4.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.806 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 20.1 t80 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.335 -0.841 . . . . 0.0 110.879 179.924 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.8 0.333 . . . . 0.0 111.208 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.41 101.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.84 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -75.04 127.03 32.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.989 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -149.09 -64.89 0.23 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.887 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 59.89 99.48 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.944 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 83.8 p -72.38 -42.78 64.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.826 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -130.88 174.98 9.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.817 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.417 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -178.19 -61.95 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.055 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.417 ' CD ' ' CB ' ' A' ' 26' ' ' LYS . 39.7 Cg_endo -67.0 145.59 74.39 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.488 2.126 . . . . 0.0 112.366 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -154.44 -170.43 3.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.803 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.5 m -151.37 138.07 18.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.903 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -60.33 160.76 8.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.771 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -74.86 -99.84 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.802 -179.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -140.4 128.79 22.61 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.68 0.276 . . . . 0.0 110.743 179.831 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 10.6 t -69.7 114.9 8.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.58 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.1 tp -118.16 -41.95 2.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.28 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -148.53 -167.92 14.07 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.233 -0.984 . . . . 0.0 113.056 -179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.422 ' CD2' ' HG3' ' A' ' 49' ' ' GLU . 46.1 m80 -144.58 161.04 40.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.862 0.363 . . . . 0.0 110.683 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 23.5 mt -127.11 112.85 15.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.666 179.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.5 t -95.92 121.77 46.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.135 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -90.23 125.96 35.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.933 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.8 mp -106.1 106.81 17.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.802 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.8 mm -124.03 138.17 30.2 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.086 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -55.78 87.11 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.4 2.067 . . . . 0.0 112.205 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 139.51 -22.55 2.86 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.662 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.9 mtpt 177.01 164.03 0.49 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.861 0.363 . . . . 0.0 110.814 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -122.61 -178.19 3.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.906 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.53 134.93 16.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.882 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -109.03 122.7 47.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.854 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.3 t -122.47 151.12 26.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.211 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.422 ' HG3' ' CD2' ' A' ' 36' ' ' HIS . 0.4 OUTLIER -94.69 130.65 41.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.602 179.852 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 3.1 tt -116.1 128.88 73.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.084 0.469 . . . . 0.0 111.578 -179.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -96.79 168.12 10.69 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.196 179.539 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . 0.526 ' HA ' ' HB3' ' A' ' 82' ' ' LEU . 56.5 m-80 -68.51 -89.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.333 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.598 ' C ' ' H ' ' A' ' 55' ' ' VAL . 12.9 ttt-85 72.79 -1.09 3.12 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 179.013 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.404 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 1.3 m-20 70.33 -34.06 0.28 Allowed 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.096 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.598 ' H ' ' C ' ' A' ' 53' ' ' ARG . 64.1 t -137.04 134.84 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 CA-C-O 121.012 0.434 . . . . 0.0 110.949 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.467 ' N ' ' O ' ' A' ' 80' ' ' PHE . 50.6 m -125.28 132.17 52.96 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.061 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.405 ' HB ' ' CB ' ' A' ' 64' ' ' CYS . 0.0 OUTLIER -104.33 143.84 32.44 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.843 0.354 . . . . 0.0 111.231 -179.786 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.8 mp -130.76 126.72 60.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.083 -179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 164.98 -139.28 5.73 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.667 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.41 ' HB2' ' CG2' ' A' ' 73' ' ' ILE . 10.6 ttp180 -106.85 -26.59 11.18 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.749 0.309 . . . . 0.0 110.969 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -52.12 136.5 29.68 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.24 -179.741 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.74 -31.89 72.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.915 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 46.2 p -69.95 -23.91 63.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.942 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.405 ' CB ' ' HB ' ' A' ' 57' ' ' THR . 96.4 m -56.64 171.87 0.29 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.944 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.414 ' HB2' HG23 ' A' ' 56' ' ' THR . 0.7 OUTLIER -85.07 -68.16 0.75 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.002 0.429 . . . . 0.0 110.885 179.813 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.2 t -105.95 115.31 47.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.899 179.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.4 pt -91.94 104.97 16.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.553 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.435 ' O ' ' O ' ' A' ' 69' ' ' SER . 1.8 mp -66.85 -155.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.837 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.482 ' O ' ' CB ' ' A' ' 70' ' ' GLU . 19.1 p -41.81 -96.43 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 117.592 0.178 . . . . 0.0 111.193 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.519 ' CB ' ' HD3' ' A' ' 71' ' ' PRO . 1.5 mt-10 159.19 -60.93 0.0 OUTLIER Pre-proline 0 N--CA 1.466 0.366 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.519 ' HD3' ' CB ' ' A' ' 70' ' ' GLU . 36.4 Cg_exo -57.4 -40.31 82.47 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.206 1.937 . . . . 0.0 113.241 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -116.53 28.86 8.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.698 0.285 . . . . 0.0 111.313 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.429 HD11 ' CD2' ' A' ' 68' ' ' LEU . 4.9 tp -110.6 126.74 67.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.99 0.424 . . . . 0.0 111.293 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 1.5 m -79.03 134.66 36.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.194 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 72.0 m -61.03 -29.16 69.56 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.02 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.431 ' O ' ' C ' ' A' ' 77' ' ' HIS . 0.3 OUTLIER -106.91 14.02 27.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.237 0.541 . . . . 0.0 111.598 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.458 ' CE1' ' HB3' ' A' ' 127' ' ' PHE . 1.4 t-160 -24.41 -71.11 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.759 -1.109 . . . . 0.0 112.747 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -163.43 164.12 24.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.062 0.458 . . . . 0.0 112.019 -179.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -124.35 140.88 52.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.342 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.467 ' O ' ' N ' ' A' ' 56' ' ' THR . 3.2 m-85 -119.22 131.15 55.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.751 0.31 . . . . 0.0 110.863 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -94.82 116.47 28.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.909 0.385 . . . . 0.0 111.038 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.526 ' HB3' ' HA ' ' A' ' 52' ' ' ASN . 0.1 OUTLIER -106.41 109.55 21.51 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.107 179.866 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.23 130.62 53.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.814 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 5.7 tm0? -107.0 128.12 54.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.925 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 9.4 ttt -152.03 143.15 23.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.928 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -99.89 131.13 46.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.852 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 19.8 t -137.01 134.46 47.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.112 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 61.11 39.83 15.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.833 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 62.26 32.67 17.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.856 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -145.68 157.09 43.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.882 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -82.98 127.92 33.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.905 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -117.01 117.44 29.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.008 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 12.4 m120 -105.42 119.96 40.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.766 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.4 mt -118.2 125.65 50.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.077 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.403 HG13 ' CE1' ' A' ' 135' ' ' PHE . 11.7 mm -115.0 133.3 61.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.013 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -113.94 143.49 44.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.635 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.433 HG13 ' CE1' ' A' ' 80' ' ' PHE . 18.0 t -109.12 132.63 56.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.381 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.422 HG22 HD11 ' A' ' 98' ' ' ILE . 25.3 mm -130.05 120.93 50.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.029 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -102.23 127.05 49.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.964 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.4 mmtp -140.69 31.54 1.85 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.886 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.6 m -123.92 178.35 5.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.953 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -121.95 31.25 6.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.951 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -103.58 -56.29 2.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.186 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 138.05 120.78 1.9 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.514 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.8 m -125.59 122.95 37.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.813 0.34 . . . . 0.0 110.911 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 46.1 m-85 -116.31 129.15 56.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.848 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.1 tp -123.08 137.24 57.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.445 0.641 . . . . 0.0 111.378 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 61.86 29.71 17.98 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.838 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.64 12.98 74.49 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.87 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 73.3 m-80 -133.47 152.01 51.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.798 0.332 . . . . 0.0 110.849 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -68.0 143.05 55.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.932 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -85.46 126.31 33.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.865 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.2 p -112.16 -40.81 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.113 179.994 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 7.6 tptp -76.56 163.71 26.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.968 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.68 -29.25 18.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.902 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -121.13 82.06 1.87 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.018 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -84.09 139.21 32.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.673 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.407 ' O ' ' CG2' ' A' ' 118' ' ' ILE . 8.7 tp -98.52 118.52 45.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.435 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.0 tt -103.2 143.93 31.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.841 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.3 mmtt -127.51 178.01 6.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.851 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.439 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 11.7 p-10 -59.94 148.07 36.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.973 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 64.05 43.71 96.92 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.413 179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -114.69 130.74 56.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.774 0.321 . . . . 0.0 111.069 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.2 mmm-85 -83.87 130.77 34.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.712 179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.43 ' HB ' ' CE1' ' A' ' 133' ' ' PHE . 2.7 mt -126.8 128.14 70.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.356 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 40.6 t -122.76 124.01 69.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.734 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.458 ' HB3' ' CE1' ' A' ' 77' ' ' HIS . 3.3 m-85 -113.47 145.98 40.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.969 0.414 . . . . 0.0 111.306 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 70.6 -65.17 0.82 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.435 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 173.83 -50.18 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.853 0.358 . . . . 0.0 110.859 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 89.1 p -96.15 -36.15 11.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.203 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 24.7 m -57.66 104.49 0.19 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.003 0.43 . . . . 0.0 111.124 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.41 124.14 41.69 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.951 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.43 ' CE1' ' HB ' ' A' ' 125' ' ' ILE . 8.4 p90 -142.13 153.64 44.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.966 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.0 tt -112.22 133.93 54.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.766 179.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.403 ' CE1' HG13 ' A' ' 95' ' ' ILE . 48.0 t80 -106.42 141.4 37.79 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 121.958 0.885 . . . . 0.0 111.802 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.55 157.44 38.29 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 113.928 -1.487 . . . . 0.0 111.119 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.439 ' CE2' ' HB3' ' A' ' 121' ' ' ASN . 6.7 m-85 -86.0 139.87 30.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.761 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -117.73 130.37 56.28 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.125 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 33.8 t -133.2 163.14 29.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.93 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 75.1 p -153.34 165.2 36.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.889 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.3 m -124.76 -44.44 1.95 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.929 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.42 -58.54 2.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.898 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 39.9 p -131.99 176.74 8.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -90.34 -28.19 18.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.984 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.7 mp -144.45 118.18 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 CA-C-O 121.798 0.808 . . . . 0.0 109.556 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -166.37 -61.11 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 114.33 -1.305 . . . . 0.0 110.803 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -73.78 109.0 6.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.832 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.45 107.03 10.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.821 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -126.57 178.29 5.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.816 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 21.9 mp0 -130.94 134.46 46.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.921 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 33.3 mttm -93.9 -35.64 12.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.94 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 11.6 m -80.2 76.53 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.065 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.6 p -166.09 162.1 17.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.899 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 16.6 t -109.75 -40.56 4.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.87 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 60.22 32.32 20.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.937 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 3.9 m 60.63 79.59 0.24 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.887 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -84.88 159.95 20.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.942 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 2.1 t -109.96 95.18 5.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.927 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.28 -0.867 . . . . 0.0 110.86 -179.978 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.2 mmtt . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.787 0.327 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.19 29.43 18.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.19 -174.55 2.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.874 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 61.19 103.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.931 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -129.17 171.86 12.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.877 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.9 m -62.74 137.06 58.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -160.38 -53.88 0.05 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.866 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.45 109.38 49.97 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.794 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -57.92 152.9 47.61 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.522 2.148 . . . . 0.0 112.202 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 67.1 m -139.97 -64.04 0.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.861 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.3 p -155.47 88.14 1.13 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.919 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 60.04 165.54 0.07 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.876 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.496 ' HB2' HG23 ' A' ' 51' ' ' THR . 83.2 m-85 -104.13 -121.38 0.2 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.546 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.414 ' N ' HG23 ' A' ' 51' ' ' THR . 0.1 OUTLIER -140.25 129.32 23.55 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.776 0.322 . . . . 0.0 110.692 179.815 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 4.4 t -62.05 138.43 58.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.07 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.1 tp -142.54 -47.83 0.34 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.708 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -137.63 -174.68 13.47 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.287 179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.402 ' NE2' ' CG ' ' A' ' 49' ' ' GLU . 50.5 m80 -144.83 163.76 33.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.893 0.378 . . . . 0.0 111.031 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.0 mt -126.59 131.05 51.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.683 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.1 t -105.33 121.92 58.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.094 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.401 ' N ' ' OD1' ' A' ' 39' ' ' ASN . 1.1 m-20 -89.99 126.01 35.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.794 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.94 106.54 18.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.88 0.371 . . . . 0.0 110.782 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.529 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 4.3 mp -124.49 141.06 36.68 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.906 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.529 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 58.9 Cg_endo -74.44 83.31 1.72 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.102 1.868 . . . . 0.0 111.978 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 143.33 -14.3 2.29 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.531 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.02 176.18 0.92 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 120.716 0.293 . . . . 0.0 110.672 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -132.73 160.62 36.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.141 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -137.78 130.27 29.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.814 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 33.6 tttt -106.21 127.28 53.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.007 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 23.5 t -117.47 147.73 20.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.083 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.402 ' CG ' ' NE2' ' A' ' 36' ' ' HIS . 3.4 mt-10 -97.26 135.72 38.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.844 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.1 tt -115.25 132.15 65.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.093 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.496 HG23 ' HB2' ' A' ' 31' ' ' TYR . 0.7 OUTLIER -106.46 168.46 9.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.253 -179.653 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -85.07 68.93 10.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.153 0.502 . . . . 0.0 110.511 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.602 ' C ' ' H ' ' A' ' 55' ' ' VAL . 19.3 ttt-85 -87.77 4.45 44.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.814 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.498 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 10.3 m120 69.0 -35.08 0.29 Allowed 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -178.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.602 ' H ' ' C ' ' A' ' 53' ' ' ARG . 70.5 t -137.27 135.23 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.599 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.467 ' N ' ' O ' ' A' ' 80' ' ' PHE . 53.4 m -125.15 126.52 45.4 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.023 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.73 131.05 51.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.964 0.411 . . . . 0.0 110.732 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.452 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 5.0 mp -119.77 118.91 58.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.929 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 172.46 -137.18 4.1 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.449 -0.881 . . . . 0.0 113.201 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.461 ' HD2' ' O ' ' A' ' 70' ' ' GLU . 11.2 ttt-85 -103.29 -38.13 7.36 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.815 0.34 . . . . 0.0 111.103 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -45.8 127.52 8.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.583 -179.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.8 -29.1 69.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.737 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 94.2 p -69.93 -23.67 63.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.826 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 87.9 m -53.3 158.15 1.73 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.87 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 8.8 t0 -74.09 -47.62 35.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.847 0.356 . . . . 0.0 111.008 -179.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.452 ' O ' ' HA ' ' A' ' 58' ' ' ILE . 20.8 t -125.08 133.27 69.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.559 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 4.7 pt -100.24 118.93 47.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.603 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.434 ' HG ' ' CZ ' ' A' ' 133' ' ' PHE . 2.3 mp -84.83 -86.67 0.13 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.784 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 38.9 m -107.7 -109.77 0.31 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.596 ' CB ' ' HD3' ' A' ' 71' ' ' PRO . 0.1 OUTLIER 168.34 -63.49 0.0 OUTLIER Pre-proline 0 CA--C 1.529 0.157 0 O-C-N 122.375 -0.203 . . . . 0.0 111.541 178.862 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.596 ' HD3' ' CB ' ' A' ' 70' ' ' GLU . 21.5 Cg_exo -64.74 -22.14 64.28 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 121.977 1.785 . . . . 0.0 112.867 -179.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -136.32 22.07 3.2 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.684 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.46 ' CG2' ' HB2' ' A' ' 60' ' ' ARG . 4.7 tp -105.68 121.25 57.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.06 0.457 . . . . 0.0 110.957 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 13.8 m -65.24 133.08 50.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.484 -179.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 77.8 m -58.73 -35.34 72.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.974 179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.43 ' O ' ' C ' ' A' ' 77' ' ' HIS . 0.2 OUTLIER -112.01 14.14 20.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.225 0.536 . . . . 0.0 111.361 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.43 ' C ' ' O ' ' A' ' 76' ' ' PHE . 14.8 t60 -24.88 -69.14 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.648 -179.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -149.77 163.96 36.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.07 0.462 . . . . 0.0 112.056 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -129.01 137.98 51.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.462 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.467 ' O ' ' N ' ' A' ' 56' ' ' THR . 2.0 m-85 -119.57 125.98 50.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.848 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.406 ' CD2' HD12 ' A' ' 98' ' ' ILE . 10.1 m-70 -94.84 116.19 28.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.913 0.387 . . . . 0.0 111.294 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.64 109.5 21.44 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.714 179.399 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.9 tp -122.49 140.2 53.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.2 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -122.82 120.95 35.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.807 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -115.47 126.58 54.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.985 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -107.07 117.56 34.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.904 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 25.3 t -133.54 125.08 49.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.015 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.5 t70 70.61 -61.55 0.47 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.048 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -176.54 -39.64 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.845 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -89.48 101.28 13.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.68 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -82.93 145.44 29.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.051 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 2.8 ttp-105 -113.1 141.13 47.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.808 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -107.35 129.92 54.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.029 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -126.7 133.9 50.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.718 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.8 mp -117.48 140.77 39.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.22 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -117.82 125.82 51.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.825 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.422 HG21 ' CZ ' ' A' ' 80' ' ' PHE . 18.0 t -96.34 131.48 43.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.131 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.406 HD12 ' CD2' ' A' ' 81' ' ' HIS . 32.4 mt -123.0 120.95 61.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.03 179.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.48 117.88 26.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.93 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.04 30.06 1.82 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.885 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 18.5 m -96.04 177.71 5.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.825 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.9 29.58 1.87 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.093 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 34.7 p-10 -135.18 -44.85 0.71 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.964 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 157.33 117.01 0.52 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.739 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.401 HG23 ' CD1' ' A' ' 127' ' ' PHE . 62.5 m -132.04 122.75 25.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.734 0.302 . . . . 0.0 110.79 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -121.21 139.07 53.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.188 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.3 tp -122.79 137.34 56.62 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 CA-C-O 121.443 0.639 . . . . 0.0 111.196 179.729 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 60.52 30.0 19.43 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.65 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.69 12.67 74.36 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.843 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -134.14 152.03 51.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.819 0.342 . . . . 0.0 110.769 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.83 143.09 44.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.872 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.2 mp -74.74 131.33 40.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.942 -179.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.3 p -114.73 -37.09 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.07 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 9.9 tttt -115.38 149.77 37.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.871 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.3 165.94 21.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.027 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 27.5 t70 62.48 64.73 0.91 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.988 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -84.04 138.47 33.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.846 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.4 tp -98.7 120.28 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.226 -179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.7 tt -103.07 139.06 39.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.992 -179.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 13.0 mmtp -129.84 178.17 6.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.74 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.446 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 4.8 p-10 -53.41 148.0 9.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.153 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 64.08 37.5 94.68 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.565 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -109.81 127.85 54.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.821 0.343 . . . . 0.0 110.96 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 54.2 mtt180 -93.6 132.69 37.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.858 179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -118.42 122.0 68.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.087 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 46.7 t -112.71 123.9 68.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.771 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.401 ' CD1' HG23 ' A' ' 105' ' ' THR . 68.5 m-85 -120.38 148.03 44.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.951 0.405 . . . . 0.0 111.211 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 73.79 -65.84 1.78 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.348 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 175.35 -50.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.807 0.337 . . . . 0.0 111.022 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.06 -33.13 9.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.681 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 21.6 m -55.74 105.46 0.18 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.884 0.373 . . . . 0.0 110.98 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 13.7 p -124.22 136.76 54.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.918 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.434 ' CZ ' ' HG ' ' A' ' 68' ' ' LEU . 15.5 m-85 -142.25 156.21 45.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.151 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.8 tt -121.66 116.1 23.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.711 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 21.4 t80 -94.7 141.56 28.47 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 122.054 0.931 . . . . 0.0 111.895 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 6.8 tttt -154.62 160.4 41.43 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 113.781 -1.554 . . . . 0.0 110.85 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.446 ' CE2' ' HB3' ' A' ' 121' ' ' ASN . 3.7 m-85 -86.07 139.98 30.66 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.051 0.453 . . . . 0.0 110.681 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -95.7 170.51 9.27 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.058 179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 12.0 m -109.39 156.98 19.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.014 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 60.5 p -111.45 31.53 6.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.847 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -99.76 -170.03 1.83 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.942 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.2 m -80.42 138.64 36.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.986 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 18.9 p -113.28 -36.56 4.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.931 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 61.11 173.7 0.11 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.894 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 19.1 mm -106.37 24.93 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 CA-C-O 121.551 0.691 . . . . 0.0 111.345 179.984 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -105.3 110.29 22.6 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.8 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -138.17 107.5 6.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.846 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 23.8 p30 -88.4 167.75 13.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.941 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -134.43 -55.37 0.85 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.905 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -175.71 -41.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.897 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 7.5 mttp -67.86 127.96 34.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 10.9 p -115.43 -38.26 2.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.098 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 96.7 p -109.49 150.13 28.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.894 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.4 m -80.5 117.19 21.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.955 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -117.57 -40.91 2.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.848 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.9 m -60.07 157.64 12.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.855 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -89.45 78.13 7.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.881 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.74 179.2 4.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.9 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 1.4 t80 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.95 -179.971 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.5 mptt . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.832 0.348 . . . . 0.0 111.119 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.7 mtt180 -75.1 169.48 17.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.808 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 60.24 97.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.88 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 24.4 pt20 -112.98 171.7 7.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.885 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.45 162.4 28.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.843 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.93 113.79 11.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.833 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 41.9 p30 -165.36 -177.42 4.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.873 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -142.19 134.93 13.84 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.908 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.85 155.47 32.67 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.311 2.007 . . . . 0.0 112.325 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.38 -177.75 2.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.94 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.35 171.74 2.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.945 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -172.07 -71.93 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.903 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -71.29 -108.75 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.834 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.28 129.03 23.1 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 120.868 0.366 . . . . 0.0 110.517 179.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 40.6 t -59.84 120.17 9.08 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.158 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.3 mm? -117.04 -34.97 4.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.705 179.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -168.54 -177.9 39.84 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.274 179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 23.2 m80 -138.08 166.05 25.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.084 0.468 . . . . 0.0 111.138 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.1 mt -127.28 114.73 18.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.614 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 20.0 t -95.92 121.59 46.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.129 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -90.37 142.04 28.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.939 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.6 mt -107.43 106.49 16.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.681 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.9 mt -124.39 138.67 31.41 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.983 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_exo -52.12 -25.39 22.82 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.475 2.117 . . . . 0.0 112.516 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -85.52 -34.01 15.04 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.736 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 177.15 -174.28 0.12 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.835 0.35 . . . . 0.0 110.948 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -107.92 157.53 18.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.918 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -135.41 120.26 18.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.954 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.7 mmtp -100.72 128.2 46.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.882 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.1 t -122.4 139.71 48.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.156 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -92.43 127.42 37.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.724 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 15.9 tt -116.05 132.08 66.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.04 0.448 . . . . 0.0 111.468 -179.731 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.81 167.87 10.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.454 179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -61.14 -92.18 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.684 -0.235 . . . . 0.0 110.387 179.592 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.584 ' C ' ' H ' ' A' ' 55' ' ' VAL . 8.0 ttt180 75.2 -5.77 2.1 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 179.15 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.413 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 7.9 t-20 71.03 -32.97 0.26 Allowed 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.786 -0.365 . . . . 0.0 110.199 -179.137 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.584 ' H ' ' C ' ' A' ' 53' ' ' ARG . 61.6 t -135.82 138.33 47.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 CA-C-O 120.926 0.393 . . . . 0.0 110.931 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.455 ' N ' ' O ' ' A' ' 80' ' ' PHE . 94.0 m -125.38 130.5 52.04 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.579 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.413 ' O ' ' N ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -104.01 139.76 38.69 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.821 0.343 . . . . 0.0 111.025 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.4 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 4.7 mp -132.2 130.87 60.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.335 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.35 -135.31 3.99 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.971 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.472 ' HB2' ' CG2' ' A' ' 73' ' ' ILE . 7.5 ttt-85 -100.59 -40.9 7.18 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 120.855 0.36 . . . . 0.0 110.918 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -44.83 118.82 1.73 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.446 -179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 15.9 mtt85 -57.42 -27.42 62.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.884 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.7 m -69.82 -25.62 63.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.778 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 89.8 m -54.73 166.6 0.46 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.78 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.413 ' N ' ' O ' ' A' ' 57' ' ' THR . 0.6 OUTLIER -73.52 -58.33 3.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.875 0.369 . . . . 0.0 111.117 -179.945 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.4 ' O ' ' HA ' ' A' ' 58' ' ' ILE . 21.2 t -121.51 125.36 73.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.647 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.3 pt -95.81 118.19 41.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.567 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.457 ' HB2' HG12 ' A' ' 73' ' ' ILE . 9.1 mt -77.01 -91.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.686 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.46 ' O ' ' CB ' ' A' ' 70' ' ' GLU . 1.3 p -101.42 -102.11 0.26 Allowed 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.064 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.57 ' CB ' ' HD3' ' A' ' 71' ' ' PRO . 3.6 mt-10 162.4 -63.96 0.0 OUTLIER Pre-proline 0 CA--C 1.531 0.228 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.57 ' HD3' ' CB ' ' A' ' 70' ' ' GLU . 46.8 Cg_exo -56.09 -40.13 86.86 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.107 1.871 . . . . 0.0 113.355 -178.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -124.19 25.67 7.72 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.472 ' CG2' ' HB2' ' A' ' 60' ' ' ARG . 3.1 tp -104.31 121.93 56.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.137 0.494 . . . . 0.0 111.223 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.6 m -62.9 136.31 57.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.285 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 65.8 m -64.4 -40.57 96.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.806 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.452 ' O ' ' C ' ' A' ' 77' ' ' HIS . 3.5 m-85 -99.24 13.86 31.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.232 0.539 . . . . 0.0 111.448 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.452 ' C ' ' O ' ' A' ' 76' ' ' PHE . 1.0 OUTLIER -20.6 -69.8 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.705 -1.134 . . . . 0.0 112.76 -179.346 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -156.64 164.05 38.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.214 0.53 . . . . 0.0 112.099 -179.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -129.52 133.78 47.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.085 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.455 ' O ' ' N ' ' A' ' 56' ' ' THR . 5.1 m-85 -119.2 131.22 55.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.975 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.413 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 8.1 m-70 -94.67 116.33 28.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.991 0.424 . . . . 0.0 110.906 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.43 109.65 21.63 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.058 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.31 137.56 54.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.794 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -109.64 129.2 55.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.868 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.88 141.22 34.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.948 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.8 p-10 -106.95 115.95 31.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.856 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.0 m -124.95 117.41 50.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.3 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.7 t0 58.35 77.51 0.29 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.081 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 63.18 -80.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.994 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -63.67 151.72 41.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.917 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -118.63 136.72 53.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.96 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.7 mtp180 -112.64 149.74 32.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.997 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -112.12 125.61 54.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.716 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.3 mp -107.78 127.29 53.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.927 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.1 mp -118.09 137.41 52.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.076 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -114.01 144.09 43.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.041 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.419 HG12 ' CE1' ' A' ' 80' ' ' PHE . 14.1 t -106.45 127.13 62.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.253 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 11.9 mt -130.03 120.91 50.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.851 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -100.14 136.5 39.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.021 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.7 mmtt -133.47 30.55 3.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.913 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.7 m -160.68 150.78 17.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.841 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -102.21 44.76 0.99 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.954 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -83.65 -31.71 26.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.242 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 121.33 89.21 1.03 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.51 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 67.4 m -112.36 126.09 54.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.9 0.381 . . . . 0.0 110.912 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -121.03 118.31 29.49 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.956 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.7 tp -115.49 137.33 49.41 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-O 121.551 0.691 . . . . 0.0 111.255 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 59.98 28.09 17.57 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.838 -1.073 . . . . 0.0 110.931 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.74 9.89 70.82 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.878 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -134.04 152.0 51.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.823 0.344 . . . . 0.0 110.854 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.04 136.74 43.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.894 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.91 144.96 52.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.866 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.2 p -141.11 56.13 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.106 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -177.25 -176.4 0.64 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.835 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.41 25.84 9.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.024 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -166.46 72.9 0.15 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.778 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -84.14 139.4 32.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.833 -179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 7.8 tp -98.51 117.62 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-O 120.984 0.421 . . . . 0.0 111.242 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.417 HD22 ' CD2' ' A' ' 135' ' ' PHE . 0.5 OUTLIER -103.1 132.54 49.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.035 -179.834 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -130.84 178.09 6.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.799 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.423 ' HB2' ' CE2' ' A' ' 137' ' ' TYR . 0.3 OUTLIER -54.81 141.32 33.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.061 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 71.8 53.04 10.16 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.5 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -129.14 127.12 40.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.895 0.378 . . . . 0.0 111.009 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -91.13 124.38 35.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.747 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 3.2 mp -115.0 131.57 66.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.283 -179.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.7 t -122.71 128.14 75.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.943 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.43 ' CD2' HD11 ' A' ' 68' ' ' LEU . 44.5 m-85 -121.77 118.22 28.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.983 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 86.63 -8.17 76.39 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.84 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 76.74 27.98 0.72 Allowed 'General case' 0 CA--C 1.522 -0.11 0 CA-C-O 120.939 0.4 . . . . 0.0 110.243 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.2 p -138.13 -48.24 0.54 Allowed 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.94 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 1.8 m -88.41 112.04 22.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.865 179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 23.0 t -120.08 123.35 43.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.036 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.431 ' CE1' HD21 ' A' ' 68' ' ' LEU . 3.1 p90 -142.16 156.22 45.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.118 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 7.1 tt -108.07 138.79 43.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.706 179.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.417 ' CD2' HD22 ' A' ' 119' ' ' LEU . 56.5 t80 -105.18 141.57 36.49 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.992 0.901 . . . . 0.0 111.938 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.43 155.11 34.37 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 113.846 -1.525 . . . . 0.0 110.747 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.423 ' CE2' ' HB2' ' A' ' 121' ' ' ASN . 1.1 m-85 -85.06 139.74 31.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.945 0.403 . . . . 0.0 110.847 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -118.9 -168.6 1.58 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.065 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -160.78 -46.34 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.927 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.9 m -74.03 132.89 42.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.928 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.3 t -119.56 -40.42 2.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.965 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.1 m -58.1 -48.52 79.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.007 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 60.65 31.61 20.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.894 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -166.86 119.0 0.96 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.882 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.424 HG21 HD11 ' A' ' 145' ' ' ILE . 19.2 mt -103.2 25.2 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 CA-C-O 121.623 0.725 . . . . 0.0 111.278 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 61.99 93.47 0.05 OUTLIER 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.899 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -128.93 112.44 14.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.908 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -116.15 -64.81 1.26 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.966 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -129.69 -45.98 1.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.852 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 61.09 102.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.86 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.74 32.51 4.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.872 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.5 t -69.95 -60.89 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.085 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 26.1 t -77.16 98.18 5.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.842 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 2.1 p -114.14 140.6 48.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.968 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -68.45 78.85 0.27 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.907 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 3.9 m 60.07 165.52 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.907 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 37.2 mtt-85 -73.87 115.27 13.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.901 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 47.9 t -117.94 89.97 3.23 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.887 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 36.5 t80 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.886 -179.984 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.4 mttm . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.835 0.35 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 61.05 110.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.864 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 59.66 94.4 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.966 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -146.75 115.85 6.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.927 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.66 -71.63 0.72 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.829 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.01 31.43 5.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.863 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -103.43 111.97 24.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.874 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.4 mtmt -132.43 149.11 72.21 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.859 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -68.58 140.91 48.74 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.589 2.193 . . . . 0.0 112.21 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.0 t -113.19 94.36 4.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.03 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.4 p -77.94 -58.61 3.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.756 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -178.73 -69.23 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.807 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.438 ' HB2' ' HB ' ' A' ' 51' ' ' THR . 17.8 m-85 -97.18 -108.13 0.16 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.865 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.27 128.72 22.71 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 120.726 0.298 . . . . 0.0 110.635 179.758 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 13.2 t -76.43 114.86 15.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.901 0.382 . . . . 0.0 111.071 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.19 -35.8 3.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.889 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -141.03 -177.81 16.67 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.565 179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.421 ' CD2' ' HG2' ' A' ' 49' ' ' GLU . 31.9 m80 -142.13 157.87 44.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.836 0.35 . . . . 0.0 110.832 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.0 pp -127.08 123.05 35.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.722 179.846 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.3 t -105.89 121.93 58.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.197 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -86.3 115.16 23.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.751 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 45.1 mt -83.87 106.87 15.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.986 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.538 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 4.4 mt -124.25 141.5 37.55 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.806 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.538 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 57.5 Cg_endo -73.66 84.91 1.36 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.253 1.968 . . . . 0.0 112.018 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 141.34 -14.04 2.76 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.41 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -179.03 173.68 1.15 Allowed 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 120.767 0.317 . . . . 0.0 110.628 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -139.04 160.76 39.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.075 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -141.5 123.35 15.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.959 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.406 ' HE2' ' CD2' ' A' ' 36' ' ' HIS . 28.4 tttt -110.68 126.17 54.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.819 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 38.5 t -124.05 144.67 33.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.235 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.421 ' HG2' ' CD2' ' A' ' 36' ' ' HIS . 48.0 mt-10 -80.87 135.64 35.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.546 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.9 tt -111.65 131.99 61.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.043 0.449 . . . . 0.0 111.444 -179.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.438 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 0.9 OUTLIER -102.7 168.02 9.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.465 179.804 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 34.1 m-80 -68.43 -91.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.289 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.611 ' C ' ' H ' ' A' ' 55' ' ' VAL . 5.8 ttt85 69.75 -2.48 1.97 Allowed 'General case' 0 C--O 1.231 0.126 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 178.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 70.29 -32.21 0.23 Allowed 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 -179.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.611 ' H ' ' C ' ' A' ' 53' ' ' ARG . 81.6 t -136.99 143.25 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.822 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.451 ' N ' ' O ' ' A' ' 80' ' ' PHE . 9.2 m -125.49 131.2 52.87 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.458 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 65' ' ' ASP . 0.1 OUTLIER -103.98 137.46 41.93 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.908 0.385 . . . . 0.0 111.087 -179.862 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.424 HD11 ' CD1' ' A' ' 80' ' ' PHE . 3.4 mp -132.1 128.47 59.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.096 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 168.9 -135.27 3.53 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.754 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.438 ' HB3' HG21 ' A' ' 73' ' ' ILE . 14.8 ptt85 -108.11 -29.4 8.97 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.663 0.268 . . . . 0.0 111.022 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 2.8 t -57.46 121.73 10.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.831 0.348 . . . . 0.0 110.816 -179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.68 -25.36 39.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.07 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.97 -24.63 63.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.0 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 87.7 m -58.22 166.47 1.62 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.038 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.446 ' N ' ' O ' ' A' ' 57' ' ' THR . 0.5 OUTLIER -71.01 -57.1 4.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.003 0.43 . . . . 0.0 110.832 179.742 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.0 t -125.2 133.3 69.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.67 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.6 pt -101.72 125.32 55.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.722 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 4.3 mp -93.28 -85.98 0.26 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.944 -179.722 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.401 ' O ' ' CB ' ' A' ' 70' ' ' GLU . 10.0 t -98.33 -101.93 0.21 Allowed 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.531 ' CB ' ' CD ' ' A' ' 71' ' ' PRO . 0.1 OUTLIER 167.21 -70.2 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.189 0 CA-C-O 120.528 0.204 . . . . 0.0 111.299 179.369 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.531 ' CD ' ' CB ' ' A' ' 70' ' ' GLU . 47.0 Cg_endo -67.86 -38.19 13.95 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.56 2.173 . . . . 0.0 113.579 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -105.71 10.51 32.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.757 0.313 . . . . 0.0 111.226 -179.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.449 ' O ' ' CG2' ' A' ' 73' ' ' ILE . 2.9 tp -105.88 117.29 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-O 121.016 0.436 . . . . 0.0 110.612 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.402 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 0.3 OUTLIER -67.22 135.97 54.26 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.16 -179.163 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 64.1 m -49.33 -44.02 44.09 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.826 179.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.448 ' O ' ' C ' ' A' ' 77' ' ' HIS . 5.7 p90 -106.85 14.1 27.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.22 0.533 . . . . 0.0 111.327 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.448 ' C ' ' O ' ' A' ' 76' ' ' PHE . 3.9 t-160 -20.2 -58.51 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.609 -1.178 . . . . 0.0 112.826 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.431 ' CB ' ' CZ ' ' A' ' 127' ' ' PHE . . . -150.63 157.89 43.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.97 0.414 . . . . 0.0 111.583 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -133.06 133.49 43.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.684 179.82 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.451 ' O ' ' N ' ' A' ' 56' ' ' THR . 5.0 m-85 -119.3 131.33 55.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.608 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 9.0 m-70 -94.41 116.43 28.79 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.985 0.421 . . . . 0.0 111.092 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.8 tt -106.49 109.88 21.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.814 179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -121.6 137.4 54.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.895 179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -108.93 136.91 47.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.856 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -126.88 131.77 51.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.869 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -88.54 120.17 29.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.904 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.5 t -139.96 139.13 37.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.065 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -50.1 132.86 23.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.078 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 35.6 m120 62.47 99.35 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.792 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 63.16 133.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.999 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -82.93 158.71 22.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.897 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.91 111.82 20.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.974 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.9 m-80 -113.34 138.92 49.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.837 179.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 7.9 mp -130.03 137.17 50.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.995 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.8 mp -119.59 139.02 48.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.078 179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -116.88 144.13 44.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.688 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.422 HG23 ' CD2' ' A' ' 80' ' ' PHE . 16.4 t -116.2 132.15 66.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.271 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.432 HG23 HD13 ' A' ' 98' ' ' ILE . 20.5 mm -127.11 131.06 71.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.119 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -90.22 128.35 36.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.861 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.5 mmmt -119.93 -35.36 3.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.278 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.8 m -78.07 -44.84 25.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.117 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.51 21.54 10.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.904 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -85.95 -30.51 22.73 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.855 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 167.36 73.37 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.506 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.423 HG23 ' CE1' ' A' ' 127' ' ' PHE . 62.0 m -104.72 122.76 46.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.888 0.375 . . . . 0.0 110.869 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -121.14 119.29 31.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.874 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.9 tp -118.09 137.29 52.52 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 CA-C-O 121.524 0.678 . . . . 0.0 111.202 179.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 60.15 27.29 16.75 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.818 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.75 9.86 70.81 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.818 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -134.03 152.02 51.67 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.749 0.309 . . . . 0.0 110.958 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 30.1 mtm180 -65.1 142.97 58.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.902 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.1 pp -99.17 129.57 45.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.898 179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.6 m -111.85 -30.79 2.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.189 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 16.9 mtmt -80.64 142.22 34.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.937 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -77.73 -32.75 53.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.875 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -105.64 75.04 1.11 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.927 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -80.75 139.03 36.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.822 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.6 tp -98.54 119.06 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.37 -179.738 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.6 tt -103.0 138.51 39.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.982 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.02 178.11 7.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.862 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.438 ' HB2' ' CE2' ' A' ' 137' ' ' TYR . 2.0 t30 -55.31 142.06 33.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.084 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 68.08 48.62 52.47 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.406 179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -123.44 124.24 42.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.843 0.354 . . . . 0.0 111.072 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 48.6 ttt-85 -90.22 122.19 32.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.801 179.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.444 ' CG2' ' CE2' ' A' ' 133' ' ' PHE . 0.5 OUTLIER -120.63 136.41 57.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.933 0.397 . . . . 0.0 111.317 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.4 t -124.09 133.95 67.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.815 179.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.431 ' CZ ' ' CB ' ' A' ' 78' ' ' ALA . 9.7 m-85 -124.85 138.42 54.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.955 0.407 . . . . 0.0 111.142 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 86.77 -69.83 3.03 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.343 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 176.67 -39.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.729 0.3 . . . . 0.0 111.076 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.38 -40.21 4.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.804 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 33.6 m -53.92 103.95 0.09 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.071 0.462 . . . . 0.0 111.268 -179.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 5.6 p -124.6 129.34 50.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.902 179.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.457 ' CD1' ' N ' ' A' ' 133' ' ' PHE . 1.3 p90 -142.16 156.08 45.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.058 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.5 tt -115.11 136.16 53.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.83 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 21.6 t80 -105.67 141.56 36.92 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.95 0.881 . . . . 0.0 111.774 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -154.31 159.67 41.35 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 113.828 -1.533 . . . . 0.0 110.756 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.438 ' CE2' ' HB2' ' A' ' 121' ' ' ASN . 4.5 m-85 -85.29 140.11 31.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.059 0.457 . . . . 0.0 110.618 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.405 ' HB1' ' CE1' ' A' ' 36' ' ' HIS . . . -91.17 138.93 31.22 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.191 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.17 94.23 9.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.919 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 52.9 p -139.89 48.36 1.8 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.882 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.76 31.94 0.22 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.803 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -79.43 -56.88 4.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.923 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 15.0 t 45.32 -167.6 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.366 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -151.63 178.96 8.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.9 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 3.3 mp -105.01 25.04 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-O 121.707 0.765 . . . . 0.0 111.37 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -138.4 138.66 38.43 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.941 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -166.24 -45.24 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.88 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.62 -33.06 12.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.86 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -94.89 125.96 39.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.872 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -84.63 151.64 24.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.906 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 20.0 mttt -85.85 174.84 9.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.952 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.4 m -125.73 115.68 43.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.12 179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 2.5 m -129.24 -57.73 1.14 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.962 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.73 -179.29 0.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.901 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -126.04 160.75 29.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.858 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 73.3 m -153.71 78.84 1.14 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.874 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 1.8 mtp-105 -98.33 123.34 42.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.913 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.3 m 60.75 80.92 0.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.9 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.873 -179.953 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.4 mttp . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.836 0.351 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.89 153.39 40.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.762 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -126.29 177.75 6.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.92 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.431 ' O ' ' HG2' ' A' ' 23' ' ' ARG . 0.5 OUTLIER -112.62 -175.06 2.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.85 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . 0.431 ' HG2' ' O ' ' A' ' 22' ' ' GLN . 0.1 OUTLIER 34.65 50.46 0.42 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.905 179.909 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 92.8 p -84.08 -26.2 29.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.08 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -55.33 -71.07 0.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.037 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.2 mmtt -134.95 139.39 31.97 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.876 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.14 146.68 58.54 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.471 2.114 . . . . 0.0 112.224 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.8 t -75.66 85.49 2.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.886 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.9 161.15 29.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.892 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -142.42 -65.64 0.4 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.762 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.44 ' HB2' ' CG2' ' A' ' 51' ' ' THR . 49.0 m-85 -114.99 -118.19 0.32 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.618 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.18 137.42 34.35 Favored 'General case' 0 N--CA 1.457 -0.082 0 CA-C-O 120.823 0.344 . . . . 0.0 110.73 179.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.8 t -59.81 145.07 46.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.117 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.3 tt -152.2 -44.98 0.1 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.945 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -157.72 172.82 35.04 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.445 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.423 ' CE1' ' HB2' ' A' ' 138' ' ' ALA . 32.1 m80 -133.47 161.19 35.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.008 0.432 . . . . 0.0 111.208 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.43 HD11 ' CE1' ' A' ' 133' ' ' PHE . 57.9 mt -127.19 107.92 10.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.596 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.2 t -96.78 121.74 47.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.825 0.345 . . . . 0.0 111.366 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -90.16 119.44 30.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.836 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.5 mt -79.26 106.8 11.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.898 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.4 mt -124.27 139.27 32.45 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.914 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -50.11 91.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.41 2.074 . . . . 0.0 112.286 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 116.03 -105.6 1.42 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.263 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.85 -168.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.791 0.329 . . . . 0.0 111.023 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -155.5 141.7 18.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.985 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -110.46 120.17 41.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.82 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.57 126.14 54.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.993 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.7 t -117.21 143.99 26.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.975 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -93.7 131.16 39.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.925 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 30.5 mm -111.33 122.38 65.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.002 179.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.44 ' CG2' ' HB2' ' A' ' 31' ' ' TYR . 0.4 OUTLIER -102.48 168.2 9.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.899 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 17.2 p30 -93.19 71.38 4.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.704 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.626 ' C ' ' H ' ' A' ' 55' ' ' VAL . 2.6 ptp180 -98.35 15.62 24.09 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.618 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 68.97 -29.26 0.17 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.706 0.289 . . . . 0.0 110.333 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.626 ' H ' ' C ' ' A' ' 53' ' ' ARG . 59.3 t -137.09 134.64 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 CA-C-O 121.193 0.52 . . . . 0.0 111.548 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.463 ' N ' ' O ' ' A' ' 80' ' ' PHE . 39.7 m -125.06 122.53 37.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.756 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.88 133.84 48.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.901 0.382 . . . . 0.0 111.038 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.4 mp -119.11 116.52 51.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.721 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 174.72 -146.09 8.32 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.571 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.507 ' HB3' ' HA ' ' A' ' 70' ' ' GLU . 9.4 ptt180 -100.21 -27.67 13.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.702 0.287 . . . . 0.0 111.102 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.06 121.4 7.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.911 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.7 ptt85 -54.96 -28.78 54.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.067 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.91 -24.99 63.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.836 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 99.8 m -55.36 158.8 3.0 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.001 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 62.0 t0 -76.3 -52.89 9.05 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.905 0.383 . . . . 0.0 110.943 -179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.6 t -101.64 129.83 52.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.253 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 14.6 pt -99.82 125.84 53.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.158 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.405 ' O ' ' C ' ' A' ' 69' ' ' SER . 3.3 mp -113.71 -163.69 0.88 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.249 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.596 ' O ' ' CB ' ' A' ' 70' ' ' GLU . 1.2 m -35.56 -58.46 0.59 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.574 0.226 . . . . 0.0 110.975 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.596 ' CB ' ' O ' ' A' ' 69' ' ' SER . 9.0 tm-20 109.84 -61.74 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.529 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.702 178.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.556 ' HD2' ' C ' ' A' ' 69' ' ' SER . 44.0 Cg_endo -67.75 -33.51 27.26 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 121.888 1.726 . . . . 0.0 113.199 -179.358 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -112.04 21.56 15.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.701 0.286 . . . . 0.0 111.301 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.423 HG23 ' HB3' ' A' ' 60' ' ' ARG . 4.8 tp -117.8 128.85 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-O 120.916 0.388 . . . . 0.0 111.147 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.8 m -63.55 132.78 52.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.057 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.8 m -59.81 -33.48 71.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.897 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.448 ' O ' ' C ' ' A' ' 77' ' ' HIS . 14.9 m-85 -112.1 13.88 20.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.474 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.448 ' C ' ' O ' ' A' ' 76' ' ' PHE . 2.1 t-160 -21.62 -69.49 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.726 -1.125 . . . . 0.0 112.574 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -153.06 159.68 42.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.125 0.488 . . . . 0.0 112.045 -179.687 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -126.53 134.2 50.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.41 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.463 ' O ' ' N ' ' A' ' 56' ' ' THR . 7.5 m-85 -119.4 131.45 55.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.888 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 9.9 m-70 -94.63 116.37 28.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.917 0.389 . . . . 0.0 111.011 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 12.8 tp -106.47 109.69 21.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.915 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.1 140.08 52.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -116.3 125.13 51.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.864 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 32.6 tpp -138.84 133.39 31.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.912 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -107.04 133.66 51.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.93 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.5 t -135.8 134.19 51.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.002 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.8 t70 75.04 -58.24 0.58 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.021 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -176.31 -39.02 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.894 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -86.63 146.11 26.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.775 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -97.07 137.84 35.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.032 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.2 mtm-85 -114.3 144.8 42.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.873 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -114.08 121.34 43.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.854 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.8 tt -115.72 132.84 56.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.877 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.424 HD13 ' CE1' ' A' ' 135' ' ' PHE . 3.2 mp -122.27 140.99 44.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.146 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -113.94 144.0 43.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.823 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.414 HG13 ' CZ ' ' A' ' 80' ' ' PHE . 22.7 t -109.15 122.91 64.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.193 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 25.1 mt -130.1 122.32 53.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.089 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -107.71 138.6 43.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.863 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.9 mmtp -92.65 -6.02 50.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.414 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.8 m 63.05 44.37 5.92 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.882 0.372 . . . . 0.0 110.877 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -95.32 -45.84 6.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.86 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -123.99 -43.59 2.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.244 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 136.34 110.61 1.04 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.504 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 35.8 m -114.39 123.13 48.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.721 0.296 . . . . 0.0 110.942 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.419 ' CE2' ' HB2' ' A' ' 111' ' ' ARG . 6.2 m-85 -121.04 120.34 35.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.808 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.8 tp -102.75 137.24 31.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.493 0.663 . . . . 0.0 111.263 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 61.65 30.55 18.6 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.79 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.67 11.32 72.84 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.849 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -134.01 150.58 51.24 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.782 0.325 . . . . 0.0 110.877 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.419 ' HB2' ' CE2' ' A' ' 106' ' ' PHE . 57.4 ttt-85 -74.97 137.89 41.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.902 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -98.58 134.86 40.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.882 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 15.0 p -107.46 -37.27 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.186 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.1 tttp -61.39 151.52 32.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.874 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.14 30.91 3.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.888 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -169.76 60.25 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.783 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -73.25 136.46 44.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.746 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.441 ' C ' ' CD1' ' A' ' 118' ' ' ILE . 0.0 OUTLIER -98.83 116.71 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.817 -179.887 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.8 tt -101.41 145.87 28.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.977 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 8.4 mmmt -133.51 178.06 7.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.807 179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.429 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 12.6 p30 -56.19 141.65 40.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.081 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 70.11 46.45 50.93 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.523 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 -120.29 120.78 37.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.768 0.318 . . . . 0.0 110.945 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -85.19 124.47 31.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.811 179.886 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.456 ' CG2' ' CE1' ' A' ' 127' ' ' PHE . 1.2 mp -121.49 135.16 62.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.111 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.9 t -115.84 125.42 72.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.069 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.513 ' CE1' ' CZ ' ' A' ' 133' ' ' PHE . 67.4 m-85 -116.51 113.45 22.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.014 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 86.92 -8.63 75.35 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.918 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 6.0 tttm 78.82 28.54 0.41 Allowed 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.869 0.366 . . . . 0.0 110.477 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.37 -47.57 0.34 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.929 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 18.7 m -96.11 109.99 22.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.871 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -122.07 126.63 48.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.946 -179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.513 ' CZ ' ' CE1' ' A' ' 127' ' ' PHE . 13.5 p90 -139.22 155.93 47.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.886 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.6 tp -105.35 136.21 45.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.97 -179.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.424 ' CE1' HD13 ' A' ' 95' ' ' ILE . 24.7 t80 -96.53 141.54 29.69 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 121.971 0.891 . . . . 0.0 111.604 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 29.3 mttp -154.57 153.11 30.88 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 113.885 -1.507 . . . . 0.0 110.867 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.429 ' CE2' ' HB3' ' A' ' 121' ' ' ASN . 3.7 m-85 -79.26 139.68 37.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.94 0.4 . . . . 0.0 110.696 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.423 ' HB2' ' CE1' ' A' ' 36' ' ' HIS . . . -93.0 44.58 1.15 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.173 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.1 p -97.46 59.37 1.54 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.684 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 6.1 t -57.99 156.98 8.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.975 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.2 m -152.04 72.88 1.03 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.872 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 98.3 p -140.76 170.71 15.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.867 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 16.1 m -148.41 -63.29 0.25 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.862 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -153.26 -178.91 7.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.892 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.459 ' CG2' ' H ' ' A' ' 146' ' ' GLU . 2.2 mt -110.24 -143.7 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.459 ' H ' ' CG2' ' A' ' 145' ' ' ILE . 0.0 OUTLIER -64.88 145.96 55.57 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.882 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -81.1 141.98 33.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.846 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -157.55 121.12 4.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.85 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -105.48 158.6 16.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.867 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.24 -47.79 7.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.823 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -96.51 116.83 29.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.896 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.4 t -69.19 132.86 32.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.148 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.89 128.62 36.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.898 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 5.5 p -175.2 -53.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.866 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -141.23 122.23 14.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.909 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 24.3 p -114.37 150.6 34.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.883 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 18.1 mtm180 -124.27 -64.83 1.09 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.859 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 15.3 p -78.68 -57.08 3.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.907 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.87 179.976 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.6 mttt . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 120.858 0.361 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.15 174.15 9.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.869 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -63.19 174.17 1.26 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.836 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 60.2 90.13 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.902 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.55 146.08 5.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.912 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.1 m -67.21 88.8 0.18 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.91 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.7 p30 -146.16 171.93 14.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.805 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.91 132.95 22.95 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.855 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.13 157.92 58.13 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.449 2.1 . . . . 0.0 112.231 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.2 m 58.99 93.41 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.953 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 68.4 p -149.82 79.77 1.37 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.864 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -100.41 138.48 37.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.003 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.455 ' N ' HG22 ' A' ' 51' ' ' THR . 3.4 m-85 -61.78 -97.07 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.921 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.44 134.72 31.17 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-O 120.72 0.295 . . . . 0.0 110.573 179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 2.0 t -59.95 127.57 32.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.971 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -128.91 -44.1 1.33 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.713 179.936 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -157.33 -165.21 14.74 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.43 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 52.9 m80 -146.18 163.9 33.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.87 0.367 . . . . 0.0 111.065 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.7 mp -126.81 119.97 28.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.644 179.863 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.4 t -96.12 121.92 47.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.209 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.417 ' HA ' ' CD1' ' A' ' 133' ' ' PHE . 4.3 m-20 -89.39 113.98 25.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.767 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.1 mt -88.59 106.51 18.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.996 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.54 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 1.7 mp -124.5 140.73 35.93 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.509 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.54 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 53.1 Cg_endo -72.24 80.86 1.54 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.003 1.802 . . . . 0.0 112.011 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 145.16 -14.47 1.89 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.686 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.4 tptm -178.34 164.28 1.71 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.806 0.336 . . . . 0.0 110.863 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -125.56 164.99 19.34 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.053 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -150.34 124.92 9.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.911 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.5 mtpt -102.41 134.66 45.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.879 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.7 t -121.71 150.18 24.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.112 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -94.93 132.4 39.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.808 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 5.0 tt -115.98 132.14 66.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.212 -179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.455 HG22 ' N ' ' A' ' 31' ' ' TYR . 0.2 OUTLIER -98.98 168.1 10.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.925 -179.832 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 13.5 p30 -102.72 74.97 1.38 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.444 179.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.64 ' C ' ' H ' ' A' ' 55' ' ' VAL . 0.7 OUTLIER -99.04 23.19 9.31 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.526 -179.601 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.54 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 1.6 m-20 67.53 -28.91 0.14 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.487 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.64 ' H ' ' C ' ' A' ' 53' ' ' ARG . 60.2 t -137.76 136.56 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 CA-C-O 120.964 0.412 . . . . 0.0 111.749 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.428 ' HB ' ' HB2' ' A' ' 80' ' ' PHE . 99.5 m -125.51 129.9 50.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.062 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.456 ' O ' ' N ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -104.0 138.82 39.99 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.954 0.407 . . . . 0.0 111.529 -179.448 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.406 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 4.6 mp -132.52 135.19 58.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.093 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 157.12 -137.36 5.36 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.305 -0.95 . . . . 0.0 113.227 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.472 ' HB2' ' CG2' ' A' ' 73' ' ' ILE . 21.3 ttp180 -94.89 -49.24 5.66 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.753 0.311 . . . . 0.0 111.22 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -43.71 117.02 1.06 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.497 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.1 mtt85 -57.37 -23.3 48.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.015 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.78 -24.19 63.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.76 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 96.4 m -57.42 168.25 0.83 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.824 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.456 ' N ' ' O ' ' A' ' 57' ' ' THR . 0.5 OUTLIER -69.85 -56.62 6.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.952 0.406 . . . . 0.0 110.778 179.827 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 58' ' ' ILE . 21.3 t -125.2 132.95 70.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.594 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 7.9 pt -102.8 128.05 55.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.816 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -89.19 -71.35 0.6 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.781 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.441 ' HB3' ' HB ' ' A' ' 73' ' ' ILE . 12.8 t -121.3 -111.67 0.33 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.076 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.448 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . 9.7 tt0 170.63 -64.15 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.264 0 O-C-N 122.298 -0.251 . . . . 0.0 111.575 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.448 ' CD ' ' HB3' ' A' ' 70' ' ' GLU . 25.2 Cg_endo -62.0 -40.05 46.05 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.35 2.033 . . . . 0.0 113.28 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -122.49 28.87 7.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.569 0.223 . . . . 0.0 111.503 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.472 ' CG2' ' HB2' ' A' ' 60' ' ' ARG . 4.4 tp -110.8 125.94 68.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.971 0.415 . . . . 0.0 111.116 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -59.48 134.01 56.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.484 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 36.2 m -65.91 -44.21 85.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.856 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.448 ' O ' ' C ' ' A' ' 77' ' ' HIS . 2.1 m-85 -100.27 13.73 33.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.27 0.557 . . . . 0.0 111.153 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.459 ' CE1' ' HB3' ' A' ' 127' ' ' PHE . 0.4 OUTLIER -15.51 -71.39 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.403 -1.271 . . . . 0.0 113.175 -179.338 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.423 ' HB3' ' CE1' ' A' ' 127' ' ' PHE . . . -153.75 164.08 38.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.225 0.536 . . . . 0.0 112.293 -179.234 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -132.5 132.64 42.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.962 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.428 ' HB2' ' HB ' ' A' ' 56' ' ' THR . 3.9 m-85 -119.39 131.08 55.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.781 0.324 . . . . 0.0 110.96 -179.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.54 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 24.8 m-70 -95.89 116.81 29.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.245 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.2 mp -106.3 109.37 21.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.669 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -122.58 140.19 53.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.032 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -104.21 120.95 42.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.754 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -119.68 142.62 48.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.0 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -107.13 124.89 50.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.902 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 4.0 m -121.88 132.48 70.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.149 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 68.45 -65.58 0.26 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.059 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 179.82 39.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.818 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -145.94 -177.29 5.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.695 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.29 129.12 55.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.999 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 9.4 mtm180 -116.32 150.21 38.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.85 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -114.03 123.67 50.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.944 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.8 mp -130.05 123.84 31.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.825 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.3 mp -116.25 141.07 35.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.057 -179.911 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -114.03 144.06 43.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.862 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.419 HG22 ' CE2' ' A' ' 80' ' ' PHE . 18.1 t -115.36 126.09 72.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.23 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.3 mp -127.99 135.57 62.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.071 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -107.55 120.23 41.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.822 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.45 32.38 2.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.006 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 21.8 m -126.85 178.78 5.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.898 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.1 ptp85 -127.55 39.13 3.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.922 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -106.67 -60.62 1.64 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.228 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 145.06 103.36 0.4 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.539 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.464 ' CG2' ' CE1' ' A' ' 127' ' ' PHE . 85.5 m -117.95 124.92 49.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.861 0.362 . . . . 0.0 110.979 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' A' ' 106' ' ' PHE . 5.0 m-85 -121.03 123.71 43.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.829 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.0 tp -109.95 137.29 42.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.464 0.649 . . . . 0.0 111.391 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 60.66 29.59 19.12 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.817 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.63 11.38 72.75 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.834 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -134.02 152.06 51.69 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.759 0.314 . . . . 0.0 110.877 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -63.53 142.96 58.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.964 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -83.95 133.11 34.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.769 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.8 p -120.62 -42.8 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.149 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.92 147.46 47.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.794 -179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.89 -37.38 48.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.795 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -111.36 77.79 1.07 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.862 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -80.05 135.95 36.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.867 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.7 tp -98.73 122.28 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.289 -179.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 4.8 tt -103.06 132.78 49.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.879 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.78 178.07 5.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.838 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.418 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 8.2 p30 -60.41 138.55 57.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.07 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 74.76 56.0 5.14 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.595 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -130.96 132.91 45.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.794 0.33 . . . . 0.0 110.981 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.15 132.68 34.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.877 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 21.1 mm -117.64 121.77 68.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.166 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 59.0 t -115.13 128.35 72.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.66 179.72 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.464 ' CE1' ' CG2' ' A' ' 105' ' ' THR . 15.1 m-85 -132.08 111.88 11.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.923 0.392 . . . . 0.0 111.659 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.48 ' O ' ' HB2' ' A' ' 129' ' ' LYS . . . 108.91 -81.9 0.29 Allowed Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.206 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 128' ' ' GLY . 14.1 tttp 172.22 37.03 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.887 0.375 . . . . 0.0 110.664 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 24.9 p 178.83 -48.82 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.95 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 77.6 m -56.7 104.7 0.16 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.887 -179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.3 111.94 16.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.149 -179.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.417 ' CD1' ' HA ' ' A' ' 39' ' ' ASN . 3.0 m-85 -120.45 156.07 32.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.864 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 6.0 tt -111.74 140.1 46.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.944 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -116.33 141.76 47.73 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.885 0.85 . . . . 0.0 111.733 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -154.44 159.74 41.23 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.06 -1.427 . . . . 0.0 111.022 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.418 ' CE2' ' HB3' ' A' ' 121' ' ' ASN . 3.3 m-85 -84.25 140.25 31.8 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.057 0.456 . . . . 0.0 110.741 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -104.05 -53.92 2.65 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.165 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.4 170.31 2.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.956 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 43.9 m -116.51 -40.35 3.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.902 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.2 t 63.56 52.84 2.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.952 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.1 t 59.53 -169.34 0.14 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.908 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.5 t -112.84 -176.48 2.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.85 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -121.92 -79.88 0.62 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.859 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.495 ' CG2' ' H ' ' A' ' 146' ' ' GLU . 0.7 OUTLIER -110.95 -143.17 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.495 ' H ' ' CG2' ' A' ' 145' ' ' ILE . 0.4 OUTLIER -175.73 117.22 0.15 Allowed 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.865 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 61.12 36.62 18.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.906 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -134.29 92.36 2.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.971 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -152.82 120.66 6.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.828 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.55 156.8 45.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.943 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.7 tttt -153.38 107.02 3.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.886 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 10.8 m -86.25 86.27 2.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.112 179.963 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 5.8 t -145.53 33.12 1.06 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.822 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 16.5 t -77.42 107.47 9.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -147.58 158.28 43.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.925 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 38.8 t -78.19 126.09 30.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.857 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.4 121.69 15.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.838 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.2 m 60.43 106.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.895 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.163 -0.922 . . . . 0.0 110.86 -179.965 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.1 mmtt . . . . . 0 N--CA 1.488 1.465 0 CA-C-O 120.814 0.34 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.4 mmt-85 -109.24 -60.78 1.72 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.901 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -132.31 -177.78 4.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.937 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -62.31 -63.06 1.35 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.855 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 62.19 117.19 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.926 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.6 p -107.87 157.77 17.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.93 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -170.32 141.2 1.98 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.868 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.63 99.98 7.59 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.885 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.48 140.94 53.97 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.451 2.101 . . . . 0.0 112.277 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.4 t -87.48 163.83 16.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.943 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.6 m -113.12 168.1 9.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -72.29 -69.11 0.42 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.897 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -90.77 -106.08 0.1 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.859 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -140.39 128.88 22.74 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.801 0.334 . . . . 0.0 110.731 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 2.1 t -67.01 143.89 56.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.942 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.5 tp -156.21 -67.65 0.11 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.902 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -114.13 167.09 12.23 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.446 -179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.418 ' CD2' ' HG3' ' A' ' 49' ' ' GLU . 33.4 m80 -136.19 160.67 37.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.907 0.384 . . . . 0.0 111.017 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 97.8 mt -127.23 117.96 23.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.709 179.857 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.4 t -101.8 121.59 52.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.205 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -90.26 136.97 32.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.891 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.8 mt -108.36 106.56 16.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.974 0.416 . . . . 0.0 110.848 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.541 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 4.1 mt -124.4 141.25 37.09 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.857 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.541 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 56.9 Cg_endo -73.36 81.46 1.77 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.172 1.915 . . . . 0.0 112.041 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 148.93 -18.78 1.23 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.403 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 11.9 ttmm -177.65 165.0 2.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.709 0.29 . . . . 0.0 110.655 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -122.11 149.76 43.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.028 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -121.43 134.05 55.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.74 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.95 124.88 53.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.137 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 31.6 t -120.15 150.52 22.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.998 179.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.418 ' HG3' ' CD2' ' A' ' 36' ' ' HIS . 0.0 OUTLIER -103.01 142.07 34.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.037 -179.867 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.1 mm -115.38 122.68 69.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.839 179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.87 168.16 10.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.144 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -100.11 73.87 1.74 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.593 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.624 ' C ' ' H ' ' A' ' 55' ' ' VAL . 4.0 ptp180 -107.05 22.04 16.61 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.437 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.49 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 30.6 m-80 67.1 -27.9 0.13 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.659 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.624 ' H ' ' C ' ' A' ' 53' ' ' ARG . 61.6 t -137.72 137.67 45.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 CA-C-O 121.006 0.431 . . . . 0.0 111.96 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.504 ' HB ' ' HB2' ' A' ' 80' ' ' PHE . 0.4 OUTLIER -125.36 128.28 47.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.72 178.911 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.464 ' O ' ' N ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -104.06 136.22 44.11 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.976 0.417 . . . . 0.0 111.488 -179.463 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.414 HD11 ' CD2' ' A' ' 80' ' ' PHE . 4.4 mp -132.2 127.17 57.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.974 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 164.08 -142.13 7.59 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.074 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.421 ' N ' HG21 ' A' ' 73' ' ' ILE . 14.3 ttp180 -88.65 -43.19 11.51 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.811 0.339 . . . . 0.0 111.027 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -45.93 115.09 0.89 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.461 -179.527 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.04 -27.41 61.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.942 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.2 m -70.03 -24.71 63.32 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.814 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.414 ' CB ' ' HB ' ' A' ' 57' ' ' THR . 98.7 m -53.08 167.93 0.15 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.76 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.464 ' N ' ' O ' ' A' ' 57' ' ' THR . 0.6 OUTLIER -69.5 -53.88 16.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.922 0.391 . . . . 0.0 111.038 179.943 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 22.1 t -125.05 125.69 69.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.517 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.3 pt -99.65 131.06 47.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.504 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.4 mp -100.89 -100.33 0.25 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.344 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.2 p -92.14 -103.9 0.11 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 121.224 -0.19 . . . . 0.0 110.724 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.448 ' CB ' ' CD ' ' A' ' 71' ' ' PRO . 3.0 mt-10 167.17 -64.78 0.0 OUTLIER Pre-proline 0 CA--C 1.529 0.136 0 CA-C-O 120.68 0.276 . . . . 0.0 111.145 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.448 ' CD ' ' CB ' ' A' ' 70' ' ' GLU . 28.9 Cg_endo -62.89 -37.49 54.26 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.359 2.039 . . . . 0.0 112.56 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -112.04 17.06 19.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.276 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.421 HG21 ' N ' ' A' ' 60' ' ' ARG . 4.5 tp -108.79 127.48 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 CA-C-O 120.925 0.393 . . . . 0.0 111.093 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.42 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 0.9 OUTLIER -83.79 133.67 34.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.367 -179.578 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 57.3 m -57.94 -30.74 66.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.078 179.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.414 ' O ' ' C ' ' A' ' 77' ' ' HIS . 39.6 m-85 -110.27 13.97 22.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.237 0.541 . . . . 0.0 111.536 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.429 ' CE1' ' HB3' ' A' ' 127' ' ' PHE . 0.1 OUTLIER -25.94 -64.75 0.06 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.779 -1.1 . . . . 0.0 112.702 -179.277 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.423 ' HB1' ' CE1' ' A' ' 127' ' ' PHE . . . -157.66 163.98 37.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.116 0.484 . . . . 0.0 112.027 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . 0.462 ' HA ' ' O ' ' A' ' 56' ' ' THR . 0.8 OUTLIER -134.81 141.4 46.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.319 179.405 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.504 ' HB2' ' HB ' ' A' ' 56' ' ' THR . 47.0 m-85 -119.44 131.51 55.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.942 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.49 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 4.1 m-70 -94.63 116.53 28.87 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.832 0.349 . . . . 0.0 110.756 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -106.28 109.89 21.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.03 -179.89 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.07 133.86 55.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.705 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -101.69 128.82 47.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.917 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.7 ttt -141.45 111.97 7.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.864 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -79.03 116.02 19.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.953 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.5 t -140.0 114.3 6.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.072 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 60.83 -165.83 0.21 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.79 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -48.92 132.4 18.49 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.281 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 61.11 155.04 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.904 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -85.98 139.78 30.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.953 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 80.1 mtt180 -109.92 122.64 48.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.865 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -113.04 146.73 38.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.84 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.2 mt -128.81 140.04 51.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.927 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.1 mp -120.97 138.48 51.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.06 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -113.94 143.31 44.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.021 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.418 HG13 ' CE1' ' A' ' 80' ' ' PHE . 3.9 t -104.41 135.08 43.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.173 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 22.6 mt -129.86 146.33 34.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.18 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -119.74 123.49 43.88 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.902 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.67 -41.7 1.98 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.119 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.2 m -71.56 157.76 37.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.065 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.43 29.01 8.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.844 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -86.97 -42.2 13.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.227 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 136.48 100.58 0.58 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.671 -0.775 . . . . 0.0 112.595 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 93.7 m -109.4 123.37 49.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.8 0.333 . . . . 0.0 110.735 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.416 ' CE1' ' HB3' ' A' ' 111' ' ' ARG . 47.2 m-85 -120.87 115.06 22.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.932 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.6 tp -118.31 137.26 52.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.428 0.632 . . . . 0.0 111.196 179.883 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 61.77 32.2 18.26 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.798 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.76 10.9 72.78 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.859 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -134.05 151.96 51.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.743 0.306 . . . . 0.0 110.851 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.416 ' HB3' ' CE1' ' A' ' 106' ' ' PHE . 6.6 ptm180 -70.95 139.05 50.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.894 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -85.49 129.3 34.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.88 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.2 p -125.58 -44.65 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.11 179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.6 mmmp? -66.23 172.83 3.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.908 179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -119.03 31.38 6.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.931 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -162.23 57.86 0.24 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.801 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.98 139.09 38.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.84 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.404 ' O ' ' CG2' ' A' ' 118' ' ' ILE . 7.8 tp -98.59 117.31 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-O 121.004 0.43 . . . . 0.0 111.228 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.425 HD22 ' CD2' ' A' ' 135' ' ' PHE . 7.6 tt -103.07 131.23 50.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.057 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.26 178.03 6.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.781 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.457 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 5.0 p-10 -57.72 141.29 49.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.966 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 74.86 47.66 13.77 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.311 -179.917 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -123.46 131.34 53.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.795 0.331 . . . . 0.0 111.081 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.74 122.6 41.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.65 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.424 HG22 ' CZ ' ' A' ' 127' ' ' PHE . 1.7 mp -114.97 133.56 60.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.314 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.2 t -124.02 123.81 67.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.968 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.429 ' HB3' ' CE1' ' A' ' 77' ' ' HIS . 23.5 m-85 -116.27 111.92 20.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.85 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . 0.402 ' O ' ' CB ' ' A' ' 129' ' ' LYS . . . 88.61 -15.31 57.45 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.88 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . 0.402 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 10.9 tttt 79.32 30.65 0.3 Allowed 'General case' 0 CA--C 1.522 -0.109 0 CA-C-O 121.002 0.43 . . . . 0.0 110.378 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 15.3 p -128.22 -50.07 1.31 Allowed 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.99 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 7.0 m -109.59 112.58 24.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.977 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -116.8 131.06 57.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.931 179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -141.25 156.04 45.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.074 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 7.7 tt -107.74 140.05 41.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.8 179.919 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.425 ' CD2' HD22 ' A' ' 119' ' ' LEU . 87.7 t80 -101.57 141.56 34.25 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 122.002 0.906 . . . . 0.0 111.933 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt -154.37 145.87 23.13 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 113.748 -1.569 . . . . 0.0 110.707 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.457 ' CE2' ' HB3' ' A' ' 121' ' ' ASN . 4.4 m-85 -73.62 139.75 45.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.992 0.425 . . . . 0.0 110.736 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.416 ' HB2' ' CE1' ' A' ' 36' ' ' HIS . . . -119.15 87.78 2.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.045 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 5.4 t -90.65 141.59 28.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.959 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.1 m -102.0 157.42 16.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.888 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 1.3 m 60.6 101.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.899 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 19.1 m -142.67 -61.91 0.43 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.921 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 68.4 p -78.72 117.23 19.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.923 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -111.13 -25.65 9.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.114 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 6.3 mm -143.46 117.38 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 CA-C-O 121.699 0.762 . . . . 0.0 109.558 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -116.28 82.37 1.77 Allowed 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 114.341 -1.299 . . . . 0.0 110.852 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -76.05 -41.27 51.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.875 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -87.21 160.9 18.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.909 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.58 123.67 24.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.834 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -142.59 152.62 42.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.892 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -163.0 107.19 1.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.835 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.5 t -112.31 -58.95 3.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.124 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 7.3 m -134.28 32.7 3.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.906 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 2.6 p -104.4 170.55 7.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.883 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -144.1 144.59 31.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.962 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.3 m -82.45 140.28 33.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.899 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 60.71 36.63 19.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.918 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 58.3 m -137.66 95.69 3.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.943 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.116 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.819 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.6 mttt . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.796 0.331 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.2 ptt85 -133.22 -46.67 0.84 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.835 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.76 143.89 40.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.837 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -81.31 104.47 11.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.926 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -170.25 -62.24 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.918 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.2 95.76 7.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.875 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -117.31 163.56 16.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.845 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.87 143.36 26.5 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.789 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.01 146.25 58.1 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.579 2.186 . . . . 0.0 112.316 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 75.9 p -83.58 -33.93 25.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.856 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.3 t -144.71 144.37 31.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.928 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.454 ' C ' ' CG ' ' A' ' 31' ' ' TYR . 6.0 tt0 -107.12 164.15 12.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.923 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.454 ' CG ' ' C ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -167.81 115.7 0.75 Allowed 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 121.237 0.542 . . . . 0.0 110.464 179.629 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.1 m -97.6 158.72 15.34 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.725 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 44.9 t -59.92 137.23 58.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.882 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.4 tt -130.21 -44.98 1.13 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.971 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -157.67 -167.89 19.3 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.567 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 54.2 m80 -147.0 164.06 34.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.841 0.353 . . . . 0.0 110.911 -179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.42 ' HB3' ' CD2' ' A' ' 133' ' ' PHE . 2.4 mp -127.03 108.0 10.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.809 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.5 t -97.96 121.96 49.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.163 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -90.06 117.06 28.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.785 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.4 mt -81.14 106.53 13.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.831 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.53 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 4.8 mt -124.25 140.83 35.85 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.917 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.53 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 58.0 Cg_endo -74.43 81.82 1.99 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.161 1.908 . . . . 0.0 111.867 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 145.02 -14.19 1.92 Allowed Glycine 0 CA--C 1.52 0.382 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.483 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -179.0 173.8 1.14 Allowed 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 120.774 0.321 . . . . 0.0 110.604 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -132.75 156.32 47.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.098 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -135.37 112.17 10.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.804 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.63 132.29 51.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.02 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.1 t -121.09 151.1 24.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.014 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -94.87 131.41 40.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.807 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.6 tt -116.05 124.67 72.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.248 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -100.93 168.14 9.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.959 -179.765 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -80.32 66.36 5.8 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.173 0.511 . . . . 0.0 110.313 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.599 ' C ' ' H ' ' A' ' 55' ' ' VAL . 8.8 ttt85 -79.48 1.55 25.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.796 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 72.12 -36.55 0.36 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -178.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.599 ' H ' ' C ' ' A' ' 53' ' ' ARG . 66.5 t -137.36 132.75 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.781 179.282 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.435 ' HB ' ' HB2' ' A' ' 80' ' ' PHE . 21.7 m -125.22 124.32 41.46 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.917 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.65 132.37 49.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.876 0.369 . . . . 0.0 110.777 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.435 HG21 HD11 ' A' ' 58' ' ' ILE . 34.6 mt -115.19 120.37 64.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.286 -179.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 170.71 -134.09 3.01 Favored Glycine 0 C--N 1.331 0.259 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.235 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.574 ' HB3' ' HA ' ' A' ' 70' ' ' GLU . 0.2 OUTLIER -118.76 -21.96 7.61 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.585 0.231 . . . . 0.0 111.305 179.806 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -52.01 126.48 18.54 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.864 0.364 . . . . 0.0 110.96 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.4 mmm180 -55.05 -26.25 36.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.104 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.0 m -77.3 -22.68 51.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.12 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 98.5 m -54.71 162.26 1.26 Allowed 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.151 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.414 ' HB3' ' CG2' ' A' ' 56' ' ' THR . 12.9 t0 -83.69 -49.0 9.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.128 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 58' ' ' ILE . 26.7 t -123.77 116.85 49.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.371 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 16.5 pt -100.76 127.8 53.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.975 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.417 HD12 ' CE1' ' A' ' 133' ' ' PHE . 3.8 mm? -98.18 -92.21 0.25 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.697 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.411 ' O ' ' CB ' ' A' ' 70' ' ' GLU . 48.0 m -87.58 -108.01 0.07 Allowed 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.574 ' HA ' ' HB3' ' A' ' 60' ' ' ARG . 1.0 OUTLIER 167.48 -64.51 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.275 0 N-CA-C 111.644 0.238 . . . . 0.0 111.644 178.871 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.573 ' HD3' ' HB3' ' A' ' 70' ' ' GLU . 15.9 Cg_exo -67.61 -40.28 10.47 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.123 1.882 . . . . 0.0 112.998 -179.433 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -109.22 21.29 17.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.303 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.476 ' CG2' ' HB3' ' A' ' 60' ' ' ARG . 4.8 tp -112.26 120.62 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-O 120.905 0.384 . . . . 0.0 110.817 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.426 ' HB2' ' CG ' ' A' ' 77' ' ' HIS . 0.5 OUTLIER -57.92 131.48 50.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.075 -179.527 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.5 m -59.12 -44.01 91.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.688 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.473 ' O ' ' C ' ' A' ' 77' ' ' HIS . 1.6 m-85 -105.62 13.75 29.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.184 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.473 ' C ' ' O ' ' A' ' 76' ' ' PHE . 0.2 OUTLIER -15.0 -70.18 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.618 -1.174 . . . . 0.0 112.763 -179.479 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -151.21 153.3 34.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.065 0.459 . . . . 0.0 111.937 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -117.21 133.8 55.56 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.255 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.435 ' HB2' ' HB ' ' A' ' 56' ' ' THR . 8.2 m-85 -119.45 131.11 55.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.142 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.418 ' CD2' HD13 ' A' ' 98' ' ' ILE . 17.7 m-70 -94.88 116.67 29.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.857 0.361 . . . . 0.0 111.107 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -106.34 109.62 21.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.69 179.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.6 tt -122.19 139.38 53.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.125 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -129.1 131.89 47.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.724 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.15 148.48 40.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.078 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -107.09 125.76 51.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.779 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.5 t -139.96 126.33 22.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.158 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 58.82 42.21 20.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.987 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 62.04 29.11 17.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.949 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -139.45 130.91 27.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.814 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 20.8 mm100 -85.58 132.26 34.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.971 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -111.7 124.65 52.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.794 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -103.81 122.56 45.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.021 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.8 mt -132.08 122.96 26.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.727 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 7.2 mm -113.16 137.25 46.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.02 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.01 135.35 54.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.821 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.414 HG11 ' CZ ' ' A' ' 80' ' ' PHE . 18.7 t -112.82 128.55 69.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.195 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.418 HD13 ' CD2' ' A' ' 81' ' ' HIS . 7.5 mt -129.64 120.97 51.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.004 179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -102.32 134.01 46.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.937 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.6 pttp -149.73 32.17 0.7 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.835 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.8 m -119.94 -178.0 3.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.01 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.35 38.1 2.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.876 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -105.53 -38.32 6.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.278 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 131.95 98.5 0.73 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.521 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.418 HG23 ' CE1' ' A' ' 127' ' ' PHE . 71.0 m -117.54 124.13 47.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.846 0.355 . . . . 0.0 110.835 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -120.98 121.79 38.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.956 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.2 tp -120.57 137.1 55.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.414 0.626 . . . . 0.0 111.282 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 9.9 m120 56.56 31.45 19.08 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.892 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.69 13.05 74.73 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.875 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 24.7 p30 -134.08 150.34 51.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.785 0.326 . . . . 0.0 110.912 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 3.7 ttm180 -62.83 141.82 58.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.983 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.1 tt -100.06 125.7 46.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.831 -179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.0 p -149.94 49.62 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.128 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.46 -177.47 3.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.827 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.3 mtpt -111.56 -33.75 6.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.908 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -137.59 76.8 1.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.97 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -84.0 136.38 34.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.768 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.407 ' O ' ' CG2' ' A' ' 118' ' ' ILE . 8.8 tp -98.64 118.95 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.261 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.4 tt -103.09 145.59 29.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.928 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 13.6 mttt -132.1 178.06 7.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.84 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.411 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 15.5 p30 -58.25 138.81 56.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.0 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 78.13 58.04 3.28 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.523 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -134.22 126.57 30.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.798 0.332 . . . . 0.0 110.889 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 7.9 ttm180 -93.3 127.64 38.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.846 -180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.418 HG23 ' CE2' ' A' ' 127' ' ' PHE . 1.7 mp -121.67 134.23 65.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.188 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.7 t -124.12 123.92 67.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.946 179.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.429 ' HB3' ' CE1' ' A' ' 77' ' ' HIS . 79.7 m-85 -113.98 111.89 22.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.002 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 84.04 -10.27 61.05 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.846 -0.692 . . . . 0.0 113.057 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 77.28 30.02 0.54 Allowed 'General case' 0 CA--C 1.522 -0.133 0 CA-C-O 120.985 0.421 . . . . 0.0 110.273 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 26.9 p -125.84 -44.06 1.81 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.99 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 1.8 m -118.6 116.92 27.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.032 -179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 77.2 p -124.06 130.66 52.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.795 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.42 ' CD2' ' HB3' ' A' ' 37' ' ' LEU . 8.8 p90 -141.98 156.01 45.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.023 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 2.2 tp -105.79 130.88 53.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.785 179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 26.9 t80 -94.31 141.44 28.57 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.886 0.85 . . . . 0.0 111.729 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.3 tttp -154.7 149.85 26.99 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 113.938 -1.483 . . . . 0.0 111.041 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.411 ' CE2' ' HB3' ' A' ' 121' ' ' ASN . 5.6 m-85 -76.25 140.09 41.43 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.987 0.422 . . . . 0.0 110.645 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -97.25 158.89 15.23 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.043 -179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 4.8 m 61.6 86.33 0.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.842 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 67.6 m -56.85 147.18 24.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.023 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 98.8 p -128.41 117.36 21.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.902 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 61.51 87.2 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.905 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 25.4 p -104.28 -179.24 3.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.929 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -126.19 130.97 52.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.896 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 19.9 mm -103.23 25.1 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 CA-C-O 121.642 0.734 . . . . 0.0 111.314 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 60.81 77.41 0.33 Allowed 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.89 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -76.86 -65.63 0.92 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.88 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 59.79 104.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.825 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -168.03 149.24 5.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.861 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -131.0 -178.7 4.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 39.4 mttm -139.85 174.21 10.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.853 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 14.8 p -117.68 38.94 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.997 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.78 97.74 3.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.953 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 22.4 m -137.53 -61.65 0.63 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.879 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 60.05 -175.88 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.899 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.4 p -62.85 170.74 2.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.861 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 11.8 ttp180 -164.79 161.57 20.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.897 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 18.4 t -117.35 96.93 5.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.925 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 36.7 t80 . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.935 179.995 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.839 0.352 . . . . 0.0 111.176 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -157.26 -46.31 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.822 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -99.7 -68.48 0.8 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.948 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -176.04 -64.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.915 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.8 mtp180 -89.1 119.04 29.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.931 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.8 m -147.35 33.85 0.88 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.938 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -158.68 139.09 12.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.877 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.3 mttm -146.77 138.58 13.46 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.992 -179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -57.97 159.11 18.96 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.52 2.147 . . . . 0.0 112.212 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.0 m -92.57 43.16 1.12 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.953 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 178.23 -179.34 0.29 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.747 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 60.09 69.69 0.68 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.889 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.422 ' HB2' ' HB ' ' A' ' 51' ' ' THR . 33.3 m-85 -107.29 -112.03 0.29 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.786 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.21 136.32 33.27 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.833 0.349 . . . . 0.0 110.435 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 51.3 t -59.83 145.19 46.41 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.367 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.6 tp -150.72 -44.22 0.12 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.665 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -153.03 -175.57 24.61 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.041 -0.599 . . . . 0.0 112.127 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.415 ' CE1' ' HG3' ' A' ' 49' ' ' GLU . 40.4 m80 -147.01 166.06 27.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.012 0.434 . . . . 0.0 111.221 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.7 mp -127.07 136.01 51.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.59 179.718 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 1.7 t -101.66 123.61 54.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.125 -179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -90.15 120.91 31.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.779 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.3 mt -97.86 107.73 20.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.965 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.415 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 3.3 mp -116.82 138.77 24.93 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.757 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.415 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 91.5 Cg_exo -44.42 -27.67 2.21 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.623 2.215 . . . . 0.0 112.708 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -149.22 45.32 0.7 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.601 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 20.8 tptt -179.86 164.15 1.17 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.792 0.329 . . . . 0.0 111.01 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -146.92 134.39 20.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.634 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -129.62 145.51 51.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.157 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.0 133.24 55.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.739 179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.1 t -121.97 149.25 25.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.941 0.4 . . . . 0.0 111.237 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.415 ' HG3' ' CE1' ' A' ' 36' ' ' HIS . 48.6 tt0 -107.97 128.53 54.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.655 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 1.2 tt -105.92 132.03 53.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.264 -179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.422 ' HB ' ' HB2' ' A' ' 31' ' ' TYR . 0.8 OUTLIER -98.55 168.42 10.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.044 -179.707 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 12.1 p30 -86.09 62.94 7.75 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.198 0.523 . . . . 0.0 110.17 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.611 ' C ' ' H ' ' A' ' 55' ' ' VAL . 23.5 ttt-85 -82.83 1.78 37.44 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.005 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 71.93 -33.62 0.27 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -178.677 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.611 ' H ' ' C ' ' A' ' 53' ' ' ARG . 74.0 t -136.79 141.33 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.428 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.44 ' N ' ' O ' ' A' ' 80' ' ' PHE . 51.0 m -125.18 126.79 45.79 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.336 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.79 139.1 39.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.823 0.344 . . . . 0.0 110.517 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.5 mp -130.8 132.66 63.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.063 -179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 164.89 -151.9 21.16 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.472 -0.871 . . . . 0.0 113.09 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.427 ' HB2' ' CG2' ' A' ' 73' ' ' ILE . 14.7 ttp180 -86.2 -45.43 11.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.76 0.314 . . . . 0.0 111.25 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 11.5 p -52.05 128.72 25.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.358 -179.47 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.98 -16.49 61.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.141 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.72 -26.62 64.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.817 0.342 . . . . 0.0 110.708 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 83.1 m -59.85 156.32 14.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.627 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 7.4 t70 -62.07 -46.3 89.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.913 0.387 . . . . 0.0 110.495 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.9 t -125.18 132.98 70.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.316 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.4 mt -104.35 115.2 45.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.025 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.427 HD13 ' CD2' ' A' ' 127' ' ' PHE . 14.5 mt -87.22 -134.92 0.08 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.517 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.444 ' O ' ' CB ' ' A' ' 70' ' ' GLU . 17.4 m -57.04 -105.99 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 O-C-N 122.404 -0.185 . . . . 0.0 110.941 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.444 ' CB ' ' O ' ' A' ' 69' ' ' SER . 2.9 mt-10 163.72 -62.64 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.264 0 CA-C-O 120.597 0.236 . . . . 0.0 111.398 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.429 ' CD ' ' CB ' ' A' ' 70' ' ' GLU . 19.7 Cg_endo -58.93 -39.98 75.96 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.661 2.24 . . . . 0.0 113.009 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -118.55 27.12 9.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.682 0.277 . . . . 0.0 111.538 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.427 ' CG2' ' HB2' ' A' ' 60' ' ' ARG . 4.8 tp -109.7 127.65 66.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.96 0.409 . . . . 0.0 111.606 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.17 134.17 45.55 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.045 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 87.6 m -50.73 -44.06 58.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.271 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.494 ' O ' ' C ' ' A' ' 77' ' ' HIS . 12.1 p90 -106.69 13.86 27.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.081 0.467 . . . . 0.0 111.677 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.494 ' C ' ' O ' ' A' ' 76' ' ' PHE . 4.2 t60 -6.38 -69.09 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.671 -1.15 . . . . 0.0 112.979 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -152.81 164.05 38.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.951 0.405 . . . . 0.0 111.632 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -130.09 128.97 42.95 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.864 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.44 ' O ' ' N ' ' A' ' 56' ' ' THR . 5.6 m-85 -119.44 131.15 55.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.719 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -94.72 116.34 28.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.964 0.412 . . . . 0.0 111.266 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 22.3 tp -106.74 109.73 21.71 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.849 179.622 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.22 140.09 53.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.012 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.4 tm0? -106.03 137.18 44.39 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.759 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 7.6 mtt -107.03 136.76 46.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.841 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -97.87 116.48 30.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.035 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 17.5 t -139.97 139.15 37.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.943 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -48.36 -51.61 25.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.188 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -53.66 -65.74 0.51 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.163 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -162.67 163.11 27.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.826 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.0 128.0 34.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.913 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.3 mmm180 -108.1 129.69 55.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.82 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -114.07 120.0 39.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.01 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.2 mt -115.55 130.1 56.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.752 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.422 HD13 ' CE1' ' A' ' 135' ' ' PHE . 3.7 mp -114.66 136.04 52.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.275 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -114.28 138.76 50.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.731 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.428 ' CG1' ' CZ ' ' A' ' 80' ' ' PHE . 17.4 t -101.02 134.95 39.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.274 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 32.4 mt -129.3 134.96 62.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.071 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 20.6 p-10 -105.55 118.86 37.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.849 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.3 mtpp -133.17 31.11 3.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.922 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.2 m -144.03 174.67 10.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.881 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.94 30.44 4.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.894 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -85.32 -34.46 21.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.142 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 120.94 88.79 1.04 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.527 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 75.6 m -107.12 126.98 53.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.903 0.382 . . . . 0.0 110.946 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -120.93 117.85 28.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.904 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.6 tp -113.01 137.23 46.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.449 0.643 . . . . 0.0 111.297 179.981 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 62.94 27.69 16.05 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.933 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.74 12.77 74.66 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.811 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -134.02 152.05 51.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.82 0.343 . . . . 0.0 110.903 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.0 ttp180 -73.61 129.79 38.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.85 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 3.6 pp -88.52 144.82 26.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.993 179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 14.2 m -143.46 32.21 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.112 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -147.43 149.39 32.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.881 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.6 mtmm -98.63 34.84 1.94 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.942 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -152.76 50.27 0.74 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.972 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -83.89 136.63 34.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.843 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.9 tp -98.56 117.27 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-O 120.983 0.42 . . . . 0.0 111.216 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 10.0 tt -103.16 135.52 44.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.024 -179.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 35.7 mttt -131.99 178.03 7.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.765 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.432 ' HB3' ' CD2' ' A' ' 137' ' ' TYR . 9.9 p-10 -62.15 142.86 57.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.871 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 72.67 42.41 47.15 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.5 -179.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -118.08 127.3 53.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.8 0.333 . . . . 0.0 110.932 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.57 118.5 23.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.837 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 2.9 mt -114.93 122.68 69.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.206 -179.832 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 24.7 t -118.48 128.22 75.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.96 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.427 ' CD2' HD13 ' A' ' 68' ' ' LEU . 49.1 m-85 -111.4 137.16 49.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.963 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 74.48 -65.85 2.03 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.351 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 174.94 -50.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.812 0.339 . . . . 0.0 110.95 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.2 p -91.33 -42.74 10.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.253 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . 0.403 ' HB3' ' CZ ' ' A' ' 133' ' ' PHE . 25.9 m -54.93 108.17 0.37 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.121 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 41.5 t -123.76 129.97 51.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.856 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.408 ' CZ ' HD23 ' A' ' 68' ' ' LEU . 1.5 m-85 -141.98 154.24 44.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.797 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -120.02 139.82 51.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.937 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.422 ' CE1' HD13 ' A' ' 95' ' ' ILE . 28.3 t80 -112.37 141.48 46.05 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.964 0.887 . . . . 0.0 111.859 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.65 159.02 40.53 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 113.853 -1.522 . . . . 0.0 110.761 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.432 ' CD2' ' HB3' ' A' ' 121' ' ' ASN . 3.6 m-85 -86.05 139.72 30.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.933 0.397 . . . . 0.0 110.763 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -115.28 -37.37 4.08 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.083 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.39 162.95 3.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.922 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 41.4 t 60.66 162.32 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.867 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 91.5 p -61.91 106.78 0.74 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.903 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.05 76.78 1.72 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.879 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.6 p -137.28 -67.85 0.48 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.984 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -159.01 148.88 19.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.824 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 8.1 mt -147.02 119.83 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.329 0 CA-C-O 121.71 0.767 . . . . 0.0 109.573 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -98.3 107.83 20.39 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 114.414 -1.266 . . . . 0.0 110.907 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -165.83 143.89 5.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.914 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 7.3 t70 60.28 35.85 20.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.907 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -98.79 31.38 2.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.904 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.64 -51.57 2.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.852 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 12.0 tttm 60.22 91.3 0.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.917 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.5 t -95.34 -60.07 2.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.138 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 18.6 p -124.82 120.21 31.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.889 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 22.8 p -151.0 179.74 8.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.896 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -127.5 143.63 51.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.94 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 4.0 m -167.34 179.14 5.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.925 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 9.2 mtt-85 -135.69 70.59 1.43 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.866 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.9 m -148.56 156.0 41.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.941 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.854 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.2 mttp . . . . . 0 N--CA 1.488 1.429 0 CA-C-O 120.867 0.365 . . . . 0.0 111.133 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.2 ttm-85 -132.08 104.19 6.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.928 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -132.1 30.72 4.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.845 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 59.35 -176.45 0.09 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.946 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -162.5 150.25 14.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.934 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.3 m -108.91 91.05 3.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.895 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 59.1 m-20 -90.55 168.21 11.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.931 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.2 mmtm -63.01 120.09 57.93 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.882 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.0 144.55 53.12 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.355 2.037 . . . . 0.0 112.315 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.4 m -66.12 174.24 2.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.904 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -150.47 84.38 1.37 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.832 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.17 131.51 3.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.064 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.484 ' N ' HG23 ' A' ' 51' ' ' THR . 2.1 m-85 -53.65 -96.21 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.983 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.409 ' N ' HG22 ' A' ' 51' ' ' THR . 0.2 OUTLIER -140.45 132.12 27.26 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.454 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.8 t -59.71 144.89 46.87 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.101 0.477 . . . . 0.0 111.341 -179.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -151.52 -45.04 0.11 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.338 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -147.36 157.61 27.45 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.926 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.429 ' CE1' ' HB3' ' A' ' 138' ' ' ALA . 51.8 m80 -119.83 160.4 22.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.99 0.424 . . . . 0.0 111.295 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 59.2 mt -127.09 112.77 15.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.607 179.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.2 t -99.71 121.74 50.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.133 -179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -90.19 114.87 26.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.763 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 32.0 mt -88.21 106.85 18.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.84 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.4 mt -124.11 139.27 32.29 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.08 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.34 92.86 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.377 2.051 . . . . 0.0 112.251 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.71 34.21 10.42 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.364 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -179.94 150.55 0.39 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.806 0.336 . . . . 0.0 110.859 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -151.22 152.0 32.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.991 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -143.6 126.22 15.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.739 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.0 ttpt -104.65 126.07 51.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.929 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.0 t -111.6 150.8 13.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.104 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.409 ' HG3' ' CD2' ' A' ' 36' ' ' HIS . 0.4 OUTLIER -100.46 119.95 39.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.97 -179.891 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 31.0 mm -96.12 132.09 41.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.07 179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.484 HG23 ' N ' ' A' ' 31' ' ' TYR . 1.1 p -110.0 168.51 9.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.788 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 3.9 p30 -81.32 60.43 4.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.149 0.5 . . . . 0.0 110.291 179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.612 ' C ' ' H ' ' A' ' 55' ' ' VAL . 20.0 ttt-85 -82.86 1.38 39.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.757 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.401 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 11.9 m-20 71.54 -33.28 0.27 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -178.696 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.612 ' H ' ' C ' ' A' ' 53' ' ' ARG . 78.8 t -137.19 140.75 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.58 179.379 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.461 ' N ' ' O ' ' A' ' 80' ' ' PHE . 30.5 m -125.29 128.33 48.08 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.054 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.405 ' HB ' ' HA ' ' A' ' 64' ' ' CYS . 0.0 OUTLIER -103.91 130.69 51.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.809 0.338 . . . . 0.0 110.768 -179.986 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 2.7 mp -124.06 120.94 60.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.09 -179.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 171.35 -143.11 7.41 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.735 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.414 ' HB2' ' CG2' ' A' ' 73' ' ' ILE . 11.8 ttp180 -95.18 -32.34 13.1 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.803 0.335 . . . . 0.0 111.093 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -48.79 133.91 16.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.331 -179.575 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 48.6 mtp85 -67.12 -31.14 71.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.741 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -70.98 -22.83 62.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.039 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.405 ' HA ' ' HB ' ' A' ' 57' ' ' THR . 66.9 m -52.1 146.62 8.57 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.88 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.401 ' HB3' ' CG2' ' A' ' 56' ' ' THR . 63.6 t0 -61.07 -43.82 98.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.876 0.37 . . . . 0.0 110.727 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 23.0 t -125.17 132.95 70.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.357 -179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 6.7 pt -109.86 127.16 66.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.856 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 8.0 mt -103.67 -132.76 0.3 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.881 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.405 ' O ' ' CB ' ' A' ' 70' ' ' GLU . 29.4 t -57.67 -105.67 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 O-C-N 122.336 -0.227 . . . . 0.0 111.002 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.448 ' CB ' ' CD ' ' A' ' 71' ' ' PRO . 2.7 mt-10 167.02 -64.37 0.0 OUTLIER Pre-proline 0 N--CA 1.463 0.207 0 CA-C-O 120.605 0.24 . . . . 0.0 111.213 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.448 ' CD ' ' CB ' ' A' ' 70' ' ' GLU . 21.5 Cg_endo -61.04 -40.08 54.78 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.6 2.2 . . . . 0.0 112.673 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -110.34 20.81 17.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.307 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.414 ' CG2' ' HB2' ' A' ' 60' ' ' ARG . 4.7 tp -109.39 121.8 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-O 121.114 0.483 . . . . 0.0 111.098 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 45.1 t -83.4 136.23 34.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.357 -179.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 63.6 m -61.24 -30.01 70.18 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.988 179.68 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.406 ' O ' ' C ' ' A' ' 77' ' ' HIS . 12.2 m-85 -103.92 14.23 31.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.731 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.41 ' HB2' ' O ' ' A' ' 74' ' ' SER . 0.1 OUTLIER -29.81 -72.95 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.348 -179.232 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.424 ' HB3' ' CE2' ' A' ' 127' ' ' PHE . . . -156.48 164.1 38.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.979 0.419 . . . . 0.0 111.821 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.23 136.05 49.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.651 179.666 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.461 ' O ' ' N ' ' A' ' 56' ' ' THR . 9.3 m-85 -119.3 127.88 53.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.64 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.401 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 9.0 m-70 -94.88 116.41 28.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.975 0.416 . . . . 0.0 111.53 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -106.68 109.74 21.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.551 179.386 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.18 140.08 53.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.207 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -102.4 122.38 44.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.67 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.31 113.43 20.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.15 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -107.09 121.54 44.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.816 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 11.4 p -139.98 120.1 13.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.26 -179.892 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 57.99 65.53 1.28 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.001 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.8 t30 66.66 -73.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.998 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -60.47 122.63 15.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.864 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -111.17 129.14 56.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.919 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -106.64 135.52 48.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.942 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -99.97 131.29 46.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.903 -179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -121.93 128.42 51.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.814 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 3.5 mp -112.97 141.13 29.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.076 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -113.99 143.93 43.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.769 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.443 ' CG2' ' CE2' ' A' ' 80' ' ' PHE . 12.0 t -107.01 126.67 63.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.153 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.9 mp -128.23 120.97 54.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.02 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -114.17 138.75 50.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.941 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.21 -11.05 19.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.208 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.0 m 65.67 102.39 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.825 0.345 . . . . 0.0 110.913 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 12.6 mmp_? -128.1 -69.04 0.74 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.865 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 35.7 p-10 -110.97 -32.65 6.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.868 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 147.42 100.94 0.26 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.466 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -119.83 123.92 44.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.769 0.319 . . . . 0.0 110.93 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . 0.414 ' CE2' ' HG3' ' A' ' 111' ' ' ARG . 4.7 m-85 -121.15 138.12 54.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.849 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.4 tp -121.68 137.3 55.77 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-O 121.59 0.71 . . . . 0.0 111.367 179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 60.05 30.41 19.9 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.69 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.8 13.03 75.1 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.782 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -129.53 152.05 49.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.946 0.403 . . . . 0.0 111.048 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.414 ' HG3' ' CE2' ' A' ' 106' ' ' PHE . 30.5 ttt180 -75.02 143.46 43.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.939 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -69.71 138.25 52.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.024 -179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 16.8 m -134.39 -46.14 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.05 179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -88.34 162.98 16.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.925 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.16 31.93 5.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.912 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -161.81 65.66 0.25 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.904 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -84.1 139.11 32.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.8 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.4 tp -98.58 121.42 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.221 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 3.4 tp -103.14 132.75 49.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.902 -179.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -126.38 178.03 6.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.79 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.44 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 7.1 p30 -63.05 143.13 58.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.9 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 69.37 50.36 33.03 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.535 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -117.73 142.24 47.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.767 0.318 . . . . 0.0 111.025 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 61.9 mtt85 -100.94 127.14 47.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.83 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.409 ' HB ' ' CE2' ' A' ' 133' ' ' PHE . 1.6 mp -123.37 136.91 58.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.185 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 38.1 t -124.01 124.05 68.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.92 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.424 ' CE2' ' HB3' ' A' ' 78' ' ' ALA . 3.3 m-85 -111.8 133.03 54.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.09 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 82.36 -67.55 3.68 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.419 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.35 -41.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.772 0.32 . . . . 0.0 111.118 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.81 -41.98 4.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.701 -179.418 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 29.1 m -51.98 105.65 0.12 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.934 0.397 . . . . 0.0 111.231 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 32.4 p -124.36 134.72 53.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.909 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.409 ' CE2' ' HB ' ' A' ' 125' ' ' ILE . 6.8 p90 -141.97 155.03 45.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.01 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.3 tp -112.64 138.38 49.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.777 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 47.7 t80 -108.15 141.48 39.81 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 122.005 0.907 . . . . 0.0 111.802 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 9.2 ptpt -154.59 154.13 32.53 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 113.883 -1.508 . . . . 0.0 110.873 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.44 ' CE2' ' HB3' ' A' ' 121' ' ' ASN . 0.8 OUTLIER -86.0 139.6 31.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.913 0.387 . . . . 0.0 110.734 179.643 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . 0.429 ' HB3' ' CE1' ' A' ' 36' ' ' HIS . . . -89.48 -30.05 18.55 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.121 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.33 160.41 31.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.787 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.6 m -134.64 169.56 17.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.911 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 55.0 p -80.25 -44.07 20.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.949 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -98.07 127.87 44.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.807 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 20.2 m -114.38 89.99 3.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.846 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -146.48 -56.63 0.28 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.851 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 17.9 mt -103.87 25.14 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.575 0.702 . . . . 0.0 111.302 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -114.27 160.02 19.51 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.88 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -101.78 97.15 7.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.873 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -120.23 -48.27 2.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.893 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -145.88 -49.53 0.22 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.892 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 59.24 90.45 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.941 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.22 87.32 2.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.913 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.5 t -77.08 124.95 36.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.152 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -93.35 166.57 12.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.847 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 34.8 t -171.03 149.2 2.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.919 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -76.93 147.38 37.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.899 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 49.6 m -149.22 -59.88 0.22 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.951 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.27 134.54 45.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.868 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.4 p -119.38 -179.58 3.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.84 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.255 -0.878 . . . . 0.0 110.861 179.976 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.931 0.396 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.34 176.73 4.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.888 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -60.22 104.01 0.28 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -75.89 -178.1 4.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.9 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -178.63 -35.8 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.026 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 80.8 p -76.94 -51.89 10.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.896 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -87.25 -179.69 6.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.9 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.73 119.61 75.79 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.776 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.06 145.49 55.56 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.385 2.056 . . . . 0.0 112.387 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.9 m -71.11 73.58 0.64 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.896 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.1 t -168.88 33.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.969 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -155.95 121.59 4.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.761 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -89.4 -108.78 0.08 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.851 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.401 ' N ' HG21 ' A' ' 51' ' ' THR . 0.0 OUTLIER -140.44 134.17 30.38 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.778 0.323 . . . . 0.0 110.613 179.742 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 49.7 t -59.88 145.02 47.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.094 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 8.4 tt -150.96 -46.68 0.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.844 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -151.16 -176.95 24.52 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.473 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 40.9 m80 -147.08 157.89 43.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.872 0.368 . . . . 0.0 111.041 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -127.02 129.42 48.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.716 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.3 t -109.03 122.0 63.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.224 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -90.01 119.89 30.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.805 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 66.3 mt -75.68 108.69 8.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.887 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 14.4 mt -122.24 138.52 29.13 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -46.94 -27.95 6.49 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.568 2.178 . . . . 0.0 112.529 -179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -114.15 -125.55 4.18 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.413 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -53.89 138.31 36.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.795 0.331 . . . . 0.0 111.129 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -82.12 150.52 27.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.833 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -117.01 110.51 18.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.025 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -113.04 121.0 43.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.842 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.8 t -124.53 151.06 29.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.153 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -100.26 142.15 32.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.786 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 6.1 tt -116.03 132.21 66.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.373 -179.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.401 HG21 ' N ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -97.59 168.08 10.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.819 -179.848 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -85.01 62.71 7.68 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.134 0.492 . . . . 0.0 110.238 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.597 ' C ' ' H ' ' A' ' 55' ' ' VAL . 22.3 ttt-85 -81.24 2.75 26.55 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.051 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 72.06 -35.24 0.32 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 -178.77 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.597 ' H ' ' C ' ' A' ' 53' ' ' ARG . 73.5 t -137.18 138.43 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.424 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.467 ' N ' ' O ' ' A' ' 80' ' ' PHE . 96.9 m -125.2 129.66 50.54 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.587 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.418 ' O ' ' N ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -103.98 140.72 37.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.897 0.379 . . . . 0.0 110.954 -179.825 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.404 HD12 ' CE2' ' A' ' 127' ' ' PHE . 9.6 mt -132.05 123.41 50.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.964 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 171.78 -148.46 10.96 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.717 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.431 ' HB2' ' CG2' ' A' ' 73' ' ' ILE . 9.4 tpt85 -93.55 -33.11 13.88 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.754 0.311 . . . . 0.0 111.083 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 3.5 t -53.61 139.98 30.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.133 -179.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.17 -25.41 61.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.119 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 63.6 p -69.81 -24.69 63.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.99 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 93.3 m -59.1 163.94 3.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.873 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.418 ' N ' ' O ' ' A' ' 57' ' ' THR . 0.9 OUTLIER -72.16 -59.18 2.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.033 0.444 . . . . 0.0 110.692 179.807 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.8 t -109.64 122.01 63.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.111 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.1 pt -98.4 105.11 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.917 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -64.94 -25.92 68.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.92 -179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 49.1 m 62.63 26.68 15.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.98 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.412 ' CB ' ' HB ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -85.37 148.52 49.91 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.707 179.837 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.04 -14.05 42.12 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.678 2.252 . . . . 0.0 113.061 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -135.17 23.27 3.51 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.431 ' CG2' ' HB2' ' A' ' 60' ' ' ARG . 5.2 tp -77.33 120.37 27.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.979 0.418 . . . . 0.0 110.996 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 47.0 t -62.39 133.99 55.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.311 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 94.3 m -57.94 -31.76 67.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.733 179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.465 ' O ' ' C ' ' A' ' 77' ' ' HIS . 13.5 m-85 -110.36 13.9 22.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.48 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.465 ' C ' ' O ' ' A' ' 76' ' ' PHE . 1.9 t60 -18.93 -67.69 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.708 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -156.34 162.29 40.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.0 0.428 . . . . 0.0 111.982 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -128.55 132.56 48.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.385 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.467 ' O ' ' N ' ' A' ' 56' ' ' THR . 6.0 m-85 -119.28 129.39 54.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.838 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -94.88 116.19 28.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.855 0.36 . . . . 0.0 111.348 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 7.1 tt -106.85 109.88 21.9 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.714 179.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.28 139.93 52.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.933 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -107.31 133.29 52.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.871 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -140.18 140.7 35.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.881 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -97.33 119.68 36.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.897 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.4 t -135.74 114.53 15.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.205 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 59.59 78.1 0.28 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.944 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 64.08 -79.25 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.03 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -69.59 159.53 33.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.914 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -111.91 140.63 46.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.921 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -104.05 148.42 26.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.824 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.42 ' HB2' ' CD1' ' A' ' 137' ' ' TYR . 14.3 m120 -114.01 120.03 39.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.99 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.1 mm? -105.37 127.52 53.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.766 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 26.7 mm -113.1 141.12 29.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.182 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -115.83 144.09 44.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.672 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.418 HG23 ' CE2' ' A' ' 80' ' ' PHE . 22.0 t -112.32 134.3 55.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.228 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 27.7 mt -130.01 129.87 65.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.1 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -98.22 125.04 43.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.866 -179.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 26.9 mmtp -147.42 31.37 0.9 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.893 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.1 m -105.42 171.68 7.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.878 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 21.1 mtt85 -110.36 -31.53 7.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.884 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -69.07 -73.31 0.15 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.235 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 176.36 135.41 2.14 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.672 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 88.2 m -131.82 122.96 26.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.773 0.321 . . . . 0.0 110.536 179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -120.37 130.91 54.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.042 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.2 tp -123.02 137.35 56.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.49 0.662 . . . . 0.0 111.216 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 62.75 28.8 16.65 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.823 -1.08 . . . . 0.0 110.776 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.81 6.0 62.38 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.925 -0.655 . . . . 0.0 113.073 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -134.21 144.26 48.34 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.788 0.328 . . . . 0.0 110.825 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.3 ttm180 -70.32 128.94 37.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.818 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -76.26 139.2 41.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.98 -179.966 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 30.6 m -111.78 -34.85 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.028 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -105.99 166.0 10.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.84 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.43 171.47 8.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.939 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.9 t70 62.65 56.23 2.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.023 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -79.0 137.58 37.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.745 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.5 tp -98.65 119.62 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-O 121.013 0.435 . . . . 0.0 111.418 -179.683 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 5.9 tt -103.19 132.62 49.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.849 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 29.5 mttt -114.63 178.09 4.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.443 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 5.6 p-10 -56.23 136.69 52.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.019 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 69.47 51.36 26.72 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.3 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -111.64 129.55 56.05 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.789 0.328 . . . . 0.0 111.028 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 11.7 ttm-85 -88.23 123.96 33.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.829 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.428 ' HB ' ' CZ ' ' A' ' 133' ' ' PHE . 2.1 mp -123.07 130.43 74.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.159 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 43.7 t -124.03 134.09 67.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.179 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.404 ' CE2' HD12 ' A' ' 58' ' ' ILE . 8.6 m-85 -115.78 139.32 50.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.92 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 71.29 -64.63 1.01 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.477 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 15.0 mttt 170.34 -37.24 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.755 0.312 . . . . 0.0 111.011 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 23.8 p -99.89 -43.55 6.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.406 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 76.5 m -53.17 104.47 0.1 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.936 0.398 . . . . 0.0 111.311 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.56 127.71 47.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.963 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.428 ' CZ ' ' HB ' ' A' ' 125' ' ' ILE . 4.0 p90 -142.14 156.26 45.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.966 0.412 . . . . 0.0 111.283 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -116.33 120.3 38.44 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.625 179.788 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -97.93 141.66 30.63 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.978 0.894 . . . . 0.0 111.976 -179.682 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.35 147.09 24.27 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 113.807 -1.542 . . . . 0.0 110.828 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.443 ' CE2' ' HB3' ' A' ' 121' ' ' ASN . 10.1 m-85 -76.56 140.01 40.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.037 0.446 . . . . 0.0 110.812 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -117.55 30.8 7.08 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.14 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 3.3 m -113.18 -44.16 3.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.912 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.0 t -117.97 129.8 55.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.95 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 94.0 p -90.04 163.0 15.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.874 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.7 t -160.54 79.57 0.65 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.922 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 29.0 m -105.45 88.2 2.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -131.2 67.54 1.51 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.84 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 2.4 mt -106.84 24.88 2.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.72 0.771 . . . . 0.0 111.257 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -97.63 127.75 43.82 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.912 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -116.19 32.24 6.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.837 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -89.07 147.93 23.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.908 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.39 143.49 49.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.799 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -113.12 170.91 7.88 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.886 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 19.4 mtpp 60.33 100.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.862 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.5 t 62.79 102.31 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.047 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 5.0 p -85.8 160.34 19.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.894 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 4.6 m -128.35 94.05 3.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.901 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -87.89 93.72 9.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.899 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 4.6 t -118.82 82.43 1.86 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.895 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -116.96 149.73 39.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 32.0 p -109.41 -28.79 8.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.933 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.872 -179.948 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.6 tptt . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.78 0.324 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.79 96.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.908 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -131.21 -48.2 1.0 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.988 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -91.71 126.98 36.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.951 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.6 ptt180 -121.51 -174.77 2.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.893 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.2 t -127.0 -66.23 0.91 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.886 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -80.51 109.8 15.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.934 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.48 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 3.0 mtpp -74.24 -46.91 6.16 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.096 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 26' ' ' LYS . 33.0 Cg_exo -57.81 141.56 95.83 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.285 1.99 . . . . 0.0 112.291 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.7 m 60.08 177.97 0.09 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.9 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 52.9 p -163.47 99.17 0.91 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.947 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -146.05 131.06 18.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.748 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -77.34 -105.44 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.83 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -140.64 129.04 22.54 Favored 'General case' 0 N--CA 1.457 -0.093 0 CA-C-O 120.721 0.296 . . . . 0.0 110.776 179.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 52.4 t -61.82 137.5 58.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.855 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 5.3 tt -142.93 -50.44 0.35 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.969 179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -140.3 -177.35 15.87 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.544 -179.906 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 47.5 m80 -144.69 161.02 40.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.899 0.38 . . . . 0.0 110.987 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.422 HD23 ' CD1' ' A' ' 133' ' ' PHE . 4.0 mt -121.94 121.02 36.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.637 179.794 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.3 t -96.04 121.89 47.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.345 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.16 131.79 35.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.425 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.9 mp -113.38 106.83 15.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.935 0.398 . . . . 0.0 111.21 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.402 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 22.0 mt -124.15 138.33 30.59 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.887 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.402 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 83.0 Cg_exo -45.38 -28.8 4.17 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.478 2.119 . . . . 0.0 112.639 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -85.02 -30.12 26.67 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.406 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 174.88 -169.54 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.879 0.371 . . . . 0.0 110.969 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -129.37 -178.53 4.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.946 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -162.52 151.09 14.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.975 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.7 tttt -113.01 131.53 55.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.008 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.1 t -119.1 147.48 22.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.135 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -100.16 128.54 46.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.859 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.427 ' O ' HG21 ' A' ' 50' ' ' ILE . 15.3 tt -115.93 132.3 65.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.247 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -97.99 168.11 10.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.884 -179.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -102.33 75.56 1.49 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.43 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.644 ' C ' ' H ' ' A' ' 55' ' ' VAL . 1.6 ptp85 -101.05 23.59 10.56 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.39 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 68.59 -28.31 0.15 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.717 0.294 . . . . 0.0 110.216 -179.35 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.644 ' H ' ' C ' ' A' ' 53' ' ' ARG . 65.3 t -137.27 139.73 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 CA-C-O 121.087 0.47 . . . . 0.0 111.352 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.446 ' N ' ' O ' ' A' ' 80' ' ' PHE . 38.5 m -125.28 125.47 43.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.046 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.88 137.24 42.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.801 0.334 . . . . 0.0 110.806 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.2 mp -128.53 121.28 54.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.98 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 172.68 -151.8 15.03 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.656 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.42 ' HB2' ' CG2' ' A' ' 73' ' ' ILE . 6.3 ttp180 -87.67 -31.26 19.84 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.775 0.321 . . . . 0.0 110.974 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -55.53 127.54 30.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.226 -179.751 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.81 -25.53 68.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.915 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 91.0 p -69.87 -25.48 63.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.927 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 88.8 m -56.11 153.49 9.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.87 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -62.7 -45.93 90.49 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.988 0.423 . . . . 0.0 110.664 -179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.5 t -120.31 129.16 75.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.947 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 31.2 mt -102.6 104.87 17.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.241 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.413 ' O ' ' O ' ' A' ' 69' ' ' SER . 1.3 tp -77.67 -154.58 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.132 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.471 ' O ' ' CB ' ' A' ' 70' ' ' GLU . 26.9 m -44.14 -97.79 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 111.262 0.097 . . . . 0.0 111.262 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.471 ' CB ' ' O ' ' A' ' 69' ' ' SER . 2.5 mt-10 158.81 -65.12 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.446 0 CA-C-O 120.704 0.287 . . . . 0.0 111.427 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.462 ' CD ' ' CB ' ' A' ' 70' ' ' GLU . 12.0 Cg_endo -55.93 -40.05 87.44 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.705 2.27 . . . . 0.0 113.146 -178.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -117.97 28.4 8.42 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.663 0.245 . . . . 0.0 111.663 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.42 ' CG2' ' HB2' ' A' ' 60' ' ' ARG . 4.9 tp -112.64 125.37 69.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.046 0.45 . . . . 0.0 111.459 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.424 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 57.3 m -76.87 137.71 39.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.186 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 52.8 m -60.09 -40.96 91.42 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.09 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.45 ' O ' ' C ' ' A' ' 77' ' ' HIS . 14.0 m-85 -99.46 14.13 30.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.088 0.47 . . . . 0.0 111.922 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.45 ' C ' ' O ' ' A' ' 76' ' ' PHE . 0.8 OUTLIER -22.74 -69.38 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.598 -179.361 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -154.61 164.1 39.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.054 0.455 . . . . 0.0 111.837 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -131.8 130.36 41.69 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.457 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.454 ' CZ ' ' CG1' ' A' ' 97' ' ' VAL . 7.3 m-85 -119.47 131.56 55.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.949 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 9.6 m170 -94.3 116.41 28.79 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.937 0.399 . . . . 0.0 111.075 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 3.9 tt -106.44 109.96 22.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.913 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.1 mp -117.85 139.22 51.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.009 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -126.57 128.74 47.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.905 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.09 146.15 38.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.913 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -104.66 115.92 31.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.85 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.4 m -122.96 110.95 27.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.262 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 57.63 82.68 0.12 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.109 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 62.47 -79.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.094 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -58.99 170.53 0.83 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.941 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -126.7 140.46 52.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.919 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.32 119.37 39.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.844 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -108.6 123.75 49.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.805 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.6 mt -125.68 132.6 52.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.981 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.0 mp -114.87 141.02 33.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.026 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -113.97 144.07 43.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.998 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.454 ' CG1' ' CZ ' ' A' ' 80' ' ' PHE . 18.2 t -110.48 127.73 67.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.136 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 33.1 mt -130.01 121.0 50.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.146 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -113.84 117.36 31.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.786 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.26 24.56 10.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.099 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 46.5 m 63.19 142.57 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.888 0.375 . . . . 0.0 110.939 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 6.4 tpt180 -178.71 -68.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.721 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -123.32 -31.01 3.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.249 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 128.82 120.46 2.27 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.281 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.451 ' CG2' ' CE1' ' A' ' 127' ' ' PHE . 90.6 m -123.27 128.47 50.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.847 0.355 . . . . 0.0 111.063 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -120.98 114.99 22.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.766 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.2 tp -120.51 137.25 54.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.522 0.677 . . . . 0.0 111.496 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 59.18 28.16 17.38 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.05 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.71 13.07 74.79 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.952 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -133.17 150.13 52.02 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.835 0.35 . . . . 0.0 110.948 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 19.3 ttt-85 -74.96 142.35 43.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.92 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.88 127.86 35.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.847 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.7 p -117.82 -40.07 2.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.155 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 4.4 mmmt -84.18 173.74 10.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.823 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.5 ptpt -121.2 32.86 5.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.818 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -145.94 49.55 1.2 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.9 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -81.56 138.11 35.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.796 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.8 tp -98.56 118.93 45.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.195 -179.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.9 tt -103.1 136.21 43.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.015 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.9 mtmt -125.65 178.06 5.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.789 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.431 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 4.7 p30 -59.53 137.74 57.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.004 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 74.2 55.57 5.64 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.444 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -117.31 139.29 51.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.925 0.393 . . . . 0.0 110.849 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 3.1 ttt180 -103.18 123.62 47.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.855 -179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.443 ' CG2' ' CE2' ' A' ' 127' ' ' PHE . 1.4 mp -126.75 135.7 62.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.184 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.4 t -120.63 125.09 73.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.058 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.451 ' CE1' ' CG2' ' A' ' 105' ' ' THR . 90.1 m-85 -120.61 130.61 54.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.114 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 84.07 -6.0 77.26 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.899 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 12.2 mtpt 77.2 28.78 0.6 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.911 0.386 . . . . 0.0 110.525 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.29 -45.08 0.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.073 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 99.6 m -77.37 107.75 10.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.804 179.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 47.3 t -124.07 126.32 46.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.971 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.422 ' CD1' HD23 ' A' ' 37' ' ' LEU . 12.9 p90 -142.05 155.51 45.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.926 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.47 140.05 39.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.773 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -103.52 141.66 35.62 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 121.924 0.868 . . . . 0.0 111.809 -179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.8 tttt -154.26 147.69 25.03 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 113.953 -1.476 . . . . 0.0 110.932 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.467 ' CD1' ' N ' ' A' ' 137' ' ' TYR . 0.8 OUTLIER -79.88 139.73 37.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.712 179.729 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -109.98 162.91 14.07 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.141 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.4 m -127.18 -178.65 4.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.844 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 10.6 t -79.67 101.61 8.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.902 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 48.8 m -92.69 80.16 4.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.911 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.3 p -73.14 87.5 1.41 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.839 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 56.4 p -140.95 102.94 4.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.869 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 60.55 87.15 0.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.835 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.461 ' CG2' ' H ' ' A' ' 146' ' ' GLU . 0.7 OUTLIER -110.35 -143.51 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.973 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.461 ' H ' ' CG2' ' A' ' 145' ' ' ILE . 17.8 mt-10 -104.33 160.26 15.04 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.91 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -124.62 -58.22 1.51 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.867 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -67.87 145.86 54.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.909 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -98.95 175.95 5.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.912 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -129.21 -46.98 1.21 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.938 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 4.4 mmtm -70.48 -49.32 49.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.903 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 30.9 m -101.61 127.94 54.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.095 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -148.39 144.68 27.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.842 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.8 t -160.56 -55.07 0.05 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.851 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 59.25 96.72 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.886 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 28.2 p -171.56 116.33 0.4 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.914 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.98 86.43 2.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.913 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.1 t -175.17 91.52 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.958 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.891 -179.945 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.5 ttmt . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.812 0.339 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -99.22 161.77 13.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -112.13 116.64 30.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.96 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -128.99 -55.09 1.2 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.853 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.31 161.47 41.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.817 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.8 m -143.38 33.27 1.32 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.873 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -92.7 -175.8 4.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.848 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.56 157.8 87.12 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.984 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.7 143.08 49.99 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.57 2.18 . . . . 0.0 112.304 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -145.63 160.14 42.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.946 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 64.5 p -121.35 136.86 54.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.845 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.464 ' C ' ' CG ' ' A' ' 31' ' ' TYR . 21.5 mt-10 -121.1 28.99 7.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.963 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.464 ' CG ' ' C ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -168.37 115.84 0.69 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.29 0.567 . . . . 0.0 110.443 179.583 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.2 m -100.25 163.55 12.35 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.648 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 53.6 t -59.96 134.77 57.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.842 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 3.7 tt -133.79 -46.11 0.8 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.987 -179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -156.85 -176.66 29.17 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.594 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -142.29 166.05 25.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.87 0.366 . . . . 0.0 110.901 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 3.8 mt -127.19 110.21 12.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.862 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.2 t -102.23 121.77 53.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.136 179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -90.08 123.78 34.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.863 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.8 mt -83.8 106.68 15.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.82 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 1.5 mt -124.16 138.01 30.03 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.925 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -46.99 -27.76 6.36 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.454 2.103 . . . . 0.0 112.531 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -133.22 107.36 0.68 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.483 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 36.7 mttt 63.16 129.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.796 0.332 . . . . 0.0 110.916 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -95.64 170.22 9.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.929 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -126.32 121.94 34.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.897 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -102.97 129.07 49.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.936 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.2 t -121.6 130.71 74.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.065 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.12 124.2 32.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.935 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 2.9 tt -116.02 132.14 66.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.138 -179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -99.76 168.39 9.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.245 -179.541 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 16.8 p30 -82.26 68.3 8.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.342 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.599 ' C ' ' H ' ' A' ' 55' ' ' VAL . 23.5 ttt-85 -83.01 6.58 18.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.041 -179.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.469 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 2.2 t30 71.43 -38.45 0.42 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -178.797 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.599 ' H ' ' C ' ' A' ' 53' ' ' ARG . 75.6 t -137.64 133.49 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.531 179.153 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.449 ' N ' ' O ' ' A' ' 80' ' ' PHE . 33.0 m -125.24 131.25 53.16 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.178 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.404 ' HB ' ' HA ' ' A' ' 64' ' ' CYS . 0.0 OUTLIER -103.91 133.86 48.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.892 0.377 . . . . 0.0 111.037 -179.874 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 3.9 mp -118.22 123.58 71.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.201 -179.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 166.98 -130.08 2.05 Favored Glycine 0 C--N 1.331 0.267 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.275 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.498 ' HB3' ' HA ' ' A' ' 70' ' ' GLU . 7.2 ptt180 -122.23 -25.96 4.77 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.55 0.214 . . . . 0.0 111.288 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -48.53 125.38 9.71 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.881 0.372 . . . . 0.0 110.999 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.97 -25.47 29.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.163 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 41.1 p -78.23 -23.42 47.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.993 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . 0.404 ' HA ' ' HB ' ' A' ' 57' ' ' THR . 93.8 m -57.16 169.27 0.59 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.967 179.945 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.401 ' CG ' ' HA ' ' A' ' 56' ' ' THR . 1.6 m-20 -85.91 -68.31 0.74 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.984 0.421 . . . . 0.0 110.909 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 27.7 t -101.99 133.05 46.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.085 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 15.7 pt -112.78 127.82 69.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.161 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 13.4 mt -94.04 -84.28 0.32 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.487 179.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.412 ' O ' ' CB ' ' A' ' 70' ' ' GLU . 10.8 t -102.55 -104.52 0.27 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.138 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.628 ' CB ' ' HD3' ' A' ' 71' ' ' PRO . 0.0 OUTLIER 166.76 -64.66 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.19 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 178.937 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.628 ' HD3' ' CB ' ' A' ' 70' ' ' GLU . 15.6 Cg_exo -67.84 -40.23 9.97 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.299 1.999 . . . . 0.0 113.519 -179.16 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -110.55 16.06 21.72 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -179.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.493 ' CG2' ' HB3' ' A' ' 60' ' ' ARG . 3.6 tp -107.15 124.72 63.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.865 0.364 . . . . 0.0 110.773 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.5 m -57.47 131.52 50.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.408 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 35.2 m -63.69 -39.96 95.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.436 179.607 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.465 ' O ' ' C ' ' A' ' 77' ' ' HIS . 4.4 m-85 -104.99 13.74 30.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.164 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.488 ' CD2' ' CD1' ' A' ' 127' ' ' PHE . 1.5 t60 -16.65 -69.1 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.582 -1.19 . . . . 0.0 112.708 -179.276 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.422 ' HB3' ' CZ ' ' A' ' 127' ' ' PHE . . . -158.88 164.1 35.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.916 0.389 . . . . 0.0 111.611 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -124.0 140.36 53.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.872 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.449 ' O ' ' N ' ' A' ' 56' ' ' THR . 4.8 m-85 -119.54 131.06 55.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.542 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.469 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 21.1 m-70 -102.91 116.11 31.9 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.691 -0.403 . . . . 0.0 111.674 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . 0.401 ' CD1' ' OG1' ' A' ' 56' ' ' THR . 0.2 OUTLIER -107.06 109.84 21.8 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.635 179.116 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.2 mt -120.67 140.05 52.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.992 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 56.8 mt-30 -109.49 125.76 52.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.768 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 11.1 mtp -129.62 148.53 51.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.952 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -107.07 119.92 40.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.856 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.4 t -129.44 110.96 21.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.138 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.8 t70 58.67 68.52 0.82 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.934 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 68.26 -68.36 0.17 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.951 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -64.57 146.93 53.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.865 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.91 128.04 54.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.985 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -98.54 144.68 27.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.832 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -109.14 127.01 53.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.988 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.1 mt -123.41 129.19 50.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.691 179.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.456 HD12 HG21 ' A' ' 95' ' ' ILE . 30.6 mm -117.93 138.01 50.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.903 0.383 . . . . 0.0 111.284 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -113.9 144.08 43.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.745 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.423 ' CG1' ' CE1' ' A' ' 80' ' ' PHE . 18.2 t -114.65 134.8 56.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.178 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 25.4 mm -121.04 121.01 63.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.03 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -97.75 123.71 41.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.941 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.98 -26.36 31.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.97 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.4 m 65.28 99.02 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.909 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.68 -42.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.888 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -104.26 -55.66 2.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.228 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 143.6 106.65 0.56 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.501 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.416 HG23 ' CD1' ' A' ' 127' ' ' PHE . 90.9 m -118.39 126.86 52.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.71 0.29 . . . . 0.0 110.898 179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -120.93 115.03 22.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.921 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . 0.416 HG12 ' CZ ' ' A' ' 117' ' ' TYR . 2.5 tp -114.16 137.36 47.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.464 0.649 . . . . 0.0 111.21 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 63.09 29.05 16.26 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.826 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.78 7.98 66.93 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.974 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -134.17 144.14 48.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.758 0.313 . . . . 0.0 110.856 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.4 ttp180 -70.51 128.99 38.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.81 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -92.2 137.97 31.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.917 -179.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 6.2 m -121.51 -42.08 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.1 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.4 mttm -65.37 -174.55 0.19 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.852 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.0 tttt -124.0 171.15 9.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.803 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.5 t70 60.48 63.42 1.36 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.872 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . 0.416 ' CZ ' HG12 ' A' ' 107' ' ' ILE . 10.7 t80 -84.2 139.13 32.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.785 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.4 tp -98.37 118.5 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.253 -179.621 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.461 HD12 ' CD1' ' A' ' 135' ' ' PHE . 3.2 tm? -100.84 120.0 39.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.767 -179.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -118.7 178.07 4.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.882 -179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.441 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 17.8 p30 -60.06 135.79 57.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.017 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 75.04 56.32 4.86 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.582 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -123.09 135.06 54.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.845 0.355 . . . . 0.0 111.04 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.47 117.33 33.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.825 -179.977 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 5.1 mt -115.0 133.21 61.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.114 -179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.4 t -124.09 127.69 73.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.072 179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.488 ' CD1' ' CD2' ' A' ' 77' ' ' HIS . 4.8 m-85 -116.66 126.19 52.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.042 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 92.87 -71.09 1.51 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.36 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 174.55 -43.57 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.788 0.328 . . . . 0.0 111.171 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.0 p -98.08 -41.91 7.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.545 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 25.3 m -54.13 106.17 0.18 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.955 0.407 . . . . 0.0 111.222 -179.61 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 13.9 p -124.38 122.54 37.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.773 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -142.04 156.23 45.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.034 0.445 . . . . 0.0 111.276 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.1 tp -114.37 134.44 54.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.66 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.461 ' CD1' HD12 ' A' ' 119' ' ' LEU . 14.5 t80 -98.2 141.17 31.44 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 121.929 0.871 . . . . 0.0 111.754 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . 0.428 ' N ' ' CD1' ' A' ' 135' ' ' PHE . 9.6 tptt -154.86 154.71 33.14 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 113.878 -1.51 . . . . 0.0 111.128 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.441 ' CE2' ' HB3' ' A' ' 121' ' ' ASN . 13.2 m-85 -86.13 140.15 30.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.623 179.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -100.59 158.73 15.72 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.124 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 46.9 m -96.82 -59.83 1.72 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.95 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 7.2 t -158.54 112.07 2.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.917 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.15 85.05 7.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.854 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.58 -68.72 0.53 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.894 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 17.1 p -103.38 94.12 5.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.918 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -72.34 147.31 46.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.956 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 19.5 mm -102.73 25.0 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 CA-C-O 121.599 0.714 . . . . 0.0 111.316 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -106.97 167.64 9.75 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.587 -1.188 . . . . 0.0 110.898 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -86.99 173.89 9.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.931 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 60.71 36.79 19.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.924 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -93.67 -43.07 8.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.892 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -110.84 86.72 2.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.973 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.41 176.38 10.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.9 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 14.5 m -140.43 -179.67 2.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.14 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 62.18 100.89 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.857 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 7.7 t -147.05 -56.48 0.25 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.874 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.41 -44.08 0.84 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.029 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.11 -68.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.968 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 3.1 mtt85 -151.57 162.54 40.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.866 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 7.1 t -175.8 175.71 1.97 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.976 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.213 -0.899 . . . . 0.0 110.845 -179.939 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.79 0.329 . . . . 0.0 111.251 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -131.09 -46.78 1.01 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.993 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -60.19 131.25 50.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.875 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -160.55 175.58 12.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.7 mtp85 -129.3 -179.84 5.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.911 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.75 -177.12 3.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.87 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -74.79 -43.52 54.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.904 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.4 tttm -79.97 134.32 56.68 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.787 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.02 155.12 65.84 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.477 2.118 . . . . 0.0 112.391 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.28 -68.41 0.48 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.728 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.2 t 60.07 110.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.046 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -73.16 166.39 23.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.702 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -70.95 -108.35 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.717 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.6 145.03 36.15 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-O 120.692 0.282 . . . . 0.0 110.705 179.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 52.6 t -64.66 144.79 56.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.954 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 10.2 tp -155.33 -46.32 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.705 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -154.67 169.69 32.94 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.229 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 27.2 m80 -131.52 163.62 27.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.948 0.404 . . . . 0.0 110.946 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 19.1 mt -127.06 111.07 13.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.801 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.4 t -95.92 121.88 46.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.119 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -89.17 120.88 30.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.912 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.0 mp -79.71 107.05 12.18 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.888 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 11.7 mt -123.98 138.39 30.52 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.856 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -47.59 -27.47 7.73 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.494 2.129 . . . . 0.0 112.429 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.96 -126.09 2.99 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.465 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.9 mttt -53.1 101.72 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.824 0.345 . . . . 0.0 111.134 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -65.36 172.27 3.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.844 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -133.61 131.1 39.23 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.906 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.07 127.36 56.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.863 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 28.6 t -119.94 150.98 22.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.14 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -103.44 138.16 40.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.863 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 26.2 mm -116.08 126.67 73.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.328 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -98.3 168.13 10.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.74 179.786 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 26.4 p30 -100.25 66.8 1.32 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.008 0.432 . . . . 0.0 110.762 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.622 ' C ' ' H ' ' A' ' 55' ' ' VAL . 0.6 OUTLIER -97.73 21.65 10.16 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.374 179.993 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.418 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 0.6 OUTLIER 68.23 -27.87 0.14 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.485 -179.726 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.622 ' H ' ' C ' ' A' ' 53' ' ' ARG . 62.9 t -137.31 139.31 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 CA-C-O 121.075 0.465 . . . . 0.0 111.826 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.443 ' HB ' ' HB2' ' A' ' 80' ' ' PHE . 0.4 OUTLIER -125.24 128.05 47.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.005 179.338 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.459 ' O ' ' N ' ' A' ' 65' ' ' ASP . 0.1 OUTLIER -103.95 138.93 39.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.971 0.415 . . . . 0.0 111.417 -179.519 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 32.8 mt -132.3 131.24 60.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.13 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 162.78 -146.67 12.09 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.264 -0.969 . . . . 0.0 113.283 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.441 ' HB2' ' CG2' ' A' ' 73' ' ' ILE . 4.1 ttp-105 -87.59 -44.54 11.17 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.83 0.348 . . . . 0.0 111.392 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 33.2 t -50.51 122.15 6.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.483 -179.272 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 -60.43 -20.28 59.21 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.905 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 16.3 m -69.75 -27.43 64.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.698 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 84.4 m -56.33 164.67 1.27 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.671 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.459 ' N ' ' O ' ' A' ' 57' ' ' THR . 0.6 OUTLIER -66.94 -52.86 37.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.979 0.418 . . . . 0.0 110.802 179.827 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.3 t -125.12 126.79 71.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.508 -179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.8 mp -97.51 119.71 45.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.498 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . 0.424 HD13 ' CD2' ' A' ' 127' ' ' PHE . 19.4 mt -83.4 -86.61 0.11 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.078 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 34.4 m -108.66 -109.88 0.32 Allowed 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 110.251 -0.278 . . . . 0.0 110.251 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.576 ' CB ' ' HD3' ' A' ' 71' ' ' PRO . 0.2 OUTLIER 169.66 -63.11 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.192 0 CA-C-O 120.496 0.188 . . . . 0.0 111.412 179.414 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.576 ' HD3' ' CB ' ' A' ' 70' ' ' GLU . 37.2 Cg_exo -60.29 -40.19 61.15 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.043 1.829 . . . . 0.0 112.899 -179.437 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -115.13 12.73 16.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.587 -179.573 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.441 ' CG2' ' HB2' ' A' ' 60' ' ' ARG . 2.6 tp -104.55 133.32 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-O 120.831 0.348 . . . . 0.0 110.975 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.467 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 4.1 p -98.82 131.76 44.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.546 -179.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 19.6 m -53.48 -30.17 39.69 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.159 179.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -93.92 14.12 20.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.018 -179.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.467 ' HB2' ' O ' ' A' ' 74' ' ' SER . 1.4 t-160 -34.51 -66.65 0.16 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.07 -179.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.406 ' HB2' ' CE2' ' A' ' 127' ' ' PHE . . . -161.62 163.24 30.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.097 0.475 . . . . 0.0 111.765 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -129.47 135.16 48.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.237 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.449 ' CZ ' ' CG1' ' A' ' 97' ' ' VAL . 6.3 m-85 -119.34 131.46 55.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.999 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.418 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 11.9 m170 -94.69 116.45 28.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.954 0.407 . . . . 0.0 110.928 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.6 tp -106.45 109.95 22.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.948 179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.2 tp -118.57 140.09 50.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.89 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.4 tm0? -100.4 132.0 46.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.937 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.3 130.1 56.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.85 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -95.12 130.77 41.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.964 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.4 t -140.09 138.8 37.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.135 179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.35 67.38 0.33 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.797 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 173.4 -52.67 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.748 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -153.03 172.24 17.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -94.78 127.94 41.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.942 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -101.12 125.4 47.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.869 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . 0.419 ' HB2' ' CE1' ' A' ' 137' ' ' TYR . 24.4 m120 -112.77 125.08 53.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.994 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.3 tp -122.52 129.3 51.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.694 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.429 HD13 ' CE1' ' A' ' 135' ' ' PHE . 3.2 mp -122.96 141.01 44.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.204 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -116.53 144.01 44.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.827 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.449 ' CG1' ' CZ ' ' A' ' 80' ' ' PHE . 22.0 t -112.17 124.63 69.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.193 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . 0.413 HD11 ' CD2' ' A' ' 81' ' ' HIS . 20.4 mt -130.01 124.95 59.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.071 179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -114.03 127.83 56.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.946 -179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.71 -7.47 59.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.372 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 21.6 m 64.25 79.02 0.27 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.779 0.324 . . . . 0.0 110.884 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.43 -39.95 3.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.919 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -133.19 -46.02 0.84 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.192 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 145.47 103.16 0.38 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.406 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 28.0 m -113.46 131.57 55.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.788 0.328 . . . . 0.0 110.92 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -116.49 117.71 30.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.871 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.0 tp -112.5 137.32 45.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.424 0.631 . . . . 0.0 111.281 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 62.15 27.66 16.65 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.942 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.59 10.22 70.74 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.94 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -133.99 151.34 51.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.775 0.321 . . . . 0.0 110.957 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.58 130.0 40.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.859 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 7.0 tt -70.19 139.28 52.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.818 -179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 10.8 p -121.98 -44.66 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.077 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.61 167.45 16.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.946 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -108.85 28.52 8.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.942 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -158.62 62.45 0.43 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.005 0.431 . . . . 0.0 110.8 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -84.06 139.11 32.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.803 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 8.6 tp -98.48 120.14 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-O 121.01 0.433 . . . . 0.0 111.408 -179.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 6.6 tt -103.1 142.21 34.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.923 179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 9.6 mmtp -129.76 178.13 6.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.817 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.446 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 9.2 p30 -56.35 144.44 30.55 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.083 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 65.51 45.49 89.65 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.42 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -112.37 133.59 54.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.91 0.386 . . . . 0.0 110.973 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -91.42 130.77 37.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.819 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.8 mp -129.83 121.92 53.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.255 -179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 39.2 t -113.13 130.55 66.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.033 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.427 ' HB3' ' CE1' ' A' ' 77' ' ' HIS . 3.3 m-85 -114.61 141.39 47.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.071 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 71.59 -64.67 1.11 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.49 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 169.91 -38.2 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.884 0.373 . . . . 0.0 110.963 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 82.7 p -101.75 -39.97 7.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.041 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 57.1 m -57.17 106.38 0.31 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.998 -179.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 1.3 m -124.21 123.7 40.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.889 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -142.09 156.01 45.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.111 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.4 tt -117.89 140.02 50.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.717 179.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.429 ' CE1' HD13 ' A' ' 95' ' ' ILE . 20.3 t80 -104.94 141.39 36.64 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.945 0.879 . . . . 0.0 111.935 -179.746 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -154.73 159.35 40.63 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 113.711 -1.586 . . . . 0.0 110.591 179.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.446 ' CE2' ' HB3' ' A' ' 121' ' ' ASN . 2.5 m-85 -83.83 139.81 32.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.021 0.438 . . . . 0.0 110.697 179.588 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -96.9 87.43 4.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.131 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.11 175.12 5.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.98 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.9 127.1 35.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.902 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.3 t -153.42 -61.05 0.14 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.907 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.21 31.02 1.38 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.969 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.7 p -106.56 22.71 15.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.035 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -117.47 -30.65 5.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.084 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 17.8 mt -100.94 25.04 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 CA-C-O 121.628 0.727 . . . . 0.0 111.415 -179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -152.8 33.14 0.49 Allowed 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.881 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -87.89 91.51 8.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.829 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -99.12 149.54 22.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.951 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -148.97 -47.51 0.14 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.923 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -58.9 132.91 55.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.923 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.89 87.57 0.09 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.85 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 14.2 m -90.02 149.12 4.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.115 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.37 -174.07 0.08 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.838 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.2 m -128.82 -70.31 0.68 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.917 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.12 -177.62 0.28 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.862 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 6.9 m 60.78 -170.81 0.15 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.918 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.36 -39.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.902 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 62.66 177.48 0.14 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.91 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 23.4 t80 . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.937 179.981 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.847 0.356 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.4 164.63 12.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.837 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.38 117.97 3.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.92 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -151.52 159.82 43.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.961 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.7 ttt-85 -111.06 -31.87 6.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.938 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.2 p -94.17 162.15 13.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.889 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.2 m-20 60.16 54.8 3.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.882 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . 0.415 ' N ' ' HD2' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -70.35 -61.4 2.72 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.036 -179.989 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . 0.415 ' HD2' ' N ' ' A' ' 26' ' ' LYS . 36.9 Cg_endo -65.67 156.42 63.95 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.472 2.115 . . . . 0.0 112.283 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.2 p -89.32 56.64 3.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.921 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -114.77 85.02 2.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.918 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.7 pm0 -136.6 -175.35 3.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.96 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -110.3 -119.39 0.28 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.588 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.1 130.15 24.9 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 120.797 0.332 . . . . 0.0 110.554 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.8 t -60.71 145.05 50.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.063 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 9.6 mt -147.76 -53.68 0.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.908 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -140.65 -175.28 14.48 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.564 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 50.4 m80 -146.07 166.05 27.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.904 0.383 . . . . 0.0 110.936 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.7 mp -125.69 107.85 10.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.539 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.6 t -96.13 121.98 47.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.167 -179.838 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -89.98 113.98 25.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.86 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -87.65 106.75 18.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.878 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.533 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 18.9 mt -124.17 141.0 36.12 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.835 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.533 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 50.2 Cg_endo -72.59 83.95 1.26 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.078 1.852 . . . . 0.0 111.967 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 118.0 25.98 2.88 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.372 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 170.58 155.31 0.06 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.691 0.282 . . . . 0.0 110.555 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -142.47 151.91 42.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.975 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -140.29 128.79 22.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.176 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.04 131.24 55.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.806 179.82 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.8 t -125.46 151.02 31.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.29 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -104.24 132.92 49.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.626 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.425 ' O ' HG23 ' A' ' 50' ' ' ILE . 2.3 tt -116.07 132.02 66.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.01 0.433 . . . . 0.0 111.492 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.01 168.05 9.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.033 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -76.28 63.39 1.91 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.307 179.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.57 ' C ' ' H ' ' A' ' 55' ' ' VAL . 11.1 ttt-85 -80.88 0.12 36.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.013 -179.42 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . 0.437 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 8.3 m120 71.51 -35.88 0.34 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -178.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.57 ' H ' ' C ' ' A' ' 53' ' ' ARG . 68.0 t -137.37 134.14 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.061 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.445 ' N ' ' O ' ' A' ' 80' ' ' PHE . 51.8 m -125.29 124.19 41.08 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.893 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.66 127.34 51.12 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.952 0.406 . . . . 0.0 111.11 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.433 HD13 ' CD1' ' A' ' 80' ' ' PHE . 4.6 mp -107.98 117.74 54.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.003 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 172.95 -144.96 8.14 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.405 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.3 ttm105 -111.15 -19.93 12.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.715 0.293 . . . . 0.0 111.245 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -50.27 151.67 2.03 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.895 0.379 . . . . 0.0 111.141 -179.859 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -72.91 -38.74 66.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.93 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 6.0 m -70.1 -19.62 63.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.209 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 48.8 m -53.91 149.25 9.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.028 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -75.16 -53.68 8.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.904 0.383 . . . . 0.0 110.836 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.5 t -114.83 116.99 54.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.216 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 20.0 pt -99.15 131.05 47.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.061 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 5.0 mp -86.45 -175.93 5.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.911 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.2 t -118.34 34.61 5.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.98 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -109.68 118.51 50.12 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.667 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -57.74 -16.11 23.79 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.566 2.177 . . . . 0.0 112.804 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -119.8 36.61 4.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.765 0.317 . . . . 0.0 111.029 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.421 HD13 ' CE1' ' A' ' 77' ' ' HIS . 7.3 tp -82.45 147.7 5.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.27 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.405 ' HB3' ' CG ' ' A' ' 77' ' ' HIS . 2.5 t -77.17 129.91 36.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.103 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 1.8 m -65.37 -39.21 92.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.726 179.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.434 ' O ' ' C ' ' A' ' 77' ' ' HIS . 1.1 m-85 -103.8 13.94 31.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.295 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.434 ' C ' ' O ' ' A' ' 76' ' ' PHE . 0.3 OUTLIER -22.31 -71.87 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.647 -1.161 . . . . 0.0 112.595 -179.349 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -158.6 164.03 36.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.074 0.464 . . . . 0.0 111.928 -179.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -129.09 136.49 50.3 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.471 179.484 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.448 ' CZ ' ' CG1' ' A' ' 97' ' ' VAL . 6.1 m-85 -119.54 131.17 55.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.887 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . 0.437 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 6.3 m-70 -94.87 116.38 28.64 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.89 0.376 . . . . 0.0 111.049 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -106.51 109.58 21.54 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.711 179.57 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.4 mp -122.2 140.14 52.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.166 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.0 tm0? -108.97 133.34 53.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.892 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -141.89 122.69 14.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.939 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -97.05 116.1 28.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.944 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 4.2 m -119.68 110.92 30.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.243 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 59.25 72.82 0.51 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.004 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 66.08 -74.54 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.042 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -52.85 144.41 14.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.152 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -108.83 130.95 55.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.94 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -116.5 125.61 52.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.796 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -106.98 135.37 48.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.939 179.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.66 139.62 53.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.773 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . . . . . . . . . 4.0 mp -127.79 138.29 55.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.205 -179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -113.88 140.62 48.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.772 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.448 ' CG1' ' CZ ' ' A' ' 80' ' ' PHE . 16.9 t -103.99 121.99 56.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.156 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 28.6 mt -114.21 124.2 70.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.046 179.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -87.78 138.23 31.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.941 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.1 -25.68 14.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.013 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.1 m 65.47 81.37 0.21 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.943 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -137.07 -47.07 0.58 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.883 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -124.74 -48.83 1.77 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.157 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 154.32 129.39 1.29 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.547 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.453 ' CG2' ' CE1' ' A' ' 127' ' ' PHE . 1.7 m -131.94 123.7 27.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.758 0.314 . . . . 0.0 110.954 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -121.16 123.28 41.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.809 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.9 tp -119.01 137.32 53.36 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-O 121.426 0.631 . . . . 0.0 111.337 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 62.38 27.97 16.62 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.859 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.66 9.82 70.33 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.971 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -133.99 152.04 51.69 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.825 0.345 . . . . 0.0 110.859 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.02 129.21 39.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.88 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 4.1 pp -71.44 140.13 49.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.954 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.0 m -135.02 31.41 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.171 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 23.9 mmtt -145.93 149.09 33.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.931 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 17.9 ttpp -98.77 31.13 3.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.813 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -166.57 66.93 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.862 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -82.81 139.03 33.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.941 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.482 HD12 HG21 ' A' ' 118' ' ' ILE . 0.0 OUTLIER -98.73 117.61 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.749 -179.841 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.7 tt -103.0 136.89 41.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.186 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 3.1 mmmm -136.14 178.15 7.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.764 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.433 ' HB3' ' CZ ' ' A' ' 137' ' ' TYR . 12.7 p30 -55.48 139.31 44.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.034 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 71.27 52.93 11.36 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.479 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -124.8 125.25 43.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.794 0.33 . . . . 0.0 110.974 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 11.2 mtp180 -93.67 131.81 38.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.818 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . 0.412 ' HB ' ' CE1' ' A' ' 133' ' ' PHE . 2.7 mt -125.74 137.95 56.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.123 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 22.9 t -120.36 123.98 71.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.065 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.453 ' CE1' ' CG2' ' A' ' 105' ' ' THR . 3.6 m-85 -119.22 128.97 54.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.139 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 80.97 -3.38 76.42 Favored Glycine 0 CA--C 1.518 0.252 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.072 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 8.6 tttt 76.31 24.5 1.09 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.861 0.362 . . . . 0.0 110.511 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.88 -52.63 0.13 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.012 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 91.1 m -77.48 107.76 10.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.671 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 79.8 p -121.99 133.33 54.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.992 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.412 ' CE1' ' HB ' ' A' ' 125' ' ' ILE . 2.8 p90 -142.01 155.69 45.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.905 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 7.9 tt -112.35 139.98 47.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.774 179.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 74.1 t80 -101.5 141.5 34.28 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.944 0.878 . . . . 0.0 111.838 -179.815 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.31 154.11 32.82 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 113.864 -1.516 . . . . 0.0 110.784 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.479 ' CD1' ' N ' ' A' ' 137' ' ' TYR . 0.6 OUTLIER -85.53 139.72 31.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.992 0.425 . . . . 0.0 110.752 179.74 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -115.19 107.74 15.69 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.097 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 3.2 m -137.35 31.45 2.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.937 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.1 m -83.98 78.14 9.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.88 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -95.7 90.76 5.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.889 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.1 p -111.27 155.28 23.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.898 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.3 t -135.96 -50.29 0.7 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.875 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -168.86 87.17 0.18 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.897 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . 0.475 ' CG2' ' H ' ' A' ' 146' ' ' GLU . 0.8 OUTLIER -110.89 -143.44 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.847 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . 0.475 ' H ' ' CG2' ' A' ' 145' ' ' ILE . 5.6 tp10 -102.04 152.44 20.97 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.924 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 60.64 177.5 0.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.874 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.52 128.18 35.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.921 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -119.76 164.84 15.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.871 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 60.44 -178.83 0.1 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.811 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.93 134.8 36.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.87 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 11.3 p -148.81 57.89 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.061 179.981 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 16.7 p -93.0 -31.76 14.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.871 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.4 t -105.39 -45.64 4.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.896 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -158.73 158.82 34.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.865 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -95.68 -169.02 1.87 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.926 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.22 46.71 1.17 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.862 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.9 m 60.86 107.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.909 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 26.3 t80 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.205 -0.902 . . . . 0.0 110.868 179.932 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.7 mttt . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.861 0.362 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 60.28 92.71 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.967 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 59.18 30.62 20.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.971 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.35 84.04 1.8 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.89 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.02 -47.48 0.23 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.803 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 88.5 p -90.85 170.46 10.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.929 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -116.46 160.58 20.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.869 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.2 mtpp -135.94 83.05 35.52 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.927 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.94 159.05 19.02 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.576 2.184 . . . . 0.0 112.28 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.0 t -108.74 -61.19 1.64 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.916 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' SER . . . . . 0.401 ' O ' ' CZ ' ' A' ' 31' ' ' TYR . 67.2 m -88.5 151.68 22.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . 0.446 ' C ' ' CG ' ' A' ' 31' ' ' TYR . 7.3 mm-40 -95.03 167.41 11.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.842 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.446 ' CG ' ' C ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -168.48 115.78 0.68 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.247 0.546 . . . . 0.0 110.413 179.602 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.4 m -102.01 152.51 20.87 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.749 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.8 t -60.07 135.21 57.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.868 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.9 tp -136.65 -63.61 0.61 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.97 -179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -139.6 178.25 19.82 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.498 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 31.0 m80 -133.52 166.0 23.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.788 0.328 . . . . 0.0 110.911 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 18.9 mt -126.5 113.71 17.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.96 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.5 t -96.24 121.89 47.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.948 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -90.0 113.85 25.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.892 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 2.9 mt -77.76 106.75 9.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.785 179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.513 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 1.6 mp -124.15 140.26 34.47 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.97 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' PRO . . . . . 0.513 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 67.9 Cg_endo -76.13 83.84 1.92 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.304 2.003 . . . . 0.0 112.029 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 115.62 24.04 4.18 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.382 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -179.5 166.96 1.45 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.794 0.33 . . . . 0.0 110.612 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -144.41 128.27 17.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.045 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -116.17 118.82 33.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.835 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -108.82 124.83 51.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.909 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.2 t -120.36 137.64 53.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.096 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.75 132.84 34.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.84 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 33.4 mm -108.76 116.25 51.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.264 179.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.412 ' HB ' ' CB ' ' A' ' 31' ' ' TYR . 0.2 OUTLIER -100.88 167.77 10.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.66 179.729 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -61.68 -95.65 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.324 179.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . 0.594 ' C ' ' H ' ' A' ' 55' ' ' VAL . 3.9 ttt-85 70.79 -4.41 1.71 Allowed 'General case' 0 C--O 1.232 0.15 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 179.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 70.24 -32.93 0.25 Allowed 'General case' 0 C--N 1.331 -0.226 0 O-C-N 122.156 -0.34 . . . . 0.0 110.247 -179.035 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' VAL . . . . . 0.594 ' H ' ' C ' ' A' ' 53' ' ' ARG . 65.7 t -136.72 140.72 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-O 121.082 0.468 . . . . 0.0 111.055 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . 0.46 ' N ' ' O ' ' A' ' 80' ' ' PHE . 14.2 m -125.35 130.19 51.44 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.101 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.98 135.48 45.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.818 0.342 . . . . 0.0 110.684 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ILE . . . . . 0.428 ' CD1' ' CD1' ' A' ' 80' ' ' PHE . 5.9 mt -128.5 124.07 61.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.342 -179.625 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 166.55 -134.48 3.29 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.47 -0.872 . . . . 0.0 113.068 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ARG . . . . . 0.462 ' HB2' ' CG2' ' A' ' 73' ' ' ILE . 8.2 ttp180 -99.99 -40.12 7.8 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.886 0.374 . . . . 0.0 111.158 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -46.18 118.11 1.79 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.481 -179.52 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.85 -28.37 56.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.76 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -69.93 -22.96 63.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.88 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 86.8 m -54.33 154.27 4.69 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.774 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.438 ' HB3' ' CG2' ' A' ' 56' ' ' THR . 64.1 t0 -65.88 -46.25 79.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.823 0.344 . . . . 0.0 110.957 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 58' ' ' ILE . 21.3 t -125.18 133.24 69.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.436 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.8 pt -106.16 122.43 59.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.69 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -94.15 -88.35 0.24 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.94 -179.688 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 28.0 t -104.79 -115.64 0.23 Allowed 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.513 ' CB ' ' HD3' ' A' ' 71' ' ' PRO . 3.4 tt0 171.79 -62.1 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.327 0 O-C-N 122.372 -0.205 . . . . 0.0 111.117 179.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PRO . . . . . 0.513 ' HD3' ' CB ' ' A' ' 70' ' ' GLU . 38.8 Cg_exo -59.44 -40.17 69.49 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 121.924 1.749 . . . . 0.0 112.86 -179.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -118.73 19.85 13.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.507 -179.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.462 ' CG2' ' HB2' ' A' ' 60' ' ' ARG . 4.6 tp -103.97 122.2 56.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.078 0.466 . . . . 0.0 110.942 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' SER . . . . . 0.416 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 2.6 p -71.81 134.87 46.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.406 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 91.4 m -61.99 -30.35 70.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.716 179.63 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' PHE . . . . . 0.422 ' O ' ' C ' ' A' ' 77' ' ' HIS . 0.4 OUTLIER -108.77 14.08 24.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.514 -179.939 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' HIS . . . . . 0.504 ' CD2' ' CD1' ' A' ' 127' ' ' PHE . 1.1 t60 -25.68 -68.73 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.796 -1.093 . . . . 0.0 112.668 -179.345 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . 0.446 ' CB ' ' CZ ' ' A' ' 127' ' ' PHE . . . -157.09 164.1 38.25 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.017 0.437 . . . . 0.0 111.647 -179.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -131.67 137.95 48.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.822 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' PHE . . . . . 0.46 ' O ' ' N ' ' A' ' 56' ' ' THR . 7.0 m-85 -119.28 130.14 55.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.534 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 4.4 m-70 -94.78 116.17 28.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.802 0.334 . . . . 0.0 111.14 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 11.1 tp -106.54 109.49 21.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.718 179.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.46 140.23 52.97 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.035 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -98.45 134.89 40.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.682 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.02 122.94 47.45 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.984 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -96.97 119.53 35.61 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.002 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.4 t -140.05 139.15 37.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.098 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -48.59 -56.44 8.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.198 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 -51.08 -75.11 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.152 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -147.65 155.27 41.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.801 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -82.92 127.93 33.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.967 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.04 134.93 54.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.984 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 20.1 m-20 -111.43 140.62 45.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.733 179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 4.6 tp -132.02 139.47 48.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.054 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ILE . . . . . 0.42 HD11 ' CE1' ' A' ' 135' ' ' PHE . 2.6 mp -125.02 134.31 67.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.049 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -114.04 144.01 43.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.817 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' VAL . . . . . 0.457 ' CG1' ' CZ ' ' A' ' 80' ' ' PHE . 16.3 t -108.78 131.61 58.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.187 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.8 mp -130.05 121.31 51.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.985 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 21.1 p30 -84.88 139.09 32.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.93 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -143.6 30.48 1.35 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.959 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.6 m -153.97 152.2 30.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.829 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 11.7 mmt180 -106.18 34.6 3.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.987 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -89.19 -31.22 18.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.207 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 121.19 115.99 2.43 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.452 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' THR . . . . . 0.463 ' CG2' ' CE1' ' A' ' 127' ' ' PHE . 99.5 m -131.72 128.45 38.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.811 0.338 . . . . 0.0 110.886 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -121.05 114.96 22.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.746 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.8 tp -111.56 137.29 44.74 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 CA-C-O 121.435 0.636 . . . . 0.0 111.342 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 61.93 26.53 16.05 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.739 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.72 8.95 69.01 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.858 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 51.9 m-80 -134.11 151.99 51.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.792 0.33 . . . . 0.0 110.901 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 10.5 mtm105 -74.96 132.82 41.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.739 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -83.05 143.5 30.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.95 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 14.5 p -128.75 14.56 2.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.39 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -121.85 -178.56 3.87 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.806 0.336 . . . . 0.0 110.768 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.3 mttt -110.2 -29.64 8.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.95 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -112.63 78.87 1.16 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.899 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -80.79 139.33 36.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.903 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . 0.409 ' O ' ' CG2' ' A' ' 118' ' ' ILE . 7.5 tp -98.46 115.98 40.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.035 0.445 . . . . 0.0 111.241 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -103.12 132.85 49.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.964 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 19.4 mttm -135.99 178.23 7.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.76 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ASN . . . . . 0.46 ' ND2' ' CD2' ' A' ' 137' ' ' TYR . 3.2 t-20 -50.93 139.99 16.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.176 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 70.75 51.46 19.78 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.497 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.46 130.07 53.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.918 0.39 . . . . 0.0 110.952 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 1.4 ttm-85 -98.15 124.11 42.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.918 179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ILE . . . . . . . . . . . . . 1.9 mp -115.53 134.71 57.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.17 -179.855 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 29.2 t -124.1 133.95 67.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.104 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' PHE . . . . . 0.504 ' CD1' ' CD2' ' A' ' 77' ' ' HIS . 7.5 m-85 -131.84 134.33 45.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.055 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 81.02 -2.23 81.72 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.95 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 2.8 mtpp 75.47 27.77 1.02 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.914 0.388 . . . . 0.0 110.424 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 63.9 p -154.01 -60.03 0.13 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.834 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 55.6 m -61.91 109.05 1.14 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.727 179.761 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.0 p -120.51 128.0 52.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.004 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' PHE . . . . . 0.435 ' CD1' ' N ' ' A' ' 133' ' ' PHE . 2.1 p90 -142.06 155.99 45.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.953 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 3.9 tt -113.37 140.11 48.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.834 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . 0.42 ' CE1' HD11 ' A' ' 95' ' ' ILE . 26.4 t80 -104.54 141.48 36.32 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.984 0.897 . . . . 0.0 111.81 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 8.7 pttt -154.71 158.97 40.37 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 113.914 -1.494 . . . . 0.0 110.867 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' TYR . . . . . 0.46 ' CD2' ' ND2' ' A' ' 121' ' ' ASN . 3.2 m-85 -86.07 139.74 30.87 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.716 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -106.39 35.6 2.9 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.22 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.37 31.6 5.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.942 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 60.5 90.68 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.863 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -130.21 123.4 30.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.817 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.1 p -94.85 147.98 22.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.953 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.9 t -126.57 125.2 41.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.933 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -107.37 -174.88 2.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.853 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 20.2 mm -101.6 25.04 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 CA-C-O 121.699 0.762 . . . . 0.0 111.375 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -163.51 98.12 0.89 Allowed 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.603 -1.18 . . . . 0.0 110.858 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -59.6 -37.43 78.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.969 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -73.74 153.56 39.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.931 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -151.73 131.84 13.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.879 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -175.54 -40.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.896 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -73.06 116.94 14.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.886 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 28.6 m -122.02 120.05 60.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.127 -179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.29 -59.88 2.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.908 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 94.8 p -119.65 168.64 10.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.863 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -68.5 113.3 5.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.907 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 16.3 m -153.97 86.49 1.18 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.827 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -121.1 97.73 5.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.855 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 62.3 m 60.29 -178.42 0.1 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.843 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 20.8 t80 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.297 -0.859 . . . . 0.0 110.875 -179.947 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.467 ' N ' HG22 ' A' ' 51' ' ' THR . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.703 0.287 . . . . 0.0 110.471 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.8 t -64.46 130.71 44.78 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.91 0.386 . . . . 0.0 111.036 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.12 -47.0 0.64 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.77 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.644 ' C ' HG22 ' A' ' 50' ' ' ILE . . . -138.83 -178.84 16.7 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.357 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.43 ' CD2' ' HA ' ' A' ' 49' ' ' GLU . 49.4 m80 -147.02 162.36 38.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.865 0.364 . . . . 0.0 110.919 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.492 HD11 ' HB ' ' A' ' 50' ' ' ILE . 1.0 OUTLIER -127.07 119.7 27.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.754 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.5 t -97.53 122.96 49.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.104 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -89.99 126.48 35.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.884 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.654 HD13 ' NH2' ' A' ' 124' ' ' ARG . 0.9 OUTLIER -90.62 106.82 18.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.54 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 20.8 mt -124.09 140.65 35.25 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.934 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.54 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 57.2 Cg_endo -73.86 87.99 1.1 Allowed 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.162 1.908 . . . . 0.0 111.983 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 137.79 -12.08 3.68 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.386 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.1 pttp 178.2 173.51 0.63 Allowed 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 120.727 0.299 . . . . 0.0 110.689 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -135.7 160.68 37.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.048 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.61 134.08 33.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.947 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.04 127.7 56.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.82 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.448 ' O ' HD12 ' A' ' 37' ' ' LEU . 30.6 t -119.48 130.79 73.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.182 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.43 ' HA ' ' CD2' ' A' ' 36' ' ' HIS . 3.3 pm0 -81.6 136.6 35.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.734 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.644 HG22 ' C ' ' A' ' 35' ' ' GLY . 16.7 tt -116.02 132.11 66.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.338 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.467 HG22 ' N ' ' A' ' 32' ' ' THR . 0.7 OUTLIER -97.05 168.09 10.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.999 -179.682 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.417 ' HA ' HD22 ' A' ' 82' ' ' LEU . 7.0 p30 -92.63 66.16 4.43 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.079 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.571 ' C ' ' H ' ' A' ' 55' ' ' VAL . 0.1 OUTLIER -90.37 13.26 15.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.016 -179.253 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.447 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 0.7 OUTLIER 69.28 -34.6 0.28 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -179.524 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.571 ' H ' ' C ' ' A' ' 53' ' ' ARG . 62.3 t -137.28 124.09 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-O 120.948 0.404 . . . . 0.0 111.343 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.769 HG23 ' HB3' ' A' ' 65' ' ' ASP . 15.9 m -111.04 128.8 55.98 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.624 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.74 138.67 40.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.908 0.385 . . . . 0.0 111.043 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.594 HD11 ' HD2' ' A' ' 80' ' ' PHE . 4.7 mp -126.64 117.98 49.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.033 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 176.68 -160.73 28.29 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.667 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.504 ' HB2' HG23 ' A' ' 73' ' ' ILE . 5.2 ttp180 -83.39 -29.82 27.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.726 0.298 . . . . 0.0 110.979 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.682 ' HB2' HG23 ' A' ' 75' ' ' THR . 7.2 t -58.09 129.32 41.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.968 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.42 -22.64 67.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.022 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 6.3 m -69.89 -27.58 64.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.004 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 97.5 m -57.16 151.61 15.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.82 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.769 ' HB3' HG23 ' A' ' 56' ' ' THR . 63.9 t0 -61.31 -43.96 98.01 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.884 0.374 . . . . 0.0 110.603 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.8 t -125.03 114.92 42.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.093 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.595 HG23 ' O ' ' A' ' 67' ' ' ILE . 19.6 tt -93.75 107.4 19.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.026 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.801 HD13 HD11 ' A' ' 73' ' ' ILE . 18.0 mt -65.36 -177.97 0.46 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.928 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.9 p -123.39 65.05 1.0 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.238 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.87 141.1 40.67 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.606 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.22 -19.22 50.72 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.605 2.203 . . . . 0.0 112.911 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -133.86 34.78 3.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.794 0.331 . . . . 0.0 111.31 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.801 HD11 HD13 ' A' ' 68' ' ' LEU . 3.2 tp -71.86 128.7 35.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.165 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.4 m -59.92 133.35 56.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.212 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.682 HG23 ' HB2' ' A' ' 61' ' ' SER . 86.7 m -64.46 -44.03 92.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.802 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.456 ' O ' ' C ' ' A' ' 77' ' ' HIS . 34.9 m-85 -99.68 13.9 31.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.405 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.456 ' C ' ' O ' ' A' ' 76' ' ' PHE . 1.8 t-160 -19.0 -69.94 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.737 -1.12 . . . . 0.0 112.771 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -153.78 164.08 38.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.986 0.422 . . . . 0.0 111.731 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.15 138.96 50.91 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.737 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.594 ' HD2' HD11 ' A' ' 58' ' ' ILE . 38.3 m-85 -119.53 131.07 55.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.55 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.447 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 9.0 m-70 -94.77 115.84 28.0 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.139 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.476 HD13 HG12 ' A' ' 50' ' ' ILE . 0.4 OUTLIER -107.08 109.81 21.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.796 179.485 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.0 pp -120.1 140.07 51.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.048 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -117.44 128.11 54.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.878 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.3 ttm -135.65 151.4 50.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.892 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -106.52 121.01 43.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.947 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.464 ' O ' HG13 ' A' ' 87' ' ' VAL . 10.5 p -126.92 121.44 58.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.929 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.8 t0 75.18 -58.0 0.58 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.062 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -173.17 -40.61 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.842 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -89.54 132.92 34.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.773 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.01 131.0 35.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.929 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -113.49 143.49 44.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.821 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -113.99 142.79 45.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.983 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.578 ' HG ' HD11 ' A' ' 118' ' ' ILE . 1.5 tp -131.91 136.19 47.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.739 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.631 ' N ' HD12 ' A' ' 95' ' ' ILE . 3.4 mp -114.7 140.95 33.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.125 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -117.54 133.54 55.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.785 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.531 HG13 ' CE1' ' A' ' 80' ' ' PHE . 7.7 t -96.36 127.34 48.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.238 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 9.9 mt -130.09 139.14 52.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.962 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -114.19 129.92 56.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.979 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.11 31.42 0.76 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.86 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.3 m -135.11 -178.74 5.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.881 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.02 37.68 3.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.882 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -101.13 -30.11 11.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.2 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 115.27 106.26 2.58 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.441 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.521 HG23 ' CE1' ' A' ' 127' ' ' PHE . 89.4 m -122.34 123.26 40.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.843 0.354 . . . . 0.0 110.948 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -121.0 115.0 22.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.855 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.8 tp -110.56 137.29 43.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.506 0.67 . . . . 0.0 111.318 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.9 m120 59.84 31.54 20.81 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.75 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.63 9.32 69.3 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.893 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -134.13 151.97 51.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.843 0.354 . . . . 0.0 110.838 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 30.4 ttp180 -74.73 140.54 44.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.908 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.64 HD22 ' O ' ' A' ' 114' ' ' LYS . 0.4 OUTLIER -75.98 133.68 40.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.915 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.47 HG23 ' HG3' ' A' ' 114' ' ' LYS . 5.8 m -112.08 -34.3 2.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.128 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.64 ' O ' HD22 ' A' ' 112' ' ' LEU . 44.1 mttp -100.34 -178.16 3.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.895 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.6 mttp -121.17 32.08 6.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.85 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -154.23 56.17 0.71 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.989 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.45 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 1.8 t80 -84.15 139.25 32.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.815 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.578 HD11 ' HG ' ' A' ' 94' ' ' LEU . 8.2 tp -98.53 118.89 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.217 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.629 HD11 HD11 ' A' ' 125' ' ' ILE . 9.2 tt -103.08 136.74 42.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.007 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 9.0 mttt -130.54 178.08 6.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.751 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.409 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 28.5 p30 -53.1 148.07 8.69 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.089 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.484 ' HA2' HD21 ' A' ' 134' ' ' LEU . . . 66.65 37.48 92.5 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.507 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.91 131.5 53.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.77 0.319 . . . . 0.0 110.87 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.654 ' NH2' HD13 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -97.99 125.54 42.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.837 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.629 HD11 HD11 ' A' ' 119' ' ' LEU . 2.9 mp -121.96 135.53 61.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.14 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.9 t -120.85 126.34 75.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.977 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.521 ' CE1' HG23 ' A' ' 105' ' ' THR . 44.8 m-85 -123.39 124.93 44.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.955 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 85.88 -6.16 81.76 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.864 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 77.74 27.8 0.58 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.93 0.395 . . . . 0.0 110.492 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 82.5 p -153.13 -46.36 0.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.797 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' CYS . . . . . 0.6 ' HB3' HD22 ' A' ' 68' ' ' LEU . 60.1 m -80.37 108.29 13.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.861 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 48.3 t -124.0 125.61 44.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.927 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -138.03 155.0 49.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.813 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.484 HD21 ' HA2' ' A' ' 122' ' ' GLY . 1.5 tt -108.29 130.02 55.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.79 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.622 ' HE2' HG21 ' A' ' 50' ' ' ILE . 30.2 t80 -99.68 141.58 32.3 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 122.025 0.917 . . . . 0.0 111.712 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 12.8 tttm -154.47 155.09 34.28 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 113.853 -1.521 . . . . 0.0 110.726 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.409 ' CE2' ' HB3' ' A' ' 121' ' ' ASN . 3.4 m-85 -81.62 139.51 34.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.958 0.409 . . . . 0.0 110.793 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.466 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.03 -179.914 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' A' ' 51' ' ' THR . 0.9 OUTLIER . . . . . 0 N--CA 1.457 -0.109 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.8 t -59.89 144.79 47.91 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.816 0.341 . . . . 0.0 111.114 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.948 HD22 HD21 ' A' ' 82' ' ' LEU . 1.1 tp -157.49 -67.35 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.968 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -118.98 165.25 13.03 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.526 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.517 ' ND1' ' HB2' ' A' ' 138' ' ' ALA . 32.0 m80 -136.83 161.12 36.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.848 0.356 . . . . 0.0 111.078 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.966 HD11 HD11 ' A' ' 50' ' ' ILE . 2.9 mt -120.58 111.08 17.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.669 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.6 t -96.02 121.76 46.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.02 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -90.17 113.91 25.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.882 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.74 106.81 14.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.814 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.525 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 22.0 mt -124.2 140.44 34.92 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.847 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.525 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 57.8 Cg_endo -74.29 86.42 1.31 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.186 1.924 . . . . 0.0 111.955 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 115.6 23.74 4.28 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.256 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 176.92 -168.36 0.06 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.738 0.304 . . . . 0.0 110.593 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -177.47 152.39 0.83 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.886 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -137.97 130.81 29.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.087 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.3 tttt -113.07 134.84 54.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.905 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.735 HG11 HG13 ' A' ' 66' ' ' VAL . 37.5 t -121.62 151.02 24.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.202 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -100.82 133.62 45.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.789 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.966 HD11 HD11 ' A' ' 37' ' ' LEU . 33.1 mm -116.07 129.51 72.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.173 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.961 ' O ' HD13 ' A' ' 82' ' ' LEU . 2.0 p -106.08 167.99 9.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.96 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.938 ' HA ' HD22 ' A' ' 82' ' ' LEU . 6.9 m-80 -85.1 63.67 8.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.168 0.508 . . . . 0.0 110.256 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.579 ' C ' ' H ' ' A' ' 55' ' ' VAL . 23.2 ttt-85 -87.3 2.76 49.25 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.914 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.411 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 0.7 OUTLIER 71.68 -34.63 0.3 Allowed 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -178.573 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.579 ' H ' ' C ' ' A' ' 53' ' ' ARG . 75.6 t -137.22 136.06 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.473 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.714 HG23 ' HB3' ' A' ' 65' ' ' ASP . 18.8 m -125.12 129.68 50.67 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.957 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.81 136.12 44.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.911 0.386 . . . . 0.0 110.846 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.415 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 36.6 mt -125.68 128.4 72.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.983 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 168.91 -143.95 8.4 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.222 -0.99 . . . . 0.0 113.353 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.493 ' HB2' ' CG2' ' A' ' 73' ' ' ILE . 5.8 ttp-105 -96.9 -40.55 8.85 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.904 0.383 . . . . 0.0 111.145 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.891 ' HB3' HG23 ' A' ' 75' ' ' THR . 4.7 p -53.91 127.27 25.54 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.309 -179.188 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 28.6 ptt85 -59.84 -20.12 55.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.024 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.77 -27.06 64.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.558 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 60.3 m -56.99 149.08 19.66 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.411 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.714 ' HB3' HG23 ' A' ' 56' ' ' THR . 7.9 t0 -61.36 -44.71 96.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.947 0.403 . . . . 0.0 110.794 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.735 HG13 HG11 ' A' ' 48' ' ' VAL . 56.0 t -125.21 133.17 70.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.551 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.4 pt -100.62 112.6 33.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.349 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.449 ' HA ' HD23 ' A' ' 68' ' ' LEU . 6.4 mt -78.72 -88.22 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.006 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 30.9 t -108.22 -108.65 0.32 Allowed 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.556 ' CB ' ' HD3' ' A' ' 71' ' ' PRO . 0.0 OUTLIER 169.27 -60.86 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.198 0 N-CA-C 111.574 0.212 . . . . 0.0 111.574 179.25 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.556 ' HD3' ' CB ' ' A' ' 70' ' ' GLU . 25.6 Cg_exo -62.39 -40.05 42.3 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 121.955 1.77 . . . . 0.0 113.061 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -121.74 25.26 9.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.676 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.493 ' CG2' ' HB2' ' A' ' 60' ' ' ARG . 5.0 tp -106.77 121.48 59.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.178 0.513 . . . . 0.0 111.102 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.448 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 0.7 OUTLIER -69.7 137.47 52.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.457 -179.298 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.891 HG23 ' HB3' ' A' ' 61' ' ' SER . 27.6 m -57.66 -43.99 85.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.942 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.47 ' O ' ' C ' ' A' ' 77' ' ' HIS . 2.9 m-85 -100.85 14.19 32.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.662 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.47 ' C ' ' O ' ' A' ' 76' ' ' PHE . 2.0 t-160 -18.92 -69.09 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.883 -1.053 . . . . 0.0 112.814 -179.218 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -155.57 164.07 39.14 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.929 0.395 . . . . 0.0 111.643 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.42 ' HA ' ' O ' ' A' ' 56' ' ' THR . 0.2 OUTLIER -125.95 138.99 53.8 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.848 179.802 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.735 ' CE1' HG13 ' A' ' 97' ' ' VAL . 2.6 m-85 -119.58 131.07 55.42 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.86 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.411 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 15.2 m-70 -97.29 116.3 29.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.81 0.338 . . . . 0.0 111.384 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.961 HD13 ' O ' ' A' ' 51' ' ' THR . 6.0 tt -106.82 109.93 21.96 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.058 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.8 mp -119.26 139.94 51.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.812 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -123.88 139.06 54.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.117 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -155.03 132.81 11.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.927 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.6 p-10 -107.04 128.73 54.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.914 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.8 m -130.8 139.12 51.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.201 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 68.43 -67.99 0.19 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.137 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -178.1 38.16 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.839 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -148.14 -177.93 6.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.669 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -121.37 127.94 51.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.94 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.13 110.88 20.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.738 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.571 ' OD1' HD21 ' A' ' 34' ' ' LEU . 17.5 m-80 -114.04 129.06 56.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.079 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.83 136.22 52.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.655 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.497 ' HB ' HD23 ' A' ' 119' ' ' LEU . 4.2 mp -113.78 141.01 31.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.11 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -119.72 143.95 47.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.793 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.735 HG13 ' CE1' ' A' ' 80' ' ' PHE . 16.8 t -109.88 129.93 63.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.208 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 24.0 mm -124.27 124.15 67.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.054 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.86 131.37 48.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.994 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -93.72 10.54 32.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.325 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.4 m 59.83 64.1 1.35 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.868 0.366 . . . . 0.0 110.88 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -161.38 132.2 5.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.941 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 70.23 5.8 5.49 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.988 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 61.76 130.87 0.01 OUTLIER Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.766 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.449 ' CG2' ' CE1' ' A' ' 127' ' ' PHE . 95.8 m -132.04 125.86 32.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.791 0.329 . . . . 0.0 110.814 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -117.62 123.92 47.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.92 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.485 HG21 ' CD1' ' A' ' 112' ' ' LEU . 2.3 tp -122.08 137.2 56.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.511 0.672 . . . . 0.0 111.152 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 62.4 29.04 17.15 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.881 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.7 9.44 69.83 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.911 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -134.0 152.03 51.69 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.748 0.308 . . . . 0.0 110.839 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 8.1 mtp-105 -68.5 142.64 55.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.852 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.485 ' CD1' HG21 ' A' ' 107' ' ' ILE . 1.3 tp -77.48 140.28 39.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.953 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.459 HG23 ' N ' ' A' ' 114' ' ' LYS . 19.3 m -126.05 -44.58 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.077 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.459 ' N ' HG23 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -67.71 -178.64 0.97 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.897 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.03 -29.04 8.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.902 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -122.66 83.86 2.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.884 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -82.3 139.18 34.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.808 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.482 ' O ' HG23 ' A' ' 118' ' ' ILE . 8.2 tp -98.51 121.61 49.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.969 0.414 . . . . 0.0 111.395 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.567 HD22 ' HE2' ' A' ' 80' ' ' PHE . 3.8 tp -103.07 134.0 47.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.894 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 2.4 mttp -129.19 178.12 6.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.858 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.436 ' HB2' ' CE2' ' A' ' 137' ' ' TYR . 3.6 t30 -54.89 144.93 21.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.223 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 64.55 44.68 94.77 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.379 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -117.04 122.36 43.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.762 0.315 . . . . 0.0 111.089 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.57 ' CG ' HD12 ' A' ' 134' ' ' LEU . 78.1 mtt180 -89.89 133.05 34.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.718 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.508 HD11 HD11 ' A' ' 119' ' ' LEU . 2.9 mp -126.67 132.35 70.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.251 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.9 t -118.33 126.15 74.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.958 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.449 ' CE1' ' CG2' ' A' ' 105' ' ' THR . 45.2 m-85 -122.74 144.23 49.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.075 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 81.56 -67.09 3.7 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.391 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 170.51 -33.91 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.773 0.321 . . . . 0.0 111.036 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 9.6 p -116.41 -37.49 3.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.413 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 48.6 m -55.15 103.95 0.11 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.977 0.418 . . . . 0.0 111.184 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 44.3 t -124.62 124.54 42.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.035 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.429 ' CE1' HD21 ' A' ' 68' ' ' LEU . 24.8 p90 -142.08 156.12 45.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.919 0.39 . . . . 0.0 110.998 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.57 HD12 ' CG ' ' A' ' 124' ' ' ARG . 1.0 OUTLIER -111.78 140.02 46.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.864 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.548 ' CG ' HD21 ' A' ' 119' ' ' LEU . 20.0 t80 -100.46 141.27 33.55 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.924 0.869 . . . . 0.0 111.695 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.403 ' HG3' HD23 ' A' ' 134' ' ' LEU . 8.6 mtmt -154.78 157.11 37.46 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 113.864 -1.516 . . . . 0.0 110.95 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.436 ' CE2' ' HB2' ' A' ' 121' ' ' ASN . 4.8 m-85 -86.02 139.61 31.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.928 0.394 . . . . 0.0 110.616 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.517 ' HB2' ' ND1' ' A' ' 36' ' ' HIS . . . . . . . . 0 C--N 1.324 -0.507 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.06 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.534 ' N ' HG22 ' A' ' 51' ' ' THR . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.052 0 CA-C-O 120.796 0.331 . . . . 0.0 110.648 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.8 t -67.36 122.86 18.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.999 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.458 HD21 ' OD1' ' A' ' 93' ' ' ASN . 5.0 tp -133.29 -62.39 0.79 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.675 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.5 162.77 12.26 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.298 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.42 ' CD2' ' HG3' ' A' ' 49' ' ' GLU . 27.3 m80 -132.24 160.38 36.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.961 0.41 . . . . 0.0 111.185 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.964 HD12 HD11 ' A' ' 50' ' ' ILE . 78.9 mt -127.11 118.72 24.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.845 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.5 t -100.36 121.85 51.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.129 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -89.7 125.27 35.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.888 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.7 mp -86.74 106.97 18.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.877 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.66 HG22 ' HD2' ' A' ' 42' ' ' PRO . 1.7 mt -124.11 141.39 37.07 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.63 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.66 ' HD2' HG22 ' A' ' 41' ' ' ILE . 56.2 Cg_endo -72.14 -8.33 22.64 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.171 1.914 . . . . 0.0 112.489 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -109.29 -14.2 15.31 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.555 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 175.97 -165.84 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.705 0.288 . . . . 0.0 110.744 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -137.99 132.42 32.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.923 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -108.13 133.59 52.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.1 tttm -113.06 122.93 49.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.942 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 18.6 t -111.56 151.16 13.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.997 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.42 ' HG3' ' CD2' ' A' ' 36' ' ' HIS . 0.3 OUTLIER -104.85 119.42 38.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.063 -179.878 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.964 HD11 HD12 ' A' ' 37' ' ' LEU . 27.3 mm -98.37 132.09 44.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.829 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.534 HG22 ' N ' ' A' ' 32' ' ' THR . 0.5 OUTLIER -103.2 168.03 9.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.063 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.834 ' HA ' HD22 ' A' ' 82' ' ' LEU . 0.4 OUTLIER -97.68 73.64 2.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.435 179.606 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.585 ' C ' ' H ' ' A' ' 55' ' ' VAL . 6.1 ptp180 -103.47 16.9 25.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.614 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.426 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 13.7 m120 68.49 -29.16 0.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.585 ' H ' ' C ' ' A' ' 53' ' ' ARG . 59.4 t -137.38 131.3 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-O 121.072 0.463 . . . . 0.0 111.623 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.677 HG23 ' HB3' ' A' ' 65' ' ' ASP . 45.7 m -125.29 125.86 44.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.688 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.4 ' HB ' ' CB ' ' A' ' 64' ' ' CYS . 0.1 OUTLIER -103.67 130.76 51.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.986 0.422 . . . . 0.0 111.183 -179.64 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.86 HG23 HD11 ' A' ' 68' ' ' LEU . 5.2 mp -112.23 117.17 54.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.789 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 172.56 -141.92 6.51 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.357 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.541 ' HB3' ' HA ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -111.47 -23.17 10.9 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.696 0.284 . . . . 0.0 111.233 179.891 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.622 ' HB2' HG23 ' A' ' 75' ' ' THR . 0.1 OUTLIER -51.88 126.06 17.03 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.8 0.334 . . . . 0.0 111.072 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.22 -28.61 59.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.049 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.27 -22.45 59.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.113 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.4 ' CB ' ' HB ' ' A' ' 57' ' ' THR . 94.2 m -55.76 168.14 0.47 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.982 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.677 ' HB3' HG23 ' A' ' 56' ' ' THR . 65.9 t0 -89.24 -51.37 5.61 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.863 0.363 . . . . 0.0 110.893 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.403 HG23 ' CG2' ' A' ' 56' ' ' THR . 21.6 t -104.22 132.02 51.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.029 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.4 pt -108.16 128.96 63.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.357 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.86 HD11 HG23 ' A' ' 58' ' ' ILE . 1.3 mp -114.3 -152.32 0.5 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.304 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.575 ' O ' ' CB ' ' A' ' 70' ' ' GLU . 0.5 OUTLIER -42.08 -58.45 2.1 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.506 0.193 . . . . 0.0 110.753 179.779 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.702 ' HB3' ' HD3' ' A' ' 71' ' ' PRO . 0.7 OUTLIER 110.42 -56.04 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.585 0 C-N-CA 123.594 0.758 . . . . 0.0 112.209 178.708 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.702 ' HD3' ' HB3' ' A' ' 70' ' ' GLU . 16.9 Cg_exo -67.22 -40.08 11.94 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.177 1.918 . . . . 0.0 112.899 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -107.06 23.92 13.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.828 0.347 . . . . 0.0 111.016 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.839 HG12 HD13 ' A' ' 68' ' ' LEU . 4.8 tp -115.94 127.9 73.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.103 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 54.7 m -67.48 131.76 46.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.902 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.622 HG23 ' HB2' ' A' ' 61' ' ' SER . 85.1 m -58.75 -33.12 69.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.574 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.442 ' O ' ' C ' ' A' ' 77' ' ' HIS . 0.1 OUTLIER -112.19 13.96 20.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.537 179.859 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.442 ' C ' ' O ' ' A' ' 76' ' ' PHE . 1.0 OUTLIER -22.03 -69.61 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.748 -1.115 . . . . 0.0 112.576 -179.339 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.737 ' HB3' ' CE2' ' A' ' 127' ' ' PHE . . . -159.33 164.06 35.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.101 0.477 . . . . 0.0 111.936 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -123.74 140.23 53.2 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.405 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.672 ' CE1' HG13 ' A' ' 97' ' ' VAL . 2.3 m-85 -119.38 131.16 55.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.866 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.426 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 4.4 m-70 -95.28 116.26 28.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.82 0.343 . . . . 0.0 111.082 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.834 HD22 ' HA ' ' A' ' 52' ' ' ASN . 0.3 OUTLIER -106.64 109.62 21.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.853 179.588 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.462 HD12 ' C ' ' A' ' 82' ' ' LEU . 7.1 mp -122.32 140.15 52.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.978 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -111.92 121.02 43.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.834 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -132.37 130.09 40.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.929 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -107.06 128.56 54.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.936 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.6 t -129.83 136.08 59.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.953 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.0 t0 71.98 -60.67 0.52 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.982 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -176.09 -39.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.767 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -81.03 131.85 35.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.731 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -82.96 128.14 34.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.032 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -112.98 143.1 44.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.783 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.458 ' OD1' HD21 ' A' ' 34' ' ' LEU . 68.7 m-20 -114.01 129.56 56.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.051 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.753 HD22 HD11 ' A' ' 118' ' ' ILE . 7.9 mt -120.62 142.36 49.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.703 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.467 HG13 ' CE1' ' A' ' 135' ' ' PHE . 10.7 mm -124.26 141.17 45.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.245 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -113.8 138.54 50.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.743 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.672 HG13 ' CE1' ' A' ' 80' ' ' PHE . 21.4 t -109.63 120.85 61.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.311 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 13.9 mt -130.15 120.94 50.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.88 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.416 ' OD1' HD13 ' A' ' 112' ' ' LEU . 2.1 m-20 -115.32 126.12 54.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.957 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.05 28.38 5.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.056 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 58.11 106.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.05 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.21 -76.08 0.28 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.893 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -125.02 27.87 6.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.254 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 66.79 128.14 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.597 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 63.1 m -131.29 123.02 27.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.821 0.343 . . . . 0.0 110.751 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.414 ' CE2' ' HG3' ' A' ' 111' ' ' ARG . 62.2 m-85 -120.02 114.97 22.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.93 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.714 ' CG2' HG22 ' A' ' 125' ' ' ILE . 2.1 pp -109.48 131.19 61.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.118 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 10.4 m120 59.59 31.75 21.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.968 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.63 13.05 74.5 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.96 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -129.12 132.36 47.36 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.845 0.355 . . . . 0.0 110.895 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.414 ' HG3' ' CE2' ' A' ' 106' ' ' PHE . 5.4 ttt180 -68.41 142.99 55.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.92 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.416 HD13 ' OD1' ' A' ' 99' ' ' ASP . 0.4 OUTLIER -81.47 132.74 35.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.851 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.633 ' O ' HG22 ' A' ' 113' ' ' VAL . 14.7 p -144.06 32.62 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.081 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 4.1 mptt -131.12 138.18 49.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.843 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.08 -40.05 86.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.896 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -126.31 78.43 1.77 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.939 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -84.05 139.07 32.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.819 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.753 HD11 HD22 ' A' ' 94' ' ' LEU . 8.5 tp -98.52 119.94 47.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.011 0.434 . . . . 0.0 111.289 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.788 HD23 ' N ' ' A' ' 120' ' ' LYS . 3.1 tt -103.18 142.37 34.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.014 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.788 ' N ' HD23 ' A' ' 119' ' ' LEU . 6.3 mttt -125.42 178.03 5.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.072 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.453 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 7.9 p30 -62.73 146.86 51.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.173 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 68.92 51.86 27.0 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.342 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.736 ' HB2' HD21 ' A' ' 119' ' ' LEU . 0.7 OUTLIER -127.61 124.31 37.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.843 0.354 . . . . 0.0 111.191 -179.752 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.721 ' CA ' HD12 ' A' ' 134' ' ' LEU . 24.8 ttm180 -84.7 132.3 34.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.707 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.714 HG22 ' CG2' ' A' ' 107' ' ' ILE . 22.5 pt -129.56 128.4 65.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.212 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.534 HG13 ' O ' ' A' ' 131' ' ' CYS . 21.6 t -113.56 129.63 69.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.0 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.737 ' CE2' ' HB3' ' A' ' 78' ' ' ALA . 5.5 m-85 -116.77 111.96 20.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.004 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 104.76 -75.55 0.25 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.479 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 5.6 tttt 179.42 -38.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.769 0.319 . . . . 0.0 110.989 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 12.0 p -104.51 -40.59 5.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.287 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' CYS . . . . . 0.534 ' O ' HG13 ' A' ' 126' ' ' VAL . 22.0 m -57.93 107.04 0.42 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.842 0.353 . . . . 0.0 111.079 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 29.7 t -124.21 119.92 30.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.788 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.446 ' N ' ' CD1' ' A' ' 133' ' ' PHE . 1.1 p90 -141.9 150.32 41.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.091 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.721 HD12 ' CA ' ' A' ' 124' ' ' ARG . 0.5 OUTLIER -109.22 140.13 43.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.777 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.618 ' HD2' HD21 ' A' ' 37' ' ' LEU . 12.3 t80 -102.25 141.26 35.38 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 121.893 0.854 . . . . 0.0 111.664 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.449 ' N ' ' CD1' ' A' ' 135' ' ' PHE . 7.2 mttp -154.68 155.4 34.55 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 113.829 -1.532 . . . . 0.0 111.128 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.453 ' CE2' ' HB3' ' A' ' 121' ' ' ASN . 8.7 m-85 -86.16 140.0 30.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.003 0.43 . . . . 0.0 110.638 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.407 ' HB3' ' CE1' ' A' ' 36' ' ' HIS . . . . . . . . 0 C--N 1.324 -0.509 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.123 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.655 ' N ' HG22 ' A' ' 51' ' ' THR . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.842 0.353 . . . . 0.0 110.675 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.8 t -72.27 120.57 18.07 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.977 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.585 HD23 ' O ' ' A' ' 34' ' ' LEU . 7.7 tt -119.81 -40.5 2.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.893 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.677 ' C ' HG22 ' A' ' 50' ' ' ILE . . . -149.25 -169.6 15.95 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.49 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 51.1 m80 -146.96 160.65 42.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.774 0.321 . . . . 0.0 110.919 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.574 HD11 ' HB ' ' A' ' 50' ' ' ILE . 2.4 mp -127.1 119.33 26.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.799 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.4 t -98.28 121.76 49.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.179 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -89.93 119.16 30.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.844 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.421 ' N ' HD22 ' A' ' 40' ' ' LEU . 3.8 mm? -75.37 106.88 7.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.915 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.43 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 18.9 mt -124.11 138.75 31.27 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.847 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.43 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 86.6 Cg_exo -44.46 -28.76 2.78 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.48 2.12 . . . . 0.0 112.441 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -111.18 -143.4 9.37 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.268 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.0 mtpt -53.89 113.77 1.33 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.83 0.347 . . . . 0.0 111.134 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -59.93 168.02 1.99 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.955 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -135.66 125.01 24.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.015 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.01 134.28 54.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.92 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.8 t -125.42 139.42 51.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.122 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -80.31 139.67 36.5 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.748 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.696 HG21 ' HE2' ' A' ' 135' ' ' PHE . 2.2 tt -116.01 130.86 70.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.895 0.378 . . . . 0.0 111.398 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.655 HG22 ' N ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -96.77 168.11 10.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.6 179.733 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.579 ' ND2' HG23 ' A' ' 32' ' ' THR . 0.4 OUTLIER -110.76 73.16 0.81 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.677 179.751 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.595 ' C ' ' H ' ' A' ' 55' ' ' VAL . 0.1 OUTLIER -98.65 23.36 8.76 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.115 -179.788 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 69.83 -28.3 0.17 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.595 ' H ' ' C ' ' A' ' 53' ' ' ARG . 58.6 t -137.29 134.18 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-O 121.111 0.481 . . . . 0.0 111.506 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.697 HG23 ' HB3' ' A' ' 65' ' ' ASP . 18.0 m -125.45 125.9 44.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.372 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.78 133.24 49.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.956 0.408 . . . . 0.0 111.213 -179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.576 HD12 ' N ' ' A' ' 58' ' ' ILE . 3.9 mp -118.35 116.73 52.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.896 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLY . . . . . 0.402 ' HA2' HG13 ' A' ' 73' ' ' ILE . . . 173.42 -142.37 6.58 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.657 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.423 ' HB2' ' CG2' ' A' ' 73' ' ' ILE . 11.7 ttp180 -103.76 -30.94 10.08 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.777 0.322 . . . . 0.0 110.947 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.719 ' HB2' HG23 ' A' ' 75' ' ' THR . 0.2 OUTLIER -49.17 124.46 9.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.241 -179.696 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 47.6 mtm180 -57.04 -30.32 64.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.904 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.4 m -69.99 -21.96 63.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.081 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 86.5 m -55.8 166.17 0.77 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.995 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.697 ' HB3' HG23 ' A' ' 56' ' ' THR . 11.7 t70 -83.58 -48.13 10.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.816 0.341 . . . . 0.0 111.033 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 58' ' ' ILE . 21.3 t -124.93 125.43 69.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.515 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.6 pt -98.28 131.04 46.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.786 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.661 HD22 ' HB3' ' A' ' 131' ' ' CYS . 19.9 mt -118.25 105.17 11.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.263 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.59 ' C ' ' HD2' ' A' ' 71' ' ' PRO . 0.6 OUTLIER 68.75 -70.27 0.14 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.571 179.991 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.57 ' CB ' ' O ' ' A' ' 69' ' ' SER . 31.1 mt-10 112.18 -60.71 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.84 0 C-N-CA 123.992 0.917 . . . . 0.0 112.336 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.59 ' HD2' ' C ' ' A' ' 69' ' ' SER . 38.1 Cg_endo -66.74 -14.15 42.73 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.123 1.882 . . . . 0.0 113.367 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -129.18 25.72 5.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.66 0.267 . . . . 0.0 111.269 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.45 ' HB ' ' O ' ' A' ' 68' ' ' LEU . 4.9 tp -119.89 150.61 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-O 120.943 0.402 . . . . 0.0 111.566 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 45.0 t -94.88 129.38 41.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.063 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.719 HG23 ' HB2' ' A' ' 61' ' ' SER . 58.0 m -53.7 -33.39 55.33 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.157 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -112.3 14.0 20.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.167 0.508 . . . . 0.0 111.838 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.47 ' HB2' ' O ' ' A' ' 74' ' ' SER . 2.0 t-160 -29.17 -70.38 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.901 -1.045 . . . . 0.0 112.617 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.652 ' HB3' ' CE2' ' A' ' 127' ' ' PHE . . . -154.96 164.15 39.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.08 0.467 . . . . 0.0 112.126 -179.34 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -127.79 139.23 52.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.206 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.812 ' CZ ' HG13 ' A' ' 97' ' ' VAL . 5.5 m-85 -119.42 131.33 55.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.984 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 5.2 m80 -94.59 116.39 28.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.972 0.415 . . . . 0.0 110.964 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.661 HD13 HG13 ' A' ' 95' ' ' ILE . 4.2 mm? -106.47 109.72 21.72 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.775 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.9 tp -120.79 140.0 52.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.065 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -107.63 126.36 52.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.745 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -126.09 143.09 51.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.984 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -95.84 116.91 29.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.895 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.6 t -138.71 121.05 17.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.073 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 62.11 -176.59 0.13 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.825 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 22.7 t30 -50.7 -31.13 15.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.257 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -94.46 -177.53 4.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.922 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -115.67 128.66 56.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.849 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.19 123.2 43.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.923 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -113.51 138.26 50.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.745 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.494 ' N ' HD12 ' A' ' 94' ' ' LEU . 0.5 OUTLIER -132.07 134.22 45.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.95 -179.957 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.661 HG13 HD13 ' A' ' 82' ' ' LEU . 3.6 mp -115.45 141.11 33.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.976 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -113.91 137.66 51.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.844 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.812 HG13 ' CZ ' ' A' ' 80' ' ' PHE . 12.1 t -105.78 126.36 61.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.222 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 33.9 mt -129.95 120.99 51.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.984 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.76 139.01 54.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.951 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.3 mmtm -99.92 6.27 45.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.332 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.6 m 58.08 101.83 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.75 0.31 . . . . 0.0 111.014 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 14.3 ttt180 -149.23 -63.72 0.23 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.889 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -96.2 -45.61 6.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.235 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 132.96 106.08 0.97 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.554 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.9 m -118.52 126.36 51.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.835 0.35 . . . . 0.0 110.949 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.408 ' CE2' ' HB2' ' A' ' 111' ' ' ARG . 19.3 m-85 -120.83 121.26 37.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.882 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.6 HD12 ' O ' ' A' ' 124' ' ' ARG . 2.3 tp -108.51 137.29 40.97 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 CA-C-O 121.522 0.677 . . . . 0.0 111.193 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.0 m120 61.71 28.05 17.26 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.825 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.69 9.55 69.99 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.947 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -134.1 152.0 51.64 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.804 0.335 . . . . 0.0 110.862 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.408 ' HB2' ' CE2' ' A' ' 106' ' ' PHE . 0.6 OUTLIER -71.77 133.02 45.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.954 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.9 pp -88.57 134.62 33.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.924 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 13.0 m -110.52 -30.22 2.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.224 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.2 153.97 31.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.983 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.62 -36.3 16.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.895 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -102.93 74.62 1.33 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.917 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -83.72 139.04 32.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.815 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.505 ' O ' HG23 ' A' ' 118' ' ' ILE . 8.6 tp -98.63 118.99 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.148 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.914 HD11 HD11 ' A' ' 125' ' ' ILE . 6.1 tt -103.04 135.88 43.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.056 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -131.07 178.12 6.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.743 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.429 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 4.5 p-10 -52.95 143.77 16.34 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.091 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 68.51 44.04 74.48 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.475 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -112.85 121.19 43.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.806 0.336 . . . . 0.0 110.916 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.608 ' HG3' HD12 ' A' ' 134' ' ' LEU . 1.5 mpt_? -90.51 119.03 30.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.871 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.914 HD11 HD11 ' A' ' 119' ' ' LEU . 3.6 mt -114.94 132.07 65.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.061 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.625 HG22 ' OG ' ' A' ' 132' ' ' SER . 29.6 t -116.57 131.84 67.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.174 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.652 ' CE2' ' HB3' ' A' ' 78' ' ' ALA . 8.3 m-85 -118.57 133.63 55.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.975 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 80.19 -66.19 3.67 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.446 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 170.38 -33.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.814 0.34 . . . . 0.0 110.998 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.3 p -107.19 -42.76 4.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.287 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' CYS . . . . . 0.661 ' HB3' HD22 ' A' ' 68' ' ' LEU . 59.5 m -56.4 104.78 0.16 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.874 0.369 . . . . 0.0 111.194 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.625 ' OG ' HG22 ' A' ' 126' ' ' VAL . 0.3 OUTLIER -124.42 125.01 43.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.922 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.445 ' CE1' HD11 ' A' ' 68' ' ' LEU . 2.1 p90 -142.15 156.12 45.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.93 0.395 . . . . 0.0 111.091 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.608 HD12 ' HG3' ' A' ' 124' ' ' ARG . 9.6 tt -116.25 138.97 50.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.645 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.696 ' HE2' HG21 ' A' ' 50' ' ' ILE . 25.4 t80 -103.38 141.4 36.01 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 122.029 0.919 . . . . 0.0 111.875 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 11.4 mtmt -154.67 143.8 21.09 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 113.787 -1.552 . . . . 0.0 110.74 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.429 ' CE2' ' HB3' ' A' ' 121' ' ' ASN . 4.0 m-85 -72.86 139.72 47.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.002 0.43 . . . . 0.0 110.72 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.462 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.092 -179.97 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.582 ' N ' HG22 ' A' ' 51' ' ' THR . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.68 0.276 . . . . 0.0 110.743 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 10.6 t -69.7 114.9 8.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.58 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.761 HD22 HD23 ' A' ' 82' ' ' LEU . 3.1 tp -118.16 -41.95 2.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.28 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.465 ' C ' HG22 ' A' ' 50' ' ' ILE . . . -148.53 -167.92 14.07 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.233 -0.984 . . . . 0.0 113.056 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.43 ' CD2' ' HG3' ' A' ' 49' ' ' GLU . 46.1 m80 -144.58 161.04 40.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.862 0.363 . . . . 0.0 110.683 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.477 ' CD1' HG21 ' A' ' 66' ' ' VAL . 23.5 mt -127.11 112.85 15.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.666 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.5 t -95.92 121.77 46.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.135 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -90.23 125.96 35.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.933 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.458 HD12 ' HA ' ' A' ' 133' ' ' PHE . 4.8 mp -106.1 106.81 17.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.802 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.8 mm -124.03 138.17 30.2 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.086 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -55.78 87.11 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.4 2.067 . . . . 0.0 112.205 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 139.51 -22.55 2.86 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.662 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.9 mtpt 177.01 164.03 0.49 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.861 0.363 . . . . 0.0 110.814 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -122.61 -178.19 3.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.906 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.53 134.93 16.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.882 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -109.03 122.7 47.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.854 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.3 t -122.47 151.12 26.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.211 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.43 ' HG3' ' CD2' ' A' ' 36' ' ' HIS . 0.4 OUTLIER -94.69 130.65 41.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.602 179.852 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.721 HG21 ' HE2' ' A' ' 135' ' ' PHE . 3.1 tt -116.1 128.88 73.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.084 0.469 . . . . 0.0 111.578 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.582 HG22 ' N ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -96.79 168.12 10.69 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.196 179.539 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.684 ' HA ' HD22 ' A' ' 82' ' ' LEU . 56.5 m-80 -68.51 -89.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.333 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.571 ' C ' ' H ' ' A' ' 55' ' ' VAL . 12.9 ttt-85 72.79 -1.09 3.12 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 179.013 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 1.3 m-20 70.33 -34.06 0.28 Allowed 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.096 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.571 ' H ' ' C ' ' A' ' 53' ' ' ARG . 64.1 t -137.04 134.84 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 CA-C-O 121.012 0.434 . . . . 0.0 110.949 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.807 HG23 ' CB ' ' A' ' 65' ' ' ASP . 50.6 m -125.28 132.17 52.96 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.061 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.401 ' HB ' ' CB ' ' A' ' 64' ' ' CYS . 0.0 OUTLIER -104.33 143.84 32.44 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.843 0.354 . . . . 0.0 111.231 -179.786 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.445 HD12 ' N ' ' A' ' 58' ' ' ILE . 4.8 mp -130.76 126.72 60.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.083 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 164.98 -139.28 5.73 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.667 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.42 ' HB2' HG23 ' A' ' 73' ' ' ILE . 10.6 ttp180 -106.85 -26.59 11.18 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.749 0.309 . . . . 0.0 110.969 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.733 ' HB2' HG23 ' A' ' 75' ' ' THR . 0.1 OUTLIER -52.12 136.5 29.68 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.24 -179.741 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.74 -31.89 72.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.915 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 46.2 p -69.95 -23.91 63.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.942 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.401 ' CB ' ' HB ' ' A' ' 57' ' ' THR . 96.4 m -56.64 171.87 0.29 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.944 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.807 ' CB ' HG23 ' A' ' 56' ' ' THR . 0.7 OUTLIER -85.07 -68.16 0.75 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.002 0.429 . . . . 0.0 110.885 179.813 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.477 HG21 ' CD1' ' A' ' 37' ' ' LEU . 21.2 t -105.95 115.31 47.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.899 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.4 pt -91.94 104.97 16.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.553 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.498 HD11 ' CE2' ' A' ' 133' ' ' PHE . 1.8 mp -66.85 -155.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.837 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.482 ' O ' ' CB ' ' A' ' 70' ' ' GLU . 19.1 p -41.81 -96.43 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 117.592 0.178 . . . . 0.0 111.193 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.535 ' CB ' ' HD3' ' A' ' 71' ' ' PRO . 1.5 mt-10 159.19 -60.93 0.0 OUTLIER Pre-proline 0 N--CA 1.466 0.366 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.535 ' HD3' ' CB ' ' A' ' 70' ' ' GLU . 36.4 Cg_exo -57.4 -40.31 82.47 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.206 1.937 . . . . 0.0 113.241 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -116.53 28.86 8.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.698 0.285 . . . . 0.0 111.313 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.469 HD11 HD22 ' A' ' 68' ' ' LEU . 4.9 tp -110.6 126.74 67.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.99 0.424 . . . . 0.0 111.293 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.417 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 1.5 m -79.03 134.66 36.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.194 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.733 HG23 ' HB2' ' A' ' 61' ' ' SER . 72.0 m -61.03 -29.16 69.56 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.02 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.431 ' O ' ' C ' ' A' ' 77' ' ' HIS . 0.3 OUTLIER -106.91 14.02 27.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.237 0.541 . . . . 0.0 111.598 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.462 ' CE1' ' HB3' ' A' ' 127' ' ' PHE . 1.4 t-160 -24.41 -71.11 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.759 -1.109 . . . . 0.0 112.747 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.541 ' HB3' ' HE2' ' A' ' 127' ' ' PHE . . . -163.43 164.12 24.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.062 0.458 . . . . 0.0 112.019 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -124.35 140.88 52.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.342 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.656 ' CE1' HG13 ' A' ' 97' ' ' VAL . 3.2 m-85 -119.22 131.15 55.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.751 0.31 . . . . 0.0 110.863 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -94.82 116.47 28.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.909 0.385 . . . . 0.0 111.038 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.761 HD23 HD22 ' A' ' 34' ' ' LEU . 0.1 OUTLIER -106.41 109.55 21.51 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.107 179.866 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.23 130.62 53.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.814 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 5.7 tm0? -107.0 128.12 54.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.925 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 9.4 ttt -152.03 143.15 23.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.928 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -99.89 131.13 46.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.852 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 19.8 t -137.01 134.46 47.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.112 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 61.11 39.83 15.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.833 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 62.26 32.67 17.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.856 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -145.68 157.09 43.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.882 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -82.98 127.92 33.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.905 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -117.01 117.44 29.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.008 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 51.2 m-20 -105.42 119.96 40.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.766 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.4 mt -118.2 125.65 50.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.077 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.407 HG13 ' CE1' ' A' ' 135' ' ' PHE . 11.7 mm -115.0 133.3 61.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.013 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -113.94 143.49 44.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.635 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.656 HG13 ' CE1' ' A' ' 80' ' ' PHE . 18.0 t -109.12 132.63 56.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.381 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.472 HD13 ' O ' ' A' ' 97' ' ' VAL . 25.3 mm -130.05 120.93 50.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.029 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -102.23 127.05 49.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.964 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.4 mmtp -140.69 31.54 1.85 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.886 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.6 m -123.92 178.35 5.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.953 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -121.95 31.25 6.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.951 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -103.58 -56.29 2.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.186 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 138.05 120.78 1.9 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.514 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.8 m -125.59 122.95 37.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.813 0.34 . . . . 0.0 110.911 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.401 ' CE2' ' HB3' ' A' ' 111' ' ' ARG . 46.1 m-85 -116.31 129.15 56.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.848 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.1 tp -123.08 137.24 57.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.445 0.641 . . . . 0.0 111.378 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.8 m120 61.86 29.71 17.98 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.838 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.64 12.98 74.49 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.87 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 73.3 m-80 -133.47 152.01 51.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.798 0.332 . . . . 0.0 110.849 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.401 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -68.0 143.05 55.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.932 -179.996 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.457 HD21 ' HB2' ' A' ' 117' ' ' TYR . 0.3 OUTLIER -85.46 126.31 33.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.865 179.991 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.406 HG13 ' N ' ' A' ' 114' ' ' LYS . 11.2 p -112.16 -40.81 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.113 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.406 ' N ' HG13 ' A' ' 113' ' ' VAL . 7.6 tptp -76.56 163.71 26.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.968 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.68 -29.25 18.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.902 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -121.13 82.06 1.87 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.018 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.457 ' HB2' HD21 ' A' ' 112' ' ' LEU . 57.6 t80 -84.09 139.21 32.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.673 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.542 ' O ' HG23 ' A' ' 118' ' ' ILE . 8.7 tp -98.52 118.52 45.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.435 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.714 HD11 HD11 ' A' ' 125' ' ' ILE . 7.0 tt -103.2 143.93 31.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.841 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.3 mmtt -127.51 178.01 6.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.851 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.434 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 11.7 p-10 -59.94 148.07 36.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.973 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.529 ' HA2' HD21 ' A' ' 134' ' ' LEU . . . 64.05 43.71 96.92 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.413 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -114.69 130.74 56.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.774 0.321 . . . . 0.0 111.069 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.54 ' HD3' HD12 ' A' ' 134' ' ' LEU . 1.2 mmm-85 -83.87 130.77 34.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.712 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.714 HD11 HD11 ' A' ' 119' ' ' LEU . 2.7 mt -126.8 128.14 70.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.356 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 40.6 t -122.76 124.01 69.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.734 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.541 ' HE2' ' HB3' ' A' ' 78' ' ' ALA . 3.3 m-85 -113.47 145.98 40.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.969 0.414 . . . . 0.0 111.306 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 70.6 -65.17 0.82 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.435 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 173.83 -50.18 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.853 0.358 . . . . 0.0 110.859 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 89.1 p -96.15 -36.15 11.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.203 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' CYS . . . . . 0.488 ' SG ' HD23 ' A' ' 68' ' ' LEU . 24.7 m -57.66 104.49 0.19 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.003 0.43 . . . . 0.0 111.124 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.41 124.14 41.69 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.951 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.498 ' CE2' HD11 ' A' ' 68' ' ' LEU . 8.4 p90 -142.13 153.64 44.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.966 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.54 HD12 ' HD3' ' A' ' 124' ' ' ARG . 2.0 tt -112.22 133.93 54.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.766 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.721 ' HE2' HG21 ' A' ' 50' ' ' ILE . 48.0 t80 -106.42 141.4 37.79 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 121.958 0.885 . . . . 0.0 111.802 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.55 157.44 38.29 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 113.928 -1.487 . . . . 0.0 111.119 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.434 ' CE2' ' HB3' ' A' ' 121' ' ' ASN . 6.7 m-85 -86.0 139.87 30.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.761 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.564 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.125 179.972 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.55 ' C ' HG22 ' A' ' 51' ' ' THR . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.776 0.322 . . . . 0.0 110.692 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 4.4 t -62.05 138.43 58.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.07 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.1 tp -142.54 -47.83 0.34 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.708 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.721 ' C ' HG22 ' A' ' 50' ' ' ILE . . . -137.63 -174.68 13.47 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.287 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.413 ' ND1' ' HB2' ' A' ' 138' ' ' ALA . 50.5 m80 -144.83 163.76 33.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.893 0.378 . . . . 0.0 111.031 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.0 mt -126.59 131.05 51.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.683 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.1 t -105.33 121.92 58.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.094 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.412 ' CB ' HD11 ' A' ' 41' ' ' ILE . 1.1 m-20 -89.99 126.01 35.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.794 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.94 106.54 18.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.88 0.371 . . . . 0.0 110.782 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.543 HG23 ' HD2' ' A' ' 42' ' ' PRO . 4.3 mp -124.49 141.06 36.68 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.906 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.543 ' HD2' HG23 ' A' ' 41' ' ' ILE . 58.9 Cg_endo -74.44 83.31 1.72 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.102 1.868 . . . . 0.0 111.978 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 143.33 -14.3 2.29 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.531 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.02 176.18 0.92 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 120.716 0.293 . . . . 0.0 110.672 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -132.73 160.62 36.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.141 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -137.78 130.27 29.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.814 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 33.6 tttt -106.21 127.28 53.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.007 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 23.5 t -117.47 147.73 20.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.083 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.402 ' CG ' ' NE2' ' A' ' 36' ' ' HIS . 3.4 mt-10 -97.26 135.72 38.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.844 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.721 HG22 ' C ' ' A' ' 35' ' ' GLY . 1.1 tt -115.25 132.15 65.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.093 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.567 ' O ' HD22 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -106.46 168.46 9.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.253 -179.653 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -85.07 68.93 10.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.153 0.502 . . . . 0.0 110.511 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.576 ' C ' ' H ' ' A' ' 55' ' ' VAL . 19.3 ttt-85 -87.77 4.45 44.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.814 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.506 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 10.3 m120 69.0 -35.08 0.29 Allowed 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -178.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.576 ' H ' ' C ' ' A' ' 53' ' ' ARG . 70.5 t -137.27 135.23 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.599 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.669 HG23 ' HB3' ' A' ' 65' ' ' ASP . 53.4 m -125.15 126.52 45.4 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.023 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.73 131.05 51.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.964 0.411 . . . . 0.0 110.732 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.856 HG23 HD13 ' A' ' 68' ' ' LEU . 5.0 mp -119.77 118.91 58.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.929 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 172.46 -137.18 4.1 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.449 -0.881 . . . . 0.0 113.201 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.493 ' HD2' ' O ' ' A' ' 70' ' ' GLU . 11.2 ttt-85 -103.29 -38.13 7.36 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.815 0.34 . . . . 0.0 111.103 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.682 ' HB2' HG23 ' A' ' 75' ' ' THR . 0.3 OUTLIER -45.8 127.52 8.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.583 -179.389 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.8 -29.1 69.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.737 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 94.2 p -69.93 -23.67 63.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.826 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 87.9 m -53.3 158.15 1.73 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.87 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.669 ' HB3' HG23 ' A' ' 56' ' ' THR . 8.8 t0 -74.09 -47.62 35.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.847 0.356 . . . . 0.0 111.008 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 58' ' ' ILE . 20.8 t -125.08 133.27 69.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.559 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 4.7 pt -100.24 118.93 47.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.603 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.856 HD13 HG23 ' A' ' 58' ' ' ILE . 2.3 mp -84.83 -86.67 0.13 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.784 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 38.9 m -107.7 -109.77 0.31 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.611 ' CB ' ' HD3' ' A' ' 71' ' ' PRO . 0.1 OUTLIER 168.34 -63.49 0.0 OUTLIER Pre-proline 0 CA--C 1.529 0.157 0 O-C-N 122.375 -0.203 . . . . 0.0 111.541 178.862 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.611 ' HD3' ' CB ' ' A' ' 70' ' ' GLU . 21.5 Cg_exo -64.74 -22.14 64.28 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 121.977 1.785 . . . . 0.0 112.867 -179.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -136.32 22.07 3.2 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.684 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.468 ' CG2' ' HB2' ' A' ' 60' ' ' ARG . 4.7 tp -105.68 121.25 57.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.06 0.457 . . . . 0.0 110.957 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.415 ' HB2' ' CA ' ' A' ' 77' ' ' HIS . 13.8 m -65.24 133.08 50.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.484 -179.11 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.682 HG23 ' HB2' ' A' ' 61' ' ' SER . 77.8 m -58.73 -35.34 72.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.974 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.43 ' O ' ' C ' ' A' ' 77' ' ' HIS . 0.2 OUTLIER -112.01 14.14 20.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.225 0.536 . . . . 0.0 111.361 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.43 ' C ' ' O ' ' A' ' 76' ' ' PHE . 14.8 t60 -24.88 -69.14 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.648 -179.139 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -149.77 163.96 36.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.07 0.462 . . . . 0.0 112.056 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -129.01 137.98 51.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.462 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.813 ' CE1' HG13 ' A' ' 97' ' ' VAL . 2.0 m-85 -119.57 125.98 50.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.848 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -94.84 116.19 28.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.913 0.387 . . . . 0.0 111.294 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.567 HD22 ' O ' ' A' ' 51' ' ' THR . 0.1 OUTLIER -106.64 109.5 21.44 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.714 179.399 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.9 tp -122.49 140.2 53.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.2 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -122.82 120.95 35.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.807 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -115.47 126.58 54.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.985 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -107.07 117.56 34.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.904 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 25.3 t -133.54 125.08 49.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.015 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.5 t70 70.61 -61.55 0.47 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.048 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -176.54 -39.64 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.845 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -89.48 101.28 13.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.68 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -82.93 145.44 29.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.051 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 2.8 ttp-105 -113.1 141.13 47.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.808 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -107.35 129.92 54.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.029 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.705 HD23 HD11 ' A' ' 118' ' ' ILE . 0.3 OUTLIER -126.7 133.9 50.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.718 179.883 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.623 HD13 HD23 ' A' ' 119' ' ' LEU . 3.8 mp -117.48 140.77 39.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.22 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -117.82 125.82 51.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.825 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.813 HG13 ' CE1' ' A' ' 80' ' ' PHE . 18.0 t -96.34 131.48 43.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.131 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 32.4 mt -123.0 120.95 61.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.03 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.48 117.88 26.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.93 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.04 30.06 1.82 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.885 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 18.5 m -96.04 177.71 5.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.825 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.9 29.58 1.87 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.093 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 34.7 p-10 -135.18 -44.85 0.71 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.964 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 157.33 117.01 0.52 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.739 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.689 HG23 ' CD1' ' A' ' 127' ' ' PHE . 62.5 m -132.04 122.75 25.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.734 0.302 . . . . 0.0 110.79 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -121.21 139.07 53.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.188 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.825 HD13 HG22 ' A' ' 125' ' ' ILE . 3.3 tp -122.79 137.34 56.62 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 CA-C-O 121.443 0.639 . . . . 0.0 111.196 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.7 m120 60.52 30.0 19.43 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.65 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.69 12.67 74.36 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.843 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -134.14 152.03 51.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.819 0.342 . . . . 0.0 110.769 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.83 143.09 44.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.872 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.518 ' CD1' HG22 ' A' ' 107' ' ' ILE . 3.2 mp -74.74 131.33 40.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.942 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.3 p -114.73 -37.09 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.07 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 9.9 tttt -115.38 149.77 37.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.871 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.3 165.94 21.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.027 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 27.5 t70 62.48 64.73 0.91 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.988 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -84.04 138.47 33.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.846 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.705 HD11 HD23 ' A' ' 94' ' ' LEU . 8.4 tp -98.7 120.28 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.226 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.646 HD13 ' HE2' ' A' ' 80' ' ' PHE . 4.7 tt -103.07 139.06 39.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.992 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 13.0 mmtp -129.84 178.17 6.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.74 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.442 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 4.8 p-10 -53.41 148.0 9.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.153 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 64.08 37.5 94.68 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.565 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -109.81 127.85 54.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.821 0.343 . . . . 0.0 110.96 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.413 ' O ' HD12 ' A' ' 107' ' ' ILE . 54.2 mtt180 -93.6 132.69 37.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.858 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.825 HG22 HD13 ' A' ' 107' ' ' ILE . 0.1 OUTLIER -118.42 122.0 68.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.087 179.877 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 46.7 t -112.71 123.9 68.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.771 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.689 ' CD1' HG23 ' A' ' 105' ' ' THR . 68.5 m-85 -120.38 148.03 44.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.951 0.405 . . . . 0.0 111.211 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 73.79 -65.84 1.78 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.348 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 175.35 -50.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.807 0.337 . . . . 0.0 111.022 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.06 -33.13 9.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.681 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 21.6 m -55.74 105.46 0.18 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.884 0.373 . . . . 0.0 110.98 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 13.7 p -124.22 136.76 54.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.918 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.439 ' CZ ' ' HG ' ' A' ' 68' ' ' LEU . 15.5 m-85 -142.25 156.21 45.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.151 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.8 tt -121.66 116.1 23.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.711 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.569 ' HE2' HG21 ' A' ' 50' ' ' ILE . 21.4 t80 -94.7 141.56 28.47 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 122.054 0.931 . . . . 0.0 111.895 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 6.8 tttt -154.62 160.4 41.43 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 113.781 -1.554 . . . . 0.0 110.85 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.461 ' HE1' HD11 ' A' ' 95' ' ' ILE . 3.7 m-85 -86.07 139.98 30.66 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.051 0.453 . . . . 0.0 110.681 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.413 ' HB2' ' ND1' ' A' ' 36' ' ' HIS . . . . . . . . 0 C--N 1.324 -0.535 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.058 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.474 ' N ' HG22 ' A' ' 51' ' ' THR . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.868 0.366 . . . . 0.0 110.517 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 40.6 t -59.84 120.17 9.08 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.158 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.567 HD23 HD22 ' A' ' 52' ' ' ASN . 1.3 mm? -117.04 -34.97 4.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.705 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.6 ' O ' HG22 ' A' ' 50' ' ' ILE . . . -168.54 -177.9 39.84 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.274 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 23.2 m80 -138.08 166.05 25.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.084 0.468 . . . . 0.0 111.138 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.493 HD22 ' CE2' ' A' ' 133' ' ' PHE . 1.1 mt -127.28 114.73 18.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.614 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.426 HG22 ' HG2' ' A' ' 47' ' ' LYS . 20.0 t -95.92 121.59 46.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.129 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -90.37 142.04 28.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.939 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.6 mt -107.43 106.49 16.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.681 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.9 mt -124.39 138.67 31.41 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.983 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_exo -52.12 -25.39 22.82 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.475 2.117 . . . . 0.0 112.516 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -85.52 -34.01 15.04 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.736 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 177.15 -174.28 0.12 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.835 0.35 . . . . 0.0 110.948 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -107.92 157.53 18.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.918 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -135.41 120.26 18.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.954 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.426 ' HG2' HG22 ' A' ' 38' ' ' VAL . 1.7 mmtp -100.72 128.2 46.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.882 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.1 t -122.4 139.71 48.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.156 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -92.43 127.42 37.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.724 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.6 HG22 ' O ' ' A' ' 35' ' ' GLY . 15.9 tt -116.05 132.08 66.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.04 0.448 . . . . 0.0 111.468 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.474 HG22 ' N ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -98.81 167.87 10.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.454 179.74 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.567 HD22 HD23 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -61.14 -92.18 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.684 -0.235 . . . . 0.0 110.387 179.592 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.558 ' C ' ' H ' ' A' ' 55' ' ' VAL . 8.0 ttt180 75.2 -5.77 2.1 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 179.15 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.423 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 7.9 t-20 71.03 -32.97 0.26 Allowed 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.786 -0.365 . . . . 0.0 110.199 -179.137 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.558 ' H ' ' C ' ' A' ' 53' ' ' ARG . 61.6 t -135.82 138.33 47.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 CA-C-O 120.926 0.393 . . . . 0.0 110.931 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.762 HG23 ' CB ' ' A' ' 65' ' ' ASP . 94.0 m -125.38 130.5 52.04 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.579 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.413 ' O ' ' N ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -104.01 139.76 38.69 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.821 0.343 . . . . 0.0 111.025 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.419 HD12 ' N ' ' A' ' 58' ' ' ILE . 4.7 mp -132.2 130.87 60.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.335 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.35 -135.31 3.99 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.971 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.482 ' HB2' ' CG2' ' A' ' 73' ' ' ILE . 7.5 ttt-85 -100.59 -40.9 7.18 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 120.855 0.36 . . . . 0.0 110.918 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.607 ' HB2' HG23 ' A' ' 75' ' ' THR . 0.3 OUTLIER -44.83 118.82 1.73 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.446 -179.568 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 15.9 mtt85 -57.42 -27.42 62.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.884 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.7 m -69.82 -25.62 63.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.778 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 89.8 m -54.73 166.6 0.46 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.78 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.762 ' CB ' HG23 ' A' ' 56' ' ' THR . 0.6 OUTLIER -73.52 -58.33 3.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.875 0.369 . . . . 0.0 111.117 -179.945 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.408 HG21 ' CD1' ' A' ' 37' ' ' LEU . 21.2 t -121.51 125.36 73.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.647 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.3 pt -95.81 118.19 41.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.567 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.49 HD13 HD11 ' A' ' 73' ' ' ILE . 9.1 mt -77.01 -91.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.686 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.583 ' OG ' HD13 ' A' ' 73' ' ' ILE . 1.3 p -101.42 -102.11 0.26 Allowed 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.064 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.583 ' CB ' ' HD3' ' A' ' 71' ' ' PRO . 3.6 mt-10 162.4 -63.96 0.0 OUTLIER Pre-proline 0 CA--C 1.531 0.228 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.583 ' HD3' ' CB ' ' A' ' 70' ' ' GLU . 46.8 Cg_exo -56.09 -40.13 86.86 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.107 1.871 . . . . 0.0 113.355 -178.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -124.19 25.67 7.72 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.583 HD13 ' OG ' ' A' ' 69' ' ' SER . 3.1 tp -104.31 121.93 56.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.137 0.494 . . . . 0.0 111.223 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.6 m -62.9 136.31 57.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.285 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.607 HG23 ' HB2' ' A' ' 61' ' ' SER . 65.8 m -64.4 -40.57 96.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.806 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.452 ' O ' ' C ' ' A' ' 77' ' ' HIS . 3.5 m-85 -99.24 13.86 31.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.232 0.539 . . . . 0.0 111.448 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.452 ' C ' ' O ' ' A' ' 76' ' ' PHE . 1.0 OUTLIER -20.6 -69.8 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.705 -1.134 . . . . 0.0 112.76 -179.346 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -156.64 164.05 38.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.214 0.53 . . . . 0.0 112.099 -179.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -129.52 133.78 47.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.085 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.836 ' CE1' HG13 ' A' ' 97' ' ' VAL . 5.1 m-85 -119.2 131.22 55.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.975 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.423 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 8.1 m-70 -94.67 116.33 28.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.991 0.424 . . . . 0.0 110.906 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.43 109.65 21.63 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.058 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.31 137.56 54.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.794 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.419 ' HG3' HD11 ' A' ' 34' ' ' LEU . 2.0 tt0 -109.64 129.2 55.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.868 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.88 141.22 34.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.948 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.8 p-10 -106.95 115.95 31.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.856 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.0 m -124.95 117.41 50.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.3 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.7 t0 58.35 77.51 0.29 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.081 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 63.18 -80.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.994 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -63.67 151.72 41.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.917 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -118.63 136.72 53.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.96 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.7 mtp180 -112.64 149.74 32.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.997 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 49.5 m-20 -112.12 125.61 54.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.716 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.3 mp -107.78 127.29 53.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.927 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.491 ' N ' HD12 ' A' ' 95' ' ' ILE . 4.1 mp -118.09 137.41 52.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.076 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -114.01 144.09 43.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.041 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.836 HG13 ' CE1' ' A' ' 80' ' ' PHE . 14.1 t -106.45 127.13 62.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.253 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 11.9 mt -130.03 120.91 50.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.851 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -100.14 136.5 39.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.021 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.7 mmtt -133.47 30.55 3.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.913 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.7 m -160.68 150.78 17.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.841 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -102.21 44.76 0.99 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.954 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -83.65 -31.71 26.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.242 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 121.33 89.21 1.03 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.51 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 67.4 m -112.36 126.09 54.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.9 0.381 . . . . 0.0 110.912 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -121.03 118.31 29.49 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.956 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.436 HD12 ' O ' ' A' ' 124' ' ' ARG . 2.7 tp -115.49 137.33 49.41 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-O 121.551 0.691 . . . . 0.0 111.255 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.8 m120 59.98 28.09 17.57 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.838 -1.073 . . . . 0.0 110.931 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.74 9.89 70.82 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.878 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -134.04 152.0 51.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.823 0.344 . . . . 0.0 110.854 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.04 136.74 43.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.894 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.91 144.96 52.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.866 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.534 ' O ' HG22 ' A' ' 113' ' ' VAL . 10.2 p -141.11 56.13 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.106 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -177.25 -176.4 0.64 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.835 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.41 25.84 9.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.024 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -166.46 72.9 0.15 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.778 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.429 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 0.7 OUTLIER -84.14 139.4 32.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.833 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.543 ' O ' HG23 ' A' ' 118' ' ' ILE . 7.8 tp -98.51 117.62 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-O 120.984 0.421 . . . . 0.0 111.242 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.734 HD21 ' CD2' ' A' ' 135' ' ' PHE . 0.5 OUTLIER -103.1 132.54 49.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.035 -179.834 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -130.84 178.09 6.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.799 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.423 ' HB2' ' CE2' ' A' ' 137' ' ' TYR . 0.3 OUTLIER -54.81 141.32 33.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.061 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 71.8 53.04 10.16 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.5 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -129.14 127.12 40.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.895 0.378 . . . . 0.0 111.009 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.724 ' HD2' HD12 ' A' ' 134' ' ' LEU . 0.3 OUTLIER -91.13 124.38 35.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.747 179.958 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.427 HD11 HD11 ' A' ' 119' ' ' LEU . 3.2 mp -115.0 131.57 66.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.283 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.7 t -122.71 128.14 75.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.943 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.483 ' CB ' HD13 ' A' ' 68' ' ' LEU . 44.5 m-85 -121.77 118.22 28.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.983 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 86.63 -8.17 76.39 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.84 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 76.74 27.98 0.72 Allowed 'General case' 0 CA--C 1.522 -0.11 0 CA-C-O 120.939 0.4 . . . . 0.0 110.243 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.2 p -138.13 -48.24 0.54 Allowed 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.94 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' CYS . . . . . 0.465 ' HB3' HD22 ' A' ' 68' ' ' LEU . 1.8 m -88.41 112.04 22.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.865 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 23.0 t -120.08 123.35 43.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.036 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.493 ' CE2' HD22 ' A' ' 37' ' ' LEU . 3.1 p90 -142.16 156.22 45.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.118 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.724 HD12 ' HD2' ' A' ' 124' ' ' ARG . 7.1 tt -108.07 138.79 43.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.706 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.734 ' CD2' HD21 ' A' ' 119' ' ' LEU . 56.5 t80 -105.18 141.57 36.49 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.992 0.901 . . . . 0.0 111.938 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.43 155.11 34.37 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 113.846 -1.525 . . . . 0.0 110.747 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.423 ' CE2' ' HB2' ' A' ' 121' ' ' ASN . 1.1 m-85 -85.06 139.74 31.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.945 0.403 . . . . 0.0 110.847 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.47 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.065 -179.942 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.478 ' C ' HG22 ' A' ' 51' ' ' THR . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.726 0.298 . . . . 0.0 110.635 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 13.2 t -76.43 114.86 15.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.901 0.382 . . . . 0.0 111.071 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.19 -35.8 3.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.889 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.711 ' C ' HG22 ' A' ' 50' ' ' ILE . . . -141.03 -177.81 16.67 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.565 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.638 ' ND1' ' HB2' ' A' ' 138' ' ' ALA . 31.9 m80 -142.13 157.87 44.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.836 0.35 . . . . 0.0 110.832 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.494 ' O ' HD12 ' A' ' 37' ' ' LEU . 3.0 pp -127.08 123.05 35.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.722 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.3 t -105.89 121.93 58.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.197 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -86.3 115.16 23.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.751 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 45.1 mt -83.87 106.87 15.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.986 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.547 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 4.4 mt -124.25 141.5 37.55 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.806 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.547 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 57.5 Cg_endo -73.66 84.91 1.36 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.253 1.968 . . . . 0.0 112.018 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 141.34 -14.04 2.76 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.41 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -179.03 173.68 1.15 Allowed 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 120.767 0.317 . . . . 0.0 110.628 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -139.04 160.76 39.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.075 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -141.5 123.35 15.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.959 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.42 ' HE2' ' CD2' ' A' ' 36' ' ' HIS . 28.4 tttt -110.68 126.17 54.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.819 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 38.5 t -124.05 144.67 33.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.235 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.442 ' HG2' ' CD2' ' A' ' 36' ' ' HIS . 48.0 mt-10 -80.87 135.64 35.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.546 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.711 HG22 ' C ' ' A' ' 35' ' ' GLY . 2.9 tt -111.65 131.99 61.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.043 0.449 . . . . 0.0 111.444 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.585 ' O ' HD13 ' A' ' 82' ' ' LEU . 0.9 OUTLIER -102.7 168.02 9.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.465 179.804 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.769 ' HA ' HD22 ' A' ' 82' ' ' LEU . 34.1 m-80 -68.43 -91.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.574 ' C ' ' H ' ' A' ' 55' ' ' VAL . 5.8 ttt85 69.75 -2.48 1.97 Allowed 'General case' 0 C--O 1.231 0.126 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 178.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.417 ' HA ' HD22 ' A' ' 83' ' ' LEU . 1.8 m-20 70.29 -32.21 0.23 Allowed 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 -179.008 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.574 ' H ' ' C ' ' A' ' 53' ' ' ARG . 81.6 t -136.99 143.25 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.822 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.499 HG23 ' CB ' ' A' ' 65' ' ' ASP . 9.2 m -125.49 131.2 52.87 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.458 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 65' ' ' ASP . 0.1 OUTLIER -103.98 137.46 41.93 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.908 0.385 . . . . 0.0 111.087 -179.862 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.416 HD13 ' CE1' ' A' ' 80' ' ' PHE . 3.4 mp -132.1 128.47 59.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.096 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 168.9 -135.27 3.53 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.754 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.448 ' HB3' ' HA ' ' A' ' 70' ' ' GLU . 14.8 ptt85 -108.11 -29.4 8.97 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.663 0.268 . . . . 0.0 111.022 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.713 ' CB ' HG23 ' A' ' 75' ' ' THR . 2.8 t -57.46 121.73 10.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.831 0.348 . . . . 0.0 110.816 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.68 -25.36 39.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.07 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.97 -24.63 63.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.0 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 87.7 m -58.22 166.47 1.62 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.038 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.499 ' CB ' HG23 ' A' ' 56' ' ' THR . 0.5 OUTLIER -71.01 -57.1 4.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.003 0.43 . . . . 0.0 110.832 179.742 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.47 HG21 ' CD2' ' A' ' 37' ' ' LEU . 21.0 t -125.2 133.3 69.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.67 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.6 pt -101.72 125.32 55.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.722 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.531 HD23 ' CB ' ' A' ' 131' ' ' CYS . 4.3 mp -93.28 -85.98 0.26 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.944 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.401 ' O ' ' CB ' ' A' ' 70' ' ' GLU . 10.0 t -98.33 -101.93 0.21 Allowed 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.531 ' CB ' ' CD ' ' A' ' 71' ' ' PRO . 0.1 OUTLIER 167.21 -70.2 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.189 0 CA-C-O 120.528 0.204 . . . . 0.0 111.299 179.369 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.531 ' CD ' ' CB ' ' A' ' 70' ' ' GLU . 47.0 Cg_endo -67.86 -38.19 13.95 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.56 2.173 . . . . 0.0 113.579 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -105.71 10.51 32.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.757 0.313 . . . . 0.0 111.226 -179.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.449 ' O ' ' CG2' ' A' ' 73' ' ' ILE . 2.9 tp -105.88 117.29 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-O 121.016 0.436 . . . . 0.0 110.612 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.429 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 0.3 OUTLIER -67.22 135.97 54.26 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.16 -179.163 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.713 HG23 ' CB ' ' A' ' 61' ' ' SER . 64.1 m -49.33 -44.02 44.09 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.826 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.448 ' O ' ' C ' ' A' ' 77' ' ' HIS . 5.7 p90 -106.85 14.1 27.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.22 0.533 . . . . 0.0 111.327 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.448 ' C ' ' O ' ' A' ' 76' ' ' PHE . 3.9 t-160 -20.2 -58.51 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.609 -1.178 . . . . 0.0 112.826 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.431 ' CB ' ' CZ ' ' A' ' 127' ' ' PHE . . . -150.63 157.89 43.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.97 0.414 . . . . 0.0 111.583 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 56' ' ' THR . 16.2 pt-20 -133.06 133.49 43.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.684 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.664 ' CE2' HG22 ' A' ' 97' ' ' VAL . 5.0 m-85 -119.3 131.33 55.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.608 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.4 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 9.0 m-70 -94.41 116.43 28.79 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.985 0.421 . . . . 0.0 111.092 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.769 HD22 ' HA ' ' A' ' 52' ' ' ASN . 1.8 tt -106.49 109.88 21.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.814 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' LEU . . . . . 0.417 HD22 ' HA ' ' A' ' 54' ' ' ASN . 1.1 mm? -121.6 137.4 54.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.895 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -108.93 136.91 47.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.856 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -126.88 131.77 51.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.869 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -88.54 120.17 29.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.904 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.5 t -139.96 139.13 37.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.065 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -50.1 132.86 23.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.078 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 35.6 m120 62.47 99.35 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.792 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 63.16 133.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.999 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -82.93 158.71 22.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.897 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.91 111.82 20.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.974 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.495 ' C ' HD12 ' A' ' 94' ' ' LEU . 11.9 m-80 -113.34 138.92 49.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.837 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.495 HD12 ' C ' ' A' ' 93' ' ' ASN . 7.9 mp -130.03 137.17 50.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.995 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.454 ' O ' HD12 ' A' ' 118' ' ' ILE . 3.8 mp -119.59 139.02 48.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.078 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -116.88 144.13 44.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.688 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.664 HG22 ' CE2' ' A' ' 80' ' ' PHE . 16.4 t -116.2 132.15 66.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.271 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.558 HD13 ' O ' ' A' ' 115' ' ' LYS . 20.5 mm -127.11 131.06 71.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.119 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -90.22 128.35 36.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.861 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.5 mmmt -119.93 -35.36 3.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.278 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.8 m -78.07 -44.84 25.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.117 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.51 21.54 10.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.904 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -85.95 -30.51 22.73 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.855 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 167.36 73.37 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.506 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.456 HG23 ' CE1' ' A' ' 127' ' ' PHE . 62.0 m -104.72 122.76 46.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.888 0.375 . . . . 0.0 110.869 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -121.14 119.29 31.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.874 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.789 HD13 HD12 ' A' ' 125' ' ' ILE . 2.9 tp -118.09 137.29 52.52 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 CA-C-O 121.524 0.678 . . . . 0.0 111.202 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.8 m120 60.15 27.29 16.75 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.818 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.75 9.86 70.81 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.818 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -134.03 152.02 51.67 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.749 0.309 . . . . 0.0 110.958 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 30.1 mtm180 -65.1 142.97 58.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.902 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.418 HD21 ' HB ' ' A' ' 105' ' ' THR . 3.1 pp -99.17 129.57 45.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.898 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.6 m -111.85 -30.79 2.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.189 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 16.9 mtmt -80.64 142.22 34.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.937 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.558 ' O ' HD13 ' A' ' 98' ' ' ILE . 0.2 OUTLIER -77.73 -32.75 53.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.875 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -105.64 75.04 1.11 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.927 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -80.75 139.03 36.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.822 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.525 ' O ' HG23 ' A' ' 118' ' ' ILE . 8.6 tp -98.54 119.06 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.37 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.6 tt -103.0 138.51 39.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.982 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.02 178.11 7.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.862 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.445 ' HB2' ' CE2' ' A' ' 137' ' ' TYR . 2.0 t30 -55.31 142.06 33.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.084 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.501 ' HA2' HD21 ' A' ' 134' ' ' LEU . . . 68.08 48.62 52.47 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.406 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -123.44 124.24 42.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.843 0.354 . . . . 0.0 111.072 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.473 ' O ' HD12 ' A' ' 107' ' ' ILE . 48.6 ttt-85 -90.22 122.19 32.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.801 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.789 HD12 HD13 ' A' ' 107' ' ' ILE . 0.5 OUTLIER -120.63 136.41 57.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.933 0.397 . . . . 0.0 111.317 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.432 HG22 ' HB3' ' A' ' 132' ' ' SER . 21.4 t -124.09 133.95 67.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.815 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.456 ' CE1' HG23 ' A' ' 105' ' ' THR . 9.7 m-85 -124.85 138.42 54.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.955 0.407 . . . . 0.0 111.142 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 86.77 -69.83 3.03 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.343 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 176.67 -39.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.729 0.3 . . . . 0.0 111.076 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.38 -40.21 4.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.804 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' CYS . . . . . 0.531 ' CB ' HD23 ' A' ' 68' ' ' LEU . 33.6 m -53.92 103.95 0.09 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.071 0.462 . . . . 0.0 111.268 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.432 ' HB3' HG22 ' A' ' 126' ' ' VAL . 5.6 p -124.6 129.34 50.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.902 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.457 ' N ' ' CD1' ' A' ' 133' ' ' PHE . 1.3 p90 -142.16 156.08 45.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.058 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.583 HD23 ' N ' ' A' ' 135' ' ' PHE . 3.5 tt -115.11 136.16 53.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.83 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.7 ' HE2' HG21 ' A' ' 50' ' ' ILE . 21.6 t80 -105.67 141.56 36.92 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.95 0.881 . . . . 0.0 111.774 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -154.31 159.67 41.35 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 113.828 -1.533 . . . . 0.0 110.756 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.445 ' CE2' ' HB2' ' A' ' 121' ' ' ASN . 4.5 m-85 -85.29 140.11 31.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.059 0.457 . . . . 0.0 110.618 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.638 ' HB2' ' ND1' ' A' ' 36' ' ' HIS . . . . . . . . 0 C--N 1.323 -0.573 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.191 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.4 ' O ' HG22 ' A' ' 51' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.082 0 CA-C-O 120.823 0.344 . . . . 0.0 110.73 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.8 t -59.81 145.07 46.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.117 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.618 HD22 HD21 ' A' ' 82' ' ' LEU . 8.3 tt -152.2 -44.98 0.1 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.945 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -157.72 172.82 35.04 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.445 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.546 ' ND1' ' HB2' ' A' ' 138' ' ' ALA . 32.1 m80 -133.47 161.19 35.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.008 0.432 . . . . 0.0 111.208 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.608 HD12 HD11 ' A' ' 50' ' ' ILE . 57.9 mt -127.19 107.92 10.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.596 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.2 t -96.78 121.74 47.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.825 0.345 . . . . 0.0 111.366 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -90.16 119.44 30.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.836 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.5 mt -79.26 106.8 11.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.898 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.4 mt -124.27 139.27 32.45 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.914 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -50.11 91.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.41 2.074 . . . . 0.0 112.286 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 116.03 -105.6 1.42 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.263 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.85 -168.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.791 0.329 . . . . 0.0 111.023 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -155.5 141.7 18.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.985 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -110.46 120.17 41.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.82 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.57 126.14 54.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.993 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.7 t -117.21 143.99 26.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.975 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -93.7 131.16 39.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.925 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.608 HD11 HD12 ' A' ' 37' ' ' LEU . 30.5 mm -111.33 122.38 65.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.002 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.757 ' O ' HD23 ' A' ' 82' ' ' LEU . 0.4 OUTLIER -102.48 168.2 9.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.899 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 17.2 p30 -93.19 71.38 4.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.704 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.587 ' C ' ' H ' ' A' ' 55' ' ' VAL . 2.6 ptp180 -98.35 15.62 24.09 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.618 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 68.97 -29.26 0.17 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.706 0.289 . . . . 0.0 110.333 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.587 ' H ' ' C ' ' A' ' 53' ' ' ARG . 59.3 t -137.09 134.64 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 CA-C-O 121.193 0.52 . . . . 0.0 111.548 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.659 HG23 ' HB3' ' A' ' 65' ' ' ASP . 39.7 m -125.06 122.53 37.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.756 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.88 133.84 48.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.901 0.382 . . . . 0.0 111.038 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.4 mp -119.11 116.52 51.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.721 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 174.72 -146.09 8.32 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.571 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.524 ' HB3' ' HA ' ' A' ' 70' ' ' GLU . 9.4 ptt180 -100.21 -27.67 13.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.702 0.287 . . . . 0.0 111.102 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.06 121.4 7.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.911 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.7 ptt85 -54.96 -28.78 54.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.067 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.91 -24.99 63.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.836 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 99.8 m -55.36 158.8 3.0 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.001 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.659 ' HB3' HG23 ' A' ' 56' ' ' THR . 62.0 t0 -76.3 -52.89 9.05 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.905 0.383 . . . . 0.0 110.943 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.6 t -101.64 129.83 52.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.253 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 14.6 pt -99.82 125.84 53.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.158 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.405 ' O ' ' C ' ' A' ' 69' ' ' SER . 3.3 mp -113.71 -163.69 0.88 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.249 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.596 ' O ' ' CB ' ' A' ' 70' ' ' GLU . 1.2 m -35.56 -58.46 0.59 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.574 0.226 . . . . 0.0 110.975 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.596 ' CB ' ' O ' ' A' ' 69' ' ' SER . 9.0 tm-20 109.84 -61.74 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.529 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.702 178.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.585 ' HD2' ' C ' ' A' ' 69' ' ' SER . 44.0 Cg_endo -67.75 -33.51 27.26 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 121.888 1.726 . . . . 0.0 113.199 -179.358 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -112.04 21.56 15.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.701 0.286 . . . . 0.0 111.301 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.424 HD12 ' HA ' ' A' ' 73' ' ' ILE . 4.8 tp -117.8 128.85 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-O 120.916 0.388 . . . . 0.0 111.147 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.8 m -63.55 132.78 52.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.057 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.8 m -59.81 -33.48 71.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.897 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.448 ' O ' ' C ' ' A' ' 77' ' ' HIS . 14.9 m-85 -112.1 13.88 20.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.474 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.449 ' CE1' ' HB3' ' A' ' 127' ' ' PHE . 2.1 t-160 -21.62 -69.49 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.726 -1.125 . . . . 0.0 112.574 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.465 ' HB3' ' HE2' ' A' ' 127' ' ' PHE . . . -153.06 159.68 42.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.125 0.488 . . . . 0.0 112.045 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -126.53 134.2 50.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.41 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.655 ' CZ ' HG13 ' A' ' 97' ' ' VAL . 7.5 m-85 -119.4 131.45 55.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.888 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 9.9 m-70 -94.63 116.37 28.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.917 0.389 . . . . 0.0 111.011 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.757 HD23 ' O ' ' A' ' 51' ' ' THR . 12.8 tp -106.47 109.69 21.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.915 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.1 140.08 52.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -116.3 125.13 51.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.864 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 32.6 tpp -138.84 133.39 31.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.912 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -107.04 133.66 51.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.93 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.5 t -135.8 134.19 51.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.002 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.8 t70 75.04 -58.24 0.58 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.021 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -176.31 -39.02 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.894 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -86.63 146.11 26.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.775 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -97.07 137.84 35.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.032 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.2 mtm-85 -114.3 144.8 42.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.873 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 73.2 m-80 -114.08 121.34 43.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.854 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.668 HD21 HG12 ' A' ' 118' ' ' ILE . 1.8 tt -115.72 132.84 56.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.877 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.528 ' N ' HD12 ' A' ' 95' ' ' ILE . 3.2 mp -122.27 140.99 44.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.146 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -113.94 144.0 43.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.823 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.655 HG13 ' CZ ' ' A' ' 80' ' ' PHE . 22.7 t -109.15 122.91 64.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.193 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 25.1 mt -130.1 122.32 53.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.089 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -107.71 138.6 43.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.863 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.9 mmtp -92.65 -6.02 50.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.414 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.8 m 63.05 44.37 5.92 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.882 0.372 . . . . 0.0 110.877 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -95.32 -45.84 6.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.86 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -123.99 -43.59 2.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.244 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 136.34 110.61 1.04 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.504 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 35.8 m -114.39 123.13 48.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.721 0.296 . . . . 0.0 110.942 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.414 ' CE2' ' HB2' ' A' ' 111' ' ' ARG . 6.2 m-85 -121.04 120.34 35.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.808 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.577 HG22 HD22 ' A' ' 112' ' ' LEU . 2.8 tp -102.75 137.24 31.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.493 0.663 . . . . 0.0 111.263 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.8 m120 61.65 30.55 18.6 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.79 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.67 11.32 72.84 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.849 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -134.01 150.58 51.24 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.782 0.325 . . . . 0.0 110.877 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.414 ' HB2' ' CE2' ' A' ' 106' ' ' PHE . 57.4 ttt-85 -74.97 137.89 41.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.902 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.577 HD22 HG22 ' A' ' 107' ' ' ILE . 0.5 OUTLIER -98.58 134.86 40.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.882 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 15.0 p -107.46 -37.27 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.186 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.1 tttp -61.39 151.52 32.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.874 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.14 30.91 3.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.888 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -169.76 60.25 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.783 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -73.25 136.46 44.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.746 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.668 HG12 HD21 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -98.83 116.71 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.817 -179.887 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.767 HD11 HD11 ' A' ' 125' ' ' ILE . 7.8 tt -101.41 145.87 28.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.977 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.511 ' HD3' HD11 ' A' ' 118' ' ' ILE . 8.4 mmmt -133.51 178.06 7.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.807 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.421 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 12.6 p30 -56.19 141.65 40.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.081 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.728 ' HA2' HD21 ' A' ' 134' ' ' LEU . . . 70.11 46.45 50.93 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.523 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ASP . . . . . 0.458 ' C ' HD12 ' A' ' 134' ' ' LEU . 7.6 m-20 -120.29 120.78 37.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.768 0.318 . . . . 0.0 110.945 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.566 ' N ' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -85.19 124.47 31.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.811 179.886 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.767 HD11 HD11 ' A' ' 119' ' ' LEU . 1.2 mp -121.49 135.16 62.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.111 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.683 HG22 ' HB3' ' A' ' 132' ' ' SER . 21.9 t -115.84 125.42 72.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.069 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.513 ' CE1' ' CZ ' ' A' ' 133' ' ' PHE . 67.4 m-85 -116.51 113.45 22.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.014 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 86.92 -8.63 75.35 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.918 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 6.0 tttm 78.82 28.54 0.41 Allowed 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.869 0.366 . . . . 0.0 110.477 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.37 -47.57 0.34 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.929 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 18.7 m -96.11 109.99 22.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.871 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.683 ' HB3' HG22 ' A' ' 126' ' ' VAL . 0.2 OUTLIER -122.07 126.63 48.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.946 -179.902 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.551 ' CE1' HD13 ' A' ' 37' ' ' LEU . 13.5 p90 -139.22 155.93 47.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.886 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.728 HD21 ' HA2' ' A' ' 122' ' ' GLY . 3.6 tp -105.35 136.21 45.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.97 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.577 ' HD2' HD21 ' A' ' 37' ' ' LEU . 24.7 t80 -96.53 141.54 29.69 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 121.971 0.891 . . . . 0.0 111.604 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 29.3 mttp -154.57 153.11 30.88 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 113.885 -1.507 . . . . 0.0 110.867 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.446 ' HE1' HD11 ' A' ' 95' ' ' ILE . 3.7 m-85 -79.26 139.68 37.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.94 0.4 . . . . 0.0 110.696 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.546 ' HB2' ' ND1' ' A' ' 36' ' ' HIS . . . . . . . . 0 C--N 1.324 -0.524 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.173 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.583 ' N ' HG22 ' A' ' 51' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.458 -0.07 0 CA-C-O 120.72 0.295 . . . . 0.0 110.573 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 2.0 t -59.95 127.57 32.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.971 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.542 ' O ' HD13 ' A' ' 34' ' ' LEU . 1.3 tm? -128.91 -44.1 1.33 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.713 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.704 ' C ' HG22 ' A' ' 50' ' ' ILE . . . -157.33 -165.21 14.74 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.43 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 52.9 m80 -146.18 163.9 33.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.87 0.367 . . . . 0.0 111.065 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.524 HD11 ' HB ' ' A' ' 50' ' ' ILE . 1.7 mp -126.81 119.97 28.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.644 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.4 t -96.12 121.92 47.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.209 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.429 ' HA ' ' CD1' ' A' ' 133' ' ' PHE . 4.3 m-20 -89.39 113.98 25.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.767 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.1 mt -88.59 106.51 18.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.996 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.55 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 1.7 mp -124.5 140.73 35.93 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.509 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.55 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 53.1 Cg_endo -72.24 80.86 1.54 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.003 1.802 . . . . 0.0 112.011 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 145.16 -14.47 1.89 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.686 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.4 tptm -178.34 164.28 1.71 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.806 0.336 . . . . 0.0 110.863 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -125.56 164.99 19.34 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.053 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -150.34 124.92 9.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.911 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.5 mtpt -102.41 134.66 45.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.879 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.7 t -121.71 150.18 24.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.112 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -94.93 132.4 39.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.808 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.743 HG21 ' HE2' ' A' ' 135' ' ' PHE . 5.0 tt -115.98 132.14 66.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.212 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.583 HG22 ' N ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -98.98 168.1 10.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.925 -179.832 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.414 ' O ' ' ND2' ' A' ' 52' ' ' ASN . 0.4 OUTLIER -102.72 74.97 1.38 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.444 179.419 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.594 ' C ' ' H ' ' A' ' 55' ' ' VAL . 0.7 OUTLIER -99.04 23.19 9.31 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.526 -179.601 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.552 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 1.6 m-20 67.53 -28.91 0.14 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.487 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.594 ' H ' ' C ' ' A' ' 53' ' ' ARG . 60.2 t -137.76 136.56 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 CA-C-O 120.964 0.412 . . . . 0.0 111.749 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.748 HG23 ' CB ' ' A' ' 65' ' ' ASP . 99.5 m -125.51 129.9 50.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.062 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.455 ' O ' ' N ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -104.0 138.82 39.99 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.954 0.407 . . . . 0.0 111.529 -179.448 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.612 HG22 HD11 ' A' ' 68' ' ' LEU . 4.6 mp -132.52 135.19 58.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.093 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 157.12 -137.36 5.36 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.305 -0.95 . . . . 0.0 113.227 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.473 ' HB2' ' CG2' ' A' ' 73' ' ' ILE . 21.3 ttp180 -94.89 -49.24 5.66 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.753 0.311 . . . . 0.0 111.22 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.494 ' OG ' HG23 ' A' ' 75' ' ' THR . 0.0 OUTLIER -43.71 117.02 1.06 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.497 -179.373 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.1 mtt85 -57.37 -23.3 48.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.015 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.78 -24.19 63.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.76 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 96.4 m -57.42 168.25 0.83 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.824 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.748 ' CB ' HG23 ' A' ' 56' ' ' THR . 0.5 OUTLIER -69.85 -56.62 6.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.952 0.406 . . . . 0.0 110.778 179.827 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 58' ' ' ILE . 21.3 t -125.2 132.95 70.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.594 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 7.9 pt -102.8 128.05 55.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.816 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.81 HD23 ' CE2' ' A' ' 133' ' ' PHE . 0.5 OUTLIER -89.19 -71.35 0.6 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.781 -179.769 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.448 ' HB3' ' HB ' ' A' ' 73' ' ' ILE . 12.8 t -121.3 -111.67 0.33 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.076 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.442 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . 9.7 tt0 170.63 -64.15 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.264 0 O-C-N 122.298 -0.251 . . . . 0.0 111.575 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.442 ' CD ' ' HB3' ' A' ' 70' ' ' GLU . 25.2 Cg_endo -62.0 -40.05 46.05 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.35 2.033 . . . . 0.0 113.28 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -122.49 28.87 7.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.569 0.223 . . . . 0.0 111.503 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.532 HD11 HD13 ' A' ' 68' ' ' LEU . 4.4 tp -110.8 125.94 68.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.971 0.415 . . . . 0.0 111.116 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -59.48 134.01 56.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.484 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.494 HG23 ' OG ' ' A' ' 61' ' ' SER . 36.2 m -65.91 -44.21 85.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.856 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.448 ' O ' ' C ' ' A' ' 77' ' ' HIS . 2.1 m-85 -100.27 13.73 33.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.27 0.557 . . . . 0.0 111.153 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.461 ' CE1' ' HB3' ' A' ' 127' ' ' PHE . 0.4 OUTLIER -15.51 -71.39 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.403 -1.271 . . . . 0.0 113.175 -179.338 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.405 ' HB2' ' HE1' ' A' ' 127' ' ' PHE . . . -153.75 164.08 38.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.225 0.536 . . . . 0.0 112.293 -179.234 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -132.5 132.64 42.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.962 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.642 ' CE2' HG22 ' A' ' 97' ' ' VAL . 3.9 m-85 -119.39 131.08 55.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.781 0.324 . . . . 0.0 110.96 -179.446 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.552 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 24.8 m-70 -95.89 116.81 29.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.245 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.2 mp -106.3 109.37 21.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.669 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -122.58 140.19 53.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.032 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -104.21 120.95 42.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.754 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -119.68 142.62 48.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.0 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -107.13 124.89 50.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.902 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.437 HG21 ' HE ' ' A' ' 92' ' ' ARG . 4.0 m -121.88 132.48 70.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.149 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 68.45 -65.58 0.26 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.059 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 179.82 39.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.818 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -145.94 -177.29 5.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.695 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 4.8 pm0 -117.29 129.12 55.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.999 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.437 ' HE ' HG21 ' A' ' 87' ' ' VAL . 9.4 mtm180 -116.32 150.21 38.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.85 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 38.4 m-20 -114.03 123.67 50.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.944 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.8 mp -130.05 123.84 31.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.825 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.414 ' N ' HD12 ' A' ' 95' ' ' ILE . 4.3 mp -116.25 141.07 35.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.057 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -114.03 144.06 43.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.862 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.642 HG22 ' CE2' ' A' ' 80' ' ' PHE . 18.1 t -115.36 126.09 72.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.23 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.3 mp -127.99 135.57 62.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.071 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -107.55 120.23 41.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.822 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.45 32.38 2.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.006 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 21.8 m -126.85 178.78 5.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.898 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.1 ptp85 -127.55 39.13 3.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.922 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -106.67 -60.62 1.64 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.228 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 145.06 103.36 0.4 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.539 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.464 ' CG2' ' CE1' ' A' ' 127' ' ' PHE . 85.5 m -117.95 124.92 49.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.861 0.362 . . . . 0.0 110.979 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' A' ' 106' ' ' PHE . 5.0 m-85 -121.03 123.71 43.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.829 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.604 ' CD1' HD13 ' A' ' 125' ' ' ILE . 3.0 tp -109.95 137.29 42.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.464 0.649 . . . . 0.0 111.391 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.0 m120 60.66 29.59 19.12 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.817 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.63 11.38 72.75 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.834 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -134.02 152.06 51.69 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.759 0.314 . . . . 0.0 110.877 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -63.53 142.96 58.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.964 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.407 HD23 ' N ' ' A' ' 113' ' ' VAL . 0.7 OUTLIER -83.95 133.11 34.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.769 -179.991 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.45 HG13 ' N ' ' A' ' 114' ' ' LYS . 11.8 p -120.62 -42.8 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.149 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.45 ' N ' HG13 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -71.92 147.46 47.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.794 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.89 -37.38 48.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.795 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -111.36 77.79 1.07 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.862 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -80.05 135.95 36.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.867 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.493 ' O ' HG23 ' A' ' 118' ' ' ILE . 8.7 tp -98.73 122.28 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.289 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.743 ' CD1' HD11 ' A' ' 125' ' ' ILE . 4.8 tt -103.06 132.78 49.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.879 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.78 178.07 5.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.838 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.417 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 8.2 p30 -60.41 138.55 57.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.07 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 74.76 56.0 5.14 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.595 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -130.96 132.91 45.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.794 0.33 . . . . 0.0 110.981 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.15 132.68 34.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.877 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.743 HD11 ' CD1' ' A' ' 119' ' ' LEU . 21.1 mm -117.64 121.77 68.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.166 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.421 HG22 ' OG ' ' A' ' 132' ' ' SER . 59.0 t -115.13 128.35 72.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.66 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.464 ' CE1' ' CG2' ' A' ' 105' ' ' THR . 15.1 m-85 -132.08 111.88 11.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.923 0.392 . . . . 0.0 111.659 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.495 ' O ' ' HB2' ' A' ' 129' ' ' LYS . . . 108.91 -81.9 0.29 Allowed Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.206 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.495 ' HB2' ' O ' ' A' ' 128' ' ' GLY . 14.1 tttp 172.22 37.03 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.887 0.375 . . . . 0.0 110.664 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 24.9 p 178.83 -48.82 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.95 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' CYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 77.6 m -56.7 104.7 0.16 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.887 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.421 ' OG ' HG22 ' A' ' 126' ' ' VAL . 0.3 OUTLIER -124.3 111.94 16.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.149 -179.766 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.81 ' CE2' HD23 ' A' ' 68' ' ' LEU . 3.0 m-85 -120.45 156.07 32.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.864 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.41 HD23 ' N ' ' A' ' 135' ' ' PHE . 6.0 tt -111.74 140.1 46.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.944 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.743 ' HE2' HG21 ' A' ' 50' ' ' ILE . 18.9 t80 -116.33 141.76 47.73 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.885 0.85 . . . . 0.0 111.733 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -154.44 159.74 41.23 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.06 -1.427 . . . . 0.0 111.022 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.417 ' CE2' ' HB3' ' A' ' 121' ' ' ASN . 3.3 m-85 -84.25 140.25 31.8 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.057 0.456 . . . . 0.0 110.741 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.537 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.165 179.968 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.428 ' N ' HG22 ' A' ' 51' ' ' THR . 0.8 OUTLIER . . . . . 0 N--CA 1.46 0.027 0 CA-C-O 120.801 0.334 . . . . 0.0 110.731 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 2.1 t -67.01 143.89 56.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.942 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.709 HD22 HD11 ' A' ' 82' ' ' LEU . 1.5 tp -156.21 -67.65 0.11 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.902 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.403 ' HA3' ' CE1' ' A' ' 135' ' ' PHE . . . -114.13 167.09 12.23 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.446 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.42 ' CE1' ' HB3' ' A' ' 138' ' ' ALA . 33.4 m80 -136.19 160.67 37.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.907 0.384 . . . . 0.0 111.017 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.815 ' CD1' HD11 ' A' ' 50' ' ' ILE . 97.8 mt -127.23 117.96 23.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.709 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.4 t -101.8 121.59 52.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.205 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -90.26 136.97 32.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.891 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.8 mt -108.36 106.56 16.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.974 0.416 . . . . 0.0 110.848 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.548 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 4.1 mt -124.4 141.25 37.09 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.857 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.548 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 56.9 Cg_endo -73.36 81.46 1.77 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.172 1.915 . . . . 0.0 112.041 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 148.93 -18.78 1.23 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.403 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 11.9 ttmm -177.65 165.0 2.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.709 0.29 . . . . 0.0 110.655 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -122.11 149.76 43.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.028 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -121.43 134.05 55.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.74 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.95 124.88 53.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.137 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.547 HG11 HG13 ' A' ' 66' ' ' VAL . 31.6 t -120.15 150.52 22.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.998 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.419 ' HG3' ' CD2' ' A' ' 36' ' ' HIS . 0.0 OUTLIER -103.01 142.07 34.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.037 -179.867 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.815 HD11 ' CD1' ' A' ' 37' ' ' LEU . 33.1 mm -115.38 122.68 69.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.839 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.428 HG22 ' N ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -99.87 168.16 10.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.144 -179.885 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -100.11 73.87 1.74 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.593 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.577 ' C ' ' H ' ' A' ' 55' ' ' VAL . 4.0 ptp180 -107.05 22.04 16.61 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.437 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.505 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 30.6 m-80 67.1 -27.9 0.13 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.659 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.577 ' H ' ' C ' ' A' ' 53' ' ' ARG . 61.6 t -137.72 137.67 45.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 CA-C-O 121.006 0.431 . . . . 0.0 111.96 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.49 HG22 ' CB ' ' A' ' 65' ' ' ASP . 0.4 OUTLIER -125.36 128.28 47.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.72 178.911 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.464 ' O ' ' N ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -104.06 136.22 44.11 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.976 0.417 . . . . 0.0 111.488 -179.463 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.561 HD11 ' HD2' ' A' ' 80' ' ' PHE . 4.4 mp -132.2 127.17 57.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.974 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 164.08 -142.13 7.59 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.074 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.529 ' HB2' HG23 ' A' ' 73' ' ' ILE . 14.3 ttp180 -88.65 -43.19 11.51 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.811 0.339 . . . . 0.0 111.027 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.757 ' HB2' HG23 ' A' ' 75' ' ' THR . 0.4 OUTLIER -45.93 115.09 0.89 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.461 -179.527 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.04 -27.41 61.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.942 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.2 m -70.03 -24.71 63.32 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.814 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' CYS . . . . . 0.417 ' CB ' ' HB ' ' A' ' 57' ' ' THR . 98.7 m -53.08 167.93 0.15 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.76 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.49 ' CB ' HG22 ' A' ' 56' ' ' THR . 0.6 OUTLIER -69.5 -53.88 16.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.922 0.391 . . . . 0.0 111.038 179.943 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.609 HG21 HD12 ' A' ' 37' ' ' LEU . 22.1 t -125.05 125.69 69.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.517 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.3 pt -99.65 131.06 47.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.504 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.627 HD23 ' HB2' ' A' ' 131' ' ' CYS . 8.4 mp -100.89 -100.33 0.25 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.344 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.2 p -92.14 -103.9 0.11 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 121.224 -0.19 . . . . 0.0 110.724 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.554 ' HA ' HG22 ' A' ' 73' ' ' ILE . 3.0 mt-10 167.17 -64.78 0.0 OUTLIER Pre-proline 0 CA--C 1.529 0.136 0 CA-C-O 120.68 0.276 . . . . 0.0 111.145 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.448 ' CD ' ' CB ' ' A' ' 70' ' ' GLU . 28.9 Cg_endo -62.89 -37.49 54.26 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.359 2.039 . . . . 0.0 112.56 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -112.04 17.06 19.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.276 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.554 HG22 ' HA ' ' A' ' 70' ' ' GLU . 4.5 tp -108.79 127.48 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 CA-C-O 120.925 0.393 . . . . 0.0 111.093 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.42 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 0.9 OUTLIER -83.79 133.67 34.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.367 -179.578 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.757 HG23 ' HB2' ' A' ' 61' ' ' SER . 57.3 m -57.94 -30.74 66.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.078 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.414 ' O ' ' C ' ' A' ' 77' ' ' HIS . 39.6 m-85 -110.27 13.97 22.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.237 0.541 . . . . 0.0 111.536 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.444 ' CE1' ' HB3' ' A' ' 127' ' ' PHE . 0.1 OUTLIER -25.94 -64.75 0.06 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.779 -1.1 . . . . 0.0 112.702 -179.277 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.45 ' HB3' ' CZ ' ' A' ' 127' ' ' PHE . . . -157.66 163.98 37.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.116 0.484 . . . . 0.0 112.027 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.48 ' HA ' ' O ' ' A' ' 56' ' ' THR . 0.8 OUTLIER -134.81 141.4 46.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.319 179.405 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.561 ' HD2' HD11 ' A' ' 58' ' ' ILE . 47.0 m-85 -119.44 131.51 55.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.942 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.505 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 4.1 m-70 -94.63 116.53 28.87 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.832 0.349 . . . . 0.0 110.756 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.709 HD11 HD22 ' A' ' 34' ' ' LEU . 0.1 OUTLIER -106.28 109.89 21.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.03 -179.89 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.07 133.86 55.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.705 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -101.69 128.82 47.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.917 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.7 ttt -141.45 111.97 7.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.864 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -79.03 116.02 19.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.953 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.5 t -140.0 114.3 6.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.072 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 60.83 -165.83 0.21 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.79 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -48.92 132.4 18.49 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.281 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 61.11 155.04 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.904 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -85.98 139.78 30.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.953 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 80.1 mtt180 -109.92 122.64 48.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.865 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -113.04 146.73 38.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.84 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.2 mt -128.81 140.04 51.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.927 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.482 HG13 HD22 ' A' ' 82' ' ' LEU . 4.1 mp -120.97 138.48 51.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.06 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -113.94 143.31 44.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.021 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.558 HG22 ' HE1' ' A' ' 80' ' ' PHE . 3.9 t -104.41 135.08 43.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.173 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 22.6 mt -129.86 146.33 34.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.18 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.559 ' OD1' HD22 ' A' ' 112' ' ' LEU . 2.9 p-10 -119.74 123.49 43.88 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.902 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.67 -41.7 1.98 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.119 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.2 m -71.56 157.76 37.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.065 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.43 29.01 8.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.844 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -86.97 -42.2 13.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.227 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 136.48 100.58 0.58 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.671 -0.775 . . . . 0.0 112.595 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.53 HG23 ' CD1' ' A' ' 127' ' ' PHE . 93.7 m -109.4 123.37 49.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.8 0.333 . . . . 0.0 110.735 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.425 ' CE1' ' HB3' ' A' ' 111' ' ' ARG . 47.2 m-85 -120.87 115.06 22.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.932 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.403 ' CD1' HG13 ' A' ' 125' ' ' ILE . 2.6 tp -118.31 137.26 52.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.428 0.632 . . . . 0.0 111.196 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.7 m120 61.77 32.2 18.26 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.798 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.76 10.9 72.78 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.859 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -134.05 151.96 51.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.743 0.306 . . . . 0.0 110.851 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.425 ' HB3' ' CE1' ' A' ' 106' ' ' PHE . 6.6 ptm180 -70.95 139.05 50.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.894 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.559 HD22 ' OD1' ' A' ' 99' ' ' ASP . 0.8 OUTLIER -85.49 129.3 34.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.88 -179.933 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.489 HG13 ' N ' ' A' ' 114' ' ' LYS . 12.2 p -125.58 -44.65 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.11 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.489 ' N ' HG13 ' A' ' 113' ' ' VAL . 2.6 mmmp? -66.23 172.83 3.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.908 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -119.03 31.38 6.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.931 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -162.23 57.86 0.24 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.801 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.98 139.09 38.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.84 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.546 ' O ' HG23 ' A' ' 118' ' ' ILE . 7.8 tp -98.59 117.31 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-O 121.004 0.43 . . . . 0.0 111.228 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.444 HD22 ' HB ' ' A' ' 95' ' ' ILE . 7.6 tt -103.07 131.23 50.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.057 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.26 178.03 6.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.781 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.451 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 5.0 p-10 -57.72 141.29 49.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.966 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.782 ' HA2' HD21 ' A' ' 134' ' ' LEU . . . 74.86 47.66 13.77 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.311 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -123.46 131.34 53.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.795 0.331 . . . . 0.0 111.081 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.74 122.6 41.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.65 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.54 HG21 ' HZ ' ' A' ' 80' ' ' PHE . 1.7 mp -114.97 133.56 60.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.314 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.632 HG22 ' HB3' ' A' ' 132' ' ' SER . 21.2 t -124.02 123.81 67.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.968 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.53 ' CD1' HG23 ' A' ' 105' ' ' THR . 23.5 m-85 -116.27 111.92 20.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.85 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLY . . . . . 0.402 ' O ' ' CB ' ' A' ' 129' ' ' LYS . . . 88.61 -15.31 57.45 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.88 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LYS . . . . . 0.402 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 10.9 tttt 79.32 30.65 0.3 Allowed 'General case' 0 CA--C 1.522 -0.109 0 CA-C-O 121.002 0.43 . . . . 0.0 110.378 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 15.3 p -128.22 -50.07 1.31 Allowed 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.99 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' CYS . . . . . 0.627 ' HB2' HD23 ' A' ' 68' ' ' LEU . 7.0 m -109.59 112.58 24.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.977 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.632 ' HB3' HG22 ' A' ' 126' ' ' VAL . 0.7 OUTLIER -116.8 131.06 57.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.931 179.95 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.409 ' CD1' HD22 ' A' ' 37' ' ' LEU . 6.0 p90 -141.25 156.04 45.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.074 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.782 HD21 ' HA2' ' A' ' 122' ' ' GLY . 7.7 tt -107.74 140.05 41.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.8 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.431 ' CD2' HD21 ' A' ' 119' ' ' LEU . 87.7 t80 -101.57 141.56 34.25 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 122.002 0.906 . . . . 0.0 111.933 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt -154.37 145.87 23.13 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 113.748 -1.569 . . . . 0.0 110.707 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.451 ' CE2' ' HB3' ' A' ' 121' ' ' ASN . 4.4 m-85 -73.62 139.75 45.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.992 0.425 . . . . 0.0 110.736 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.42 ' HB3' ' CE1' ' A' ' 36' ' ' HIS . . . . . . . . 0 C--N 1.325 -0.482 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.045 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.1 m . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.719 0.295 . . . . 0.0 110.725 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 44.9 t -59.92 137.23 58.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.882 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.751 HD13 HD23 ' A' ' 82' ' ' LEU . 8.4 tt -130.21 -44.98 1.13 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.971 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.622 ' C ' HG22 ' A' ' 50' ' ' ILE . . . -157.67 -167.89 19.3 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.567 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.535 ' ND1' ' HB2' ' A' ' 138' ' ' ALA . 54.2 m80 -147.0 164.06 34.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.841 0.353 . . . . 0.0 110.911 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.574 HD11 ' HB ' ' A' ' 50' ' ' ILE . 2.4 mp -127.03 108.0 10.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.809 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.5 t -97.96 121.96 49.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.163 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -90.06 117.06 28.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.785 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.4 mt -81.14 106.53 13.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.831 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.54 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 4.8 mt -124.25 140.83 35.85 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.917 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.54 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 58.0 Cg_endo -74.43 81.82 1.99 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.161 1.908 . . . . 0.0 111.867 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 145.02 -14.19 1.92 Allowed Glycine 0 CA--C 1.52 0.382 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.483 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -179.0 173.8 1.14 Allowed 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 120.774 0.321 . . . . 0.0 110.604 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -132.75 156.32 47.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.098 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -135.37 112.17 10.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.804 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.63 132.29 51.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.02 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.1 t -121.09 151.1 24.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.014 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -94.87 131.41 40.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.807 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.689 HG21 ' HE2' ' A' ' 135' ' ' PHE . 1.6 tt -116.05 124.67 72.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.248 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.515 ' O ' HD22 ' A' ' 82' ' ' LEU . 0.2 OUTLIER -100.93 168.14 9.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.959 -179.765 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -80.32 66.36 5.8 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.173 0.511 . . . . 0.0 110.313 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.555 ' C ' ' H ' ' A' ' 55' ' ' VAL . 8.8 ttt85 -79.48 1.55 25.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.796 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.4 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 1.2 t-20 72.12 -36.55 0.36 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -178.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.555 ' H ' ' C ' ' A' ' 53' ' ' ARG . 66.5 t -137.36 132.75 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.781 179.282 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.743 HG23 ' HB3' ' A' ' 65' ' ' ASP . 21.7 m -125.22 124.32 41.46 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.917 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.65 132.37 49.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.876 0.369 . . . . 0.0 110.777 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.436 HD12 ' CZ ' ' A' ' 127' ' ' PHE . 34.6 mt -115.19 120.37 64.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.286 -179.641 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 170.71 -134.09 3.01 Favored Glycine 0 C--N 1.331 0.259 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.235 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.61 ' HB3' ' HA ' ' A' ' 70' ' ' GLU . 0.2 OUTLIER -118.76 -21.96 7.61 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.585 0.231 . . . . 0.0 111.305 179.806 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.454 ' HB2' HG23 ' A' ' 75' ' ' THR . 0.2 OUTLIER -52.01 126.48 18.54 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.864 0.364 . . . . 0.0 110.96 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.4 mmm180 -55.05 -26.25 36.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.104 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.0 m -77.3 -22.68 51.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.12 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 98.5 m -54.71 162.26 1.26 Allowed 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.151 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.743 ' HB3' HG23 ' A' ' 56' ' ' THR . 12.9 t0 -83.69 -49.0 9.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.128 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 58' ' ' ILE . 26.7 t -123.77 116.85 49.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.371 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 16.5 pt -100.76 127.8 53.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.975 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.514 HD12 ' HB3' ' A' ' 131' ' ' CYS . 3.8 mm? -98.18 -92.21 0.25 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.697 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.411 ' O ' ' CB ' ' A' ' 70' ' ' GLU . 48.0 m -87.58 -108.01 0.07 Allowed 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.332 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.61 ' HA ' ' HB3' ' A' ' 60' ' ' ARG . 1.0 OUTLIER 167.48 -64.51 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.275 0 N-CA-C 111.644 0.238 . . . . 0.0 111.644 178.871 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.593 ' HD3' ' HB3' ' A' ' 70' ' ' GLU . 15.9 Cg_exo -67.61 -40.28 10.47 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.123 1.882 . . . . 0.0 112.998 -179.433 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -109.22 21.29 17.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.303 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.471 ' CG2' ' HB3' ' A' ' 60' ' ' ARG . 4.8 tp -112.26 120.62 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-O 120.905 0.384 . . . . 0.0 110.817 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.451 ' HB2' ' CG ' ' A' ' 77' ' ' HIS . 0.5 OUTLIER -57.92 131.48 50.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.075 -179.527 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.454 HG23 ' HB2' ' A' ' 61' ' ' SER . 91.5 m -59.12 -44.01 91.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.688 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.473 ' O ' ' C ' ' A' ' 77' ' ' HIS . 1.6 m-85 -105.62 13.75 29.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.184 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.473 ' C ' ' O ' ' A' ' 76' ' ' PHE . 0.2 OUTLIER -15.0 -70.18 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.618 -1.174 . . . . 0.0 112.763 -179.479 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -151.21 153.3 34.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.065 0.459 . . . . 0.0 111.937 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -117.21 133.8 55.56 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.255 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.755 ' CE2' HG22 ' A' ' 97' ' ' VAL . 8.2 m-85 -119.45 131.11 55.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.142 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.4 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 17.7 m-70 -94.88 116.67 29.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.857 0.361 . . . . 0.0 111.107 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.751 HD23 HD13 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -106.34 109.62 21.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.69 179.737 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.6 tt -122.19 139.38 53.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.125 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -129.1 131.89 47.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.724 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.15 148.48 40.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.078 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -107.09 125.76 51.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.779 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.5 t -139.96 126.33 22.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.158 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 58.82 42.21 20.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.987 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 62.04 29.11 17.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.949 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -139.45 130.91 27.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.814 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 20.8 mm100 -85.58 132.26 34.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.971 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -111.7 124.65 52.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.794 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -103.81 122.56 45.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.021 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.8 mt -132.08 122.96 26.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.727 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.607 HD12 ' HG ' ' A' ' 82' ' ' LEU . 7.2 mm -113.16 137.25 46.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.02 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -114.01 135.35 54.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.821 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.755 HG22 ' CE2' ' A' ' 80' ' ' PHE . 18.7 t -112.82 128.55 69.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.195 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 7.5 mt -129.64 120.97 51.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.004 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -102.32 134.01 46.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.937 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.6 pttp -149.73 32.17 0.7 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.835 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.8 m -119.94 -178.0 3.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.01 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.35 38.1 2.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.876 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -105.53 -38.32 6.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.278 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 131.95 98.5 0.73 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.521 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 71.0 m -117.54 124.13 47.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.846 0.355 . . . . 0.0 110.835 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -120.98 121.79 38.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.956 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.45 HD13 ' CG1' ' A' ' 125' ' ' ILE . 3.2 tp -120.57 137.1 55.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.414 0.626 . . . . 0.0 111.282 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 56.56 31.45 19.08 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.892 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.69 13.05 74.73 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.875 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 24.7 p30 -134.08 150.34 51.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.785 0.326 . . . . 0.0 110.912 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 3.7 ttm180 -62.83 141.82 58.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.983 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.413 HD23 ' N ' ' A' ' 113' ' ' VAL . 1.1 tt -100.06 125.7 46.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.831 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.572 ' O ' HG22 ' A' ' 113' ' ' VAL . 12.0 p -149.94 49.62 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.128 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.46 -177.47 3.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.827 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.3 mtpt -111.56 -33.75 6.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.908 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -137.59 76.8 1.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.97 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -84.0 136.38 34.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.768 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.519 ' O ' HG23 ' A' ' 118' ' ' ILE . 8.8 tp -98.64 118.95 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.261 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.479 ' C ' HD23 ' A' ' 119' ' ' LEU . 7.4 tt -103.09 145.59 29.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.928 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 13.6 mttt -132.1 178.06 7.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.84 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.404 ' HB3' ' CD2' ' A' ' 137' ' ' TYR . 15.5 p30 -58.25 138.81 56.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.0 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.439 ' HA2' HD21 ' A' ' 134' ' ' LEU . . . 78.13 58.04 3.28 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.523 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -134.22 126.57 30.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.798 0.332 . . . . 0.0 110.889 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.425 ' N ' HD12 ' A' ' 134' ' ' LEU . 7.9 ttm180 -93.3 127.64 38.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.846 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.45 ' CG1' HD13 ' A' ' 107' ' ' ILE . 1.7 mp -121.67 134.23 65.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.188 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.582 HG22 ' HB3' ' A' ' 132' ' ' SER . 21.7 t -124.12 123.92 67.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.946 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.443 ' HB3' ' CE1' ' A' ' 77' ' ' HIS . 79.7 m-85 -113.98 111.89 22.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.002 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 84.04 -10.27 61.05 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.846 -0.692 . . . . 0.0 113.057 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 77.28 30.02 0.54 Allowed 'General case' 0 CA--C 1.522 -0.133 0 CA-C-O 120.985 0.421 . . . . 0.0 110.273 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 26.9 p -125.84 -44.06 1.81 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.99 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' CYS . . . . . 0.514 ' HB3' HD12 ' A' ' 68' ' ' LEU . 1.8 m -118.6 116.92 27.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.032 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.582 ' HB3' HG22 ' A' ' 126' ' ' VAL . 77.2 p -124.06 130.66 52.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.795 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.529 ' CE2' HD23 ' A' ' 37' ' ' LEU . 8.8 p90 -141.98 156.01 45.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.023 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.439 HD21 ' HA2' ' A' ' 122' ' ' GLY . 2.2 tp -105.79 130.88 53.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.785 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.689 ' HE2' HG21 ' A' ' 50' ' ' ILE . 26.9 t80 -94.31 141.44 28.57 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.886 0.85 . . . . 0.0 111.729 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.3 tttp -154.7 149.85 26.99 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 113.938 -1.483 . . . . 0.0 111.041 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.404 ' CD2' ' HB3' ' A' ' 121' ' ' ASN . 5.6 m-85 -76.25 140.09 41.43 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.987 0.422 . . . . 0.0 110.645 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.535 ' HB2' ' ND1' ' A' ' 36' ' ' HIS . . . . . . . . 0 C--N 1.324 -0.519 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.043 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.833 0.349 . . . . 0.0 110.435 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 51.3 t -59.83 145.19 46.41 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.367 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.6 tp -150.72 -44.22 0.12 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.665 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.743 ' C ' HG22 ' A' ' 50' ' ' ILE . . . -153.03 -175.57 24.61 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.041 -0.599 . . . . 0.0 112.127 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.41 ' CE1' ' HG3' ' A' ' 49' ' ' GLU . 40.4 m80 -147.01 166.06 27.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.012 0.434 . . . . 0.0 111.221 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.418 ' N ' HD12 ' A' ' 37' ' ' LEU . 4.7 mp -127.07 136.01 51.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.59 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.409 HG22 ' HE3' ' A' ' 47' ' ' LYS . 1.7 t -101.66 123.61 54.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.125 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -90.15 120.91 31.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.779 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.3 mt -97.86 107.73 20.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.965 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.421 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 3.3 mp -116.82 138.77 24.93 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.757 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.421 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 91.5 Cg_exo -44.42 -27.67 2.21 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.623 2.215 . . . . 0.0 112.708 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -149.22 45.32 0.7 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.601 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 20.8 tptt -179.86 164.15 1.17 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.792 0.329 . . . . 0.0 111.01 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -146.92 134.39 20.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.634 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -129.62 145.51 51.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.157 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.409 ' HE3' HG22 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -113.0 133.24 55.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.739 179.794 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.1 t -121.97 149.25 25.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.941 0.4 . . . . 0.0 111.237 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.41 ' HG3' ' CE1' ' A' ' 36' ' ' HIS . 48.6 tt0 -107.97 128.53 54.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.655 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.743 HG22 ' C ' ' A' ' 35' ' ' GLY . 1.2 tt -105.92 132.03 53.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.264 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.648 ' O ' HD23 ' A' ' 82' ' ' LEU . 0.8 OUTLIER -98.55 168.42 10.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.044 -179.707 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -86.09 62.94 7.75 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.198 0.523 . . . . 0.0 110.17 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.578 ' C ' ' H ' ' A' ' 55' ' ' VAL . 23.5 ttt-85 -82.83 1.78 37.44 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.005 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 71.93 -33.62 0.27 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -178.677 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.578 ' H ' ' C ' ' A' ' 53' ' ' ARG . 74.0 t -136.79 141.33 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.428 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.592 HG23 ' HB3' ' A' ' 65' ' ' ASP . 51.0 m -125.18 126.79 45.79 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.336 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.79 139.1 39.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.823 0.344 . . . . 0.0 110.517 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.571 ' CG2' HD11 ' A' ' 68' ' ' LEU . 4.5 mp -130.8 132.66 63.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.063 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 164.89 -151.9 21.16 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.472 -0.871 . . . . 0.0 113.09 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.422 ' HB2' ' CG2' ' A' ' 73' ' ' ILE . 14.7 ttp180 -86.2 -45.43 11.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.76 0.314 . . . . 0.0 111.25 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.833 ' HB3' HG23 ' A' ' 75' ' ' THR . 11.5 p -52.05 128.72 25.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.358 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.98 -16.49 61.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.141 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.72 -26.62 64.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.817 0.342 . . . . 0.0 110.708 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 83.1 m -59.85 156.32 14.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.627 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.592 ' HB3' HG23 ' A' ' 56' ' ' THR . 7.4 t70 -62.07 -46.3 89.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.913 0.387 . . . . 0.0 110.495 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.9 t -125.18 132.98 70.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.316 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.4 mt -104.35 115.2 45.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.025 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.793 HD12 HD11 ' A' ' 73' ' ' ILE . 14.5 mt -87.22 -134.92 0.08 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.517 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.444 ' O ' ' CB ' ' A' ' 70' ' ' GLU . 17.4 m -57.04 -105.99 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 O-C-N 122.404 -0.185 . . . . 0.0 110.941 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.444 ' CB ' ' O ' ' A' ' 69' ' ' SER . 2.9 mt-10 163.72 -62.64 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.264 0 CA-C-O 120.597 0.236 . . . . 0.0 111.398 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 70' ' ' GLU . 19.7 Cg_endo -58.93 -39.98 75.96 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.661 2.24 . . . . 0.0 113.009 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -118.55 27.12 9.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.682 0.277 . . . . 0.0 111.538 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.793 HD11 HD12 ' A' ' 68' ' ' LEU . 4.8 tp -109.7 127.65 66.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.96 0.409 . . . . 0.0 111.606 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.17 134.17 45.55 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.045 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.833 HG23 ' HB3' ' A' ' 61' ' ' SER . 87.6 m -50.73 -44.06 58.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.271 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.494 ' O ' ' C ' ' A' ' 77' ' ' HIS . 12.1 p90 -106.69 13.86 27.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.081 0.467 . . . . 0.0 111.677 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.494 ' C ' ' O ' ' A' ' 76' ' ' PHE . 4.2 t60 -6.38 -69.09 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.671 -1.15 . . . . 0.0 112.979 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -152.81 164.05 38.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.951 0.405 . . . . 0.0 111.632 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -130.09 128.97 42.95 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.864 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.914 ' CZ ' HG13 ' A' ' 97' ' ' VAL . 5.6 m-85 -119.44 131.15 55.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.719 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -94.72 116.34 28.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.964 0.412 . . . . 0.0 111.266 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.712 HD22 HG12 ' A' ' 50' ' ' ILE . 22.3 tp -106.74 109.73 21.71 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.849 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.22 140.09 53.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.012 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.4 tm0? -106.03 137.18 44.39 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.759 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 7.6 mtt -107.03 136.76 46.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.841 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -97.87 116.48 30.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.035 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 17.5 t -139.97 139.15 37.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.943 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -48.36 -51.61 25.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.188 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -53.66 -65.74 0.51 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.163 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -162.67 163.11 27.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.826 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.0 128.0 34.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.913 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.3 mmm180 -108.1 129.69 55.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.82 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 42.3 m-20 -114.07 120.0 39.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.01 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.2 mt -115.55 130.1 56.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.752 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.652 HG13 HD12 ' A' ' 82' ' ' LEU . 3.7 mp -114.66 136.04 52.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.275 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -114.28 138.76 50.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.731 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.914 HG13 ' CZ ' ' A' ' 80' ' ' PHE . 17.4 t -101.02 134.95 39.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.274 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 32.4 mt -129.3 134.96 62.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.071 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.421 ' HB3' HD11 ' A' ' 112' ' ' LEU . 20.6 p-10 -105.55 118.86 37.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.849 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.3 mtpp -133.17 31.11 3.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.922 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.2 m -144.03 174.67 10.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.881 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.94 30.44 4.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.894 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -85.32 -34.46 21.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.142 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 120.94 88.79 1.04 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.527 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.555 HG23 ' CD1' ' A' ' 127' ' ' PHE . 75.6 m -107.12 126.98 53.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.903 0.382 . . . . 0.0 110.946 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -120.93 117.85 28.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.904 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.42 HD13 HG12 ' A' ' 125' ' ' ILE . 2.6 tp -113.01 137.23 46.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.449 0.643 . . . . 0.0 111.297 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 62.94 27.69 16.05 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.933 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.74 12.77 74.66 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.811 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -134.02 152.05 51.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.82 0.343 . . . . 0.0 110.903 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.0 ttp180 -73.61 129.79 38.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.85 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.421 HD11 ' HB3' ' A' ' 99' ' ' ASP . 3.6 pp -88.52 144.82 26.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.993 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 14.2 m -143.46 32.21 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.112 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -147.43 149.39 32.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.881 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.6 mtmm -98.63 34.84 1.94 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.942 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -152.76 50.27 0.74 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.972 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -83.89 136.63 34.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.843 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.542 ' O ' HG23 ' A' ' 118' ' ' ILE . 8.9 tp -98.56 117.27 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-O 120.983 0.42 . . . . 0.0 111.216 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.75 HD11 HD11 ' A' ' 125' ' ' ILE . 10.0 tt -103.16 135.52 44.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.024 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 35.7 mttt -131.99 178.03 7.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.765 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.431 ' HB3' ' CD2' ' A' ' 137' ' ' TYR . 9.9 p-10 -62.15 142.86 57.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.871 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.484 ' HA2' HD21 ' A' ' 134' ' ' LEU . . . 72.67 42.41 47.15 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.5 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -118.08 127.3 53.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.8 0.333 . . . . 0.0 110.932 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.57 118.5 23.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.837 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.75 HD11 HD11 ' A' ' 119' ' ' LEU . 2.9 mt -114.93 122.68 69.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.206 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 24.7 t -118.48 128.22 75.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.96 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.555 ' CD1' HG23 ' A' ' 105' ' ' THR . 49.1 m-85 -111.4 137.16 49.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.963 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 74.48 -65.85 2.03 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.351 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 174.94 -50.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.812 0.339 . . . . 0.0 110.95 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.2 p -91.33 -42.74 10.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.253 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' CYS . . . . . 0.412 ' HB3' ' CZ ' ' A' ' 133' ' ' PHE . 25.9 m -54.93 108.17 0.37 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.121 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 41.5 t -123.76 129.97 51.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.856 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.505 ' CZ ' HD22 ' A' ' 68' ' ' LEU . 1.5 m-85 -141.98 154.24 44.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.797 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.484 HD21 ' HA2' ' A' ' 122' ' ' GLY . 0.6 OUTLIER -120.02 139.82 51.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.937 179.901 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.412 ' HE2' HG21 ' A' ' 50' ' ' ILE . 28.3 t80 -112.37 141.48 46.05 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.964 0.887 . . . . 0.0 111.859 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.65 159.02 40.53 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 113.853 -1.522 . . . . 0.0 110.761 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.431 ' CD2' ' HB3' ' A' ' 121' ' ' ASN . 3.6 m-85 -86.05 139.72 30.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.933 0.397 . . . . 0.0 110.763 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.504 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.083 -179.875 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.456 -0.13 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.8 t -59.71 144.89 46.87 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.101 0.477 . . . . 0.0 111.341 -179.138 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.464 HD12 ' HB3' ' A' ' 52' ' ' ASN . 0.8 OUTLIER -151.52 -45.04 0.11 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.338 179.787 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -147.36 157.61 27.45 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.926 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.835 ' CD2' ' HB2' ' A' ' 138' ' ' ALA . 37.7 m-70 -119.83 160.4 22.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.99 0.424 . . . . 0.0 111.295 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.967 HD12 HD11 ' A' ' 50' ' ' ILE . 59.2 mt -127.09 112.77 15.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.607 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.867 HG22 ' HG3' ' A' ' 47' ' ' LYS . 27.2 t -99.71 121.74 50.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.133 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -90.19 114.87 26.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.763 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 32.0 mt -88.21 106.85 18.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.84 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.4 mt -124.11 139.27 32.29 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.08 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.34 92.86 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.377 2.051 . . . . 0.0 112.251 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.71 34.21 10.42 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.364 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -179.94 150.55 0.39 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.806 0.336 . . . . 0.0 110.859 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -151.22 152.0 32.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.991 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -143.6 126.22 15.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.739 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.867 ' HG3' HG22 ' A' ' 38' ' ' VAL . 5.0 ttpt -104.65 126.07 51.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.929 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.0 t -111.6 150.8 13.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.104 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.578 ' HG3' ' CE1' ' A' ' 36' ' ' HIS . 0.4 OUTLIER -100.46 119.95 39.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.97 -179.891 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.967 HD11 HD12 ' A' ' 37' ' ' LEU . 31.0 mm -96.12 132.09 41.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.07 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.1 p -110.0 168.51 9.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.788 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.464 ' HB3' HD12 ' A' ' 34' ' ' LEU . 2.1 p-10 -81.32 60.43 4.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.149 0.5 . . . . 0.0 110.291 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.583 ' C ' ' H ' ' A' ' 55' ' ' VAL . 20.0 ttt-85 -82.86 1.38 39.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.757 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.407 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 11.9 m-20 71.54 -33.28 0.27 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -178.696 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.583 ' H ' ' C ' ' A' ' 53' ' ' ARG . 78.8 t -137.19 140.75 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.58 179.379 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.697 HG23 ' HB3' ' A' ' 65' ' ' ASP . 30.5 m -125.29 128.33 48.08 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.054 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.91 130.69 51.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.809 0.338 . . . . 0.0 110.768 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.558 ' CG2' HD11 ' A' ' 68' ' ' LEU . 2.7 mp -124.06 120.94 60.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.09 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 171.35 -143.11 7.41 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.735 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.547 ' HB2' HG23 ' A' ' 73' ' ' ILE . 11.8 ttp180 -95.18 -32.34 13.1 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.803 0.335 . . . . 0.0 111.093 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.928 ' HB2' HG23 ' A' ' 75' ' ' THR . 0.3 OUTLIER -48.79 133.91 16.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.331 -179.575 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 48.6 mtp85 -67.12 -31.14 71.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.741 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -70.98 -22.83 62.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.039 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 66.9 m -52.1 146.62 8.57 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.88 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.697 ' HB3' HG23 ' A' ' 56' ' ' THR . 63.6 t0 -61.07 -43.82 98.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.876 0.37 . . . . 0.0 110.727 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.424 HG21 ' CD1' ' A' ' 37' ' ' LEU . 23.0 t -125.17 132.95 70.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.357 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 6.7 pt -109.86 127.16 66.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.856 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.592 ' CD1' HD11 ' A' ' 73' ' ' ILE . 8.0 mt -103.67 -132.76 0.3 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.881 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.405 ' O ' ' CB ' ' A' ' 70' ' ' GLU . 29.4 t -57.67 -105.67 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 O-C-N 122.336 -0.227 . . . . 0.0 111.002 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.479 ' HA ' HG22 ' A' ' 73' ' ' ILE . 2.7 mt-10 167.02 -64.37 0.0 OUTLIER Pre-proline 0 N--CA 1.463 0.207 0 CA-C-O 120.605 0.24 . . . . 0.0 111.213 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.448 ' CD ' ' CB ' ' A' ' 70' ' ' GLU . 21.5 Cg_endo -61.04 -40.08 54.78 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.6 2.2 . . . . 0.0 112.673 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -110.34 20.81 17.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.307 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.592 HD11 ' CD1' ' A' ' 68' ' ' LEU . 4.7 tp -109.39 121.8 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-O 121.114 0.483 . . . . 0.0 111.098 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 45.1 t -83.4 136.23 34.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.357 -179.398 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.928 HG23 ' HB2' ' A' ' 61' ' ' SER . 63.6 m -61.24 -30.01 70.18 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.988 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.406 ' O ' ' C ' ' A' ' 77' ' ' HIS . 12.2 m-85 -103.92 14.23 31.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.731 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.494 ' CE1' HD12 ' A' ' 73' ' ' ILE . 0.1 OUTLIER -29.81 -72.95 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.348 -179.232 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.718 ' HB3' ' CZ ' ' A' ' 127' ' ' PHE . . . -156.48 164.1 38.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.979 0.419 . . . . 0.0 111.821 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 56' ' ' THR . 0.0 OUTLIER -129.23 136.05 49.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.651 179.666 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.965 ' CE2' HG22 ' A' ' 97' ' ' VAL . 9.3 m-85 -119.3 127.88 53.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.64 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.407 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 4.2 m80 -94.88 116.41 28.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.975 0.416 . . . . 0.0 111.53 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.673 HD13 HG21 ' A' ' 50' ' ' ILE . 0.3 OUTLIER -106.68 109.74 21.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.551 179.386 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.18 140.08 53.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.207 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -102.4 122.38 44.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.67 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.31 113.43 20.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.15 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -107.09 121.54 44.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.816 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.488 ' O ' HG13 ' A' ' 87' ' ' VAL . 11.4 p -139.98 120.1 13.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.26 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 57.99 65.53 1.28 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.001 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.8 t30 66.66 -73.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.998 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -60.47 122.63 15.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.864 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -111.17 129.14 56.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.919 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -106.64 135.52 48.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.942 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.524 ' C ' HD22 ' A' ' 94' ' ' LEU . 9.3 m-80 -99.97 131.29 46.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.903 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.524 HD22 ' C ' ' A' ' 93' ' ' ASN . 3.9 mm? -121.93 128.42 51.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.814 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.61 ' N ' HD12 ' A' ' 95' ' ' ILE . 3.5 mp -112.97 141.13 29.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.076 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -113.99 143.93 43.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.769 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.965 HG22 ' CE2' ' A' ' 80' ' ' PHE . 12.0 t -107.01 126.67 63.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.153 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.451 ' N ' HD12 ' A' ' 98' ' ' ILE . 3.9 mp -128.23 120.97 54.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.02 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -114.17 138.75 50.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.941 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.21 -11.05 19.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.208 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.0 m 65.67 102.39 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.825 0.345 . . . . 0.0 110.913 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 12.6 mmp_? -128.1 -69.04 0.74 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.865 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 35.7 p-10 -110.97 -32.65 6.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.868 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 147.42 100.94 0.26 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.466 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.502 ' O ' HD23 ' A' ' 112' ' ' LEU . 0.9 OUTLIER -119.83 123.92 44.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.769 0.319 . . . . 0.0 110.93 -179.96 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PHE . . . . . 0.406 ' CE2' ' HG3' ' A' ' 111' ' ' ARG . 4.7 m-85 -121.15 138.12 54.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.849 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.804 HG22 ' CD2' ' A' ' 112' ' ' LEU . 3.4 tp -121.68 137.3 55.77 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-O 121.59 0.71 . . . . 0.0 111.367 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.7 m120 60.05 30.41 19.9 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.69 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.8 13.03 75.1 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.782 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -129.53 152.05 49.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.946 0.403 . . . . 0.0 111.048 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ARG . . . . . 0.406 ' HG3' ' CE2' ' A' ' 106' ' ' PHE . 30.5 ttt180 -75.02 143.46 43.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.939 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.804 ' CD2' HG22 ' A' ' 107' ' ' ILE . 4.0 mm? -69.71 138.25 52.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.024 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.464 HG23 ' N ' ' A' ' 114' ' ' LYS . 16.8 m -134.39 -46.14 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.05 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.464 ' N ' HG23 ' A' ' 113' ' ' VAL . 0.5 OUTLIER -88.34 162.98 16.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.925 179.916 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.16 31.93 5.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.912 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -161.81 65.66 0.25 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.904 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -84.1 139.11 32.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.8 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.485 ' O ' HG23 ' A' ' 118' ' ' ILE . 8.4 tp -98.58 121.42 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.221 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.647 HD21 ' CD2' ' A' ' 135' ' ' PHE . 3.4 tp -103.14 132.75 49.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.902 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -126.38 178.03 6.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.79 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.439 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 7.1 p30 -63.05 143.13 58.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.9 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 69.37 50.36 33.03 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.535 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -117.73 142.24 47.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.767 0.318 . . . . 0.0 111.025 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 61.9 mtt85 -100.94 127.14 47.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.83 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.419 ' HB ' ' CE2' ' A' ' 133' ' ' PHE . 1.6 mp -123.37 136.91 58.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.185 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 38.1 t -124.01 124.05 68.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.92 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.718 ' CZ ' ' HB3' ' A' ' 78' ' ' ALA . 3.3 m-85 -111.8 133.03 54.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.09 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 82.36 -67.55 3.68 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.419 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.35 -41.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.772 0.32 . . . . 0.0 111.118 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.81 -41.98 4.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.701 -179.418 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 29.1 m -51.98 105.65 0.12 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.934 0.397 . . . . 0.0 111.231 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 32.4 p -124.36 134.72 53.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.909 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.419 ' CE2' ' HB ' ' A' ' 125' ' ' ILE . 6.8 p90 -141.97 155.03 45.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.01 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.3 tp -112.64 138.38 49.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.777 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.647 ' CD2' HD21 ' A' ' 119' ' ' LEU . 47.7 t80 -108.15 141.48 39.81 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 122.005 0.907 . . . . 0.0 111.802 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 9.2 ptpt -154.59 154.13 32.53 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 113.883 -1.508 . . . . 0.0 110.873 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.439 ' CE2' ' HB3' ' A' ' 121' ' ' ASN . 0.8 OUTLIER -86.0 139.6 31.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.913 0.387 . . . . 0.0 110.734 179.643 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.835 ' HB2' ' CD2' ' A' ' 36' ' ' HIS . . . . . . . . 0 C--N 1.325 -0.484 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.121 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.454 ' N ' HG22 ' A' ' 51' ' ' THR . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.778 0.323 . . . . 0.0 110.613 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 49.7 t -59.88 145.02 47.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.094 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.804 HD13 HD21 ' A' ' 82' ' ' LEU . 8.4 tt -150.96 -46.68 0.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.844 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.616 ' C ' HG22 ' A' ' 50' ' ' ILE . . . -151.16 -176.95 24.52 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.473 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 40.9 m80 -147.08 157.89 43.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.872 0.368 . . . . 0.0 111.041 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.575 HD23 ' N ' ' A' ' 37' ' ' LEU . 0.3 OUTLIER -127.02 129.42 48.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.716 179.712 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.63 HG22 ' HD2' ' A' ' 47' ' ' LYS . 21.3 t -109.03 122.0 63.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.224 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -90.01 119.89 30.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.805 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 66.3 mt -75.68 108.69 8.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.887 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.408 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 14.4 mt -122.24 138.52 29.13 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.408 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 87.8 Cg_exo -46.94 -27.95 6.49 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.568 2.178 . . . . 0.0 112.529 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -114.15 -125.55 4.18 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.413 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -53.89 138.31 36.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.795 0.331 . . . . 0.0 111.129 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -82.12 150.52 27.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.833 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -117.01 110.51 18.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.025 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.63 ' HD2' HG22 ' A' ' 38' ' ' VAL . 0.5 OUTLIER -113.04 121.0 43.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.842 179.891 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.8 t -124.53 151.06 29.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.153 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -100.26 142.15 32.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.786 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.616 HG22 ' C ' ' A' ' 35' ' ' GLY . 6.1 tt -116.03 132.21 66.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.373 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.454 HG22 ' N ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -97.59 168.08 10.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.819 -179.848 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.884 ' HA ' HD22 ' A' ' 82' ' ' LEU . 0.4 OUTLIER -85.01 62.71 7.68 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.134 0.492 . . . . 0.0 110.238 179.373 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.562 ' C ' ' H ' ' A' ' 55' ' ' VAL . 22.3 ttt-85 -81.24 2.75 26.55 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.051 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.404 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 0.5 OUTLIER 72.06 -35.24 0.32 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 -178.77 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.562 ' H ' ' C ' ' A' ' 53' ' ' ARG . 73.5 t -137.18 138.43 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.424 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.732 HG23 ' CB ' ' A' ' 65' ' ' ASP . 96.9 m -125.2 129.66 50.54 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.587 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.418 ' O ' ' N ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -103.98 140.72 37.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.897 0.379 . . . . 0.0 110.954 -179.825 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.543 HD13 ' HE2' ' A' ' 127' ' ' PHE . 9.6 mt -132.05 123.41 50.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.964 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 171.78 -148.46 10.96 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.717 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.47 ' HB2' HG23 ' A' ' 73' ' ' ILE . 9.4 tpt85 -93.55 -33.11 13.88 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.754 0.311 . . . . 0.0 111.083 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.7 ' HB2' HG23 ' A' ' 75' ' ' THR . 3.5 t -53.61 139.98 30.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.133 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.17 -25.41 61.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.119 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 63.6 p -69.81 -24.69 63.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.99 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 93.3 m -59.1 163.94 3.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.873 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.732 ' CB ' HG23 ' A' ' 56' ' ' THR . 0.9 OUTLIER -72.16 -59.18 2.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.033 0.444 . . . . 0.0 110.692 179.807 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.8 t -109.64 122.01 63.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.111 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.1 pt -98.4 105.11 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.917 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.441 ' HA ' HD13 ' A' ' 68' ' ' LEU . 1.6 mm? -64.94 -25.92 68.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.92 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 49.1 m 62.63 26.68 15.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.98 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.423 ' CB ' ' HB ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -85.37 148.52 49.91 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.707 179.837 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.04 -14.05 42.12 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.678 2.252 . . . . 0.0 113.061 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -135.17 23.27 3.51 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.488 ' O ' HG23 ' A' ' 73' ' ' ILE . 5.2 tp -77.33 120.37 27.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.979 0.418 . . . . 0.0 110.996 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.401 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 47.0 t -62.39 133.99 55.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.311 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.7 HG23 ' HB2' ' A' ' 61' ' ' SER . 94.3 m -57.94 -31.76 67.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.733 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.465 ' O ' ' C ' ' A' ' 77' ' ' HIS . 13.5 m-85 -110.36 13.9 22.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.48 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.465 ' C ' ' O ' ' A' ' 76' ' ' PHE . 1.9 t60 -18.93 -67.69 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.708 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -156.34 162.29 40.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.0 0.428 . . . . 0.0 111.982 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -128.55 132.56 48.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.385 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.813 ' CZ ' HG13 ' A' ' 97' ' ' VAL . 6.0 m-85 -119.28 129.39 54.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.838 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.404 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 27.9 m80 -94.88 116.19 28.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.855 0.36 . . . . 0.0 111.348 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.884 HD22 ' HA ' ' A' ' 52' ' ' ASN . 7.1 tt -106.85 109.88 21.9 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.714 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.28 139.93 52.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.933 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -107.31 133.29 52.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.871 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -140.18 140.7 35.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.881 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -97.33 119.68 36.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.897 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.4 t -135.74 114.53 15.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.205 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 59.59 78.1 0.28 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.944 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 64.08 -79.25 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.03 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -69.59 159.53 33.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.914 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -111.91 140.63 46.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.921 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -104.05 148.42 26.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.824 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.435 ' HB2' ' CD1' ' A' ' 137' ' ' TYR . 14.3 m120 -114.01 120.03 39.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.99 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.95 HD12 HD11 ' A' ' 118' ' ' ILE . 4.1 mm? -105.37 127.52 53.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.766 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.472 ' HB ' HD22 ' A' ' 119' ' ' LEU . 26.7 mm -113.1 141.12 29.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.182 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -115.83 144.09 44.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.672 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.813 HG13 ' CZ ' ' A' ' 80' ' ' PHE . 22.0 t -112.32 134.3 55.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.228 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 27.7 mt -130.01 129.87 65.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.1 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.778 ' HB2' HD11 ' A' ' 112' ' ' LEU . 44.1 t0 -98.22 125.04 43.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.866 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 26.9 mmtp -147.42 31.37 0.9 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.893 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.1 m -105.42 171.68 7.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.878 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 21.1 mtt85 -110.36 -31.53 7.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.884 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -69.07 -73.31 0.15 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.235 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 176.36 135.41 2.14 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.672 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.513 HG23 ' CD1' ' A' ' 127' ' ' PHE . 88.2 m -131.82 122.96 26.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.773 0.321 . . . . 0.0 110.536 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -120.37 130.91 54.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.042 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.2 tp -123.02 137.35 56.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.49 0.662 . . . . 0.0 111.216 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.8 m120 62.75 28.8 16.65 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.823 -1.08 . . . . 0.0 110.776 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.81 6.0 62.38 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.925 -0.655 . . . . 0.0 113.073 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -134.21 144.26 48.34 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.788 0.328 . . . . 0.0 110.825 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.3 ttm180 -70.32 128.94 37.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.818 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.778 HD11 ' HB2' ' A' ' 99' ' ' ASP . 0.8 OUTLIER -76.26 139.2 41.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.98 -179.966 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 30.6 m -111.78 -34.85 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.028 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -105.99 166.0 10.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.84 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.43 171.47 8.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.939 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.9 t70 62.65 56.23 2.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.023 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.404 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 0.2 OUTLIER -79.0 137.58 37.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.745 179.879 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.95 HD11 HD12 ' A' ' 94' ' ' LEU . 8.5 tp -98.65 119.62 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-O 121.013 0.435 . . . . 0.0 111.418 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.839 HD11 HD11 ' A' ' 125' ' ' ILE . 5.9 tt -103.19 132.62 49.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.849 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 29.5 mttt -114.63 178.09 4.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.442 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 5.6 p-10 -56.23 136.69 52.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.019 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 69.47 51.36 26.72 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.3 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -111.64 129.55 56.05 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.789 0.328 . . . . 0.0 111.028 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.513 ' NH1' HD23 ' A' ' 134' ' ' LEU . 11.7 ttm-85 -88.23 123.96 33.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.829 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.839 HD11 HD11 ' A' ' 119' ' ' LEU . 2.1 mp -123.07 130.43 74.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.159 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 43.7 t -124.03 134.09 67.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.179 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.543 ' HE2' HD13 ' A' ' 58' ' ' ILE . 8.6 m-85 -115.78 139.32 50.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.92 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 71.29 -64.63 1.01 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.477 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 15.0 mttt 170.34 -37.24 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.755 0.312 . . . . 0.0 111.011 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 23.8 p -99.89 -43.55 6.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.406 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 76.5 m -53.17 104.47 0.1 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.936 0.398 . . . . 0.0 111.311 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.56 127.71 47.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.963 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.432 ' CE2' ' HB ' ' A' ' 125' ' ' ILE . 4.0 p90 -142.14 156.26 45.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.966 0.412 . . . . 0.0 111.283 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.513 HD23 ' NH1' ' A' ' 124' ' ' ARG . 0.3 OUTLIER -116.33 120.3 38.44 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.625 179.788 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.477 ' HE2' HG21 ' A' ' 50' ' ' ILE . 45.7 t80 -97.93 141.66 30.63 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.978 0.894 . . . . 0.0 111.976 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.35 147.09 24.27 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 113.807 -1.542 . . . . 0.0 110.828 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.442 ' CE2' ' HB3' ' A' ' 121' ' ' ASN . 10.1 m-85 -76.56 140.01 40.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.037 0.446 . . . . 0.0 110.812 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.542 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.14 -179.992 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.493 ' N ' HG22 ' A' ' 51' ' ' THR . 0.7 OUTLIER . . . . . 0 N--CA 1.457 -0.093 0 CA-C-O 120.721 0.296 . . . . 0.0 110.776 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 52.4 t -61.82 137.5 58.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.855 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.661 HD11 ' OD1' ' A' ' 93' ' ' ASN . 5.3 tt -142.93 -50.44 0.35 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.969 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.616 ' C ' HG22 ' A' ' 50' ' ' ILE . . . -140.3 -177.35 15.87 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.544 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 47.5 m80 -144.69 161.02 40.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.899 0.38 . . . . 0.0 110.987 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.0 mt -121.94 121.02 36.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.637 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.3 t -96.04 121.89 47.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.345 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.16 131.79 35.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.425 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' A' ' 133' ' ' PHE . 1.9 mp -113.38 106.83 15.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.935 0.398 . . . . 0.0 111.21 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.414 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 22.0 mt -124.15 138.33 30.59 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.887 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.414 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 83.0 Cg_exo -45.38 -28.8 4.17 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.478 2.119 . . . . 0.0 112.639 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -85.02 -30.12 26.67 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.406 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 174.88 -169.54 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.879 0.371 . . . . 0.0 110.969 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -129.37 -178.53 4.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.946 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -162.52 151.09 14.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.975 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.7 tttt -113.01 131.53 55.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.008 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.1 t -119.1 147.48 22.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.135 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -100.16 128.54 46.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.859 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.662 HG21 ' HE1' ' A' ' 135' ' ' PHE . 15.3 tt -115.93 132.3 65.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.247 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.493 HG22 ' N ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -97.99 168.11 10.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.884 -179.824 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.462 ' ND2' ' O ' ' A' ' 52' ' ' ASN . 2.2 p-10 -102.33 75.56 1.49 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.43 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.601 ' C ' ' H ' ' A' ' 55' ' ' VAL . 1.6 ptp85 -101.05 23.59 10.56 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.39 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 68.59 -28.31 0.15 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.717 0.294 . . . . 0.0 110.216 -179.35 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.601 ' H ' ' C ' ' A' ' 53' ' ' ARG . 65.3 t -137.27 139.73 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 CA-C-O 121.087 0.47 . . . . 0.0 111.352 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.651 HG23 ' HB3' ' A' ' 65' ' ' ASP . 38.5 m -125.28 125.47 43.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.046 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.88 137.24 42.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.801 0.334 . . . . 0.0 110.806 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.2 mp -128.53 121.28 54.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.98 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 172.68 -151.8 15.03 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.656 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.416 ' HB2' ' CG2' ' A' ' 73' ' ' ILE . 6.3 ttp180 -87.67 -31.26 19.84 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.775 0.321 . . . . 0.0 110.974 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.898 ' HB2' HG23 ' A' ' 75' ' ' THR . 0.1 OUTLIER -55.53 127.54 30.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.226 -179.751 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.81 -25.53 68.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.915 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 91.0 p -69.87 -25.48 63.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.927 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 88.8 m -56.11 153.49 9.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.87 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.651 ' HB3' HG23 ' A' ' 56' ' ' THR . 10.0 t70 -62.7 -45.93 90.49 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.988 0.423 . . . . 0.0 110.664 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.5 t -120.31 129.16 75.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.947 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 31.2 mt -102.6 104.87 17.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.241 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.604 HD11 ' CE2' ' A' ' 133' ' ' PHE . 1.3 tp -77.67 -154.58 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.132 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.471 ' O ' ' CB ' ' A' ' 70' ' ' GLU . 26.9 m -44.14 -97.79 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 111.262 0.097 . . . . 0.0 111.262 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.471 ' CB ' ' O ' ' A' ' 69' ' ' SER . 2.5 mt-10 158.81 -65.12 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.446 0 CA-C-O 120.704 0.287 . . . . 0.0 111.427 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.462 ' CD ' ' CB ' ' A' ' 70' ' ' GLU . 12.0 Cg_endo -55.93 -40.05 87.44 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.705 2.27 . . . . 0.0 113.146 -178.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -117.97 28.4 8.42 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.663 0.245 . . . . 0.0 111.663 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.537 HD11 ' CD2' ' A' ' 68' ' ' LEU . 4.9 tp -112.64 125.37 69.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.046 0.45 . . . . 0.0 111.459 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.432 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 57.3 m -76.87 137.71 39.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.186 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.898 HG23 ' HB2' ' A' ' 61' ' ' SER . 52.8 m -60.09 -40.96 91.42 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.09 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.45 ' O ' ' C ' ' A' ' 77' ' ' HIS . 14.0 m-85 -99.46 14.13 30.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.088 0.47 . . . . 0.0 111.922 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.45 ' C ' ' O ' ' A' ' 76' ' ' PHE . 0.8 OUTLIER -22.74 -69.38 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.598 -179.361 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -154.61 164.1 39.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.054 0.455 . . . . 0.0 111.837 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -131.8 130.36 41.69 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.457 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.887 ' CZ ' HG13 ' A' ' 97' ' ' VAL . 7.3 m-85 -119.47 131.56 55.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.949 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 9.6 m170 -94.3 116.41 28.79 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.937 0.399 . . . . 0.0 111.075 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.448 HD13 ' O ' ' A' ' 51' ' ' THR . 3.9 tt -106.44 109.96 22.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.913 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.1 mp -117.85 139.22 51.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.009 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -126.57 128.74 47.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.905 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.09 146.15 38.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.913 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -104.66 115.92 31.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.85 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.4 m -122.96 110.95 27.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.262 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 57.63 82.68 0.12 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.109 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 62.47 -79.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.094 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -58.99 170.53 0.83 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.941 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -126.7 140.46 52.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.919 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.32 119.37 39.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.844 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.661 ' OD1' HD11 ' A' ' 34' ' ' LEU . 3.0 m-80 -108.6 123.75 49.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.805 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.6 mt -125.68 132.6 52.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.981 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.543 ' N ' HD12 ' A' ' 95' ' ' ILE . 4.0 mp -114.87 141.02 33.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.026 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -113.97 144.07 43.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.998 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.887 HG13 ' CZ ' ' A' ' 80' ' ' PHE . 18.2 t -110.48 127.73 67.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.136 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 33.1 mt -130.01 121.0 50.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.146 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -113.84 117.36 31.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.786 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.26 24.56 10.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.099 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 46.5 m 63.19 142.57 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.888 0.375 . . . . 0.0 110.939 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 6.4 tpt180 -178.71 -68.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.721 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -123.32 -31.01 3.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.249 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 128.82 120.46 2.27 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.281 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.476 HG23 ' CE1' ' A' ' 127' ' ' PHE . 90.6 m -123.27 128.47 50.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.847 0.355 . . . . 0.0 111.063 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -120.98 114.99 22.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.766 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.846 HD12 ' O ' ' A' ' 124' ' ' ARG . 2.2 tp -120.51 137.25 54.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.522 0.677 . . . . 0.0 111.496 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 59.18 28.16 17.38 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.05 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.71 13.07 74.79 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.952 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -133.17 150.13 52.02 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.835 0.35 . . . . 0.0 110.948 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 19.3 ttt-85 -74.96 142.35 43.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.92 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.88 127.86 35.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.847 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.484 HG13 ' HG2' ' A' ' 114' ' ' LYS . 12.7 p -117.82 -40.07 2.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.155 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.484 ' HG2' HG13 ' A' ' 113' ' ' VAL . 4.4 mmmt -84.18 173.74 10.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.823 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.5 ptpt -121.2 32.86 5.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.818 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -145.94 49.55 1.2 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.9 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -81.56 138.11 35.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.796 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.516 ' O ' HG23 ' A' ' 118' ' ' ILE . 8.8 tp -98.56 118.93 45.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.195 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.546 HD11 HD11 ' A' ' 125' ' ' ILE . 7.9 tt -103.1 136.21 43.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.015 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.9 mtmt -125.65 178.06 5.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.789 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.431 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 4.7 p30 -59.53 137.74 57.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.004 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 74.2 55.57 5.64 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.444 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -117.31 139.29 51.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.925 0.393 . . . . 0.0 110.849 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.846 ' O ' HD12 ' A' ' 107' ' ' ILE . 3.1 ttt180 -103.18 123.62 47.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.855 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.546 HD11 HD11 ' A' ' 119' ' ' LEU . 1.4 mp -126.75 135.7 62.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.184 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.4 t -120.63 125.09 73.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.058 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.476 ' CE1' HG23 ' A' ' 105' ' ' THR . 90.1 m-85 -120.61 130.61 54.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.114 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 84.07 -6.0 77.26 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.899 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 12.2 mtpt 77.2 28.78 0.6 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.911 0.386 . . . . 0.0 110.525 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.29 -45.08 0.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.073 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' CYS . . . . . 0.471 ' CB ' HD21 ' A' ' 68' ' ' LEU . 99.6 m -77.37 107.75 10.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.804 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 47.3 t -124.07 126.32 46.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.971 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.604 ' CE2' HD11 ' A' ' 68' ' ' LEU . 12.9 p90 -142.05 155.51 45.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.926 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.47 140.05 39.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.773 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.662 ' HE1' HG21 ' A' ' 50' ' ' ILE . 55.6 t80 -103.52 141.66 35.62 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 121.924 0.868 . . . . 0.0 111.809 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.8 tttt -154.26 147.69 25.03 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 113.953 -1.476 . . . . 0.0 110.932 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.467 ' N ' ' CD1' ' A' ' 137' ' ' TYR . 0.8 OUTLIER -79.88 139.73 37.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.712 179.729 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.476 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.141 -179.836 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.456 -0.135 0 CA-C-O 120.737 0.303 . . . . 0.0 110.648 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 53.6 t -59.96 134.77 57.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.842 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.492 HD12 ' CG ' ' A' ' 84' ' ' GLN . 3.7 tt -133.79 -46.11 0.8 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.987 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.57 ' O ' HG22 ' A' ' 50' ' ' ILE . . . -156.85 -176.66 29.17 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.594 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -142.29 166.05 25.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.87 0.366 . . . . 0.0 110.901 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.651 ' CD1' HG21 ' A' ' 66' ' ' VAL . 3.8 mt -127.19 110.21 12.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.862 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.598 HG22 ' HD3' ' A' ' 47' ' ' LYS . 23.2 t -102.23 121.77 53.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.136 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -90.08 123.78 34.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.863 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.8 mt -83.8 106.68 15.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.82 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.708 HD12 ' HA ' ' A' ' 45' ' ' GLU . 1.5 mt -124.16 138.01 30.03 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.925 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -46.99 -27.76 6.36 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.454 2.103 . . . . 0.0 112.531 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -133.22 107.36 0.68 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.483 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 36.7 mttt 63.16 129.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.796 0.332 . . . . 0.0 110.916 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' GLU . . . . . 0.708 ' HA ' HD12 ' A' ' 41' ' ' ILE . 42.3 mt-10 -95.64 170.22 9.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.929 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -126.32 121.94 34.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.897 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.598 ' HD3' HG22 ' A' ' 38' ' ' VAL . 1.1 mmmp? -102.97 129.07 49.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.936 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.2 t -121.6 130.71 74.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.065 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.12 124.2 32.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.935 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.57 HG22 ' O ' ' A' ' 35' ' ' GLY . 2.9 tt -116.02 132.14 66.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.138 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.517 ' O ' HD13 ' A' ' 82' ' ' LEU . 0.1 OUTLIER -99.76 168.39 9.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.245 -179.541 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.458 ' HB3' HD13 ' A' ' 34' ' ' LEU . 0.4 OUTLIER -82.26 68.3 8.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.342 179.534 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.558 ' C ' ' H ' ' A' ' 55' ' ' VAL . 23.5 ttt-85 -83.01 6.58 18.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.041 -179.425 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.477 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 2.2 t30 71.43 -38.45 0.42 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -178.797 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.558 ' H ' ' C ' ' A' ' 53' ' ' ARG . 75.6 t -137.64 133.49 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.531 179.153 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.919 ' OG1' HD11 ' A' ' 82' ' ' LEU . 33.0 m -125.24 131.25 53.16 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.178 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.91 133.86 48.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.892 0.377 . . . . 0.0 111.037 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.581 HD12 ' N ' ' A' ' 58' ' ' ILE . 3.9 mp -118.22 123.58 71.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.201 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 166.98 -130.08 2.05 Favored Glycine 0 C--N 1.331 0.267 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.275 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.533 ' HB3' ' HA ' ' A' ' 70' ' ' GLU . 7.2 ptt180 -122.23 -25.96 4.77 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.55 0.214 . . . . 0.0 111.288 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.428 ' HB2' HG23 ' A' ' 75' ' ' THR . 0.2 OUTLIER -48.53 125.38 9.71 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.881 0.372 . . . . 0.0 110.999 -179.919 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.97 -25.47 29.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.163 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 41.1 p -78.23 -23.42 47.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.993 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 93.8 m -57.16 169.27 0.59 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.967 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.8 ' CB ' HG23 ' A' ' 56' ' ' THR . 1.6 m-20 -85.91 -68.31 0.74 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.984 0.421 . . . . 0.0 110.909 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.651 HG21 ' CD1' ' A' ' 37' ' ' LEU . 27.7 t -101.99 133.05 46.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.085 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 15.7 pt -112.78 127.82 69.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.161 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.762 HD22 ' HB3' ' A' ' 131' ' ' CYS . 13.4 mt -94.04 -84.28 0.32 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.487 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.412 ' O ' ' CB ' ' A' ' 70' ' ' GLU . 10.8 t -102.55 -104.52 0.27 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.138 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.639 ' CB ' ' HD3' ' A' ' 71' ' ' PRO . 0.0 OUTLIER 166.76 -64.66 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.19 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 178.937 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.639 ' HD3' ' CB ' ' A' ' 70' ' ' GLU . 15.6 Cg_exo -67.84 -40.23 9.97 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.299 1.999 . . . . 0.0 113.519 -179.16 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -110.55 16.06 21.72 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -179.018 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.499 ' CG2' ' HB3' ' A' ' 60' ' ' ARG . 3.6 tp -107.15 124.72 63.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.865 0.364 . . . . 0.0 110.773 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.5 m -57.47 131.52 50.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.408 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.428 HG23 ' HB2' ' A' ' 61' ' ' SER . 35.2 m -63.69 -39.96 95.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.436 179.607 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.465 ' O ' ' C ' ' A' ' 77' ' ' HIS . 4.4 m-85 -104.99 13.74 30.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.164 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.488 ' CD2' ' CD1' ' A' ' 127' ' ' PHE . 1.5 t60 -16.65 -69.1 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.582 -1.19 . . . . 0.0 112.708 -179.276 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.581 ' HB3' ' CZ ' ' A' ' 127' ' ' PHE . . . -158.88 164.1 35.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.916 0.389 . . . . 0.0 111.611 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -124.0 140.36 53.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.872 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.933 ' CE1' HG13 ' A' ' 97' ' ' VAL . 4.8 m-85 -119.54 131.06 55.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.542 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.477 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 21.1 m-70 -102.91 116.11 31.9 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.691 -0.403 . . . . 0.0 111.674 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.919 HD11 ' OG1' ' A' ' 56' ' ' THR . 0.2 OUTLIER -107.06 109.84 21.8 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.635 179.116 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.2 mt -120.67 140.05 52.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.992 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.492 ' CG ' HD12 ' A' ' 34' ' ' LEU . 19.3 mt-30 -109.49 125.76 52.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.768 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 11.1 mtp -129.62 148.53 51.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.952 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -107.07 119.92 40.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.856 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.4 t -129.44 110.96 21.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.138 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.8 t70 58.67 68.52 0.82 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.934 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 68.26 -68.36 0.17 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.951 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -64.57 146.93 53.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.865 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.91 128.04 54.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.985 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -98.54 144.68 27.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.832 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -109.14 127.01 53.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.988 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.419 ' CD2' HD11 ' A' ' 118' ' ' ILE . 1.1 mt -123.41 129.19 50.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.691 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.63 HD12 HD23 ' A' ' 82' ' ' LEU . 30.6 mm -117.93 138.01 50.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.903 0.383 . . . . 0.0 111.284 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -113.9 144.08 43.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.745 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.933 HG13 ' CE1' ' A' ' 80' ' ' PHE . 18.2 t -114.65 134.8 56.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.178 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 25.4 mm -121.04 121.01 63.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.03 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -97.75 123.71 41.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.941 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.98 -26.36 31.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.97 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.4 m 65.28 99.02 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.909 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.68 -42.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.888 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -104.26 -55.66 2.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.228 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 143.6 106.65 0.56 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.501 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 90.9 m -118.39 126.86 52.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.71 0.29 . . . . 0.0 110.898 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -120.93 115.03 22.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.921 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.728 HD12 ' O ' ' A' ' 124' ' ' ARG . 2.5 tp -114.16 137.36 47.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.464 0.649 . . . . 0.0 111.21 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 63.09 29.05 16.26 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.826 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.78 7.98 66.93 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.974 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -134.17 144.14 48.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.758 0.313 . . . . 0.0 110.856 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.4 ttp180 -70.51 128.99 38.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.81 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.729 HD13 ' N ' ' A' ' 113' ' ' VAL . 0.3 OUTLIER -92.2 137.97 31.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.917 -179.957 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.729 ' N ' HD13 ' A' ' 112' ' ' LEU . 6.2 m -121.51 -42.08 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.1 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.4 mttm -65.37 -174.55 0.19 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.852 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.0 tttt -124.0 171.15 9.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.803 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.5 t70 60.48 63.42 1.36 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.872 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' TYR . . . . . 0.437 ' CZ ' HG12 ' A' ' 107' ' ' ILE . 10.7 t80 -84.2 139.13 32.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.785 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.534 ' O ' HG23 ' A' ' 118' ' ' ILE . 8.4 tp -98.37 118.5 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.253 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.561 HD13 ' C ' ' A' ' 119' ' ' LEU . 3.2 tm? -100.84 120.0 39.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.767 -179.798 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.427 ' N ' HD13 ' A' ' 119' ' ' LEU . 0.4 OUTLIER -118.7 178.07 4.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.882 -179.955 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.443 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 17.8 p30 -60.06 135.79 57.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.017 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 75.04 56.32 4.86 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.582 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -123.09 135.06 54.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.845 0.355 . . . . 0.0 111.04 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.728 ' O ' HD12 ' A' ' 107' ' ' ILE . 0.0 OUTLIER -99.47 117.33 33.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.825 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.611 HG12 HD13 ' A' ' 107' ' ' ILE . 5.1 mt -115.0 133.21 61.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.114 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.566 HG13 ' O ' ' A' ' 131' ' ' CYS . 21.4 t -124.09 127.69 73.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.072 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.581 ' CZ ' ' HB3' ' A' ' 78' ' ' ALA . 4.8 m-85 -116.66 126.19 52.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.042 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 92.87 -71.09 1.51 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.36 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 174.55 -43.57 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.788 0.328 . . . . 0.0 111.171 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.0 p -98.08 -41.91 7.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.545 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' CYS . . . . . 0.762 ' HB3' HD22 ' A' ' 68' ' ' LEU . 25.3 m -54.13 106.17 0.18 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.955 0.407 . . . . 0.0 111.222 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 13.9 p -124.38 122.54 37.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.773 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -142.04 156.23 45.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.034 0.445 . . . . 0.0 111.276 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.1 tp -114.37 134.44 54.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.66 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.428 ' CD1' ' N ' ' A' ' 136' ' ' LYS . 14.5 t80 -98.2 141.17 31.44 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 121.929 0.871 . . . . 0.0 111.754 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.428 ' N ' ' CD1' ' A' ' 135' ' ' PHE . 9.6 tptt -154.86 154.71 33.14 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 113.878 -1.51 . . . . 0.0 111.128 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.443 ' CE2' ' HB3' ' A' ' 121' ' ' ASN . 13.2 m-85 -86.13 140.15 30.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.623 179.331 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.542 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.124 -179.83 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 32' ' ' THR . . . . . 0.457 ' O ' HG22 ' A' ' 51' ' ' THR . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.692 0.282 . . . . 0.0 110.705 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 52.6 t -64.66 144.79 56.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.954 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.586 HD22 ' HB3' ' A' ' 52' ' ' ASN . 10.2 tp -155.33 -46.32 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.705 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -154.67 169.69 32.94 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.229 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.563 ' ND1' ' HB2' ' A' ' 138' ' ' ALA . 27.2 m80 -131.52 163.62 27.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.948 0.404 . . . . 0.0 110.946 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.649 HD12 HG21 ' A' ' 66' ' ' VAL . 19.1 mt -127.06 111.07 13.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.801 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.4 t -95.92 121.88 46.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.119 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -89.17 120.88 30.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.912 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.0 mp -79.71 107.05 12.18 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.888 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.403 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 11.7 mt -123.98 138.39 30.52 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.856 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.403 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 84.4 Cg_exo -47.59 -27.47 7.73 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.494 2.129 . . . . 0.0 112.429 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.96 -126.09 2.99 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.465 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.9 mttt -53.1 101.72 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.824 0.345 . . . . 0.0 111.134 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -65.36 172.27 3.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.844 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -133.61 131.1 39.23 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.906 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.07 127.36 56.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.863 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.675 HG11 HG13 ' A' ' 66' ' ' VAL . 28.6 t -119.94 150.98 22.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.14 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -103.44 138.16 40.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.863 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.665 HG22 HD22 ' A' ' 82' ' ' LEU . 26.2 mm -116.08 126.67 73.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.328 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.457 HG22 ' O ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -98.3 168.13 10.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.74 179.786 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.586 ' HB3' HD22 ' A' ' 34' ' ' LEU . 26.4 p30 -100.25 66.8 1.32 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.008 0.432 . . . . 0.0 110.762 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.576 ' C ' ' H ' ' A' ' 55' ' ' VAL . 0.6 OUTLIER -97.73 21.65 10.16 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.374 179.993 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.431 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 0.6 OUTLIER 68.23 -27.87 0.14 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.485 -179.726 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.576 ' H ' ' C ' ' A' ' 53' ' ' ARG . 62.9 t -137.31 139.31 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 CA-C-O 121.075 0.465 . . . . 0.0 111.826 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.472 HG22 ' CB ' ' A' ' 65' ' ' ASP . 0.4 OUTLIER -125.24 128.05 47.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.005 179.338 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.459 ' O ' ' N ' ' A' ' 65' ' ' ASP . 0.1 OUTLIER -103.95 138.93 39.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.971 0.415 . . . . 0.0 111.417 -179.519 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 32.8 mt -132.3 131.24 60.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.13 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 162.78 -146.67 12.09 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.264 -0.969 . . . . 0.0 113.283 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.583 ' HB2' HG23 ' A' ' 73' ' ' ILE . 4.1 ttp-105 -87.59 -44.54 11.17 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.83 0.348 . . . . 0.0 111.392 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.564 ' HB3' HG23 ' A' ' 75' ' ' THR . 33.2 t -50.51 122.15 6.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.483 -179.272 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 -60.43 -20.28 59.21 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.905 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 16.3 m -69.75 -27.43 64.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.698 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 84.4 m -56.33 164.67 1.27 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.671 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.472 ' CB ' HG22 ' A' ' 56' ' ' THR . 0.6 OUTLIER -66.94 -52.86 37.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.979 0.418 . . . . 0.0 110.802 179.827 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.675 HG13 HG11 ' A' ' 48' ' ' VAL . 21.3 t -125.12 126.79 71.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.508 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.8 mp -97.51 119.71 45.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.498 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.713 HD22 ' HB3' ' A' ' 131' ' ' CYS . 19.4 mt -83.4 -86.61 0.11 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.078 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 34.4 m -108.66 -109.88 0.32 Allowed 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 110.251 -0.278 . . . . 0.0 110.251 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.655 ' HA ' HG22 ' A' ' 73' ' ' ILE . 0.2 OUTLIER 169.66 -63.11 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.192 0 CA-C-O 120.496 0.188 . . . . 0.0 111.412 179.414 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.588 ' HD3' ' CB ' ' A' ' 70' ' ' GLU . 37.2 Cg_exo -60.29 -40.19 61.15 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.043 1.829 . . . . 0.0 112.899 -179.437 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -115.13 12.73 16.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.587 -179.573 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.655 HG22 ' HA ' ' A' ' 70' ' ' GLU . 2.6 tp -104.55 133.32 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-O 120.831 0.348 . . . . 0.0 110.975 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.476 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 4.1 p -98.82 131.76 44.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.546 -179.29 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.564 HG23 ' HB3' ' A' ' 61' ' ' SER . 19.6 m -53.48 -30.17 39.69 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.159 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -93.92 14.12 20.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.018 -179.56 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.476 ' HB2' ' O ' ' A' ' 74' ' ' SER . 1.4 t-160 -34.51 -66.65 0.16 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.07 -179.392 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.57 ' HB3' ' CE2' ' A' ' 127' ' ' PHE . . . -161.62 163.24 30.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.097 0.475 . . . . 0.0 111.765 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -129.47 135.16 48.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.237 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.954 ' CE2' HG22 ' A' ' 97' ' ' VAL . 6.3 m-85 -119.34 131.46 55.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.999 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.431 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 11.9 m170 -94.69 116.45 28.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.954 0.407 . . . . 0.0 110.928 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.665 HD22 HG22 ' A' ' 50' ' ' ILE . 1.6 tp -106.45 109.95 22.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.948 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.2 tp -118.57 140.09 50.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.89 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.4 tm0? -100.4 132.0 46.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.937 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.3 130.1 56.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.85 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -95.12 130.77 41.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.964 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' VAL . . . . . 0.465 HG21 ' HD3' ' A' ' 92' ' ' ARG . 21.4 t -140.09 138.8 37.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.135 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.35 67.38 0.33 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.797 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 173.4 -52.67 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.748 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -153.03 172.24 17.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -94.78 127.94 41.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.942 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.465 ' HD3' HG21 ' A' ' 87' ' ' VAL . 0.8 OUTLIER -101.12 125.4 47.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.869 179.914 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.438 ' HB2' ' CE1' ' A' ' 137' ' ' TYR . 38.7 m-80 -112.77 125.08 53.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.994 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.648 ' HG ' HD11 ' A' ' 118' ' ' ILE . 1.3 tp -122.52 129.3 51.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.694 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.476 ' N ' HD12 ' A' ' 95' ' ' ILE . 3.2 mp -122.96 141.01 44.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.204 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -116.53 144.01 44.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.827 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.954 HG22 ' CE2' ' A' ' 80' ' ' PHE . 22.0 t -112.17 124.63 69.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.193 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 20.4 mt -130.01 124.95 59.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.071 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' ASP . . . . . 0.449 ' HB2' HD22 ' A' ' 112' ' ' LEU . 26.7 m-20 -114.03 127.83 56.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.946 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.71 -7.47 59.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.372 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 21.6 m 64.25 79.02 0.27 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.779 0.324 . . . . 0.0 110.884 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.43 -39.95 3.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.919 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -133.19 -46.02 0.84 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.192 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 145.47 103.16 0.38 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.406 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.449 HG23 ' CD1' ' A' ' 127' ' ' PHE . 28.0 m -113.46 131.57 55.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.788 0.328 . . . . 0.0 110.92 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -116.49 117.71 30.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.871 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.447 HD13 HG23 ' A' ' 125' ' ' ILE . 3.0 tp -112.5 137.32 45.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.424 0.631 . . . . 0.0 111.281 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 62.15 27.66 16.65 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.942 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.59 10.22 70.74 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.94 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -133.99 151.34 51.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.775 0.321 . . . . 0.0 110.957 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.58 130.0 40.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.859 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.709 HD21 ' O ' ' A' ' 114' ' ' LYS . 7.0 tt -70.19 139.28 52.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.818 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.472 HG13 ' N ' ' A' ' 114' ' ' LYS . 10.8 p -121.98 -44.66 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.077 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' LYS . . . . . 0.709 ' O ' HD21 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -84.61 167.45 16.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.946 179.97 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -108.85 28.52 8.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.942 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -158.62 62.45 0.43 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.005 0.431 . . . . 0.0 110.8 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -84.06 139.11 32.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.803 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.648 HD11 ' HG ' ' A' ' 94' ' ' LEU . 8.6 tp -98.48 120.14 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-O 121.01 0.433 . . . . 0.0 111.408 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.679 HD11 HD11 ' A' ' 125' ' ' ILE . 6.6 tt -103.1 142.21 34.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.923 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 9.6 mmtp -129.76 178.13 6.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.817 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.45 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 9.2 p30 -56.35 144.44 30.55 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.083 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.433 ' HA2' HD21 ' A' ' 134' ' ' LEU . . . 65.51 45.49 89.65 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.42 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -112.37 133.59 54.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.91 0.386 . . . . 0.0 110.973 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.607 ' HG2' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -91.42 130.77 37.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.819 179.931 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.679 HD11 HD11 ' A' ' 119' ' ' LEU . 1.8 mp -129.83 121.92 53.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.255 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.572 HG22 ' OG ' ' A' ' 132' ' ' SER . 39.2 t -113.13 130.55 66.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.033 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.57 ' CE2' ' HB3' ' A' ' 78' ' ' ALA . 3.3 m-85 -114.61 141.39 47.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.071 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 71.59 -64.67 1.11 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.49 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 169.91 -38.2 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.884 0.373 . . . . 0.0 110.963 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 82.7 p -101.75 -39.97 7.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.041 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' CYS . . . . . 0.713 ' HB3' HD22 ' A' ' 68' ' ' LEU . 57.1 m -57.17 106.38 0.31 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.998 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' SER . . . . . 0.572 ' OG ' HG22 ' A' ' 126' ' ' VAL . 1.3 m -124.21 123.7 40.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.889 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -142.09 156.01 45.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.111 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.607 HD12 ' HG2' ' A' ' 124' ' ' ARG . 1.4 tt -117.89 140.02 50.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.717 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -104.94 141.39 36.64 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.945 0.879 . . . . 0.0 111.935 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -154.73 159.35 40.63 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 113.711 -1.586 . . . . 0.0 110.591 179.459 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.45 ' CE2' ' HB3' ' A' ' 121' ' ' ASN . 2.5 m-85 -83.83 139.81 32.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.021 0.438 . . . . 0.0 110.697 179.588 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.563 ' HB2' ' ND1' ' A' ' 36' ' ' HIS . . . . . . . . 0 C--N 1.326 -0.441 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.131 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.797 0.332 . . . . 0.0 110.554 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.8 t -60.71 145.05 50.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.063 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.551 HD22 ' OD1' ' A' ' 93' ' ' ASN . 9.6 mt -147.76 -53.68 0.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.908 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.689 ' C ' HG22 ' A' ' 50' ' ' ILE . . . -140.65 -175.28 14.48 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.564 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 50.4 m80 -146.07 166.05 27.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.904 0.383 . . . . 0.0 110.936 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.7 mp -125.69 107.85 10.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.539 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.65 HG22 ' HG2' ' A' ' 47' ' ' LYS . 27.6 t -96.13 121.98 47.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.167 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -89.98 113.98 25.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.86 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -87.65 106.75 18.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.878 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.542 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 18.9 mt -124.17 141.0 36.12 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.835 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.542 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 50.2 Cg_endo -72.59 83.95 1.26 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.078 1.852 . . . . 0.0 111.967 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 118.0 25.98 2.88 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.372 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 170.58 155.31 0.06 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.691 0.282 . . . . 0.0 110.555 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -142.47 151.91 42.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.975 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -140.29 128.79 22.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.176 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.65 ' HG2' HG22 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -113.04 131.24 55.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.806 179.82 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.8 t -125.46 151.02 31.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.29 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -104.24 132.92 49.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.626 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.689 HG22 ' C ' ' A' ' 35' ' ' GLY . 2.3 tt -116.07 132.02 66.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.01 0.433 . . . . 0.0 111.492 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.01 168.05 9.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.033 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.482 ' HB3' HD12 ' A' ' 34' ' ' LEU . 6.7 p30 -76.28 63.39 1.91 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.307 179.384 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.542 ' C ' ' H ' ' A' ' 55' ' ' VAL . 11.1 ttt-85 -80.88 0.12 36.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.013 -179.42 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.451 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 8.3 m120 71.51 -35.88 0.34 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -178.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.542 ' H ' ' C ' ' A' ' 53' ' ' ARG . 68.0 t -137.37 134.14 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.061 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.653 HG23 ' HB3' ' A' ' 65' ' ' ASP . 51.8 m -125.29 124.19 41.08 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.893 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.66 127.34 51.12 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.952 0.406 . . . . 0.0 111.11 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.725 ' CG2' HD11 ' A' ' 68' ' ' LEU . 4.6 mp -107.98 117.74 54.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.003 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 172.95 -144.96 8.14 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.405 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.3 ttm105 -111.15 -19.93 12.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.715 0.293 . . . . 0.0 111.245 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.449 ' HB2' HG22 ' A' ' 75' ' ' THR . 0.1 OUTLIER -50.27 151.67 2.03 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.895 0.379 . . . . 0.0 111.141 -179.859 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -72.91 -38.74 66.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.93 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 6.0 m -70.1 -19.62 63.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.209 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 48.8 m -53.91 149.25 9.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.028 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.653 ' HB3' HG23 ' A' ' 56' ' ' THR . 10.4 t70 -75.16 -53.68 8.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.904 0.383 . . . . 0.0 110.836 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.5 t -114.83 116.99 54.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.216 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 20.0 pt -99.15 131.05 47.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.061 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.834 HD13 HG12 ' A' ' 73' ' ' ILE . 5.0 mp -86.45 -175.93 5.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.911 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.2 t -118.34 34.61 5.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.98 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.419 ' HB3' ' HB ' ' A' ' 73' ' ' ILE . 5.4 tp10 -109.68 118.51 50.12 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.667 179.787 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -57.74 -16.11 23.79 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.566 2.177 . . . . 0.0 112.804 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -119.8 36.61 4.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.765 0.317 . . . . 0.0 111.029 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.834 HG12 HD13 ' A' ' 68' ' ' LEU . 7.3 tp -82.45 147.7 5.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.27 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.427 ' HB3' ' CG ' ' A' ' 77' ' ' HIS . 2.5 t -77.17 129.91 36.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.103 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.449 HG22 ' HB2' ' A' ' 61' ' ' SER . 1.8 m -65.37 -39.21 92.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.726 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.434 ' O ' ' C ' ' A' ' 77' ' ' HIS . 1.1 m-85 -103.8 13.94 31.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.295 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.434 ' C ' ' O ' ' A' ' 76' ' ' PHE . 0.3 OUTLIER -22.31 -71.87 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.647 -1.161 . . . . 0.0 112.595 -179.349 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.601 ' HB3' ' CE2' ' A' ' 127' ' ' PHE . . . -158.6 164.03 36.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.074 0.464 . . . . 0.0 111.928 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' GLU . . . . . 0.58 ' HG3' HD12 ' A' ' 98' ' ' ILE . 11.1 pt-20 -129.09 136.49 50.3 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.471 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.883 ' CZ ' HG13 ' A' ' 97' ' ' VAL . 6.1 m-85 -119.54 131.17 55.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.887 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.451 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 6.3 m-70 -94.87 116.38 28.64 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.89 0.376 . . . . 0.0 111.049 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.498 HD12 HG12 ' A' ' 95' ' ' ILE . 0.4 OUTLIER -106.51 109.58 21.54 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.711 179.57 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.4 mp -122.2 140.14 52.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.166 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.0 tm0? -108.97 133.34 53.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.892 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -141.89 122.69 14.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.939 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -97.05 116.1 28.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.944 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 4.2 m -119.68 110.92 30.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.243 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 59.25 72.82 0.51 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.004 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 66.08 -74.54 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.042 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -52.85 144.41 14.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.152 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -108.83 130.95 55.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.94 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -116.5 125.61 52.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.796 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.551 ' OD1' HD22 ' A' ' 34' ' ' LEU . 5.1 m120 -106.98 135.37 48.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.939 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.66 139.62 53.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.773 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.498 HG12 HD12 ' A' ' 82' ' ' LEU . 4.0 mp -127.79 138.29 55.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.205 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.88 140.62 48.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.772 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.883 HG13 ' CZ ' ' A' ' 80' ' ' PHE . 16.9 t -103.99 121.99 56.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.156 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ILE . . . . . 0.58 HD12 ' HG3' ' A' ' 79' ' ' GLU . 28.6 mt -114.21 124.2 70.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.046 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -87.78 138.23 31.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.941 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.1 -25.68 14.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.013 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.1 m 65.47 81.37 0.21 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.943 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -137.07 -47.07 0.58 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.883 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -124.74 -48.83 1.77 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.157 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 154.32 129.39 1.29 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.547 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.493 HG23 ' CE1' ' A' ' 127' ' ' PHE . 1.7 m -131.94 123.7 27.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.758 0.314 . . . . 0.0 110.954 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -121.16 123.28 41.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.809 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.479 HD12 ' O ' ' A' ' 124' ' ' ARG . 2.9 tp -119.01 137.32 53.36 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-O 121.426 0.631 . . . . 0.0 111.337 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.7 m120 62.38 27.97 16.62 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.859 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.66 9.82 70.33 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.971 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -133.99 152.04 51.69 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.825 0.345 . . . . 0.0 110.859 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.02 129.21 39.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.88 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.474 HD21 ' HB ' ' A' ' 105' ' ' THR . 4.1 pp -71.44 140.13 49.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.954 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.0 m -135.02 31.41 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.171 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 23.9 mmtt -145.93 149.09 33.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.931 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 17.9 ttpp -98.77 31.13 3.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.813 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -166.57 66.93 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.862 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -82.81 139.03 33.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.941 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.633 HD13 ' C ' ' A' ' 118' ' ' ILE . 0.0 OUTLIER -98.73 117.61 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.749 -179.841 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.779 HD11 HD11 ' A' ' 125' ' ' ILE . 7.7 tt -103.0 136.89 41.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.186 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' LYS . . . . . 0.542 ' N ' HD23 ' A' ' 119' ' ' LEU . 3.1 mmmm -136.14 178.15 7.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.764 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.433 ' HB3' ' CZ ' ' A' ' 137' ' ' TYR . 12.7 p30 -55.48 139.31 44.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.034 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 71.27 52.93 11.36 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.479 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -124.8 125.25 43.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.794 0.33 . . . . 0.0 110.974 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.613 ' HG3' HD12 ' A' ' 134' ' ' LEU . 11.2 mtp180 -93.67 131.81 38.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.818 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.779 HD11 HD11 ' A' ' 119' ' ' LEU . 2.7 mt -125.74 137.95 56.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.123 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 22.9 t -120.36 123.98 71.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.065 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.601 ' CE2' ' HB3' ' A' ' 78' ' ' ALA . 3.6 m-85 -119.22 128.97 54.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.139 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 80.97 -3.38 76.42 Favored Glycine 0 CA--C 1.518 0.252 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.072 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 8.6 tttt 76.31 24.5 1.09 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.861 0.362 . . . . 0.0 110.511 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.88 -52.63 0.13 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.012 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 91.1 m -77.48 107.76 10.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.671 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 79.8 p -121.99 133.33 54.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.992 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.423 ' CE1' ' HB ' ' A' ' 125' ' ' ILE . 2.8 p90 -142.01 155.69 45.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.905 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.613 HD12 ' HG3' ' A' ' 124' ' ' ARG . 7.9 tt -112.35 139.98 47.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.774 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.558 ' HE1' HG21 ' A' ' 50' ' ' ILE . 74.1 t80 -101.5 141.5 34.28 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.944 0.878 . . . . 0.0 111.838 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.31 154.11 32.82 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 113.864 -1.516 . . . . 0.0 110.784 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.479 ' N ' ' CD1' ' A' ' 137' ' ' TYR . 0.6 OUTLIER -85.53 139.72 31.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.992 0.425 . . . . 0.0 110.752 179.74 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.414 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.097 -179.918 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.4 m . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.842 0.353 . . . . 0.0 110.749 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.8 t -60.07 135.21 57.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.868 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.631 HD11 HD21 ' A' ' 93' ' ' ASN . 4.9 tp -136.65 -63.61 0.61 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.97 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -139.6 178.25 19.82 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.498 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.43 ' ND1' ' HB2' ' A' ' 138' ' ' ALA . 31.0 m80 -133.52 166.0 23.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.788 0.328 . . . . 0.0 110.911 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.656 HD22 ' HD2' ' A' ' 133' ' ' PHE . 18.9 mt -126.5 113.71 17.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.96 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.462 HG22 ' HD3' ' A' ' 47' ' ' LYS . 28.5 t -96.24 121.89 47.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.948 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -90.0 113.85 25.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.892 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LEU . . . . . 0.555 HD13 HH12 ' A' ' 124' ' ' ARG . 2.9 mt -77.76 106.75 9.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.785 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.523 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 1.6 mp -124.15 140.26 34.47 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.97 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' PRO . . . . . 0.523 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 67.9 Cg_endo -76.13 83.84 1.92 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.304 2.003 . . . . 0.0 112.029 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 115.62 24.04 4.18 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.382 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -179.5 166.96 1.45 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.794 0.33 . . . . 0.0 110.612 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -144.41 128.27 17.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.045 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -116.17 118.82 33.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.835 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.462 ' HD3' HG22 ' A' ' 38' ' ' VAL . 1.1 mmmp? -108.82 124.83 51.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.909 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.617 HG11 HG13 ' A' ' 66' ' ' VAL . 26.2 t -120.36 137.64 53.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.096 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.75 132.84 34.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.84 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.541 HD11 HD12 ' A' ' 37' ' ' LEU . 33.4 mm -108.76 116.25 51.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.264 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.566 ' O ' HD23 ' A' ' 82' ' ' LEU . 0.2 OUTLIER -100.88 167.77 10.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.66 179.729 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASN . . . . . 0.532 ' HA ' HD23 ' A' ' 82' ' ' LEU . 3.4 m120 -61.68 -95.65 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.324 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ARG . . . . . 0.564 ' C ' ' H ' ' A' ' 55' ' ' VAL . 3.9 ttt-85 70.79 -4.41 1.71 Allowed 'General case' 0 C--O 1.232 0.15 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 179.207 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' ASN . . . . . 0.4 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 0.1 OUTLIER 70.24 -32.93 0.25 Allowed 'General case' 0 C--N 1.331 -0.226 0 O-C-N 122.156 -0.34 . . . . 0.0 110.247 -179.035 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 55' ' ' VAL . . . . . 0.564 ' H ' ' C ' ' A' ' 53' ' ' ARG . 65.7 t -136.72 140.72 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-O 121.082 0.468 . . . . 0.0 111.055 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.816 HG23 ' HB3' ' A' ' 65' ' ' ASP . 14.2 m -125.35 130.19 51.44 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.101 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.98 135.48 45.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.818 0.342 . . . . 0.0 110.684 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ILE . . . . . 0.74 ' CG2' HD23 ' A' ' 68' ' ' LEU . 5.9 mt -128.5 124.07 61.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.342 -179.625 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 166.55 -134.48 3.29 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.47 -0.872 . . . . 0.0 113.068 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ARG . . . . . 0.466 ' HB2' HG23 ' A' ' 73' ' ' ILE . 8.2 ttp180 -99.99 -40.12 7.8 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.886 0.374 . . . . 0.0 111.158 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' SER . . . . . 0.804 ' HB2' HG23 ' A' ' 75' ' ' THR . 0.3 OUTLIER -46.18 118.11 1.79 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.481 -179.52 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.85 -28.37 56.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.76 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -69.93 -22.96 63.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.88 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 86.8 m -54.33 154.27 4.69 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.774 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.816 ' HB3' HG23 ' A' ' 56' ' ' THR . 64.1 t0 -65.88 -46.25 79.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.823 0.344 . . . . 0.0 110.957 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' VAL . . . . . 0.617 HG13 HG11 ' A' ' 48' ' ' VAL . 21.3 t -125.18 133.24 69.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.436 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.8 pt -106.16 122.43 59.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.69 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . 0.74 HD23 ' CG2' ' A' ' 58' ' ' ILE . 2.7 mm? -94.15 -88.35 0.24 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.94 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 28.0 t -104.79 -115.64 0.23 Allowed 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.584 ' HA ' HG22 ' A' ' 73' ' ' ILE . 3.4 tt0 171.79 -62.1 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.327 0 O-C-N 122.372 -0.205 . . . . 0.0 111.117 179.373 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' PRO . . . . . 0.524 ' HD3' ' CB ' ' A' ' 70' ' ' GLU . 38.8 Cg_exo -59.44 -40.17 69.49 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 121.924 1.749 . . . . 0.0 112.86 -179.476 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -118.73 19.85 13.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.507 -179.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.584 HG22 ' HA ' ' A' ' 70' ' ' GLU . 4.6 tp -103.97 122.2 56.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.078 0.466 . . . . 0.0 110.942 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' SER . . . . . 0.429 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 2.6 p -71.81 134.87 46.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.406 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.804 HG23 ' HB2' ' A' ' 61' ' ' SER . 91.4 m -61.99 -30.35 70.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.716 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' PHE . . . . . 0.422 ' O ' ' C ' ' A' ' 77' ' ' HIS . 0.4 OUTLIER -108.77 14.08 24.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.514 -179.939 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 77' ' ' HIS . . . . . 0.504 ' CD2' ' CD1' ' A' ' 127' ' ' PHE . 1.1 t60 -25.68 -68.73 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.796 -1.093 . . . . 0.0 112.668 -179.345 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ALA . . . . . 0.569 ' HB3' ' CZ ' ' A' ' 127' ' ' PHE . . . -157.09 164.1 38.25 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.017 0.437 . . . . 0.0 111.647 -179.575 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -131.67 137.95 48.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.822 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' PHE . . . . . 0.898 ' CE2' HG22 ' A' ' 97' ' ' VAL . 7.0 m-85 -119.28 130.14 55.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.534 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' HIS . . . . . 0.4 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 4.4 m-70 -94.78 116.17 28.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.802 0.334 . . . . 0.0 111.14 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LEU . . . . . 0.566 HD23 ' O ' ' A' ' 51' ' ' THR . 11.1 tp -106.54 109.49 21.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.718 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.46 140.23 52.97 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.035 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLN . . . . . 0.467 ' HB2' HD22 ' A' ' 52' ' ' ASN . 0.6 OUTLIER -98.45 134.89 40.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.682 179.767 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.02 122.94 47.45 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.984 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -96.97 119.53 35.61 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.002 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.4 t -140.05 139.15 37.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.098 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -48.59 -56.44 8.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.198 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 -51.08 -75.11 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.152 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -147.65 155.27 41.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.801 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -82.92 127.93 33.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.967 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.04 134.93 54.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.984 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' ASN . . . . . 0.631 HD21 HD11 ' A' ' 34' ' ' LEU . 20.1 m-20 -111.43 140.62 45.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.733 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LEU . . . . . 0.619 ' HG ' HD11 ' A' ' 118' ' ' ILE . 4.6 tp -132.02 139.47 48.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.054 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ILE . . . . . 0.641 HD13 HD23 ' A' ' 119' ' ' LEU . 2.6 mp -125.02 134.31 67.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.049 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -114.04 144.01 43.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.817 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' VAL . . . . . 0.898 HG22 ' CE2' ' A' ' 80' ' ' PHE . 16.3 t -108.78 131.61 58.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.187 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.8 mp -130.05 121.31 51.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.985 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 21.1 p30 -84.88 139.09 32.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.93 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -143.6 30.48 1.35 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.959 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.6 m -153.97 152.2 30.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.829 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 11.7 mmt180 -106.18 34.6 3.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.987 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -89.19 -31.22 18.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.207 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 121.19 115.99 2.43 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.452 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' THR . . . . . 0.463 ' CG2' ' CE1' ' A' ' 127' ' ' PHE . 99.5 m -131.72 128.45 38.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.811 0.338 . . . . 0.0 110.886 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -121.05 114.96 22.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.746 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ILE . . . . . 0.639 HD12 ' O ' ' A' ' 124' ' ' ARG . 2.8 tp -111.56 137.29 44.74 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 CA-C-O 121.435 0.636 . . . . 0.0 111.342 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 61.93 26.53 16.05 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.739 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.72 8.95 69.01 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.858 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 51.9 m-80 -134.11 151.99 51.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.792 0.33 . . . . 0.0 110.901 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 10.5 mtm105 -74.96 132.82 41.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.739 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.432 HD23 ' H ' ' A' ' 112' ' ' LEU . 0.6 OUTLIER -83.05 143.5 30.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.95 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.636 ' O ' HG22 ' A' ' 113' ' ' VAL . 14.5 p -128.75 14.56 2.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.39 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -121.85 -178.56 3.87 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.806 0.336 . . . . 0.0 110.768 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.3 mttt -110.2 -29.64 8.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.95 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -112.63 78.87 1.16 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.899 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -80.79 139.33 36.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.903 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.619 HD11 ' HG ' ' A' ' 94' ' ' LEU . 7.5 tp -98.46 115.98 40.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.035 0.445 . . . . 0.0 111.241 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.641 HD23 HD13 ' A' ' 95' ' ' ILE . 0.7 OUTLIER -103.12 132.85 49.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.964 -179.862 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 19.4 mttm -135.99 178.23 7.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.76 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ASN . . . . . 0.46 ' ND2' ' CD2' ' A' ' 137' ' ' TYR . 3.2 t-20 -50.93 139.99 16.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.176 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' GLY . . . . . 0.508 ' HA2' HD21 ' A' ' 134' ' ' LEU . . . 70.75 51.46 19.78 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.497 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.46 130.07 53.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.918 0.39 . . . . 0.0 110.952 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ARG . . . . . 0.639 ' O ' HD12 ' A' ' 107' ' ' ILE . 1.4 ttm-85 -98.15 124.11 42.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.918 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' ILE . . . . . 0.529 HD11 HD11 ' A' ' 119' ' ' LEU . 1.9 mp -115.53 134.71 57.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.17 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 29.2 t -124.1 133.95 67.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.104 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' PHE . . . . . 0.569 ' CZ ' ' HB3' ' A' ' 78' ' ' ALA . 7.5 m-85 -131.84 134.33 45.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.055 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 81.02 -2.23 81.72 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.95 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 2.8 mtpp 75.47 27.77 1.02 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.914 0.388 . . . . 0.0 110.424 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 63.9 p -154.01 -60.03 0.13 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.834 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' CYS . . . . . 0.71 ' HB3' HD12 ' A' ' 68' ' ' LEU . 55.6 m -61.91 109.05 1.14 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.727 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.0 p -120.51 128.0 52.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.004 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' PHE . . . . . 0.656 ' HD2' HD22 ' A' ' 37' ' ' LEU . 2.1 p90 -142.06 155.99 45.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.953 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' LEU . . . . . 0.508 HD21 ' HA2' ' A' ' 122' ' ' GLY . 3.9 tt -113.37 140.11 48.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.834 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' PHE . . . . . 0.507 ' HE2' HG21 ' A' ' 50' ' ' ILE . 26.4 t80 -104.54 141.48 36.32 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.984 0.897 . . . . 0.0 111.81 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 8.7 pttt -154.71 158.97 40.37 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 113.914 -1.494 . . . . 0.0 110.867 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' TYR . . . . . 0.46 ' CD2' ' ND2' ' A' ' 121' ' ' ASN . 3.2 m-85 -86.07 139.74 30.87 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.716 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' ALA . . . . . 0.43 ' HB2' ' ND1' ' A' ' 36' ' ' HIS . . . . . . . . 0 C--N 1.325 -0.483 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.22 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 120.81 0.338 . . . . 0.0 111.266 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -87.13 -32.57 19.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.809 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -91.42 124.58 35.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.894 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -116.3 166.23 12.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.864 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.5 164.89 18.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.935 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 60.16 -179.09 0.1 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.914 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -80.2 143.53 33.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.811 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.2 mtpt -115.93 148.78 42.06 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.966 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.77 144.19 53.17 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.552 2.168 . . . . 0.0 112.326 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 37.7 p -121.37 -52.71 2.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.804 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.1 m -105.56 -33.09 8.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.837 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.22 130.03 35.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.864 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.401 ' N ' HG21 ' A' ' 51' ' ' THR . 3.0 m-85 -57.88 -99.26 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.993 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.467 ' N ' HG22 ' A' ' 51' ' ' THR . 0.2 OUTLIER -140.59 128.94 22.5 Favored 'General case' 0 C--N 1.334 -0.075 0 CA-C-O 120.703 0.287 . . . . 0.0 110.471 179.813 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.8 t -64.46 130.71 44.78 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.91 0.386 . . . . 0.0 111.036 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.12 -47.0 0.64 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.77 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.644 ' C ' HG22 ' A' ' 50' ' ' ILE . . . -138.83 -178.84 16.7 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.357 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.43 ' CD2' ' HA ' ' A' ' 49' ' ' GLU . 49.4 m80 -147.02 162.36 38.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.865 0.364 . . . . 0.0 110.919 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.492 HD11 ' HB ' ' A' ' 50' ' ' ILE . 1.0 OUTLIER -127.07 119.7 27.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.754 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.5 t -97.53 122.96 49.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.104 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -89.99 126.48 35.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.884 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.654 HD13 ' NH2' ' A' ' 124' ' ' ARG . 0.9 OUTLIER -90.62 106.82 18.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.54 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 20.8 mt -124.09 140.65 35.25 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.934 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.54 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 57.2 Cg_endo -73.86 87.99 1.1 Allowed 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.162 1.908 . . . . 0.0 111.983 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 137.79 -12.08 3.68 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.386 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.1 pttp 178.2 173.51 0.63 Allowed 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 120.727 0.299 . . . . 0.0 110.689 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -135.7 160.68 37.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.048 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.61 134.08 33.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.947 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.04 127.7 56.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.82 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.448 ' O ' HD12 ' A' ' 37' ' ' LEU . 30.6 t -119.48 130.79 73.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.182 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.43 ' HA ' ' CD2' ' A' ' 36' ' ' HIS . 3.3 pm0 -81.6 136.6 35.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.734 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.644 HG22 ' C ' ' A' ' 35' ' ' GLY . 16.7 tt -116.02 132.11 66.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.338 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.467 HG22 ' N ' ' A' ' 32' ' ' THR . 0.7 OUTLIER -97.05 168.09 10.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.999 -179.682 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.417 ' HA ' HD22 ' A' ' 82' ' ' LEU . 7.0 p30 -92.63 66.16 4.43 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.079 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.571 ' C ' ' H ' ' A' ' 55' ' ' VAL . 0.1 OUTLIER -90.37 13.26 15.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.016 -179.253 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.447 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 0.7 OUTLIER 69.28 -34.6 0.28 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -179.524 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.571 ' H ' ' C ' ' A' ' 53' ' ' ARG . 62.3 t -137.28 124.09 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-O 120.948 0.404 . . . . 0.0 111.343 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.769 HG23 ' HB3' ' A' ' 65' ' ' ASP . 15.9 m -111.04 128.8 55.98 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.624 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.74 138.67 40.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.908 0.385 . . . . 0.0 111.043 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.594 HD11 ' HD2' ' A' ' 80' ' ' PHE . 4.7 mp -126.64 117.98 49.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.033 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 176.68 -160.73 28.29 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.667 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.504 ' HB2' HG23 ' A' ' 73' ' ' ILE . 5.2 ttp180 -83.39 -29.82 27.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.726 0.298 . . . . 0.0 110.979 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.682 ' HB2' HG23 ' A' ' 75' ' ' THR . 7.2 t -58.09 129.32 41.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.968 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.42 -22.64 67.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.022 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 6.3 m -69.89 -27.58 64.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.004 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 97.5 m -57.16 151.61 15.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.82 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.769 ' HB3' HG23 ' A' ' 56' ' ' THR . 63.9 t0 -61.31 -43.96 98.01 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.884 0.374 . . . . 0.0 110.603 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.8 t -125.03 114.92 42.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.093 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.595 HG23 ' O ' ' A' ' 67' ' ' ILE . 19.6 tt -93.75 107.4 19.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.026 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.801 HD13 HD11 ' A' ' 73' ' ' ILE . 18.0 mt -65.36 -177.97 0.46 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.928 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.9 p -123.39 65.05 1.0 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.238 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.87 141.1 40.67 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.606 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.22 -19.22 50.72 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.605 2.203 . . . . 0.0 112.911 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -133.86 34.78 3.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.794 0.331 . . . . 0.0 111.31 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.801 HD11 HD13 ' A' ' 68' ' ' LEU . 3.2 tp -71.86 128.7 35.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.165 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.4 m -59.92 133.35 56.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.212 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.682 HG23 ' HB2' ' A' ' 61' ' ' SER . 86.7 m -64.46 -44.03 92.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.802 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.456 ' O ' ' C ' ' A' ' 77' ' ' HIS . 34.9 m-85 -99.68 13.9 31.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.405 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.456 ' C ' ' O ' ' A' ' 76' ' ' PHE . 1.8 t-160 -19.0 -69.94 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.737 -1.12 . . . . 0.0 112.771 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -153.78 164.08 38.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.986 0.422 . . . . 0.0 111.731 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.15 138.96 50.91 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.737 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.594 ' HD2' HD11 ' A' ' 58' ' ' ILE . 38.3 m-85 -119.53 131.07 55.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.55 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.447 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 9.0 m-70 -94.77 115.84 28.0 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.139 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.476 HD13 HG12 ' A' ' 50' ' ' ILE . 0.4 OUTLIER -107.08 109.81 21.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.796 179.485 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.0 pp -120.1 140.07 51.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.048 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -117.44 128.11 54.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.878 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.3 ttm -135.65 151.4 50.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.892 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -106.52 121.01 43.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.947 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.464 ' O ' HG13 ' A' ' 87' ' ' VAL . 10.5 p -126.92 121.44 58.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.929 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.8 t0 75.18 -58.0 0.58 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.062 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -173.17 -40.61 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.842 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -89.54 132.92 34.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.773 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.01 131.0 35.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.929 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -113.49 143.49 44.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.821 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -113.99 142.79 45.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.983 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.578 ' HG ' HD11 ' A' ' 118' ' ' ILE . 1.5 tp -131.91 136.19 47.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.739 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.631 ' N ' HD12 ' A' ' 95' ' ' ILE . 3.4 mp -114.7 140.95 33.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.125 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -117.54 133.54 55.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.785 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.531 HG13 ' CE1' ' A' ' 80' ' ' PHE . 7.7 t -96.36 127.34 48.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.238 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 9.9 mt -130.09 139.14 52.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.962 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -114.19 129.92 56.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.979 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.11 31.42 0.76 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.86 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.3 m -135.11 -178.74 5.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.881 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.02 37.68 3.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.882 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -101.13 -30.11 11.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.2 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 115.27 106.26 2.58 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.441 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.521 HG23 ' CE1' ' A' ' 127' ' ' PHE . 89.4 m -122.34 123.26 40.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.843 0.354 . . . . 0.0 110.948 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -121.0 115.0 22.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.855 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.8 tp -110.56 137.29 43.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.506 0.67 . . . . 0.0 111.318 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.9 m120 59.84 31.54 20.81 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.75 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.63 9.32 69.3 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.893 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -134.13 151.97 51.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.843 0.354 . . . . 0.0 110.838 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 30.4 ttp180 -74.73 140.54 44.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.908 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.64 HD22 ' O ' ' A' ' 114' ' ' LYS . 0.4 OUTLIER -75.98 133.68 40.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.915 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.47 HG23 ' HG3' ' A' ' 114' ' ' LYS . 5.8 m -112.08 -34.3 2.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.128 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.64 ' O ' HD22 ' A' ' 112' ' ' LEU . 44.1 mttp -100.34 -178.16 3.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.895 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.6 mttp -121.17 32.08 6.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.85 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -154.23 56.17 0.71 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.989 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.45 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 1.8 t80 -84.15 139.25 32.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.815 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.578 HD11 ' HG ' ' A' ' 94' ' ' LEU . 8.2 tp -98.53 118.89 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.217 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.629 HD11 HD11 ' A' ' 125' ' ' ILE . 9.2 tt -103.08 136.74 42.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.007 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 9.0 mttt -130.54 178.08 6.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.751 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.409 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 28.5 p30 -53.1 148.07 8.69 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.089 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.484 ' HA2' HD21 ' A' ' 134' ' ' LEU . . . 66.65 37.48 92.5 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.507 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.91 131.5 53.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.77 0.319 . . . . 0.0 110.87 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.654 ' NH2' HD13 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -97.99 125.54 42.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.837 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.629 HD11 HD11 ' A' ' 119' ' ' LEU . 2.9 mp -121.96 135.53 61.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.14 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.9 t -120.85 126.34 75.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.977 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.521 ' CE1' HG23 ' A' ' 105' ' ' THR . 44.8 m-85 -123.39 124.93 44.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.955 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 85.88 -6.16 81.76 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.864 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 77.74 27.8 0.58 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.93 0.395 . . . . 0.0 110.492 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 82.5 p -153.13 -46.36 0.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.797 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' CYS . . . . . 0.6 ' HB3' HD22 ' A' ' 68' ' ' LEU . 60.1 m -80.37 108.29 13.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.861 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 48.3 t -124.0 125.61 44.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.927 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -138.03 155.0 49.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.813 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.484 HD21 ' HA2' ' A' ' 122' ' ' GLY . 1.5 tt -108.29 130.02 55.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.79 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.622 ' HE2' HG21 ' A' ' 50' ' ' ILE . 30.2 t80 -99.68 141.58 32.3 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 122.025 0.917 . . . . 0.0 111.712 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 12.8 tttm -154.47 155.09 34.28 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 113.853 -1.521 . . . . 0.0 110.726 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.409 ' CE2' ' HB3' ' A' ' 121' ' ' ASN . 3.4 m-85 -81.62 139.51 34.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.958 0.409 . . . . 0.0 110.793 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -120.39 68.69 0.85 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.03 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.4 -49.15 67.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.92 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.58 -45.15 1.49 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.951 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 1.1 m 60.81 107.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.826 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.7 m -102.82 129.38 49.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.874 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.4 p -151.07 38.13 0.65 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.911 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.74 104.06 8.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.865 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.583 HG22 ' H ' ' A' ' 146' ' ' GLU . 3.2 mm -110.66 -143.75 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.175 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.583 ' H ' HG22 ' A' ' 145' ' ' ILE . 0.6 OUTLIER -132.2 -46.43 0.92 Allowed 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.885 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -129.65 95.11 3.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.87 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.48 143.79 31.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.846 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.91 80.07 5.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.879 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -176.69 130.68 0.19 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.949 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.28 129.46 37.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.89 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.472 ' O ' HG23 ' A' ' 152' ' ' VAL . 29.9 m -130.76 119.89 46.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.128 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 33.4 t -128.5 157.36 41.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.915 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 10.3 p -111.32 -34.51 6.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.922 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -93.83 175.08 6.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.883 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 4.0 t -132.47 154.09 50.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.899 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 2.6 mtp85 59.91 31.77 20.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.799 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.35 162.32 41.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.95 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 8.4 t80 . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.913 179.985 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.4 mtmt . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.813 0.34 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 24.7 ptt85 -129.56 106.46 8.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.921 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -138.04 148.12 44.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.912 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -157.83 162.05 38.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.856 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.8 mmm180 -107.7 149.54 28.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.807 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.5 m -98.56 32.81 2.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.968 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -162.58 152.13 15.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.892 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.6 mttp -95.78 110.85 53.61 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.847 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.3 141.14 50.78 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.384 2.056 . . . . 0.0 112.34 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -107.9 158.58 17.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.918 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -166.01 -174.13 2.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.898 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 65.77 98.7 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.081 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.504 ' N ' HG21 ' A' ' 51' ' ' THR . 1.9 m-85 -52.6 -94.53 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.007 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' A' ' 51' ' ' THR . 0.9 OUTLIER -140.31 128.63 22.54 Favored 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 179.552 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.8 t -59.89 144.79 47.91 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.816 0.341 . . . . 0.0 111.114 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.948 HD22 HD21 ' A' ' 82' ' ' LEU . 1.1 tp -157.49 -67.35 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.968 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -118.98 165.25 13.03 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.526 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.517 ' ND1' ' HB2' ' A' ' 138' ' ' ALA . 32.0 m80 -136.83 161.12 36.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.848 0.356 . . . . 0.0 111.078 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.966 HD11 HD11 ' A' ' 50' ' ' ILE . 2.9 mt -120.58 111.08 17.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.669 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.6 t -96.02 121.76 46.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.02 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -90.17 113.91 25.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.882 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.74 106.81 14.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.814 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.525 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 22.0 mt -124.2 140.44 34.92 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.847 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.525 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 57.8 Cg_endo -74.29 86.42 1.31 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.186 1.924 . . . . 0.0 111.955 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 115.6 23.74 4.28 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.256 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 176.92 -168.36 0.06 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.738 0.304 . . . . 0.0 110.593 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -177.47 152.39 0.83 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.886 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -137.97 130.81 29.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.087 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.3 tttt -113.07 134.84 54.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.905 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.735 HG11 HG13 ' A' ' 66' ' ' VAL . 37.5 t -121.62 151.02 24.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.202 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -100.82 133.62 45.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.789 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.966 HD11 HD11 ' A' ' 37' ' ' LEU . 33.1 mm -116.07 129.51 72.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.173 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.961 ' O ' HD13 ' A' ' 82' ' ' LEU . 2.0 p -106.08 167.99 9.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.96 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.938 ' HA ' HD22 ' A' ' 82' ' ' LEU . 6.9 m-80 -85.1 63.67 8.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.168 0.508 . . . . 0.0 110.256 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.579 ' C ' ' H ' ' A' ' 55' ' ' VAL . 23.2 ttt-85 -87.3 2.76 49.25 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.914 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.411 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 0.7 OUTLIER 71.68 -34.63 0.3 Allowed 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -178.573 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.579 ' H ' ' C ' ' A' ' 53' ' ' ARG . 75.6 t -137.22 136.06 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.473 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.714 HG23 ' HB3' ' A' ' 65' ' ' ASP . 18.8 m -125.12 129.68 50.67 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.957 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.81 136.12 44.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.911 0.386 . . . . 0.0 110.846 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.415 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 36.6 mt -125.68 128.4 72.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.983 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 168.91 -143.95 8.4 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.222 -0.99 . . . . 0.0 113.353 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.493 ' HB2' ' CG2' ' A' ' 73' ' ' ILE . 5.8 ttp-105 -96.9 -40.55 8.85 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.904 0.383 . . . . 0.0 111.145 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.891 ' HB3' HG23 ' A' ' 75' ' ' THR . 4.7 p -53.91 127.27 25.54 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.309 -179.188 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 28.6 ptt85 -59.84 -20.12 55.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.024 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.77 -27.06 64.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.558 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 60.3 m -56.99 149.08 19.66 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.411 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.714 ' HB3' HG23 ' A' ' 56' ' ' THR . 7.9 t0 -61.36 -44.71 96.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.947 0.403 . . . . 0.0 110.794 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.735 HG13 HG11 ' A' ' 48' ' ' VAL . 56.0 t -125.21 133.17 70.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.551 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.4 pt -100.62 112.6 33.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.349 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.449 ' HA ' HD23 ' A' ' 68' ' ' LEU . 6.4 mt -78.72 -88.22 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.006 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 30.9 t -108.22 -108.65 0.32 Allowed 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.556 ' CB ' ' HD3' ' A' ' 71' ' ' PRO . 0.0 OUTLIER 169.27 -60.86 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.198 0 N-CA-C 111.574 0.212 . . . . 0.0 111.574 179.25 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.556 ' HD3' ' CB ' ' A' ' 70' ' ' GLU . 25.6 Cg_exo -62.39 -40.05 42.3 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 121.955 1.77 . . . . 0.0 113.061 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -121.74 25.26 9.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.676 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.493 ' CG2' ' HB2' ' A' ' 60' ' ' ARG . 5.0 tp -106.77 121.48 59.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.178 0.513 . . . . 0.0 111.102 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.448 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 0.7 OUTLIER -69.7 137.47 52.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.457 -179.298 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.891 HG23 ' HB3' ' A' ' 61' ' ' SER . 27.6 m -57.66 -43.99 85.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.942 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.47 ' O ' ' C ' ' A' ' 77' ' ' HIS . 2.9 m-85 -100.85 14.19 32.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.662 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.47 ' C ' ' O ' ' A' ' 76' ' ' PHE . 2.0 t-160 -18.92 -69.09 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.883 -1.053 . . . . 0.0 112.814 -179.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -155.57 164.07 39.14 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.929 0.395 . . . . 0.0 111.643 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.42 ' HA ' ' O ' ' A' ' 56' ' ' THR . 0.2 OUTLIER -125.95 138.99 53.8 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.848 179.802 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.735 ' CE1' HG13 ' A' ' 97' ' ' VAL . 2.6 m-85 -119.58 131.07 55.42 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.86 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.411 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 15.2 m-70 -97.29 116.3 29.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.81 0.338 . . . . 0.0 111.384 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.961 HD13 ' O ' ' A' ' 51' ' ' THR . 6.0 tt -106.82 109.93 21.96 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.058 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.8 mp -119.26 139.94 51.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.812 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -123.88 139.06 54.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.117 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -155.03 132.81 11.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.927 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.6 p-10 -107.04 128.73 54.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.914 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.8 m -130.8 139.12 51.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.201 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 68.43 -67.99 0.19 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.137 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -178.1 38.16 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.839 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -148.14 -177.93 6.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.669 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -121.37 127.94 51.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.94 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.13 110.88 20.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.738 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.571 ' OD1' HD21 ' A' ' 34' ' ' LEU . 17.5 m-80 -114.04 129.06 56.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.079 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.83 136.22 52.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.655 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.497 ' HB ' HD23 ' A' ' 119' ' ' LEU . 4.2 mp -113.78 141.01 31.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.11 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -119.72 143.95 47.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.793 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.735 HG13 ' CE1' ' A' ' 80' ' ' PHE . 16.8 t -109.88 129.93 63.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.208 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 24.0 mm -124.27 124.15 67.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.054 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.86 131.37 48.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.994 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -93.72 10.54 32.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.325 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.4 m 59.83 64.1 1.35 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.868 0.366 . . . . 0.0 110.88 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -161.38 132.2 5.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.941 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 70.23 5.8 5.49 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.988 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 61.76 130.87 0.01 OUTLIER Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.766 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.449 ' CG2' ' CE1' ' A' ' 127' ' ' PHE . 95.8 m -132.04 125.86 32.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.791 0.329 . . . . 0.0 110.814 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -117.62 123.92 47.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.92 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.485 HG21 ' CD1' ' A' ' 112' ' ' LEU . 2.3 tp -122.08 137.2 56.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.511 0.672 . . . . 0.0 111.152 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 62.4 29.04 17.15 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.881 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.7 9.44 69.83 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.911 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -134.0 152.03 51.69 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.748 0.308 . . . . 0.0 110.839 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 8.1 mtp-105 -68.5 142.64 55.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.852 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.485 ' CD1' HG21 ' A' ' 107' ' ' ILE . 1.3 tp -77.48 140.28 39.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.953 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.459 HG23 ' N ' ' A' ' 114' ' ' LYS . 19.3 m -126.05 -44.58 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.077 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.459 ' N ' HG23 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -67.71 -178.64 0.97 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.897 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.03 -29.04 8.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.902 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -122.66 83.86 2.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.884 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -82.3 139.18 34.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.808 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.482 ' O ' HG23 ' A' ' 118' ' ' ILE . 8.2 tp -98.51 121.61 49.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.969 0.414 . . . . 0.0 111.395 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.567 HD22 ' HE2' ' A' ' 80' ' ' PHE . 3.8 tp -103.07 134.0 47.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.894 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 2.4 mttp -129.19 178.12 6.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.858 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.436 ' HB2' ' CE2' ' A' ' 137' ' ' TYR . 3.6 t30 -54.89 144.93 21.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.223 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 64.55 44.68 94.77 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.379 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -117.04 122.36 43.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.762 0.315 . . . . 0.0 111.089 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.57 ' CG ' HD12 ' A' ' 134' ' ' LEU . 78.1 mtt180 -89.89 133.05 34.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.718 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.508 HD11 HD11 ' A' ' 119' ' ' LEU . 2.9 mp -126.67 132.35 70.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.251 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.9 t -118.33 126.15 74.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.958 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.449 ' CE1' ' CG2' ' A' ' 105' ' ' THR . 45.2 m-85 -122.74 144.23 49.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.075 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 81.56 -67.09 3.7 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.391 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 170.51 -33.91 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.773 0.321 . . . . 0.0 111.036 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 9.6 p -116.41 -37.49 3.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.413 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 48.6 m -55.15 103.95 0.11 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.977 0.418 . . . . 0.0 111.184 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 44.3 t -124.62 124.54 42.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.035 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.429 ' CE1' HD21 ' A' ' 68' ' ' LEU . 24.8 p90 -142.08 156.12 45.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.919 0.39 . . . . 0.0 110.998 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.57 HD12 ' CG ' ' A' ' 124' ' ' ARG . 1.0 OUTLIER -111.78 140.02 46.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.864 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.548 ' CG ' HD21 ' A' ' 119' ' ' LEU . 20.0 t80 -100.46 141.27 33.55 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.924 0.869 . . . . 0.0 111.695 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.403 ' HG3' HD23 ' A' ' 134' ' ' LEU . 8.6 mtmt -154.78 157.11 37.46 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 113.864 -1.516 . . . . 0.0 110.95 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.436 ' CE2' ' HB2' ' A' ' 121' ' ' ASN . 4.8 m-85 -86.02 139.61 31.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.928 0.394 . . . . 0.0 110.616 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.517 ' HB2' ' ND1' ' A' ' 36' ' ' HIS . . . -105.15 101.41 10.97 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.06 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 3.5 m -62.13 107.15 0.83 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.903 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 6.0 p -169.77 139.05 1.9 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.825 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.55 87.9 1.74 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.936 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.5 m -128.48 -67.63 0.79 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.895 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 11.3 p 54.52 -169.79 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.978 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -154.5 96.35 1.89 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.866 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.587 HG22 ' H ' ' A' ' 146' ' ' GLU . 0.7 OUTLIER -110.27 -143.67 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.587 ' H ' HG22 ' A' ' 145' ' ' ILE . 0.3 OUTLIER -135.26 121.26 19.91 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.858 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 10.2 p30 -96.44 142.18 28.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.896 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -100.43 162.94 12.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.922 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -156.62 -62.52 0.1 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.967 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 60.31 31.18 20.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.898 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.92 99.24 0.46 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.863 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 14.8 m -128.41 34.05 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.133 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.6 t -172.45 -63.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.935 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 2.2 m 60.9 31.35 19.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.857 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -161.11 104.09 1.3 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.924 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.93 176.15 5.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.938 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 14.3 ttt85 -130.08 -58.76 1.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.898 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.29 86.72 2.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.895 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.883 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.8 mttt . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.758 0.313 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.5 mtt-85 -76.01 116.13 16.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.913 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 61.32 170.69 0.11 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.987 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 63.28 143.74 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.884 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -150.38 157.15 42.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.821 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -175.68 -179.54 1.24 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.967 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -116.34 106.45 13.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.925 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.417 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.2 OUTLIER -77.15 -62.48 0.59 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.014 -179.842 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.417 ' CD ' ' CB ' ' A' ' 26' ' ' LYS . 55.7 Cg_endo -70.21 159.05 54.43 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.48 2.12 . . . . 0.0 112.362 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 61.57 49.33 5.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.919 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.4 t -116.51 85.28 2.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.91 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -59.9 176.42 0.3 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.926 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.429 ' CD2' ' HB3' ' A' ' 53' ' ' ARG . 10.6 m-85 -80.15 -101.63 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.936 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.534 ' N ' HG22 ' A' ' 51' ' ' THR . 0.0 OUTLIER -140.46 128.95 22.72 Favored 'General case' 0 C--N 1.334 -0.085 0 CA-C-O 120.796 0.331 . . . . 0.0 110.648 179.883 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.8 t -67.36 122.86 18.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.999 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.458 HD21 ' OD1' ' A' ' 93' ' ' ASN . 5.0 tp -133.29 -62.39 0.79 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.675 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.5 162.77 12.26 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.298 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.42 ' CD2' ' HG3' ' A' ' 49' ' ' GLU . 27.3 m80 -132.24 160.38 36.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.961 0.41 . . . . 0.0 111.185 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.964 HD12 HD11 ' A' ' 50' ' ' ILE . 78.9 mt -127.11 118.72 24.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.845 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.5 t -100.36 121.85 51.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.129 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -89.7 125.27 35.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.888 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.7 mp -86.74 106.97 18.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.877 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.66 HG22 ' HD2' ' A' ' 42' ' ' PRO . 1.7 mt -124.11 141.39 37.07 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.63 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.66 ' HD2' HG22 ' A' ' 41' ' ' ILE . 56.2 Cg_endo -72.14 -8.33 22.64 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.171 1.914 . . . . 0.0 112.489 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -109.29 -14.2 15.31 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.555 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 175.97 -165.84 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.705 0.288 . . . . 0.0 110.744 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -137.99 132.42 32.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.923 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -108.13 133.59 52.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.1 tttm -113.06 122.93 49.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.942 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 18.6 t -111.56 151.16 13.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.997 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.42 ' HG3' ' CD2' ' A' ' 36' ' ' HIS . 0.3 OUTLIER -104.85 119.42 38.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.063 -179.878 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.964 HD11 HD12 ' A' ' 37' ' ' LEU . 27.3 mm -98.37 132.09 44.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.829 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.534 HG22 ' N ' ' A' ' 32' ' ' THR . 0.5 OUTLIER -103.2 168.03 9.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.063 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.834 ' HA ' HD22 ' A' ' 82' ' ' LEU . 0.4 OUTLIER -97.68 73.64 2.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.435 179.606 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.585 ' C ' ' H ' ' A' ' 55' ' ' VAL . 6.1 ptp180 -103.47 16.9 25.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.614 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.426 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 13.7 m120 68.49 -29.16 0.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.585 ' H ' ' C ' ' A' ' 53' ' ' ARG . 59.4 t -137.38 131.3 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-O 121.072 0.463 . . . . 0.0 111.623 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.677 HG23 ' HB3' ' A' ' 65' ' ' ASP . 45.7 m -125.29 125.86 44.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.688 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.4 ' HB ' ' CB ' ' A' ' 64' ' ' CYS . 0.1 OUTLIER -103.67 130.76 51.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.986 0.422 . . . . 0.0 111.183 -179.64 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.86 HG23 HD11 ' A' ' 68' ' ' LEU . 5.2 mp -112.23 117.17 54.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.789 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 172.56 -141.92 6.51 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.357 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.541 ' HB3' ' HA ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -111.47 -23.17 10.9 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.696 0.284 . . . . 0.0 111.233 179.891 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.622 ' HB2' HG23 ' A' ' 75' ' ' THR . 0.1 OUTLIER -51.88 126.06 17.03 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.8 0.334 . . . . 0.0 111.072 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.22 -28.61 59.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.049 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.27 -22.45 59.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.113 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.4 ' CB ' ' HB ' ' A' ' 57' ' ' THR . 94.2 m -55.76 168.14 0.47 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.982 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.677 ' HB3' HG23 ' A' ' 56' ' ' THR . 65.9 t0 -89.24 -51.37 5.61 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.863 0.363 . . . . 0.0 110.893 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.403 HG23 ' CG2' ' A' ' 56' ' ' THR . 21.6 t -104.22 132.02 51.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.029 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.4 pt -108.16 128.96 63.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.357 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.86 HD11 HG23 ' A' ' 58' ' ' ILE . 1.3 mp -114.3 -152.32 0.5 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.304 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.575 ' O ' ' CB ' ' A' ' 70' ' ' GLU . 0.5 OUTLIER -42.08 -58.45 2.1 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.506 0.193 . . . . 0.0 110.753 179.779 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.702 ' HB3' ' HD3' ' A' ' 71' ' ' PRO . 0.7 OUTLIER 110.42 -56.04 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.585 0 C-N-CA 123.594 0.758 . . . . 0.0 112.209 178.708 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.702 ' HD3' ' HB3' ' A' ' 70' ' ' GLU . 16.9 Cg_exo -67.22 -40.08 11.94 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.177 1.918 . . . . 0.0 112.899 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -107.06 23.92 13.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.828 0.347 . . . . 0.0 111.016 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.839 HG12 HD13 ' A' ' 68' ' ' LEU . 4.8 tp -115.94 127.9 73.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.103 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 54.7 m -67.48 131.76 46.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.902 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.622 HG23 ' HB2' ' A' ' 61' ' ' SER . 85.1 m -58.75 -33.12 69.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.574 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.442 ' O ' ' C ' ' A' ' 77' ' ' HIS . 0.1 OUTLIER -112.19 13.96 20.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.537 179.859 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.442 ' C ' ' O ' ' A' ' 76' ' ' PHE . 1.0 OUTLIER -22.03 -69.61 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.748 -1.115 . . . . 0.0 112.576 -179.339 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.737 ' HB3' ' CE2' ' A' ' 127' ' ' PHE . . . -159.33 164.06 35.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.101 0.477 . . . . 0.0 111.936 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -123.74 140.23 53.2 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.405 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.672 ' CE1' HG13 ' A' ' 97' ' ' VAL . 2.3 m-85 -119.38 131.16 55.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.866 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.426 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 4.4 m-70 -95.28 116.26 28.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.82 0.343 . . . . 0.0 111.082 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.834 HD22 ' HA ' ' A' ' 52' ' ' ASN . 0.3 OUTLIER -106.64 109.62 21.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.853 179.588 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.462 HD12 ' C ' ' A' ' 82' ' ' LEU . 7.1 mp -122.32 140.15 52.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.978 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -111.92 121.02 43.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.834 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -132.37 130.09 40.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.929 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -107.06 128.56 54.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.936 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.6 t -129.83 136.08 59.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.953 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.0 t0 71.98 -60.67 0.52 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.982 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -176.09 -39.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.767 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -81.03 131.85 35.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.731 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -82.96 128.14 34.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.032 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -112.98 143.1 44.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.783 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.458 ' OD1' HD21 ' A' ' 34' ' ' LEU . 68.7 m-20 -114.01 129.56 56.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.051 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.753 HD22 HD11 ' A' ' 118' ' ' ILE . 7.9 mt -120.62 142.36 49.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.703 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.467 HG13 ' CE1' ' A' ' 135' ' ' PHE . 10.7 mm -124.26 141.17 45.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.245 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -113.8 138.54 50.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.743 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.672 HG13 ' CE1' ' A' ' 80' ' ' PHE . 21.4 t -109.63 120.85 61.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.311 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 13.9 mt -130.15 120.94 50.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.88 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.416 ' OD1' HD13 ' A' ' 112' ' ' LEU . 2.1 m-20 -115.32 126.12 54.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.957 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.05 28.38 5.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.056 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 58.11 106.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.05 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.21 -76.08 0.28 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.893 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -125.02 27.87 6.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.254 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 66.79 128.14 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.597 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 63.1 m -131.29 123.02 27.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.821 0.343 . . . . 0.0 110.751 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.414 ' CE2' ' HG3' ' A' ' 111' ' ' ARG . 62.2 m-85 -120.02 114.97 22.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.93 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.714 ' CG2' HG22 ' A' ' 125' ' ' ILE . 2.1 pp -109.48 131.19 61.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.118 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 10.4 m120 59.59 31.75 21.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.968 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.63 13.05 74.5 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.96 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -129.12 132.36 47.36 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.845 0.355 . . . . 0.0 110.895 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.414 ' HG3' ' CE2' ' A' ' 106' ' ' PHE . 5.4 ttt180 -68.41 142.99 55.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.92 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.416 HD13 ' OD1' ' A' ' 99' ' ' ASP . 0.4 OUTLIER -81.47 132.74 35.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.851 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.633 ' O ' HG22 ' A' ' 113' ' ' VAL . 14.7 p -144.06 32.62 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.081 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 4.1 mptt -131.12 138.18 49.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.843 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.08 -40.05 86.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.896 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -126.31 78.43 1.77 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.939 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -84.05 139.07 32.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.819 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.753 HD11 HD22 ' A' ' 94' ' ' LEU . 8.5 tp -98.52 119.94 47.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.011 0.434 . . . . 0.0 111.289 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.788 HD23 ' N ' ' A' ' 120' ' ' LYS . 3.1 tt -103.18 142.37 34.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.014 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.788 ' N ' HD23 ' A' ' 119' ' ' LEU . 6.3 mttt -125.42 178.03 5.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.072 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.453 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 7.9 p30 -62.73 146.86 51.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.173 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 68.92 51.86 27.0 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.342 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.736 ' HB2' HD21 ' A' ' 119' ' ' LEU . 0.7 OUTLIER -127.61 124.31 37.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.843 0.354 . . . . 0.0 111.191 -179.752 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.721 ' CA ' HD12 ' A' ' 134' ' ' LEU . 24.8 ttm180 -84.7 132.3 34.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.707 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.714 HG22 ' CG2' ' A' ' 107' ' ' ILE . 22.5 pt -129.56 128.4 65.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.212 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.534 HG13 ' O ' ' A' ' 131' ' ' CYS . 21.6 t -113.56 129.63 69.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.0 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.737 ' CE2' ' HB3' ' A' ' 78' ' ' ALA . 5.5 m-85 -116.77 111.96 20.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.004 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 104.76 -75.55 0.25 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.479 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 5.6 tttt 179.42 -38.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.769 0.319 . . . . 0.0 110.989 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 12.0 p -104.51 -40.59 5.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.287 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' CYS . . . . . 0.534 ' O ' HG13 ' A' ' 126' ' ' VAL . 22.0 m -57.93 107.04 0.42 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.842 0.353 . . . . 0.0 111.079 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 29.7 t -124.21 119.92 30.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.788 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.446 ' N ' ' CD1' ' A' ' 133' ' ' PHE . 1.1 p90 -141.9 150.32 41.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.091 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.721 HD12 ' CA ' ' A' ' 124' ' ' ARG . 0.5 OUTLIER -109.22 140.13 43.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.777 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.618 ' HD2' HD21 ' A' ' 37' ' ' LEU . 12.3 t80 -102.25 141.26 35.38 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 121.893 0.854 . . . . 0.0 111.664 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.449 ' N ' ' CD1' ' A' ' 135' ' ' PHE . 7.2 mttp -154.68 155.4 34.55 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 113.829 -1.532 . . . . 0.0 111.128 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.453 ' CE2' ' HB3' ' A' ' 121' ' ' ASN . 8.7 m-85 -86.16 140.0 30.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.003 0.43 . . . . 0.0 110.638 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.407 ' HB3' ' CE1' ' A' ' 36' ' ' HIS . . . -127.24 70.71 1.31 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.123 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 3.2 m -93.29 -52.0 4.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.866 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.0 t -111.57 149.12 31.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.857 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.09 96.92 1.88 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.946 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.3 m -124.8 -44.62 1.94 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.881 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.9 m -136.9 88.63 2.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.922 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -154.29 31.17 0.43 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.894 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.617 ' O ' HG22 ' A' ' 145' ' ' ILE . 1.8 mt -111.06 24.99 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 CA-C-O 121.611 0.72 . . . . 0.0 111.308 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -125.14 172.13 9.74 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.902 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -95.31 145.15 25.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.914 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -76.02 125.44 29.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.93 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -105.63 32.66 4.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.912 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -120.63 -48.15 2.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.877 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -88.69 -60.15 2.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.881 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.5 t -84.01 147.46 5.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.039 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 80.2 p -155.87 97.81 1.85 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.929 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 18.0 m -119.65 88.81 3.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.86 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -149.13 110.72 4.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.859 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 4.3 t -136.23 36.17 2.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.859 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -106.23 130.28 54.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.929 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 29.7 t -91.64 96.76 10.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.971 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 10.6 t80 . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.295 -0.86 . . . . 0.0 110.844 -179.973 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.3 mmtp . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.756 0.312 . . . . 0.0 111.254 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.38 31.73 4.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.842 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -112.28 -36.76 5.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.857 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.46 137.46 34.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.846 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -131.25 -59.65 0.97 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.877 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -119.4 137.73 53.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.907 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -81.18 -35.75 31.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.878 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.3 mttp -107.92 104.86 54.82 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.894 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -68.17 141.51 52.6 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.353 2.036 . . . . 0.0 112.364 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.7 m -105.48 165.67 10.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.965 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.06 160.18 21.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.927 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -144.6 130.44 19.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.811 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.433 ' H ' HG21 ' A' ' 51' ' ' THR . 4.6 m-85 -70.08 -100.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.938 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.655 ' N ' HG22 ' A' ' 51' ' ' THR . 0.1 OUTLIER -140.48 137.34 33.8 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.842 0.353 . . . . 0.0 110.675 179.764 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.8 t -72.27 120.57 18.07 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.977 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.585 HD23 ' O ' ' A' ' 34' ' ' LEU . 7.7 tt -119.81 -40.5 2.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.893 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.677 ' C ' HG22 ' A' ' 50' ' ' ILE . . . -149.25 -169.6 15.95 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.49 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 51.1 m80 -146.96 160.65 42.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.774 0.321 . . . . 0.0 110.919 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.574 HD11 ' HB ' ' A' ' 50' ' ' ILE . 2.4 mp -127.1 119.33 26.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.799 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.4 t -98.28 121.76 49.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.179 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.6 m-80 -89.93 119.16 30.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.844 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.421 ' N ' HD22 ' A' ' 40' ' ' LEU . 3.8 mm? -75.37 106.88 7.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.915 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.43 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 18.9 mt -124.11 138.75 31.27 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.847 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.43 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 86.6 Cg_exo -44.46 -28.76 2.78 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.48 2.12 . . . . 0.0 112.441 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -111.18 -143.4 9.37 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.268 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.0 mtpt -53.89 113.77 1.33 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.83 0.347 . . . . 0.0 111.134 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -59.93 168.02 1.99 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.955 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -135.66 125.01 24.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.015 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.01 134.28 54.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.92 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.8 t -125.42 139.42 51.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.122 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -80.31 139.67 36.5 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.748 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.696 HG21 ' HE2' ' A' ' 135' ' ' PHE . 2.2 tt -116.01 130.86 70.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.895 0.378 . . . . 0.0 111.398 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.655 HG22 ' N ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -96.77 168.11 10.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.6 179.733 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.579 ' ND2' HG23 ' A' ' 32' ' ' THR . 0.4 OUTLIER -110.76 73.16 0.81 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.677 179.751 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.595 ' C ' ' H ' ' A' ' 55' ' ' VAL . 0.1 OUTLIER -98.65 23.36 8.76 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.115 -179.788 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 69.83 -28.3 0.17 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.595 ' H ' ' C ' ' A' ' 53' ' ' ARG . 58.6 t -137.29 134.18 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-O 121.111 0.481 . . . . 0.0 111.506 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.697 HG23 ' HB3' ' A' ' 65' ' ' ASP . 18.0 m -125.45 125.9 44.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.372 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.78 133.24 49.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.956 0.408 . . . . 0.0 111.213 -179.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.576 HD12 ' N ' ' A' ' 58' ' ' ILE . 3.9 mp -118.35 116.73 52.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.896 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLY . . . . . 0.402 ' HA2' HG13 ' A' ' 73' ' ' ILE . . . 173.42 -142.37 6.58 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.657 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.423 ' HB2' ' CG2' ' A' ' 73' ' ' ILE . 11.7 ttp180 -103.76 -30.94 10.08 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.777 0.322 . . . . 0.0 110.947 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.719 ' HB2' HG23 ' A' ' 75' ' ' THR . 0.2 OUTLIER -49.17 124.46 9.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.241 -179.696 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 47.6 mtm180 -57.04 -30.32 64.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.904 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.4 m -69.99 -21.96 63.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.081 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 86.5 m -55.8 166.17 0.77 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.995 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.697 ' HB3' HG23 ' A' ' 56' ' ' THR . 11.7 t70 -83.58 -48.13 10.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.816 0.341 . . . . 0.0 111.033 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 58' ' ' ILE . 21.3 t -124.93 125.43 69.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.515 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.6 pt -98.28 131.04 46.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.786 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.661 HD22 ' HB3' ' A' ' 131' ' ' CYS . 19.9 mt -118.25 105.17 11.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.263 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.59 ' C ' ' HD2' ' A' ' 71' ' ' PRO . 0.6 OUTLIER 68.75 -70.27 0.14 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.571 179.991 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.57 ' CB ' ' O ' ' A' ' 69' ' ' SER . 31.1 mt-10 112.18 -60.71 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.84 0 C-N-CA 123.992 0.917 . . . . 0.0 112.336 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.59 ' HD2' ' C ' ' A' ' 69' ' ' SER . 38.1 Cg_endo -66.74 -14.15 42.73 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.123 1.882 . . . . 0.0 113.367 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -129.18 25.72 5.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.66 0.267 . . . . 0.0 111.269 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.45 ' HB ' ' O ' ' A' ' 68' ' ' LEU . 4.9 tp -119.89 150.61 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-O 120.943 0.402 . . . . 0.0 111.566 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 45.0 t -94.88 129.38 41.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.063 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.719 HG23 ' HB2' ' A' ' 61' ' ' SER . 58.0 m -53.7 -33.39 55.33 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.157 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -112.3 14.0 20.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.167 0.508 . . . . 0.0 111.838 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.47 ' HB2' ' O ' ' A' ' 74' ' ' SER . 2.0 t-160 -29.17 -70.38 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.901 -1.045 . . . . 0.0 112.617 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.652 ' HB3' ' CE2' ' A' ' 127' ' ' PHE . . . -154.96 164.15 39.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.08 0.467 . . . . 0.0 112.126 -179.34 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -127.79 139.23 52.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.206 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.812 ' CZ ' HG13 ' A' ' 97' ' ' VAL . 5.5 m-85 -119.42 131.33 55.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.984 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 5.2 m80 -94.59 116.39 28.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.972 0.415 . . . . 0.0 110.964 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.661 HD13 HG13 ' A' ' 95' ' ' ILE . 4.2 mm? -106.47 109.72 21.72 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.775 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.9 tp -120.79 140.0 52.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.065 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -107.63 126.36 52.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.745 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -126.09 143.09 51.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.984 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -95.84 116.91 29.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.895 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.6 t -138.71 121.05 17.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.073 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 62.11 -176.59 0.13 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.825 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 22.7 t30 -50.7 -31.13 15.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.257 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -94.46 -177.53 4.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.922 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -115.67 128.66 56.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.849 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.19 123.2 43.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.923 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 37.9 m-80 -113.51 138.26 50.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.745 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.494 ' N ' HD12 ' A' ' 94' ' ' LEU . 0.5 OUTLIER -132.07 134.22 45.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.95 -179.957 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.661 HG13 HD13 ' A' ' 82' ' ' LEU . 3.6 mp -115.45 141.11 33.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.976 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -113.91 137.66 51.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.844 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.812 HG13 ' CZ ' ' A' ' 80' ' ' PHE . 12.1 t -105.78 126.36 61.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.222 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 33.9 mt -129.95 120.99 51.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.984 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.76 139.01 54.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.951 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.3 mmtm -99.92 6.27 45.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.332 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.6 m 58.08 101.83 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.75 0.31 . . . . 0.0 111.014 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 14.3 ttt180 -149.23 -63.72 0.23 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.889 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -96.2 -45.61 6.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.235 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 132.96 106.08 0.97 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.554 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.9 m -118.52 126.36 51.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.835 0.35 . . . . 0.0 110.949 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.408 ' CE2' ' HB2' ' A' ' 111' ' ' ARG . 19.3 m-85 -120.83 121.26 37.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.882 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.6 HD12 ' O ' ' A' ' 124' ' ' ARG . 2.3 tp -108.51 137.29 40.97 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 CA-C-O 121.522 0.677 . . . . 0.0 111.193 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.0 m120 61.71 28.05 17.26 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.825 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.69 9.55 69.99 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.947 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -134.1 152.0 51.64 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.804 0.335 . . . . 0.0 110.862 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.408 ' HB2' ' CE2' ' A' ' 106' ' ' PHE . 0.6 OUTLIER -71.77 133.02 45.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.954 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.9 pp -88.57 134.62 33.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.924 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 13.0 m -110.52 -30.22 2.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.224 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.2 153.97 31.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.983 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.62 -36.3 16.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.895 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -102.93 74.62 1.33 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.917 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -83.72 139.04 32.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.815 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.505 ' O ' HG23 ' A' ' 118' ' ' ILE . 8.6 tp -98.63 118.99 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.148 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.914 HD11 HD11 ' A' ' 125' ' ' ILE . 6.1 tt -103.04 135.88 43.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.056 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -131.07 178.12 6.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.743 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.429 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 4.5 p-10 -52.95 143.77 16.34 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.091 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 68.51 44.04 74.48 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.475 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -112.85 121.19 43.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.806 0.336 . . . . 0.0 110.916 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.608 ' HG3' HD12 ' A' ' 134' ' ' LEU . 1.5 mpt_? -90.51 119.03 30.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.871 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.914 HD11 HD11 ' A' ' 119' ' ' LEU . 3.6 mt -114.94 132.07 65.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.061 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.625 HG22 ' OG ' ' A' ' 132' ' ' SER . 29.6 t -116.57 131.84 67.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.174 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.652 ' CE2' ' HB3' ' A' ' 78' ' ' ALA . 8.3 m-85 -118.57 133.63 55.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.975 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 80.19 -66.19 3.67 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.446 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 170.38 -33.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.814 0.34 . . . . 0.0 110.998 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.3 p -107.19 -42.76 4.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.287 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' CYS . . . . . 0.661 ' HB3' HD22 ' A' ' 68' ' ' LEU . 59.5 m -56.4 104.78 0.16 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.874 0.369 . . . . 0.0 111.194 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.625 ' OG ' HG22 ' A' ' 126' ' ' VAL . 0.3 OUTLIER -124.42 125.01 43.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.922 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.445 ' CE1' HD11 ' A' ' 68' ' ' LEU . 2.1 p90 -142.15 156.12 45.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.93 0.395 . . . . 0.0 111.091 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.608 HD12 ' HG3' ' A' ' 124' ' ' ARG . 9.6 tt -116.25 138.97 50.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.645 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.696 ' HE2' HG21 ' A' ' 50' ' ' ILE . 25.4 t80 -103.38 141.4 36.01 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 122.029 0.919 . . . . 0.0 111.875 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 11.4 mtmt -154.67 143.8 21.09 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 113.787 -1.552 . . . . 0.0 110.74 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.429 ' CE2' ' HB3' ' A' ' 121' ' ' ASN . 4.0 m-85 -72.86 139.72 47.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.002 0.43 . . . . 0.0 110.72 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -119.69 103.47 9.42 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.092 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 35.7 p -87.95 163.65 16.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.951 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.3 m -111.22 -34.42 6.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.66 133.29 17.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.825 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.4 t -117.98 -41.55 2.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.888 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 40.8 p -94.69 179.26 5.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.907 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -132.18 128.82 38.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.854 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.573 HG22 ' H ' ' A' ' 146' ' ' GLU . 2.4 mt -110.4 -143.39 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.098 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.573 ' H ' HG22 ' A' ' 145' ' ' ILE . 0.0 OUTLIER -152.96 34.31 0.48 Allowed 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.913 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 36.3 m120 61.68 56.1 2.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.904 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -95.88 109.71 22.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.848 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -106.22 31.63 5.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.947 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.16 87.26 4.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.86 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 17.9 mttp -77.32 93.03 3.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.971 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 5.7 m -120.0 -41.66 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.056 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.9 p -96.49 105.11 17.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.854 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 79.7 p -171.0 165.65 7.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.884 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 60.74 31.7 20.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.816 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 8.9 m -119.74 -66.9 1.02 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.82 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.38 84.27 0.91 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.847 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.8 p -167.98 145.84 4.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.806 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 20.1 t80 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.335 -0.841 . . . . 0.0 110.879 179.924 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.8 0.333 . . . . 0.0 111.208 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.41 101.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.84 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -75.04 127.03 32.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.989 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -149.09 -64.89 0.23 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.887 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 59.89 99.48 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.944 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 83.8 p -72.38 -42.78 64.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.826 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -130.88 174.98 9.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.817 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.417 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -178.19 -61.95 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.055 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.417 ' CD ' ' CB ' ' A' ' 26' ' ' LYS . 39.7 Cg_endo -67.0 145.59 74.39 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.488 2.126 . . . . 0.0 112.366 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -154.44 -170.43 3.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.803 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.5 m -151.37 138.07 18.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.903 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -60.33 160.76 8.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.771 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.441 ' H ' HG21 ' A' ' 51' ' ' THR . 5.2 m-85 -74.86 -99.84 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.802 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.582 ' N ' HG22 ' A' ' 51' ' ' THR . 1.0 OUTLIER -140.4 128.79 22.61 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.68 0.276 . . . . 0.0 110.743 179.831 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 10.6 t -69.7 114.9 8.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.58 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.761 HD22 HD23 ' A' ' 82' ' ' LEU . 3.1 tp -118.16 -41.95 2.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.28 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.465 ' C ' HG22 ' A' ' 50' ' ' ILE . . . -148.53 -167.92 14.07 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.233 -0.984 . . . . 0.0 113.056 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.43 ' CD2' ' HG3' ' A' ' 49' ' ' GLU . 46.1 m80 -144.58 161.04 40.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.862 0.363 . . . . 0.0 110.683 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.477 ' CD1' HG21 ' A' ' 66' ' ' VAL . 23.5 mt -127.11 112.85 15.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.666 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.5 t -95.92 121.77 46.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.135 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -90.23 125.96 35.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.933 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.458 HD12 ' HA ' ' A' ' 133' ' ' PHE . 4.8 mp -106.1 106.81 17.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.802 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.8 mm -124.03 138.17 30.2 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.086 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -55.78 87.11 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.4 2.067 . . . . 0.0 112.205 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 139.51 -22.55 2.86 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.662 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.9 mtpt 177.01 164.03 0.49 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.861 0.363 . . . . 0.0 110.814 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -122.61 -178.19 3.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.906 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.53 134.93 16.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.882 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -109.03 122.7 47.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.854 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.3 t -122.47 151.12 26.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.211 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.43 ' HG3' ' CD2' ' A' ' 36' ' ' HIS . 0.4 OUTLIER -94.69 130.65 41.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.602 179.852 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.721 HG21 ' HE2' ' A' ' 135' ' ' PHE . 3.1 tt -116.1 128.88 73.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.084 0.469 . . . . 0.0 111.578 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.582 HG22 ' N ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -96.79 168.12 10.69 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.196 179.539 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.684 ' HA ' HD22 ' A' ' 82' ' ' LEU . 56.5 m-80 -68.51 -89.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.333 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.571 ' C ' ' H ' ' A' ' 55' ' ' VAL . 12.9 ttt-85 72.79 -1.09 3.12 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 179.013 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 1.3 m-20 70.33 -34.06 0.28 Allowed 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.096 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.571 ' H ' ' C ' ' A' ' 53' ' ' ARG . 64.1 t -137.04 134.84 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 CA-C-O 121.012 0.434 . . . . 0.0 110.949 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.807 HG23 ' CB ' ' A' ' 65' ' ' ASP . 50.6 m -125.28 132.17 52.96 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.061 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.401 ' HB ' ' CB ' ' A' ' 64' ' ' CYS . 0.0 OUTLIER -104.33 143.84 32.44 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.843 0.354 . . . . 0.0 111.231 -179.786 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.445 HD12 ' N ' ' A' ' 58' ' ' ILE . 4.8 mp -130.76 126.72 60.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.083 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 164.98 -139.28 5.73 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.667 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.42 ' HB2' HG23 ' A' ' 73' ' ' ILE . 10.6 ttp180 -106.85 -26.59 11.18 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.749 0.309 . . . . 0.0 110.969 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.733 ' HB2' HG23 ' A' ' 75' ' ' THR . 0.1 OUTLIER -52.12 136.5 29.68 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.24 -179.741 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.74 -31.89 72.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.915 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 46.2 p -69.95 -23.91 63.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.942 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.401 ' CB ' ' HB ' ' A' ' 57' ' ' THR . 96.4 m -56.64 171.87 0.29 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.944 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.807 ' CB ' HG23 ' A' ' 56' ' ' THR . 0.7 OUTLIER -85.07 -68.16 0.75 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.002 0.429 . . . . 0.0 110.885 179.813 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.477 HG21 ' CD1' ' A' ' 37' ' ' LEU . 21.2 t -105.95 115.31 47.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.899 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.4 pt -91.94 104.97 16.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.553 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.498 HD11 ' CE2' ' A' ' 133' ' ' PHE . 1.8 mp -66.85 -155.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.837 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.482 ' O ' ' CB ' ' A' ' 70' ' ' GLU . 19.1 p -41.81 -96.43 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 117.592 0.178 . . . . 0.0 111.193 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.535 ' CB ' ' HD3' ' A' ' 71' ' ' PRO . 1.5 mt-10 159.19 -60.93 0.0 OUTLIER Pre-proline 0 N--CA 1.466 0.366 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.535 ' HD3' ' CB ' ' A' ' 70' ' ' GLU . 36.4 Cg_exo -57.4 -40.31 82.47 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.206 1.937 . . . . 0.0 113.241 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -116.53 28.86 8.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.698 0.285 . . . . 0.0 111.313 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.469 HD11 HD22 ' A' ' 68' ' ' LEU . 4.9 tp -110.6 126.74 67.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.99 0.424 . . . . 0.0 111.293 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.417 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 1.5 m -79.03 134.66 36.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.194 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.733 HG23 ' HB2' ' A' ' 61' ' ' SER . 72.0 m -61.03 -29.16 69.56 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.02 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.431 ' O ' ' C ' ' A' ' 77' ' ' HIS . 0.3 OUTLIER -106.91 14.02 27.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.237 0.541 . . . . 0.0 111.598 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.462 ' CE1' ' HB3' ' A' ' 127' ' ' PHE . 1.4 t-160 -24.41 -71.11 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.759 -1.109 . . . . 0.0 112.747 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.541 ' HB3' ' HE2' ' A' ' 127' ' ' PHE . . . -163.43 164.12 24.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.062 0.458 . . . . 0.0 112.019 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -124.35 140.88 52.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.342 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.656 ' CE1' HG13 ' A' ' 97' ' ' VAL . 3.2 m-85 -119.22 131.15 55.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.751 0.31 . . . . 0.0 110.863 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -94.82 116.47 28.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.909 0.385 . . . . 0.0 111.038 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.761 HD23 HD22 ' A' ' 34' ' ' LEU . 0.1 OUTLIER -106.41 109.55 21.51 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.107 179.866 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.23 130.62 53.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.814 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 5.7 tm0? -107.0 128.12 54.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.925 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 9.4 ttt -152.03 143.15 23.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.928 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -99.89 131.13 46.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.852 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 19.8 t -137.01 134.46 47.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.112 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 61.11 39.83 15.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.833 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 62.26 32.67 17.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.856 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -145.68 157.09 43.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.882 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -82.98 127.92 33.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.905 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -117.01 117.44 29.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.008 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 51.2 m-20 -105.42 119.96 40.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.766 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.4 mt -118.2 125.65 50.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.077 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.407 HG13 ' CE1' ' A' ' 135' ' ' PHE . 11.7 mm -115.0 133.3 61.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.013 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -113.94 143.49 44.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.635 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.656 HG13 ' CE1' ' A' ' 80' ' ' PHE . 18.0 t -109.12 132.63 56.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.381 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.472 HD13 ' O ' ' A' ' 97' ' ' VAL . 25.3 mm -130.05 120.93 50.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.029 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -102.23 127.05 49.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.964 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.4 mmtp -140.69 31.54 1.85 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.886 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.6 m -123.92 178.35 5.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.953 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -121.95 31.25 6.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.951 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -103.58 -56.29 2.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.186 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 138.05 120.78 1.9 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.514 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.8 m -125.59 122.95 37.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.813 0.34 . . . . 0.0 110.911 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.401 ' CE2' ' HB3' ' A' ' 111' ' ' ARG . 46.1 m-85 -116.31 129.15 56.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.848 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.1 tp -123.08 137.24 57.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.445 0.641 . . . . 0.0 111.378 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.8 m120 61.86 29.71 17.98 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.838 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.64 12.98 74.49 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.87 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 73.3 m-80 -133.47 152.01 51.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.798 0.332 . . . . 0.0 110.849 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.401 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -68.0 143.05 55.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.932 -179.996 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.457 HD21 ' HB2' ' A' ' 117' ' ' TYR . 0.3 OUTLIER -85.46 126.31 33.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.865 179.991 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.406 HG13 ' N ' ' A' ' 114' ' ' LYS . 11.2 p -112.16 -40.81 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.113 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.406 ' N ' HG13 ' A' ' 113' ' ' VAL . 7.6 tptp -76.56 163.71 26.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.968 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.68 -29.25 18.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.902 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -121.13 82.06 1.87 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.018 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.457 ' HB2' HD21 ' A' ' 112' ' ' LEU . 57.6 t80 -84.09 139.21 32.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.673 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.542 ' O ' HG23 ' A' ' 118' ' ' ILE . 8.7 tp -98.52 118.52 45.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.435 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.714 HD11 HD11 ' A' ' 125' ' ' ILE . 7.0 tt -103.2 143.93 31.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.841 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.3 mmtt -127.51 178.01 6.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.851 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.434 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 11.7 p-10 -59.94 148.07 36.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.973 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.529 ' HA2' HD21 ' A' ' 134' ' ' LEU . . . 64.05 43.71 96.92 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.413 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -114.69 130.74 56.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.774 0.321 . . . . 0.0 111.069 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.54 ' HD3' HD12 ' A' ' 134' ' ' LEU . 1.2 mmm-85 -83.87 130.77 34.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.712 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.714 HD11 HD11 ' A' ' 119' ' ' LEU . 2.7 mt -126.8 128.14 70.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.356 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 40.6 t -122.76 124.01 69.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.734 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.541 ' HE2' ' HB3' ' A' ' 78' ' ' ALA . 3.3 m-85 -113.47 145.98 40.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.969 0.414 . . . . 0.0 111.306 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 70.6 -65.17 0.82 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.435 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 173.83 -50.18 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.853 0.358 . . . . 0.0 110.859 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 89.1 p -96.15 -36.15 11.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.203 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' CYS . . . . . 0.488 ' SG ' HD23 ' A' ' 68' ' ' LEU . 24.7 m -57.66 104.49 0.19 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.003 0.43 . . . . 0.0 111.124 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.41 124.14 41.69 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.951 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.498 ' CE2' HD11 ' A' ' 68' ' ' LEU . 8.4 p90 -142.13 153.64 44.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.966 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.54 HD12 ' HD3' ' A' ' 124' ' ' ARG . 2.0 tt -112.22 133.93 54.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.766 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.721 ' HE2' HG21 ' A' ' 50' ' ' ILE . 48.0 t80 -106.42 141.4 37.79 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 121.958 0.885 . . . . 0.0 111.802 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.55 157.44 38.29 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 113.928 -1.487 . . . . 0.0 111.119 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.434 ' CE2' ' HB3' ' A' ' 121' ' ' ASN . 6.7 m-85 -86.0 139.87 30.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.761 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -117.73 130.37 56.28 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.125 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 33.8 t -133.2 163.14 29.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.93 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 75.1 p -153.34 165.2 36.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.889 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.3 m -124.76 -44.44 1.95 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.929 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.42 -58.54 2.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.898 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 39.9 p -131.99 176.74 8.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -90.34 -28.19 18.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.984 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.7 mp -144.45 118.18 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 CA-C-O 121.798 0.808 . . . . 0.0 109.556 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -166.37 -61.11 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 114.33 -1.305 . . . . 0.0 110.803 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -73.78 109.0 6.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.832 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.45 107.03 10.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.821 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -126.57 178.29 5.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.816 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 21.9 mp0 -130.94 134.46 46.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.921 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 33.3 mttm -93.9 -35.64 12.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.94 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.444 ' O ' HG23 ' A' ' 152' ' ' VAL . 11.6 m -80.2 76.53 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.065 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.6 p -166.09 162.1 17.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.899 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 16.6 t -109.75 -40.56 4.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.87 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 60.22 32.32 20.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.937 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 3.9 m 60.63 79.59 0.24 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.887 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -84.88 159.95 20.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.942 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 2.1 t -109.96 95.18 5.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.927 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.28 -0.867 . . . . 0.0 110.86 -179.978 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.2 mmtt . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.787 0.327 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.19 29.43 18.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.19 -174.55 2.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.874 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 61.19 103.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.931 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -129.17 171.86 12.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.877 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.9 m -62.74 137.06 58.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -160.38 -53.88 0.05 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.866 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.45 109.38 49.97 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.794 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -57.92 152.9 47.61 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.522 2.148 . . . . 0.0 112.202 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 67.1 m -139.97 -64.04 0.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.861 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.3 p -155.47 88.14 1.13 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.919 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 60.04 165.54 0.07 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.876 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.426 ' CE2' ' HG3' ' A' ' 53' ' ' ARG . 83.2 m-85 -104.13 -121.38 0.2 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.546 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.55 ' C ' HG22 ' A' ' 51' ' ' THR . 0.1 OUTLIER -140.25 129.32 23.55 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.776 0.322 . . . . 0.0 110.692 179.815 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 4.4 t -62.05 138.43 58.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.07 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.1 tp -142.54 -47.83 0.34 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.708 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.721 ' C ' HG22 ' A' ' 50' ' ' ILE . . . -137.63 -174.68 13.47 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.287 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.413 ' ND1' ' HB2' ' A' ' 138' ' ' ALA . 50.5 m80 -144.83 163.76 33.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.893 0.378 . . . . 0.0 111.031 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.0 mt -126.59 131.05 51.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.683 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.1 t -105.33 121.92 58.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.094 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.412 ' CB ' HD11 ' A' ' 41' ' ' ILE . 1.1 m-20 -89.99 126.01 35.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.794 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.94 106.54 18.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.88 0.371 . . . . 0.0 110.782 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.543 HG23 ' HD2' ' A' ' 42' ' ' PRO . 4.3 mp -124.49 141.06 36.68 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.906 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.543 ' HD2' HG23 ' A' ' 41' ' ' ILE . 58.9 Cg_endo -74.44 83.31 1.72 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.102 1.868 . . . . 0.0 111.978 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 143.33 -14.3 2.29 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.531 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.02 176.18 0.92 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 120.716 0.293 . . . . 0.0 110.672 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -132.73 160.62 36.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.141 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -137.78 130.27 29.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.814 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 33.6 tttt -106.21 127.28 53.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.007 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 23.5 t -117.47 147.73 20.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.083 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.402 ' CG ' ' NE2' ' A' ' 36' ' ' HIS . 3.4 mt-10 -97.26 135.72 38.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.844 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.721 HG22 ' C ' ' A' ' 35' ' ' GLY . 1.1 tt -115.25 132.15 65.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.093 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.567 ' O ' HD22 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -106.46 168.46 9.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.253 -179.653 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -85.07 68.93 10.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.153 0.502 . . . . 0.0 110.511 179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.576 ' C ' ' H ' ' A' ' 55' ' ' VAL . 19.3 ttt-85 -87.77 4.45 44.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.814 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.506 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 10.3 m120 69.0 -35.08 0.29 Allowed 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -178.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.576 ' H ' ' C ' ' A' ' 53' ' ' ARG . 70.5 t -137.27 135.23 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.599 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.669 HG23 ' HB3' ' A' ' 65' ' ' ASP . 53.4 m -125.15 126.52 45.4 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.023 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.73 131.05 51.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.964 0.411 . . . . 0.0 110.732 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.856 HG23 HD13 ' A' ' 68' ' ' LEU . 5.0 mp -119.77 118.91 58.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.929 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 172.46 -137.18 4.1 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.449 -0.881 . . . . 0.0 113.201 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.493 ' HD2' ' O ' ' A' ' 70' ' ' GLU . 11.2 ttt-85 -103.29 -38.13 7.36 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.815 0.34 . . . . 0.0 111.103 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.682 ' HB2' HG23 ' A' ' 75' ' ' THR . 0.3 OUTLIER -45.8 127.52 8.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.583 -179.389 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.8 -29.1 69.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.737 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 94.2 p -69.93 -23.67 63.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.826 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 87.9 m -53.3 158.15 1.73 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.87 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.669 ' HB3' HG23 ' A' ' 56' ' ' THR . 8.8 t0 -74.09 -47.62 35.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.847 0.356 . . . . 0.0 111.008 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 58' ' ' ILE . 20.8 t -125.08 133.27 69.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.559 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 4.7 pt -100.24 118.93 47.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.603 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.856 HD13 HG23 ' A' ' 58' ' ' ILE . 2.3 mp -84.83 -86.67 0.13 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.784 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 38.9 m -107.7 -109.77 0.31 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.611 ' CB ' ' HD3' ' A' ' 71' ' ' PRO . 0.1 OUTLIER 168.34 -63.49 0.0 OUTLIER Pre-proline 0 CA--C 1.529 0.157 0 O-C-N 122.375 -0.203 . . . . 0.0 111.541 178.862 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.611 ' HD3' ' CB ' ' A' ' 70' ' ' GLU . 21.5 Cg_exo -64.74 -22.14 64.28 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 121.977 1.785 . . . . 0.0 112.867 -179.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -136.32 22.07 3.2 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.684 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.468 ' CG2' ' HB2' ' A' ' 60' ' ' ARG . 4.7 tp -105.68 121.25 57.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.06 0.457 . . . . 0.0 110.957 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.415 ' HB2' ' CA ' ' A' ' 77' ' ' HIS . 13.8 m -65.24 133.08 50.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.484 -179.11 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.682 HG23 ' HB2' ' A' ' 61' ' ' SER . 77.8 m -58.73 -35.34 72.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.974 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.43 ' O ' ' C ' ' A' ' 77' ' ' HIS . 0.2 OUTLIER -112.01 14.14 20.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.225 0.536 . . . . 0.0 111.361 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.43 ' C ' ' O ' ' A' ' 76' ' ' PHE . 14.8 t60 -24.88 -69.14 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.648 -179.139 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -149.77 163.96 36.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.07 0.462 . . . . 0.0 112.056 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -129.01 137.98 51.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.462 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.813 ' CE1' HG13 ' A' ' 97' ' ' VAL . 2.0 m-85 -119.57 125.98 50.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.848 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -94.84 116.19 28.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.913 0.387 . . . . 0.0 111.294 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.567 HD22 ' O ' ' A' ' 51' ' ' THR . 0.1 OUTLIER -106.64 109.5 21.44 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.714 179.399 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.9 tp -122.49 140.2 53.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.2 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -122.82 120.95 35.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.807 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -115.47 126.58 54.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.985 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -107.07 117.56 34.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.904 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 25.3 t -133.54 125.08 49.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.015 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.5 t70 70.61 -61.55 0.47 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.048 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -176.54 -39.64 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.845 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -89.48 101.28 13.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.68 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -82.93 145.44 29.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.051 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 2.8 ttp-105 -113.1 141.13 47.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.808 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -107.35 129.92 54.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.029 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.705 HD23 HD11 ' A' ' 118' ' ' ILE . 0.3 OUTLIER -126.7 133.9 50.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.718 179.883 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.623 HD13 HD23 ' A' ' 119' ' ' LEU . 3.8 mp -117.48 140.77 39.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.22 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -117.82 125.82 51.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.825 179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.813 HG13 ' CE1' ' A' ' 80' ' ' PHE . 18.0 t -96.34 131.48 43.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.131 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 32.4 mt -123.0 120.95 61.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.03 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.48 117.88 26.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.93 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.04 30.06 1.82 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.885 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 18.5 m -96.04 177.71 5.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.825 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.9 29.58 1.87 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.093 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 34.7 p-10 -135.18 -44.85 0.71 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.964 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 157.33 117.01 0.52 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.739 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.689 HG23 ' CD1' ' A' ' 127' ' ' PHE . 62.5 m -132.04 122.75 25.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.734 0.302 . . . . 0.0 110.79 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -121.21 139.07 53.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.188 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.825 HD13 HG22 ' A' ' 125' ' ' ILE . 3.3 tp -122.79 137.34 56.62 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 CA-C-O 121.443 0.639 . . . . 0.0 111.196 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.7 m120 60.52 30.0 19.43 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.65 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.69 12.67 74.36 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.843 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -134.14 152.03 51.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.819 0.342 . . . . 0.0 110.769 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.83 143.09 44.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.872 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.518 ' CD1' HG22 ' A' ' 107' ' ' ILE . 3.2 mp -74.74 131.33 40.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.942 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.3 p -114.73 -37.09 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.07 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 9.9 tttt -115.38 149.77 37.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.871 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.3 165.94 21.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.027 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 27.5 t70 62.48 64.73 0.91 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.988 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -84.04 138.47 33.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.846 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.705 HD11 HD23 ' A' ' 94' ' ' LEU . 8.4 tp -98.7 120.28 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.226 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.646 HD13 ' HE2' ' A' ' 80' ' ' PHE . 4.7 tt -103.07 139.06 39.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.992 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 13.0 mmtp -129.84 178.17 6.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.74 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.442 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 4.8 p-10 -53.41 148.0 9.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.153 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 64.08 37.5 94.68 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.565 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -109.81 127.85 54.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.821 0.343 . . . . 0.0 110.96 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.413 ' O ' HD12 ' A' ' 107' ' ' ILE . 54.2 mtt180 -93.6 132.69 37.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.858 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.825 HG22 HD13 ' A' ' 107' ' ' ILE . 0.1 OUTLIER -118.42 122.0 68.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.087 179.877 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 46.7 t -112.71 123.9 68.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.771 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.689 ' CD1' HG23 ' A' ' 105' ' ' THR . 68.5 m-85 -120.38 148.03 44.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.951 0.405 . . . . 0.0 111.211 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 73.79 -65.84 1.78 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.348 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 175.35 -50.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.807 0.337 . . . . 0.0 111.022 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.06 -33.13 9.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.681 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 21.6 m -55.74 105.46 0.18 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.884 0.373 . . . . 0.0 110.98 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 13.7 p -124.22 136.76 54.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.918 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.439 ' CZ ' ' HG ' ' A' ' 68' ' ' LEU . 15.5 m-85 -142.25 156.21 45.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.151 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.8 tt -121.66 116.1 23.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.711 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.569 ' HE2' HG21 ' A' ' 50' ' ' ILE . 21.4 t80 -94.7 141.56 28.47 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 122.054 0.931 . . . . 0.0 111.895 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 6.8 tttt -154.62 160.4 41.43 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 113.781 -1.554 . . . . 0.0 110.85 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.461 ' HE1' HD11 ' A' ' 95' ' ' ILE . 3.7 m-85 -86.07 139.98 30.66 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.051 0.453 . . . . 0.0 110.681 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.413 ' HB2' ' ND1' ' A' ' 36' ' ' HIS . . . -95.7 170.51 9.27 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.058 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 12.0 m -109.39 156.98 19.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.014 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 60.5 p -111.45 31.53 6.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.847 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -99.76 -170.03 1.83 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.942 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.2 m -80.42 138.64 36.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.986 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 18.9 p -113.28 -36.56 4.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.931 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 61.11 173.7 0.11 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.894 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.585 ' O ' HG22 ' A' ' 145' ' ' ILE . 19.1 mm -106.37 24.93 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 CA-C-O 121.551 0.691 . . . . 0.0 111.345 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -105.3 110.29 22.6 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.8 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -138.17 107.5 6.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.846 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 23.8 p30 -88.4 167.75 13.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.941 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -134.43 -55.37 0.85 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.905 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -175.71 -41.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.897 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 7.5 mttp -67.86 127.96 34.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 10.9 p -115.43 -38.26 2.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.098 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 96.7 p -109.49 150.13 28.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.894 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.4 m -80.5 117.19 21.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.955 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -117.57 -40.91 2.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.848 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.9 m -60.07 157.64 12.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.855 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -89.45 78.13 7.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.881 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.74 179.2 4.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.9 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 1.4 t80 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.95 -179.971 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.5 mptt . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.832 0.348 . . . . 0.0 111.119 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.7 mtt180 -75.1 169.48 17.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.808 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 60.24 97.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.88 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 24.4 pt20 -112.98 171.7 7.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.885 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.45 162.4 28.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.843 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.93 113.79 11.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.833 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 41.9 p30 -165.36 -177.42 4.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.873 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -142.19 134.93 13.84 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.908 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.85 155.47 32.67 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.311 2.007 . . . . 0.0 112.325 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.38 -177.75 2.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.94 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.35 171.74 2.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.945 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -172.07 -71.93 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.903 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -71.29 -108.75 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.834 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.474 ' N ' HG22 ' A' ' 51' ' ' THR . 0.2 OUTLIER -140.28 129.03 23.1 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 120.868 0.366 . . . . 0.0 110.517 179.665 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 40.6 t -59.84 120.17 9.08 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.158 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.567 HD23 HD22 ' A' ' 52' ' ' ASN . 1.3 mm? -117.04 -34.97 4.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.705 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.6 ' O ' HG22 ' A' ' 50' ' ' ILE . . . -168.54 -177.9 39.84 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.274 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 23.2 m80 -138.08 166.05 25.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.084 0.468 . . . . 0.0 111.138 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.493 HD22 ' CE2' ' A' ' 133' ' ' PHE . 1.1 mt -127.28 114.73 18.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.614 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.426 HG22 ' HG2' ' A' ' 47' ' ' LYS . 20.0 t -95.92 121.59 46.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.129 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -90.37 142.04 28.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.939 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.6 mt -107.43 106.49 16.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.681 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.9 mt -124.39 138.67 31.41 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.983 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_exo -52.12 -25.39 22.82 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.475 2.117 . . . . 0.0 112.516 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -85.52 -34.01 15.04 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.736 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 177.15 -174.28 0.12 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.835 0.35 . . . . 0.0 110.948 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -107.92 157.53 18.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.918 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -135.41 120.26 18.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.954 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.426 ' HG2' HG22 ' A' ' 38' ' ' VAL . 1.7 mmtp -100.72 128.2 46.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.882 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.1 t -122.4 139.71 48.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.156 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -92.43 127.42 37.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.724 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.6 HG22 ' O ' ' A' ' 35' ' ' GLY . 15.9 tt -116.05 132.08 66.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.04 0.448 . . . . 0.0 111.468 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.474 HG22 ' N ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -98.81 167.87 10.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.454 179.74 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.567 HD22 HD23 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -61.14 -92.18 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.684 -0.235 . . . . 0.0 110.387 179.592 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.558 ' C ' ' H ' ' A' ' 55' ' ' VAL . 8.0 ttt180 75.2 -5.77 2.1 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 179.15 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.423 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 7.9 t-20 71.03 -32.97 0.26 Allowed 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.786 -0.365 . . . . 0.0 110.199 -179.137 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.558 ' H ' ' C ' ' A' ' 53' ' ' ARG . 61.6 t -135.82 138.33 47.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 CA-C-O 120.926 0.393 . . . . 0.0 110.931 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.762 HG23 ' CB ' ' A' ' 65' ' ' ASP . 94.0 m -125.38 130.5 52.04 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.579 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.413 ' O ' ' N ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -104.01 139.76 38.69 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.821 0.343 . . . . 0.0 111.025 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.419 HD12 ' N ' ' A' ' 58' ' ' ILE . 4.7 mp -132.2 130.87 60.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.335 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.35 -135.31 3.99 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.971 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.482 ' HB2' ' CG2' ' A' ' 73' ' ' ILE . 7.5 ttt-85 -100.59 -40.9 7.18 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 120.855 0.36 . . . . 0.0 110.918 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.607 ' HB2' HG23 ' A' ' 75' ' ' THR . 0.3 OUTLIER -44.83 118.82 1.73 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.446 -179.568 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 15.9 mtt85 -57.42 -27.42 62.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.884 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.7 m -69.82 -25.62 63.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.778 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 89.8 m -54.73 166.6 0.46 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.78 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.762 ' CB ' HG23 ' A' ' 56' ' ' THR . 0.6 OUTLIER -73.52 -58.33 3.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.875 0.369 . . . . 0.0 111.117 -179.945 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.408 HG21 ' CD1' ' A' ' 37' ' ' LEU . 21.2 t -121.51 125.36 73.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.647 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.3 pt -95.81 118.19 41.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.567 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.49 HD13 HD11 ' A' ' 73' ' ' ILE . 9.1 mt -77.01 -91.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.686 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.583 ' OG ' HD13 ' A' ' 73' ' ' ILE . 1.3 p -101.42 -102.11 0.26 Allowed 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.064 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.583 ' CB ' ' HD3' ' A' ' 71' ' ' PRO . 3.6 mt-10 162.4 -63.96 0.0 OUTLIER Pre-proline 0 CA--C 1.531 0.228 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.583 ' HD3' ' CB ' ' A' ' 70' ' ' GLU . 46.8 Cg_exo -56.09 -40.13 86.86 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.107 1.871 . . . . 0.0 113.355 -178.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -124.19 25.67 7.72 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.583 HD13 ' OG ' ' A' ' 69' ' ' SER . 3.1 tp -104.31 121.93 56.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.137 0.494 . . . . 0.0 111.223 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.6 m -62.9 136.31 57.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.285 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.607 HG23 ' HB2' ' A' ' 61' ' ' SER . 65.8 m -64.4 -40.57 96.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.806 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.452 ' O ' ' C ' ' A' ' 77' ' ' HIS . 3.5 m-85 -99.24 13.86 31.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.232 0.539 . . . . 0.0 111.448 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.452 ' C ' ' O ' ' A' ' 76' ' ' PHE . 1.0 OUTLIER -20.6 -69.8 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.705 -1.134 . . . . 0.0 112.76 -179.346 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -156.64 164.05 38.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.214 0.53 . . . . 0.0 112.099 -179.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -129.52 133.78 47.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.085 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.836 ' CE1' HG13 ' A' ' 97' ' ' VAL . 5.1 m-85 -119.2 131.22 55.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.975 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.423 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 8.1 m-70 -94.67 116.33 28.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.991 0.424 . . . . 0.0 110.906 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.43 109.65 21.63 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.058 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.31 137.56 54.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.794 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.419 ' HG3' HD11 ' A' ' 34' ' ' LEU . 2.0 tt0 -109.64 129.2 55.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.868 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.88 141.22 34.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.948 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.8 p-10 -106.95 115.95 31.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.856 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.0 m -124.95 117.41 50.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.3 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.7 t0 58.35 77.51 0.29 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.081 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 63.18 -80.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.994 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -63.67 151.72 41.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.917 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -118.63 136.72 53.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.96 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.7 mtp180 -112.64 149.74 32.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.997 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 49.5 m-20 -112.12 125.61 54.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.716 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.3 mp -107.78 127.29 53.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.927 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.491 ' N ' HD12 ' A' ' 95' ' ' ILE . 4.1 mp -118.09 137.41 52.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.076 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -114.01 144.09 43.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.041 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.836 HG13 ' CE1' ' A' ' 80' ' ' PHE . 14.1 t -106.45 127.13 62.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.253 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 11.9 mt -130.03 120.91 50.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.851 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -100.14 136.5 39.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.021 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.7 mmtt -133.47 30.55 3.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.913 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.7 m -160.68 150.78 17.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.841 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -102.21 44.76 0.99 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.954 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -83.65 -31.71 26.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.242 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 121.33 89.21 1.03 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.51 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 67.4 m -112.36 126.09 54.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.9 0.381 . . . . 0.0 110.912 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -121.03 118.31 29.49 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.956 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.436 HD12 ' O ' ' A' ' 124' ' ' ARG . 2.7 tp -115.49 137.33 49.41 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-O 121.551 0.691 . . . . 0.0 111.255 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.8 m120 59.98 28.09 17.57 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.838 -1.073 . . . . 0.0 110.931 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.74 9.89 70.82 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.878 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -134.04 152.0 51.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.823 0.344 . . . . 0.0 110.854 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.04 136.74 43.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.894 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.91 144.96 52.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.866 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.534 ' O ' HG22 ' A' ' 113' ' ' VAL . 10.2 p -141.11 56.13 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.106 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -177.25 -176.4 0.64 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.835 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.41 25.84 9.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.024 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -166.46 72.9 0.15 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.778 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.429 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 0.7 OUTLIER -84.14 139.4 32.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.833 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.543 ' O ' HG23 ' A' ' 118' ' ' ILE . 7.8 tp -98.51 117.62 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-O 120.984 0.421 . . . . 0.0 111.242 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.734 HD21 ' CD2' ' A' ' 135' ' ' PHE . 0.5 OUTLIER -103.1 132.54 49.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.035 -179.834 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -130.84 178.09 6.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.799 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.423 ' HB2' ' CE2' ' A' ' 137' ' ' TYR . 0.3 OUTLIER -54.81 141.32 33.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.061 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 71.8 53.04 10.16 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.5 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -129.14 127.12 40.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.895 0.378 . . . . 0.0 111.009 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.724 ' HD2' HD12 ' A' ' 134' ' ' LEU . 0.3 OUTLIER -91.13 124.38 35.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.747 179.958 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.427 HD11 HD11 ' A' ' 119' ' ' LEU . 3.2 mp -115.0 131.57 66.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.283 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.7 t -122.71 128.14 75.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.943 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.483 ' CB ' HD13 ' A' ' 68' ' ' LEU . 44.5 m-85 -121.77 118.22 28.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.983 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 86.63 -8.17 76.39 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.84 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 76.74 27.98 0.72 Allowed 'General case' 0 CA--C 1.522 -0.11 0 CA-C-O 120.939 0.4 . . . . 0.0 110.243 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.2 p -138.13 -48.24 0.54 Allowed 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.94 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' CYS . . . . . 0.465 ' HB3' HD22 ' A' ' 68' ' ' LEU . 1.8 m -88.41 112.04 22.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.865 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 23.0 t -120.08 123.35 43.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.036 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.493 ' CE2' HD22 ' A' ' 37' ' ' LEU . 3.1 p90 -142.16 156.22 45.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.118 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.724 HD12 ' HD2' ' A' ' 124' ' ' ARG . 7.1 tt -108.07 138.79 43.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.706 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.734 ' CD2' HD21 ' A' ' 119' ' ' LEU . 56.5 t80 -105.18 141.57 36.49 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.992 0.901 . . . . 0.0 111.938 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.43 155.11 34.37 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 113.846 -1.525 . . . . 0.0 110.747 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.423 ' CE2' ' HB2' ' A' ' 121' ' ' ASN . 1.1 m-85 -85.06 139.74 31.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.945 0.403 . . . . 0.0 110.847 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -118.9 -168.6 1.58 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.065 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -160.78 -46.34 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.927 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.9 m -74.03 132.89 42.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.928 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.3 t -119.56 -40.42 2.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.965 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.1 m -58.1 -48.52 79.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.007 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 60.65 31.61 20.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.894 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -166.86 119.0 0.96 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.882 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.6 ' O ' HG22 ' A' ' 145' ' ' ILE . 19.2 mt -103.2 25.2 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 CA-C-O 121.623 0.725 . . . . 0.0 111.278 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 61.99 93.47 0.05 OUTLIER 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.899 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -128.93 112.44 14.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.908 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -116.15 -64.81 1.26 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.966 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -129.69 -45.98 1.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.852 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 61.09 102.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.86 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.74 32.51 4.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.872 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.5 t -69.95 -60.89 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.085 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 26.1 t -77.16 98.18 5.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.842 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 2.1 p -114.14 140.6 48.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.968 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -68.45 78.85 0.27 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.907 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 3.9 m 60.07 165.52 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.907 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 37.2 mtt-85 -73.87 115.27 13.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.901 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 47.9 t -117.94 89.97 3.23 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.887 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 36.5 t80 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.886 -179.984 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.4 mttm . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.835 0.35 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 61.05 110.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.864 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 59.66 94.4 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.966 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -146.75 115.85 6.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.927 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.66 -71.63 0.72 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.829 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.01 31.43 5.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.863 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -103.43 111.97 24.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.874 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.4 mtmt -132.43 149.11 72.21 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.859 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -68.58 140.91 48.74 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.589 2.193 . . . . 0.0 112.21 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.0 t -113.19 94.36 4.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.03 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.4 p -77.94 -58.61 3.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.756 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -178.73 -69.23 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.807 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.422 ' HB2' ' HB ' ' A' ' 51' ' ' THR . 17.8 m-85 -97.18 -108.13 0.16 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.865 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.478 ' C ' HG22 ' A' ' 51' ' ' THR . 0.7 OUTLIER -140.27 128.72 22.71 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 120.726 0.298 . . . . 0.0 110.635 179.758 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 13.2 t -76.43 114.86 15.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.901 0.382 . . . . 0.0 111.071 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.19 -35.8 3.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.889 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.711 ' C ' HG22 ' A' ' 50' ' ' ILE . . . -141.03 -177.81 16.67 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.565 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.638 ' ND1' ' HB2' ' A' ' 138' ' ' ALA . 31.9 m80 -142.13 157.87 44.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.836 0.35 . . . . 0.0 110.832 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.494 ' O ' HD12 ' A' ' 37' ' ' LEU . 3.0 pp -127.08 123.05 35.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.722 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.3 t -105.89 121.93 58.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.197 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 24.3 m-80 -86.3 115.16 23.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.751 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 45.1 mt -83.87 106.87 15.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.986 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.547 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 4.4 mt -124.25 141.5 37.55 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.806 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.547 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 57.5 Cg_endo -73.66 84.91 1.36 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.253 1.968 . . . . 0.0 112.018 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 141.34 -14.04 2.76 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.41 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -179.03 173.68 1.15 Allowed 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 120.767 0.317 . . . . 0.0 110.628 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -139.04 160.76 39.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.075 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -141.5 123.35 15.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.959 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.42 ' HE2' ' CD2' ' A' ' 36' ' ' HIS . 28.4 tttt -110.68 126.17 54.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.819 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 38.5 t -124.05 144.67 33.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.235 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.442 ' HG2' ' CD2' ' A' ' 36' ' ' HIS . 48.0 mt-10 -80.87 135.64 35.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.546 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.711 HG22 ' C ' ' A' ' 35' ' ' GLY . 2.9 tt -111.65 131.99 61.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.043 0.449 . . . . 0.0 111.444 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.585 ' O ' HD13 ' A' ' 82' ' ' LEU . 0.9 OUTLIER -102.7 168.02 9.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.465 179.804 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.769 ' HA ' HD22 ' A' ' 82' ' ' LEU . 34.1 m-80 -68.43 -91.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.574 ' C ' ' H ' ' A' ' 55' ' ' VAL . 5.8 ttt85 69.75 -2.48 1.97 Allowed 'General case' 0 C--O 1.231 0.126 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 178.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.417 ' HA ' HD22 ' A' ' 83' ' ' LEU . 1.8 m-20 70.29 -32.21 0.23 Allowed 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 -179.008 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.574 ' H ' ' C ' ' A' ' 53' ' ' ARG . 81.6 t -136.99 143.25 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.822 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.499 HG23 ' CB ' ' A' ' 65' ' ' ASP . 9.2 m -125.49 131.2 52.87 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.458 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 65' ' ' ASP . 0.1 OUTLIER -103.98 137.46 41.93 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.908 0.385 . . . . 0.0 111.087 -179.862 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.416 HD13 ' CE1' ' A' ' 80' ' ' PHE . 3.4 mp -132.1 128.47 59.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.096 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 168.9 -135.27 3.53 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.754 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.448 ' HB3' ' HA ' ' A' ' 70' ' ' GLU . 14.8 ptt85 -108.11 -29.4 8.97 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.663 0.268 . . . . 0.0 111.022 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.713 ' CB ' HG23 ' A' ' 75' ' ' THR . 2.8 t -57.46 121.73 10.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.831 0.348 . . . . 0.0 110.816 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.68 -25.36 39.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.07 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.97 -24.63 63.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.0 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 87.7 m -58.22 166.47 1.62 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.038 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.499 ' CB ' HG23 ' A' ' 56' ' ' THR . 0.5 OUTLIER -71.01 -57.1 4.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.003 0.43 . . . . 0.0 110.832 179.742 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.47 HG21 ' CD2' ' A' ' 37' ' ' LEU . 21.0 t -125.2 133.3 69.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.67 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.6 pt -101.72 125.32 55.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.722 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.531 HD23 ' CB ' ' A' ' 131' ' ' CYS . 4.3 mp -93.28 -85.98 0.26 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.944 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.401 ' O ' ' CB ' ' A' ' 70' ' ' GLU . 10.0 t -98.33 -101.93 0.21 Allowed 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.531 ' CB ' ' CD ' ' A' ' 71' ' ' PRO . 0.1 OUTLIER 167.21 -70.2 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.189 0 CA-C-O 120.528 0.204 . . . . 0.0 111.299 179.369 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.531 ' CD ' ' CB ' ' A' ' 70' ' ' GLU . 47.0 Cg_endo -67.86 -38.19 13.95 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.56 2.173 . . . . 0.0 113.579 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -105.71 10.51 32.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.757 0.313 . . . . 0.0 111.226 -179.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.449 ' O ' ' CG2' ' A' ' 73' ' ' ILE . 2.9 tp -105.88 117.29 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-O 121.016 0.436 . . . . 0.0 110.612 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.429 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 0.3 OUTLIER -67.22 135.97 54.26 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.16 -179.163 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.713 HG23 ' CB ' ' A' ' 61' ' ' SER . 64.1 m -49.33 -44.02 44.09 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.826 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.448 ' O ' ' C ' ' A' ' 77' ' ' HIS . 5.7 p90 -106.85 14.1 27.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.22 0.533 . . . . 0.0 111.327 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.448 ' C ' ' O ' ' A' ' 76' ' ' PHE . 3.9 t-160 -20.2 -58.51 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.609 -1.178 . . . . 0.0 112.826 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.431 ' CB ' ' CZ ' ' A' ' 127' ' ' PHE . . . -150.63 157.89 43.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.97 0.414 . . . . 0.0 111.583 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 56' ' ' THR . 16.2 pt-20 -133.06 133.49 43.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.684 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.664 ' CE2' HG22 ' A' ' 97' ' ' VAL . 5.0 m-85 -119.3 131.33 55.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.608 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.4 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 9.0 m-70 -94.41 116.43 28.79 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.985 0.421 . . . . 0.0 111.092 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.769 HD22 ' HA ' ' A' ' 52' ' ' ASN . 1.8 tt -106.49 109.88 21.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.814 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' LEU . . . . . 0.417 HD22 ' HA ' ' A' ' 54' ' ' ASN . 1.1 mm? -121.6 137.4 54.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.895 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -108.93 136.91 47.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.856 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -126.88 131.77 51.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.869 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -88.54 120.17 29.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.904 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.5 t -139.96 139.13 37.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.065 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -50.1 132.86 23.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.078 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 35.6 m120 62.47 99.35 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.792 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 63.16 133.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.999 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -82.93 158.71 22.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.897 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.91 111.82 20.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.974 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.495 ' C ' HD12 ' A' ' 94' ' ' LEU . 11.9 m-80 -113.34 138.92 49.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.837 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.495 HD12 ' C ' ' A' ' 93' ' ' ASN . 7.9 mp -130.03 137.17 50.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.995 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.454 ' O ' HD12 ' A' ' 118' ' ' ILE . 3.8 mp -119.59 139.02 48.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.078 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -116.88 144.13 44.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.688 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.664 HG22 ' CE2' ' A' ' 80' ' ' PHE . 16.4 t -116.2 132.15 66.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.271 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.558 HD13 ' O ' ' A' ' 115' ' ' LYS . 20.5 mm -127.11 131.06 71.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.119 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -90.22 128.35 36.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.861 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.5 mmmt -119.93 -35.36 3.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.278 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.8 m -78.07 -44.84 25.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.117 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.51 21.54 10.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.904 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -85.95 -30.51 22.73 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.855 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 167.36 73.37 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.506 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.456 HG23 ' CE1' ' A' ' 127' ' ' PHE . 62.0 m -104.72 122.76 46.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.888 0.375 . . . . 0.0 110.869 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -121.14 119.29 31.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.874 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.789 HD13 HD12 ' A' ' 125' ' ' ILE . 2.9 tp -118.09 137.29 52.52 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 CA-C-O 121.524 0.678 . . . . 0.0 111.202 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.8 m120 60.15 27.29 16.75 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.818 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.75 9.86 70.81 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.818 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 5.3 m120 -134.03 152.02 51.67 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.749 0.309 . . . . 0.0 110.958 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 30.1 mtm180 -65.1 142.97 58.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.902 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.418 HD21 ' HB ' ' A' ' 105' ' ' THR . 3.1 pp -99.17 129.57 45.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.898 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.6 m -111.85 -30.79 2.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.189 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 16.9 mtmt -80.64 142.22 34.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.937 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.558 ' O ' HD13 ' A' ' 98' ' ' ILE . 0.2 OUTLIER -77.73 -32.75 53.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.875 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -105.64 75.04 1.11 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.927 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -80.75 139.03 36.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.822 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.525 ' O ' HG23 ' A' ' 118' ' ' ILE . 8.6 tp -98.54 119.06 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.37 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.6 tt -103.0 138.51 39.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.982 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.02 178.11 7.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.862 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.445 ' HB2' ' CE2' ' A' ' 137' ' ' TYR . 2.0 t30 -55.31 142.06 33.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.084 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.501 ' HA2' HD21 ' A' ' 134' ' ' LEU . . . 68.08 48.62 52.47 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.406 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -123.44 124.24 42.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.843 0.354 . . . . 0.0 111.072 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.473 ' O ' HD12 ' A' ' 107' ' ' ILE . 48.6 ttt-85 -90.22 122.19 32.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.801 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.789 HD12 HD13 ' A' ' 107' ' ' ILE . 0.5 OUTLIER -120.63 136.41 57.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.933 0.397 . . . . 0.0 111.317 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.432 HG22 ' HB3' ' A' ' 132' ' ' SER . 21.4 t -124.09 133.95 67.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.815 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.456 ' CE1' HG23 ' A' ' 105' ' ' THR . 9.7 m-85 -124.85 138.42 54.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.955 0.407 . . . . 0.0 111.142 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 86.77 -69.83 3.03 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.343 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 176.67 -39.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.729 0.3 . . . . 0.0 111.076 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.38 -40.21 4.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.804 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' CYS . . . . . 0.531 ' CB ' HD23 ' A' ' 68' ' ' LEU . 33.6 m -53.92 103.95 0.09 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.071 0.462 . . . . 0.0 111.268 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.432 ' HB3' HG22 ' A' ' 126' ' ' VAL . 5.6 p -124.6 129.34 50.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.902 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.457 ' N ' ' CD1' ' A' ' 133' ' ' PHE . 1.3 p90 -142.16 156.08 45.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.058 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.583 HD23 ' N ' ' A' ' 135' ' ' PHE . 3.5 tt -115.11 136.16 53.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.83 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.7 ' HE2' HG21 ' A' ' 50' ' ' ILE . 21.6 t80 -105.67 141.56 36.92 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.95 0.881 . . . . 0.0 111.774 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -154.31 159.67 41.35 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 113.828 -1.533 . . . . 0.0 110.756 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.445 ' CE2' ' HB2' ' A' ' 121' ' ' ASN . 4.5 m-85 -85.29 140.11 31.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.059 0.457 . . . . 0.0 110.618 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.638 ' HB2' ' ND1' ' A' ' 36' ' ' HIS . . . -91.17 138.93 31.22 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.191 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.17 94.23 9.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.919 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 52.9 p -139.89 48.36 1.8 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.882 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.76 31.94 0.22 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.803 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.478 ' O ' HG22 ' A' ' 143' ' ' THR . 0.2 OUTLIER -79.43 -56.88 4.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.923 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 143' ' ' THR . . . . . 0.478 HG22 ' O ' ' A' ' 142' ' ' SER . 15.0 t 45.32 -167.6 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.366 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -151.63 178.96 8.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.9 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.605 ' O ' HG22 ' A' ' 145' ' ' ILE . 3.3 mp -105.01 25.04 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-O 121.707 0.765 . . . . 0.0 111.37 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -138.4 138.66 38.43 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.941 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -166.24 -45.24 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.88 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.62 -33.06 12.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.86 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -94.89 125.96 39.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.872 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -84.63 151.64 24.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.906 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 20.0 mttt -85.85 174.84 9.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.952 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.482 ' O ' HG23 ' A' ' 152' ' ' VAL . 21.4 m -125.73 115.68 43.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.12 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 2.5 m -129.24 -57.73 1.14 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.962 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.73 -179.29 0.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.901 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -126.04 160.75 29.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.858 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 73.3 m -153.71 78.84 1.14 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.874 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 1.8 mtp-105 -98.33 123.34 42.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.913 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.3 m 60.75 80.92 0.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.9 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.873 -179.953 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.4 mttp . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.836 0.351 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.89 153.39 40.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.762 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -126.29 177.75 6.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.92 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.444 ' O ' ' HG2' ' A' ' 23' ' ' ARG . 0.5 OUTLIER -112.62 -175.06 2.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.85 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ARG . . . . . 0.444 ' HG2' ' O ' ' A' ' 22' ' ' GLN . 0.1 OUTLIER 34.65 50.46 0.42 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.905 179.909 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 92.8 p -84.08 -26.2 29.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.08 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -55.33 -71.07 0.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.037 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.2 mmtt -134.95 139.39 31.97 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.876 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.14 146.68 58.54 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.471 2.114 . . . . 0.0 112.224 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.8 t -75.66 85.49 2.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.886 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.9 161.15 29.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.892 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -142.42 -65.64 0.4 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.762 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.464 ' HB2' ' CG2' ' A' ' 51' ' ' THR . 49.0 m-85 -114.99 -118.19 0.32 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.618 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.4 ' O ' HG22 ' A' ' 51' ' ' THR . 0.0 OUTLIER -140.18 137.42 34.35 Favored 'General case' 0 N--CA 1.457 -0.082 0 CA-C-O 120.823 0.344 . . . . 0.0 110.73 179.917 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.8 t -59.81 145.07 46.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.117 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.618 HD22 HD21 ' A' ' 82' ' ' LEU . 8.3 tt -152.2 -44.98 0.1 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.945 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -157.72 172.82 35.04 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.445 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.546 ' ND1' ' HB2' ' A' ' 138' ' ' ALA . 32.1 m80 -133.47 161.19 35.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.008 0.432 . . . . 0.0 111.208 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.608 HD12 HD11 ' A' ' 50' ' ' ILE . 57.9 mt -127.19 107.92 10.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.596 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.2 t -96.78 121.74 47.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.825 0.345 . . . . 0.0 111.366 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -90.16 119.44 30.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.836 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.5 mt -79.26 106.8 11.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.898 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.4 mt -124.27 139.27 32.45 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.914 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -50.11 91.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.41 2.074 . . . . 0.0 112.286 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 116.03 -105.6 1.42 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.263 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.85 -168.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.791 0.329 . . . . 0.0 111.023 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -155.5 141.7 18.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.985 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -110.46 120.17 41.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.82 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.57 126.14 54.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.993 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.7 t -117.21 143.99 26.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.975 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -93.7 131.16 39.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.925 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.608 HD11 HD12 ' A' ' 37' ' ' LEU . 30.5 mm -111.33 122.38 65.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.002 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.757 ' O ' HD23 ' A' ' 82' ' ' LEU . 0.4 OUTLIER -102.48 168.2 9.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.899 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 17.2 p30 -93.19 71.38 4.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.704 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.587 ' C ' ' H ' ' A' ' 55' ' ' VAL . 2.6 ptp180 -98.35 15.62 24.09 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.618 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 68.97 -29.26 0.17 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.706 0.289 . . . . 0.0 110.333 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.587 ' H ' ' C ' ' A' ' 53' ' ' ARG . 59.3 t -137.09 134.64 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 CA-C-O 121.193 0.52 . . . . 0.0 111.548 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.659 HG23 ' HB3' ' A' ' 65' ' ' ASP . 39.7 m -125.06 122.53 37.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.756 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.88 133.84 48.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.901 0.382 . . . . 0.0 111.038 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.4 mp -119.11 116.52 51.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.721 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 174.72 -146.09 8.32 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.571 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.524 ' HB3' ' HA ' ' A' ' 70' ' ' GLU . 9.4 ptt180 -100.21 -27.67 13.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.702 0.287 . . . . 0.0 111.102 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.06 121.4 7.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.911 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.7 ptt85 -54.96 -28.78 54.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.067 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.91 -24.99 63.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.836 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 99.8 m -55.36 158.8 3.0 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.001 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.659 ' HB3' HG23 ' A' ' 56' ' ' THR . 62.0 t0 -76.3 -52.89 9.05 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.905 0.383 . . . . 0.0 110.943 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.6 t -101.64 129.83 52.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.253 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 14.6 pt -99.82 125.84 53.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.158 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.405 ' O ' ' C ' ' A' ' 69' ' ' SER . 3.3 mp -113.71 -163.69 0.88 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.249 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.596 ' O ' ' CB ' ' A' ' 70' ' ' GLU . 1.2 m -35.56 -58.46 0.59 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.574 0.226 . . . . 0.0 110.975 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.596 ' CB ' ' O ' ' A' ' 69' ' ' SER . 9.0 tm-20 109.84 -61.74 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.529 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.702 178.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.585 ' HD2' ' C ' ' A' ' 69' ' ' SER . 44.0 Cg_endo -67.75 -33.51 27.26 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 121.888 1.726 . . . . 0.0 113.199 -179.358 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -112.04 21.56 15.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.701 0.286 . . . . 0.0 111.301 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.424 HD12 ' HA ' ' A' ' 73' ' ' ILE . 4.8 tp -117.8 128.85 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-O 120.916 0.388 . . . . 0.0 111.147 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.8 m -63.55 132.78 52.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.057 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.8 m -59.81 -33.48 71.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.897 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.448 ' O ' ' C ' ' A' ' 77' ' ' HIS . 14.9 m-85 -112.1 13.88 20.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.474 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.449 ' CE1' ' HB3' ' A' ' 127' ' ' PHE . 2.1 t-160 -21.62 -69.49 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.726 -1.125 . . . . 0.0 112.574 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.465 ' HB3' ' HE2' ' A' ' 127' ' ' PHE . . . -153.06 159.68 42.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.125 0.488 . . . . 0.0 112.045 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -126.53 134.2 50.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.41 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.655 ' CZ ' HG13 ' A' ' 97' ' ' VAL . 7.5 m-85 -119.4 131.45 55.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.888 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 9.9 m-70 -94.63 116.37 28.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.917 0.389 . . . . 0.0 111.011 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.757 HD23 ' O ' ' A' ' 51' ' ' THR . 12.8 tp -106.47 109.69 21.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.915 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.1 140.08 52.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -116.3 125.13 51.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.864 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 32.6 tpp -138.84 133.39 31.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.912 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -107.04 133.66 51.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.93 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.5 t -135.8 134.19 51.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.002 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.8 t70 75.04 -58.24 0.58 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.021 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -176.31 -39.02 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.894 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -86.63 146.11 26.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.775 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -97.07 137.84 35.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.032 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.2 mtm-85 -114.3 144.8 42.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.873 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 73.2 m-80 -114.08 121.34 43.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.854 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.668 HD21 HG12 ' A' ' 118' ' ' ILE . 1.8 tt -115.72 132.84 56.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.877 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.528 ' N ' HD12 ' A' ' 95' ' ' ILE . 3.2 mp -122.27 140.99 44.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.146 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -113.94 144.0 43.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.823 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.655 HG13 ' CZ ' ' A' ' 80' ' ' PHE . 22.7 t -109.15 122.91 64.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.193 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 25.1 mt -130.1 122.32 53.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.089 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -107.71 138.6 43.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.863 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.9 mmtp -92.65 -6.02 50.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.414 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.8 m 63.05 44.37 5.92 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.882 0.372 . . . . 0.0 110.877 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -95.32 -45.84 6.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.86 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -123.99 -43.59 2.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.244 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 136.34 110.61 1.04 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.504 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 35.8 m -114.39 123.13 48.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.721 0.296 . . . . 0.0 110.942 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.414 ' CE2' ' HB2' ' A' ' 111' ' ' ARG . 6.2 m-85 -121.04 120.34 35.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.808 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.577 HG22 HD22 ' A' ' 112' ' ' LEU . 2.8 tp -102.75 137.24 31.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.493 0.663 . . . . 0.0 111.263 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.8 m120 61.65 30.55 18.6 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.79 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.67 11.32 72.84 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.849 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -134.01 150.58 51.24 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.782 0.325 . . . . 0.0 110.877 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.414 ' HB2' ' CE2' ' A' ' 106' ' ' PHE . 57.4 ttt-85 -74.97 137.89 41.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.902 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.577 HD22 HG22 ' A' ' 107' ' ' ILE . 0.5 OUTLIER -98.58 134.86 40.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.882 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 15.0 p -107.46 -37.27 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.186 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.1 tttp -61.39 151.52 32.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.874 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.14 30.91 3.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.888 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -169.76 60.25 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.783 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -73.25 136.46 44.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.746 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.668 HG12 HD21 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -98.83 116.71 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.817 -179.887 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.767 HD11 HD11 ' A' ' 125' ' ' ILE . 7.8 tt -101.41 145.87 28.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.977 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.511 ' HD3' HD11 ' A' ' 118' ' ' ILE . 8.4 mmmt -133.51 178.06 7.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.807 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.421 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 12.6 p30 -56.19 141.65 40.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.081 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.728 ' HA2' HD21 ' A' ' 134' ' ' LEU . . . 70.11 46.45 50.93 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.523 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ASP . . . . . 0.458 ' C ' HD12 ' A' ' 134' ' ' LEU . 7.6 m-20 -120.29 120.78 37.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.768 0.318 . . . . 0.0 110.945 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.566 ' N ' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -85.19 124.47 31.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.811 179.886 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.767 HD11 HD11 ' A' ' 119' ' ' LEU . 1.2 mp -121.49 135.16 62.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.111 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.683 HG22 ' HB3' ' A' ' 132' ' ' SER . 21.9 t -115.84 125.42 72.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.069 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.513 ' CE1' ' CZ ' ' A' ' 133' ' ' PHE . 67.4 m-85 -116.51 113.45 22.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.014 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 86.92 -8.63 75.35 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.918 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 6.0 tttm 78.82 28.54 0.41 Allowed 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.869 0.366 . . . . 0.0 110.477 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.37 -47.57 0.34 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.929 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 18.7 m -96.11 109.99 22.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.871 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.683 ' HB3' HG22 ' A' ' 126' ' ' VAL . 0.2 OUTLIER -122.07 126.63 48.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.946 -179.902 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.551 ' CE1' HD13 ' A' ' 37' ' ' LEU . 13.5 p90 -139.22 155.93 47.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.886 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.728 HD21 ' HA2' ' A' ' 122' ' ' GLY . 3.6 tp -105.35 136.21 45.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.97 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.577 ' HD2' HD21 ' A' ' 37' ' ' LEU . 24.7 t80 -96.53 141.54 29.69 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 121.971 0.891 . . . . 0.0 111.604 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 29.3 mttp -154.57 153.11 30.88 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 113.885 -1.507 . . . . 0.0 110.867 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.446 ' HE1' HD11 ' A' ' 95' ' ' ILE . 3.7 m-85 -79.26 139.68 37.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.94 0.4 . . . . 0.0 110.696 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.546 ' HB2' ' ND1' ' A' ' 36' ' ' HIS . . . -93.0 44.58 1.15 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.173 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.1 p -97.46 59.37 1.54 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.684 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 6.1 t -57.99 156.98 8.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.975 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.2 m -152.04 72.88 1.03 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.872 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 98.3 p -140.76 170.71 15.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.867 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 16.1 m -148.41 -63.29 0.25 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.862 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -153.26 -178.91 7.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.892 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.578 HG22 ' H ' ' A' ' 146' ' ' GLU . 2.2 mt -110.24 -143.7 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.578 ' H ' HG22 ' A' ' 145' ' ' ILE . 0.0 OUTLIER -64.88 145.96 55.57 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.882 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -81.1 141.98 33.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.846 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -157.55 121.12 4.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.85 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -105.48 158.6 16.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.867 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.24 -47.79 7.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.823 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -96.51 116.83 29.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.896 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.4 t -69.19 132.86 32.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.148 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.89 128.62 36.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.898 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 5.5 p -175.2 -53.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.866 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -141.23 122.23 14.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.909 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 24.3 p -114.37 150.6 34.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.883 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 18.1 mtm180 -124.27 -64.83 1.09 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.859 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 15.3 p -78.68 -57.08 3.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.907 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.87 179.976 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.6 mttt . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 120.858 0.361 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.15 174.15 9.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.869 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -63.19 174.17 1.26 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.836 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 60.2 90.13 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.902 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.55 146.08 5.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.912 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.1 m -67.21 88.8 0.18 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.91 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.7 p30 -146.16 171.93 14.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.805 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.91 132.95 22.95 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.855 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.13 157.92 58.13 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.449 2.1 . . . . 0.0 112.231 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.2 m 58.99 93.41 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.953 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 68.4 p -149.82 79.77 1.37 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.864 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -100.41 138.48 37.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.003 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.546 ' N ' HG21 ' A' ' 51' ' ' THR . 3.4 m-85 -61.78 -97.07 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.921 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.583 ' N ' HG22 ' A' ' 51' ' ' THR . 0.2 OUTLIER -140.44 134.72 31.17 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-O 120.72 0.295 . . . . 0.0 110.573 179.761 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 2.0 t -59.95 127.57 32.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.971 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.542 ' O ' HD13 ' A' ' 34' ' ' LEU . 1.3 tm? -128.91 -44.1 1.33 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.713 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.704 ' C ' HG22 ' A' ' 50' ' ' ILE . . . -157.33 -165.21 14.74 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.43 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 52.9 m80 -146.18 163.9 33.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.87 0.367 . . . . 0.0 111.065 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.524 HD11 ' HB ' ' A' ' 50' ' ' ILE . 1.7 mp -126.81 119.97 28.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.644 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.4 t -96.12 121.92 47.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.209 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.429 ' HA ' ' CD1' ' A' ' 133' ' ' PHE . 4.3 m-20 -89.39 113.98 25.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.767 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.1 mt -88.59 106.51 18.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.996 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.55 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 1.7 mp -124.5 140.73 35.93 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.509 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.55 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 53.1 Cg_endo -72.24 80.86 1.54 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.003 1.802 . . . . 0.0 112.011 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 145.16 -14.47 1.89 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.686 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.4 tptm -178.34 164.28 1.71 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.806 0.336 . . . . 0.0 110.863 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -125.56 164.99 19.34 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.053 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -150.34 124.92 9.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.911 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.5 mtpt -102.41 134.66 45.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.879 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.7 t -121.71 150.18 24.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.112 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -94.93 132.4 39.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.808 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.743 HG21 ' HE2' ' A' ' 135' ' ' PHE . 5.0 tt -115.98 132.14 66.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.212 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.583 HG22 ' N ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -98.98 168.1 10.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.925 -179.832 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.414 ' O ' ' ND2' ' A' ' 52' ' ' ASN . 0.4 OUTLIER -102.72 74.97 1.38 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.444 179.419 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.594 ' C ' ' H ' ' A' ' 55' ' ' VAL . 0.7 OUTLIER -99.04 23.19 9.31 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.526 -179.601 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.552 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 1.6 m-20 67.53 -28.91 0.14 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.487 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.594 ' H ' ' C ' ' A' ' 53' ' ' ARG . 60.2 t -137.76 136.56 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 CA-C-O 120.964 0.412 . . . . 0.0 111.749 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.748 HG23 ' CB ' ' A' ' 65' ' ' ASP . 99.5 m -125.51 129.9 50.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.062 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.455 ' O ' ' N ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -104.0 138.82 39.99 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.954 0.407 . . . . 0.0 111.529 -179.448 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.612 HG22 HD11 ' A' ' 68' ' ' LEU . 4.6 mp -132.52 135.19 58.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.093 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 157.12 -137.36 5.36 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.305 -0.95 . . . . 0.0 113.227 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.473 ' HB2' ' CG2' ' A' ' 73' ' ' ILE . 21.3 ttp180 -94.89 -49.24 5.66 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.753 0.311 . . . . 0.0 111.22 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.494 ' OG ' HG23 ' A' ' 75' ' ' THR . 0.0 OUTLIER -43.71 117.02 1.06 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.497 -179.373 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.1 mtt85 -57.37 -23.3 48.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.015 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.78 -24.19 63.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.76 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 96.4 m -57.42 168.25 0.83 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.824 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.748 ' CB ' HG23 ' A' ' 56' ' ' THR . 0.5 OUTLIER -69.85 -56.62 6.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.952 0.406 . . . . 0.0 110.778 179.827 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 58' ' ' ILE . 21.3 t -125.2 132.95 70.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.594 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 7.9 pt -102.8 128.05 55.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.816 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.81 HD23 ' CE2' ' A' ' 133' ' ' PHE . 0.5 OUTLIER -89.19 -71.35 0.6 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.781 -179.769 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.448 ' HB3' ' HB ' ' A' ' 73' ' ' ILE . 12.8 t -121.3 -111.67 0.33 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.076 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.442 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . 9.7 tt0 170.63 -64.15 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.264 0 O-C-N 122.298 -0.251 . . . . 0.0 111.575 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.442 ' CD ' ' HB3' ' A' ' 70' ' ' GLU . 25.2 Cg_endo -62.0 -40.05 46.05 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.35 2.033 . . . . 0.0 113.28 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -122.49 28.87 7.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.569 0.223 . . . . 0.0 111.503 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.532 HD11 HD13 ' A' ' 68' ' ' LEU . 4.4 tp -110.8 125.94 68.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.971 0.415 . . . . 0.0 111.116 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -59.48 134.01 56.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.484 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.494 HG23 ' OG ' ' A' ' 61' ' ' SER . 36.2 m -65.91 -44.21 85.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.856 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.448 ' O ' ' C ' ' A' ' 77' ' ' HIS . 2.1 m-85 -100.27 13.73 33.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.27 0.557 . . . . 0.0 111.153 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.461 ' CE1' ' HB3' ' A' ' 127' ' ' PHE . 0.4 OUTLIER -15.51 -71.39 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.403 -1.271 . . . . 0.0 113.175 -179.338 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.405 ' HB2' ' HE1' ' A' ' 127' ' ' PHE . . . -153.75 164.08 38.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.225 0.536 . . . . 0.0 112.293 -179.234 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -132.5 132.64 42.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.962 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.642 ' CE2' HG22 ' A' ' 97' ' ' VAL . 3.9 m-85 -119.39 131.08 55.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.781 0.324 . . . . 0.0 110.96 -179.446 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.552 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 24.8 m-70 -95.89 116.81 29.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.245 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.2 mp -106.3 109.37 21.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.669 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -122.58 140.19 53.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.032 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 -104.21 120.95 42.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.754 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -119.68 142.62 48.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.0 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -107.13 124.89 50.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.902 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.437 HG21 ' HE ' ' A' ' 92' ' ' ARG . 4.0 m -121.88 132.48 70.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.149 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 68.45 -65.58 0.26 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.059 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER 179.82 39.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.818 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -145.94 -177.29 5.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.695 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.29 129.12 55.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.999 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.437 ' HE ' HG21 ' A' ' 87' ' ' VAL . 9.4 mtm180 -116.32 150.21 38.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.85 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 38.4 m-20 -114.03 123.67 50.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.944 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.8 mp -130.05 123.84 31.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.825 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.414 ' N ' HD12 ' A' ' 95' ' ' ILE . 4.3 mp -116.25 141.07 35.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.057 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -114.03 144.06 43.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.862 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.642 HG22 ' CE2' ' A' ' 80' ' ' PHE . 18.1 t -115.36 126.09 72.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.23 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.3 mp -127.99 135.57 62.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.071 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -107.55 120.23 41.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.822 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.45 32.38 2.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.006 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 21.8 m -126.85 178.78 5.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.898 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.1 ptp85 -127.55 39.13 3.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.922 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -106.67 -60.62 1.64 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.228 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 145.06 103.36 0.4 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.539 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.464 ' CG2' ' CE1' ' A' ' 127' ' ' PHE . 85.5 m -117.95 124.92 49.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.861 0.362 . . . . 0.0 110.979 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' A' ' 106' ' ' PHE . 5.0 m-85 -121.03 123.71 43.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.829 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.604 ' CD1' HD13 ' A' ' 125' ' ' ILE . 3.0 tp -109.95 137.29 42.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.464 0.649 . . . . 0.0 111.391 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.0 m120 60.66 29.59 19.12 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.817 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.63 11.38 72.75 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.834 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -134.02 152.06 51.69 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.759 0.314 . . . . 0.0 110.877 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -63.53 142.96 58.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.964 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.407 HD23 ' N ' ' A' ' 113' ' ' VAL . 0.7 OUTLIER -83.95 133.11 34.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.769 -179.991 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.45 HG13 ' N ' ' A' ' 114' ' ' LYS . 11.8 p -120.62 -42.8 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.149 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.45 ' N ' HG13 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -71.92 147.46 47.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.794 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.89 -37.38 48.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.795 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -111.36 77.79 1.07 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.862 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -80.05 135.95 36.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.867 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.493 ' O ' HG23 ' A' ' 118' ' ' ILE . 8.7 tp -98.73 122.28 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.289 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.743 ' CD1' HD11 ' A' ' 125' ' ' ILE . 4.8 tt -103.06 132.78 49.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.879 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.78 178.07 5.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.838 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.417 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 8.2 p30 -60.41 138.55 57.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.07 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 74.76 56.0 5.14 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.595 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -130.96 132.91 45.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.794 0.33 . . . . 0.0 110.981 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.15 132.68 34.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.877 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.743 HD11 ' CD1' ' A' ' 119' ' ' LEU . 21.1 mm -117.64 121.77 68.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.166 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.421 HG22 ' OG ' ' A' ' 132' ' ' SER . 59.0 t -115.13 128.35 72.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.66 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.464 ' CE1' ' CG2' ' A' ' 105' ' ' THR . 15.1 m-85 -132.08 111.88 11.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.923 0.392 . . . . 0.0 111.659 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.495 ' O ' ' HB2' ' A' ' 129' ' ' LYS . . . 108.91 -81.9 0.29 Allowed Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.206 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.495 ' HB2' ' O ' ' A' ' 128' ' ' GLY . 14.1 tttp 172.22 37.03 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.887 0.375 . . . . 0.0 110.664 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 24.9 p 178.83 -48.82 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.95 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' CYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 77.6 m -56.7 104.7 0.16 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.887 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.421 ' OG ' HG22 ' A' ' 126' ' ' VAL . 0.3 OUTLIER -124.3 111.94 16.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.149 -179.766 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.81 ' CE2' HD23 ' A' ' 68' ' ' LEU . 3.0 m-85 -120.45 156.07 32.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.864 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.41 HD23 ' N ' ' A' ' 135' ' ' PHE . 6.0 tt -111.74 140.1 46.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.944 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.743 ' HE2' HG21 ' A' ' 50' ' ' ILE . 18.9 t80 -116.33 141.76 47.73 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.885 0.85 . . . . 0.0 111.733 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -154.44 159.74 41.23 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.06 -1.427 . . . . 0.0 111.022 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.417 ' CE2' ' HB3' ' A' ' 121' ' ' ASN . 3.3 m-85 -84.25 140.25 31.8 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.057 0.456 . . . . 0.0 110.741 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -104.05 -53.92 2.65 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.165 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.4 170.31 2.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.956 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 43.9 m -116.51 -40.35 3.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.902 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.2 t 63.56 52.84 2.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.952 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.1 t 59.53 -169.34 0.14 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.908 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.5 t -112.84 -176.48 2.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.85 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -121.92 -79.88 0.62 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.859 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.618 HG22 ' H ' ' A' ' 146' ' ' GLU . 0.7 OUTLIER -110.95 -143.17 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.618 ' H ' HG22 ' A' ' 145' ' ' ILE . 0.4 OUTLIER -175.73 117.22 0.15 Allowed 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.865 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 61.12 36.62 18.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.906 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -134.29 92.36 2.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.971 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -152.82 120.66 6.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.828 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.55 156.8 45.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.943 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.7 tttt -153.38 107.02 3.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.886 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.483 ' O ' HG23 ' A' ' 152' ' ' VAL . 10.8 m -86.25 86.27 2.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.112 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 5.8 t -145.53 33.12 1.06 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.822 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 16.5 t -77.42 107.47 9.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -147.58 158.28 43.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.925 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 38.8 t -78.19 126.09 30.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.857 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.4 121.69 15.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.838 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.2 m 60.43 106.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.895 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.163 -0.922 . . . . 0.0 110.86 -179.965 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.1 mmtt . . . . . 0 N--CA 1.488 1.465 0 CA-C-O 120.814 0.34 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.4 mmt-85 -109.24 -60.78 1.72 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.901 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -132.31 -177.78 4.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.937 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -62.31 -63.06 1.35 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.855 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 62.19 117.19 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.926 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.6 p -107.87 157.77 17.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.93 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -170.32 141.2 1.98 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.868 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.63 99.98 7.59 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.885 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.48 140.94 53.97 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.451 2.101 . . . . 0.0 112.277 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.4 t -87.48 163.83 16.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.943 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.6 m -113.12 168.1 9.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -72.29 -69.11 0.42 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.897 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -90.77 -106.08 0.1 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.859 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.428 ' N ' HG22 ' A' ' 51' ' ' THR . 0.8 OUTLIER -140.39 128.88 22.74 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.801 0.334 . . . . 0.0 110.731 179.882 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 2.1 t -67.01 143.89 56.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.942 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.709 HD22 HD11 ' A' ' 82' ' ' LEU . 1.5 tp -156.21 -67.65 0.11 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.902 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.403 ' HA3' ' CE1' ' A' ' 135' ' ' PHE . . . -114.13 167.09 12.23 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.446 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.42 ' CE1' ' HB3' ' A' ' 138' ' ' ALA . 33.4 m80 -136.19 160.67 37.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.907 0.384 . . . . 0.0 111.017 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.815 ' CD1' HD11 ' A' ' 50' ' ' ILE . 97.8 mt -127.23 117.96 23.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.709 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.4 t -101.8 121.59 52.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.205 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -90.26 136.97 32.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.891 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.8 mt -108.36 106.56 16.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.974 0.416 . . . . 0.0 110.848 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.548 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 4.1 mt -124.4 141.25 37.09 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.857 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.548 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 56.9 Cg_endo -73.36 81.46 1.77 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.172 1.915 . . . . 0.0 112.041 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 148.93 -18.78 1.23 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.403 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 11.9 ttmm -177.65 165.0 2.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.709 0.29 . . . . 0.0 110.655 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -122.11 149.76 43.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.028 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -121.43 134.05 55.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.74 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.95 124.88 53.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.137 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.547 HG11 HG13 ' A' ' 66' ' ' VAL . 31.6 t -120.15 150.52 22.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.998 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.419 ' HG3' ' CD2' ' A' ' 36' ' ' HIS . 0.0 OUTLIER -103.01 142.07 34.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.037 -179.867 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.815 HD11 ' CD1' ' A' ' 37' ' ' LEU . 33.1 mm -115.38 122.68 69.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.839 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.428 HG22 ' N ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -99.87 168.16 10.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.144 -179.885 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -100.11 73.87 1.74 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.593 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.577 ' C ' ' H ' ' A' ' 55' ' ' VAL . 4.0 ptp180 -107.05 22.04 16.61 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.437 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.505 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 30.6 m-80 67.1 -27.9 0.13 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.659 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.577 ' H ' ' C ' ' A' ' 53' ' ' ARG . 61.6 t -137.72 137.67 45.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 CA-C-O 121.006 0.431 . . . . 0.0 111.96 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.49 HG22 ' CB ' ' A' ' 65' ' ' ASP . 0.4 OUTLIER -125.36 128.28 47.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.72 178.911 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.464 ' O ' ' N ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -104.06 136.22 44.11 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.976 0.417 . . . . 0.0 111.488 -179.463 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.561 HD11 ' HD2' ' A' ' 80' ' ' PHE . 4.4 mp -132.2 127.17 57.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.974 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 164.08 -142.13 7.59 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.074 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.529 ' HB2' HG23 ' A' ' 73' ' ' ILE . 14.3 ttp180 -88.65 -43.19 11.51 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.811 0.339 . . . . 0.0 111.027 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.757 ' HB2' HG23 ' A' ' 75' ' ' THR . 0.4 OUTLIER -45.93 115.09 0.89 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.461 -179.527 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.04 -27.41 61.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.942 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.2 m -70.03 -24.71 63.32 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.814 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' CYS . . . . . 0.417 ' CB ' ' HB ' ' A' ' 57' ' ' THR . 98.7 m -53.08 167.93 0.15 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.76 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.49 ' CB ' HG22 ' A' ' 56' ' ' THR . 0.6 OUTLIER -69.5 -53.88 16.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.922 0.391 . . . . 0.0 111.038 179.943 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.609 HG21 HD12 ' A' ' 37' ' ' LEU . 22.1 t -125.05 125.69 69.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.517 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.3 pt -99.65 131.06 47.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.504 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.627 HD23 ' HB2' ' A' ' 131' ' ' CYS . 8.4 mp -100.89 -100.33 0.25 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.344 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.2 p -92.14 -103.9 0.11 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 121.224 -0.19 . . . . 0.0 110.724 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.554 ' HA ' HG22 ' A' ' 73' ' ' ILE . 3.0 mt-10 167.17 -64.78 0.0 OUTLIER Pre-proline 0 CA--C 1.529 0.136 0 CA-C-O 120.68 0.276 . . . . 0.0 111.145 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.448 ' CD ' ' CB ' ' A' ' 70' ' ' GLU . 28.9 Cg_endo -62.89 -37.49 54.26 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.359 2.039 . . . . 0.0 112.56 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -112.04 17.06 19.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.276 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.554 HG22 ' HA ' ' A' ' 70' ' ' GLU . 4.5 tp -108.79 127.48 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 CA-C-O 120.925 0.393 . . . . 0.0 111.093 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.42 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 0.9 OUTLIER -83.79 133.67 34.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.367 -179.578 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.757 HG23 ' HB2' ' A' ' 61' ' ' SER . 57.3 m -57.94 -30.74 66.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.078 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.414 ' O ' ' C ' ' A' ' 77' ' ' HIS . 39.6 m-85 -110.27 13.97 22.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.237 0.541 . . . . 0.0 111.536 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.444 ' CE1' ' HB3' ' A' ' 127' ' ' PHE . 0.1 OUTLIER -25.94 -64.75 0.06 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.779 -1.1 . . . . 0.0 112.702 -179.277 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.45 ' HB3' ' CZ ' ' A' ' 127' ' ' PHE . . . -157.66 163.98 37.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.116 0.484 . . . . 0.0 112.027 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.48 ' HA ' ' O ' ' A' ' 56' ' ' THR . 0.8 OUTLIER -134.81 141.4 46.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.319 179.405 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.561 ' HD2' HD11 ' A' ' 58' ' ' ILE . 47.0 m-85 -119.44 131.51 55.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.942 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.505 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 4.1 m-70 -94.63 116.53 28.87 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.832 0.349 . . . . 0.0 110.756 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.709 HD11 HD22 ' A' ' 34' ' ' LEU . 0.1 OUTLIER -106.28 109.89 21.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.03 -179.89 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.07 133.86 55.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.705 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -101.69 128.82 47.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.917 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.7 ttt -141.45 111.97 7.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.864 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -79.03 116.02 19.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.953 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.5 t -140.0 114.3 6.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.072 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 60.83 -165.83 0.21 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.79 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -48.92 132.4 18.49 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.281 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 61.11 155.04 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.904 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -85.98 139.78 30.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.953 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 80.1 mtt180 -109.92 122.64 48.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.865 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -113.04 146.73 38.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.84 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.2 mt -128.81 140.04 51.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.927 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.482 HG13 HD22 ' A' ' 82' ' ' LEU . 4.1 mp -120.97 138.48 51.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.06 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -113.94 143.31 44.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.021 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.558 HG22 ' HE1' ' A' ' 80' ' ' PHE . 3.9 t -104.41 135.08 43.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.173 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 22.6 mt -129.86 146.33 34.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.18 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.559 ' OD1' HD22 ' A' ' 112' ' ' LEU . 2.9 p-10 -119.74 123.49 43.88 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.902 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.67 -41.7 1.98 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.119 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.2 m -71.56 157.76 37.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.065 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.43 29.01 8.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.844 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -86.97 -42.2 13.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.227 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 136.48 100.58 0.58 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.671 -0.775 . . . . 0.0 112.595 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.53 HG23 ' CD1' ' A' ' 127' ' ' PHE . 93.7 m -109.4 123.37 49.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.8 0.333 . . . . 0.0 110.735 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.425 ' CE1' ' HB3' ' A' ' 111' ' ' ARG . 47.2 m-85 -120.87 115.06 22.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.932 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.403 ' CD1' HG13 ' A' ' 125' ' ' ILE . 2.6 tp -118.31 137.26 52.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.428 0.632 . . . . 0.0 111.196 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.7 m120 61.77 32.2 18.26 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.798 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.76 10.9 72.78 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.859 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -134.05 151.96 51.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.743 0.306 . . . . 0.0 110.851 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.425 ' HB3' ' CE1' ' A' ' 106' ' ' PHE . 6.6 ptm180 -70.95 139.05 50.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.894 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.559 HD22 ' OD1' ' A' ' 99' ' ' ASP . 0.8 OUTLIER -85.49 129.3 34.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.88 -179.933 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.489 HG13 ' N ' ' A' ' 114' ' ' LYS . 12.2 p -125.58 -44.65 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.11 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.489 ' N ' HG13 ' A' ' 113' ' ' VAL . 2.6 mmmp? -66.23 172.83 3.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.908 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -119.03 31.38 6.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.931 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -162.23 57.86 0.24 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.801 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.98 139.09 38.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.84 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.546 ' O ' HG23 ' A' ' 118' ' ' ILE . 7.8 tp -98.59 117.31 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-O 121.004 0.43 . . . . 0.0 111.228 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.444 HD22 ' HB ' ' A' ' 95' ' ' ILE . 7.6 tt -103.07 131.23 50.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.057 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.26 178.03 6.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.781 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.451 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 5.0 p-10 -57.72 141.29 49.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.966 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.782 ' HA2' HD21 ' A' ' 134' ' ' LEU . . . 74.86 47.66 13.77 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.311 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -123.46 131.34 53.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.795 0.331 . . . . 0.0 111.081 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.74 122.6 41.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.65 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.54 HG21 ' HZ ' ' A' ' 80' ' ' PHE . 1.7 mp -114.97 133.56 60.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.314 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.632 HG22 ' HB3' ' A' ' 132' ' ' SER . 21.2 t -124.02 123.81 67.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.968 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.53 ' CD1' HG23 ' A' ' 105' ' ' THR . 23.5 m-85 -116.27 111.92 20.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.85 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLY . . . . . 0.402 ' O ' ' CB ' ' A' ' 129' ' ' LYS . . . 88.61 -15.31 57.45 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.88 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LYS . . . . . 0.402 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 10.9 tttt 79.32 30.65 0.3 Allowed 'General case' 0 CA--C 1.522 -0.109 0 CA-C-O 121.002 0.43 . . . . 0.0 110.378 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 15.3 p -128.22 -50.07 1.31 Allowed 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.99 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' CYS . . . . . 0.627 ' HB2' HD23 ' A' ' 68' ' ' LEU . 7.0 m -109.59 112.58 24.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.977 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.632 ' HB3' HG22 ' A' ' 126' ' ' VAL . 0.7 OUTLIER -116.8 131.06 57.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.931 179.95 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.409 ' CD1' HD22 ' A' ' 37' ' ' LEU . 6.0 p90 -141.25 156.04 45.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.074 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.782 HD21 ' HA2' ' A' ' 122' ' ' GLY . 7.7 tt -107.74 140.05 41.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.8 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.431 ' CD2' HD21 ' A' ' 119' ' ' LEU . 87.7 t80 -101.57 141.56 34.25 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 122.002 0.906 . . . . 0.0 111.933 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt -154.37 145.87 23.13 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 113.748 -1.569 . . . . 0.0 110.707 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.451 ' CE2' ' HB3' ' A' ' 121' ' ' ASN . 4.4 m-85 -73.62 139.75 45.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.992 0.425 . . . . 0.0 110.736 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.42 ' HB3' ' CE1' ' A' ' 36' ' ' HIS . . . -119.15 87.78 2.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.045 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 5.4 t -90.65 141.59 28.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.959 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.1 m -102.0 157.42 16.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.888 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 1.3 m 60.6 101.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.899 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 19.1 m -142.67 -61.91 0.43 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.921 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 68.4 p -78.72 117.23 19.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.923 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' ASP . . . . . 0.807 ' O ' HD13 ' A' ' 145' ' ' ILE . 6.2 p-10 -111.13 -25.65 9.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.114 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.807 HD13 ' O ' ' A' ' 144' ' ' ASP . 6.3 mm -143.46 117.38 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 CA-C-O 121.699 0.762 . . . . 0.0 109.558 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -116.28 82.37 1.77 Allowed 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 114.341 -1.299 . . . . 0.0 110.852 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -76.05 -41.27 51.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.875 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -87.21 160.9 18.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.909 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.58 123.67 24.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.834 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -142.59 152.62 42.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.892 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -163.0 107.19 1.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.835 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.5 t -112.31 -58.95 3.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.124 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 7.3 m -134.28 32.7 3.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.906 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 2.6 p -104.4 170.55 7.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.883 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -144.1 144.59 31.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.962 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.3 m -82.45 140.28 33.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.899 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 60.71 36.63 19.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.918 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 58.3 m -137.66 95.69 3.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.943 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.116 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.819 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.6 mttt . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.796 0.331 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.2 ptt85 -133.22 -46.67 0.84 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.835 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.76 143.89 40.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.837 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -81.31 104.47 11.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.926 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -170.25 -62.24 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.918 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.2 95.76 7.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.875 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -117.31 163.56 16.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.845 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.87 143.36 26.5 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.789 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.01 146.25 58.1 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.579 2.186 . . . . 0.0 112.316 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 75.9 p -83.58 -33.93 25.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.856 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.3 t -144.71 144.37 31.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.928 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.454 ' C ' ' CG ' ' A' ' 31' ' ' TYR . 6.0 tt0 -107.12 164.15 12.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.923 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.454 ' CG ' ' C ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -167.81 115.7 0.75 Allowed 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 121.237 0.542 . . . . 0.0 110.464 179.629 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.1 m -97.6 158.72 15.34 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.725 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 44.9 t -59.92 137.23 58.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.882 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.751 HD13 HD23 ' A' ' 82' ' ' LEU . 8.4 tt -130.21 -44.98 1.13 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.971 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.622 ' C ' HG22 ' A' ' 50' ' ' ILE . . . -157.67 -167.89 19.3 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.567 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.535 ' ND1' ' HB2' ' A' ' 138' ' ' ALA . 54.2 m80 -147.0 164.06 34.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.841 0.353 . . . . 0.0 110.911 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.574 HD11 ' HB ' ' A' ' 50' ' ' ILE . 2.4 mp -127.03 108.0 10.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.809 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.5 t -97.96 121.96 49.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.163 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -90.06 117.06 28.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.785 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.4 mt -81.14 106.53 13.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.831 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.54 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 4.8 mt -124.25 140.83 35.85 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.917 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.54 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 58.0 Cg_endo -74.43 81.82 1.99 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.161 1.908 . . . . 0.0 111.867 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 145.02 -14.19 1.92 Allowed Glycine 0 CA--C 1.52 0.382 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.483 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -179.0 173.8 1.14 Allowed 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 120.774 0.321 . . . . 0.0 110.604 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -132.75 156.32 47.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.098 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -135.37 112.17 10.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.804 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.63 132.29 51.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.02 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.1 t -121.09 151.1 24.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.014 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -94.87 131.41 40.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.807 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.689 HG21 ' HE2' ' A' ' 135' ' ' PHE . 1.6 tt -116.05 124.67 72.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.248 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.515 ' O ' HD22 ' A' ' 82' ' ' LEU . 0.2 OUTLIER -100.93 168.14 9.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.959 -179.765 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -80.32 66.36 5.8 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.173 0.511 . . . . 0.0 110.313 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.555 ' C ' ' H ' ' A' ' 55' ' ' VAL . 8.8 ttt85 -79.48 1.55 25.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.796 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.4 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 1.2 t-20 72.12 -36.55 0.36 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -178.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.555 ' H ' ' C ' ' A' ' 53' ' ' ARG . 66.5 t -137.36 132.75 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.781 179.282 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.743 HG23 ' HB3' ' A' ' 65' ' ' ASP . 21.7 m -125.22 124.32 41.46 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.917 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.65 132.37 49.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.876 0.369 . . . . 0.0 110.777 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.436 HD12 ' CZ ' ' A' ' 127' ' ' PHE . 34.6 mt -115.19 120.37 64.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.286 -179.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 170.71 -134.09 3.01 Favored Glycine 0 C--N 1.331 0.259 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.235 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.61 ' HB3' ' HA ' ' A' ' 70' ' ' GLU . 0.2 OUTLIER -118.76 -21.96 7.61 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.585 0.231 . . . . 0.0 111.305 179.806 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.454 ' HB2' HG23 ' A' ' 75' ' ' THR . 0.2 OUTLIER -52.01 126.48 18.54 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.864 0.364 . . . . 0.0 110.96 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.4 mmm180 -55.05 -26.25 36.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.104 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.0 m -77.3 -22.68 51.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.12 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 98.5 m -54.71 162.26 1.26 Allowed 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.151 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.743 ' HB3' HG23 ' A' ' 56' ' ' THR . 12.9 t0 -83.69 -49.0 9.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.128 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 58' ' ' ILE . 26.7 t -123.77 116.85 49.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.371 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 16.5 pt -100.76 127.8 53.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.975 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.514 HD12 ' HB3' ' A' ' 131' ' ' CYS . 3.8 mm? -98.18 -92.21 0.25 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.697 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.411 ' O ' ' CB ' ' A' ' 70' ' ' GLU . 48.0 m -87.58 -108.01 0.07 Allowed 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.332 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.61 ' HA ' ' HB3' ' A' ' 60' ' ' ARG . 1.0 OUTLIER 167.48 -64.51 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.275 0 N-CA-C 111.644 0.238 . . . . 0.0 111.644 178.871 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.593 ' HD3' ' HB3' ' A' ' 70' ' ' GLU . 15.9 Cg_exo -67.61 -40.28 10.47 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.123 1.882 . . . . 0.0 112.998 -179.433 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -109.22 21.29 17.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.303 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.471 ' CG2' ' HB3' ' A' ' 60' ' ' ARG . 4.8 tp -112.26 120.62 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-O 120.905 0.384 . . . . 0.0 110.817 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.451 ' HB2' ' CG ' ' A' ' 77' ' ' HIS . 0.5 OUTLIER -57.92 131.48 50.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.075 -179.527 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.454 HG23 ' HB2' ' A' ' 61' ' ' SER . 91.5 m -59.12 -44.01 91.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.688 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.473 ' O ' ' C ' ' A' ' 77' ' ' HIS . 1.6 m-85 -105.62 13.75 29.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.184 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.473 ' C ' ' O ' ' A' ' 76' ' ' PHE . 0.2 OUTLIER -15.0 -70.18 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.618 -1.174 . . . . 0.0 112.763 -179.479 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -151.21 153.3 34.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.065 0.459 . . . . 0.0 111.937 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -117.21 133.8 55.56 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.255 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.755 ' CE2' HG22 ' A' ' 97' ' ' VAL . 8.2 m-85 -119.45 131.11 55.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.142 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.4 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 17.7 m-70 -94.88 116.67 29.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.857 0.361 . . . . 0.0 111.107 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.751 HD23 HD13 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -106.34 109.62 21.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.69 179.737 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.6 tt -122.19 139.38 53.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.125 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -129.1 131.89 47.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.724 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.15 148.48 40.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.078 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -107.09 125.76 51.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.779 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.5 t -139.96 126.33 22.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.158 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 58.82 42.21 20.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.987 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 62.04 29.11 17.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.949 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -139.45 130.91 27.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.814 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 20.8 mm100 -85.58 132.26 34.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.971 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -111.7 124.65 52.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.794 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -103.81 122.56 45.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.021 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.8 mt -132.08 122.96 26.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.727 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.607 HD12 ' HG ' ' A' ' 82' ' ' LEU . 7.2 mm -113.16 137.25 46.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.02 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -114.01 135.35 54.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.821 179.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.755 HG22 ' CE2' ' A' ' 80' ' ' PHE . 18.7 t -112.82 128.55 69.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.195 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 7.5 mt -129.64 120.97 51.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.004 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -102.32 134.01 46.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.937 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.6 pttp -149.73 32.17 0.7 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.835 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.8 m -119.94 -178.0 3.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.01 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.35 38.1 2.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.876 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -105.53 -38.32 6.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.278 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 131.95 98.5 0.73 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.521 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 71.0 m -117.54 124.13 47.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.846 0.355 . . . . 0.0 110.835 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -120.98 121.79 38.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.956 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.45 HD13 ' CG1' ' A' ' 125' ' ' ILE . 3.2 tp -120.57 137.1 55.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.414 0.626 . . . . 0.0 111.282 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 50.4 m-20 56.56 31.45 19.08 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.892 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.69 13.05 74.73 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.875 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 24.7 p30 -134.08 150.34 51.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.785 0.326 . . . . 0.0 110.912 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 3.7 ttm180 -62.83 141.82 58.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.983 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.413 HD23 ' N ' ' A' ' 113' ' ' VAL . 1.1 tt -100.06 125.7 46.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.831 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.572 ' O ' HG22 ' A' ' 113' ' ' VAL . 12.0 p -149.94 49.62 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.128 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.46 -177.47 3.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.827 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.3 mtpt -111.56 -33.75 6.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.908 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -137.59 76.8 1.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.97 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -84.0 136.38 34.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.768 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.519 ' O ' HG23 ' A' ' 118' ' ' ILE . 8.8 tp -98.64 118.95 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.261 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.479 ' C ' HD23 ' A' ' 119' ' ' LEU . 7.4 tt -103.09 145.59 29.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.928 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 13.6 mttt -132.1 178.06 7.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.84 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.404 ' HB3' ' CD2' ' A' ' 137' ' ' TYR . 15.5 p30 -58.25 138.81 56.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.0 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.439 ' HA2' HD21 ' A' ' 134' ' ' LEU . . . 78.13 58.04 3.28 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.523 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -134.22 126.57 30.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.798 0.332 . . . . 0.0 110.889 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.425 ' N ' HD12 ' A' ' 134' ' ' LEU . 7.9 ttm180 -93.3 127.64 38.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.846 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.45 ' CG1' HD13 ' A' ' 107' ' ' ILE . 1.7 mp -121.67 134.23 65.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.188 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.582 HG22 ' HB3' ' A' ' 132' ' ' SER . 21.7 t -124.12 123.92 67.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.946 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.443 ' HB3' ' CE1' ' A' ' 77' ' ' HIS . 79.7 m-85 -113.98 111.89 22.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.002 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 84.04 -10.27 61.05 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.846 -0.692 . . . . 0.0 113.057 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 77.28 30.02 0.54 Allowed 'General case' 0 CA--C 1.522 -0.133 0 CA-C-O 120.985 0.421 . . . . 0.0 110.273 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 26.9 p -125.84 -44.06 1.81 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.99 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' CYS . . . . . 0.514 ' HB3' HD12 ' A' ' 68' ' ' LEU . 1.8 m -118.6 116.92 27.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.032 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.582 ' HB3' HG22 ' A' ' 126' ' ' VAL . 77.2 p -124.06 130.66 52.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.795 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.529 ' CE2' HD23 ' A' ' 37' ' ' LEU . 8.8 p90 -141.98 156.01 45.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.023 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.439 HD21 ' HA2' ' A' ' 122' ' ' GLY . 2.2 tp -105.79 130.88 53.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.785 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.689 ' HE2' HG21 ' A' ' 50' ' ' ILE . 26.9 t80 -94.31 141.44 28.57 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.886 0.85 . . . . 0.0 111.729 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.3 tttp -154.7 149.85 26.99 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 113.938 -1.483 . . . . 0.0 111.041 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.404 ' CD2' ' HB3' ' A' ' 121' ' ' ASN . 5.6 m-85 -76.25 140.09 41.43 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.987 0.422 . . . . 0.0 110.645 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.535 ' HB2' ' ND1' ' A' ' 36' ' ' HIS . . . -97.25 158.89 15.23 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.043 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 4.8 m 61.6 86.33 0.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.842 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 67.6 m -56.85 147.18 24.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.023 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 98.8 p -128.41 117.36 21.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.902 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 61.51 87.2 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.905 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 25.4 p -104.28 -179.24 3.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.929 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -126.19 130.97 52.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.896 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.607 ' O ' HG22 ' A' ' 145' ' ' ILE . 19.9 mm -103.23 25.1 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 CA-C-O 121.642 0.734 . . . . 0.0 111.314 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 60.81 77.41 0.33 Allowed 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.89 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -76.86 -65.63 0.92 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.88 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 59.79 104.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.825 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -168.03 149.24 5.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.861 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -131.0 -178.7 4.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 39.4 mttm -139.85 174.21 10.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.853 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.591 ' O ' HG22 ' A' ' 152' ' ' VAL . 14.8 p -117.68 38.94 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.997 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.78 97.74 3.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.953 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 22.4 m -137.53 -61.65 0.63 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.879 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 60.05 -175.88 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.899 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.4 p -62.85 170.74 2.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.861 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 11.8 ttp180 -164.79 161.57 20.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.897 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 18.4 t -117.35 96.93 5.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.925 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 36.7 t80 . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.935 179.995 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.839 0.352 . . . . 0.0 111.176 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -157.26 -46.31 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.822 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -99.7 -68.48 0.8 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.948 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -176.04 -64.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.915 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.8 mtp180 -89.1 119.04 29.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.931 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.8 m -147.35 33.85 0.88 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.938 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -158.68 139.09 12.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.877 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.415 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 20.3 mttm -146.77 138.58 13.46 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.992 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 26' ' ' LYS . 32.4 Cg_exo -57.97 159.11 18.96 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.52 2.147 . . . . 0.0 112.212 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.0 m -92.57 43.16 1.12 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.953 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 178.23 -179.34 0.29 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.747 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 60.09 69.69 0.68 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.889 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.43 ' HB2' ' CG2' ' A' ' 51' ' ' THR . 33.3 m-85 -107.29 -112.03 0.29 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.786 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.21 136.32 33.27 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.833 0.349 . . . . 0.0 110.435 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 51.3 t -59.83 145.19 46.41 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.367 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.6 tp -150.72 -44.22 0.12 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.665 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.743 ' C ' HG22 ' A' ' 50' ' ' ILE . . . -153.03 -175.57 24.61 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.041 -0.599 . . . . 0.0 112.127 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.41 ' CE1' ' HG3' ' A' ' 49' ' ' GLU . 40.4 m80 -147.01 166.06 27.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.012 0.434 . . . . 0.0 111.221 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.418 ' N ' HD12 ' A' ' 37' ' ' LEU . 4.7 mp -127.07 136.01 51.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.59 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.409 HG22 ' HE3' ' A' ' 47' ' ' LYS . 1.7 t -101.66 123.61 54.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.125 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -90.15 120.91 31.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.779 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.3 mt -97.86 107.73 20.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.965 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.421 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 3.3 mp -116.82 138.77 24.93 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.757 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.421 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 91.5 Cg_exo -44.42 -27.67 2.21 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.623 2.215 . . . . 0.0 112.708 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -149.22 45.32 0.7 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.601 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 20.8 tptt -179.86 164.15 1.17 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.792 0.329 . . . . 0.0 111.01 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -146.92 134.39 20.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.634 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.6 tp-100 -129.62 145.51 51.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.157 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.409 ' HE3' HG22 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -113.0 133.24 55.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.739 179.794 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.1 t -121.97 149.25 25.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.941 0.4 . . . . 0.0 111.237 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.41 ' HG3' ' CE1' ' A' ' 36' ' ' HIS . 48.6 tt0 -107.97 128.53 54.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.655 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.743 HG22 ' C ' ' A' ' 35' ' ' GLY . 1.2 tt -105.92 132.03 53.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.264 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.648 ' O ' HD23 ' A' ' 82' ' ' LEU . 0.8 OUTLIER -98.55 168.42 10.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.044 -179.707 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -86.09 62.94 7.75 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.198 0.523 . . . . 0.0 110.17 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.578 ' C ' ' H ' ' A' ' 55' ' ' VAL . 23.5 ttt-85 -82.83 1.78 37.44 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.005 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 71.93 -33.62 0.27 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -178.677 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.578 ' H ' ' C ' ' A' ' 53' ' ' ARG . 74.0 t -136.79 141.33 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.428 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.592 HG23 ' HB3' ' A' ' 65' ' ' ASP . 51.0 m -125.18 126.79 45.79 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.336 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.79 139.1 39.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.823 0.344 . . . . 0.0 110.517 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.571 ' CG2' HD11 ' A' ' 68' ' ' LEU . 4.5 mp -130.8 132.66 63.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.063 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 164.89 -151.9 21.16 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.472 -0.871 . . . . 0.0 113.09 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.422 ' HB2' ' CG2' ' A' ' 73' ' ' ILE . 14.7 ttp180 -86.2 -45.43 11.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.76 0.314 . . . . 0.0 111.25 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.833 ' HB3' HG23 ' A' ' 75' ' ' THR . 11.5 p -52.05 128.72 25.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.358 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.98 -16.49 61.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.141 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.72 -26.62 64.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.817 0.342 . . . . 0.0 110.708 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 83.1 m -59.85 156.32 14.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.627 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.592 ' HB3' HG23 ' A' ' 56' ' ' THR . 7.4 t70 -62.07 -46.3 89.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.913 0.387 . . . . 0.0 110.495 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.9 t -125.18 132.98 70.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.316 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.4 mt -104.35 115.2 45.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.025 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.793 HD12 HD11 ' A' ' 73' ' ' ILE . 14.5 mt -87.22 -134.92 0.08 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.517 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.444 ' O ' ' CB ' ' A' ' 70' ' ' GLU . 17.4 m -57.04 -105.99 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 O-C-N 122.404 -0.185 . . . . 0.0 110.941 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.444 ' CB ' ' O ' ' A' ' 69' ' ' SER . 2.9 mt-10 163.72 -62.64 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.264 0 CA-C-O 120.597 0.236 . . . . 0.0 111.398 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 70' ' ' GLU . 19.7 Cg_endo -58.93 -39.98 75.96 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.661 2.24 . . . . 0.0 113.009 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -118.55 27.12 9.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.682 0.277 . . . . 0.0 111.538 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.793 HD11 HD12 ' A' ' 68' ' ' LEU . 4.8 tp -109.7 127.65 66.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.96 0.409 . . . . 0.0 111.606 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.17 134.17 45.55 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.045 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.833 HG23 ' HB3' ' A' ' 61' ' ' SER . 87.6 m -50.73 -44.06 58.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.271 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.494 ' O ' ' C ' ' A' ' 77' ' ' HIS . 12.1 p90 -106.69 13.86 27.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.081 0.467 . . . . 0.0 111.677 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.494 ' C ' ' O ' ' A' ' 76' ' ' PHE . 4.2 t60 -6.38 -69.09 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.671 -1.15 . . . . 0.0 112.979 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -152.81 164.05 38.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.951 0.405 . . . . 0.0 111.632 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -130.09 128.97 42.95 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.864 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.914 ' CZ ' HG13 ' A' ' 97' ' ' VAL . 5.6 m-85 -119.44 131.15 55.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.719 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -94.72 116.34 28.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.964 0.412 . . . . 0.0 111.266 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.712 HD22 HG12 ' A' ' 50' ' ' ILE . 22.3 tp -106.74 109.73 21.71 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.849 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.22 140.09 53.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.012 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.4 tm0? -106.03 137.18 44.39 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.759 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 7.6 mtt -107.03 136.76 46.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.841 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -97.87 116.48 30.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.035 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 17.5 t -139.97 139.15 37.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.943 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -48.36 -51.61 25.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.188 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -53.66 -65.74 0.51 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.163 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.494 ' CD2' HG23 ' A' ' 145' ' ' ILE . 8.3 m-85 -162.67 163.11 27.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.826 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.0 128.0 34.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.913 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.3 mmm180 -108.1 129.69 55.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.82 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 42.3 m-20 -114.07 120.0 39.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.01 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.2 mt -115.55 130.1 56.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.752 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.652 HG13 HD12 ' A' ' 82' ' ' LEU . 3.7 mp -114.66 136.04 52.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.275 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -114.28 138.76 50.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.731 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.914 HG13 ' CZ ' ' A' ' 80' ' ' PHE . 17.4 t -101.02 134.95 39.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.274 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 32.4 mt -129.3 134.96 62.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.071 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.421 ' HB3' HD11 ' A' ' 112' ' ' LEU . 20.6 p-10 -105.55 118.86 37.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.849 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.3 mtpp -133.17 31.11 3.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.922 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.2 m -144.03 174.67 10.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.881 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.94 30.44 4.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.894 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -85.32 -34.46 21.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.142 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 120.94 88.79 1.04 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.527 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.555 HG23 ' CD1' ' A' ' 127' ' ' PHE . 75.6 m -107.12 126.98 53.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.903 0.382 . . . . 0.0 110.946 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -120.93 117.85 28.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.904 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.42 HD13 HG12 ' A' ' 125' ' ' ILE . 2.6 tp -113.01 137.23 46.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.449 0.643 . . . . 0.0 111.297 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 62.94 27.69 16.05 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.933 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.74 12.77 74.66 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.811 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -134.02 152.05 51.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.82 0.343 . . . . 0.0 110.903 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.0 ttp180 -73.61 129.79 38.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.85 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.421 HD11 ' HB3' ' A' ' 99' ' ' ASP . 3.6 pp -88.52 144.82 26.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.993 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 14.2 m -143.46 32.21 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.112 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -147.43 149.39 32.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.881 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.6 mtmm -98.63 34.84 1.94 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.942 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -152.76 50.27 0.74 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.972 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -83.89 136.63 34.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.843 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.542 ' O ' HG23 ' A' ' 118' ' ' ILE . 8.9 tp -98.56 117.27 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-O 120.983 0.42 . . . . 0.0 111.216 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.75 HD11 HD11 ' A' ' 125' ' ' ILE . 10.0 tt -103.16 135.52 44.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.024 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 35.7 mttt -131.99 178.03 7.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.765 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.431 ' HB3' ' CD2' ' A' ' 137' ' ' TYR . 9.9 p-10 -62.15 142.86 57.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.871 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.484 ' HA2' HD21 ' A' ' 134' ' ' LEU . . . 72.67 42.41 47.15 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.5 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -118.08 127.3 53.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.8 0.333 . . . . 0.0 110.932 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.57 118.5 23.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.837 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.75 HD11 HD11 ' A' ' 119' ' ' LEU . 2.9 mt -114.93 122.68 69.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.206 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 24.7 t -118.48 128.22 75.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.96 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.555 ' CD1' HG23 ' A' ' 105' ' ' THR . 49.1 m-85 -111.4 137.16 49.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.963 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 74.48 -65.85 2.03 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.351 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 174.94 -50.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.812 0.339 . . . . 0.0 110.95 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.2 p -91.33 -42.74 10.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.253 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' CYS . . . . . 0.412 ' HB3' ' CZ ' ' A' ' 133' ' ' PHE . 25.9 m -54.93 108.17 0.37 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.121 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 41.5 t -123.76 129.97 51.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.856 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.505 ' CZ ' HD22 ' A' ' 68' ' ' LEU . 1.5 m-85 -141.98 154.24 44.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.797 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.484 HD21 ' HA2' ' A' ' 122' ' ' GLY . 0.6 OUTLIER -120.02 139.82 51.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.937 179.901 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.412 ' HE2' HG21 ' A' ' 50' ' ' ILE . 28.3 t80 -112.37 141.48 46.05 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.964 0.887 . . . . 0.0 111.859 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.65 159.02 40.53 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 113.853 -1.522 . . . . 0.0 110.761 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.431 ' CD2' ' HB3' ' A' ' 121' ' ' ASN . 3.6 m-85 -86.05 139.72 30.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.933 0.397 . . . . 0.0 110.763 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -115.28 -37.37 4.08 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.083 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.39 162.95 3.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.922 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 41.4 t 60.66 162.32 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.867 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 91.5 p -61.91 106.78 0.74 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.903 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.05 76.78 1.72 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.879 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.6 p -137.28 -67.85 0.48 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.984 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -159.01 148.88 19.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.824 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.494 HG23 ' CD2' ' A' ' 90' ' ' PHE . 8.1 mt -147.02 119.83 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.329 0 CA-C-O 121.71 0.767 . . . . 0.0 109.573 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -98.3 107.83 20.39 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 114.414 -1.266 . . . . 0.0 110.907 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -165.83 143.89 5.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.914 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 7.3 t70 60.28 35.85 20.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.907 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -98.79 31.38 2.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.904 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.64 -51.57 2.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.852 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 12.0 tttm 60.22 91.3 0.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.917 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.5 t -95.34 -60.07 2.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.138 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 18.6 p -124.82 120.21 31.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.889 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 22.8 p -151.0 179.74 8.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.896 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -127.5 143.63 51.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.94 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 4.0 m -167.34 179.14 5.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.925 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 9.2 mtt-85 -135.69 70.59 1.43 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.866 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.9 m -148.56 156.0 41.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.941 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.854 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.2 mttp . . . . . 0 N--CA 1.488 1.429 0 CA-C-O 120.867 0.365 . . . . 0.0 111.133 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.2 ttm-85 -132.08 104.19 6.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.928 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -132.1 30.72 4.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.845 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 59.35 -176.45 0.09 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.946 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -162.5 150.25 14.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.934 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.3 m -108.91 91.05 3.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.895 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 59.1 m-20 -90.55 168.21 11.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.931 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.2 mmtm -63.01 120.09 57.93 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.882 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.0 144.55 53.12 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.355 2.037 . . . . 0.0 112.315 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.4 m -66.12 174.24 2.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.904 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -150.47 84.38 1.37 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.832 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.17 131.51 3.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.064 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.506 ' N ' HG21 ' A' ' 51' ' ' THR . 2.1 m-85 -53.65 -96.21 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.983 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.45 132.12 27.26 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.8 t -59.71 144.89 46.87 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.101 0.477 . . . . 0.0 111.341 -179.138 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.464 HD12 ' HB3' ' A' ' 52' ' ' ASN . 0.8 OUTLIER -151.52 -45.04 0.11 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.338 179.787 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -147.36 157.61 27.45 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.926 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.835 ' CD2' ' HB2' ' A' ' 138' ' ' ALA . 37.7 m-70 -119.83 160.4 22.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.99 0.424 . . . . 0.0 111.295 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.967 HD12 HD11 ' A' ' 50' ' ' ILE . 59.2 mt -127.09 112.77 15.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.607 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.867 HG22 ' HG3' ' A' ' 47' ' ' LYS . 27.2 t -99.71 121.74 50.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.133 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 56.1 m-80 -90.19 114.87 26.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.763 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 32.0 mt -88.21 106.85 18.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.84 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.4 mt -124.11 139.27 32.29 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.08 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.34 92.86 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.377 2.051 . . . . 0.0 112.251 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.71 34.21 10.42 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.364 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -179.94 150.55 0.39 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.806 0.336 . . . . 0.0 110.859 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -151.22 152.0 32.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.991 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -143.6 126.22 15.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.739 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.867 ' HG3' HG22 ' A' ' 38' ' ' VAL . 5.0 ttpt -104.65 126.07 51.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.929 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.0 t -111.6 150.8 13.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.104 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.578 ' HG3' ' CE1' ' A' ' 36' ' ' HIS . 0.4 OUTLIER -100.46 119.95 39.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.97 -179.891 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.967 HD11 HD12 ' A' ' 37' ' ' LEU . 31.0 mm -96.12 132.09 41.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.07 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.506 HG21 ' N ' ' A' ' 31' ' ' TYR . 1.1 p -110.0 168.51 9.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.788 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.464 ' HB3' HD12 ' A' ' 34' ' ' LEU . 2.1 p-10 -81.32 60.43 4.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.149 0.5 . . . . 0.0 110.291 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.583 ' C ' ' H ' ' A' ' 55' ' ' VAL . 20.0 ttt-85 -82.86 1.38 39.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.757 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.407 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 11.9 m-20 71.54 -33.28 0.27 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -178.696 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.583 ' H ' ' C ' ' A' ' 53' ' ' ARG . 78.8 t -137.19 140.75 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.58 179.379 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.697 HG23 ' HB3' ' A' ' 65' ' ' ASP . 30.5 m -125.29 128.33 48.08 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.054 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.91 130.69 51.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.809 0.338 . . . . 0.0 110.768 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.558 ' CG2' HD11 ' A' ' 68' ' ' LEU . 2.7 mp -124.06 120.94 60.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.09 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 171.35 -143.11 7.41 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.735 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.547 ' HB2' HG23 ' A' ' 73' ' ' ILE . 11.8 ttp180 -95.18 -32.34 13.1 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.803 0.335 . . . . 0.0 111.093 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.928 ' HB2' HG23 ' A' ' 75' ' ' THR . 0.3 OUTLIER -48.79 133.91 16.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.331 -179.575 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 48.6 mtp85 -67.12 -31.14 71.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.741 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -70.98 -22.83 62.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.039 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 66.9 m -52.1 146.62 8.57 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.88 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.697 ' HB3' HG23 ' A' ' 56' ' ' THR . 63.6 t0 -61.07 -43.82 98.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.876 0.37 . . . . 0.0 110.727 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.424 HG21 ' CD1' ' A' ' 37' ' ' LEU . 23.0 t -125.17 132.95 70.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.357 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 6.7 pt -109.86 127.16 66.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.856 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.592 ' CD1' HD11 ' A' ' 73' ' ' ILE . 8.0 mt -103.67 -132.76 0.3 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.881 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.405 ' O ' ' CB ' ' A' ' 70' ' ' GLU . 29.4 t -57.67 -105.67 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 O-C-N 122.336 -0.227 . . . . 0.0 111.002 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.479 ' HA ' HG22 ' A' ' 73' ' ' ILE . 2.7 mt-10 167.02 -64.37 0.0 OUTLIER Pre-proline 0 N--CA 1.463 0.207 0 CA-C-O 120.605 0.24 . . . . 0.0 111.213 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.448 ' CD ' ' CB ' ' A' ' 70' ' ' GLU . 21.5 Cg_endo -61.04 -40.08 54.78 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.6 2.2 . . . . 0.0 112.673 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -110.34 20.81 17.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.307 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.592 HD11 ' CD1' ' A' ' 68' ' ' LEU . 4.7 tp -109.39 121.8 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-O 121.114 0.483 . . . . 0.0 111.098 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 45.1 t -83.4 136.23 34.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.357 -179.398 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.928 HG23 ' HB2' ' A' ' 61' ' ' SER . 63.6 m -61.24 -30.01 70.18 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.988 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.406 ' O ' ' C ' ' A' ' 77' ' ' HIS . 12.2 m-85 -103.92 14.23 31.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.731 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.494 ' CE1' HD12 ' A' ' 73' ' ' ILE . 0.1 OUTLIER -29.81 -72.95 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.348 -179.232 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.718 ' HB3' ' CZ ' ' A' ' 127' ' ' PHE . . . -156.48 164.1 38.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.979 0.419 . . . . 0.0 111.821 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 56' ' ' THR . 0.0 OUTLIER -129.23 136.05 49.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.651 179.666 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.965 ' CE2' HG22 ' A' ' 97' ' ' VAL . 9.3 m-85 -119.3 127.88 53.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.64 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.407 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 4.2 m80 -94.88 116.41 28.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.975 0.416 . . . . 0.0 111.53 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.673 HD13 HG21 ' A' ' 50' ' ' ILE . 0.3 OUTLIER -106.68 109.74 21.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.551 179.386 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.18 140.08 53.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.207 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -102.4 122.38 44.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.67 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.31 113.43 20.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.15 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -107.09 121.54 44.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.816 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.488 ' O ' HG13 ' A' ' 87' ' ' VAL . 11.4 p -139.98 120.1 13.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.26 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 57.99 65.53 1.28 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.001 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.8 t30 66.66 -73.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.998 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -60.47 122.63 15.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.864 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -111.17 129.14 56.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.919 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -106.64 135.52 48.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.942 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.524 ' C ' HD22 ' A' ' 94' ' ' LEU . 9.3 m-80 -99.97 131.29 46.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.903 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.524 HD22 ' C ' ' A' ' 93' ' ' ASN . 3.9 mm? -121.93 128.42 51.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.814 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.61 ' N ' HD12 ' A' ' 95' ' ' ILE . 3.5 mp -112.97 141.13 29.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.076 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -113.99 143.93 43.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.769 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.965 HG22 ' CE2' ' A' ' 80' ' ' PHE . 12.0 t -107.01 126.67 63.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.153 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.451 ' N ' HD12 ' A' ' 98' ' ' ILE . 3.9 mp -128.23 120.97 54.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.02 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -114.17 138.75 50.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.941 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.21 -11.05 19.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.208 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.0 m 65.67 102.39 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.825 0.345 . . . . 0.0 110.913 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 12.6 mmp_? -128.1 -69.04 0.74 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.865 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 35.7 p-10 -110.97 -32.65 6.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.868 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 147.42 100.94 0.26 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.466 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.502 ' O ' HD23 ' A' ' 112' ' ' LEU . 0.9 OUTLIER -119.83 123.92 44.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.769 0.319 . . . . 0.0 110.93 -179.96 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PHE . . . . . 0.406 ' CE2' ' HG3' ' A' ' 111' ' ' ARG . 4.7 m-85 -121.15 138.12 54.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.849 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.804 HG22 ' CD2' ' A' ' 112' ' ' LEU . 3.4 tp -121.68 137.3 55.77 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-O 121.59 0.71 . . . . 0.0 111.367 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.7 m120 60.05 30.41 19.9 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.69 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.8 13.03 75.1 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.782 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -129.53 152.05 49.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.946 0.403 . . . . 0.0 111.048 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.406 ' HG3' ' CE2' ' A' ' 106' ' ' PHE . 30.5 ttt180 -75.02 143.46 43.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.939 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.804 ' CD2' HG22 ' A' ' 107' ' ' ILE . 4.0 mm? -69.71 138.25 52.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.024 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.464 HG23 ' N ' ' A' ' 114' ' ' LYS . 16.8 m -134.39 -46.14 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.05 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.464 ' N ' HG23 ' A' ' 113' ' ' VAL . 0.5 OUTLIER -88.34 162.98 16.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.925 179.916 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.16 31.93 5.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.912 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -161.81 65.66 0.25 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.904 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -84.1 139.11 32.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.8 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.485 ' O ' HG23 ' A' ' 118' ' ' ILE . 8.4 tp -98.58 121.42 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.221 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.647 HD21 ' CD2' ' A' ' 135' ' ' PHE . 3.4 tp -103.14 132.75 49.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.902 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -126.38 178.03 6.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.79 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.439 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 7.1 p30 -63.05 143.13 58.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.9 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 69.37 50.36 33.03 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.535 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -117.73 142.24 47.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.767 0.318 . . . . 0.0 111.025 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 61.9 mtt85 -100.94 127.14 47.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.83 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.419 ' HB ' ' CE2' ' A' ' 133' ' ' PHE . 1.6 mp -123.37 136.91 58.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.185 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 38.1 t -124.01 124.05 68.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.92 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.718 ' CZ ' ' HB3' ' A' ' 78' ' ' ALA . 3.3 m-85 -111.8 133.03 54.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.09 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 82.36 -67.55 3.68 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.419 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.35 -41.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.772 0.32 . . . . 0.0 111.118 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.81 -41.98 4.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.701 -179.418 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 29.1 m -51.98 105.65 0.12 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.934 0.397 . . . . 0.0 111.231 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 32.4 p -124.36 134.72 53.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.909 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.419 ' CE2' ' HB ' ' A' ' 125' ' ' ILE . 6.8 p90 -141.97 155.03 45.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.01 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.3 tp -112.64 138.38 49.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.777 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.647 ' CD2' HD21 ' A' ' 119' ' ' LEU . 47.7 t80 -108.15 141.48 39.81 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 122.005 0.907 . . . . 0.0 111.802 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 9.2 ptpt -154.59 154.13 32.53 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 113.883 -1.508 . . . . 0.0 110.873 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.439 ' CE2' ' HB3' ' A' ' 121' ' ' ASN . 0.8 OUTLIER -86.0 139.6 31.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.913 0.387 . . . . 0.0 110.734 179.643 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.835 ' HB2' ' CD2' ' A' ' 36' ' ' HIS . . . -89.48 -30.05 18.55 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.121 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.33 160.41 31.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.787 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.6 m -134.64 169.56 17.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.911 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 55.0 p -80.25 -44.07 20.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.949 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -98.07 127.87 44.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.807 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 20.2 m -114.38 89.99 3.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.846 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -146.48 -56.63 0.28 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.851 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.596 ' O ' HG22 ' A' ' 145' ' ' ILE . 17.9 mt -103.87 25.14 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.575 0.702 . . . . 0.0 111.302 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -114.27 160.02 19.51 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.88 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -101.78 97.15 7.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.873 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -120.23 -48.27 2.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.893 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -145.88 -49.53 0.22 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.892 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 59.24 90.45 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.941 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.22 87.32 2.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.913 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.5 t -77.08 124.95 36.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.152 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -93.35 166.57 12.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.847 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 34.8 t -171.03 149.2 2.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.919 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -76.93 147.38 37.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.899 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 49.6 m -149.22 -59.88 0.22 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.951 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.27 134.54 45.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.868 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.4 p -119.38 -179.58 3.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.84 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.255 -0.878 . . . . 0.0 110.861 179.976 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.931 0.396 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.34 176.73 4.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.888 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -60.22 104.01 0.28 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -75.89 -178.1 4.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.9 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -178.63 -35.8 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.026 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 80.8 p -76.94 -51.89 10.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.896 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -87.25 -179.69 6.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.9 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.73 119.61 75.79 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.776 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.06 145.49 55.56 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.385 2.056 . . . . 0.0 112.387 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.9 m -71.11 73.58 0.64 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.896 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.1 t -168.88 33.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.969 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -155.95 121.59 4.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.761 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -89.4 -108.78 0.08 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.851 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.454 ' N ' HG22 ' A' ' 51' ' ' THR . 0.0 OUTLIER -140.44 134.17 30.38 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.778 0.323 . . . . 0.0 110.613 179.742 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 49.7 t -59.88 145.02 47.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.094 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.804 HD13 HD21 ' A' ' 82' ' ' LEU . 8.4 tt -150.96 -46.68 0.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.844 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.616 ' C ' HG22 ' A' ' 50' ' ' ILE . . . -151.16 -176.95 24.52 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.473 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 40.9 m80 -147.08 157.89 43.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.872 0.368 . . . . 0.0 111.041 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.575 HD23 ' N ' ' A' ' 37' ' ' LEU . 0.3 OUTLIER -127.02 129.42 48.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.716 179.712 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.63 HG22 ' HD2' ' A' ' 47' ' ' LYS . 21.3 t -109.03 122.0 63.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.224 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -90.01 119.89 30.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.805 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 66.3 mt -75.68 108.69 8.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.887 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.408 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 14.4 mt -122.24 138.52 29.13 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.408 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 87.8 Cg_exo -46.94 -27.95 6.49 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.568 2.178 . . . . 0.0 112.529 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -114.15 -125.55 4.18 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.413 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -53.89 138.31 36.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.795 0.331 . . . . 0.0 111.129 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -82.12 150.52 27.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.833 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -117.01 110.51 18.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.025 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.63 ' HD2' HG22 ' A' ' 38' ' ' VAL . 0.5 OUTLIER -113.04 121.0 43.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.842 179.891 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.8 t -124.53 151.06 29.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.153 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -100.26 142.15 32.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.786 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.616 HG22 ' C ' ' A' ' 35' ' ' GLY . 6.1 tt -116.03 132.21 66.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.373 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.454 HG22 ' N ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -97.59 168.08 10.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.819 -179.848 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.884 ' HA ' HD22 ' A' ' 82' ' ' LEU . 0.4 OUTLIER -85.01 62.71 7.68 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.134 0.492 . . . . 0.0 110.238 179.373 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.562 ' C ' ' H ' ' A' ' 55' ' ' VAL . 22.3 ttt-85 -81.24 2.75 26.55 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.051 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.404 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 0.5 OUTLIER 72.06 -35.24 0.32 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 -178.77 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.562 ' H ' ' C ' ' A' ' 53' ' ' ARG . 73.5 t -137.18 138.43 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.424 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.732 HG23 ' CB ' ' A' ' 65' ' ' ASP . 96.9 m -125.2 129.66 50.54 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.587 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.418 ' O ' ' N ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -103.98 140.72 37.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.897 0.379 . . . . 0.0 110.954 -179.825 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.543 HD13 ' HE2' ' A' ' 127' ' ' PHE . 9.6 mt -132.05 123.41 50.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.964 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 171.78 -148.46 10.96 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.717 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.47 ' HB2' HG23 ' A' ' 73' ' ' ILE . 9.4 tpt85 -93.55 -33.11 13.88 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.754 0.311 . . . . 0.0 111.083 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.7 ' HB2' HG23 ' A' ' 75' ' ' THR . 3.5 t -53.61 139.98 30.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.133 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.17 -25.41 61.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.119 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 63.6 p -69.81 -24.69 63.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.99 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 93.3 m -59.1 163.94 3.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.873 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.732 ' CB ' HG23 ' A' ' 56' ' ' THR . 0.9 OUTLIER -72.16 -59.18 2.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.033 0.444 . . . . 0.0 110.692 179.807 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.8 t -109.64 122.01 63.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.111 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.1 pt -98.4 105.11 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.917 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.441 ' HA ' HD13 ' A' ' 68' ' ' LEU . 1.6 mm? -64.94 -25.92 68.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.92 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 49.1 m 62.63 26.68 15.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.98 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.423 ' CB ' ' HB ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -85.37 148.52 49.91 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.707 179.837 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.04 -14.05 42.12 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.678 2.252 . . . . 0.0 113.061 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -135.17 23.27 3.51 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.488 ' O ' HG23 ' A' ' 73' ' ' ILE . 5.2 tp -77.33 120.37 27.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.979 0.418 . . . . 0.0 110.996 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.401 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 47.0 t -62.39 133.99 55.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.311 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.7 HG23 ' HB2' ' A' ' 61' ' ' SER . 94.3 m -57.94 -31.76 67.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.733 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.465 ' O ' ' C ' ' A' ' 77' ' ' HIS . 13.5 m-85 -110.36 13.9 22.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.48 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.465 ' C ' ' O ' ' A' ' 76' ' ' PHE . 1.9 t60 -18.93 -67.69 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.708 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -156.34 162.29 40.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.0 0.428 . . . . 0.0 111.982 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -128.55 132.56 48.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.385 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.813 ' CZ ' HG13 ' A' ' 97' ' ' VAL . 6.0 m-85 -119.28 129.39 54.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.838 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.404 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 27.9 m80 -94.88 116.19 28.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.855 0.36 . . . . 0.0 111.348 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.884 HD22 ' HA ' ' A' ' 52' ' ' ASN . 7.1 tt -106.85 109.88 21.9 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.714 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.28 139.93 52.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.933 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -107.31 133.29 52.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.871 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -140.18 140.7 35.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.881 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -97.33 119.68 36.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.897 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.4 t -135.74 114.53 15.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.205 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 59.59 78.1 0.28 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.944 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 64.08 -79.25 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.03 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -69.59 159.53 33.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.914 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -111.91 140.63 46.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.921 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -104.05 148.42 26.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.824 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.435 ' HB2' ' CD1' ' A' ' 137' ' ' TYR . 14.3 m120 -114.01 120.03 39.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.99 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.95 HD12 HD11 ' A' ' 118' ' ' ILE . 4.1 mm? -105.37 127.52 53.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.766 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.472 ' HB ' HD22 ' A' ' 119' ' ' LEU . 26.7 mm -113.1 141.12 29.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.182 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -115.83 144.09 44.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.672 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.813 HG13 ' CZ ' ' A' ' 80' ' ' PHE . 22.0 t -112.32 134.3 55.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.228 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 27.7 mt -130.01 129.87 65.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.1 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.778 ' HB2' HD11 ' A' ' 112' ' ' LEU . 44.1 t0 -98.22 125.04 43.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.866 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 26.9 mmtp -147.42 31.37 0.9 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.893 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.1 m -105.42 171.68 7.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.878 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 21.1 mtt85 -110.36 -31.53 7.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.884 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -69.07 -73.31 0.15 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.235 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 176.36 135.41 2.14 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.672 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.513 HG23 ' CD1' ' A' ' 127' ' ' PHE . 88.2 m -131.82 122.96 26.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.773 0.321 . . . . 0.0 110.536 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -120.37 130.91 54.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.042 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.2 tp -123.02 137.35 56.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.49 0.662 . . . . 0.0 111.216 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.8 m120 62.75 28.8 16.65 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.823 -1.08 . . . . 0.0 110.776 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.81 6.0 62.38 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.925 -0.655 . . . . 0.0 113.073 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -134.21 144.26 48.34 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.788 0.328 . . . . 0.0 110.825 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.3 ttm180 -70.32 128.94 37.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.818 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.778 HD11 ' HB2' ' A' ' 99' ' ' ASP . 0.8 OUTLIER -76.26 139.2 41.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.98 -179.966 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 30.6 m -111.78 -34.85 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.028 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -105.99 166.0 10.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.84 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.43 171.47 8.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.939 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.9 t70 62.65 56.23 2.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.023 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.404 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 0.2 OUTLIER -79.0 137.58 37.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.745 179.879 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.95 HD11 HD12 ' A' ' 94' ' ' LEU . 8.5 tp -98.65 119.62 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-O 121.013 0.435 . . . . 0.0 111.418 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.839 HD11 HD11 ' A' ' 125' ' ' ILE . 5.9 tt -103.19 132.62 49.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.849 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 29.5 mttt -114.63 178.09 4.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.442 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 5.6 p-10 -56.23 136.69 52.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.019 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 69.47 51.36 26.72 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.3 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -111.64 129.55 56.05 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.789 0.328 . . . . 0.0 111.028 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.513 ' NH1' HD23 ' A' ' 134' ' ' LEU . 11.7 ttm-85 -88.23 123.96 33.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.829 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.839 HD11 HD11 ' A' ' 119' ' ' LEU . 2.1 mp -123.07 130.43 74.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.159 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 43.7 t -124.03 134.09 67.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.179 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.543 ' HE2' HD13 ' A' ' 58' ' ' ILE . 8.6 m-85 -115.78 139.32 50.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.92 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 71.29 -64.63 1.01 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.477 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 15.0 mttt 170.34 -37.24 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.755 0.312 . . . . 0.0 111.011 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 23.8 p -99.89 -43.55 6.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.406 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 76.5 m -53.17 104.47 0.1 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.936 0.398 . . . . 0.0 111.311 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.56 127.71 47.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.963 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.432 ' CE2' ' HB ' ' A' ' 125' ' ' ILE . 4.0 p90 -142.14 156.26 45.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.966 0.412 . . . . 0.0 111.283 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.513 HD23 ' NH1' ' A' ' 124' ' ' ARG . 0.3 OUTLIER -116.33 120.3 38.44 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.625 179.788 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.477 ' HE2' HG21 ' A' ' 50' ' ' ILE . 45.7 t80 -97.93 141.66 30.63 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.978 0.894 . . . . 0.0 111.976 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.35 147.09 24.27 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 113.807 -1.542 . . . . 0.0 110.828 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.442 ' CE2' ' HB3' ' A' ' 121' ' ' ASN . 10.1 m-85 -76.56 140.01 40.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.037 0.446 . . . . 0.0 110.812 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -117.55 30.8 7.08 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.14 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 3.3 m -113.18 -44.16 3.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.912 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.0 t -117.97 129.8 55.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.95 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 94.0 p -90.04 163.0 15.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.874 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.7 t -160.54 79.57 0.65 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.922 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 29.0 m -105.45 88.2 2.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -131.2 67.54 1.51 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.84 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.624 ' O ' HG22 ' A' ' 145' ' ' ILE . 2.4 mt -106.84 24.88 2.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.72 0.771 . . . . 0.0 111.257 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -97.63 127.75 43.82 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.912 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -116.19 32.24 6.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.837 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -89.07 147.93 23.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.908 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.39 143.49 49.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.799 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -113.12 170.91 7.88 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.886 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 19.4 mtpp 60.33 100.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.862 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.5 t 62.79 102.31 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.047 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 5.0 p -85.8 160.34 19.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.894 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 4.6 m -128.35 94.05 3.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.901 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -87.89 93.72 9.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.899 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 4.6 t -118.82 82.43 1.86 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.895 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -116.96 149.73 39.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 32.0 p -109.41 -28.79 8.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.933 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.872 -179.948 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.6 tptt . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.78 0.324 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.79 96.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.908 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -131.21 -48.2 1.0 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.988 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -91.71 126.98 36.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.951 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.6 ptt180 -121.51 -174.77 2.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.893 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.2 t -127.0 -66.23 0.91 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.886 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -80.51 109.8 15.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.934 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.48 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 3.0 mtpp -74.24 -46.91 6.16 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.096 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 26' ' ' LYS . 33.0 Cg_exo -57.81 141.56 95.83 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.285 1.99 . . . . 0.0 112.291 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.7 m 60.08 177.97 0.09 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.9 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 52.9 p -163.47 99.17 0.91 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.947 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -146.05 131.06 18.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.748 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -77.34 -105.44 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.83 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.493 ' N ' HG22 ' A' ' 51' ' ' THR . 0.7 OUTLIER -140.64 129.04 22.54 Favored 'General case' 0 N--CA 1.457 -0.093 0 CA-C-O 120.721 0.296 . . . . 0.0 110.776 179.803 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 52.4 t -61.82 137.5 58.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.855 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.661 HD11 ' OD1' ' A' ' 93' ' ' ASN . 5.3 tt -142.93 -50.44 0.35 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.969 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.616 ' C ' HG22 ' A' ' 50' ' ' ILE . . . -140.3 -177.35 15.87 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.544 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 47.5 m80 -144.69 161.02 40.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.899 0.38 . . . . 0.0 110.987 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.0 mt -121.94 121.02 36.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.637 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.3 t -96.04 121.89 47.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.345 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.16 131.79 35.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.425 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' A' ' 133' ' ' PHE . 1.9 mp -113.38 106.83 15.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.935 0.398 . . . . 0.0 111.21 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.414 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 22.0 mt -124.15 138.33 30.59 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.887 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.414 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 83.0 Cg_exo -45.38 -28.8 4.17 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.478 2.119 . . . . 0.0 112.639 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -85.02 -30.12 26.67 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.406 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 174.88 -169.54 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.879 0.371 . . . . 0.0 110.969 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -129.37 -178.53 4.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.946 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -162.52 151.09 14.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.975 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.7 tttt -113.01 131.53 55.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.008 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.1 t -119.1 147.48 22.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.135 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -100.16 128.54 46.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.859 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.662 HG21 ' HE1' ' A' ' 135' ' ' PHE . 15.3 tt -115.93 132.3 65.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.247 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.493 HG22 ' N ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -97.99 168.11 10.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.884 -179.824 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.462 ' ND2' ' O ' ' A' ' 52' ' ' ASN . 2.2 p-10 -102.33 75.56 1.49 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.43 179.618 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.601 ' C ' ' H ' ' A' ' 55' ' ' VAL . 1.6 ptp85 -101.05 23.59 10.56 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.39 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 68.59 -28.31 0.15 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.717 0.294 . . . . 0.0 110.216 -179.35 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.601 ' H ' ' C ' ' A' ' 53' ' ' ARG . 65.3 t -137.27 139.73 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 CA-C-O 121.087 0.47 . . . . 0.0 111.352 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.651 HG23 ' HB3' ' A' ' 65' ' ' ASP . 38.5 m -125.28 125.47 43.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.046 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.88 137.24 42.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.801 0.334 . . . . 0.0 110.806 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.2 mp -128.53 121.28 54.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.98 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 172.68 -151.8 15.03 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.656 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.416 ' HB2' ' CG2' ' A' ' 73' ' ' ILE . 6.3 ttp180 -87.67 -31.26 19.84 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.775 0.321 . . . . 0.0 110.974 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.898 ' HB2' HG23 ' A' ' 75' ' ' THR . 0.1 OUTLIER -55.53 127.54 30.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.226 -179.751 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.81 -25.53 68.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.915 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 91.0 p -69.87 -25.48 63.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.927 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 88.8 m -56.11 153.49 9.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.87 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.651 ' HB3' HG23 ' A' ' 56' ' ' THR . 10.0 t70 -62.7 -45.93 90.49 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.988 0.423 . . . . 0.0 110.664 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.5 t -120.31 129.16 75.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.947 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 31.2 mt -102.6 104.87 17.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.241 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.604 HD11 ' CE2' ' A' ' 133' ' ' PHE . 1.3 tp -77.67 -154.58 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.132 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.471 ' O ' ' CB ' ' A' ' 70' ' ' GLU . 26.9 m -44.14 -97.79 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 111.262 0.097 . . . . 0.0 111.262 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.471 ' CB ' ' O ' ' A' ' 69' ' ' SER . 2.5 mt-10 158.81 -65.12 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.446 0 CA-C-O 120.704 0.287 . . . . 0.0 111.427 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.462 ' CD ' ' CB ' ' A' ' 70' ' ' GLU . 12.0 Cg_endo -55.93 -40.05 87.44 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.705 2.27 . . . . 0.0 113.146 -178.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -117.97 28.4 8.42 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.663 0.245 . . . . 0.0 111.663 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.537 HD11 ' CD2' ' A' ' 68' ' ' LEU . 4.9 tp -112.64 125.37 69.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.046 0.45 . . . . 0.0 111.459 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.432 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 57.3 m -76.87 137.71 39.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.186 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.898 HG23 ' HB2' ' A' ' 61' ' ' SER . 52.8 m -60.09 -40.96 91.42 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.09 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.45 ' O ' ' C ' ' A' ' 77' ' ' HIS . 14.0 m-85 -99.46 14.13 30.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.088 0.47 . . . . 0.0 111.922 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.45 ' C ' ' O ' ' A' ' 76' ' ' PHE . 0.8 OUTLIER -22.74 -69.38 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.598 -179.361 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -154.61 164.1 39.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.054 0.455 . . . . 0.0 111.837 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -131.8 130.36 41.69 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.457 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.887 ' CZ ' HG13 ' A' ' 97' ' ' VAL . 7.3 m-85 -119.47 131.56 55.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.949 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 9.6 m170 -94.3 116.41 28.79 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.937 0.399 . . . . 0.0 111.075 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.448 HD13 ' O ' ' A' ' 51' ' ' THR . 3.9 tt -106.44 109.96 22.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.913 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.1 mp -117.85 139.22 51.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.009 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -126.57 128.74 47.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.905 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.09 146.15 38.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.913 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -104.66 115.92 31.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.85 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.4 m -122.96 110.95 27.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.262 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 57.63 82.68 0.12 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.109 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 62.47 -79.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.094 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -58.99 170.53 0.83 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.941 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -126.7 140.46 52.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.919 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.32 119.37 39.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.844 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.661 ' OD1' HD11 ' A' ' 34' ' ' LEU . 3.0 m-80 -108.6 123.75 49.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.805 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.6 mt -125.68 132.6 52.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.981 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.543 ' N ' HD12 ' A' ' 95' ' ' ILE . 4.0 mp -114.87 141.02 33.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.026 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -113.97 144.07 43.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.998 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.887 HG13 ' CZ ' ' A' ' 80' ' ' PHE . 18.2 t -110.48 127.73 67.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.136 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 33.1 mt -130.01 121.0 50.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.146 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -113.84 117.36 31.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.786 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.26 24.56 10.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.099 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 46.5 m 63.19 142.57 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.888 0.375 . . . . 0.0 110.939 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 6.4 tpt180 -178.71 -68.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.721 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -123.32 -31.01 3.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.249 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 128.82 120.46 2.27 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.281 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.476 HG23 ' CE1' ' A' ' 127' ' ' PHE . 90.6 m -123.27 128.47 50.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.847 0.355 . . . . 0.0 111.063 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -120.98 114.99 22.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.766 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.846 HD12 ' O ' ' A' ' 124' ' ' ARG . 2.2 tp -120.51 137.25 54.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.522 0.677 . . . . 0.0 111.496 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.3 m-20 59.18 28.16 17.38 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.05 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.71 13.07 74.79 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.952 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -133.17 150.13 52.02 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.835 0.35 . . . . 0.0 110.948 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 19.3 ttt-85 -74.96 142.35 43.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.92 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.88 127.86 35.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.847 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.484 HG13 ' HG2' ' A' ' 114' ' ' LYS . 12.7 p -117.82 -40.07 2.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.155 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.484 ' HG2' HG13 ' A' ' 113' ' ' VAL . 4.4 mmmt -84.18 173.74 10.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.823 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.5 ptpt -121.2 32.86 5.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.818 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -145.94 49.55 1.2 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.9 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -81.56 138.11 35.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.796 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.516 ' O ' HG23 ' A' ' 118' ' ' ILE . 8.8 tp -98.56 118.93 45.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.195 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.546 HD11 HD11 ' A' ' 125' ' ' ILE . 7.9 tt -103.1 136.21 43.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.015 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.9 mtmt -125.65 178.06 5.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.789 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.431 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 4.7 p30 -59.53 137.74 57.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.004 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 74.2 55.57 5.64 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.444 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -117.31 139.29 51.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.925 0.393 . . . . 0.0 110.849 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.846 ' O ' HD12 ' A' ' 107' ' ' ILE . 3.1 ttt180 -103.18 123.62 47.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.855 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.546 HD11 HD11 ' A' ' 119' ' ' LEU . 1.4 mp -126.75 135.7 62.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.184 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.4 t -120.63 125.09 73.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.058 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.476 ' CE1' HG23 ' A' ' 105' ' ' THR . 90.1 m-85 -120.61 130.61 54.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.114 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 84.07 -6.0 77.26 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.899 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 12.2 mtpt 77.2 28.78 0.6 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.911 0.386 . . . . 0.0 110.525 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.29 -45.08 0.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.073 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' CYS . . . . . 0.471 ' CB ' HD21 ' A' ' 68' ' ' LEU . 99.6 m -77.37 107.75 10.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.804 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 47.3 t -124.07 126.32 46.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.971 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.604 ' CE2' HD11 ' A' ' 68' ' ' LEU . 12.9 p90 -142.05 155.51 45.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.926 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.47 140.05 39.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.773 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.662 ' HE1' HG21 ' A' ' 50' ' ' ILE . 55.6 t80 -103.52 141.66 35.62 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 121.924 0.868 . . . . 0.0 111.809 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.8 tttt -154.26 147.69 25.03 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 113.953 -1.476 . . . . 0.0 110.932 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.467 ' N ' ' CD1' ' A' ' 137' ' ' TYR . 0.8 OUTLIER -79.88 139.73 37.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.712 179.729 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -109.98 162.91 14.07 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.141 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.4 m -127.18 -178.65 4.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.844 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 10.6 t -79.67 101.61 8.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.902 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 48.8 m -92.69 80.16 4.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.911 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.3 p -73.14 87.5 1.41 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.839 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 56.4 p -140.95 102.94 4.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.869 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 60.55 87.15 0.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.835 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.596 HG22 ' H ' ' A' ' 146' ' ' GLU . 0.7 OUTLIER -110.35 -143.51 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.973 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.596 ' H ' HG22 ' A' ' 145' ' ' ILE . 17.8 mt-10 -104.33 160.26 15.04 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.91 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -124.62 -58.22 1.51 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.867 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -67.87 145.86 54.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.909 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -98.95 175.95 5.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.912 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -129.21 -46.98 1.21 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.938 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 4.4 mmtm -70.48 -49.32 49.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.903 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 30.9 m -101.61 127.94 54.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.095 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -148.39 144.68 27.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.842 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.8 t -160.56 -55.07 0.05 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.851 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 59.25 96.72 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.886 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 28.2 p -171.56 116.33 0.4 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.914 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.98 86.43 2.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.913 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.1 t -175.17 91.52 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.958 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.891 -179.945 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.5 ttmt . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.812 0.339 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -99.22 161.77 13.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -112.13 116.64 30.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.96 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -128.99 -55.09 1.2 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.853 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.31 161.47 41.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.817 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.8 m -143.38 33.27 1.32 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.873 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -92.7 -175.8 4.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.848 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.56 157.8 87.12 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.984 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.7 143.08 49.99 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.57 2.18 . . . . 0.0 112.304 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -145.63 160.14 42.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.946 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 64.5 p -121.35 136.86 54.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.845 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.464 ' C ' ' CG ' ' A' ' 31' ' ' TYR . 21.5 mt-10 -121.1 28.99 7.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.963 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.464 ' CG ' ' C ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -168.37 115.84 0.69 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.29 0.567 . . . . 0.0 110.443 179.583 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.2 m -100.25 163.55 12.35 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.648 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 53.6 t -59.96 134.77 57.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.842 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.492 HD12 ' CG ' ' A' ' 84' ' ' GLN . 3.7 tt -133.79 -46.11 0.8 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.987 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.57 ' O ' HG22 ' A' ' 50' ' ' ILE . . . -156.85 -176.66 29.17 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.594 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -142.29 166.05 25.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.87 0.366 . . . . 0.0 110.901 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.651 ' CD1' HG21 ' A' ' 66' ' ' VAL . 3.8 mt -127.19 110.21 12.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.862 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.598 HG22 ' HD3' ' A' ' 47' ' ' LYS . 23.2 t -102.23 121.77 53.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.136 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -90.08 123.78 34.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.863 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.8 mt -83.8 106.68 15.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.82 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.708 HD12 ' HA ' ' A' ' 45' ' ' GLU . 1.5 mt -124.16 138.01 30.03 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.925 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -46.99 -27.76 6.36 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.454 2.103 . . . . 0.0 112.531 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -133.22 107.36 0.68 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.483 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 36.7 mttt 63.16 129.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.796 0.332 . . . . 0.0 110.916 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.708 ' HA ' HD12 ' A' ' 41' ' ' ILE . 42.3 mt-10 -95.64 170.22 9.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.929 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -126.32 121.94 34.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.897 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.598 ' HD3' HG22 ' A' ' 38' ' ' VAL . 1.1 mmmp? -102.97 129.07 49.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.936 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.2 t -121.6 130.71 74.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.065 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.12 124.2 32.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.935 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.57 HG22 ' O ' ' A' ' 35' ' ' GLY . 2.9 tt -116.02 132.14 66.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.138 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.517 ' O ' HD13 ' A' ' 82' ' ' LEU . 0.1 OUTLIER -99.76 168.39 9.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.245 -179.541 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.458 ' HB3' HD13 ' A' ' 34' ' ' LEU . 16.8 p30 -82.26 68.3 8.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.342 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.558 ' C ' ' H ' ' A' ' 55' ' ' VAL . 23.5 ttt-85 -83.01 6.58 18.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.041 -179.425 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.477 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 2.2 t30 71.43 -38.45 0.42 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -178.797 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.558 ' H ' ' C ' ' A' ' 53' ' ' ARG . 75.6 t -137.64 133.49 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.531 179.153 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.919 ' OG1' HD11 ' A' ' 82' ' ' LEU . 33.0 m -125.24 131.25 53.16 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.178 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.91 133.86 48.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.892 0.377 . . . . 0.0 111.037 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.581 HD12 ' N ' ' A' ' 58' ' ' ILE . 3.9 mp -118.22 123.58 71.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.201 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 166.98 -130.08 2.05 Favored Glycine 0 C--N 1.331 0.267 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.275 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.533 ' HB3' ' HA ' ' A' ' 70' ' ' GLU . 7.2 ptt180 -122.23 -25.96 4.77 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.55 0.214 . . . . 0.0 111.288 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.428 ' HB2' HG23 ' A' ' 75' ' ' THR . 0.2 OUTLIER -48.53 125.38 9.71 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.881 0.372 . . . . 0.0 110.999 -179.919 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.97 -25.47 29.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.163 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 41.1 p -78.23 -23.42 47.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.993 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 93.8 m -57.16 169.27 0.59 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.967 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.8 ' CB ' HG23 ' A' ' 56' ' ' THR . 1.6 m-20 -85.91 -68.31 0.74 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.984 0.421 . . . . 0.0 110.909 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.651 HG21 ' CD1' ' A' ' 37' ' ' LEU . 27.7 t -101.99 133.05 46.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.085 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 15.7 pt -112.78 127.82 69.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.161 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.762 HD22 ' HB3' ' A' ' 131' ' ' CYS . 13.4 mt -94.04 -84.28 0.32 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.487 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.412 ' O ' ' CB ' ' A' ' 70' ' ' GLU . 10.8 t -102.55 -104.52 0.27 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.138 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.639 ' CB ' ' HD3' ' A' ' 71' ' ' PRO . 0.0 OUTLIER 166.76 -64.66 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.19 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 178.937 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.639 ' HD3' ' CB ' ' A' ' 70' ' ' GLU . 15.6 Cg_exo -67.84 -40.23 9.97 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.299 1.999 . . . . 0.0 113.519 -179.16 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -110.55 16.06 21.72 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -179.018 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.499 ' CG2' ' HB3' ' A' ' 60' ' ' ARG . 3.6 tp -107.15 124.72 63.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.865 0.364 . . . . 0.0 110.773 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.5 m -57.47 131.52 50.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.408 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.428 HG23 ' HB2' ' A' ' 61' ' ' SER . 35.2 m -63.69 -39.96 95.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.436 179.607 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.465 ' O ' ' C ' ' A' ' 77' ' ' HIS . 4.4 m-85 -104.99 13.74 30.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.164 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.488 ' CD2' ' CD1' ' A' ' 127' ' ' PHE . 1.5 t60 -16.65 -69.1 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.582 -1.19 . . . . 0.0 112.708 -179.276 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.581 ' HB3' ' CZ ' ' A' ' 127' ' ' PHE . . . -158.88 164.1 35.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.916 0.389 . . . . 0.0 111.611 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -124.0 140.36 53.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.872 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.933 ' CE1' HG13 ' A' ' 97' ' ' VAL . 4.8 m-85 -119.54 131.06 55.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.542 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.477 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 21.1 m-70 -102.91 116.11 31.9 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.691 -0.403 . . . . 0.0 111.674 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.919 HD11 ' OG1' ' A' ' 56' ' ' THR . 0.2 OUTLIER -107.06 109.84 21.8 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.635 179.116 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.2 mt -120.67 140.05 52.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.992 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.492 ' CG ' HD12 ' A' ' 34' ' ' LEU . 19.3 mt-30 -109.49 125.76 52.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.768 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 11.1 mtp -129.62 148.53 51.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.952 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -107.07 119.92 40.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.856 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.4 t -129.44 110.96 21.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.138 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.8 t70 58.67 68.52 0.82 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.934 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 68.26 -68.36 0.17 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.951 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -64.57 146.93 53.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.865 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.91 128.04 54.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.985 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -98.54 144.68 27.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.832 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 79.6 m-20 -109.14 127.01 53.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.988 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.419 ' CD2' HD11 ' A' ' 118' ' ' ILE . 1.1 mt -123.41 129.19 50.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.691 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.63 HD12 HD23 ' A' ' 82' ' ' LEU . 30.6 mm -117.93 138.01 50.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.903 0.383 . . . . 0.0 111.284 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -113.9 144.08 43.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.745 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.933 HG13 ' CE1' ' A' ' 80' ' ' PHE . 18.2 t -114.65 134.8 56.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.178 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 25.4 mm -121.04 121.01 63.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.03 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -97.75 123.71 41.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.941 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.98 -26.36 31.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.97 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.4 m 65.28 99.02 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.909 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.68 -42.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.888 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -104.26 -55.66 2.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.228 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 143.6 106.65 0.56 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.501 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 90.9 m -118.39 126.86 52.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.71 0.29 . . . . 0.0 110.898 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -120.93 115.03 22.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.921 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.728 HD12 ' O ' ' A' ' 124' ' ' ARG . 2.5 tp -114.16 137.36 47.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.464 0.649 . . . . 0.0 111.21 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 63.09 29.05 16.26 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.826 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.78 7.98 66.93 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.974 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -134.17 144.14 48.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.758 0.313 . . . . 0.0 110.856 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.4 ttp180 -70.51 128.99 38.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.81 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.729 HD13 ' N ' ' A' ' 113' ' ' VAL . 0.3 OUTLIER -92.2 137.97 31.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.917 -179.957 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.729 ' N ' HD13 ' A' ' 112' ' ' LEU . 6.2 m -121.51 -42.08 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.1 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.4 mttm -65.37 -174.55 0.19 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.852 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.0 tttt -124.0 171.15 9.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.803 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.5 t70 60.48 63.42 1.36 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.872 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' TYR . . . . . 0.437 ' CZ ' HG12 ' A' ' 107' ' ' ILE . 10.7 t80 -84.2 139.13 32.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.785 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.534 ' O ' HG23 ' A' ' 118' ' ' ILE . 8.4 tp -98.37 118.5 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.253 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.561 HD13 ' C ' ' A' ' 119' ' ' LEU . 3.2 tm? -100.84 120.0 39.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.767 -179.798 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.427 ' N ' HD13 ' A' ' 119' ' ' LEU . 0.4 OUTLIER -118.7 178.07 4.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.882 -179.955 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.443 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 17.8 p30 -60.06 135.79 57.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.017 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 75.04 56.32 4.86 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.582 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -123.09 135.06 54.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.845 0.355 . . . . 0.0 111.04 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.728 ' O ' HD12 ' A' ' 107' ' ' ILE . 0.0 OUTLIER -99.47 117.33 33.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.825 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.611 HG12 HD13 ' A' ' 107' ' ' ILE . 5.1 mt -115.0 133.21 61.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.114 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.566 HG13 ' O ' ' A' ' 131' ' ' CYS . 21.4 t -124.09 127.69 73.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.072 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.581 ' CZ ' ' HB3' ' A' ' 78' ' ' ALA . 4.8 m-85 -116.66 126.19 52.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.042 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 92.87 -71.09 1.51 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.36 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 174.55 -43.57 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.788 0.328 . . . . 0.0 111.171 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.0 p -98.08 -41.91 7.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.545 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' CYS . . . . . 0.762 ' HB3' HD22 ' A' ' 68' ' ' LEU . 25.3 m -54.13 106.17 0.18 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.955 0.407 . . . . 0.0 111.222 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 13.9 p -124.38 122.54 37.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.773 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -142.04 156.23 45.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.034 0.445 . . . . 0.0 111.276 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.1 tp -114.37 134.44 54.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.66 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.428 ' CD1' ' N ' ' A' ' 136' ' ' LYS . 14.5 t80 -98.2 141.17 31.44 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 121.929 0.871 . . . . 0.0 111.754 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.428 ' N ' ' CD1' ' A' ' 135' ' ' PHE . 9.6 tptt -154.86 154.71 33.14 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 113.878 -1.51 . . . . 0.0 111.128 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.443 ' CE2' ' HB3' ' A' ' 121' ' ' ASN . 13.2 m-85 -86.13 140.15 30.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.623 179.331 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -100.59 158.73 15.72 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.124 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 46.9 m -96.82 -59.83 1.72 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.95 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 7.2 t -158.54 112.07 2.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.917 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.15 85.05 7.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.854 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.58 -68.72 0.53 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.894 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 17.1 p -103.38 94.12 5.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.918 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -72.34 147.31 46.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.956 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.594 ' O ' HG22 ' A' ' 145' ' ' ILE . 19.5 mm -102.73 25.0 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 CA-C-O 121.599 0.714 . . . . 0.0 111.316 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -106.97 167.64 9.75 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.587 -1.188 . . . . 0.0 110.898 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -86.99 173.89 9.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.931 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 60.71 36.79 19.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.924 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -93.67 -43.07 8.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.892 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -110.84 86.72 2.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.973 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.41 176.38 10.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.9 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 14.5 m -140.43 -179.67 2.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.14 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 62.18 100.89 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.857 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 7.7 t -147.05 -56.48 0.25 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.874 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.41 -44.08 0.84 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.029 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.11 -68.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.968 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 3.1 mtt85 -151.57 162.54 40.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.866 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 7.1 t -175.8 175.71 1.97 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.976 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.213 -0.899 . . . . 0.0 110.845 -179.939 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.79 0.329 . . . . 0.0 111.251 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -131.09 -46.78 1.01 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.993 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -60.19 131.25 50.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.875 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -160.55 175.58 12.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.7 mtp85 -129.3 -179.84 5.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.911 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.75 -177.12 3.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.87 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -74.79 -43.52 54.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.904 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.4 tttm -79.97 134.32 56.68 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.787 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.02 155.12 65.84 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.477 2.118 . . . . 0.0 112.391 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.28 -68.41 0.48 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.728 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.2 t 60.07 110.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.046 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -73.16 166.39 23.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.702 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -70.95 -108.35 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.717 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.457 ' O ' HG22 ' A' ' 51' ' ' THR . 0.0 OUTLIER -140.6 145.03 36.15 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-O 120.692 0.282 . . . . 0.0 110.705 179.678 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 52.6 t -64.66 144.79 56.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.954 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.586 HD22 ' HB3' ' A' ' 52' ' ' ASN . 10.2 tp -155.33 -46.32 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.705 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -154.67 169.69 32.94 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.229 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.563 ' ND1' ' HB2' ' A' ' 138' ' ' ALA . 27.2 m80 -131.52 163.62 27.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.948 0.404 . . . . 0.0 110.946 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.649 HD12 HG21 ' A' ' 66' ' ' VAL . 19.1 mt -127.06 111.07 13.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.801 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.4 t -95.92 121.88 46.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.119 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -89.17 120.88 30.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.912 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.0 mp -79.71 107.05 12.18 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.888 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.403 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 11.7 mt -123.98 138.39 30.52 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.856 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.403 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 84.4 Cg_exo -47.59 -27.47 7.73 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.494 2.129 . . . . 0.0 112.429 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.96 -126.09 2.99 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.465 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.9 mttt -53.1 101.72 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.824 0.345 . . . . 0.0 111.134 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -65.36 172.27 3.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.844 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -133.61 131.1 39.23 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.906 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.07 127.36 56.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.863 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.675 HG11 HG13 ' A' ' 66' ' ' VAL . 28.6 t -119.94 150.98 22.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.14 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -103.44 138.16 40.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.863 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.665 HG22 HD22 ' A' ' 82' ' ' LEU . 26.2 mm -116.08 126.67 73.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.328 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.457 HG22 ' O ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -98.3 168.13 10.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.74 179.786 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.586 ' HB3' HD22 ' A' ' 34' ' ' LEU . 26.4 p30 -100.25 66.8 1.32 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.008 0.432 . . . . 0.0 110.762 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.576 ' C ' ' H ' ' A' ' 55' ' ' VAL . 0.6 OUTLIER -97.73 21.65 10.16 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.374 179.993 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.431 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 0.6 OUTLIER 68.23 -27.87 0.14 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.485 -179.726 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.576 ' H ' ' C ' ' A' ' 53' ' ' ARG . 62.9 t -137.31 139.31 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 CA-C-O 121.075 0.465 . . . . 0.0 111.826 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.472 HG22 ' CB ' ' A' ' 65' ' ' ASP . 0.4 OUTLIER -125.24 128.05 47.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.005 179.338 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.459 ' O ' ' N ' ' A' ' 65' ' ' ASP . 0.1 OUTLIER -103.95 138.93 39.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.971 0.415 . . . . 0.0 111.417 -179.519 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 32.8 mt -132.3 131.24 60.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.13 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 162.78 -146.67 12.09 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.264 -0.969 . . . . 0.0 113.283 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.583 ' HB2' HG23 ' A' ' 73' ' ' ILE . 4.1 ttp-105 -87.59 -44.54 11.17 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.83 0.348 . . . . 0.0 111.392 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.564 ' HB3' HG23 ' A' ' 75' ' ' THR . 33.2 t -50.51 122.15 6.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.483 -179.272 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 -60.43 -20.28 59.21 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.905 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 16.3 m -69.75 -27.43 64.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.698 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 84.4 m -56.33 164.67 1.27 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.671 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.472 ' CB ' HG22 ' A' ' 56' ' ' THR . 0.6 OUTLIER -66.94 -52.86 37.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.979 0.418 . . . . 0.0 110.802 179.827 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.675 HG13 HG11 ' A' ' 48' ' ' VAL . 21.3 t -125.12 126.79 71.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.508 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.8 mp -97.51 119.71 45.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.498 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.713 HD22 ' HB3' ' A' ' 131' ' ' CYS . 19.4 mt -83.4 -86.61 0.11 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.078 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 34.4 m -108.66 -109.88 0.32 Allowed 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 110.251 -0.278 . . . . 0.0 110.251 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.655 ' HA ' HG22 ' A' ' 73' ' ' ILE . 0.2 OUTLIER 169.66 -63.11 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.192 0 CA-C-O 120.496 0.188 . . . . 0.0 111.412 179.414 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.588 ' HD3' ' CB ' ' A' ' 70' ' ' GLU . 37.2 Cg_exo -60.29 -40.19 61.15 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.043 1.829 . . . . 0.0 112.899 -179.437 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -115.13 12.73 16.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.587 -179.573 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.655 HG22 ' HA ' ' A' ' 70' ' ' GLU . 2.6 tp -104.55 133.32 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-O 120.831 0.348 . . . . 0.0 110.975 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.476 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 4.1 p -98.82 131.76 44.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.546 -179.29 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.564 HG23 ' HB3' ' A' ' 61' ' ' SER . 19.6 m -53.48 -30.17 39.69 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.159 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -93.92 14.12 20.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.018 -179.56 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.476 ' HB2' ' O ' ' A' ' 74' ' ' SER . 1.4 t-160 -34.51 -66.65 0.16 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.07 -179.392 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.57 ' HB3' ' CE2' ' A' ' 127' ' ' PHE . . . -161.62 163.24 30.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.097 0.475 . . . . 0.0 111.765 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -129.47 135.16 48.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.237 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.954 ' CE2' HG22 ' A' ' 97' ' ' VAL . 6.3 m-85 -119.34 131.46 55.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.999 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.431 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 11.9 m170 -94.69 116.45 28.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.954 0.407 . . . . 0.0 110.928 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.665 HD22 HG22 ' A' ' 50' ' ' ILE . 1.6 tp -106.45 109.95 22.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.948 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.2 tp -118.57 140.09 50.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.89 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.4 tm0? -100.4 132.0 46.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.937 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.3 130.1 56.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.85 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -95.12 130.77 41.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.964 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' VAL . . . . . 0.465 HG21 ' HD3' ' A' ' 92' ' ' ARG . 21.4 t -140.09 138.8 37.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.135 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.35 67.38 0.33 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.797 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 173.4 -52.67 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.748 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -153.03 172.24 17.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -94.78 127.94 41.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.942 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.465 ' HD3' HG21 ' A' ' 87' ' ' VAL . 0.8 OUTLIER -101.12 125.4 47.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.869 179.914 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.438 ' HB2' ' CE1' ' A' ' 137' ' ' TYR . 38.7 m-80 -112.77 125.08 53.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.994 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.648 ' HG ' HD11 ' A' ' 118' ' ' ILE . 1.3 tp -122.52 129.3 51.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.694 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.476 ' N ' HD12 ' A' ' 95' ' ' ILE . 3.2 mp -122.96 141.01 44.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.204 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -116.53 144.01 44.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.827 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.954 HG22 ' CE2' ' A' ' 80' ' ' PHE . 22.0 t -112.17 124.63 69.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.193 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 20.4 mt -130.01 124.95 59.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.071 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' ASP . . . . . 0.449 ' HB2' HD22 ' A' ' 112' ' ' LEU . 26.7 m-20 -114.03 127.83 56.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.946 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.71 -7.47 59.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.372 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 21.6 m 64.25 79.02 0.27 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.779 0.324 . . . . 0.0 110.884 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.43 -39.95 3.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.919 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -133.19 -46.02 0.84 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.192 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 145.47 103.16 0.38 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.406 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.449 HG23 ' CD1' ' A' ' 127' ' ' PHE . 28.0 m -113.46 131.57 55.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.788 0.328 . . . . 0.0 110.92 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -116.49 117.71 30.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.871 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.447 HD13 HG23 ' A' ' 125' ' ' ILE . 3.0 tp -112.5 137.32 45.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.424 0.631 . . . . 0.0 111.281 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 62.15 27.66 16.65 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.942 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.59 10.22 70.74 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.94 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -133.99 151.34 51.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.775 0.321 . . . . 0.0 110.957 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.58 130.0 40.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.859 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.709 HD21 ' O ' ' A' ' 114' ' ' LYS . 7.0 tt -70.19 139.28 52.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.818 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.472 HG13 ' N ' ' A' ' 114' ' ' LYS . 10.8 p -121.98 -44.66 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.077 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' LYS . . . . . 0.709 ' O ' HD21 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -84.61 167.45 16.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.946 179.97 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -108.85 28.52 8.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.942 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -158.62 62.45 0.43 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.005 0.431 . . . . 0.0 110.8 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -84.06 139.11 32.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.803 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.648 HD11 ' HG ' ' A' ' 94' ' ' LEU . 8.6 tp -98.48 120.14 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-O 121.01 0.433 . . . . 0.0 111.408 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.679 HD11 HD11 ' A' ' 125' ' ' ILE . 6.6 tt -103.1 142.21 34.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.923 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 9.6 mmtp -129.76 178.13 6.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.817 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.45 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 9.2 p30 -56.35 144.44 30.55 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.083 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.433 ' HA2' HD21 ' A' ' 134' ' ' LEU . . . 65.51 45.49 89.65 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.42 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -112.37 133.59 54.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.91 0.386 . . . . 0.0 110.973 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.607 ' HG2' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -91.42 130.77 37.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.819 179.931 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.679 HD11 HD11 ' A' ' 119' ' ' LEU . 1.8 mp -129.83 121.92 53.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.255 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.572 HG22 ' OG ' ' A' ' 132' ' ' SER . 39.2 t -113.13 130.55 66.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.033 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.57 ' CE2' ' HB3' ' A' ' 78' ' ' ALA . 3.3 m-85 -114.61 141.39 47.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.071 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 71.59 -64.67 1.11 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.49 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 169.91 -38.2 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.884 0.373 . . . . 0.0 110.963 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 82.7 p -101.75 -39.97 7.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.041 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' CYS . . . . . 0.713 ' HB3' HD22 ' A' ' 68' ' ' LEU . 57.1 m -57.17 106.38 0.31 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.998 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' SER . . . . . 0.572 ' OG ' HG22 ' A' ' 126' ' ' VAL . 1.3 m -124.21 123.7 40.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.889 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -142.09 156.01 45.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.111 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.607 HD12 ' HG2' ' A' ' 124' ' ' ARG . 1.4 tt -117.89 140.02 50.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.717 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -104.94 141.39 36.64 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.945 0.879 . . . . 0.0 111.935 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -154.73 159.35 40.63 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 113.711 -1.586 . . . . 0.0 110.591 179.459 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.45 ' CE2' ' HB3' ' A' ' 121' ' ' ASN . 2.5 m-85 -83.83 139.81 32.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.021 0.438 . . . . 0.0 110.697 179.588 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.563 ' HB2' ' ND1' ' A' ' 36' ' ' HIS . . . -96.9 87.43 4.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.131 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.11 175.12 5.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.98 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.9 127.1 35.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.902 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.3 t -153.42 -61.05 0.14 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.907 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.21 31.02 1.38 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.969 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.7 p -106.56 22.71 15.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.035 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -117.47 -30.65 5.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.084 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.609 ' O ' HG22 ' A' ' 145' ' ' ILE . 17.8 mt -100.94 25.04 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 CA-C-O 121.628 0.727 . . . . 0.0 111.415 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -152.8 33.14 0.49 Allowed 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.881 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -87.89 91.51 8.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.829 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -99.12 149.54 22.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.951 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -148.97 -47.51 0.14 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.923 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -58.9 132.91 55.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.923 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.89 87.57 0.09 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.85 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 14.2 m -90.02 149.12 4.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.115 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.37 -174.07 0.08 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.838 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.2 m -128.82 -70.31 0.68 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.917 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.12 -177.62 0.28 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.862 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 6.9 m 60.78 -170.81 0.15 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.918 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.36 -39.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.902 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 62.66 177.48 0.14 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.91 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 23.4 t80 . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.937 179.981 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.847 0.356 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.4 164.63 12.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.837 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.38 117.97 3.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.92 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -151.52 159.82 43.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.961 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.7 ttt-85 -111.06 -31.87 6.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.938 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.2 p -94.17 162.15 13.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.889 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.2 m-20 60.16 54.8 3.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.882 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LYS . . . . . 0.427 ' N ' ' HD2' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -70.35 -61.4 2.72 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.036 -179.989 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 27' ' ' PRO . . . . . 0.427 ' HD2' ' N ' ' A' ' 26' ' ' LYS . 36.9 Cg_endo -65.67 156.42 63.95 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.472 2.115 . . . . 0.0 112.283 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.2 p -89.32 56.64 3.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.921 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -114.77 85.02 2.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.918 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.7 pm0 -136.6 -175.35 3.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.96 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -110.3 -119.39 0.28 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.588 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.1 130.15 24.9 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 120.797 0.332 . . . . 0.0 110.554 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.8 t -60.71 145.05 50.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.063 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.551 HD22 ' OD1' ' A' ' 93' ' ' ASN . 9.6 mt -147.76 -53.68 0.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.908 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.689 ' C ' HG22 ' A' ' 50' ' ' ILE . . . -140.65 -175.28 14.48 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.564 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 50.4 m80 -146.07 166.05 27.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.904 0.383 . . . . 0.0 110.936 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.7 mp -125.69 107.85 10.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.539 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.65 HG22 ' HG2' ' A' ' 47' ' ' LYS . 27.6 t -96.13 121.98 47.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.167 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -89.98 113.98 25.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.86 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -87.65 106.75 18.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.878 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.542 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 18.9 mt -124.17 141.0 36.12 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.835 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.542 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 50.2 Cg_endo -72.59 83.95 1.26 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.078 1.852 . . . . 0.0 111.967 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 118.0 25.98 2.88 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.372 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 170.58 155.31 0.06 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.691 0.282 . . . . 0.0 110.555 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -142.47 151.91 42.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.975 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -140.29 128.79 22.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.176 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.65 ' HG2' HG22 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -113.04 131.24 55.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.806 179.82 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.8 t -125.46 151.02 31.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.29 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -104.24 132.92 49.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.626 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.689 HG22 ' C ' ' A' ' 35' ' ' GLY . 2.3 tt -116.07 132.02 66.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.01 0.433 . . . . 0.0 111.492 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.01 168.05 9.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.033 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.482 ' HB3' HD12 ' A' ' 34' ' ' LEU . 3.8 p-10 -76.28 63.39 1.91 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.307 179.384 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.542 ' C ' ' H ' ' A' ' 55' ' ' VAL . 11.1 ttt-85 -80.88 0.12 36.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.013 -179.42 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.451 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 8.3 m120 71.51 -35.88 0.34 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -178.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.542 ' H ' ' C ' ' A' ' 53' ' ' ARG . 68.0 t -137.37 134.14 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.061 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.653 HG23 ' HB3' ' A' ' 65' ' ' ASP . 51.8 m -125.29 124.19 41.08 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.893 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.66 127.34 51.12 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.952 0.406 . . . . 0.0 111.11 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.725 ' CG2' HD11 ' A' ' 68' ' ' LEU . 4.6 mp -107.98 117.74 54.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.003 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 172.95 -144.96 8.14 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.405 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.3 ttm105 -111.15 -19.93 12.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.715 0.293 . . . . 0.0 111.245 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.449 ' HB2' HG22 ' A' ' 75' ' ' THR . 0.1 OUTLIER -50.27 151.67 2.03 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.895 0.379 . . . . 0.0 111.141 -179.859 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -72.91 -38.74 66.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.93 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 6.0 m -70.1 -19.62 63.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.209 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 48.8 m -53.91 149.25 9.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.028 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.653 ' HB3' HG23 ' A' ' 56' ' ' THR . 10.4 t70 -75.16 -53.68 8.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.904 0.383 . . . . 0.0 110.836 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.5 t -114.83 116.99 54.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.216 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 20.0 pt -99.15 131.05 47.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.061 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.834 HD13 HG12 ' A' ' 73' ' ' ILE . 5.0 mp -86.45 -175.93 5.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.911 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.2 t -118.34 34.61 5.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.98 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.419 ' HB3' ' HB ' ' A' ' 73' ' ' ILE . 5.4 tp10 -109.68 118.51 50.12 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.667 179.787 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -57.74 -16.11 23.79 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.566 2.177 . . . . 0.0 112.804 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -119.8 36.61 4.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.765 0.317 . . . . 0.0 111.029 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.834 HG12 HD13 ' A' ' 68' ' ' LEU . 7.3 tp -82.45 147.7 5.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.27 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.427 ' HB3' ' CG ' ' A' ' 77' ' ' HIS . 2.5 t -77.17 129.91 36.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.103 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.449 HG22 ' HB2' ' A' ' 61' ' ' SER . 1.8 m -65.37 -39.21 92.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.726 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.434 ' O ' ' C ' ' A' ' 77' ' ' HIS . 1.1 m-85 -103.8 13.94 31.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.295 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.434 ' C ' ' O ' ' A' ' 76' ' ' PHE . 0.3 OUTLIER -22.31 -71.87 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.647 -1.161 . . . . 0.0 112.595 -179.349 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.601 ' HB3' ' CE2' ' A' ' 127' ' ' PHE . . . -158.6 164.03 36.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.074 0.464 . . . . 0.0 111.928 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.58 ' HG3' HD12 ' A' ' 98' ' ' ILE . 11.1 pt-20 -129.09 136.49 50.3 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.471 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.883 ' CZ ' HG13 ' A' ' 97' ' ' VAL . 6.1 m-85 -119.54 131.17 55.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.887 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.451 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 6.3 m-70 -94.87 116.38 28.64 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.89 0.376 . . . . 0.0 111.049 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.498 HD12 HG12 ' A' ' 95' ' ' ILE . 0.4 OUTLIER -106.51 109.58 21.54 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.711 179.57 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.4 mp -122.2 140.14 52.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.166 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.0 tm0? -108.97 133.34 53.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.892 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -141.89 122.69 14.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.939 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -97.05 116.1 28.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.944 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 4.2 m -119.68 110.92 30.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.243 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 59.25 72.82 0.51 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.004 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 66.08 -74.54 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.042 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -52.85 144.41 14.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.152 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -108.83 130.95 55.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.94 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -116.5 125.61 52.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.796 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.551 ' OD1' HD22 ' A' ' 34' ' ' LEU . 5.1 m120 -106.98 135.37 48.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.939 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.66 139.62 53.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.773 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.498 HG12 HD12 ' A' ' 82' ' ' LEU . 4.0 mp -127.79 138.29 55.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.205 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -113.88 140.62 48.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.772 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.883 HG13 ' CZ ' ' A' ' 80' ' ' PHE . 16.9 t -103.99 121.99 56.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.156 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ILE . . . . . 0.58 HD12 ' HG3' ' A' ' 79' ' ' GLU . 28.6 mt -114.21 124.2 70.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.046 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -87.78 138.23 31.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.941 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.1 -25.68 14.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.013 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.1 m 65.47 81.37 0.21 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.943 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -137.07 -47.07 0.58 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.883 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -124.74 -48.83 1.77 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.157 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 154.32 129.39 1.29 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.547 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.493 HG23 ' CE1' ' A' ' 127' ' ' PHE . 1.7 m -131.94 123.7 27.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.758 0.314 . . . . 0.0 110.954 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -121.16 123.28 41.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.809 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.479 HD12 ' O ' ' A' ' 124' ' ' ARG . 2.9 tp -119.01 137.32 53.36 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-O 121.426 0.631 . . . . 0.0 111.337 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 2.7 m120 62.38 27.97 16.62 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.859 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.66 9.82 70.33 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.971 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -133.99 152.04 51.69 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.825 0.345 . . . . 0.0 110.859 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.02 129.21 39.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.88 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.474 HD21 ' HB ' ' A' ' 105' ' ' THR . 4.1 pp -71.44 140.13 49.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.954 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.0 m -135.02 31.41 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.171 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 23.9 mmtt -145.93 149.09 33.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.931 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 17.9 ttpp -98.77 31.13 3.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.813 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -166.57 66.93 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.862 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -82.81 139.03 33.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.941 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.633 HD13 ' C ' ' A' ' 118' ' ' ILE . 0.0 OUTLIER -98.73 117.61 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.749 -179.841 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.779 HD11 HD11 ' A' ' 125' ' ' ILE . 7.7 tt -103.0 136.89 41.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.186 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LYS . . . . . 0.542 ' N ' HD23 ' A' ' 119' ' ' LEU . 3.1 mmmm -136.14 178.15 7.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.764 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.433 ' HB3' ' CZ ' ' A' ' 137' ' ' TYR . 12.7 p30 -55.48 139.31 44.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.034 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 71.27 52.93 11.36 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.479 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -124.8 125.25 43.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.794 0.33 . . . . 0.0 110.974 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.613 ' HG3' HD12 ' A' ' 134' ' ' LEU . 11.2 mtp180 -93.67 131.81 38.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.818 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.779 HD11 HD11 ' A' ' 119' ' ' LEU . 2.7 mt -125.74 137.95 56.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.123 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 22.9 t -120.36 123.98 71.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.065 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.601 ' CE2' ' HB3' ' A' ' 78' ' ' ALA . 3.6 m-85 -119.22 128.97 54.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.139 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 80.97 -3.38 76.42 Favored Glycine 0 CA--C 1.518 0.252 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.072 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 8.6 tttt 76.31 24.5 1.09 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.861 0.362 . . . . 0.0 110.511 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.88 -52.63 0.13 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.012 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 91.1 m -77.48 107.76 10.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.671 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 79.8 p -121.99 133.33 54.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.992 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.423 ' CE1' ' HB ' ' A' ' 125' ' ' ILE . 2.8 p90 -142.01 155.69 45.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.905 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.613 HD12 ' HG3' ' A' ' 124' ' ' ARG . 7.9 tt -112.35 139.98 47.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.774 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.558 ' HE1' HG21 ' A' ' 50' ' ' ILE . 74.1 t80 -101.5 141.5 34.28 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.944 0.878 . . . . 0.0 111.838 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.31 154.11 32.82 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 113.864 -1.516 . . . . 0.0 110.784 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.479 ' N ' ' CD1' ' A' ' 137' ' ' TYR . 0.6 OUTLIER -85.53 139.72 31.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.992 0.425 . . . . 0.0 110.752 179.74 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -115.19 107.74 15.69 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.097 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 3.2 m -137.35 31.45 2.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.937 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.1 m -83.98 78.14 9.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.88 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -95.7 90.76 5.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.889 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.1 p -111.27 155.28 23.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.898 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.3 t -135.96 -50.29 0.7 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.875 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -168.86 87.17 0.18 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.897 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.6 HG22 ' H ' ' A' ' 146' ' ' GLU . 0.8 OUTLIER -110.89 -143.44 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.847 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 146' ' ' GLU . . . . . 0.6 ' H ' HG22 ' A' ' 145' ' ' ILE . 5.6 tp10 -102.04 152.44 20.97 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.924 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 60.64 177.5 0.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.874 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.52 128.18 35.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.921 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -119.76 164.84 15.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.871 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 60.44 -178.83 0.1 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.811 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.93 134.8 36.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.87 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.514 HG13 ' O ' ' A' ' 152' ' ' VAL . 11.3 p -148.81 57.89 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.061 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 16.7 p -93.0 -31.76 14.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.871 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.4 t -105.39 -45.64 4.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.896 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -158.73 158.82 34.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.865 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -95.68 -169.02 1.87 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.926 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.22 46.71 1.17 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.862 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.9 m 60.86 107.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.909 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 26.3 t80 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.205 -0.902 . . . . 0.0 110.868 179.932 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.7 mttt . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.861 0.362 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 60.28 92.71 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.967 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 59.18 30.62 20.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.971 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.35 84.04 1.8 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.89 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.02 -47.48 0.23 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.803 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 88.5 p -90.85 170.46 10.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.929 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -116.46 160.58 20.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.869 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.2 mtpp -135.94 83.05 35.52 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.927 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.94 159.05 19.02 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.576 2.184 . . . . 0.0 112.28 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.0 t -108.74 -61.19 1.64 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.916 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' SER . . . . . 0.401 ' O ' ' CZ ' ' A' ' 31' ' ' TYR . 67.2 m -88.5 151.68 22.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . 0.446 ' C ' ' CG ' ' A' ' 31' ' ' TYR . 7.3 mm-40 -95.03 167.41 11.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.842 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.446 ' CG ' ' C ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -168.48 115.78 0.68 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.247 0.546 . . . . 0.0 110.413 179.602 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.4 m -102.01 152.51 20.87 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.749 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.8 t -60.07 135.21 57.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.868 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.631 HD11 HD21 ' A' ' 93' ' ' ASN . 4.9 tp -136.65 -63.61 0.61 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.97 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -139.6 178.25 19.82 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.498 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.43 ' ND1' ' HB2' ' A' ' 138' ' ' ALA . 31.0 m80 -133.52 166.0 23.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.788 0.328 . . . . 0.0 110.911 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.656 HD22 ' HD2' ' A' ' 133' ' ' PHE . 18.9 mt -126.5 113.71 17.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.96 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.462 HG22 ' HD3' ' A' ' 47' ' ' LYS . 28.5 t -96.24 121.89 47.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.948 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -90.0 113.85 25.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.892 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LEU . . . . . 0.555 HD13 HH12 ' A' ' 124' ' ' ARG . 2.9 mt -77.76 106.75 9.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.785 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.523 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 1.6 mp -124.15 140.26 34.47 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.97 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' PRO . . . . . 0.523 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 67.9 Cg_endo -76.13 83.84 1.92 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.304 2.003 . . . . 0.0 112.029 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 115.62 24.04 4.18 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.382 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -179.5 166.96 1.45 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.794 0.33 . . . . 0.0 110.612 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -144.41 128.27 17.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.045 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -116.17 118.82 33.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.835 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.462 ' HD3' HG22 ' A' ' 38' ' ' VAL . 1.1 mmmp? -108.82 124.83 51.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.909 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.617 HG11 HG13 ' A' ' 66' ' ' VAL . 26.2 t -120.36 137.64 53.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.096 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.75 132.84 34.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.84 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.541 HD11 HD12 ' A' ' 37' ' ' LEU . 33.4 mm -108.76 116.25 51.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.264 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.566 ' O ' HD23 ' A' ' 82' ' ' LEU . 0.2 OUTLIER -100.88 167.77 10.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.66 179.729 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASN . . . . . 0.532 ' HA ' HD23 ' A' ' 82' ' ' LEU . 3.4 m120 -61.68 -95.65 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.324 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ARG . . . . . 0.564 ' C ' ' H ' ' A' ' 55' ' ' VAL . 3.9 ttt-85 70.79 -4.41 1.71 Allowed 'General case' 0 C--O 1.232 0.15 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 179.207 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' ASN . . . . . 0.4 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 0.1 OUTLIER 70.24 -32.93 0.25 Allowed 'General case' 0 C--N 1.331 -0.226 0 O-C-N 122.156 -0.34 . . . . 0.0 110.247 -179.035 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' VAL . . . . . 0.564 ' H ' ' C ' ' A' ' 53' ' ' ARG . 65.7 t -136.72 140.72 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-O 121.082 0.468 . . . . 0.0 111.055 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.816 HG23 ' HB3' ' A' ' 65' ' ' ASP . 14.2 m -125.35 130.19 51.44 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.101 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.98 135.48 45.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.818 0.342 . . . . 0.0 110.684 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ILE . . . . . 0.74 ' CG2' HD23 ' A' ' 68' ' ' LEU . 5.9 mt -128.5 124.07 61.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.342 -179.625 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 166.55 -134.48 3.29 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.47 -0.872 . . . . 0.0 113.068 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ARG . . . . . 0.466 ' HB2' HG23 ' A' ' 73' ' ' ILE . 8.2 ttp180 -99.99 -40.12 7.8 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.886 0.374 . . . . 0.0 111.158 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' SER . . . . . 0.804 ' HB2' HG23 ' A' ' 75' ' ' THR . 0.3 OUTLIER -46.18 118.11 1.79 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.481 -179.52 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.85 -28.37 56.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.76 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -69.93 -22.96 63.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.88 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 86.8 m -54.33 154.27 4.69 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.774 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.816 ' HB3' HG23 ' A' ' 56' ' ' THR . 64.1 t0 -65.88 -46.25 79.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.823 0.344 . . . . 0.0 110.957 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' VAL . . . . . 0.617 HG13 HG11 ' A' ' 48' ' ' VAL . 21.3 t -125.18 133.24 69.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.436 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.8 pt -106.16 122.43 59.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.69 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . 0.74 HD23 ' CG2' ' A' ' 58' ' ' ILE . 2.7 mm? -94.15 -88.35 0.24 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.94 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 28.0 t -104.79 -115.64 0.23 Allowed 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.584 ' HA ' HG22 ' A' ' 73' ' ' ILE . 3.4 tt0 171.79 -62.1 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.327 0 O-C-N 122.372 -0.205 . . . . 0.0 111.117 179.373 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PRO . . . . . 0.524 ' HD3' ' CB ' ' A' ' 70' ' ' GLU . 38.8 Cg_exo -59.44 -40.17 69.49 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 121.924 1.749 . . . . 0.0 112.86 -179.476 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -118.73 19.85 13.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.507 -179.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.584 HG22 ' HA ' ' A' ' 70' ' ' GLU . 4.6 tp -103.97 122.2 56.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.078 0.466 . . . . 0.0 110.942 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' SER . . . . . 0.429 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 2.6 p -71.81 134.87 46.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.406 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.804 HG23 ' HB2' ' A' ' 61' ' ' SER . 91.4 m -61.99 -30.35 70.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.716 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' PHE . . . . . 0.422 ' O ' ' C ' ' A' ' 77' ' ' HIS . 0.4 OUTLIER -108.77 14.08 24.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.514 -179.939 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 77' ' ' HIS . . . . . 0.504 ' CD2' ' CD1' ' A' ' 127' ' ' PHE . 1.1 t60 -25.68 -68.73 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.796 -1.093 . . . . 0.0 112.668 -179.345 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ALA . . . . . 0.569 ' HB3' ' CZ ' ' A' ' 127' ' ' PHE . . . -157.09 164.1 38.25 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.017 0.437 . . . . 0.0 111.647 -179.575 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -131.67 137.95 48.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.822 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' PHE . . . . . 0.898 ' CE2' HG22 ' A' ' 97' ' ' VAL . 7.0 m-85 -119.28 130.14 55.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.534 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' HIS . . . . . 0.4 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 4.4 m-70 -94.78 116.17 28.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.802 0.334 . . . . 0.0 111.14 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LEU . . . . . 0.566 HD23 ' O ' ' A' ' 51' ' ' THR . 11.1 tp -106.54 109.49 21.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.718 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.46 140.23 52.97 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.035 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLN . . . . . 0.467 ' HB2' HD22 ' A' ' 52' ' ' ASN . 0.6 OUTLIER -98.45 134.89 40.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.682 179.767 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.02 122.94 47.45 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.984 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -96.97 119.53 35.61 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.002 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.4 t -140.05 139.15 37.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.098 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -48.59 -56.44 8.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.198 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 -51.08 -75.11 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.152 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -147.65 155.27 41.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.801 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -82.92 127.93 33.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.967 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.04 134.93 54.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.984 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' ASN . . . . . 0.631 HD21 HD11 ' A' ' 34' ' ' LEU . 20.1 m-20 -111.43 140.62 45.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.733 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LEU . . . . . 0.619 ' HG ' HD11 ' A' ' 118' ' ' ILE . 4.6 tp -132.02 139.47 48.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.054 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ILE . . . . . 0.641 HD13 HD23 ' A' ' 119' ' ' LEU . 2.6 mp -125.02 134.31 67.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.049 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -114.04 144.01 43.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.817 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' VAL . . . . . 0.898 HG22 ' CE2' ' A' ' 80' ' ' PHE . 16.3 t -108.78 131.61 58.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.187 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.8 mp -130.05 121.31 51.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.985 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 21.1 p30 -84.88 139.09 32.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.93 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -143.6 30.48 1.35 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.959 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.6 m -153.97 152.2 30.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.829 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 11.7 mmt180 -106.18 34.6 3.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.987 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -89.19 -31.22 18.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.207 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 121.19 115.99 2.43 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.452 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' THR . . . . . 0.463 ' CG2' ' CE1' ' A' ' 127' ' ' PHE . 99.5 m -131.72 128.45 38.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.811 0.338 . . . . 0.0 110.886 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -121.05 114.96 22.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.746 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ILE . . . . . 0.639 HD12 ' O ' ' A' ' 124' ' ' ARG . 2.8 tp -111.56 137.29 44.74 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 CA-C-O 121.435 0.636 . . . . 0.0 111.342 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 61.93 26.53 16.05 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.739 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.72 8.95 69.01 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.858 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 51.9 m-80 -134.11 151.99 51.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.792 0.33 . . . . 0.0 110.901 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 10.5 mtm105 -74.96 132.82 41.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.739 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.432 HD23 ' H ' ' A' ' 112' ' ' LEU . 0.6 OUTLIER -83.05 143.5 30.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.95 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.636 ' O ' HG22 ' A' ' 113' ' ' VAL . 14.5 p -128.75 14.56 2.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.39 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -121.85 -178.56 3.87 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.806 0.336 . . . . 0.0 110.768 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.3 mttt -110.2 -29.64 8.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.95 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -112.63 78.87 1.16 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.899 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -80.79 139.33 36.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.903 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.619 HD11 ' HG ' ' A' ' 94' ' ' LEU . 7.5 tp -98.46 115.98 40.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.035 0.445 . . . . 0.0 111.241 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.641 HD23 HD13 ' A' ' 95' ' ' ILE . 0.7 OUTLIER -103.12 132.85 49.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.964 -179.862 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 19.4 mttm -135.99 178.23 7.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.76 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ASN . . . . . 0.46 ' ND2' ' CD2' ' A' ' 137' ' ' TYR . 3.2 t-20 -50.93 139.99 16.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.176 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' GLY . . . . . 0.508 ' HA2' HD21 ' A' ' 134' ' ' LEU . . . 70.75 51.46 19.78 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.497 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.46 130.07 53.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.918 0.39 . . . . 0.0 110.952 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ARG . . . . . 0.639 ' O ' HD12 ' A' ' 107' ' ' ILE . 1.4 ttm-85 -98.15 124.11 42.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.918 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ILE . . . . . 0.529 HD11 HD11 ' A' ' 119' ' ' LEU . 1.9 mp -115.53 134.71 57.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.17 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 29.2 t -124.1 133.95 67.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.104 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' PHE . . . . . 0.569 ' CZ ' ' HB3' ' A' ' 78' ' ' ALA . 7.5 m-85 -131.84 134.33 45.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.055 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 81.02 -2.23 81.72 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.95 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 2.8 mtpp 75.47 27.77 1.02 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.914 0.388 . . . . 0.0 110.424 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 63.9 p -154.01 -60.03 0.13 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.834 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' CYS . . . . . 0.71 ' HB3' HD12 ' A' ' 68' ' ' LEU . 55.6 m -61.91 109.05 1.14 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.727 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.0 p -120.51 128.0 52.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.004 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' PHE . . . . . 0.656 ' HD2' HD22 ' A' ' 37' ' ' LEU . 2.1 p90 -142.06 155.99 45.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.953 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' LEU . . . . . 0.508 HD21 ' HA2' ' A' ' 122' ' ' GLY . 3.9 tt -113.37 140.11 48.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.834 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' PHE . . . . . 0.507 ' HE2' HG21 ' A' ' 50' ' ' ILE . 26.4 t80 -104.54 141.48 36.32 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.984 0.897 . . . . 0.0 111.81 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 8.7 pttt -154.71 158.97 40.37 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 113.914 -1.494 . . . . 0.0 110.867 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' TYR . . . . . 0.46 ' CD2' ' ND2' ' A' ' 121' ' ' ASN . 3.2 m-85 -86.07 139.74 30.87 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.716 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' ALA . . . . . 0.43 ' HB2' ' ND1' ' A' ' 36' ' ' HIS . . . -106.39 35.6 2.9 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.22 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.37 31.6 5.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.942 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 60.5 90.68 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.863 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -130.21 123.4 30.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.817 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.1 p -94.85 147.98 22.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.953 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.9 t -126.57 125.2 41.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.933 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -107.37 -174.88 2.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.853 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ILE . . . . . 0.579 ' O ' HG22 ' A' ' 145' ' ' ILE . 20.2 mm -101.6 25.04 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 CA-C-O 121.699 0.762 . . . . 0.0 111.375 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -163.51 98.12 0.89 Allowed 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.603 -1.18 . . . . 0.0 110.858 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -59.6 -37.43 78.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.969 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -73.74 153.56 39.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.931 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -151.73 131.84 13.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.879 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -175.54 -40.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.896 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -73.06 116.94 14.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.886 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.458 ' O ' HG23 ' A' ' 152' ' ' VAL . 28.6 m -122.02 120.05 60.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.127 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.29 -59.88 2.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.908 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 94.8 p -119.65 168.64 10.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.863 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -68.5 113.3 5.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.907 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 16.3 m -153.97 86.49 1.18 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.827 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -121.1 97.73 5.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.855 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 62.3 m 60.29 -178.42 0.1 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.843 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 20.8 t80 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.297 -0.859 . . . . 0.0 110.875 -179.947 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.467 ' N ' HG22 ' A' ' 51' ' ' THR . 0.2 OUTLIER . . . . . 0 C--O 1.23 0.074 0 CA-C-O 120.703 0.287 . . . . 0.0 110.471 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.8 t -64.46 130.71 44.78 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.91 0.386 . . . . 0.0 111.036 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.12 -47.0 0.64 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.77 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.644 ' C ' HG22 ' A' ' 50' ' ' ILE . . . -138.83 -178.84 16.7 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.357 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.43 ' CD2' ' HA ' ' A' ' 49' ' ' GLU . 49.4 m80 -147.02 162.36 38.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.865 0.364 . . . . 0.0 110.919 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.492 HD11 ' HB ' ' A' ' 50' ' ' ILE . 1.0 OUTLIER -127.07 119.7 27.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.754 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.5 t -97.53 122.96 49.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.104 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -89.99 126.48 35.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.884 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.654 HD13 ' NH2' ' A' ' 124' ' ' ARG . 0.9 OUTLIER -90.62 106.82 18.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.54 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 20.8 mt -124.09 140.65 35.25 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.934 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.54 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 57.2 Cg_endo -73.86 87.99 1.1 Allowed 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.162 1.908 . . . . 0.0 111.983 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 137.79 -12.08 3.68 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.386 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.1 pttp 178.2 173.51 0.63 Allowed 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 120.727 0.299 . . . . 0.0 110.689 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -135.7 160.68 37.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.048 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.61 134.08 33.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.947 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.04 127.7 56.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.82 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.448 ' O ' HD12 ' A' ' 37' ' ' LEU . 30.6 t -119.48 130.79 73.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.182 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.43 ' HA ' ' CD2' ' A' ' 36' ' ' HIS . 3.3 pm0 -81.6 136.6 35.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.734 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.644 HG22 ' C ' ' A' ' 35' ' ' GLY . 16.7 tt -116.02 132.11 66.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.338 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.467 HG22 ' N ' ' A' ' 32' ' ' THR . 0.7 OUTLIER -97.05 168.09 10.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.999 -179.682 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.417 ' HA ' HD22 ' A' ' 82' ' ' LEU . 7.0 p30 -92.63 66.16 4.43 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.079 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.571 ' C ' ' H ' ' A' ' 55' ' ' VAL . 0.1 OUTLIER -90.37 13.26 15.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.016 -179.253 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.447 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 0.7 OUTLIER 69.28 -34.6 0.28 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -179.524 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.571 ' H ' ' C ' ' A' ' 53' ' ' ARG . 62.3 t -137.28 124.09 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-O 120.948 0.404 . . . . 0.0 111.343 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.769 HG23 ' HB3' ' A' ' 65' ' ' ASP . 15.9 m -111.04 128.8 55.98 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.624 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.74 138.67 40.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.908 0.385 . . . . 0.0 111.043 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.594 HD11 ' HD2' ' A' ' 80' ' ' PHE . 4.7 mp -126.64 117.98 49.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.033 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 176.68 -160.73 28.29 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.667 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.504 ' HB2' HG23 ' A' ' 73' ' ' ILE . 5.2 ttp180 -83.39 -29.82 27.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.726 0.298 . . . . 0.0 110.979 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.682 ' HB2' HG23 ' A' ' 75' ' ' THR . 7.2 t -58.09 129.32 41.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.968 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.42 -22.64 67.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.022 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 6.3 m -69.89 -27.58 64.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.004 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 97.5 m -57.16 151.61 15.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.82 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.769 ' HB3' HG23 ' A' ' 56' ' ' THR . 63.9 t0 -61.31 -43.96 98.01 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.884 0.374 . . . . 0.0 110.603 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.8 t -125.03 114.92 42.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.093 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.595 ' O ' HG23 ' A' ' 67' ' ' ILE . 19.6 tt -93.75 107.4 19.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.026 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.801 HD13 HD11 ' A' ' 73' ' ' ILE . 18.0 mt -65.36 -177.97 0.46 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.928 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.9 p -123.39 65.05 1.0 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.238 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.87 141.1 40.67 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.606 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.22 -19.22 50.72 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.605 2.203 . . . . 0.0 112.911 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -133.86 34.78 3.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.794 0.331 . . . . 0.0 111.31 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.801 HD11 HD13 ' A' ' 68' ' ' LEU . 3.2 tp -71.86 128.7 35.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.165 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.4 m -59.92 133.35 56.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.212 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.682 HG23 ' HB2' ' A' ' 61' ' ' SER . 86.7 m -64.46 -44.03 92.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.802 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.456 ' O ' ' C ' ' A' ' 77' ' ' HIS . 34.9 m-85 -99.68 13.9 31.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.405 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.456 ' C ' ' O ' ' A' ' 76' ' ' PHE . 1.8 t-160 -19.0 -69.94 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.737 -1.12 . . . . 0.0 112.771 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -153.78 164.08 38.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.986 0.422 . . . . 0.0 111.731 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.15 138.96 50.91 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.737 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.594 ' HD2' HD11 ' A' ' 58' ' ' ILE . 38.3 m-85 -119.53 131.07 55.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.55 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.447 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 9.0 m-70 -94.77 115.84 28.0 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.139 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.476 HD13 HG12 ' A' ' 50' ' ' ILE . 0.4 OUTLIER -107.08 109.81 21.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.796 179.485 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.0 pp -120.1 140.07 51.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.048 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -117.44 128.11 54.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.878 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.3 ttm -135.65 151.4 50.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.892 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -106.52 121.01 43.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.947 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.464 ' O ' HG13 ' A' ' 87' ' ' VAL . 10.5 p -126.92 121.44 58.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.929 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.8 t0 75.18 -58.0 0.58 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.062 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -173.17 -40.61 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.842 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -89.54 132.92 34.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.773 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.01 131.0 35.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.929 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -113.49 143.49 44.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.821 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -113.99 142.79 45.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.983 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.578 ' HG ' HD11 ' A' ' 118' ' ' ILE . 1.5 tp -131.91 136.19 47.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.739 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.631 ' N ' HD12 ' A' ' 95' ' ' ILE . 3.4 mp -114.7 140.95 33.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.125 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -117.54 133.54 55.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.785 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.531 HG13 ' CE1' ' A' ' 80' ' ' PHE . 7.7 t -96.36 127.34 48.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.238 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 9.9 mt -130.09 139.14 52.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.962 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -114.19 129.92 56.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.979 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.11 31.42 0.76 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.86 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.3 m -135.11 -178.74 5.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.881 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.02 37.68 3.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.882 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -101.13 -30.11 11.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.2 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 115.27 106.26 2.58 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.441 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.521 HG23 ' CE1' ' A' ' 127' ' ' PHE . 89.4 m -122.34 123.26 40.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.843 0.354 . . . . 0.0 110.948 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -121.0 115.0 22.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.855 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.8 tp -110.56 137.29 43.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.506 0.67 . . . . 0.0 111.318 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 59.84 31.54 20.81 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.75 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.63 9.32 69.3 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.893 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -134.13 151.97 51.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.843 0.354 . . . . 0.0 110.838 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 30.4 ttp180 -74.73 140.54 44.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.908 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.64 HD22 ' O ' ' A' ' 114' ' ' LYS . 0.4 OUTLIER -75.98 133.68 40.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.915 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.47 HG23 ' HG3' ' A' ' 114' ' ' LYS . 5.8 m -112.08 -34.3 2.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.128 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.64 ' O ' HD22 ' A' ' 112' ' ' LEU . 44.1 mttp -100.34 -178.16 3.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.895 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.6 mttp -121.17 32.08 6.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.85 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -154.23 56.17 0.71 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.989 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.45 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 1.8 t80 -84.15 139.25 32.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.815 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.578 HD11 ' HG ' ' A' ' 94' ' ' LEU . 8.2 tp -98.53 118.89 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.217 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.629 HD11 HD11 ' A' ' 125' ' ' ILE . 9.2 tt -103.08 136.74 42.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.007 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 9.0 mttt -130.54 178.08 6.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.751 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.409 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 28.5 p30 -53.1 148.07 8.69 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.089 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.484 ' HA2' HD21 ' A' ' 134' ' ' LEU . . . 66.65 37.48 92.5 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.507 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.91 131.5 53.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.77 0.319 . . . . 0.0 110.87 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.654 ' NH2' HD13 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -97.99 125.54 42.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.837 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.629 HD11 HD11 ' A' ' 119' ' ' LEU . 2.9 mp -121.96 135.53 61.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.14 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.9 t -120.85 126.34 75.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.977 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.521 ' CE1' HG23 ' A' ' 105' ' ' THR . 44.8 m-85 -123.39 124.93 44.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.955 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 85.88 -6.16 81.76 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.864 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 77.74 27.8 0.58 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.93 0.395 . . . . 0.0 110.492 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 82.5 p -153.13 -46.36 0.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.797 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . 0.6 ' HB3' HD22 ' A' ' 68' ' ' LEU . 60.1 m -80.37 108.29 13.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.861 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 48.3 t -124.0 125.61 44.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.927 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -138.03 155.0 49.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.813 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.484 HD21 ' HA2' ' A' ' 122' ' ' GLY . 1.5 tt -108.29 130.02 55.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.79 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.622 ' HE2' HG21 ' A' ' 50' ' ' ILE . 30.2 t80 -99.68 141.58 32.3 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 122.025 0.917 . . . . 0.0 111.712 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 12.8 tttm -154.47 155.09 34.28 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 113.853 -1.521 . . . . 0.0 110.726 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.409 ' CE2' ' HB3' ' A' ' 121' ' ' ASN . 3.4 m-85 -81.62 139.51 34.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.958 0.409 . . . . 0.0 110.793 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.466 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.03 -179.914 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' A' ' 51' ' ' THR . 0.9 OUTLIER . . . . . 0 N--CA 1.457 -0.109 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.8 t -59.89 144.79 47.91 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.816 0.341 . . . . 0.0 111.114 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.948 HD22 HD21 ' A' ' 82' ' ' LEU . 1.1 tp -157.49 -67.35 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.968 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -118.98 165.25 13.03 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.526 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.517 ' ND1' ' HB2' ' A' ' 138' ' ' ALA . 32.0 m80 -136.83 161.12 36.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.848 0.356 . . . . 0.0 111.078 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.966 HD11 HD11 ' A' ' 50' ' ' ILE . 2.9 mt -120.58 111.08 17.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.669 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.6 t -96.02 121.76 46.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.02 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -90.17 113.91 25.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.882 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.74 106.81 14.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.814 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.525 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 22.0 mt -124.2 140.44 34.92 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.847 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.525 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 57.8 Cg_endo -74.29 86.42 1.31 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.186 1.924 . . . . 0.0 111.955 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 115.6 23.74 4.28 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.256 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 176.92 -168.36 0.06 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.738 0.304 . . . . 0.0 110.593 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -177.47 152.39 0.83 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.886 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -137.97 130.81 29.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.087 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.3 tttt -113.07 134.84 54.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.905 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.735 HG11 HG13 ' A' ' 66' ' ' VAL . 37.5 t -121.62 151.02 24.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.202 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -100.82 133.62 45.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.789 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.966 HD11 HD11 ' A' ' 37' ' ' LEU . 33.1 mm -116.07 129.51 72.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.173 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.961 ' O ' HD13 ' A' ' 82' ' ' LEU . 2.0 p -106.08 167.99 9.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.96 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.938 ' HA ' HD22 ' A' ' 82' ' ' LEU . 6.9 m-80 -85.1 63.67 8.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.168 0.508 . . . . 0.0 110.256 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.579 ' C ' ' H ' ' A' ' 55' ' ' VAL . 23.2 ttt-85 -87.3 2.76 49.25 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.914 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.411 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 0.7 OUTLIER 71.68 -34.63 0.3 Allowed 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -178.573 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.579 ' H ' ' C ' ' A' ' 53' ' ' ARG . 75.6 t -137.22 136.06 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.473 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.714 HG23 ' HB3' ' A' ' 65' ' ' ASP . 18.8 m -125.12 129.68 50.67 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.957 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.81 136.12 44.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.911 0.386 . . . . 0.0 110.846 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.415 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 36.6 mt -125.68 128.4 72.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.983 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 168.91 -143.95 8.4 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.222 -0.99 . . . . 0.0 113.353 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.493 ' HB2' ' CG2' ' A' ' 73' ' ' ILE . 5.8 ttp-105 -96.9 -40.55 8.85 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.904 0.383 . . . . 0.0 111.145 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.891 ' HB3' HG23 ' A' ' 75' ' ' THR . 4.7 p -53.91 127.27 25.54 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.309 -179.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 28.6 ptt85 -59.84 -20.12 55.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.024 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.77 -27.06 64.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.558 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 60.3 m -56.99 149.08 19.66 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.411 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.714 ' HB3' HG23 ' A' ' 56' ' ' THR . 7.9 t0 -61.36 -44.71 96.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.947 0.403 . . . . 0.0 110.794 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.735 HG13 HG11 ' A' ' 48' ' ' VAL . 56.0 t -125.21 133.17 70.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.551 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.4 pt -100.62 112.6 33.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.349 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.449 ' HA ' HD23 ' A' ' 68' ' ' LEU . 6.4 mt -78.72 -88.22 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.006 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 30.9 t -108.22 -108.65 0.32 Allowed 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.556 ' CB ' ' HD3' ' A' ' 71' ' ' PRO . 0.0 OUTLIER 169.27 -60.86 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.198 0 N-CA-C 111.574 0.212 . . . . 0.0 111.574 179.25 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.556 ' HD3' ' CB ' ' A' ' 70' ' ' GLU . 25.6 Cg_exo -62.39 -40.05 42.3 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 121.955 1.77 . . . . 0.0 113.061 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -121.74 25.26 9.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.676 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.493 ' CG2' ' HB2' ' A' ' 60' ' ' ARG . 5.0 tp -106.77 121.48 59.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.178 0.513 . . . . 0.0 111.102 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.448 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 0.7 OUTLIER -69.7 137.47 52.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.457 -179.298 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.891 HG23 ' HB3' ' A' ' 61' ' ' SER . 27.6 m -57.66 -43.99 85.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.942 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.47 ' O ' ' C ' ' A' ' 77' ' ' HIS . 2.9 m-85 -100.85 14.19 32.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.662 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.47 ' C ' ' O ' ' A' ' 76' ' ' PHE . 2.0 t-160 -18.92 -69.09 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.883 -1.053 . . . . 0.0 112.814 -179.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -155.57 164.07 39.14 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.929 0.395 . . . . 0.0 111.643 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.42 ' HA ' ' O ' ' A' ' 56' ' ' THR . 0.2 OUTLIER -125.95 138.99 53.8 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.848 179.802 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.735 ' CE1' HG13 ' A' ' 97' ' ' VAL . 2.6 m-85 -119.58 131.07 55.42 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.86 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.411 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 15.2 m-70 -97.29 116.3 29.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.81 0.338 . . . . 0.0 111.384 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.961 HD13 ' O ' ' A' ' 51' ' ' THR . 6.0 tt -106.82 109.93 21.96 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.058 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.8 mp -119.26 139.94 51.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.812 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -123.88 139.06 54.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.117 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -155.03 132.81 11.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.927 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.6 p-10 -107.04 128.73 54.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.914 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.8 m -130.8 139.12 51.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.201 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 68.43 -67.99 0.19 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.137 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -178.1 38.16 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.839 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -148.14 -177.93 6.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.669 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -121.37 127.94 51.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.94 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.13 110.88 20.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.738 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.571 ' OD1' HD21 ' A' ' 34' ' ' LEU . 17.5 m-80 -114.04 129.06 56.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.079 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.83 136.22 52.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.655 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.497 ' HB ' HD23 ' A' ' 119' ' ' LEU . 4.2 mp -113.78 141.01 31.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.11 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -119.72 143.95 47.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.793 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.735 HG13 ' CE1' ' A' ' 80' ' ' PHE . 16.8 t -109.88 129.93 63.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.208 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 24.0 mm -124.27 124.15 67.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.054 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.86 131.37 48.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.994 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -93.72 10.54 32.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.325 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.4 m 59.83 64.1 1.35 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.868 0.366 . . . . 0.0 110.88 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -161.38 132.2 5.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.941 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 70.23 5.8 5.49 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.988 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 61.76 130.87 0.01 OUTLIER Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.766 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.449 ' CG2' ' CE1' ' A' ' 127' ' ' PHE . 95.8 m -132.04 125.86 32.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.791 0.329 . . . . 0.0 110.814 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -117.62 123.92 47.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.92 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.485 HG21 ' CD1' ' A' ' 112' ' ' LEU . 2.3 tp -122.08 137.2 56.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.511 0.672 . . . . 0.0 111.152 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 62.4 29.04 17.15 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.881 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.7 9.44 69.83 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.911 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -134.0 152.03 51.69 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.748 0.308 . . . . 0.0 110.839 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 8.1 mtp-105 -68.5 142.64 55.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.852 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.485 ' CD1' HG21 ' A' ' 107' ' ' ILE . 1.3 tp -77.48 140.28 39.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.953 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.459 HG23 ' N ' ' A' ' 114' ' ' LYS . 19.3 m -126.05 -44.58 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.077 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.459 ' N ' HG23 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -67.71 -178.64 0.97 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.897 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.03 -29.04 8.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.902 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -122.66 83.86 2.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.884 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -82.3 139.18 34.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.808 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.482 ' O ' HG23 ' A' ' 118' ' ' ILE . 8.2 tp -98.51 121.61 49.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.969 0.414 . . . . 0.0 111.395 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.567 HD22 ' HE2' ' A' ' 80' ' ' PHE . 3.8 tp -103.07 134.0 47.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.894 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 2.4 mttp -129.19 178.12 6.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.858 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.436 ' HB2' ' CE2' ' A' ' 137' ' ' TYR . 3.6 t30 -54.89 144.93 21.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.223 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 64.55 44.68 94.77 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.379 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -117.04 122.36 43.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.762 0.315 . . . . 0.0 111.089 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.57 ' CG ' HD12 ' A' ' 134' ' ' LEU . 78.1 mtt180 -89.89 133.05 34.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.718 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.508 HD11 HD11 ' A' ' 119' ' ' LEU . 2.9 mp -126.67 132.35 70.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.251 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.9 t -118.33 126.15 74.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.958 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.449 ' CE1' ' CG2' ' A' ' 105' ' ' THR . 45.2 m-85 -122.74 144.23 49.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.075 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 81.56 -67.09 3.7 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.391 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 170.51 -33.91 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.773 0.321 . . . . 0.0 111.036 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 9.6 p -116.41 -37.49 3.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.413 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 48.6 m -55.15 103.95 0.11 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.977 0.418 . . . . 0.0 111.184 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 44.3 t -124.62 124.54 42.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.035 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.429 ' CE1' HD21 ' A' ' 68' ' ' LEU . 24.8 p90 -142.08 156.12 45.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.919 0.39 . . . . 0.0 110.998 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.57 HD12 ' CG ' ' A' ' 124' ' ' ARG . 1.0 OUTLIER -111.78 140.02 46.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.864 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.548 ' CG ' HD21 ' A' ' 119' ' ' LEU . 20.0 t80 -100.46 141.27 33.55 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.924 0.869 . . . . 0.0 111.695 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.403 ' HG3' HD23 ' A' ' 134' ' ' LEU . 8.6 mtmt -154.78 157.11 37.46 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 113.864 -1.516 . . . . 0.0 110.95 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.436 ' CE2' ' HB2' ' A' ' 121' ' ' ASN . 4.8 m-85 -86.02 139.61 31.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.928 0.394 . . . . 0.0 110.616 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.517 ' HB2' ' ND1' ' A' ' 36' ' ' HIS . . . . . . . . 0 C--N 1.324 -0.507 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.06 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.534 ' N ' HG22 ' A' ' 51' ' ' THR . 0.0 OUTLIER . . . . . 0 C--O 1.23 0.052 0 CA-C-O 120.796 0.331 . . . . 0.0 110.648 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.8 t -67.36 122.86 18.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.999 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.608 HD21 ' ND2' ' A' ' 93' ' ' ASN . 5.0 tp -133.29 -62.39 0.79 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.675 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.5 162.77 12.26 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.298 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.42 ' CD2' ' HG3' ' A' ' 49' ' ' GLU . 27.3 m80 -132.24 160.38 36.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.961 0.41 . . . . 0.0 111.185 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.964 HD12 HD11 ' A' ' 50' ' ' ILE . 78.9 mt -127.11 118.72 24.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.845 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.5 t -100.36 121.85 51.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.129 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -89.7 125.27 35.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.888 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.7 mp -86.74 106.97 18.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.877 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.66 HG22 ' HD2' ' A' ' 42' ' ' PRO . 1.7 mt -124.11 141.39 37.07 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.63 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.66 ' HD2' HG22 ' A' ' 41' ' ' ILE . 56.2 Cg_endo -72.14 -8.33 22.64 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.171 1.914 . . . . 0.0 112.489 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -109.29 -14.2 15.31 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.555 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 175.97 -165.84 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.705 0.288 . . . . 0.0 110.744 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -137.99 132.42 32.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.923 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -108.13 133.59 52.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.1 tttm -113.06 122.93 49.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.942 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 18.6 t -111.56 151.16 13.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.997 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.42 ' HG3' ' CD2' ' A' ' 36' ' ' HIS . 0.3 OUTLIER -104.85 119.42 38.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.063 -179.878 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.964 HD11 HD12 ' A' ' 37' ' ' LEU . 27.3 mm -98.37 132.09 44.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.829 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.534 HG22 ' N ' ' A' ' 32' ' ' THR . 0.5 OUTLIER -103.2 168.03 9.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.063 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.834 ' HA ' HD22 ' A' ' 82' ' ' LEU . 14.3 p30 -97.68 73.64 2.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.435 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.585 ' C ' ' H ' ' A' ' 55' ' ' VAL . 6.1 ptp180 -103.47 16.9 25.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.614 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.426 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 13.7 m120 68.49 -29.16 0.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.585 ' H ' ' C ' ' A' ' 53' ' ' ARG . 59.4 t -137.38 131.3 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-O 121.072 0.463 . . . . 0.0 111.623 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.677 HG23 ' HB3' ' A' ' 65' ' ' ASP . 45.7 m -125.29 125.86 44.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.688 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.4 ' HB ' ' CB ' ' A' ' 64' ' ' CYS . 0.1 OUTLIER -103.67 130.76 51.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.986 0.422 . . . . 0.0 111.183 -179.64 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.86 HG23 HD11 ' A' ' 68' ' ' LEU . 5.2 mp -112.23 117.17 54.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.789 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 172.56 -141.92 6.51 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.357 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.541 ' HB3' ' HA ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -111.47 -23.17 10.9 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.696 0.284 . . . . 0.0 111.233 179.891 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.622 ' HB2' HG23 ' A' ' 75' ' ' THR . 0.1 OUTLIER -51.88 126.06 17.03 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.8 0.334 . . . . 0.0 111.072 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.22 -28.61 59.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.049 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.27 -22.45 59.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.113 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.4 ' CB ' ' HB ' ' A' ' 57' ' ' THR . 94.2 m -55.76 168.14 0.47 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.982 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.677 ' HB3' HG23 ' A' ' 56' ' ' THR . 65.9 t0 -89.24 -51.37 5.61 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.863 0.363 . . . . 0.0 110.893 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.403 HG23 ' CG2' ' A' ' 56' ' ' THR . 21.6 t -104.22 132.02 51.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.029 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.4 pt -108.16 128.96 63.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.357 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.86 HD11 HG23 ' A' ' 58' ' ' ILE . 1.3 mp -114.3 -152.32 0.5 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.304 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.575 ' O ' ' CB ' ' A' ' 70' ' ' GLU . 0.5 OUTLIER -42.08 -58.45 2.1 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.506 0.193 . . . . 0.0 110.753 179.779 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.702 ' HB3' ' HD3' ' A' ' 71' ' ' PRO . 0.7 OUTLIER 110.42 -56.04 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.585 0 C-N-CA 123.594 0.758 . . . . 0.0 112.209 178.708 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.702 ' HD3' ' HB3' ' A' ' 70' ' ' GLU . 16.9 Cg_exo -67.22 -40.08 11.94 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.177 1.918 . . . . 0.0 112.899 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -107.06 23.92 13.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.828 0.347 . . . . 0.0 111.016 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.839 HG12 HD13 ' A' ' 68' ' ' LEU . 4.8 tp -115.94 127.9 73.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.103 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 54.7 m -67.48 131.76 46.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.902 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.622 HG23 ' HB2' ' A' ' 61' ' ' SER . 85.1 m -58.75 -33.12 69.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.574 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.442 ' O ' ' C ' ' A' ' 77' ' ' HIS . 0.1 OUTLIER -112.19 13.96 20.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.537 179.859 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.442 ' C ' ' O ' ' A' ' 76' ' ' PHE . 1.0 OUTLIER -22.03 -69.61 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.748 -1.115 . . . . 0.0 112.576 -179.339 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.737 ' HB3' ' CE2' ' A' ' 127' ' ' PHE . . . -159.33 164.06 35.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.101 0.477 . . . . 0.0 111.936 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -123.74 140.23 53.2 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.405 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.672 ' CE1' HG13 ' A' ' 97' ' ' VAL . 2.3 m-85 -119.38 131.16 55.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.866 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.426 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 4.4 m-70 -95.28 116.26 28.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.82 0.343 . . . . 0.0 111.082 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.834 HD22 ' HA ' ' A' ' 52' ' ' ASN . 0.3 OUTLIER -106.64 109.62 21.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.853 179.588 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.462 HD12 ' C ' ' A' ' 82' ' ' LEU . 7.1 mp -122.32 140.15 52.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.978 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -111.92 121.02 43.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.834 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -132.37 130.09 40.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.929 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -107.06 128.56 54.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.936 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.6 t -129.83 136.08 59.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.953 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.0 t0 71.98 -60.67 0.52 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.982 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -176.09 -39.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.767 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -81.03 131.85 35.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.731 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -82.96 128.14 34.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.032 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -112.98 143.1 44.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.783 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.608 ' ND2' HD21 ' A' ' 34' ' ' LEU . 27.0 m120 -114.01 129.56 56.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.051 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.753 HD22 HD11 ' A' ' 118' ' ' ILE . 7.9 mt -120.62 142.36 49.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.703 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.467 HG13 ' CE1' ' A' ' 135' ' ' PHE . 10.7 mm -124.26 141.17 45.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.245 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -113.8 138.54 50.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.743 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.672 HG13 ' CE1' ' A' ' 80' ' ' PHE . 21.4 t -109.63 120.85 61.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.311 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 13.9 mt -130.15 120.94 50.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.88 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.416 ' OD1' HD13 ' A' ' 112' ' ' LEU . 2.1 m-20 -115.32 126.12 54.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.957 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.05 28.38 5.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.056 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 58.11 106.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.05 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.21 -76.08 0.28 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.893 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -125.02 27.87 6.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.254 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 66.79 128.14 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.597 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 63.1 m -131.29 123.02 27.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.821 0.343 . . . . 0.0 110.751 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.414 ' CE2' ' HG3' ' A' ' 111' ' ' ARG . 62.2 m-85 -120.02 114.97 22.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.93 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.714 ' CG2' HG22 ' A' ' 125' ' ' ILE . 2.1 pp -109.48 131.19 61.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.118 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 59.59 31.75 21.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.968 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.63 13.05 74.5 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.96 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -129.12 132.36 47.36 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.845 0.355 . . . . 0.0 110.895 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.414 ' HG3' ' CE2' ' A' ' 106' ' ' PHE . 5.4 ttt180 -68.41 142.99 55.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.92 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.416 HD13 ' OD1' ' A' ' 99' ' ' ASP . 0.4 OUTLIER -81.47 132.74 35.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.851 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.633 HG22 ' O ' ' A' ' 113' ' ' VAL . 14.7 p -144.06 32.62 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.081 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 4.1 mptt -131.12 138.18 49.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.843 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.08 -40.05 86.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.896 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -126.31 78.43 1.77 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.939 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -84.05 139.07 32.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.819 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.753 HD11 HD22 ' A' ' 94' ' ' LEU . 8.5 tp -98.52 119.94 47.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.011 0.434 . . . . 0.0 111.289 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.788 HD23 ' N ' ' A' ' 120' ' ' LYS . 3.1 tt -103.18 142.37 34.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.014 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.788 ' N ' HD23 ' A' ' 119' ' ' LEU . 6.3 mttt -125.42 178.03 5.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.072 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.453 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 7.9 p30 -62.73 146.86 51.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.173 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 68.92 51.86 27.0 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.342 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.736 ' HB2' HD21 ' A' ' 119' ' ' LEU . 0.7 OUTLIER -127.61 124.31 37.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.843 0.354 . . . . 0.0 111.191 -179.752 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.721 ' CA ' HD12 ' A' ' 134' ' ' LEU . 24.8 ttm180 -84.7 132.3 34.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.707 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.714 HG22 ' CG2' ' A' ' 107' ' ' ILE . 22.5 pt -129.56 128.4 65.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.212 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.534 HG13 ' O ' ' A' ' 131' ' ' CYS . 21.6 t -113.56 129.63 69.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.0 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.737 ' CE2' ' HB3' ' A' ' 78' ' ' ALA . 5.5 m-85 -116.77 111.96 20.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.004 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 104.76 -75.55 0.25 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.479 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 5.6 tttt 179.42 -38.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.769 0.319 . . . . 0.0 110.989 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 12.0 p -104.51 -40.59 5.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.287 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . 0.534 ' O ' HG13 ' A' ' 126' ' ' VAL . 22.0 m -57.93 107.04 0.42 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.842 0.353 . . . . 0.0 111.079 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 29.7 t -124.21 119.92 30.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.788 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.446 ' CD1' ' N ' ' A' ' 133' ' ' PHE . 1.1 p90 -141.9 150.32 41.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.091 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.721 HD12 ' CA ' ' A' ' 124' ' ' ARG . 0.5 OUTLIER -109.22 140.13 43.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.777 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.618 ' HD2' HD21 ' A' ' 37' ' ' LEU . 12.3 t80 -102.25 141.26 35.38 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 121.893 0.854 . . . . 0.0 111.664 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.449 ' N ' ' CD1' ' A' ' 135' ' ' PHE . 7.2 mttp -154.68 155.4 34.55 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 113.829 -1.532 . . . . 0.0 111.128 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.453 ' CE2' ' HB3' ' A' ' 121' ' ' ASN . 8.7 m-85 -86.16 140.0 30.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.003 0.43 . . . . 0.0 110.638 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.407 ' HB3' ' CE1' ' A' ' 36' ' ' HIS . . . . . . . . 0 C--N 1.324 -0.509 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.123 179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.655 ' N ' HG22 ' A' ' 51' ' ' THR . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.842 0.353 . . . . 0.0 110.675 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.8 t -72.27 120.57 18.07 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.977 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.585 ' O ' HD23 ' A' ' 34' ' ' LEU . 7.7 tt -119.81 -40.5 2.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.893 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.677 ' C ' HG22 ' A' ' 50' ' ' ILE . . . -149.25 -169.6 15.95 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.49 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 51.1 m80 -146.96 160.65 42.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.774 0.321 . . . . 0.0 110.919 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.574 HD11 ' HB ' ' A' ' 50' ' ' ILE . 2.4 mp -127.1 119.33 26.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.799 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.4 t -98.28 121.76 49.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.179 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -89.93 119.16 30.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.844 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.421 HD22 ' N ' ' A' ' 40' ' ' LEU . 3.8 mm? -75.37 106.88 7.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.915 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.43 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 18.9 mt -124.11 138.75 31.27 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.847 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.43 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 86.6 Cg_exo -44.46 -28.76 2.78 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.48 2.12 . . . . 0.0 112.441 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -111.18 -143.4 9.37 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.268 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.0 mtpt -53.89 113.77 1.33 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.83 0.347 . . . . 0.0 111.134 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -59.93 168.02 1.99 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.955 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -135.66 125.01 24.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.015 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.01 134.28 54.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.92 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.8 t -125.42 139.42 51.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.122 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -80.31 139.67 36.5 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.748 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.696 HG21 ' HE2' ' A' ' 135' ' ' PHE . 2.2 tt -116.01 130.86 70.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.895 0.378 . . . . 0.0 111.398 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.655 HG22 ' N ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -96.77 168.11 10.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.6 179.733 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.579 ' ND2' HG23 ' A' ' 32' ' ' THR . 0.4 OUTLIER -110.76 73.16 0.81 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.677 179.751 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.595 ' C ' ' H ' ' A' ' 55' ' ' VAL . 0.1 OUTLIER -98.65 23.36 8.76 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.115 -179.788 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 69.83 -28.3 0.17 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.595 ' H ' ' C ' ' A' ' 53' ' ' ARG . 58.6 t -137.29 134.18 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-O 121.111 0.481 . . . . 0.0 111.506 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.697 HG23 ' HB3' ' A' ' 65' ' ' ASP . 18.0 m -125.45 125.9 44.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.372 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.78 133.24 49.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.956 0.408 . . . . 0.0 111.213 -179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.576 ' N ' HD12 ' A' ' 58' ' ' ILE . 3.9 mp -118.35 116.73 52.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.896 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . 0.402 ' HA2' HG13 ' A' ' 73' ' ' ILE . . . 173.42 -142.37 6.58 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.657 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.423 ' HB2' ' CG2' ' A' ' 73' ' ' ILE . 11.7 ttp180 -103.76 -30.94 10.08 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.777 0.322 . . . . 0.0 110.947 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.719 ' HB2' HG23 ' A' ' 75' ' ' THR . 0.2 OUTLIER -49.17 124.46 9.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.241 -179.696 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 47.6 mtm180 -57.04 -30.32 64.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.904 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.4 m -69.99 -21.96 63.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.081 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 86.5 m -55.8 166.17 0.77 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.995 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.697 ' HB3' HG23 ' A' ' 56' ' ' THR . 11.7 t70 -83.58 -48.13 10.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.816 0.341 . . . . 0.0 111.033 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 58' ' ' ILE . 21.3 t -124.93 125.43 69.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.515 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.6 pt -98.28 131.04 46.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.786 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.661 HD22 ' HB3' ' A' ' 131' ' ' CYS . 19.9 mt -118.25 105.17 11.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.263 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.59 ' C ' ' HD2' ' A' ' 71' ' ' PRO . 0.6 OUTLIER 68.75 -70.27 0.14 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.571 179.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.57 ' CB ' ' O ' ' A' ' 69' ' ' SER . 31.1 mt-10 112.18 -60.71 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.84 0 C-N-CA 123.992 0.917 . . . . 0.0 112.336 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.59 ' HD2' ' C ' ' A' ' 69' ' ' SER . 38.1 Cg_endo -66.74 -14.15 42.73 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.123 1.882 . . . . 0.0 113.367 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -129.18 25.72 5.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.66 0.267 . . . . 0.0 111.269 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.45 ' HB ' ' O ' ' A' ' 68' ' ' LEU . 4.9 tp -119.89 150.61 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-O 120.943 0.402 . . . . 0.0 111.566 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 45.0 t -94.88 129.38 41.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.063 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.719 HG23 ' HB2' ' A' ' 61' ' ' SER . 58.0 m -53.7 -33.39 55.33 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.157 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -112.3 14.0 20.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.167 0.508 . . . . 0.0 111.838 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.47 ' HB2' ' O ' ' A' ' 74' ' ' SER . 2.0 t-160 -29.17 -70.38 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.901 -1.045 . . . . 0.0 112.617 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.652 ' HB3' ' CE2' ' A' ' 127' ' ' PHE . . . -154.96 164.15 39.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.08 0.467 . . . . 0.0 112.126 -179.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -127.79 139.23 52.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.206 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.812 ' CZ ' HG13 ' A' ' 97' ' ' VAL . 5.5 m-85 -119.42 131.33 55.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.984 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -94.59 116.39 28.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.972 0.415 . . . . 0.0 110.964 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.661 HD13 HG13 ' A' ' 95' ' ' ILE . 4.2 mm? -106.47 109.72 21.72 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.775 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.9 tp -120.79 140.0 52.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.065 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -107.63 126.36 52.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.745 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -126.09 143.09 51.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.984 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -95.84 116.91 29.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.895 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.6 t -138.71 121.05 17.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.073 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 62.11 -176.59 0.13 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.825 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 22.7 t30 -50.7 -31.13 15.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.257 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -94.46 -177.53 4.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.922 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -115.67 128.66 56.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.849 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.19 123.2 43.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.923 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.405 ' ND2' HD11 ' A' ' 34' ' ' LEU . 24.2 m120 -113.51 138.26 50.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.745 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.494 HD12 ' N ' ' A' ' 94' ' ' LEU . 0.5 OUTLIER -132.07 134.22 45.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.95 -179.957 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.661 HG13 HD13 ' A' ' 82' ' ' LEU . 3.6 mp -115.45 141.11 33.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.976 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -113.91 137.66 51.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.844 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.812 HG13 ' CZ ' ' A' ' 80' ' ' PHE . 12.1 t -105.78 126.36 61.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.222 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 33.9 mt -129.95 120.99 51.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.984 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.76 139.01 54.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.951 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.3 mmtm -99.92 6.27 45.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.332 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.6 m 58.08 101.83 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.75 0.31 . . . . 0.0 111.014 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 14.3 ttt180 -149.23 -63.72 0.23 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.889 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -96.2 -45.61 6.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.235 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 132.96 106.08 0.97 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.554 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.9 m -118.52 126.36 51.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.835 0.35 . . . . 0.0 110.949 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.408 ' CE2' ' HB2' ' A' ' 111' ' ' ARG . 19.3 m-85 -120.83 121.26 37.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.882 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.6 HD12 ' O ' ' A' ' 124' ' ' ARG . 2.3 tp -108.51 137.29 40.97 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 CA-C-O 121.522 0.677 . . . . 0.0 111.193 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 61.71 28.05 17.26 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.825 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.69 9.55 69.99 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.947 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -134.1 152.0 51.64 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.804 0.335 . . . . 0.0 110.862 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.408 ' HB2' ' CE2' ' A' ' 106' ' ' PHE . 0.6 OUTLIER -71.77 133.02 45.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.954 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.9 pp -88.57 134.62 33.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.924 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 13.0 m -110.52 -30.22 2.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.224 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.2 153.97 31.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.983 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.62 -36.3 16.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.895 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -102.93 74.62 1.33 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.917 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -83.72 139.04 32.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.815 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.505 ' O ' HG23 ' A' ' 118' ' ' ILE . 8.6 tp -98.63 118.99 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.148 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.914 HD11 HD11 ' A' ' 125' ' ' ILE . 6.1 tt -103.04 135.88 43.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.056 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -131.07 178.12 6.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.743 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.429 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 4.5 p-10 -52.95 143.77 16.34 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.091 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 68.51 44.04 74.48 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.475 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -112.85 121.19 43.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.806 0.336 . . . . 0.0 110.916 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.608 ' HG3' HD12 ' A' ' 134' ' ' LEU . 1.5 mpt_? -90.51 119.03 30.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.871 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.914 HD11 HD11 ' A' ' 119' ' ' LEU . 3.6 mt -114.94 132.07 65.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.061 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.625 HG22 ' OG ' ' A' ' 132' ' ' SER . 29.6 t -116.57 131.84 67.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.174 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.652 ' CE2' ' HB3' ' A' ' 78' ' ' ALA . 8.3 m-85 -118.57 133.63 55.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.975 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 80.19 -66.19 3.67 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.446 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 170.38 -33.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.814 0.34 . . . . 0.0 110.998 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.3 p -107.19 -42.76 4.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.287 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . 0.661 ' HB3' HD22 ' A' ' 68' ' ' LEU . 59.5 m -56.4 104.78 0.16 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.874 0.369 . . . . 0.0 111.194 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.625 ' OG ' HG22 ' A' ' 126' ' ' VAL . 0.3 OUTLIER -124.42 125.01 43.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.922 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.445 ' CE1' HD11 ' A' ' 68' ' ' LEU . 2.1 p90 -142.15 156.12 45.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.93 0.395 . . . . 0.0 111.091 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.608 HD12 ' HG3' ' A' ' 124' ' ' ARG . 9.6 tt -116.25 138.97 50.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.645 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.696 ' HE2' HG21 ' A' ' 50' ' ' ILE . 25.4 t80 -103.38 141.4 36.01 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 122.029 0.919 . . . . 0.0 111.875 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 11.4 mtmt -154.67 143.8 21.09 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 113.787 -1.552 . . . . 0.0 110.74 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.429 ' CE2' ' HB3' ' A' ' 121' ' ' ASN . 4.0 m-85 -72.86 139.72 47.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.002 0.43 . . . . 0.0 110.72 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.462 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.092 -179.97 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.582 ' N ' HG22 ' A' ' 51' ' ' THR . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.68 0.276 . . . . 0.0 110.743 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 10.6 t -69.7 114.9 8.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.58 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.761 HD22 HD23 ' A' ' 82' ' ' LEU . 3.1 tp -118.16 -41.95 2.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.28 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.465 ' C ' HG22 ' A' ' 50' ' ' ILE . . . -148.53 -167.92 14.07 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.233 -0.984 . . . . 0.0 113.056 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.43 ' CD2' ' HG3' ' A' ' 49' ' ' GLU . 46.1 m80 -144.58 161.04 40.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.862 0.363 . . . . 0.0 110.683 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.477 ' CD1' HG21 ' A' ' 66' ' ' VAL . 23.5 mt -127.11 112.85 15.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.666 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.5 t -95.92 121.77 46.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.135 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -90.23 125.96 35.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.933 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.458 HD12 ' HA ' ' A' ' 133' ' ' PHE . 4.8 mp -106.1 106.81 17.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.802 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.8 mm -124.03 138.17 30.2 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.086 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -55.78 87.11 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.4 2.067 . . . . 0.0 112.205 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 139.51 -22.55 2.86 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.662 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.9 mtpt 177.01 164.03 0.49 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.861 0.363 . . . . 0.0 110.814 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -122.61 -178.19 3.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.906 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.53 134.93 16.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.882 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -109.03 122.7 47.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.854 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.3 t -122.47 151.12 26.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.211 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.43 ' HG3' ' CD2' ' A' ' 36' ' ' HIS . 0.4 OUTLIER -94.69 130.65 41.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.602 179.852 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.721 HG21 ' HE2' ' A' ' 135' ' ' PHE . 3.1 tt -116.1 128.88 73.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.084 0.469 . . . . 0.0 111.578 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.582 HG22 ' N ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -96.79 168.12 10.69 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.196 179.539 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.684 ' HA ' HD22 ' A' ' 82' ' ' LEU . 56.5 m-80 -68.51 -89.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.333 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.571 ' C ' ' H ' ' A' ' 55' ' ' VAL . 12.9 ttt-85 72.79 -1.09 3.12 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 179.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 1.3 m-20 70.33 -34.06 0.28 Allowed 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.096 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.571 ' H ' ' C ' ' A' ' 53' ' ' ARG . 64.1 t -137.04 134.84 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 CA-C-O 121.012 0.434 . . . . 0.0 110.949 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.807 HG23 ' CB ' ' A' ' 65' ' ' ASP . 50.6 m -125.28 132.17 52.96 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.061 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.401 ' HB ' ' CB ' ' A' ' 64' ' ' CYS . 0.0 OUTLIER -104.33 143.84 32.44 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.843 0.354 . . . . 0.0 111.231 -179.786 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.445 ' N ' HD12 ' A' ' 58' ' ' ILE . 4.8 mp -130.76 126.72 60.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.083 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 164.98 -139.28 5.73 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.667 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.42 ' HB2' HG23 ' A' ' 73' ' ' ILE . 10.6 ttp180 -106.85 -26.59 11.18 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.749 0.309 . . . . 0.0 110.969 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.733 ' HB2' HG23 ' A' ' 75' ' ' THR . 0.1 OUTLIER -52.12 136.5 29.68 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.24 -179.741 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.74 -31.89 72.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.915 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 46.2 p -69.95 -23.91 63.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.942 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.401 ' CB ' ' HB ' ' A' ' 57' ' ' THR . 96.4 m -56.64 171.87 0.29 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.944 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.807 ' CB ' HG23 ' A' ' 56' ' ' THR . 0.7 OUTLIER -85.07 -68.16 0.75 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.002 0.429 . . . . 0.0 110.885 179.813 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.477 HG21 ' CD1' ' A' ' 37' ' ' LEU . 21.2 t -105.95 115.31 47.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.899 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.4 pt -91.94 104.97 16.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.553 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.498 HD11 ' CE2' ' A' ' 133' ' ' PHE . 1.8 mp -66.85 -155.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.837 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.482 ' O ' ' CB ' ' A' ' 70' ' ' GLU . 19.1 p -41.81 -96.43 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 117.592 0.178 . . . . 0.0 111.193 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.535 ' CB ' ' HD3' ' A' ' 71' ' ' PRO . 1.5 mt-10 159.19 -60.93 0.0 OUTLIER Pre-proline 0 N--CA 1.466 0.366 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.535 ' HD3' ' CB ' ' A' ' 70' ' ' GLU . 36.4 Cg_exo -57.4 -40.31 82.47 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.206 1.937 . . . . 0.0 113.241 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -116.53 28.86 8.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.698 0.285 . . . . 0.0 111.313 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.469 HD11 HD22 ' A' ' 68' ' ' LEU . 4.9 tp -110.6 126.74 67.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.99 0.424 . . . . 0.0 111.293 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.417 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 1.5 m -79.03 134.66 36.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.194 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.733 HG23 ' HB2' ' A' ' 61' ' ' SER . 72.0 m -61.03 -29.16 69.56 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.02 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.431 ' O ' ' C ' ' A' ' 77' ' ' HIS . 0.3 OUTLIER -106.91 14.02 27.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.237 0.541 . . . . 0.0 111.598 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.462 ' CE1' ' HB3' ' A' ' 127' ' ' PHE . 1.4 t-160 -24.41 -71.11 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.759 -1.109 . . . . 0.0 112.747 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.541 ' HB3' ' HE2' ' A' ' 127' ' ' PHE . . . -163.43 164.12 24.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.062 0.458 . . . . 0.0 112.019 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -124.35 140.88 52.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.342 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.656 ' CE1' HG13 ' A' ' 97' ' ' VAL . 3.2 m-85 -119.22 131.15 55.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.751 0.31 . . . . 0.0 110.863 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -94.82 116.47 28.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.909 0.385 . . . . 0.0 111.038 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.761 HD23 HD22 ' A' ' 34' ' ' LEU . 0.1 OUTLIER -106.41 109.55 21.51 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.107 179.866 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.23 130.62 53.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.814 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 5.7 tm0? -107.0 128.12 54.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.925 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 9.4 ttt -152.03 143.15 23.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.928 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -99.89 131.13 46.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.852 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 19.8 t -137.01 134.46 47.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.112 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 61.11 39.83 15.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.833 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 62.26 32.67 17.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.856 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -145.68 157.09 43.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.882 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -82.98 127.92 33.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.905 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -117.01 117.44 29.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.008 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.452 ' ND2' HD11 ' A' ' 34' ' ' LEU . 12.4 m120 -105.42 119.96 40.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.766 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.4 mt -118.2 125.65 50.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.077 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.407 HG13 ' CE1' ' A' ' 135' ' ' PHE . 11.7 mm -115.0 133.3 61.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.013 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -113.94 143.49 44.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.635 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.656 HG13 ' CE1' ' A' ' 80' ' ' PHE . 18.0 t -109.12 132.63 56.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.381 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.472 HD13 ' O ' ' A' ' 97' ' ' VAL . 25.3 mm -130.05 120.93 50.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.029 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -102.23 127.05 49.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.964 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.4 mmtp -140.69 31.54 1.85 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.886 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.6 m -123.92 178.35 5.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.953 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -121.95 31.25 6.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.951 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -103.58 -56.29 2.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.186 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 138.05 120.78 1.9 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.514 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.8 m -125.59 122.95 37.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.813 0.34 . . . . 0.0 110.911 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.401 ' CE2' ' HB3' ' A' ' 111' ' ' ARG . 46.1 m-85 -116.31 129.15 56.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.848 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.1 tp -123.08 137.24 57.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.445 0.641 . . . . 0.0 111.378 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 61.86 29.71 17.98 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.838 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.64 12.98 74.49 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.87 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 73.3 m-80 -133.47 152.01 51.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.798 0.332 . . . . 0.0 110.849 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.401 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -68.0 143.05 55.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.932 -179.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.457 HD21 ' HB2' ' A' ' 117' ' ' TYR . 0.3 OUTLIER -85.46 126.31 33.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.865 179.991 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.406 HG13 ' N ' ' A' ' 114' ' ' LYS . 11.2 p -112.16 -40.81 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.113 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.406 ' N ' HG13 ' A' ' 113' ' ' VAL . 7.6 tptp -76.56 163.71 26.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.968 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.68 -29.25 18.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.902 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -121.13 82.06 1.87 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.018 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.457 ' HB2' HD21 ' A' ' 112' ' ' LEU . 57.6 t80 -84.09 139.21 32.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.673 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.542 ' O ' HG23 ' A' ' 118' ' ' ILE . 8.7 tp -98.52 118.52 45.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.435 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.714 HD11 HD11 ' A' ' 125' ' ' ILE . 7.0 tt -103.2 143.93 31.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.841 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.3 mmtt -127.51 178.01 6.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.851 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.434 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 11.7 p-10 -59.94 148.07 36.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.973 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.529 ' HA2' HD21 ' A' ' 134' ' ' LEU . . . 64.05 43.71 96.92 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.413 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -114.69 130.74 56.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.774 0.321 . . . . 0.0 111.069 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.54 ' HD3' HD12 ' A' ' 134' ' ' LEU . 1.2 mmm-85 -83.87 130.77 34.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.712 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.714 HD11 HD11 ' A' ' 119' ' ' LEU . 2.7 mt -126.8 128.14 70.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.356 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 40.6 t -122.76 124.01 69.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.734 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.541 ' HE2' ' HB3' ' A' ' 78' ' ' ALA . 3.3 m-85 -113.47 145.98 40.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.969 0.414 . . . . 0.0 111.306 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 70.6 -65.17 0.82 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.435 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 173.83 -50.18 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.853 0.358 . . . . 0.0 110.859 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 89.1 p -96.15 -36.15 11.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.203 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . 0.488 ' SG ' HD23 ' A' ' 68' ' ' LEU . 24.7 m -57.66 104.49 0.19 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.003 0.43 . . . . 0.0 111.124 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.41 124.14 41.69 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.951 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.498 ' CE2' HD11 ' A' ' 68' ' ' LEU . 8.4 p90 -142.13 153.64 44.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.966 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.54 HD12 ' HD3' ' A' ' 124' ' ' ARG . 2.0 tt -112.22 133.93 54.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.766 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.721 ' HE2' HG21 ' A' ' 50' ' ' ILE . 48.0 t80 -106.42 141.4 37.79 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 121.958 0.885 . . . . 0.0 111.802 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.55 157.44 38.29 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 113.928 -1.487 . . . . 0.0 111.119 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.434 ' CE2' ' HB3' ' A' ' 121' ' ' ASN . 6.7 m-85 -86.0 139.87 30.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.761 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.564 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.125 179.972 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.55 ' C ' HG22 ' A' ' 51' ' ' THR . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.776 0.322 . . . . 0.0 110.692 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 4.4 t -62.05 138.43 58.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.07 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.1 tp -142.54 -47.83 0.34 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.708 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.721 ' C ' HG22 ' A' ' 50' ' ' ILE . . . -137.63 -174.68 13.47 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.287 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.413 ' ND1' ' HB2' ' A' ' 138' ' ' ALA . 50.5 m80 -144.83 163.76 33.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.893 0.378 . . . . 0.0 111.031 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.0 mt -126.59 131.05 51.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.683 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.1 t -105.33 121.92 58.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.094 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.412 ' CB ' HD11 ' A' ' 41' ' ' ILE . 1.1 m-20 -89.99 126.01 35.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.794 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.94 106.54 18.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.88 0.371 . . . . 0.0 110.782 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.543 HG23 ' HD2' ' A' ' 42' ' ' PRO . 4.3 mp -124.49 141.06 36.68 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.906 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.543 ' HD2' HG23 ' A' ' 41' ' ' ILE . 58.9 Cg_endo -74.44 83.31 1.72 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.102 1.868 . . . . 0.0 111.978 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 143.33 -14.3 2.29 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.531 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.02 176.18 0.92 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 120.716 0.293 . . . . 0.0 110.672 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -132.73 160.62 36.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.141 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -137.78 130.27 29.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.814 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 33.6 tttt -106.21 127.28 53.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.007 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 23.5 t -117.47 147.73 20.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.083 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.402 ' CG ' ' NE2' ' A' ' 36' ' ' HIS . 3.4 mt-10 -97.26 135.72 38.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.844 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.721 HG22 ' C ' ' A' ' 35' ' ' GLY . 1.1 tt -115.25 132.15 65.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.093 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.567 ' O ' HD22 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -106.46 168.46 9.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.253 -179.653 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -85.07 68.93 10.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.153 0.502 . . . . 0.0 110.511 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.576 ' C ' ' H ' ' A' ' 55' ' ' VAL . 19.3 ttt-85 -87.77 4.45 44.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.814 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.506 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 10.3 m120 69.0 -35.08 0.29 Allowed 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -178.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.576 ' H ' ' C ' ' A' ' 53' ' ' ARG . 70.5 t -137.27 135.23 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.599 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.669 HG23 ' HB3' ' A' ' 65' ' ' ASP . 53.4 m -125.15 126.52 45.4 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.023 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.73 131.05 51.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.964 0.411 . . . . 0.0 110.732 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.856 HG23 HD13 ' A' ' 68' ' ' LEU . 5.0 mp -119.77 118.91 58.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.929 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 172.46 -137.18 4.1 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.449 -0.881 . . . . 0.0 113.201 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.493 ' HD2' ' O ' ' A' ' 70' ' ' GLU . 11.2 ttt-85 -103.29 -38.13 7.36 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.815 0.34 . . . . 0.0 111.103 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.682 ' HB2' HG23 ' A' ' 75' ' ' THR . 0.3 OUTLIER -45.8 127.52 8.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.583 -179.389 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.8 -29.1 69.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.737 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 94.2 p -69.93 -23.67 63.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.826 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 87.9 m -53.3 158.15 1.73 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.87 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.669 ' HB3' HG23 ' A' ' 56' ' ' THR . 8.8 t0 -74.09 -47.62 35.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.847 0.356 . . . . 0.0 111.008 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 58' ' ' ILE . 20.8 t -125.08 133.27 69.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.559 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 4.7 pt -100.24 118.93 47.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.603 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.856 HD13 HG23 ' A' ' 58' ' ' ILE . 2.3 mp -84.83 -86.67 0.13 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.784 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 38.9 m -107.7 -109.77 0.31 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.611 ' CB ' ' HD3' ' A' ' 71' ' ' PRO . 0.1 OUTLIER 168.34 -63.49 0.0 OUTLIER Pre-proline 0 CA--C 1.529 0.157 0 O-C-N 122.375 -0.203 . . . . 0.0 111.541 178.862 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.611 ' HD3' ' CB ' ' A' ' 70' ' ' GLU . 21.5 Cg_exo -64.74 -22.14 64.28 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 121.977 1.785 . . . . 0.0 112.867 -179.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -136.32 22.07 3.2 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.684 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.468 ' CG2' ' HB2' ' A' ' 60' ' ' ARG . 4.7 tp -105.68 121.25 57.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.06 0.457 . . . . 0.0 110.957 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.415 ' HB2' ' CA ' ' A' ' 77' ' ' HIS . 13.8 m -65.24 133.08 50.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.484 -179.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.682 HG23 ' HB2' ' A' ' 61' ' ' SER . 77.8 m -58.73 -35.34 72.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.974 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.43 ' O ' ' C ' ' A' ' 77' ' ' HIS . 0.2 OUTLIER -112.01 14.14 20.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.225 0.536 . . . . 0.0 111.361 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.43 ' C ' ' O ' ' A' ' 76' ' ' PHE . 14.8 t60 -24.88 -69.14 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.648 -179.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -149.77 163.96 36.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.07 0.462 . . . . 0.0 112.056 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -129.01 137.98 51.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.462 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.813 ' CE1' HG13 ' A' ' 97' ' ' VAL . 2.0 m-85 -119.57 125.98 50.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.848 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -94.84 116.19 28.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.913 0.387 . . . . 0.0 111.294 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.567 HD22 ' O ' ' A' ' 51' ' ' THR . 0.1 OUTLIER -106.64 109.5 21.44 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.714 179.399 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.9 tp -122.49 140.2 53.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.2 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -122.82 120.95 35.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.807 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -115.47 126.58 54.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.985 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -107.07 117.56 34.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.904 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 25.3 t -133.54 125.08 49.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.015 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.5 t70 70.61 -61.55 0.47 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.048 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -176.54 -39.64 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.845 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -89.48 101.28 13.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.68 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -82.93 145.44 29.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.051 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 2.8 ttp-105 -113.1 141.13 47.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.808 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -107.35 129.92 54.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.029 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.705 HD23 HD11 ' A' ' 118' ' ' ILE . 0.3 OUTLIER -126.7 133.9 50.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.718 179.883 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.623 HD13 HD23 ' A' ' 119' ' ' LEU . 3.8 mp -117.48 140.77 39.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.22 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -117.82 125.82 51.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.825 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.813 HG13 ' CE1' ' A' ' 80' ' ' PHE . 18.0 t -96.34 131.48 43.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.131 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 32.4 mt -123.0 120.95 61.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.03 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.48 117.88 26.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.93 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.04 30.06 1.82 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.885 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 18.5 m -96.04 177.71 5.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.825 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.9 29.58 1.87 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.093 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 34.7 p-10 -135.18 -44.85 0.71 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.964 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 157.33 117.01 0.52 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.739 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.689 HG23 ' CD1' ' A' ' 127' ' ' PHE . 62.5 m -132.04 122.75 25.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.734 0.302 . . . . 0.0 110.79 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -121.21 139.07 53.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.188 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.825 HD13 HG22 ' A' ' 125' ' ' ILE . 3.3 tp -122.79 137.34 56.62 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 CA-C-O 121.443 0.639 . . . . 0.0 111.196 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 60.52 30.0 19.43 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.65 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.69 12.67 74.36 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.843 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -134.14 152.03 51.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.819 0.342 . . . . 0.0 110.769 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.83 143.09 44.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.872 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.518 ' CD1' HG22 ' A' ' 107' ' ' ILE . 3.2 mp -74.74 131.33 40.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.942 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.3 p -114.73 -37.09 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.07 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 9.9 tttt -115.38 149.77 37.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.871 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.3 165.94 21.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.027 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 27.5 t70 62.48 64.73 0.91 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.988 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -84.04 138.47 33.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.846 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.705 HD11 HD23 ' A' ' 94' ' ' LEU . 8.4 tp -98.7 120.28 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.226 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.646 HD13 ' HE2' ' A' ' 80' ' ' PHE . 4.7 tt -103.07 139.06 39.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.992 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 13.0 mmtp -129.84 178.17 6.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.74 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.442 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 4.8 p-10 -53.41 148.0 9.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.153 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 64.08 37.5 94.68 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.565 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -109.81 127.85 54.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.821 0.343 . . . . 0.0 110.96 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.413 ' O ' HD12 ' A' ' 107' ' ' ILE . 54.2 mtt180 -93.6 132.69 37.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.858 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.825 HG22 HD13 ' A' ' 107' ' ' ILE . 0.1 OUTLIER -118.42 122.0 68.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.087 179.877 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 46.7 t -112.71 123.9 68.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.771 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.689 ' CD1' HG23 ' A' ' 105' ' ' THR . 68.5 m-85 -120.38 148.03 44.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.951 0.405 . . . . 0.0 111.211 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 73.79 -65.84 1.78 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.348 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 175.35 -50.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.807 0.337 . . . . 0.0 111.022 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.06 -33.13 9.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.681 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 21.6 m -55.74 105.46 0.18 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.884 0.373 . . . . 0.0 110.98 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 13.7 p -124.22 136.76 54.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.918 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.439 ' CZ ' ' HG ' ' A' ' 68' ' ' LEU . 15.5 m-85 -142.25 156.21 45.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.151 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.8 tt -121.66 116.1 23.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.711 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.569 ' HE2' HG21 ' A' ' 50' ' ' ILE . 21.4 t80 -94.7 141.56 28.47 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 122.054 0.931 . . . . 0.0 111.895 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 6.8 tttt -154.62 160.4 41.43 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 113.781 -1.554 . . . . 0.0 110.85 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.461 ' HE1' HD11 ' A' ' 95' ' ' ILE . 3.7 m-85 -86.07 139.98 30.66 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.051 0.453 . . . . 0.0 110.681 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.413 ' HB2' ' ND1' ' A' ' 36' ' ' HIS . . . . . . . . 0 C--N 1.324 -0.535 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.058 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.474 ' N ' HG22 ' A' ' 51' ' ' THR . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.868 0.366 . . . . 0.0 110.517 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 40.6 t -59.84 120.17 9.08 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.158 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.567 HD23 HD22 ' A' ' 52' ' ' ASN . 1.3 mm? -117.04 -34.97 4.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.705 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.6 ' O ' HG22 ' A' ' 50' ' ' ILE . . . -168.54 -177.9 39.84 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.274 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 23.2 m80 -138.08 166.05 25.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.084 0.468 . . . . 0.0 111.138 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.493 HD22 ' CE2' ' A' ' 133' ' ' PHE . 1.1 mt -127.28 114.73 18.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.614 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.426 HG22 ' HG2' ' A' ' 47' ' ' LYS . 20.0 t -95.92 121.59 46.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.129 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -90.37 142.04 28.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.939 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.6 mt -107.43 106.49 16.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.681 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.9 mt -124.39 138.67 31.41 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.983 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_exo -52.12 -25.39 22.82 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.475 2.117 . . . . 0.0 112.516 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -85.52 -34.01 15.04 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.736 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 177.15 -174.28 0.12 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.835 0.35 . . . . 0.0 110.948 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -107.92 157.53 18.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.918 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -135.41 120.26 18.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.954 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.426 ' HG2' HG22 ' A' ' 38' ' ' VAL . 1.7 mmtp -100.72 128.2 46.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.882 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.1 t -122.4 139.71 48.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.156 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -92.43 127.42 37.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.724 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.6 HG22 ' O ' ' A' ' 35' ' ' GLY . 15.9 tt -116.05 132.08 66.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.04 0.448 . . . . 0.0 111.468 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.474 HG22 ' N ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -98.81 167.87 10.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.454 179.74 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.567 HD22 HD23 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -61.14 -92.18 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.684 -0.235 . . . . 0.0 110.387 179.592 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.558 ' C ' ' H ' ' A' ' 55' ' ' VAL . 8.0 ttt180 75.2 -5.77 2.1 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 179.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.423 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 7.9 t-20 71.03 -32.97 0.26 Allowed 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.786 -0.365 . . . . 0.0 110.199 -179.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.558 ' H ' ' C ' ' A' ' 53' ' ' ARG . 61.6 t -135.82 138.33 47.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 CA-C-O 120.926 0.393 . . . . 0.0 110.931 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.762 HG23 ' CB ' ' A' ' 65' ' ' ASP . 94.0 m -125.38 130.5 52.04 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.579 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.413 ' O ' ' N ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -104.01 139.76 38.69 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.821 0.343 . . . . 0.0 111.025 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.419 ' N ' HD12 ' A' ' 58' ' ' ILE . 4.7 mp -132.2 130.87 60.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.335 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.35 -135.31 3.99 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.971 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.482 ' HB2' ' CG2' ' A' ' 73' ' ' ILE . 7.5 ttt-85 -100.59 -40.9 7.18 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 120.855 0.36 . . . . 0.0 110.918 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.607 ' HB2' HG23 ' A' ' 75' ' ' THR . 0.3 OUTLIER -44.83 118.82 1.73 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.446 -179.568 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 15.9 mtt85 -57.42 -27.42 62.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.884 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.7 m -69.82 -25.62 63.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.778 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 89.8 m -54.73 166.6 0.46 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.78 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.762 ' CB ' HG23 ' A' ' 56' ' ' THR . 0.6 OUTLIER -73.52 -58.33 3.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.875 0.369 . . . . 0.0 111.117 -179.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.408 HG21 ' CD1' ' A' ' 37' ' ' LEU . 21.2 t -121.51 125.36 73.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.647 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.3 pt -95.81 118.19 41.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.567 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.49 HD13 HD11 ' A' ' 73' ' ' ILE . 9.1 mt -77.01 -91.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.686 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.583 ' OG ' HD13 ' A' ' 73' ' ' ILE . 1.3 p -101.42 -102.11 0.26 Allowed 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.583 ' CB ' ' HD3' ' A' ' 71' ' ' PRO . 3.6 mt-10 162.4 -63.96 0.0 OUTLIER Pre-proline 0 CA--C 1.531 0.228 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.583 ' HD3' ' CB ' ' A' ' 70' ' ' GLU . 46.8 Cg_exo -56.09 -40.13 86.86 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.107 1.871 . . . . 0.0 113.355 -178.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -124.19 25.67 7.72 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.583 HD13 ' OG ' ' A' ' 69' ' ' SER . 3.1 tp -104.31 121.93 56.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.137 0.494 . . . . 0.0 111.223 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.6 m -62.9 136.31 57.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.285 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.607 HG23 ' HB2' ' A' ' 61' ' ' SER . 65.8 m -64.4 -40.57 96.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.806 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.452 ' O ' ' C ' ' A' ' 77' ' ' HIS . 3.5 m-85 -99.24 13.86 31.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.232 0.539 . . . . 0.0 111.448 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.452 ' C ' ' O ' ' A' ' 76' ' ' PHE . 1.0 OUTLIER -20.6 -69.8 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.705 -1.134 . . . . 0.0 112.76 -179.346 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -156.64 164.05 38.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.214 0.53 . . . . 0.0 112.099 -179.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -129.52 133.78 47.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.085 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.836 ' CE1' HG13 ' A' ' 97' ' ' VAL . 5.1 m-85 -119.2 131.22 55.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.975 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.423 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 8.1 m-70 -94.67 116.33 28.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.991 0.424 . . . . 0.0 110.906 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.43 109.65 21.63 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.058 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.31 137.56 54.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.794 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.419 ' HG3' HD11 ' A' ' 34' ' ' LEU . 2.0 tt0 -109.64 129.2 55.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.868 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.88 141.22 34.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.948 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.8 p-10 -106.95 115.95 31.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.856 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.0 m -124.95 117.41 50.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.3 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.7 t0 58.35 77.51 0.29 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.081 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 63.18 -80.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.994 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -63.67 151.72 41.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.917 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -118.63 136.72 53.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.96 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.7 mtp180 -112.64 149.74 32.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.997 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -112.12 125.61 54.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.716 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.3 mp -107.78 127.29 53.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.927 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.491 ' N ' HD12 ' A' ' 95' ' ' ILE . 4.1 mp -118.09 137.41 52.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.076 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -114.01 144.09 43.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.041 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.836 HG13 ' CE1' ' A' ' 80' ' ' PHE . 14.1 t -106.45 127.13 62.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.253 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 11.9 mt -130.03 120.91 50.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.851 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -100.14 136.5 39.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.021 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.7 mmtt -133.47 30.55 3.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.913 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.7 m -160.68 150.78 17.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.841 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -102.21 44.76 0.99 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.954 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -83.65 -31.71 26.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.242 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 121.33 89.21 1.03 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.51 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 67.4 m -112.36 126.09 54.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.9 0.381 . . . . 0.0 110.912 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -121.03 118.31 29.49 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.956 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.436 HD12 ' O ' ' A' ' 124' ' ' ARG . 2.7 tp -115.49 137.33 49.41 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-O 121.551 0.691 . . . . 0.0 111.255 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 59.98 28.09 17.57 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.838 -1.073 . . . . 0.0 110.931 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.74 9.89 70.82 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.878 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -134.04 152.0 51.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.823 0.344 . . . . 0.0 110.854 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.04 136.74 43.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.894 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.91 144.96 52.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.866 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.534 HG22 ' O ' ' A' ' 113' ' ' VAL . 10.2 p -141.11 56.13 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.106 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -177.25 -176.4 0.64 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.835 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.41 25.84 9.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.024 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -166.46 72.9 0.15 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.778 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.429 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 0.7 OUTLIER -84.14 139.4 32.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.833 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.543 ' O ' HG23 ' A' ' 118' ' ' ILE . 7.8 tp -98.51 117.62 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-O 120.984 0.421 . . . . 0.0 111.242 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.734 HD21 ' CD2' ' A' ' 135' ' ' PHE . 0.5 OUTLIER -103.1 132.54 49.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.035 -179.834 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -130.84 178.09 6.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.799 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.423 ' HB2' ' CE2' ' A' ' 137' ' ' TYR . 0.3 OUTLIER -54.81 141.32 33.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.061 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 71.8 53.04 10.16 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.5 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -129.14 127.12 40.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.895 0.378 . . . . 0.0 111.009 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.724 ' HD2' HD12 ' A' ' 134' ' ' LEU . 0.3 OUTLIER -91.13 124.38 35.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.747 179.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.427 HD11 HD11 ' A' ' 119' ' ' LEU . 3.2 mp -115.0 131.57 66.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.283 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.7 t -122.71 128.14 75.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.943 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.483 ' CB ' HD13 ' A' ' 68' ' ' LEU . 44.5 m-85 -121.77 118.22 28.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.983 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 86.63 -8.17 76.39 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.84 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 76.74 27.98 0.72 Allowed 'General case' 0 CA--C 1.522 -0.11 0 CA-C-O 120.939 0.4 . . . . 0.0 110.243 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.2 p -138.13 -48.24 0.54 Allowed 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.94 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . 0.465 ' HB3' HD22 ' A' ' 68' ' ' LEU . 1.8 m -88.41 112.04 22.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.865 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 23.0 t -120.08 123.35 43.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.036 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.493 ' CE2' HD22 ' A' ' 37' ' ' LEU . 3.1 p90 -142.16 156.22 45.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.118 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.724 HD12 ' HD2' ' A' ' 124' ' ' ARG . 7.1 tt -108.07 138.79 43.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.706 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.734 ' CD2' HD21 ' A' ' 119' ' ' LEU . 56.5 t80 -105.18 141.57 36.49 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.992 0.901 . . . . 0.0 111.938 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.43 155.11 34.37 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 113.846 -1.525 . . . . 0.0 110.747 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.423 ' CE2' ' HB2' ' A' ' 121' ' ' ASN . 1.1 m-85 -85.06 139.74 31.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.945 0.403 . . . . 0.0 110.847 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.47 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.065 -179.942 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.478 ' C ' HG22 ' A' ' 51' ' ' THR . 0.7 OUTLIER . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.726 0.298 . . . . 0.0 110.635 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 13.2 t -76.43 114.86 15.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.901 0.382 . . . . 0.0 111.071 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.19 -35.8 3.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.889 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.711 ' C ' HG22 ' A' ' 50' ' ' ILE . . . -141.03 -177.81 16.67 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.565 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.638 ' ND1' ' HB2' ' A' ' 138' ' ' ALA . 31.9 m80 -142.13 157.87 44.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.836 0.35 . . . . 0.0 110.832 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.494 ' O ' HD12 ' A' ' 37' ' ' LEU . 3.0 pp -127.08 123.05 35.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.722 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.3 t -105.89 121.93 58.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.197 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -86.3 115.16 23.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.751 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 45.1 mt -83.87 106.87 15.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.986 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.547 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 4.4 mt -124.25 141.5 37.55 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.806 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.547 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 57.5 Cg_endo -73.66 84.91 1.36 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.253 1.968 . . . . 0.0 112.018 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 141.34 -14.04 2.76 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.41 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -179.03 173.68 1.15 Allowed 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 120.767 0.317 . . . . 0.0 110.628 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -139.04 160.76 39.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.075 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -141.5 123.35 15.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.959 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.42 ' HE2' ' CD2' ' A' ' 36' ' ' HIS . 28.4 tttt -110.68 126.17 54.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.819 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 38.5 t -124.05 144.67 33.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.235 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.442 ' HG2' ' CD2' ' A' ' 36' ' ' HIS . 48.0 mt-10 -80.87 135.64 35.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.546 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.711 HG22 ' C ' ' A' ' 35' ' ' GLY . 2.9 tt -111.65 131.99 61.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.043 0.449 . . . . 0.0 111.444 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.585 ' O ' HD13 ' A' ' 82' ' ' LEU . 0.9 OUTLIER -102.7 168.02 9.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.465 179.804 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.769 ' HA ' HD22 ' A' ' 82' ' ' LEU . 34.1 m-80 -68.43 -91.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.574 ' C ' ' H ' ' A' ' 55' ' ' VAL . 5.8 ttt85 69.75 -2.48 1.97 Allowed 'General case' 0 C--O 1.231 0.126 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 178.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.417 ' HA ' HD22 ' A' ' 83' ' ' LEU . 1.8 m-20 70.29 -32.21 0.23 Allowed 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 -179.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.574 ' H ' ' C ' ' A' ' 53' ' ' ARG . 81.6 t -136.99 143.25 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.822 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.499 HG23 ' CB ' ' A' ' 65' ' ' ASP . 9.2 m -125.49 131.2 52.87 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.458 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 65' ' ' ASP . 0.1 OUTLIER -103.98 137.46 41.93 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.908 0.385 . . . . 0.0 111.087 -179.862 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.416 HD13 ' CE1' ' A' ' 80' ' ' PHE . 3.4 mp -132.1 128.47 59.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.096 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 168.9 -135.27 3.53 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.754 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.448 ' HB3' ' HA ' ' A' ' 70' ' ' GLU . 14.8 ptt85 -108.11 -29.4 8.97 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.663 0.268 . . . . 0.0 111.022 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.713 ' CB ' HG23 ' A' ' 75' ' ' THR . 2.8 t -57.46 121.73 10.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.831 0.348 . . . . 0.0 110.816 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.68 -25.36 39.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.07 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.97 -24.63 63.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.0 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 87.7 m -58.22 166.47 1.62 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.038 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.499 ' CB ' HG23 ' A' ' 56' ' ' THR . 0.5 OUTLIER -71.01 -57.1 4.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.003 0.43 . . . . 0.0 110.832 179.742 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.47 HG21 ' CD2' ' A' ' 37' ' ' LEU . 21.0 t -125.2 133.3 69.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.67 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.6 pt -101.72 125.32 55.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.722 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.531 HD23 ' CB ' ' A' ' 131' ' ' CYS . 4.3 mp -93.28 -85.98 0.26 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.944 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.401 ' O ' ' CB ' ' A' ' 70' ' ' GLU . 10.0 t -98.33 -101.93 0.21 Allowed 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.531 ' CB ' ' CD ' ' A' ' 71' ' ' PRO . 0.1 OUTLIER 167.21 -70.2 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.189 0 CA-C-O 120.528 0.204 . . . . 0.0 111.299 179.369 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.531 ' CD ' ' CB ' ' A' ' 70' ' ' GLU . 47.0 Cg_endo -67.86 -38.19 13.95 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.56 2.173 . . . . 0.0 113.579 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -105.71 10.51 32.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.757 0.313 . . . . 0.0 111.226 -179.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.449 ' O ' ' CG2' ' A' ' 73' ' ' ILE . 2.9 tp -105.88 117.29 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-O 121.016 0.436 . . . . 0.0 110.612 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.429 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 0.3 OUTLIER -67.22 135.97 54.26 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.16 -179.163 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.713 HG23 ' CB ' ' A' ' 61' ' ' SER . 64.1 m -49.33 -44.02 44.09 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.826 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.448 ' O ' ' C ' ' A' ' 77' ' ' HIS . 5.7 p90 -106.85 14.1 27.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.22 0.533 . . . . 0.0 111.327 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.448 ' C ' ' O ' ' A' ' 76' ' ' PHE . 3.9 t-160 -20.2 -58.51 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.609 -1.178 . . . . 0.0 112.826 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.431 ' CB ' ' CZ ' ' A' ' 127' ' ' PHE . . . -150.63 157.89 43.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.97 0.414 . . . . 0.0 111.583 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 56' ' ' THR . 16.2 pt-20 -133.06 133.49 43.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.684 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.664 ' CE2' HG22 ' A' ' 97' ' ' VAL . 5.0 m-85 -119.3 131.33 55.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.608 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.4 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 9.0 m-70 -94.41 116.43 28.79 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.985 0.421 . . . . 0.0 111.092 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.769 HD22 ' HA ' ' A' ' 52' ' ' ASN . 1.8 tt -106.49 109.88 21.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.814 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . 0.417 HD22 ' HA ' ' A' ' 54' ' ' ASN . 1.1 mm? -121.6 137.4 54.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.895 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -108.93 136.91 47.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.856 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -126.88 131.77 51.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.869 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -88.54 120.17 29.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.904 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.5 t -139.96 139.13 37.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.065 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -50.1 132.86 23.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.078 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 35.6 m120 62.47 99.35 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.792 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 63.16 133.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.999 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -82.93 158.71 22.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.897 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.91 111.82 20.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.974 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.495 ' C ' HD12 ' A' ' 94' ' ' LEU . 11.9 m-80 -113.34 138.92 49.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.837 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.495 HD12 ' C ' ' A' ' 93' ' ' ASN . 7.9 mp -130.03 137.17 50.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.995 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.454 ' O ' HD12 ' A' ' 118' ' ' ILE . 3.8 mp -119.59 139.02 48.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.078 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -116.88 144.13 44.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.688 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.664 HG22 ' CE2' ' A' ' 80' ' ' PHE . 16.4 t -116.2 132.15 66.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.271 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.558 HD13 ' O ' ' A' ' 115' ' ' LYS . 20.5 mm -127.11 131.06 71.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.119 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -90.22 128.35 36.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.861 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.5 mmmt -119.93 -35.36 3.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.278 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.8 m -78.07 -44.84 25.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.117 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.51 21.54 10.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.904 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -85.95 -30.51 22.73 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.855 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 167.36 73.37 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.506 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.456 HG23 ' CE1' ' A' ' 127' ' ' PHE . 62.0 m -104.72 122.76 46.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.888 0.375 . . . . 0.0 110.869 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -121.14 119.29 31.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.874 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.789 HD13 HD12 ' A' ' 125' ' ' ILE . 2.9 tp -118.09 137.29 52.52 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 CA-C-O 121.524 0.678 . . . . 0.0 111.202 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 60.15 27.29 16.75 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.818 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.75 9.86 70.81 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.818 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -134.03 152.02 51.67 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.749 0.309 . . . . 0.0 110.958 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 30.1 mtm180 -65.1 142.97 58.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.902 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.418 HD21 ' HB ' ' A' ' 105' ' ' THR . 3.1 pp -99.17 129.57 45.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.898 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.6 m -111.85 -30.79 2.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.189 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 16.9 mtmt -80.64 142.22 34.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.937 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.558 ' O ' HD13 ' A' ' 98' ' ' ILE . 0.2 OUTLIER -77.73 -32.75 53.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.875 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -105.64 75.04 1.11 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.927 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -80.75 139.03 36.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.822 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.525 ' O ' HG23 ' A' ' 118' ' ' ILE . 8.6 tp -98.54 119.06 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.37 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.6 tt -103.0 138.51 39.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.982 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.02 178.11 7.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.862 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.445 ' HB2' ' CE2' ' A' ' 137' ' ' TYR . 2.0 t30 -55.31 142.06 33.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.084 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.501 ' HA2' HD21 ' A' ' 134' ' ' LEU . . . 68.08 48.62 52.47 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.406 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -123.44 124.24 42.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.843 0.354 . . . . 0.0 111.072 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.473 ' O ' HD12 ' A' ' 107' ' ' ILE . 48.6 ttt-85 -90.22 122.19 32.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.801 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.789 HD12 HD13 ' A' ' 107' ' ' ILE . 0.5 OUTLIER -120.63 136.41 57.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.933 0.397 . . . . 0.0 111.317 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.432 HG22 ' HB3' ' A' ' 132' ' ' SER . 21.4 t -124.09 133.95 67.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.815 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.456 ' CE1' HG23 ' A' ' 105' ' ' THR . 9.7 m-85 -124.85 138.42 54.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.955 0.407 . . . . 0.0 111.142 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 86.77 -69.83 3.03 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.343 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 176.67 -39.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.729 0.3 . . . . 0.0 111.076 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.38 -40.21 4.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.804 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . 0.531 ' CB ' HD23 ' A' ' 68' ' ' LEU . 33.6 m -53.92 103.95 0.09 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.071 0.462 . . . . 0.0 111.268 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.432 ' HB3' HG22 ' A' ' 126' ' ' VAL . 5.6 p -124.6 129.34 50.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.902 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.457 ' CD1' ' N ' ' A' ' 133' ' ' PHE . 1.3 p90 -142.16 156.08 45.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.058 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.583 HD23 ' N ' ' A' ' 135' ' ' PHE . 3.5 tt -115.11 136.16 53.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.83 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.7 ' HE2' HG21 ' A' ' 50' ' ' ILE . 21.6 t80 -105.67 141.56 36.92 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.95 0.881 . . . . 0.0 111.774 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -154.31 159.67 41.35 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 113.828 -1.533 . . . . 0.0 110.756 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.445 ' CE2' ' HB2' ' A' ' 121' ' ' ASN . 4.5 m-85 -85.29 140.11 31.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.059 0.457 . . . . 0.0 110.618 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.638 ' HB2' ' ND1' ' A' ' 36' ' ' HIS . . . . . . . . 0 C--N 1.323 -0.573 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.191 -179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.4 ' O ' HG22 ' A' ' 51' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.457 -0.082 0 CA-C-O 120.823 0.344 . . . . 0.0 110.73 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.8 t -59.81 145.07 46.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.117 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.618 HD22 HD21 ' A' ' 82' ' ' LEU . 8.3 tt -152.2 -44.98 0.1 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.945 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -157.72 172.82 35.04 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.445 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.546 ' ND1' ' HB2' ' A' ' 138' ' ' ALA . 32.1 m80 -133.47 161.19 35.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.008 0.432 . . . . 0.0 111.208 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.608 HD12 HD11 ' A' ' 50' ' ' ILE . 57.9 mt -127.19 107.92 10.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.596 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.2 t -96.78 121.74 47.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.825 0.345 . . . . 0.0 111.366 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -90.16 119.44 30.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.836 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.5 mt -79.26 106.8 11.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.898 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.4 mt -124.27 139.27 32.45 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.914 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -50.11 91.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.41 2.074 . . . . 0.0 112.286 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 116.03 -105.6 1.42 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.263 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.85 -168.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.791 0.329 . . . . 0.0 111.023 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -155.5 141.7 18.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.985 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -110.46 120.17 41.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.82 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.57 126.14 54.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.993 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.7 t -117.21 143.99 26.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.975 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -93.7 131.16 39.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.925 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.608 HD11 HD12 ' A' ' 37' ' ' LEU . 30.5 mm -111.33 122.38 65.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.002 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.757 ' O ' HD23 ' A' ' 82' ' ' LEU . 0.4 OUTLIER -102.48 168.2 9.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.899 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 17.2 p30 -93.19 71.38 4.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.704 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.587 ' C ' ' H ' ' A' ' 55' ' ' VAL . 2.6 ptp180 -98.35 15.62 24.09 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.618 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 68.97 -29.26 0.17 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.706 0.289 . . . . 0.0 110.333 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.587 ' H ' ' C ' ' A' ' 53' ' ' ARG . 59.3 t -137.09 134.64 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 CA-C-O 121.193 0.52 . . . . 0.0 111.548 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.659 HG23 ' HB3' ' A' ' 65' ' ' ASP . 39.7 m -125.06 122.53 37.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.756 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.88 133.84 48.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.901 0.382 . . . . 0.0 111.038 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.4 mp -119.11 116.52 51.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.721 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 174.72 -146.09 8.32 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.571 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.524 ' HB3' ' HA ' ' A' ' 70' ' ' GLU . 9.4 ptt180 -100.21 -27.67 13.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.702 0.287 . . . . 0.0 111.102 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.06 121.4 7.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.911 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.7 ptt85 -54.96 -28.78 54.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.067 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.91 -24.99 63.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.836 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 99.8 m -55.36 158.8 3.0 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.001 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.659 ' HB3' HG23 ' A' ' 56' ' ' THR . 62.0 t0 -76.3 -52.89 9.05 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.905 0.383 . . . . 0.0 110.943 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.6 t -101.64 129.83 52.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.253 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 14.6 pt -99.82 125.84 53.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.158 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.405 ' O ' ' C ' ' A' ' 69' ' ' SER . 3.3 mp -113.71 -163.69 0.88 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.249 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.596 ' O ' ' CB ' ' A' ' 70' ' ' GLU . 1.2 m -35.56 -58.46 0.59 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.574 0.226 . . . . 0.0 110.975 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.596 ' CB ' ' O ' ' A' ' 69' ' ' SER . 9.0 tm-20 109.84 -61.74 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.529 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.702 178.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.585 ' HD2' ' C ' ' A' ' 69' ' ' SER . 44.0 Cg_endo -67.75 -33.51 27.26 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 121.888 1.726 . . . . 0.0 113.199 -179.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -112.04 21.56 15.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.701 0.286 . . . . 0.0 111.301 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.424 ' HA ' HD12 ' A' ' 73' ' ' ILE . 4.8 tp -117.8 128.85 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-O 120.916 0.388 . . . . 0.0 111.147 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.8 m -63.55 132.78 52.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.057 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.8 m -59.81 -33.48 71.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.897 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.448 ' O ' ' C ' ' A' ' 77' ' ' HIS . 14.9 m-85 -112.1 13.88 20.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.474 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.449 ' CE1' ' HB3' ' A' ' 127' ' ' PHE . 2.1 t-160 -21.62 -69.49 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.726 -1.125 . . . . 0.0 112.574 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.465 ' HB3' ' HE2' ' A' ' 127' ' ' PHE . . . -153.06 159.68 42.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.125 0.488 . . . . 0.0 112.045 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -126.53 134.2 50.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.41 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.655 ' CZ ' HG13 ' A' ' 97' ' ' VAL . 7.5 m-85 -119.4 131.45 55.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.888 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 9.9 m-70 -94.63 116.37 28.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.917 0.389 . . . . 0.0 111.011 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.757 HD23 ' O ' ' A' ' 51' ' ' THR . 12.8 tp -106.47 109.69 21.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.915 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.1 140.08 52.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -116.3 125.13 51.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.864 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 32.6 tpp -138.84 133.39 31.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.912 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -107.04 133.66 51.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.93 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.5 t -135.8 134.19 51.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.002 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.8 t70 75.04 -58.24 0.58 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.021 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -176.31 -39.02 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.894 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -86.63 146.11 26.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.775 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -97.07 137.84 35.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.032 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.2 mtm-85 -114.3 144.8 42.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.873 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -114.08 121.34 43.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.854 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.668 HD21 HG12 ' A' ' 118' ' ' ILE . 1.8 tt -115.72 132.84 56.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.877 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.528 ' N ' HD12 ' A' ' 95' ' ' ILE . 3.2 mp -122.27 140.99 44.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.146 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -113.94 144.0 43.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.823 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.655 HG13 ' CZ ' ' A' ' 80' ' ' PHE . 22.7 t -109.15 122.91 64.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.193 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 25.1 mt -130.1 122.32 53.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.089 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -107.71 138.6 43.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.863 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.9 mmtp -92.65 -6.02 50.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.414 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.8 m 63.05 44.37 5.92 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.882 0.372 . . . . 0.0 110.877 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -95.32 -45.84 6.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.86 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -123.99 -43.59 2.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.244 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 136.34 110.61 1.04 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.504 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 35.8 m -114.39 123.13 48.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.721 0.296 . . . . 0.0 110.942 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.414 ' CE2' ' HB2' ' A' ' 111' ' ' ARG . 6.2 m-85 -121.04 120.34 35.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.808 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.577 HG22 HD22 ' A' ' 112' ' ' LEU . 2.8 tp -102.75 137.24 31.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.493 0.663 . . . . 0.0 111.263 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 61.65 30.55 18.6 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.79 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.67 11.32 72.84 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.849 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -134.01 150.58 51.24 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.782 0.325 . . . . 0.0 110.877 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.414 ' HB2' ' CE2' ' A' ' 106' ' ' PHE . 57.4 ttt-85 -74.97 137.89 41.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.902 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.577 HD22 HG22 ' A' ' 107' ' ' ILE . 0.5 OUTLIER -98.58 134.86 40.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.882 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 15.0 p -107.46 -37.27 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.186 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.1 tttp -61.39 151.52 32.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.874 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.14 30.91 3.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.888 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -169.76 60.25 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.783 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -73.25 136.46 44.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.746 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.668 HG12 HD21 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -98.83 116.71 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.817 -179.887 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.767 HD11 HD11 ' A' ' 125' ' ' ILE . 7.8 tt -101.41 145.87 28.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.977 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.511 ' HD3' HD11 ' A' ' 118' ' ' ILE . 8.4 mmmt -133.51 178.06 7.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.807 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.421 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 12.6 p30 -56.19 141.65 40.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.081 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.728 ' HA2' HD21 ' A' ' 134' ' ' LEU . . . 70.11 46.45 50.93 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.523 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . 0.458 ' C ' HD12 ' A' ' 134' ' ' LEU . 7.6 m-20 -120.29 120.78 37.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.768 0.318 . . . . 0.0 110.945 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.566 ' N ' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -85.19 124.47 31.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.811 179.886 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.767 HD11 HD11 ' A' ' 119' ' ' LEU . 1.2 mp -121.49 135.16 62.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.111 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.683 HG22 ' HB3' ' A' ' 132' ' ' SER . 21.9 t -115.84 125.42 72.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.069 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.513 ' CE1' ' CZ ' ' A' ' 133' ' ' PHE . 67.4 m-85 -116.51 113.45 22.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.014 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 86.92 -8.63 75.35 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.918 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 6.0 tttm 78.82 28.54 0.41 Allowed 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.869 0.366 . . . . 0.0 110.477 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.37 -47.57 0.34 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.929 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 18.7 m -96.11 109.99 22.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.871 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.683 ' HB3' HG22 ' A' ' 126' ' ' VAL . 0.2 OUTLIER -122.07 126.63 48.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.946 -179.902 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.551 ' CE1' HD13 ' A' ' 37' ' ' LEU . 13.5 p90 -139.22 155.93 47.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.886 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.728 HD21 ' HA2' ' A' ' 122' ' ' GLY . 3.6 tp -105.35 136.21 45.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.97 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.577 ' HD2' HD21 ' A' ' 37' ' ' LEU . 24.7 t80 -96.53 141.54 29.69 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 121.971 0.891 . . . . 0.0 111.604 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 29.3 mttp -154.57 153.11 30.88 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 113.885 -1.507 . . . . 0.0 110.867 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.446 ' HE1' HD11 ' A' ' 95' ' ' ILE . 3.7 m-85 -79.26 139.68 37.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.94 0.4 . . . . 0.0 110.696 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.546 ' HB2' ' ND1' ' A' ' 36' ' ' HIS . . . . . . . . 0 C--N 1.324 -0.524 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.173 179.966 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.583 ' N ' HG22 ' A' ' 51' ' ' THR . 0.2 OUTLIER . . . . . 0 N--CA 1.458 -0.07 0 CA-C-O 120.72 0.295 . . . . 0.0 110.573 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 2.0 t -59.95 127.57 32.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.971 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.632 HD23 HD22 ' A' ' 52' ' ' ASN . 1.3 tm? -128.91 -44.1 1.33 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.713 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.704 ' C ' HG22 ' A' ' 50' ' ' ILE . . . -157.33 -165.21 14.74 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.43 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 52.9 m80 -146.18 163.9 33.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.87 0.367 . . . . 0.0 111.065 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.524 HD11 ' HB ' ' A' ' 50' ' ' ILE . 1.7 mp -126.81 119.97 28.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.644 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.4 t -96.12 121.92 47.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.209 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.429 ' HA ' ' CD1' ' A' ' 133' ' ' PHE . 4.3 m-20 -89.39 113.98 25.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.767 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.1 mt -88.59 106.51 18.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.996 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.55 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 1.7 mp -124.5 140.73 35.93 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.509 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.55 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 53.1 Cg_endo -72.24 80.86 1.54 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.003 1.802 . . . . 0.0 112.011 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 145.16 -14.47 1.89 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.686 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.4 tptm -178.34 164.28 1.71 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.806 0.336 . . . . 0.0 110.863 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -125.56 164.99 19.34 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.053 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -150.34 124.92 9.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.911 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.5 mtpt -102.41 134.66 45.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.879 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.7 t -121.71 150.18 24.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.112 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -94.93 132.4 39.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.808 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.743 HG21 ' HE2' ' A' ' 135' ' ' PHE . 5.0 tt -115.98 132.14 66.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.212 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.583 HG22 ' N ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -98.98 168.1 10.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.925 -179.832 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.632 HD22 HD23 ' A' ' 34' ' ' LEU . 13.5 p30 -102.72 74.97 1.38 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.444 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.594 ' C ' ' H ' ' A' ' 55' ' ' VAL . 0.7 OUTLIER -99.04 23.19 9.31 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.526 -179.601 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.552 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 1.6 m-20 67.53 -28.91 0.14 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.487 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.594 ' H ' ' C ' ' A' ' 53' ' ' ARG . 60.2 t -137.76 136.56 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 CA-C-O 120.964 0.412 . . . . 0.0 111.749 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.748 HG23 ' CB ' ' A' ' 65' ' ' ASP . 99.5 m -125.51 129.9 50.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.062 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.455 ' O ' ' N ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -104.0 138.82 39.99 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.954 0.407 . . . . 0.0 111.529 -179.448 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.612 HG22 HD11 ' A' ' 68' ' ' LEU . 4.6 mp -132.52 135.19 58.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.093 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 157.12 -137.36 5.36 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.305 -0.95 . . . . 0.0 113.227 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.473 ' HB2' ' CG2' ' A' ' 73' ' ' ILE . 21.3 ttp180 -94.89 -49.24 5.66 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.753 0.311 . . . . 0.0 111.22 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.494 ' OG ' HG23 ' A' ' 75' ' ' THR . 0.0 OUTLIER -43.71 117.02 1.06 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.497 -179.373 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.1 mtt85 -57.37 -23.3 48.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.015 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.78 -24.19 63.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.76 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 96.4 m -57.42 168.25 0.83 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.824 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.748 ' CB ' HG23 ' A' ' 56' ' ' THR . 0.5 OUTLIER -69.85 -56.62 6.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.952 0.406 . . . . 0.0 110.778 179.827 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 58' ' ' ILE . 21.3 t -125.2 132.95 70.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.594 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 7.9 pt -102.8 128.05 55.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.816 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.81 HD23 ' CE2' ' A' ' 133' ' ' PHE . 0.5 OUTLIER -89.19 -71.35 0.6 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.781 -179.769 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.448 ' HB3' ' HB ' ' A' ' 73' ' ' ILE . 12.8 t -121.3 -111.67 0.33 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.076 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.442 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . 9.7 tt0 170.63 -64.15 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.264 0 O-C-N 122.298 -0.251 . . . . 0.0 111.575 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.442 ' CD ' ' HB3' ' A' ' 70' ' ' GLU . 25.2 Cg_endo -62.0 -40.05 46.05 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.35 2.033 . . . . 0.0 113.28 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -122.49 28.87 7.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.569 0.223 . . . . 0.0 111.503 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.532 HD11 HD13 ' A' ' 68' ' ' LEU . 4.4 tp -110.8 125.94 68.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.971 0.415 . . . . 0.0 111.116 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -59.48 134.01 56.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.484 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.494 HG23 ' OG ' ' A' ' 61' ' ' SER . 36.2 m -65.91 -44.21 85.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.856 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.448 ' O ' ' C ' ' A' ' 77' ' ' HIS . 2.1 m-85 -100.27 13.73 33.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.27 0.557 . . . . 0.0 111.153 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.461 ' CE1' ' HB3' ' A' ' 127' ' ' PHE . 0.4 OUTLIER -15.51 -71.39 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.403 -1.271 . . . . 0.0 113.175 -179.338 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.405 ' HB2' ' HE1' ' A' ' 127' ' ' PHE . . . -153.75 164.08 38.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.225 0.536 . . . . 0.0 112.293 -179.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -132.5 132.64 42.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.962 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.642 ' CE2' HG22 ' A' ' 97' ' ' VAL . 3.9 m-85 -119.39 131.08 55.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.781 0.324 . . . . 0.0 110.96 -179.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.552 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 24.8 m-70 -95.89 116.81 29.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.245 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.2 mp -106.3 109.37 21.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.669 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -122.58 140.19 53.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.032 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -104.21 120.95 42.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.754 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -119.68 142.62 48.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.0 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -107.13 124.89 50.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.902 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.437 HG21 ' HE ' ' A' ' 92' ' ' ARG . 4.0 m -121.88 132.48 70.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.149 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 68.45 -65.58 0.26 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.059 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 179.82 39.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.818 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -145.94 -177.29 5.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.695 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.29 129.12 55.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.999 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.437 ' HE ' HG21 ' A' ' 87' ' ' VAL . 9.4 mtm180 -116.32 150.21 38.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.85 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -114.03 123.67 50.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.944 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.8 mp -130.05 123.84 31.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.825 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.414 ' N ' HD12 ' A' ' 95' ' ' ILE . 4.3 mp -116.25 141.07 35.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.057 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -114.03 144.06 43.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.862 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.642 HG22 ' CE2' ' A' ' 80' ' ' PHE . 18.1 t -115.36 126.09 72.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.23 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.3 mp -127.99 135.57 62.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.071 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -107.55 120.23 41.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.822 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.45 32.38 2.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.006 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 21.8 m -126.85 178.78 5.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.898 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.1 ptp85 -127.55 39.13 3.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.922 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -106.67 -60.62 1.64 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.228 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 145.06 103.36 0.4 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.539 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.464 ' CG2' ' CE1' ' A' ' 127' ' ' PHE . 85.5 m -117.95 124.92 49.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.861 0.362 . . . . 0.0 110.979 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' A' ' 106' ' ' PHE . 5.0 m-85 -121.03 123.71 43.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.829 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.604 ' CD1' HD13 ' A' ' 125' ' ' ILE . 3.0 tp -109.95 137.29 42.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.464 0.649 . . . . 0.0 111.391 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 60.66 29.59 19.12 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.817 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.63 11.38 72.75 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.834 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -134.02 152.06 51.69 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.759 0.314 . . . . 0.0 110.877 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -63.53 142.96 58.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.964 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.407 HD23 ' N ' ' A' ' 113' ' ' VAL . 0.7 OUTLIER -83.95 133.11 34.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.769 -179.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.45 HG13 ' N ' ' A' ' 114' ' ' LYS . 11.8 p -120.62 -42.8 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.149 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.45 ' N ' HG13 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -71.92 147.46 47.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.794 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.89 -37.38 48.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.795 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -111.36 77.79 1.07 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.862 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -80.05 135.95 36.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.867 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.493 ' O ' HG23 ' A' ' 118' ' ' ILE . 8.7 tp -98.73 122.28 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.289 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.743 ' CD1' HD11 ' A' ' 125' ' ' ILE . 4.8 tt -103.06 132.78 49.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.879 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.78 178.07 5.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.838 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.417 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 8.2 p30 -60.41 138.55 57.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.07 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 74.76 56.0 5.14 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.595 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -130.96 132.91 45.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.794 0.33 . . . . 0.0 110.981 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.15 132.68 34.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.877 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.743 HD11 ' CD1' ' A' ' 119' ' ' LEU . 21.1 mm -117.64 121.77 68.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.166 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.421 HG22 ' OG ' ' A' ' 132' ' ' SER . 59.0 t -115.13 128.35 72.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.66 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.464 ' CE1' ' CG2' ' A' ' 105' ' ' THR . 15.1 m-85 -132.08 111.88 11.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.923 0.392 . . . . 0.0 111.659 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.495 ' O ' ' HB2' ' A' ' 129' ' ' LYS . . . 108.91 -81.9 0.29 Allowed Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.206 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.495 ' HB2' ' O ' ' A' ' 128' ' ' GLY . 14.1 tttp 172.22 37.03 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.887 0.375 . . . . 0.0 110.664 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 24.9 p 178.83 -48.82 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.95 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 77.6 m -56.7 104.7 0.16 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.887 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.421 ' OG ' HG22 ' A' ' 126' ' ' VAL . 0.3 OUTLIER -124.3 111.94 16.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.149 -179.766 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.81 ' CE2' HD23 ' A' ' 68' ' ' LEU . 3.0 m-85 -120.45 156.07 32.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.864 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.41 HD23 ' N ' ' A' ' 135' ' ' PHE . 6.0 tt -111.74 140.1 46.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.944 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.743 ' HE2' HG21 ' A' ' 50' ' ' ILE . 18.9 t80 -116.33 141.76 47.73 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.885 0.85 . . . . 0.0 111.733 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -154.44 159.74 41.23 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.06 -1.427 . . . . 0.0 111.022 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.417 ' CE2' ' HB3' ' A' ' 121' ' ' ASN . 3.3 m-85 -84.25 140.25 31.8 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.057 0.456 . . . . 0.0 110.741 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.537 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.165 179.968 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.428 ' N ' HG22 ' A' ' 51' ' ' THR . 0.8 OUTLIER . . . . . 0 N--CA 1.46 0.027 0 CA-C-O 120.801 0.334 . . . . 0.0 110.731 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 2.1 t -67.01 143.89 56.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.942 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.709 HD22 HD11 ' A' ' 82' ' ' LEU . 1.5 tp -156.21 -67.65 0.11 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.902 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.403 ' HA3' ' CE1' ' A' ' 135' ' ' PHE . . . -114.13 167.09 12.23 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.446 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.42 ' CE1' ' HB3' ' A' ' 138' ' ' ALA . 33.4 m80 -136.19 160.67 37.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.907 0.384 . . . . 0.0 111.017 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.815 ' CD1' HD11 ' A' ' 50' ' ' ILE . 97.8 mt -127.23 117.96 23.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.709 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.4 t -101.8 121.59 52.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.205 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -90.26 136.97 32.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.891 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.8 mt -108.36 106.56 16.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.974 0.416 . . . . 0.0 110.848 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.548 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 4.1 mt -124.4 141.25 37.09 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.857 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.548 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 56.9 Cg_endo -73.36 81.46 1.77 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.172 1.915 . . . . 0.0 112.041 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 148.93 -18.78 1.23 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.403 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 11.9 ttmm -177.65 165.0 2.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.709 0.29 . . . . 0.0 110.655 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -122.11 149.76 43.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.028 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -121.43 134.05 55.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.74 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.95 124.88 53.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.137 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.547 HG11 HG13 ' A' ' 66' ' ' VAL . 31.6 t -120.15 150.52 22.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.998 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.419 ' HG3' ' CD2' ' A' ' 36' ' ' HIS . 0.0 OUTLIER -103.01 142.07 34.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.037 -179.867 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.815 HD11 ' CD1' ' A' ' 37' ' ' LEU . 33.1 mm -115.38 122.68 69.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.839 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.428 HG22 ' N ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -99.87 168.16 10.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.144 -179.885 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -100.11 73.87 1.74 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.593 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.577 ' C ' ' H ' ' A' ' 55' ' ' VAL . 4.0 ptp180 -107.05 22.04 16.61 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.437 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.505 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 30.6 m-80 67.1 -27.9 0.13 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.659 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.577 ' H ' ' C ' ' A' ' 53' ' ' ARG . 61.6 t -137.72 137.67 45.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 CA-C-O 121.006 0.431 . . . . 0.0 111.96 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.49 HG22 ' CB ' ' A' ' 65' ' ' ASP . 0.4 OUTLIER -125.36 128.28 47.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.72 178.911 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.464 ' O ' ' N ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -104.06 136.22 44.11 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.976 0.417 . . . . 0.0 111.488 -179.463 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.561 HD11 ' HD2' ' A' ' 80' ' ' PHE . 4.4 mp -132.2 127.17 57.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.974 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 164.08 -142.13 7.59 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.074 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.529 ' HB2' HG23 ' A' ' 73' ' ' ILE . 14.3 ttp180 -88.65 -43.19 11.51 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.811 0.339 . . . . 0.0 111.027 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.757 ' HB2' HG23 ' A' ' 75' ' ' THR . 0.4 OUTLIER -45.93 115.09 0.89 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.461 -179.527 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.04 -27.41 61.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.942 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.2 m -70.03 -24.71 63.32 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.814 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . 0.417 ' CB ' ' HB ' ' A' ' 57' ' ' THR . 98.7 m -53.08 167.93 0.15 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.76 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.49 ' CB ' HG22 ' A' ' 56' ' ' THR . 0.6 OUTLIER -69.5 -53.88 16.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.922 0.391 . . . . 0.0 111.038 179.943 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.609 HG21 HD12 ' A' ' 37' ' ' LEU . 22.1 t -125.05 125.69 69.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.517 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.3 pt -99.65 131.06 47.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.504 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.627 HD23 ' HB2' ' A' ' 131' ' ' CYS . 8.4 mp -100.89 -100.33 0.25 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.344 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.2 p -92.14 -103.9 0.11 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 121.224 -0.19 . . . . 0.0 110.724 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.554 ' HA ' HG22 ' A' ' 73' ' ' ILE . 3.0 mt-10 167.17 -64.78 0.0 OUTLIER Pre-proline 0 CA--C 1.529 0.136 0 CA-C-O 120.68 0.276 . . . . 0.0 111.145 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.448 ' CD ' ' CB ' ' A' ' 70' ' ' GLU . 28.9 Cg_endo -62.89 -37.49 54.26 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.359 2.039 . . . . 0.0 112.56 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -112.04 17.06 19.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.276 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.554 HG22 ' HA ' ' A' ' 70' ' ' GLU . 4.5 tp -108.79 127.48 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 CA-C-O 120.925 0.393 . . . . 0.0 111.093 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.42 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 0.9 OUTLIER -83.79 133.67 34.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.367 -179.578 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.757 HG23 ' HB2' ' A' ' 61' ' ' SER . 57.3 m -57.94 -30.74 66.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.078 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.414 ' O ' ' C ' ' A' ' 77' ' ' HIS . 39.6 m-85 -110.27 13.97 22.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.237 0.541 . . . . 0.0 111.536 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.444 ' CE1' ' HB3' ' A' ' 127' ' ' PHE . 0.1 OUTLIER -25.94 -64.75 0.06 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.779 -1.1 . . . . 0.0 112.702 -179.277 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.45 ' HB3' ' CZ ' ' A' ' 127' ' ' PHE . . . -157.66 163.98 37.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.116 0.484 . . . . 0.0 112.027 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.48 ' HA ' ' O ' ' A' ' 56' ' ' THR . 0.8 OUTLIER -134.81 141.4 46.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.319 179.405 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.561 ' HD2' HD11 ' A' ' 58' ' ' ILE . 47.0 m-85 -119.44 131.51 55.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.942 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.505 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 4.1 m-70 -94.63 116.53 28.87 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.832 0.349 . . . . 0.0 110.756 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.709 HD11 HD22 ' A' ' 34' ' ' LEU . 0.1 OUTLIER -106.28 109.89 21.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.03 -179.89 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.07 133.86 55.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.705 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -101.69 128.82 47.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.917 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.7 ttt -141.45 111.97 7.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.864 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -79.03 116.02 19.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.953 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.5 t -140.0 114.3 6.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.072 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 60.83 -165.83 0.21 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.79 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -48.92 132.4 18.49 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.281 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 61.11 155.04 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.904 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -85.98 139.78 30.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.953 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 80.1 mtt180 -109.92 122.64 48.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.865 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -113.04 146.73 38.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.84 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.2 mt -128.81 140.04 51.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.927 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.482 HG13 HD22 ' A' ' 82' ' ' LEU . 4.1 mp -120.97 138.48 51.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.06 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -113.94 143.31 44.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.021 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.558 HG22 ' HE1' ' A' ' 80' ' ' PHE . 3.9 t -104.41 135.08 43.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.173 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 22.6 mt -129.86 146.33 34.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.18 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.559 ' OD1' HD22 ' A' ' 112' ' ' LEU . 2.9 p-10 -119.74 123.49 43.88 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.902 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.67 -41.7 1.98 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.119 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.2 m -71.56 157.76 37.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.065 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.43 29.01 8.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.844 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -86.97 -42.2 13.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.227 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 136.48 100.58 0.58 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.671 -0.775 . . . . 0.0 112.595 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.53 HG23 ' CD1' ' A' ' 127' ' ' PHE . 93.7 m -109.4 123.37 49.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.8 0.333 . . . . 0.0 110.735 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.425 ' CE1' ' HB3' ' A' ' 111' ' ' ARG . 47.2 m-85 -120.87 115.06 22.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.932 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.403 ' CD1' HG13 ' A' ' 125' ' ' ILE . 2.6 tp -118.31 137.26 52.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.428 0.632 . . . . 0.0 111.196 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 61.77 32.2 18.26 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.798 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.76 10.9 72.78 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.859 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -134.05 151.96 51.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.743 0.306 . . . . 0.0 110.851 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.425 ' HB3' ' CE1' ' A' ' 106' ' ' PHE . 6.6 ptm180 -70.95 139.05 50.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.894 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.559 HD22 ' OD1' ' A' ' 99' ' ' ASP . 0.8 OUTLIER -85.49 129.3 34.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.88 -179.933 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.489 HG13 ' N ' ' A' ' 114' ' ' LYS . 12.2 p -125.58 -44.65 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.11 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.489 ' N ' HG13 ' A' ' 113' ' ' VAL . 2.6 mmmp? -66.23 172.83 3.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.908 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -119.03 31.38 6.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.931 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -162.23 57.86 0.24 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.801 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.98 139.09 38.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.84 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.546 ' O ' HG23 ' A' ' 118' ' ' ILE . 7.8 tp -98.59 117.31 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-O 121.004 0.43 . . . . 0.0 111.228 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.444 HD22 ' HB ' ' A' ' 95' ' ' ILE . 7.6 tt -103.07 131.23 50.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.057 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.26 178.03 6.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.781 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.451 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 5.0 p-10 -57.72 141.29 49.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.966 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.782 ' HA2' HD21 ' A' ' 134' ' ' LEU . . . 74.86 47.66 13.77 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.311 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -123.46 131.34 53.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.795 0.331 . . . . 0.0 111.081 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.74 122.6 41.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.65 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.54 HG21 ' HZ ' ' A' ' 80' ' ' PHE . 1.7 mp -114.97 133.56 60.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.314 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.632 HG22 ' HB3' ' A' ' 132' ' ' SER . 21.2 t -124.02 123.81 67.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.968 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.53 ' CD1' HG23 ' A' ' 105' ' ' THR . 23.5 m-85 -116.27 111.92 20.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.85 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . 0.402 ' O ' ' CB ' ' A' ' 129' ' ' LYS . . . 88.61 -15.31 57.45 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.88 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . 0.402 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 10.9 tttt 79.32 30.65 0.3 Allowed 'General case' 0 CA--C 1.522 -0.109 0 CA-C-O 121.002 0.43 . . . . 0.0 110.378 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 15.3 p -128.22 -50.07 1.31 Allowed 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.99 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . 0.627 ' HB2' HD23 ' A' ' 68' ' ' LEU . 7.0 m -109.59 112.58 24.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.977 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.632 ' HB3' HG22 ' A' ' 126' ' ' VAL . 0.7 OUTLIER -116.8 131.06 57.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.931 179.95 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.409 ' CD1' HD22 ' A' ' 37' ' ' LEU . 6.0 p90 -141.25 156.04 45.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.074 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.782 HD21 ' HA2' ' A' ' 122' ' ' GLY . 7.7 tt -107.74 140.05 41.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.8 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.431 ' CD2' HD21 ' A' ' 119' ' ' LEU . 87.7 t80 -101.57 141.56 34.25 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 122.002 0.906 . . . . 0.0 111.933 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt -154.37 145.87 23.13 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 113.748 -1.569 . . . . 0.0 110.707 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.451 ' CE2' ' HB3' ' A' ' 121' ' ' ASN . 4.4 m-85 -73.62 139.75 45.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.992 0.425 . . . . 0.0 110.736 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.42 ' HB3' ' CE1' ' A' ' 36' ' ' HIS . . . . . . . . 0 C--N 1.325 -0.482 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.045 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.1 m . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.719 0.295 . . . . 0.0 110.725 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 44.9 t -59.92 137.23 58.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.882 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.751 HD13 HD23 ' A' ' 82' ' ' LEU . 8.4 tt -130.21 -44.98 1.13 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.971 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.622 ' C ' HG22 ' A' ' 50' ' ' ILE . . . -157.67 -167.89 19.3 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.567 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.535 ' ND1' ' HB2' ' A' ' 138' ' ' ALA . 54.2 m80 -147.0 164.06 34.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.841 0.353 . . . . 0.0 110.911 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.574 HD11 ' HB ' ' A' ' 50' ' ' ILE . 2.4 mp -127.03 108.0 10.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.809 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.5 t -97.96 121.96 49.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.163 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -90.06 117.06 28.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.785 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.4 mt -81.14 106.53 13.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.831 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.54 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 4.8 mt -124.25 140.83 35.85 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.917 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.54 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 58.0 Cg_endo -74.43 81.82 1.99 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.161 1.908 . . . . 0.0 111.867 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 145.02 -14.19 1.92 Allowed Glycine 0 CA--C 1.52 0.382 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.483 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -179.0 173.8 1.14 Allowed 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 120.774 0.321 . . . . 0.0 110.604 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -132.75 156.32 47.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.098 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -135.37 112.17 10.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.804 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.63 132.29 51.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.02 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.1 t -121.09 151.1 24.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.014 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -94.87 131.41 40.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.807 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.689 HG21 ' HE2' ' A' ' 135' ' ' PHE . 1.6 tt -116.05 124.67 72.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.248 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.515 ' O ' HD22 ' A' ' 82' ' ' LEU . 0.2 OUTLIER -100.93 168.14 9.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.959 -179.765 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -80.32 66.36 5.8 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.173 0.511 . . . . 0.0 110.313 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.555 ' C ' ' H ' ' A' ' 55' ' ' VAL . 8.8 ttt85 -79.48 1.55 25.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.796 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.4 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 1.2 t-20 72.12 -36.55 0.36 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -178.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.555 ' H ' ' C ' ' A' ' 53' ' ' ARG . 66.5 t -137.36 132.75 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.781 179.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.743 HG23 ' HB3' ' A' ' 65' ' ' ASP . 21.7 m -125.22 124.32 41.46 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.917 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.65 132.37 49.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.876 0.369 . . . . 0.0 110.777 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.436 HD12 ' CZ ' ' A' ' 127' ' ' PHE . 34.6 mt -115.19 120.37 64.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.286 -179.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 170.71 -134.09 3.01 Favored Glycine 0 C--N 1.331 0.259 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.235 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.61 ' HB3' ' HA ' ' A' ' 70' ' ' GLU . 0.2 OUTLIER -118.76 -21.96 7.61 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.585 0.231 . . . . 0.0 111.305 179.806 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.454 ' HB2' HG23 ' A' ' 75' ' ' THR . 0.2 OUTLIER -52.01 126.48 18.54 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.864 0.364 . . . . 0.0 110.96 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.4 mmm180 -55.05 -26.25 36.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.104 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.0 m -77.3 -22.68 51.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.12 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 98.5 m -54.71 162.26 1.26 Allowed 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.151 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.743 ' HB3' HG23 ' A' ' 56' ' ' THR . 12.9 t0 -83.69 -49.0 9.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.128 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 58' ' ' ILE . 26.7 t -123.77 116.85 49.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.371 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 16.5 pt -100.76 127.8 53.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.975 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.514 HD12 ' HB3' ' A' ' 131' ' ' CYS . 3.8 mm? -98.18 -92.21 0.25 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.697 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.411 ' O ' ' CB ' ' A' ' 70' ' ' GLU . 48.0 m -87.58 -108.01 0.07 Allowed 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.61 ' HA ' ' HB3' ' A' ' 60' ' ' ARG . 1.0 OUTLIER 167.48 -64.51 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.275 0 N-CA-C 111.644 0.238 . . . . 0.0 111.644 178.871 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.593 ' HD3' ' HB3' ' A' ' 70' ' ' GLU . 15.9 Cg_exo -67.61 -40.28 10.47 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.123 1.882 . . . . 0.0 112.998 -179.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -109.22 21.29 17.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.303 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.471 ' CG2' ' HB3' ' A' ' 60' ' ' ARG . 4.8 tp -112.26 120.62 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-O 120.905 0.384 . . . . 0.0 110.817 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.451 ' HB2' ' CG ' ' A' ' 77' ' ' HIS . 0.5 OUTLIER -57.92 131.48 50.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.075 -179.527 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.454 HG23 ' HB2' ' A' ' 61' ' ' SER . 91.5 m -59.12 -44.01 91.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.688 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.473 ' O ' ' C ' ' A' ' 77' ' ' HIS . 1.6 m-85 -105.62 13.75 29.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.184 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.473 ' C ' ' O ' ' A' ' 76' ' ' PHE . 0.2 OUTLIER -15.0 -70.18 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.618 -1.174 . . . . 0.0 112.763 -179.479 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -151.21 153.3 34.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.065 0.459 . . . . 0.0 111.937 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -117.21 133.8 55.56 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.255 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.755 ' CE2' HG22 ' A' ' 97' ' ' VAL . 8.2 m-85 -119.45 131.11 55.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.142 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.4 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 17.7 m-70 -94.88 116.67 29.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.857 0.361 . . . . 0.0 111.107 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.751 HD23 HD13 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -106.34 109.62 21.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.69 179.737 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.6 tt -122.19 139.38 53.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.125 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -129.1 131.89 47.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.724 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.15 148.48 40.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.078 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -107.09 125.76 51.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.779 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.5 t -139.96 126.33 22.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.158 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 58.82 42.21 20.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.987 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 62.04 29.11 17.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.949 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -139.45 130.91 27.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.814 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 20.8 mm100 -85.58 132.26 34.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.971 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -111.7 124.65 52.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.794 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -103.81 122.56 45.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.021 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.8 mt -132.08 122.96 26.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.727 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.607 HD12 ' HG ' ' A' ' 82' ' ' LEU . 7.2 mm -113.16 137.25 46.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.02 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.01 135.35 54.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.821 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.755 HG22 ' CE2' ' A' ' 80' ' ' PHE . 18.7 t -112.82 128.55 69.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.195 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 7.5 mt -129.64 120.97 51.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.004 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -102.32 134.01 46.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.937 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.6 pttp -149.73 32.17 0.7 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.835 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.8 m -119.94 -178.0 3.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.01 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.35 38.1 2.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.876 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -105.53 -38.32 6.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.278 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 131.95 98.5 0.73 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.521 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 71.0 m -117.54 124.13 47.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.846 0.355 . . . . 0.0 110.835 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -120.98 121.79 38.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.956 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.45 HD13 ' CG1' ' A' ' 125' ' ' ILE . 3.2 tp -120.57 137.1 55.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.414 0.626 . . . . 0.0 111.282 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 9.9 m120 56.56 31.45 19.08 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.892 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.69 13.05 74.73 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.875 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 24.7 p30 -134.08 150.34 51.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.785 0.326 . . . . 0.0 110.912 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 3.7 ttm180 -62.83 141.82 58.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.983 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.413 HD23 ' N ' ' A' ' 113' ' ' VAL . 1.1 tt -100.06 125.7 46.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.831 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.572 HG22 ' O ' ' A' ' 113' ' ' VAL . 12.0 p -149.94 49.62 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.128 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.46 -177.47 3.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.827 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.3 mtpt -111.56 -33.75 6.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.908 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -137.59 76.8 1.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.97 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -84.0 136.38 34.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.768 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.519 ' O ' HG23 ' A' ' 118' ' ' ILE . 8.8 tp -98.64 118.95 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.261 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.479 HD23 ' C ' ' A' ' 119' ' ' LEU . 7.4 tt -103.09 145.59 29.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.928 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 13.6 mttt -132.1 178.06 7.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.84 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.404 ' HB3' ' CD2' ' A' ' 137' ' ' TYR . 15.5 p30 -58.25 138.81 56.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.0 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.439 ' HA2' HD21 ' A' ' 134' ' ' LEU . . . 78.13 58.04 3.28 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.523 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -134.22 126.57 30.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.798 0.332 . . . . 0.0 110.889 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.425 ' N ' HD12 ' A' ' 134' ' ' LEU . 7.9 ttm180 -93.3 127.64 38.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.846 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.45 ' CG1' HD13 ' A' ' 107' ' ' ILE . 1.7 mp -121.67 134.23 65.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.188 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.582 HG22 ' HB3' ' A' ' 132' ' ' SER . 21.7 t -124.12 123.92 67.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.946 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.443 ' HB3' ' CE1' ' A' ' 77' ' ' HIS . 79.7 m-85 -113.98 111.89 22.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.002 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 84.04 -10.27 61.05 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.846 -0.692 . . . . 0.0 113.057 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 77.28 30.02 0.54 Allowed 'General case' 0 CA--C 1.522 -0.133 0 CA-C-O 120.985 0.421 . . . . 0.0 110.273 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 26.9 p -125.84 -44.06 1.81 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.99 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . 0.514 ' HB3' HD12 ' A' ' 68' ' ' LEU . 1.8 m -118.6 116.92 27.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.032 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.582 ' HB3' HG22 ' A' ' 126' ' ' VAL . 77.2 p -124.06 130.66 52.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.795 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.529 ' CE2' HD23 ' A' ' 37' ' ' LEU . 8.8 p90 -141.98 156.01 45.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.023 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.439 HD21 ' HA2' ' A' ' 122' ' ' GLY . 2.2 tp -105.79 130.88 53.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.785 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.689 ' HE2' HG21 ' A' ' 50' ' ' ILE . 26.9 t80 -94.31 141.44 28.57 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.886 0.85 . . . . 0.0 111.729 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.3 tttp -154.7 149.85 26.99 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 113.938 -1.483 . . . . 0.0 111.041 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.404 ' CD2' ' HB3' ' A' ' 121' ' ' ASN . 5.6 m-85 -76.25 140.09 41.43 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.987 0.422 . . . . 0.0 110.645 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.535 ' HB2' ' ND1' ' A' ' 36' ' ' HIS . . . . . . . . 0 C--N 1.324 -0.519 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.043 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.147 0 CA-C-O 120.833 0.349 . . . . 0.0 110.435 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 51.3 t -59.83 145.19 46.41 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.367 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.508 HD13 HD22 ' A' ' 52' ' ' ASN . 2.6 tp -150.72 -44.22 0.12 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.665 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.743 ' C ' HG22 ' A' ' 50' ' ' ILE . . . -153.03 -175.57 24.61 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.041 -0.599 . . . . 0.0 112.127 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.41 ' CE1' ' HG3' ' A' ' 49' ' ' GLU . 40.4 m80 -147.01 166.06 27.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.012 0.434 . . . . 0.0 111.221 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.418 HD12 ' N ' ' A' ' 37' ' ' LEU . 4.7 mp -127.07 136.01 51.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.59 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.409 HG22 ' HE3' ' A' ' 47' ' ' LYS . 1.7 t -101.66 123.61 54.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.125 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -90.15 120.91 31.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.779 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.3 mt -97.86 107.73 20.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.965 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.421 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 3.3 mp -116.82 138.77 24.93 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.757 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.421 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 91.5 Cg_exo -44.42 -27.67 2.21 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.623 2.215 . . . . 0.0 112.708 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -149.22 45.32 0.7 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.601 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 20.8 tptt -179.86 164.15 1.17 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.792 0.329 . . . . 0.0 111.01 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -146.92 134.39 20.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.634 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -129.62 145.51 51.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.157 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.409 ' HE3' HG22 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -113.0 133.24 55.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.739 179.794 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.1 t -121.97 149.25 25.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.941 0.4 . . . . 0.0 111.237 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.41 ' HG3' ' CE1' ' A' ' 36' ' ' HIS . 48.6 tt0 -107.97 128.53 54.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.655 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.743 HG22 ' C ' ' A' ' 35' ' ' GLY . 1.2 tt -105.92 132.03 53.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.264 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.648 ' O ' HD23 ' A' ' 82' ' ' LEU . 0.8 OUTLIER -98.55 168.42 10.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.044 -179.707 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.508 HD22 HD13 ' A' ' 34' ' ' LEU . 12.1 p30 -86.09 62.94 7.75 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.198 0.523 . . . . 0.0 110.17 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.578 ' C ' ' H ' ' A' ' 55' ' ' VAL . 23.5 ttt-85 -82.83 1.78 37.44 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.005 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 71.93 -33.62 0.27 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -178.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.578 ' H ' ' C ' ' A' ' 53' ' ' ARG . 74.0 t -136.79 141.33 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.428 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.592 HG23 ' HB3' ' A' ' 65' ' ' ASP . 51.0 m -125.18 126.79 45.79 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.336 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.79 139.1 39.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.823 0.344 . . . . 0.0 110.517 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.571 ' CG2' HD11 ' A' ' 68' ' ' LEU . 4.5 mp -130.8 132.66 63.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.063 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 164.89 -151.9 21.16 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.472 -0.871 . . . . 0.0 113.09 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.422 ' HB2' ' CG2' ' A' ' 73' ' ' ILE . 14.7 ttp180 -86.2 -45.43 11.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.76 0.314 . . . . 0.0 111.25 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.833 ' HB3' HG23 ' A' ' 75' ' ' THR . 11.5 p -52.05 128.72 25.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.358 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.98 -16.49 61.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.141 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.72 -26.62 64.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.817 0.342 . . . . 0.0 110.708 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 83.1 m -59.85 156.32 14.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.627 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.592 ' HB3' HG23 ' A' ' 56' ' ' THR . 7.4 t70 -62.07 -46.3 89.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.913 0.387 . . . . 0.0 110.495 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.9 t -125.18 132.98 70.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.316 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.4 mt -104.35 115.2 45.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.025 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.793 HD12 HD11 ' A' ' 73' ' ' ILE . 14.5 mt -87.22 -134.92 0.08 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.517 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.444 ' O ' ' CB ' ' A' ' 70' ' ' GLU . 17.4 m -57.04 -105.99 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 O-C-N 122.404 -0.185 . . . . 0.0 110.941 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.444 ' CB ' ' O ' ' A' ' 69' ' ' SER . 2.9 mt-10 163.72 -62.64 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.264 0 CA-C-O 120.597 0.236 . . . . 0.0 111.398 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 70' ' ' GLU . 19.7 Cg_endo -58.93 -39.98 75.96 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.661 2.24 . . . . 0.0 113.009 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -118.55 27.12 9.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.682 0.277 . . . . 0.0 111.538 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.793 HD11 HD12 ' A' ' 68' ' ' LEU . 4.8 tp -109.7 127.65 66.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.96 0.409 . . . . 0.0 111.606 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.17 134.17 45.55 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.045 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.833 HG23 ' HB3' ' A' ' 61' ' ' SER . 87.6 m -50.73 -44.06 58.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.271 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.494 ' O ' ' C ' ' A' ' 77' ' ' HIS . 12.1 p90 -106.69 13.86 27.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.081 0.467 . . . . 0.0 111.677 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.494 ' C ' ' O ' ' A' ' 76' ' ' PHE . 4.2 t60 -6.38 -69.09 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.671 -1.15 . . . . 0.0 112.979 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -152.81 164.05 38.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.951 0.405 . . . . 0.0 111.632 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -130.09 128.97 42.95 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.864 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.914 ' CZ ' HG13 ' A' ' 97' ' ' VAL . 5.6 m-85 -119.44 131.15 55.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.719 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -94.72 116.34 28.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.964 0.412 . . . . 0.0 111.266 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.712 HD22 HG12 ' A' ' 50' ' ' ILE . 22.3 tp -106.74 109.73 21.71 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.849 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.22 140.09 53.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.012 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.4 tm0? -106.03 137.18 44.39 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.759 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 7.6 mtt -107.03 136.76 46.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.841 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -97.87 116.48 30.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.035 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 17.5 t -139.97 139.15 37.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.943 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -48.36 -51.61 25.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.188 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -53.66 -65.74 0.51 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.163 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -162.67 163.11 27.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.826 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.0 128.0 34.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.913 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.3 mmm180 -108.1 129.69 55.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.82 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -114.07 120.0 39.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.01 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.2 mt -115.55 130.1 56.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.752 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.652 HG13 HD12 ' A' ' 82' ' ' LEU . 3.7 mp -114.66 136.04 52.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.275 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -114.28 138.76 50.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.731 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.914 HG13 ' CZ ' ' A' ' 80' ' ' PHE . 17.4 t -101.02 134.95 39.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.274 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 32.4 mt -129.3 134.96 62.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.071 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.421 ' HB3' HD11 ' A' ' 112' ' ' LEU . 20.6 p-10 -105.55 118.86 37.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.849 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.3 mtpp -133.17 31.11 3.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.922 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.2 m -144.03 174.67 10.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.881 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.94 30.44 4.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.894 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -85.32 -34.46 21.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.142 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 120.94 88.79 1.04 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.527 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.555 HG23 ' CD1' ' A' ' 127' ' ' PHE . 75.6 m -107.12 126.98 53.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.903 0.382 . . . . 0.0 110.946 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -120.93 117.85 28.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.904 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.42 HD13 HG12 ' A' ' 125' ' ' ILE . 2.6 tp -113.01 137.23 46.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.449 0.643 . . . . 0.0 111.297 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 62.94 27.69 16.05 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.933 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.74 12.77 74.66 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.811 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -134.02 152.05 51.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.82 0.343 . . . . 0.0 110.903 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.0 ttp180 -73.61 129.79 38.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.85 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.421 HD11 ' HB3' ' A' ' 99' ' ' ASP . 3.6 pp -88.52 144.82 26.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.993 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 14.2 m -143.46 32.21 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.112 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -147.43 149.39 32.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.881 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.6 mtmm -98.63 34.84 1.94 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.942 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -152.76 50.27 0.74 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.972 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -83.89 136.63 34.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.843 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.542 ' O ' HG23 ' A' ' 118' ' ' ILE . 8.9 tp -98.56 117.27 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-O 120.983 0.42 . . . . 0.0 111.216 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.75 HD11 HD11 ' A' ' 125' ' ' ILE . 10.0 tt -103.16 135.52 44.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.024 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 35.7 mttt -131.99 178.03 7.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.765 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.431 ' HB3' ' CD2' ' A' ' 137' ' ' TYR . 9.9 p-10 -62.15 142.86 57.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.871 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.484 ' HA2' HD21 ' A' ' 134' ' ' LEU . . . 72.67 42.41 47.15 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.5 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -118.08 127.3 53.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.8 0.333 . . . . 0.0 110.932 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.57 118.5 23.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.837 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.75 HD11 HD11 ' A' ' 119' ' ' LEU . 2.9 mt -114.93 122.68 69.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.206 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 24.7 t -118.48 128.22 75.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.96 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.555 ' CD1' HG23 ' A' ' 105' ' ' THR . 49.1 m-85 -111.4 137.16 49.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.963 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 74.48 -65.85 2.03 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.351 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 174.94 -50.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.812 0.339 . . . . 0.0 110.95 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.2 p -91.33 -42.74 10.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.253 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . 0.412 ' HB3' ' CZ ' ' A' ' 133' ' ' PHE . 25.9 m -54.93 108.17 0.37 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.121 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 41.5 t -123.76 129.97 51.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.856 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.505 ' CZ ' HD22 ' A' ' 68' ' ' LEU . 1.5 m-85 -141.98 154.24 44.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.797 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.484 HD21 ' HA2' ' A' ' 122' ' ' GLY . 0.6 OUTLIER -120.02 139.82 51.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.937 179.901 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.412 ' HE2' HG21 ' A' ' 50' ' ' ILE . 28.3 t80 -112.37 141.48 46.05 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.964 0.887 . . . . 0.0 111.859 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.65 159.02 40.53 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 113.853 -1.522 . . . . 0.0 110.761 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.431 ' CD2' ' HB3' ' A' ' 121' ' ' ASN . 3.6 m-85 -86.05 139.72 30.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.933 0.397 . . . . 0.0 110.763 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.504 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.083 -179.875 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.456 -0.13 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.8 t -59.71 144.89 46.87 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.101 0.477 . . . . 0.0 111.341 -179.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.464 HD12 ' HB3' ' A' ' 52' ' ' ASN . 0.8 OUTLIER -151.52 -45.04 0.11 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.338 179.787 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -147.36 157.61 27.45 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.926 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.633 ' ND1' ' HB2' ' A' ' 138' ' ' ALA . 51.8 m80 -119.83 160.4 22.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.99 0.424 . . . . 0.0 111.295 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.967 HD12 HD11 ' A' ' 50' ' ' ILE . 59.2 mt -127.09 112.77 15.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.607 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.867 HG22 ' HG3' ' A' ' 47' ' ' LYS . 27.2 t -99.71 121.74 50.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.133 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -90.19 114.87 26.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.763 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 32.0 mt -88.21 106.85 18.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.84 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.4 mt -124.11 139.27 32.29 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.08 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.34 92.86 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.377 2.051 . . . . 0.0 112.251 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.71 34.21 10.42 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.364 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -179.94 150.55 0.39 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.806 0.336 . . . . 0.0 110.859 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -151.22 152.0 32.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.991 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -143.6 126.22 15.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.739 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.867 ' HG3' HG22 ' A' ' 38' ' ' VAL . 5.0 ttpt -104.65 126.07 51.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.929 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.0 t -111.6 150.8 13.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.104 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.413 ' HG3' ' CD2' ' A' ' 36' ' ' HIS . 0.4 OUTLIER -100.46 119.95 39.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.97 -179.891 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.967 HD11 HD12 ' A' ' 37' ' ' LEU . 31.0 mm -96.12 132.09 41.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.07 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.1 p -110.0 168.51 9.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.788 -179.974 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.464 ' HB3' HD12 ' A' ' 34' ' ' LEU . 3.9 p30 -81.32 60.43 4.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.149 0.5 . . . . 0.0 110.291 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.583 ' C ' ' H ' ' A' ' 55' ' ' VAL . 20.0 ttt-85 -82.86 1.38 39.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.757 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.407 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 11.9 m-20 71.54 -33.28 0.27 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -178.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.583 ' H ' ' C ' ' A' ' 53' ' ' ARG . 78.8 t -137.19 140.75 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.58 179.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.697 HG23 ' HB3' ' A' ' 65' ' ' ASP . 30.5 m -125.29 128.33 48.08 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.054 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.91 130.69 51.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.809 0.338 . . . . 0.0 110.768 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.558 ' CG2' HD11 ' A' ' 68' ' ' LEU . 2.7 mp -124.06 120.94 60.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.09 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 171.35 -143.11 7.41 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.735 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.547 ' HB2' HG23 ' A' ' 73' ' ' ILE . 11.8 ttp180 -95.18 -32.34 13.1 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.803 0.335 . . . . 0.0 111.093 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.928 ' HB2' HG23 ' A' ' 75' ' ' THR . 0.3 OUTLIER -48.79 133.91 16.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.331 -179.575 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 48.6 mtp85 -67.12 -31.14 71.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.741 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -70.98 -22.83 62.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.039 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 66.9 m -52.1 146.62 8.57 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.88 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.697 ' HB3' HG23 ' A' ' 56' ' ' THR . 63.6 t0 -61.07 -43.82 98.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.876 0.37 . . . . 0.0 110.727 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.424 HG21 ' CD1' ' A' ' 37' ' ' LEU . 23.0 t -125.17 132.95 70.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.357 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 6.7 pt -109.86 127.16 66.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.856 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.592 ' CD1' HD11 ' A' ' 73' ' ' ILE . 8.0 mt -103.67 -132.76 0.3 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.881 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.405 ' O ' ' CB ' ' A' ' 70' ' ' GLU . 29.4 t -57.67 -105.67 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 O-C-N 122.336 -0.227 . . . . 0.0 111.002 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.479 ' HA ' HG22 ' A' ' 73' ' ' ILE . 2.7 mt-10 167.02 -64.37 0.0 OUTLIER Pre-proline 0 N--CA 1.463 0.207 0 CA-C-O 120.605 0.24 . . . . 0.0 111.213 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.448 ' CD ' ' CB ' ' A' ' 70' ' ' GLU . 21.5 Cg_endo -61.04 -40.08 54.78 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.6 2.2 . . . . 0.0 112.673 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -110.34 20.81 17.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.307 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.592 HD11 ' CD1' ' A' ' 68' ' ' LEU . 4.7 tp -109.39 121.8 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-O 121.114 0.483 . . . . 0.0 111.098 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 45.1 t -83.4 136.23 34.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.357 -179.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.928 HG23 ' HB2' ' A' ' 61' ' ' SER . 63.6 m -61.24 -30.01 70.18 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.988 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.406 ' O ' ' C ' ' A' ' 77' ' ' HIS . 12.2 m-85 -103.92 14.23 31.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.731 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.494 ' CE1' HD12 ' A' ' 73' ' ' ILE . 0.1 OUTLIER -29.81 -72.95 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.348 -179.232 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.718 ' HB3' ' CZ ' ' A' ' 127' ' ' PHE . . . -156.48 164.1 38.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.979 0.419 . . . . 0.0 111.821 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 56' ' ' THR . 0.0 OUTLIER -129.23 136.05 49.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.651 179.666 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.965 ' CE2' HG22 ' A' ' 97' ' ' VAL . 9.3 m-85 -119.3 127.88 53.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.64 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.407 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 9.0 m-70 -94.88 116.41 28.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.975 0.416 . . . . 0.0 111.53 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.673 HD13 HG21 ' A' ' 50' ' ' ILE . 0.3 OUTLIER -106.68 109.74 21.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.551 179.386 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.18 140.08 53.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.207 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -102.4 122.38 44.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.67 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.31 113.43 20.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.15 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -107.09 121.54 44.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.816 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.488 ' O ' HG13 ' A' ' 87' ' ' VAL . 11.4 p -139.98 120.1 13.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.26 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 57.99 65.53 1.28 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.001 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.8 t30 66.66 -73.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.998 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -60.47 122.63 15.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.864 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -111.17 129.14 56.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.919 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -106.64 135.52 48.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.942 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.524 ' C ' HD22 ' A' ' 94' ' ' LEU . 9.3 m-80 -99.97 131.29 46.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.903 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.524 HD22 ' C ' ' A' ' 93' ' ' ASN . 3.9 mm? -121.93 128.42 51.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.814 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.61 ' N ' HD12 ' A' ' 95' ' ' ILE . 3.5 mp -112.97 141.13 29.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.076 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -113.99 143.93 43.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.769 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.965 HG22 ' CE2' ' A' ' 80' ' ' PHE . 12.0 t -107.01 126.67 63.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.153 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.451 HD12 ' N ' ' A' ' 98' ' ' ILE . 3.9 mp -128.23 120.97 54.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.02 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -114.17 138.75 50.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.941 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.21 -11.05 19.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.208 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.0 m 65.67 102.39 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.825 0.345 . . . . 0.0 110.913 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 12.6 mmp_? -128.1 -69.04 0.74 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.865 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 35.7 p-10 -110.97 -32.65 6.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.868 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 147.42 100.94 0.26 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.466 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.502 ' O ' HD23 ' A' ' 112' ' ' LEU . 0.9 OUTLIER -119.83 123.92 44.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.769 0.319 . . . . 0.0 110.93 -179.96 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . 0.406 ' CE2' ' HG3' ' A' ' 111' ' ' ARG . 4.7 m-85 -121.15 138.12 54.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.849 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.804 HG22 ' CD2' ' A' ' 112' ' ' LEU . 3.4 tp -121.68 137.3 55.77 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-O 121.59 0.71 . . . . 0.0 111.367 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 60.05 30.41 19.9 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.69 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.8 13.03 75.1 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.782 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -129.53 152.05 49.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.946 0.403 . . . . 0.0 111.048 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . 0.406 ' HG3' ' CE2' ' A' ' 106' ' ' PHE . 30.5 ttt180 -75.02 143.46 43.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.939 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.804 ' CD2' HG22 ' A' ' 107' ' ' ILE . 4.0 mm? -69.71 138.25 52.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.024 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.464 HG23 ' N ' ' A' ' 114' ' ' LYS . 16.8 m -134.39 -46.14 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.05 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.464 ' N ' HG23 ' A' ' 113' ' ' VAL . 0.5 OUTLIER -88.34 162.98 16.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.925 179.916 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.16 31.93 5.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.912 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -161.81 65.66 0.25 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.904 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -84.1 139.11 32.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.8 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.485 ' O ' HG23 ' A' ' 118' ' ' ILE . 8.4 tp -98.58 121.42 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.221 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.647 HD21 ' CD2' ' A' ' 135' ' ' PHE . 3.4 tp -103.14 132.75 49.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.902 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -126.38 178.03 6.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.79 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.439 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 7.1 p30 -63.05 143.13 58.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.9 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 69.37 50.36 33.03 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.535 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -117.73 142.24 47.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.767 0.318 . . . . 0.0 111.025 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 61.9 mtt85 -100.94 127.14 47.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.83 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.419 ' HB ' ' CE2' ' A' ' 133' ' ' PHE . 1.6 mp -123.37 136.91 58.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.185 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 38.1 t -124.01 124.05 68.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.92 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.718 ' CZ ' ' HB3' ' A' ' 78' ' ' ALA . 3.3 m-85 -111.8 133.03 54.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.09 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 82.36 -67.55 3.68 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.419 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.35 -41.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.772 0.32 . . . . 0.0 111.118 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.81 -41.98 4.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.701 -179.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 29.1 m -51.98 105.65 0.12 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.934 0.397 . . . . 0.0 111.231 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 32.4 p -124.36 134.72 53.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.909 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.419 ' CE2' ' HB ' ' A' ' 125' ' ' ILE . 6.8 p90 -141.97 155.03 45.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.01 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.3 tp -112.64 138.38 49.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.777 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.647 ' CD2' HD21 ' A' ' 119' ' ' LEU . 47.7 t80 -108.15 141.48 39.81 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 122.005 0.907 . . . . 0.0 111.802 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 9.2 ptpt -154.59 154.13 32.53 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 113.883 -1.508 . . . . 0.0 110.873 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.439 ' CE2' ' HB3' ' A' ' 121' ' ' ASN . 0.8 OUTLIER -86.0 139.6 31.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.913 0.387 . . . . 0.0 110.734 179.643 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.633 ' HB2' ' ND1' ' A' ' 36' ' ' HIS . . . . . . . . 0 C--N 1.325 -0.484 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.121 -179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.454 ' N ' HG22 ' A' ' 51' ' ' THR . 0.0 OUTLIER . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.778 0.323 . . . . 0.0 110.613 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 49.7 t -59.88 145.02 47.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.094 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.804 HD13 HD21 ' A' ' 82' ' ' LEU . 8.4 tt -150.96 -46.68 0.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.844 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.616 ' C ' HG22 ' A' ' 50' ' ' ILE . . . -151.16 -176.95 24.52 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.473 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 40.9 m80 -147.08 157.89 43.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.872 0.368 . . . . 0.0 111.041 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.575 HD23 ' N ' ' A' ' 37' ' ' LEU . 0.3 OUTLIER -127.02 129.42 48.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.716 179.712 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.63 HG22 ' HD2' ' A' ' 47' ' ' LYS . 21.3 t -109.03 122.0 63.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.224 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -90.01 119.89 30.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.805 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 66.3 mt -75.68 108.69 8.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.887 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.408 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 14.4 mt -122.24 138.52 29.13 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.408 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 87.8 Cg_exo -46.94 -27.95 6.49 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.568 2.178 . . . . 0.0 112.529 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -114.15 -125.55 4.18 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.413 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -53.89 138.31 36.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.795 0.331 . . . . 0.0 111.129 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -82.12 150.52 27.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.833 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -117.01 110.51 18.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.025 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.63 ' HD2' HG22 ' A' ' 38' ' ' VAL . 0.5 OUTLIER -113.04 121.0 43.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.842 179.891 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.8 t -124.53 151.06 29.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.153 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -100.26 142.15 32.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.786 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.616 HG22 ' C ' ' A' ' 35' ' ' GLY . 6.1 tt -116.03 132.21 66.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.373 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.454 HG22 ' N ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -97.59 168.08 10.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.819 -179.848 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.884 ' HA ' HD22 ' A' ' 82' ' ' LEU . 11.4 p30 -85.01 62.71 7.68 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.134 0.492 . . . . 0.0 110.238 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.562 ' C ' ' H ' ' A' ' 55' ' ' VAL . 22.3 ttt-85 -81.24 2.75 26.55 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.051 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.404 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 0.5 OUTLIER 72.06 -35.24 0.32 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 -178.77 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.562 ' H ' ' C ' ' A' ' 53' ' ' ARG . 73.5 t -137.18 138.43 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.424 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.732 HG23 ' CB ' ' A' ' 65' ' ' ASP . 96.9 m -125.2 129.66 50.54 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.587 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.418 ' O ' ' N ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -103.98 140.72 37.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.897 0.379 . . . . 0.0 110.954 -179.825 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.543 HD13 ' HE2' ' A' ' 127' ' ' PHE . 9.6 mt -132.05 123.41 50.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.964 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 171.78 -148.46 10.96 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.717 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.47 ' HB2' HG23 ' A' ' 73' ' ' ILE . 9.4 tpt85 -93.55 -33.11 13.88 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.754 0.311 . . . . 0.0 111.083 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.7 ' HB2' HG23 ' A' ' 75' ' ' THR . 3.5 t -53.61 139.98 30.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.133 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.17 -25.41 61.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.119 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 63.6 p -69.81 -24.69 63.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.99 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 93.3 m -59.1 163.94 3.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.873 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.732 ' CB ' HG23 ' A' ' 56' ' ' THR . 0.9 OUTLIER -72.16 -59.18 2.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.033 0.444 . . . . 0.0 110.692 179.807 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.8 t -109.64 122.01 63.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.111 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.1 pt -98.4 105.11 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.917 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.441 HD13 ' HA ' ' A' ' 68' ' ' LEU . 1.6 mm? -64.94 -25.92 68.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.92 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 49.1 m 62.63 26.68 15.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.98 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.423 ' CB ' ' HB ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -85.37 148.52 49.91 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.707 179.837 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.04 -14.05 42.12 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.678 2.252 . . . . 0.0 113.061 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -135.17 23.27 3.51 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.488 HG23 ' O ' ' A' ' 73' ' ' ILE . 5.2 tp -77.33 120.37 27.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.979 0.418 . . . . 0.0 110.996 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.401 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 47.0 t -62.39 133.99 55.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.311 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.7 HG23 ' HB2' ' A' ' 61' ' ' SER . 94.3 m -57.94 -31.76 67.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.733 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.465 ' O ' ' C ' ' A' ' 77' ' ' HIS . 13.5 m-85 -110.36 13.9 22.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.48 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.465 ' C ' ' O ' ' A' ' 76' ' ' PHE . 1.9 t60 -18.93 -67.69 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.708 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -156.34 162.29 40.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.0 0.428 . . . . 0.0 111.982 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -128.55 132.56 48.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.385 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.813 ' CZ ' HG13 ' A' ' 97' ' ' VAL . 6.0 m-85 -119.28 129.39 54.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.838 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.404 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 16.2 m-70 -94.88 116.19 28.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.855 0.36 . . . . 0.0 111.348 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.884 HD22 ' HA ' ' A' ' 52' ' ' ASN . 7.1 tt -106.85 109.88 21.9 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.714 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.28 139.93 52.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.933 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -107.31 133.29 52.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.871 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -140.18 140.7 35.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.881 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -97.33 119.68 36.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.897 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.4 t -135.74 114.53 15.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.205 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 59.59 78.1 0.28 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.944 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 64.08 -79.25 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.03 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -69.59 159.53 33.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.914 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -111.91 140.63 46.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.921 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -104.05 148.42 26.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.824 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.435 ' HB2' ' CD1' ' A' ' 137' ' ' TYR . 14.3 m120 -114.01 120.03 39.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.99 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.95 HD12 HD11 ' A' ' 118' ' ' ILE . 4.1 mm? -105.37 127.52 53.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.766 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.472 ' HB ' HD22 ' A' ' 119' ' ' LEU . 26.7 mm -113.1 141.12 29.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.182 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -115.83 144.09 44.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.672 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.813 HG13 ' CZ ' ' A' ' 80' ' ' PHE . 22.0 t -112.32 134.3 55.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.228 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 27.7 mt -130.01 129.87 65.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.1 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.778 ' HB2' HD11 ' A' ' 112' ' ' LEU . 44.1 t0 -98.22 125.04 43.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.866 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 26.9 mmtp -147.42 31.37 0.9 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.893 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.1 m -105.42 171.68 7.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.878 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 21.1 mtt85 -110.36 -31.53 7.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.884 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -69.07 -73.31 0.15 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.235 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 176.36 135.41 2.14 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.672 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.513 HG23 ' CD1' ' A' ' 127' ' ' PHE . 88.2 m -131.82 122.96 26.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.773 0.321 . . . . 0.0 110.536 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -120.37 130.91 54.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.042 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.2 tp -123.02 137.35 56.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.49 0.662 . . . . 0.0 111.216 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 62.75 28.8 16.65 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.823 -1.08 . . . . 0.0 110.776 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.81 6.0 62.38 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.925 -0.655 . . . . 0.0 113.073 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -134.21 144.26 48.34 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.788 0.328 . . . . 0.0 110.825 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.3 ttm180 -70.32 128.94 37.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.818 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.778 HD11 ' HB2' ' A' ' 99' ' ' ASP . 0.8 OUTLIER -76.26 139.2 41.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.98 -179.966 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 30.6 m -111.78 -34.85 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.028 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -105.99 166.0 10.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.84 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.43 171.47 8.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.939 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.9 t70 62.65 56.23 2.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.023 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.404 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 0.2 OUTLIER -79.0 137.58 37.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.745 179.879 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.95 HD11 HD12 ' A' ' 94' ' ' LEU . 8.5 tp -98.65 119.62 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-O 121.013 0.435 . . . . 0.0 111.418 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.839 HD11 HD11 ' A' ' 125' ' ' ILE . 5.9 tt -103.19 132.62 49.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.849 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 29.5 mttt -114.63 178.09 4.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.442 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 5.6 p-10 -56.23 136.69 52.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.019 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 69.47 51.36 26.72 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.3 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -111.64 129.55 56.05 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.789 0.328 . . . . 0.0 111.028 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.513 ' NH1' HD23 ' A' ' 134' ' ' LEU . 11.7 ttm-85 -88.23 123.96 33.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.829 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.839 HD11 HD11 ' A' ' 119' ' ' LEU . 2.1 mp -123.07 130.43 74.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.159 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 43.7 t -124.03 134.09 67.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.179 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.543 ' HE2' HD13 ' A' ' 58' ' ' ILE . 8.6 m-85 -115.78 139.32 50.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.92 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 71.29 -64.63 1.01 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.477 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 15.0 mttt 170.34 -37.24 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.755 0.312 . . . . 0.0 111.011 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 23.8 p -99.89 -43.55 6.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.406 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 76.5 m -53.17 104.47 0.1 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.936 0.398 . . . . 0.0 111.311 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.56 127.71 47.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.963 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.432 ' CE2' ' HB ' ' A' ' 125' ' ' ILE . 4.0 p90 -142.14 156.26 45.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.966 0.412 . . . . 0.0 111.283 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.513 HD23 ' NH1' ' A' ' 124' ' ' ARG . 0.3 OUTLIER -116.33 120.3 38.44 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.625 179.788 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.477 ' HE2' HG21 ' A' ' 50' ' ' ILE . 45.7 t80 -97.93 141.66 30.63 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.978 0.894 . . . . 0.0 111.976 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.35 147.09 24.27 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 113.807 -1.542 . . . . 0.0 110.828 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.442 ' CE2' ' HB3' ' A' ' 121' ' ' ASN . 10.1 m-85 -76.56 140.01 40.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.037 0.446 . . . . 0.0 110.812 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.542 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.14 -179.992 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.493 ' N ' HG22 ' A' ' 51' ' ' THR . 0.7 OUTLIER . . . . . 0 N--CA 1.457 -0.093 0 CA-C-O 120.721 0.296 . . . . 0.0 110.776 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 52.4 t -61.82 137.5 58.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.855 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.661 HD11 ' OD1' ' A' ' 93' ' ' ASN . 5.3 tt -142.93 -50.44 0.35 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.969 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.616 ' C ' HG22 ' A' ' 50' ' ' ILE . . . -140.3 -177.35 15.87 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.544 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 47.5 m80 -144.69 161.02 40.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.899 0.38 . . . . 0.0 110.987 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.0 mt -121.94 121.02 36.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.637 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.3 t -96.04 121.89 47.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.345 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.16 131.79 35.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.425 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' A' ' 133' ' ' PHE . 1.9 mp -113.38 106.83 15.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.935 0.398 . . . . 0.0 111.21 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.414 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 22.0 mt -124.15 138.33 30.59 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.887 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.414 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 83.0 Cg_exo -45.38 -28.8 4.17 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.478 2.119 . . . . 0.0 112.639 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -85.02 -30.12 26.67 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.406 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 174.88 -169.54 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.879 0.371 . . . . 0.0 110.969 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -129.37 -178.53 4.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.946 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -162.52 151.09 14.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.975 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.7 tttt -113.01 131.53 55.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.008 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.1 t -119.1 147.48 22.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.135 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -100.16 128.54 46.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.859 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.662 HG21 ' HE1' ' A' ' 135' ' ' PHE . 15.3 tt -115.93 132.3 65.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.247 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.493 HG22 ' N ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -97.99 168.11 10.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.884 -179.824 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -102.33 75.56 1.49 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.43 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.601 ' C ' ' H ' ' A' ' 55' ' ' VAL . 1.6 ptp85 -101.05 23.59 10.56 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.39 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 68.59 -28.31 0.15 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.717 0.294 . . . . 0.0 110.216 -179.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.601 ' H ' ' C ' ' A' ' 53' ' ' ARG . 65.3 t -137.27 139.73 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 CA-C-O 121.087 0.47 . . . . 0.0 111.352 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.651 HG23 ' HB3' ' A' ' 65' ' ' ASP . 38.5 m -125.28 125.47 43.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.046 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.88 137.24 42.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.801 0.334 . . . . 0.0 110.806 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.2 mp -128.53 121.28 54.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.98 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 172.68 -151.8 15.03 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.656 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.416 ' HB2' ' CG2' ' A' ' 73' ' ' ILE . 6.3 ttp180 -87.67 -31.26 19.84 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.775 0.321 . . . . 0.0 110.974 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.898 ' HB2' HG23 ' A' ' 75' ' ' THR . 0.1 OUTLIER -55.53 127.54 30.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.226 -179.751 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.81 -25.53 68.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.915 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 91.0 p -69.87 -25.48 63.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.927 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 88.8 m -56.11 153.49 9.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.87 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.651 ' HB3' HG23 ' A' ' 56' ' ' THR . 10.0 t70 -62.7 -45.93 90.49 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.988 0.423 . . . . 0.0 110.664 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.5 t -120.31 129.16 75.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.947 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 31.2 mt -102.6 104.87 17.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.241 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.604 HD11 ' CE2' ' A' ' 133' ' ' PHE . 1.3 tp -77.67 -154.58 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.132 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.471 ' O ' ' CB ' ' A' ' 70' ' ' GLU . 26.9 m -44.14 -97.79 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 111.262 0.097 . . . . 0.0 111.262 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.471 ' CB ' ' O ' ' A' ' 69' ' ' SER . 2.5 mt-10 158.81 -65.12 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.446 0 CA-C-O 120.704 0.287 . . . . 0.0 111.427 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.462 ' CD ' ' CB ' ' A' ' 70' ' ' GLU . 12.0 Cg_endo -55.93 -40.05 87.44 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.705 2.27 . . . . 0.0 113.146 -178.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -117.97 28.4 8.42 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.663 0.245 . . . . 0.0 111.663 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.537 HD11 ' CD2' ' A' ' 68' ' ' LEU . 4.9 tp -112.64 125.37 69.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.046 0.45 . . . . 0.0 111.459 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.432 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 57.3 m -76.87 137.71 39.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.186 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.898 HG23 ' HB2' ' A' ' 61' ' ' SER . 52.8 m -60.09 -40.96 91.42 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.09 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.45 ' O ' ' C ' ' A' ' 77' ' ' HIS . 14.0 m-85 -99.46 14.13 30.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.088 0.47 . . . . 0.0 111.922 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.45 ' C ' ' O ' ' A' ' 76' ' ' PHE . 0.8 OUTLIER -22.74 -69.38 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.598 -179.361 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -154.61 164.1 39.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.054 0.455 . . . . 0.0 111.837 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -131.8 130.36 41.69 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.457 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.887 ' CZ ' HG13 ' A' ' 97' ' ' VAL . 7.3 m-85 -119.47 131.56 55.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.949 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 9.6 m170 -94.3 116.41 28.79 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.937 0.399 . . . . 0.0 111.075 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.448 HD13 ' O ' ' A' ' 51' ' ' THR . 3.9 tt -106.44 109.96 22.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.913 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.1 mp -117.85 139.22 51.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.009 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -126.57 128.74 47.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.905 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.09 146.15 38.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.913 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -104.66 115.92 31.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.85 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.4 m -122.96 110.95 27.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.262 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 57.63 82.68 0.12 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.109 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 62.47 -79.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.094 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -58.99 170.53 0.83 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.941 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -126.7 140.46 52.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.919 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.32 119.37 39.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.844 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.661 ' OD1' HD11 ' A' ' 34' ' ' LEU . 3.0 m-80 -108.6 123.75 49.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.805 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.6 mt -125.68 132.6 52.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.981 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.543 ' N ' HD12 ' A' ' 95' ' ' ILE . 4.0 mp -114.87 141.02 33.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.026 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -113.97 144.07 43.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.998 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.887 HG13 ' CZ ' ' A' ' 80' ' ' PHE . 18.2 t -110.48 127.73 67.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.136 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 33.1 mt -130.01 121.0 50.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.146 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -113.84 117.36 31.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.786 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.26 24.56 10.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.099 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 46.5 m 63.19 142.57 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.888 0.375 . . . . 0.0 110.939 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 6.4 tpt180 -178.71 -68.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.721 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -123.32 -31.01 3.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.249 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 128.82 120.46 2.27 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.281 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.476 HG23 ' CE1' ' A' ' 127' ' ' PHE . 90.6 m -123.27 128.47 50.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.847 0.355 . . . . 0.0 111.063 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -120.98 114.99 22.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.766 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.846 HD12 ' O ' ' A' ' 124' ' ' ARG . 2.2 tp -120.51 137.25 54.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.522 0.677 . . . . 0.0 111.496 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 59.18 28.16 17.38 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.05 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.71 13.07 74.79 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.952 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -133.17 150.13 52.02 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.835 0.35 . . . . 0.0 110.948 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 19.3 ttt-85 -74.96 142.35 43.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.92 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.88 127.86 35.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.847 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.484 HG13 ' HG2' ' A' ' 114' ' ' LYS . 12.7 p -117.82 -40.07 2.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.155 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.484 ' HG2' HG13 ' A' ' 113' ' ' VAL . 4.4 mmmt -84.18 173.74 10.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.823 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.5 ptpt -121.2 32.86 5.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.818 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -145.94 49.55 1.2 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.9 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -81.56 138.11 35.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.796 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.516 ' O ' HG23 ' A' ' 118' ' ' ILE . 8.8 tp -98.56 118.93 45.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.195 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.546 HD11 HD11 ' A' ' 125' ' ' ILE . 7.9 tt -103.1 136.21 43.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.015 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.9 mtmt -125.65 178.06 5.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.789 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.431 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 4.7 p30 -59.53 137.74 57.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.004 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 74.2 55.57 5.64 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.444 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -117.31 139.29 51.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.925 0.393 . . . . 0.0 110.849 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.846 ' O ' HD12 ' A' ' 107' ' ' ILE . 3.1 ttt180 -103.18 123.62 47.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.855 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.546 HD11 HD11 ' A' ' 119' ' ' LEU . 1.4 mp -126.75 135.7 62.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.184 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.4 t -120.63 125.09 73.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.058 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.476 ' CE1' HG23 ' A' ' 105' ' ' THR . 90.1 m-85 -120.61 130.61 54.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.114 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 84.07 -6.0 77.26 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.899 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 12.2 mtpt 77.2 28.78 0.6 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.911 0.386 . . . . 0.0 110.525 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.29 -45.08 0.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.073 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . 0.471 ' CB ' HD21 ' A' ' 68' ' ' LEU . 99.6 m -77.37 107.75 10.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.804 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 47.3 t -124.07 126.32 46.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.971 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.604 ' CE2' HD11 ' A' ' 68' ' ' LEU . 12.9 p90 -142.05 155.51 45.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.926 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.47 140.05 39.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.773 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.662 ' HE1' HG21 ' A' ' 50' ' ' ILE . 55.6 t80 -103.52 141.66 35.62 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 121.924 0.868 . . . . 0.0 111.809 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.8 tttt -154.26 147.69 25.03 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 113.953 -1.476 . . . . 0.0 110.932 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.467 ' CD1' ' N ' ' A' ' 137' ' ' TYR . 0.8 OUTLIER -79.88 139.73 37.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.712 179.729 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.476 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.141 -179.836 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.2 m . . . . . 0 N--CA 1.456 -0.135 0 CA-C-O 120.737 0.303 . . . . 0.0 110.648 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 53.6 t -59.96 134.77 57.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.842 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.492 HD12 ' CG ' ' A' ' 84' ' ' GLN . 3.7 tt -133.79 -46.11 0.8 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.987 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.57 ' O ' HG22 ' A' ' 50' ' ' ILE . . . -156.85 -176.66 29.17 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.594 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -142.29 166.05 25.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.87 0.366 . . . . 0.0 110.901 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.651 ' CD1' HG21 ' A' ' 66' ' ' VAL . 3.8 mt -127.19 110.21 12.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.862 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.598 HG22 ' HD3' ' A' ' 47' ' ' LYS . 23.2 t -102.23 121.77 53.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.136 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -90.08 123.78 34.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.863 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.8 mt -83.8 106.68 15.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.82 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.708 HD12 ' HA ' ' A' ' 45' ' ' GLU . 1.5 mt -124.16 138.01 30.03 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.925 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -46.99 -27.76 6.36 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.454 2.103 . . . . 0.0 112.531 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -133.22 107.36 0.68 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.483 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 36.7 mttt 63.16 129.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.796 0.332 . . . . 0.0 110.916 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . 0.708 ' HA ' HD12 ' A' ' 41' ' ' ILE . 42.3 mt-10 -95.64 170.22 9.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.929 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -126.32 121.94 34.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.897 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.598 ' HD3' HG22 ' A' ' 38' ' ' VAL . 1.1 mmmp? -102.97 129.07 49.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.936 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.2 t -121.6 130.71 74.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.065 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.12 124.2 32.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.935 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.57 HG22 ' O ' ' A' ' 35' ' ' GLY . 2.9 tt -116.02 132.14 66.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.138 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.517 ' O ' HD13 ' A' ' 82' ' ' LEU . 0.1 OUTLIER -99.76 168.39 9.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.245 -179.541 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.458 ' HB3' HD13 ' A' ' 34' ' ' LEU . 16.8 p30 -82.26 68.3 8.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.342 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.558 ' C ' ' H ' ' A' ' 55' ' ' VAL . 23.5 ttt-85 -83.01 6.58 18.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.041 -179.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.477 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 2.2 t30 71.43 -38.45 0.42 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -178.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.558 ' H ' ' C ' ' A' ' 53' ' ' ARG . 75.6 t -137.64 133.49 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.531 179.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.919 ' OG1' HD11 ' A' ' 82' ' ' LEU . 33.0 m -125.24 131.25 53.16 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.178 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.91 133.86 48.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.892 0.377 . . . . 0.0 111.037 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.581 ' N ' HD12 ' A' ' 58' ' ' ILE . 3.9 mp -118.22 123.58 71.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.201 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 166.98 -130.08 2.05 Favored Glycine 0 C--N 1.331 0.267 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.275 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.533 ' HB3' ' HA ' ' A' ' 70' ' ' GLU . 7.2 ptt180 -122.23 -25.96 4.77 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.55 0.214 . . . . 0.0 111.288 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.428 ' HB2' HG23 ' A' ' 75' ' ' THR . 0.2 OUTLIER -48.53 125.38 9.71 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.881 0.372 . . . . 0.0 110.999 -179.919 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.97 -25.47 29.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.163 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 41.1 p -78.23 -23.42 47.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.993 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 93.8 m -57.16 169.27 0.59 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.967 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.8 ' CB ' HG23 ' A' ' 56' ' ' THR . 1.6 m-20 -85.91 -68.31 0.74 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.984 0.421 . . . . 0.0 110.909 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.651 HG21 ' CD1' ' A' ' 37' ' ' LEU . 27.7 t -101.99 133.05 46.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.085 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 15.7 pt -112.78 127.82 69.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.161 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.762 HD22 ' HB3' ' A' ' 131' ' ' CYS . 13.4 mt -94.04 -84.28 0.32 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.487 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.412 ' O ' ' CB ' ' A' ' 70' ' ' GLU . 10.8 t -102.55 -104.52 0.27 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.639 ' CB ' ' HD3' ' A' ' 71' ' ' PRO . 0.0 OUTLIER 166.76 -64.66 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.19 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 178.937 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.639 ' HD3' ' CB ' ' A' ' 70' ' ' GLU . 15.6 Cg_exo -67.84 -40.23 9.97 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.299 1.999 . . . . 0.0 113.519 -179.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -110.55 16.06 21.72 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -179.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.499 ' CG2' ' HB3' ' A' ' 60' ' ' ARG . 3.6 tp -107.15 124.72 63.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.865 0.364 . . . . 0.0 110.773 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.5 m -57.47 131.52 50.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.408 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.428 HG23 ' HB2' ' A' ' 61' ' ' SER . 35.2 m -63.69 -39.96 95.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.436 179.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.465 ' O ' ' C ' ' A' ' 77' ' ' HIS . 4.4 m-85 -104.99 13.74 30.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.164 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.488 ' CD2' ' CD1' ' A' ' 127' ' ' PHE . 1.5 t60 -16.65 -69.1 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.582 -1.19 . . . . 0.0 112.708 -179.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.581 ' HB3' ' CZ ' ' A' ' 127' ' ' PHE . . . -158.88 164.1 35.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.916 0.389 . . . . 0.0 111.611 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -124.0 140.36 53.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.872 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.933 ' CE1' HG13 ' A' ' 97' ' ' VAL . 4.8 m-85 -119.54 131.06 55.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.542 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.477 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 21.1 m-70 -102.91 116.11 31.9 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.691 -0.403 . . . . 0.0 111.674 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.919 HD11 ' OG1' ' A' ' 56' ' ' THR . 0.2 OUTLIER -107.06 109.84 21.8 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.635 179.116 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.2 mt -120.67 140.05 52.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.992 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . 0.492 ' CG ' HD12 ' A' ' 34' ' ' LEU . 56.8 mt-30 -109.49 125.76 52.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.768 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 11.1 mtp -129.62 148.53 51.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.952 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -107.07 119.92 40.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.856 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.4 t -129.44 110.96 21.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.138 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.8 t70 58.67 68.52 0.82 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.934 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 68.26 -68.36 0.17 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.951 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -64.57 146.93 53.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.865 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.91 128.04 54.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.985 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -98.54 144.68 27.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.832 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -109.14 127.01 53.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.988 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.419 ' CD2' HD11 ' A' ' 118' ' ' ILE . 1.1 mt -123.41 129.19 50.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.691 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.63 HD12 HD23 ' A' ' 82' ' ' LEU . 30.6 mm -117.93 138.01 50.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.903 0.383 . . . . 0.0 111.284 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -113.9 144.08 43.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.745 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.933 HG13 ' CE1' ' A' ' 80' ' ' PHE . 18.2 t -114.65 134.8 56.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.178 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 25.4 mm -121.04 121.01 63.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.03 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -97.75 123.71 41.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.941 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.98 -26.36 31.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.97 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.4 m 65.28 99.02 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.909 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.68 -42.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.888 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -104.26 -55.66 2.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.228 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 143.6 106.65 0.56 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.501 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 90.9 m -118.39 126.86 52.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.71 0.29 . . . . 0.0 110.898 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -120.93 115.03 22.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.921 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.728 HD12 ' O ' ' A' ' 124' ' ' ARG . 2.5 tp -114.16 137.36 47.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.464 0.649 . . . . 0.0 111.21 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 63.09 29.05 16.26 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.826 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.78 7.98 66.93 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.974 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -134.17 144.14 48.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.758 0.313 . . . . 0.0 110.856 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.4 ttp180 -70.51 128.99 38.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.81 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.729 HD13 ' N ' ' A' ' 113' ' ' VAL . 0.3 OUTLIER -92.2 137.97 31.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.917 -179.957 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.729 ' N ' HD13 ' A' ' 112' ' ' LEU . 6.2 m -121.51 -42.08 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.1 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.4 mttm -65.37 -174.55 0.19 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.852 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.0 tttt -124.0 171.15 9.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.803 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.5 t70 60.48 63.42 1.36 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.872 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . 0.437 ' CZ ' HG12 ' A' ' 107' ' ' ILE . 10.7 t80 -84.2 139.13 32.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.785 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.534 ' O ' HG23 ' A' ' 118' ' ' ILE . 8.4 tp -98.37 118.5 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.253 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.561 HD13 ' C ' ' A' ' 119' ' ' LEU . 3.2 tm? -100.84 120.0 39.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.767 -179.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.427 ' N ' HD13 ' A' ' 119' ' ' LEU . 0.4 OUTLIER -118.7 178.07 4.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.882 -179.955 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.443 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 17.8 p30 -60.06 135.79 57.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.017 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 75.04 56.32 4.86 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.582 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -123.09 135.06 54.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.845 0.355 . . . . 0.0 111.04 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.728 ' O ' HD12 ' A' ' 107' ' ' ILE . 0.0 OUTLIER -99.47 117.33 33.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.825 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.611 HG12 HD13 ' A' ' 107' ' ' ILE . 5.1 mt -115.0 133.21 61.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.114 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.566 HG13 ' O ' ' A' ' 131' ' ' CYS . 21.4 t -124.09 127.69 73.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.072 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.581 ' CZ ' ' HB3' ' A' ' 78' ' ' ALA . 4.8 m-85 -116.66 126.19 52.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.042 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 92.87 -71.09 1.51 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.36 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 174.55 -43.57 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.788 0.328 . . . . 0.0 111.171 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.0 p -98.08 -41.91 7.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.545 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . 0.762 ' HB3' HD22 ' A' ' 68' ' ' LEU . 25.3 m -54.13 106.17 0.18 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.955 0.407 . . . . 0.0 111.222 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 13.9 p -124.38 122.54 37.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.773 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -142.04 156.23 45.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.034 0.445 . . . . 0.0 111.276 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.1 tp -114.37 134.44 54.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.66 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.428 ' CD1' ' N ' ' A' ' 136' ' ' LYS . 14.5 t80 -98.2 141.17 31.44 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 121.929 0.871 . . . . 0.0 111.754 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.428 ' N ' ' CD1' ' A' ' 135' ' ' PHE . 9.6 tptt -154.86 154.71 33.14 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 113.878 -1.51 . . . . 0.0 111.128 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.443 ' CE2' ' HB3' ' A' ' 121' ' ' ASN . 13.2 m-85 -86.13 140.15 30.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.623 179.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.542 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.124 -179.83 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . 0.457 ' O ' HG22 ' A' ' 51' ' ' THR . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.692 0.282 . . . . 0.0 110.705 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 52.6 t -64.66 144.79 56.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.954 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.586 HD22 ' HB3' ' A' ' 52' ' ' ASN . 10.2 tp -155.33 -46.32 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.705 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -154.67 169.69 32.94 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.229 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.563 ' ND1' ' HB2' ' A' ' 138' ' ' ALA . 27.2 m80 -131.52 163.62 27.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.948 0.404 . . . . 0.0 110.946 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.649 HD12 HG21 ' A' ' 66' ' ' VAL . 19.1 mt -127.06 111.07 13.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.801 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.4 t -95.92 121.88 46.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.119 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -89.17 120.88 30.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.912 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.0 mp -79.71 107.05 12.18 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.888 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.403 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 11.7 mt -123.98 138.39 30.52 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.856 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.403 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 84.4 Cg_exo -47.59 -27.47 7.73 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.494 2.129 . . . . 0.0 112.429 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.96 -126.09 2.99 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.465 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.9 mttt -53.1 101.72 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.824 0.345 . . . . 0.0 111.134 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -65.36 172.27 3.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.844 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -133.61 131.1 39.23 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.906 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.07 127.36 56.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.863 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.675 HG11 HG13 ' A' ' 66' ' ' VAL . 28.6 t -119.94 150.98 22.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.14 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -103.44 138.16 40.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.863 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.665 HG22 HD22 ' A' ' 82' ' ' LEU . 26.2 mm -116.08 126.67 73.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.328 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.457 HG22 ' O ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -98.3 168.13 10.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.74 179.786 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.586 ' HB3' HD22 ' A' ' 34' ' ' LEU . 26.4 p30 -100.25 66.8 1.32 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.008 0.432 . . . . 0.0 110.762 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.576 ' C ' ' H ' ' A' ' 55' ' ' VAL . 0.6 OUTLIER -97.73 21.65 10.16 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.374 179.993 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.431 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 0.6 OUTLIER 68.23 -27.87 0.14 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.485 -179.726 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.576 ' H ' ' C ' ' A' ' 53' ' ' ARG . 62.9 t -137.31 139.31 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 CA-C-O 121.075 0.465 . . . . 0.0 111.826 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.472 HG22 ' CB ' ' A' ' 65' ' ' ASP . 0.4 OUTLIER -125.24 128.05 47.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.005 179.338 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.459 ' O ' ' N ' ' A' ' 65' ' ' ASP . 0.1 OUTLIER -103.95 138.93 39.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.971 0.415 . . . . 0.0 111.417 -179.519 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 32.8 mt -132.3 131.24 60.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.13 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 162.78 -146.67 12.09 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.264 -0.969 . . . . 0.0 113.283 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.583 ' HB2' HG23 ' A' ' 73' ' ' ILE . 4.1 ttp-105 -87.59 -44.54 11.17 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.83 0.348 . . . . 0.0 111.392 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.564 ' HB3' HG23 ' A' ' 75' ' ' THR . 33.2 t -50.51 122.15 6.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.483 -179.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 -60.43 -20.28 59.21 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.905 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 16.3 m -69.75 -27.43 64.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.698 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 84.4 m -56.33 164.67 1.27 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.671 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.472 ' CB ' HG22 ' A' ' 56' ' ' THR . 0.6 OUTLIER -66.94 -52.86 37.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.979 0.418 . . . . 0.0 110.802 179.827 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.675 HG13 HG11 ' A' ' 48' ' ' VAL . 21.3 t -125.12 126.79 71.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.508 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.8 mp -97.51 119.71 45.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.498 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.713 HD22 ' HB3' ' A' ' 131' ' ' CYS . 19.4 mt -83.4 -86.61 0.11 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.078 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 34.4 m -108.66 -109.88 0.32 Allowed 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 110.251 -0.278 . . . . 0.0 110.251 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.655 ' HA ' HG22 ' A' ' 73' ' ' ILE . 0.2 OUTLIER 169.66 -63.11 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.192 0 CA-C-O 120.496 0.188 . . . . 0.0 111.412 179.414 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.588 ' HD3' ' CB ' ' A' ' 70' ' ' GLU . 37.2 Cg_exo -60.29 -40.19 61.15 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.043 1.829 . . . . 0.0 112.899 -179.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -115.13 12.73 16.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.587 -179.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.655 HG22 ' HA ' ' A' ' 70' ' ' GLU . 2.6 tp -104.55 133.32 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-O 120.831 0.348 . . . . 0.0 110.975 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.476 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 4.1 p -98.82 131.76 44.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.546 -179.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.564 HG23 ' HB3' ' A' ' 61' ' ' SER . 19.6 m -53.48 -30.17 39.69 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.159 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -93.92 14.12 20.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.018 -179.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.476 ' HB2' ' O ' ' A' ' 74' ' ' SER . 1.4 t-160 -34.51 -66.65 0.16 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.07 -179.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.57 ' HB3' ' CE2' ' A' ' 127' ' ' PHE . . . -161.62 163.24 30.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.097 0.475 . . . . 0.0 111.765 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -129.47 135.16 48.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.237 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.954 ' CE2' HG22 ' A' ' 97' ' ' VAL . 6.3 m-85 -119.34 131.46 55.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.999 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.431 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 11.9 m170 -94.69 116.45 28.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.954 0.407 . . . . 0.0 110.928 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.665 HD22 HG22 ' A' ' 50' ' ' ILE . 1.6 tp -106.45 109.95 22.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.948 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.2 tp -118.57 140.09 50.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.89 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.4 tm0? -100.4 132.0 46.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.937 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.3 130.1 56.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.85 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -95.12 130.77 41.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.964 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . 0.465 HG21 ' HD3' ' A' ' 92' ' ' ARG . 21.4 t -140.09 138.8 37.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.135 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.35 67.38 0.33 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.797 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 173.4 -52.67 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.748 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -153.03 172.24 17.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -94.78 127.94 41.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.942 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.465 ' HD3' HG21 ' A' ' 87' ' ' VAL . 0.8 OUTLIER -101.12 125.4 47.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.869 179.914 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.438 ' HB2' ' CE1' ' A' ' 137' ' ' TYR . 24.4 m120 -112.77 125.08 53.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.994 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.648 ' HG ' HD11 ' A' ' 118' ' ' ILE . 1.3 tp -122.52 129.3 51.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.694 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.476 ' N ' HD12 ' A' ' 95' ' ' ILE . 3.2 mp -122.96 141.01 44.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.204 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -116.53 144.01 44.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.827 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.954 HG22 ' CE2' ' A' ' 80' ' ' PHE . 22.0 t -112.17 124.63 69.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.193 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 20.4 mt -130.01 124.95 59.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.071 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . 0.449 ' HB2' HD22 ' A' ' 112' ' ' LEU . 26.7 m-20 -114.03 127.83 56.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.946 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.71 -7.47 59.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.372 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 21.6 m 64.25 79.02 0.27 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.779 0.324 . . . . 0.0 110.884 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.43 -39.95 3.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.919 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -133.19 -46.02 0.84 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.192 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 145.47 103.16 0.38 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.406 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.449 HG23 ' CD1' ' A' ' 127' ' ' PHE . 28.0 m -113.46 131.57 55.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.788 0.328 . . . . 0.0 110.92 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -116.49 117.71 30.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.871 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.447 HD13 HG23 ' A' ' 125' ' ' ILE . 3.0 tp -112.5 137.32 45.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.424 0.631 . . . . 0.0 111.281 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 62.15 27.66 16.65 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.942 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.59 10.22 70.74 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.94 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -133.99 151.34 51.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.775 0.321 . . . . 0.0 110.957 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.58 130.0 40.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.859 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.709 HD21 ' O ' ' A' ' 114' ' ' LYS . 7.0 tt -70.19 139.28 52.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.818 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.472 HG13 ' N ' ' A' ' 114' ' ' LYS . 10.8 p -121.98 -44.66 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.077 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . 0.709 ' O ' HD21 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -84.61 167.45 16.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.946 179.97 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -108.85 28.52 8.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.942 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -158.62 62.45 0.43 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.005 0.431 . . . . 0.0 110.8 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -84.06 139.11 32.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.803 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.648 HD11 ' HG ' ' A' ' 94' ' ' LEU . 8.6 tp -98.48 120.14 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-O 121.01 0.433 . . . . 0.0 111.408 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.679 HD11 HD11 ' A' ' 125' ' ' ILE . 6.6 tt -103.1 142.21 34.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.923 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 9.6 mmtp -129.76 178.13 6.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.817 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.45 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 9.2 p30 -56.35 144.44 30.55 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.083 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.433 ' HA2' HD21 ' A' ' 134' ' ' LEU . . . 65.51 45.49 89.65 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.42 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -112.37 133.59 54.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.91 0.386 . . . . 0.0 110.973 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.607 ' HG2' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -91.42 130.77 37.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.819 179.931 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.679 HD11 HD11 ' A' ' 119' ' ' LEU . 1.8 mp -129.83 121.92 53.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.255 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.572 HG22 ' OG ' ' A' ' 132' ' ' SER . 39.2 t -113.13 130.55 66.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.033 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.57 ' CE2' ' HB3' ' A' ' 78' ' ' ALA . 3.3 m-85 -114.61 141.39 47.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.071 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 71.59 -64.67 1.11 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.49 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 169.91 -38.2 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.884 0.373 . . . . 0.0 110.963 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 82.7 p -101.75 -39.97 7.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.041 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . 0.713 ' HB3' HD22 ' A' ' 68' ' ' LEU . 57.1 m -57.17 106.38 0.31 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.998 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . 0.572 ' OG ' HG22 ' A' ' 126' ' ' VAL . 1.3 m -124.21 123.7 40.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.889 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -142.09 156.01 45.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.111 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.607 HD12 ' HG2' ' A' ' 124' ' ' ARG . 1.4 tt -117.89 140.02 50.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.717 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -104.94 141.39 36.64 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.945 0.879 . . . . 0.0 111.935 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -154.73 159.35 40.63 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 113.711 -1.586 . . . . 0.0 110.591 179.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.45 ' CE2' ' HB3' ' A' ' 121' ' ' ASN . 2.5 m-85 -83.83 139.81 32.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.021 0.438 . . . . 0.0 110.697 179.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.563 ' HB2' ' ND1' ' A' ' 36' ' ' HIS . . . . . . . . 0 C--N 1.326 -0.441 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.131 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.232 0.134 0 CA-C-O 120.797 0.332 . . . . 0.0 110.554 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.8 t -60.71 145.05 50.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.063 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.551 HD22 ' OD1' ' A' ' 93' ' ' ASN . 9.6 mt -147.76 -53.68 0.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.908 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.689 ' C ' HG22 ' A' ' 50' ' ' ILE . . . -140.65 -175.28 14.48 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.564 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 50.4 m80 -146.07 166.05 27.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.904 0.383 . . . . 0.0 110.936 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.7 mp -125.69 107.85 10.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.539 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.65 HG22 ' HG2' ' A' ' 47' ' ' LYS . 27.6 t -96.13 121.98 47.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.167 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -89.98 113.98 25.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.86 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -87.65 106.75 18.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.878 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.542 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 18.9 mt -124.17 141.0 36.12 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.835 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.542 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 50.2 Cg_endo -72.59 83.95 1.26 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.078 1.852 . . . . 0.0 111.967 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 118.0 25.98 2.88 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.372 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 170.58 155.31 0.06 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.691 0.282 . . . . 0.0 110.555 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -142.47 151.91 42.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.975 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -140.29 128.79 22.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.176 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.65 ' HG2' HG22 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -113.04 131.24 55.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.806 179.82 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.8 t -125.46 151.02 31.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.29 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -104.24 132.92 49.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.626 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.689 HG22 ' C ' ' A' ' 35' ' ' GLY . 2.3 tt -116.07 132.02 66.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.01 0.433 . . . . 0.0 111.492 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.01 168.05 9.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.033 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.482 ' HB3' HD12 ' A' ' 34' ' ' LEU . 6.7 p30 -76.28 63.39 1.91 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.307 179.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.542 ' C ' ' H ' ' A' ' 55' ' ' VAL . 11.1 ttt-85 -80.88 0.12 36.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.013 -179.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.451 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 8.3 m120 71.51 -35.88 0.34 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -178.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.542 ' H ' ' C ' ' A' ' 53' ' ' ARG . 68.0 t -137.37 134.14 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.061 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.653 HG23 ' HB3' ' A' ' 65' ' ' ASP . 51.8 m -125.29 124.19 41.08 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.893 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.66 127.34 51.12 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.952 0.406 . . . . 0.0 111.11 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.725 ' CG2' HD11 ' A' ' 68' ' ' LEU . 4.6 mp -107.98 117.74 54.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.003 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 172.95 -144.96 8.14 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.405 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.3 ttm105 -111.15 -19.93 12.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.715 0.293 . . . . 0.0 111.245 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.449 ' HB2' HG22 ' A' ' 75' ' ' THR . 0.1 OUTLIER -50.27 151.67 2.03 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.895 0.379 . . . . 0.0 111.141 -179.859 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -72.91 -38.74 66.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.93 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 6.0 m -70.1 -19.62 63.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.209 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 48.8 m -53.91 149.25 9.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.028 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.653 ' HB3' HG23 ' A' ' 56' ' ' THR . 10.4 t70 -75.16 -53.68 8.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.904 0.383 . . . . 0.0 110.836 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.5 t -114.83 116.99 54.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.216 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 20.0 pt -99.15 131.05 47.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.061 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.834 HD13 HG12 ' A' ' 73' ' ' ILE . 5.0 mp -86.45 -175.93 5.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.911 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.2 t -118.34 34.61 5.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.98 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.419 ' HB3' ' HB ' ' A' ' 73' ' ' ILE . 5.4 tp10 -109.68 118.51 50.12 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.667 179.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -57.74 -16.11 23.79 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.566 2.177 . . . . 0.0 112.804 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -119.8 36.61 4.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.765 0.317 . . . . 0.0 111.029 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.834 HG12 HD13 ' A' ' 68' ' ' LEU . 7.3 tp -82.45 147.7 5.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.27 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.427 ' HB3' ' CG ' ' A' ' 77' ' ' HIS . 2.5 t -77.17 129.91 36.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.103 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.449 HG22 ' HB2' ' A' ' 61' ' ' SER . 1.8 m -65.37 -39.21 92.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.726 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.434 ' O ' ' C ' ' A' ' 77' ' ' HIS . 1.1 m-85 -103.8 13.94 31.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.295 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.434 ' C ' ' O ' ' A' ' 76' ' ' PHE . 0.3 OUTLIER -22.31 -71.87 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.647 -1.161 . . . . 0.0 112.595 -179.349 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.601 ' HB3' ' CE2' ' A' ' 127' ' ' PHE . . . -158.6 164.03 36.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.074 0.464 . . . . 0.0 111.928 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . 0.58 ' HG3' HD12 ' A' ' 98' ' ' ILE . 11.1 pt-20 -129.09 136.49 50.3 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.471 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.883 ' CZ ' HG13 ' A' ' 97' ' ' VAL . 6.1 m-85 -119.54 131.17 55.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.887 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.451 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 6.3 m-70 -94.87 116.38 28.64 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.89 0.376 . . . . 0.0 111.049 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.498 HD12 HG12 ' A' ' 95' ' ' ILE . 0.4 OUTLIER -106.51 109.58 21.54 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.711 179.57 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.4 mp -122.2 140.14 52.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.166 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.0 tm0? -108.97 133.34 53.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.892 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -141.89 122.69 14.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.939 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -97.05 116.1 28.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.944 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 4.2 m -119.68 110.92 30.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.243 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 59.25 72.82 0.51 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.004 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 66.08 -74.54 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.042 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -52.85 144.41 14.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.152 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -108.83 130.95 55.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.94 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -116.5 125.61 52.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.796 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.551 ' OD1' HD22 ' A' ' 34' ' ' LEU . 5.1 m120 -106.98 135.37 48.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.939 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.66 139.62 53.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.773 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.498 HG12 HD12 ' A' ' 82' ' ' LEU . 4.0 mp -127.79 138.29 55.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.205 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -113.88 140.62 48.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.772 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.883 HG13 ' CZ ' ' A' ' 80' ' ' PHE . 16.9 t -103.99 121.99 56.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.156 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . 0.58 HD12 ' HG3' ' A' ' 79' ' ' GLU . 28.6 mt -114.21 124.2 70.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.046 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -87.78 138.23 31.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.941 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.1 -25.68 14.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.013 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.1 m 65.47 81.37 0.21 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.943 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -137.07 -47.07 0.58 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.883 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -124.74 -48.83 1.77 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.157 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 154.32 129.39 1.29 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.547 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.493 HG23 ' CE1' ' A' ' 127' ' ' PHE . 1.7 m -131.94 123.7 27.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.758 0.314 . . . . 0.0 110.954 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -121.16 123.28 41.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.809 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.479 HD12 ' O ' ' A' ' 124' ' ' ARG . 2.9 tp -119.01 137.32 53.36 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-O 121.426 0.631 . . . . 0.0 111.337 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 62.38 27.97 16.62 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.859 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.66 9.82 70.33 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.971 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -133.99 152.04 51.69 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.825 0.345 . . . . 0.0 110.859 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.02 129.21 39.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.88 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.474 HD21 ' HB ' ' A' ' 105' ' ' THR . 4.1 pp -71.44 140.13 49.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.954 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.0 m -135.02 31.41 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.171 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 23.9 mmtt -145.93 149.09 33.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.931 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 17.9 ttpp -98.77 31.13 3.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.813 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -166.57 66.93 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.862 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -82.81 139.03 33.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.941 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.633 HD13 ' C ' ' A' ' 118' ' ' ILE . 0.0 OUTLIER -98.73 117.61 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.749 -179.841 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.779 HD11 HD11 ' A' ' 125' ' ' ILE . 7.7 tt -103.0 136.89 41.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.186 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . 0.542 ' N ' HD23 ' A' ' 119' ' ' LEU . 3.1 mmmm -136.14 178.15 7.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.764 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.433 ' HB3' ' CZ ' ' A' ' 137' ' ' TYR . 12.7 p30 -55.48 139.31 44.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.034 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 71.27 52.93 11.36 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.479 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -124.8 125.25 43.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.794 0.33 . . . . 0.0 110.974 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.613 ' HG3' HD12 ' A' ' 134' ' ' LEU . 11.2 mtp180 -93.67 131.81 38.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.818 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.779 HD11 HD11 ' A' ' 119' ' ' LEU . 2.7 mt -125.74 137.95 56.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.123 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 22.9 t -120.36 123.98 71.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.065 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.601 ' CE2' ' HB3' ' A' ' 78' ' ' ALA . 3.6 m-85 -119.22 128.97 54.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.139 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 80.97 -3.38 76.42 Favored Glycine 0 CA--C 1.518 0.252 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.072 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 8.6 tttt 76.31 24.5 1.09 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.861 0.362 . . . . 0.0 110.511 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.88 -52.63 0.13 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.012 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 91.1 m -77.48 107.76 10.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.671 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 79.8 p -121.99 133.33 54.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.992 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.423 ' CE1' ' HB ' ' A' ' 125' ' ' ILE . 2.8 p90 -142.01 155.69 45.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.905 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.613 HD12 ' HG3' ' A' ' 124' ' ' ARG . 7.9 tt -112.35 139.98 47.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.774 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.558 ' HE1' HG21 ' A' ' 50' ' ' ILE . 74.1 t80 -101.5 141.5 34.28 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.944 0.878 . . . . 0.0 111.838 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.31 154.11 32.82 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 113.864 -1.516 . . . . 0.0 110.784 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.479 ' CD1' ' N ' ' A' ' 137' ' ' TYR . 0.6 OUTLIER -85.53 139.72 31.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.992 0.425 . . . . 0.0 110.752 179.74 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.414 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.097 -179.918 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.4 m . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.842 0.353 . . . . 0.0 110.749 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.8 t -60.07 135.21 57.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.868 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.667 HD22 ' ND2' ' A' ' 52' ' ' ASN . 4.9 tp -136.65 -63.61 0.61 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.97 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -139.6 178.25 19.82 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.498 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.43 ' ND1' ' HB2' ' A' ' 138' ' ' ALA . 31.0 m80 -133.52 166.0 23.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.788 0.328 . . . . 0.0 110.911 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.656 HD22 ' HD2' ' A' ' 133' ' ' PHE . 18.9 mt -126.5 113.71 17.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.96 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.462 HG22 ' HD3' ' A' ' 47' ' ' LYS . 28.5 t -96.24 121.89 47.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.948 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -90.0 113.85 25.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.892 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LEU . . . . . 0.555 HD13 HH12 ' A' ' 124' ' ' ARG . 2.9 mt -77.76 106.75 9.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.785 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.523 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 1.6 mp -124.15 140.26 34.47 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.97 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' PRO . . . . . 0.523 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 67.9 Cg_endo -76.13 83.84 1.92 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.304 2.003 . . . . 0.0 112.029 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 115.62 24.04 4.18 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.382 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -179.5 166.96 1.45 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.794 0.33 . . . . 0.0 110.612 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -144.41 128.27 17.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.045 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -116.17 118.82 33.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.835 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.462 ' HD3' HG22 ' A' ' 38' ' ' VAL . 1.1 mmmp? -108.82 124.83 51.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.909 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.617 HG11 HG13 ' A' ' 66' ' ' VAL . 26.2 t -120.36 137.64 53.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.096 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.75 132.84 34.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.84 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.541 HD11 HD12 ' A' ' 37' ' ' LEU . 33.4 mm -108.76 116.25 51.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.264 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.566 ' O ' HD23 ' A' ' 82' ' ' LEU . 0.2 OUTLIER -100.88 167.77 10.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.66 179.729 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASN . . . . . 0.667 ' ND2' HD22 ' A' ' 34' ' ' LEU . 2.1 m-80 -61.68 -95.65 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.324 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ARG . . . . . 0.564 ' C ' ' H ' ' A' ' 55' ' ' VAL . 3.9 ttt-85 70.79 -4.41 1.71 Allowed 'General case' 0 C--O 1.232 0.15 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 179.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' ASN . . . . . 0.4 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 0.1 OUTLIER 70.24 -32.93 0.25 Allowed 'General case' 0 C--N 1.331 -0.226 0 O-C-N 122.156 -0.34 . . . . 0.0 110.247 -179.035 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' VAL . . . . . 0.564 ' H ' ' C ' ' A' ' 53' ' ' ARG . 65.7 t -136.72 140.72 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-O 121.082 0.468 . . . . 0.0 111.055 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.816 HG23 ' HB3' ' A' ' 65' ' ' ASP . 14.2 m -125.35 130.19 51.44 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.101 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.98 135.48 45.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.818 0.342 . . . . 0.0 110.684 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ILE . . . . . 0.74 ' CG2' HD23 ' A' ' 68' ' ' LEU . 5.9 mt -128.5 124.07 61.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.342 -179.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 166.55 -134.48 3.29 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.47 -0.872 . . . . 0.0 113.068 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ARG . . . . . 0.466 ' HB2' HG23 ' A' ' 73' ' ' ILE . 8.2 ttp180 -99.99 -40.12 7.8 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.886 0.374 . . . . 0.0 111.158 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' SER . . . . . 0.804 ' HB2' HG23 ' A' ' 75' ' ' THR . 0.3 OUTLIER -46.18 118.11 1.79 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.481 -179.52 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.85 -28.37 56.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.76 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -69.93 -22.96 63.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.88 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 86.8 m -54.33 154.27 4.69 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.774 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.816 ' HB3' HG23 ' A' ' 56' ' ' THR . 64.1 t0 -65.88 -46.25 79.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.823 0.344 . . . . 0.0 110.957 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' VAL . . . . . 0.617 HG13 HG11 ' A' ' 48' ' ' VAL . 21.3 t -125.18 133.24 69.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.436 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.8 pt -106.16 122.43 59.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.69 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . 0.74 HD23 ' CG2' ' A' ' 58' ' ' ILE . 2.7 mm? -94.15 -88.35 0.24 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.94 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 28.0 t -104.79 -115.64 0.23 Allowed 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.584 ' HA ' HG22 ' A' ' 73' ' ' ILE . 3.4 tt0 171.79 -62.1 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.327 0 O-C-N 122.372 -0.205 . . . . 0.0 111.117 179.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' PRO . . . . . 0.524 ' HD3' ' CB ' ' A' ' 70' ' ' GLU . 38.8 Cg_exo -59.44 -40.17 69.49 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 121.924 1.749 . . . . 0.0 112.86 -179.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -118.73 19.85 13.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.507 -179.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.584 HG22 ' HA ' ' A' ' 70' ' ' GLU . 4.6 tp -103.97 122.2 56.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.078 0.466 . . . . 0.0 110.942 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' SER . . . . . 0.429 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 2.6 p -71.81 134.87 46.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.406 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.804 HG23 ' HB2' ' A' ' 61' ' ' SER . 91.4 m -61.99 -30.35 70.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.716 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' PHE . . . . . 0.422 ' O ' ' C ' ' A' ' 77' ' ' HIS . 0.4 OUTLIER -108.77 14.08 24.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.514 -179.939 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' HIS . . . . . 0.504 ' CD2' ' CD1' ' A' ' 127' ' ' PHE . 1.1 t60 -25.68 -68.73 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.796 -1.093 . . . . 0.0 112.668 -179.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . 0.569 ' HB3' ' CZ ' ' A' ' 127' ' ' PHE . . . -157.09 164.1 38.25 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.017 0.437 . . . . 0.0 111.647 -179.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -131.67 137.95 48.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.822 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' PHE . . . . . 0.898 ' CE2' HG22 ' A' ' 97' ' ' VAL . 7.0 m-85 -119.28 130.14 55.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.534 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' HIS . . . . . 0.4 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 4.4 m-70 -94.78 116.17 28.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.802 0.334 . . . . 0.0 111.14 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LEU . . . . . 0.566 HD23 ' O ' ' A' ' 51' ' ' THR . 11.1 tp -106.54 109.49 21.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.718 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.46 140.23 52.97 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.035 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -98.45 134.89 40.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.682 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.02 122.94 47.45 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.984 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -96.97 119.53 35.61 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.002 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.4 t -140.05 139.15 37.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.098 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -48.59 -56.44 8.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.198 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 -51.08 -75.11 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.152 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -147.65 155.27 41.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.801 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -82.92 127.93 33.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.967 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.04 134.93 54.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.984 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' ASN . . . . . 0.631 HD21 HD11 ' A' ' 34' ' ' LEU . 20.1 m-20 -111.43 140.62 45.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.733 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LEU . . . . . 0.619 ' HG ' HD11 ' A' ' 118' ' ' ILE . 4.6 tp -132.02 139.47 48.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.054 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ILE . . . . . 0.641 HD13 HD23 ' A' ' 119' ' ' LEU . 2.6 mp -125.02 134.31 67.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.049 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -114.04 144.01 43.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.817 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' VAL . . . . . 0.898 HG22 ' CE2' ' A' ' 80' ' ' PHE . 16.3 t -108.78 131.61 58.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.187 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.8 mp -130.05 121.31 51.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.985 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 21.1 p30 -84.88 139.09 32.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.93 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -143.6 30.48 1.35 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.959 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.6 m -153.97 152.2 30.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.829 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 11.7 mmt180 -106.18 34.6 3.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.987 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -89.19 -31.22 18.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.207 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 121.19 115.99 2.43 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.452 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' THR . . . . . 0.463 ' CG2' ' CE1' ' A' ' 127' ' ' PHE . 99.5 m -131.72 128.45 38.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.811 0.338 . . . . 0.0 110.886 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -121.05 114.96 22.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.746 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ILE . . . . . 0.639 HD12 ' O ' ' A' ' 124' ' ' ARG . 2.8 tp -111.56 137.29 44.74 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 CA-C-O 121.435 0.636 . . . . 0.0 111.342 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 61.93 26.53 16.05 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.739 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.72 8.95 69.01 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.858 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 51.9 m-80 -134.11 151.99 51.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.792 0.33 . . . . 0.0 110.901 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 10.5 mtm105 -74.96 132.82 41.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.739 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.432 HD23 ' H ' ' A' ' 112' ' ' LEU . 0.6 OUTLIER -83.05 143.5 30.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.95 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.636 HG22 ' O ' ' A' ' 113' ' ' VAL . 14.5 p -128.75 14.56 2.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.39 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -121.85 -178.56 3.87 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.806 0.336 . . . . 0.0 110.768 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.3 mttt -110.2 -29.64 8.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.95 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -112.63 78.87 1.16 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.899 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -80.79 139.33 36.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.903 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.619 HD11 ' HG ' ' A' ' 94' ' ' LEU . 7.5 tp -98.46 115.98 40.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.035 0.445 . . . . 0.0 111.241 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.641 HD23 HD13 ' A' ' 95' ' ' ILE . 0.7 OUTLIER -103.12 132.85 49.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.964 -179.862 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 19.4 mttm -135.99 178.23 7.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.76 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ASN . . . . . 0.46 ' ND2' ' CD2' ' A' ' 137' ' ' TYR . 3.2 t-20 -50.93 139.99 16.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.176 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' GLY . . . . . 0.508 ' HA2' HD21 ' A' ' 134' ' ' LEU . . . 70.75 51.46 19.78 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.497 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.46 130.07 53.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.918 0.39 . . . . 0.0 110.952 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ARG . . . . . 0.639 ' O ' HD12 ' A' ' 107' ' ' ILE . 1.4 ttm-85 -98.15 124.11 42.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.918 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' ILE . . . . . 0.529 HD11 HD11 ' A' ' 119' ' ' LEU . 1.9 mp -115.53 134.71 57.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.17 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 29.2 t -124.1 133.95 67.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.104 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' PHE . . . . . 0.569 ' CZ ' ' HB3' ' A' ' 78' ' ' ALA . 7.5 m-85 -131.84 134.33 45.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.055 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 81.02 -2.23 81.72 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.95 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 2.8 mtpp 75.47 27.77 1.02 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.914 0.388 . . . . 0.0 110.424 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 63.9 p -154.01 -60.03 0.13 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.834 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . 0.71 ' HB3' HD12 ' A' ' 68' ' ' LEU . 55.6 m -61.91 109.05 1.14 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.727 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.0 p -120.51 128.0 52.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.004 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' PHE . . . . . 0.656 ' HD2' HD22 ' A' ' 37' ' ' LEU . 2.1 p90 -142.06 155.99 45.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.953 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' LEU . . . . . 0.508 HD21 ' HA2' ' A' ' 122' ' ' GLY . 3.9 tt -113.37 140.11 48.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.834 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . 0.507 ' HE2' HG21 ' A' ' 50' ' ' ILE . 26.4 t80 -104.54 141.48 36.32 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.984 0.897 . . . . 0.0 111.81 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 8.7 pttt -154.71 158.97 40.37 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 113.914 -1.494 . . . . 0.0 110.867 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' TYR . . . . . 0.46 ' CD2' ' ND2' ' A' ' 121' ' ' ASN . 3.2 m-85 -86.07 139.74 30.87 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.716 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' ALA . . . . . 0.43 ' HB2' ' ND1' ' A' ' 36' ' ' HIS . . . . . . . . 0 C--N 1.325 -0.483 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.22 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.8 mmpt? . . . . . 0 N--CA 1.485 1.319 0 CA-C-O 120.81 0.338 . . . . 0.0 111.266 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -87.13 -32.57 19.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.809 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -91.42 124.58 35.71 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.894 179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 -116.3 166.23 12.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.864 179.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.5 164.89 18.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.935 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 60.16 -179.09 0.1 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.914 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -80.2 143.53 33.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.811 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 20.2 mtpt -115.93 148.78 42.06 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.966 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.77 144.19 53.17 Favored 'Trans proline' 0 C--N 1.344 0.296 0 C-N-CA 122.552 2.168 . . . . 0.0 112.326 -179.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 37.7 p -121.37 -52.71 2.04 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.804 179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.1 m -105.56 -33.09 8.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.837 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -89.22 130.03 35.7 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.864 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.401 ' N ' HG21 ' A' ' 51' ' ' THR . 3.0 m-85 -57.88 -99.26 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.993 -179.831 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.467 ' N ' HG22 ' A' ' 51' ' ' THR . 0.2 OUTLIER -140.59 128.94 22.5 Favored 'General case' 0 C--N 1.334 -0.075 0 CA-C-O 120.703 0.287 . . . . 0.0 110.471 179.813 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.8 t -64.46 130.71 44.78 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.91 0.386 . . . . 0.0 111.036 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.12 -47.0 0.64 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.77 179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.644 ' C ' HG22 ' A' ' 50' ' ' ILE . . . -138.83 -178.84 16.7 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.742 -0.742 . . . . 0.0 112.357 179.889 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.43 ' CD2' ' HA ' ' A' ' 49' ' ' GLU . 49.4 m80 -147.02 162.36 38.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.865 0.364 . . . . 0.0 110.919 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.492 HD11 ' HB ' ' A' ' 50' ' ' ILE . 1.0 OUTLIER -127.07 119.7 27.18 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.754 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 28.5 t -97.53 122.96 49.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.104 -179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.5 m120 -89.99 126.48 35.76 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.884 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.654 HD13 ' NH2' ' A' ' 124' ' ' ARG . 0.9 OUTLIER -90.62 106.82 18.76 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.879 179.972 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.54 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 20.8 mt -124.09 140.65 35.25 Favored Pre-proline 0 C--N 1.328 -0.35 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.934 -179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.54 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 57.2 Cg_endo -73.86 87.99 1.1 Allowed 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.162 1.908 . . . . 0.0 111.983 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 137.79 -12.08 3.68 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.942 -0.647 . . . . 0.0 112.386 -179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 7.1 pttp 178.2 173.51 0.63 Allowed 'General case' 0 N--CA 1.455 -0.197 0 CA-C-O 120.727 0.299 . . . . 0.0 110.689 179.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -135.7 160.68 37.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.421 -0.354 . . . . 0.0 111.048 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.61 134.08 33.29 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.947 -179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.04 127.7 56.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.82 179.839 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.448 ' O ' HD12 ' A' ' 37' ' ' LEU . 30.6 t -119.48 130.79 73.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.182 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.43 ' HA ' ' CD2' ' A' ' 36' ' ' HIS . 3.3 pm0 -81.6 136.6 35.55 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.734 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.644 HG22 ' C ' ' A' ' 35' ' ' GLY . 16.7 tt -116.02 132.11 66.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.338 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.467 HG22 ' N ' ' A' ' 32' ' ' THR . 0.7 OUTLIER -97.05 168.09 10.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.999 -179.682 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.417 ' HA ' HD22 ' A' ' 82' ' ' LEU . 7.0 p30 -92.63 66.16 4.43 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.079 179.283 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.571 ' C ' ' H ' ' A' ' 55' ' ' VAL . 0.1 OUTLIER -90.37 13.26 15.97 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.8 -0.636 . . . . 0.0 112.016 -179.253 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.447 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 0.7 OUTLIER 69.28 -34.6 0.28 Allowed 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 110.134 -0.321 . . . . 0.0 110.134 -179.524 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.571 ' H ' ' C ' ' A' ' 53' ' ' ARG . 62.3 t -137.28 124.09 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.258 0 CA-C-O 120.948 0.404 . . . . 0.0 111.343 179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.769 HG23 ' HB3' ' A' ' 65' ' ' ASP . 15.9 m -111.04 128.8 55.98 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.624 179.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.74 138.67 40.04 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.908 0.385 . . . . 0.0 111.043 -179.575 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.594 HD11 ' HD2' ' A' ' 80' ' ' PHE . 4.7 mp -126.64 117.98 49.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.033 -179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 176.68 -160.73 28.29 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.667 179.98 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.504 ' HB2' HG23 ' A' ' 73' ' ' ILE . 5.2 ttp180 -83.39 -29.82 27.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.726 0.298 . . . . 0.0 110.979 -179.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.682 ' HB2' HG23 ' A' ' 75' ' ' THR . 7.2 t -58.09 129.32 41.4 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.968 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.42 -22.64 67.0 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.022 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 6.3 m -69.89 -27.58 64.91 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.447 -0.342 . . . . 0.0 111.004 -179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 97.5 m -57.16 151.61 15.15 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.82 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.769 ' HB3' HG23 ' A' ' 56' ' ' THR . 63.9 t0 -61.31 -43.96 98.01 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.884 0.374 . . . . 0.0 110.603 -179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.8 t -125.03 114.92 42.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.05 -0.523 . . . . 0.0 111.093 179.95 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.595 ' O ' HG23 ' A' ' 67' ' ' ILE . 19.6 tt -93.75 107.4 19.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.026 179.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.801 HD13 HD11 ' A' ' 73' ' ' ILE . 18.0 mt -65.36 -177.97 0.46 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.928 -179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 4.9 p -123.39 65.05 1.0 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.238 -179.72 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.87 141.1 40.67 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.606 179.637 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.22 -19.22 50.72 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.605 2.203 . . . . 0.0 112.911 -179.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -133.86 34.78 3.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.794 0.331 . . . . 0.0 111.31 -179.754 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.801 HD11 HD13 ' A' ' 68' ' ' LEU . 3.2 tp -71.86 128.7 35.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.165 -179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.4 m -59.92 133.35 56.01 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.048 -0.524 . . . . 0.0 111.212 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.682 HG23 ' HB2' ' A' ' 61' ' ' SER . 86.7 m -64.46 -44.03 92.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.802 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.456 ' O ' ' C ' ' A' ' 77' ' ' HIS . 34.9 m-85 -99.68 13.9 31.97 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.405 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.456 ' C ' ' O ' ' A' ' 76' ' ' PHE . 1.8 t-160 -19.0 -69.94 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.737 -1.12 . . . . 0.0 112.771 -179.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -153.78 164.08 38.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.986 0.422 . . . . 0.0 111.731 -179.526 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.15 138.96 50.91 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.737 179.735 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.594 ' HD2' HD11 ' A' ' 58' ' ' ILE . 38.3 m-85 -119.53 131.07 55.48 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.55 179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.447 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 9.0 m-70 -94.77 115.84 28.0 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.719 -0.392 . . . . 0.0 111.139 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.476 HD13 HG12 ' A' ' 50' ' ' ILE . 0.4 OUTLIER -107.08 109.81 21.76 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.796 179.485 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.0 pp -120.1 140.07 51.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.048 179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -117.44 128.11 54.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.878 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 4.3 ttm -135.65 151.4 50.18 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.892 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -106.52 121.01 43.43 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.947 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.464 ' O ' HG13 ' A' ' 87' ' ' VAL . 10.5 p -126.92 121.44 58.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.929 179.938 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.8 t0 75.18 -58.0 0.58 Allowed 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.062 -179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -173.17 -40.61 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 116.374 -0.376 . . . . 0.0 110.842 179.794 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -89.54 132.92 34.84 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.773 179.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.01 131.0 35.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.929 -179.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -113.49 143.49 44.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.821 179.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -113.99 142.79 45.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.983 -179.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.578 ' HG ' HD11 ' A' ' 118' ' ' ILE . 1.5 tp -131.91 136.19 47.2 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.739 179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.631 ' N ' HD12 ' A' ' 95' ' ' ILE . 3.4 mp -114.7 140.95 33.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.334 -0.393 . . . . 0.0 111.125 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -117.54 133.54 55.84 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.785 -179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.531 HG13 ' CE1' ' A' ' 80' ' ' PHE . 7.7 t -96.36 127.34 48.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.319 -0.401 . . . . 0.0 111.238 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 9.9 mt -130.09 139.14 52.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.962 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -114.19 129.92 56.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.979 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.11 31.42 0.76 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.86 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.3 m -135.11 -178.74 5.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.881 -179.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.02 37.68 3.74 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.882 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -101.13 -30.11 11.76 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.2 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 115.27 106.26 2.58 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.759 -0.734 . . . . 0.0 112.441 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.521 HG23 ' CE1' ' A' ' 127' ' ' PHE . 89.4 m -122.34 123.26 40.98 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.843 0.354 . . . . 0.0 110.948 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 56.0 m-85 -121.0 115.0 22.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.855 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 2.8 tp -110.56 137.29 43.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.506 0.67 . . . . 0.0 111.318 179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 59.84 31.54 20.81 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.867 -1.06 . . . . 0.0 110.75 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.63 9.32 69.3 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.935 -0.65 . . . . 0.0 112.893 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 61.1 m-80 -134.13 151.97 51.61 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.843 0.354 . . . . 0.0 110.838 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 30.4 ttp180 -74.73 140.54 44.18 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.908 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.64 HD22 ' O ' ' A' ' 114' ' ' LYS . 0.4 OUTLIER -75.98 133.68 40.36 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.915 179.984 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.47 HG23 ' HG3' ' A' ' 114' ' ' LYS . 5.8 m -112.08 -34.3 2.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.128 -179.92 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.64 ' O ' HD22 ' A' ' 112' ' ' LEU . 44.1 mttp -100.34 -178.16 3.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.895 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.6 mttp -121.17 32.08 6.09 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.85 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -154.23 56.17 0.71 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.989 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.45 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 1.8 t80 -84.15 139.25 32.55 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.815 179.862 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.578 HD11 ' HG ' ' A' ' 94' ' ' LEU . 8.2 tp -98.53 118.89 45.77 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.217 -179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.629 HD11 HD11 ' A' ' 125' ' ' ILE . 9.2 tt -103.08 136.74 42.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.083 -0.508 . . . . 0.0 111.007 -179.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 9.0 mttt -130.54 178.08 6.88 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.055 -0.521 . . . . 0.0 110.751 179.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.409 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 28.5 p30 -53.1 148.07 8.69 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.089 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.484 ' HA2' HD21 ' A' ' 134' ' ' LEU . . . 66.65 37.48 92.5 Favored Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.507 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -106.91 131.5 53.92 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.77 0.319 . . . . 0.0 110.87 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.654 ' NH2' HD13 ' A' ' 40' ' ' LEU . 0.1 OUTLIER -97.99 125.54 42.97 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.837 -179.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.629 HD11 HD11 ' A' ' 119' ' ' LEU . 2.9 mp -121.96 135.53 61.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.14 -179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.9 t -120.85 126.34 75.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.977 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.521 ' CE1' HG23 ' A' ' 105' ' ' THR . 44.8 m-85 -123.39 124.93 44.02 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.955 -179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 85.88 -6.16 81.76 Favored Glycine 0 CA--C 1.519 0.288 0 C-N-CA 120.747 -0.74 . . . . 0.0 112.864 179.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 77.74 27.8 0.58 Allowed 'General case' 0 C--N 1.333 -0.138 0 CA-C-O 120.93 0.395 . . . . 0.0 110.492 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 82.5 p -153.13 -46.36 0.1 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.797 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . 0.6 ' HB3' HD22 ' A' ' 68' ' ' LEU . 60.1 m -80.37 108.29 13.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.861 -180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 48.3 t -124.0 125.61 44.87 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.927 -179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 13.3 p90 -138.03 155.0 49.26 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.813 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.484 HD21 ' HA2' ' A' ' 122' ' ' GLY . 1.5 tt -108.29 130.02 55.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.79 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.622 ' HE2' HG21 ' A' ' 50' ' ' ILE . 30.2 t80 -99.68 141.58 32.3 Favored 'General case' 0 CA--C 1.512 -0.503 0 CA-C-O 122.025 0.917 . . . . 0.0 111.712 -179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 12.8 tttm -154.47 155.09 34.28 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 113.853 -1.521 . . . . 0.0 110.726 179.749 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.409 ' CE2' ' HB3' ' A' ' 121' ' ' ASN . 3.4 m-85 -81.62 139.51 34.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.958 0.409 . . . . 0.0 110.793 179.638 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -120.39 68.69 0.85 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.973 -0.558 . . . . 0.0 111.03 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.4 -49.15 67.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.92 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.58 -45.15 1.49 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.951 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 1.1 m 60.81 107.85 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.826 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.7 m -102.82 129.38 49.48 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.874 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.4 p -151.07 38.13 0.65 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.911 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -77.74 104.06 8.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.865 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.583 HG22 ' H ' ' A' ' 146' ' ' GLU . 3.2 mm -110.66 -143.75 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.175 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.583 ' H ' HG22 ' A' ' 145' ' ' ILE . 0.6 OUTLIER -132.2 -46.43 0.92 Allowed 'General case' 0 C--N 1.305 -1.349 0 CA-C-N 115.443 -0.799 . . . . 0.0 110.885 179.927 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -129.65 95.11 3.9 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.87 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -81.48 143.79 31.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.846 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -90.91 80.07 5.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.879 -179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 5.8 tt0 -176.69 130.68 0.19 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.949 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.28 129.46 37.47 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.89 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.472 HG23 ' O ' ' A' ' 152' ' ' VAL . 29.9 m -130.76 119.89 46.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.128 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 33.4 t -128.5 157.36 41.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.915 179.951 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 10.3 p -111.32 -34.51 6.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.922 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.6 tt0 -93.83 175.08 6.86 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.883 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 4.0 t -132.47 154.09 50.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.899 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 2.6 mtp85 59.91 31.77 20.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.799 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -153.35 162.32 41.41 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.95 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 8.4 t80 . . . . . 0 C--O 1.25 1.086 0 CA-C-O 118.212 -0.899 . . . . 0.0 110.913 179.985 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 9.4 mtmt . . . . . 0 N--CA 1.486 1.347 0 CA-C-O 120.813 0.34 . . . . 0.0 111.171 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 24.7 ptt85 -129.56 106.46 8.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.921 -179.978 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 16.5 mt-30 -138.04 148.12 44.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.912 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -157.83 162.05 38.39 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.856 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 4.8 mmm180 -107.7 149.54 28.01 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.807 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.5 m -98.56 32.81 2.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.968 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -162.58 152.13 15.74 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.892 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.6 mttp -95.78 110.85 53.61 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.847 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -68.3 141.14 50.78 Favored 'Trans proline' 0 C--N 1.348 0.506 0 C-N-CA 122.384 2.056 . . . . 0.0 112.34 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -107.9 158.58 17.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.918 179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -166.01 -174.13 2.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.898 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 65.77 98.7 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.081 179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.504 ' N ' HG21 ' A' ' 51' ' ' THR . 1.9 m-85 -52.6 -94.53 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.007 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.431 ' O ' ' HA ' ' A' ' 51' ' ' THR . 0.9 OUTLIER -140.31 128.63 22.54 Favored 'General case' 0 C--N 1.333 -0.117 0 N-CA-C 110.192 -0.299 . . . . 0.0 110.192 179.552 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.8 t -59.89 144.79 47.91 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.816 0.341 . . . . 0.0 111.114 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.948 HD22 HD21 ' A' ' 82' ' ' LEU . 1.1 tp -157.49 -67.35 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.968 -179.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -118.98 165.25 13.03 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.526 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.517 ' ND1' ' HB2' ' A' ' 138' ' ' ALA . 32.0 m80 -136.83 161.12 36.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.848 0.356 . . . . 0.0 111.078 -179.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.966 HD11 HD11 ' A' ' 50' ' ' ILE . 2.9 mt -120.58 111.08 17.21 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.669 179.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.6 t -96.02 121.76 46.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.02 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -90.17 113.91 25.78 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.882 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -82.74 106.81 14.89 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.814 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.525 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 22.0 mt -124.2 140.44 34.92 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.847 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.525 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 57.8 Cg_endo -74.29 86.42 1.31 Allowed 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.186 1.924 . . . . 0.0 111.955 179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 115.6 23.74 4.28 Favored Glycine 0 N--CA 1.451 -0.31 0 CA-C-N 115.811 -0.631 . . . . 0.0 112.256 -179.6 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 176.92 -168.36 0.06 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.738 0.304 . . . . 0.0 110.593 179.898 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -177.47 152.39 0.83 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.886 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -137.97 130.81 29.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.087 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 23.3 tttt -113.07 134.84 54.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.905 179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.735 HG11 HG13 ' A' ' 66' ' ' VAL . 37.5 t -121.62 151.02 24.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.202 -179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -100.82 133.62 45.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.789 179.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.966 HD11 HD11 ' A' ' 37' ' ' LEU . 33.1 mm -116.07 129.51 72.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.173 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.961 ' O ' HD13 ' A' ' 82' ' ' LEU . 2.0 p -106.08 167.99 9.43 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.96 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.938 ' HA ' HD22 ' A' ' 82' ' ' LEU . 6.9 m-80 -85.1 63.67 8.24 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.168 0.508 . . . . 0.0 110.256 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.579 ' C ' ' H ' ' A' ' 55' ' ' VAL . 23.2 ttt-85 -87.3 2.76 49.25 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.644 -0.707 . . . . 0.0 111.914 -179.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.411 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 0.7 OUTLIER 71.68 -34.63 0.3 Allowed 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 109.41 -0.589 . . . . 0.0 109.41 -178.573 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.579 ' H ' ' C ' ' A' ' 53' ' ' ARG . 75.6 t -137.22 136.06 47.15 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.473 179.145 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.714 HG23 ' HB3' ' A' ' 65' ' ' ASP . 18.8 m -125.12 129.68 50.67 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.957 -179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -103.81 136.12 44.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.911 0.386 . . . . 0.0 110.846 -179.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.415 ' HA ' ' O ' ' A' ' 66' ' ' VAL . 36.6 mt -125.68 128.4 72.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.983 -179.719 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 168.91 -143.95 8.4 Favored Glycine 0 C--N 1.331 0.268 0 C-N-CA 120.222 -0.99 . . . . 0.0 113.353 179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.493 ' HB2' ' CG2' ' A' ' 73' ' ' ILE . 5.8 ttp-105 -96.9 -40.55 8.85 Favored 'General case' 0 C--N 1.333 -0.131 0 CA-C-O 120.904 0.383 . . . . 0.0 111.145 -179.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.891 ' HB3' HG23 ' A' ' 75' ' ' THR . 4.7 p -53.91 127.27 25.54 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.309 -179.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 28.6 ptt85 -59.84 -20.12 55.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.015 -0.538 . . . . 0.0 111.024 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -69.77 -27.06 64.61 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.558 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 60.3 m -56.99 149.08 19.66 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.411 179.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.714 ' HB3' HG23 ' A' ' 56' ' ' THR . 7.9 t0 -61.36 -44.71 96.72 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.947 0.403 . . . . 0.0 110.794 -179.887 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.735 HG13 HG11 ' A' ' 48' ' ' VAL . 56.0 t -125.21 133.17 70.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.551 -179.792 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.4 pt -100.62 112.6 33.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.349 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.449 ' HA ' HD23 ' A' ' 68' ' ' LEU . 6.4 mt -78.72 -88.22 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.006 -179.502 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 30.9 t -108.22 -108.65 0.32 Allowed 'General case' 0 CA--C 1.531 0.233 0 N-CA-C 110.07 -0.345 . . . . 0.0 110.07 179.597 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.556 ' CB ' ' HD3' ' A' ' 71' ' ' PRO . 0.0 OUTLIER 169.27 -60.86 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.198 0 N-CA-C 111.574 0.212 . . . . 0.0 111.574 179.25 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.556 ' HD3' ' CB ' ' A' ' 70' ' ' GLU . 25.6 Cg_exo -62.39 -40.05 42.3 Favored 'Trans proline' 0 C--N 1.346 0.429 0 C-N-CA 121.955 1.77 . . . . 0.0 113.061 -179.347 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 70.9 m-20 -121.74 25.26 9.34 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.639 -0.255 . . . . 0.0 111.676 -179.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.493 ' CG2' ' HB2' ' A' ' 60' ' ' ARG . 5.0 tp -106.77 121.48 59.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.178 0.513 . . . . 0.0 111.102 179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.448 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 0.7 OUTLIER -69.7 137.47 52.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.457 -179.298 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.891 HG23 ' HB3' ' A' ' 61' ' ' SER . 27.6 m -57.66 -43.99 85.38 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.942 179.645 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.47 ' O ' ' C ' ' A' ' 77' ' ' HIS . 2.9 m-85 -100.85 14.19 32.58 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.662 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.47 ' C ' ' O ' ' A' ' 76' ' ' PHE . 2.0 t-160 -18.92 -69.09 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 114.883 -1.053 . . . . 0.0 112.814 -179.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -155.57 164.07 39.14 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.929 0.395 . . . . 0.0 111.643 -179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.42 ' HA ' ' O ' ' A' ' 56' ' ' THR . 0.2 OUTLIER -125.95 138.99 53.8 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.848 179.802 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.735 ' CE1' HG13 ' A' ' 97' ' ' VAL . 2.6 m-85 -119.58 131.07 55.42 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.86 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.411 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 15.2 m-70 -97.29 116.3 29.24 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.81 0.338 . . . . 0.0 111.384 -179.814 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.961 HD13 ' O ' ' A' ' 51' ' ' THR . 6.0 tt -106.82 109.93 21.96 Favored 'General case' 0 C--O 1.234 0.239 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.058 179.423 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.8 mp -119.26 139.94 51.08 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.812 179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -123.88 139.06 54.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.307 -0.406 . . . . 0.0 111.117 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -155.03 132.81 11.4 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.927 179.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 23.6 p-10 -107.04 128.73 54.63 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.914 179.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 1.8 m -130.8 139.12 51.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.201 -179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 17.4 m-20 68.43 -67.99 0.19 Allowed 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.137 179.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 62.1 t30 -178.1 38.16 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.839 179.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 33.9 m-85 -148.14 -177.93 6.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.669 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -121.37 127.94 51.73 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.94 -179.99 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.13 110.88 20.69 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.738 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.571 ' OD1' HD21 ' A' ' 34' ' ' LEU . 17.5 m-80 -114.04 129.06 56.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.079 -179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.83 136.22 52.06 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.655 179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.497 ' HB ' HD23 ' A' ' 119' ' ' LEU . 4.2 mp -113.78 141.01 31.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.11 -179.907 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -119.72 143.95 47.5 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.793 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.735 HG13 ' CE1' ' A' ' 80' ' ' PHE . 16.8 t -109.88 129.93 63.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.208 179.956 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 24.0 mm -124.27 124.15 67.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.054 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -101.86 131.37 48.25 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.994 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -93.72 10.54 32.51 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.325 179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 13.4 m 59.83 64.1 1.35 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.868 0.366 . . . . 0.0 110.88 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -161.38 132.2 5.23 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.941 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 70.23 5.8 5.49 Favored 'General case' 0 CA--C 1.53 0.176 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.988 179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 61.76 130.87 0.01 OUTLIER Glycine 0 C--N 1.332 0.312 0 C-N-CA 120.693 -0.765 . . . . 0.0 112.766 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.449 ' CG2' ' CE1' ' A' ' 127' ' ' PHE . 95.8 m -132.04 125.86 32.47 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.791 0.329 . . . . 0.0 110.814 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 24.3 m-85 -117.62 123.92 47.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.92 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.485 HG21 ' CD1' ' A' ' 112' ' ' LEU . 2.3 tp -122.08 137.2 56.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 121.511 0.672 . . . . 0.0 111.152 179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 62.4 29.04 17.15 Favored 'General case' 0 C--N 1.319 -0.718 0 CA-C-N 114.836 -1.075 . . . . 0.0 110.881 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.7 9.44 69.83 Favored Glycine 0 N--CA 1.445 -0.733 0 C-N-CA 120.859 -0.686 . . . . 0.0 112.911 179.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -134.0 152.03 51.69 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.748 0.308 . . . . 0.0 110.839 179.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 8.1 mtp-105 -68.5 142.64 55.22 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.313 -0.403 . . . . 0.0 110.852 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.485 ' CD1' HG21 ' A' ' 107' ' ' ILE . 1.3 tp -77.48 140.28 39.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.953 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.459 HG23 ' N ' ' A' ' 114' ' ' LYS . 19.3 m -126.05 -44.58 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.077 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.459 ' N ' HG23 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -67.71 -178.64 0.97 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.897 -179.992 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.03 -29.04 8.41 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.902 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -122.66 83.86 2.18 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.341 -0.391 . . . . 0.0 110.884 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -82.3 139.18 34.31 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.808 179.88 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.482 ' O ' HG23 ' A' ' 118' ' ' ILE . 8.2 tp -98.51 121.61 49.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.969 0.414 . . . . 0.0 111.395 -179.549 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.567 HD22 ' HE2' ' A' ' 80' ' ' PHE . 3.8 tp -103.07 134.0 47.24 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.894 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 2.4 mttp -129.19 178.12 6.66 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.858 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.436 ' HB2' ' CE2' ' A' ' 137' ' ' TYR . 3.6 t30 -54.89 144.93 21.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.223 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 64.55 44.68 94.77 Favored Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.839 -0.696 . . . . 0.0 112.379 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -117.04 122.36 43.95 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.762 0.315 . . . . 0.0 111.089 -179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.57 ' CG ' HD12 ' A' ' 134' ' ' LEU . 78.1 mtt180 -89.89 133.05 34.97 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.718 179.892 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.508 HD11 HD11 ' A' ' 119' ' ' LEU . 2.9 mp -126.67 132.35 70.25 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.251 -179.859 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.9 t -118.33 126.15 74.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.958 179.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.449 ' CE1' ' CG2' ' A' ' 105' ' ' THR . 45.2 m-85 -122.74 144.23 49.3 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.075 -179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 81.56 -67.09 3.7 Favored Glycine 0 N--CA 1.449 -0.454 0 C-N-CA 120.813 -0.708 . . . . 0.0 112.391 179.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 170.51 -33.91 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.773 0.321 . . . . 0.0 111.036 179.947 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 9.6 p -116.41 -37.49 3.73 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.257 -0.428 . . . . 0.0 111.413 -179.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 48.6 m -55.15 103.95 0.11 Allowed 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.977 0.418 . . . . 0.0 111.184 -179.661 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 44.3 t -124.62 124.54 42.43 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.946 -0.57 . . . . 0.0 111.035 179.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.429 ' CE1' HD21 ' A' ' 68' ' ' LEU . 24.8 p90 -142.08 156.12 45.39 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.919 0.39 . . . . 0.0 110.998 179.712 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.57 HD12 ' CG ' ' A' ' 124' ' ' ARG . 1.0 OUTLIER -111.78 140.02 46.77 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.864 179.954 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.548 ' CG ' HD21 ' A' ' 119' ' ' LEU . 20.0 t80 -100.46 141.27 33.55 Favored 'General case' 0 CA--C 1.512 -0.484 0 CA-C-O 121.924 0.869 . . . . 0.0 111.695 179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.403 ' HG3' HD23 ' A' ' 134' ' ' LEU . 8.6 mtmt -154.78 157.11 37.46 Favored 'General case' 0 C--N 1.31 -1.12 0 CA-C-N 113.864 -1.516 . . . . 0.0 110.95 179.745 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.436 ' CE2' ' HB2' ' A' ' 121' ' ' ASN . 4.8 m-85 -86.02 139.61 31.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.928 0.394 . . . . 0.0 110.616 179.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.517 ' HB2' ' ND1' ' A' ' 36' ' ' HIS . . . -105.15 101.41 10.97 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.993 -0.549 . . . . 0.0 111.06 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 3.5 m -62.13 107.15 0.83 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.903 179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 6.0 p -169.77 139.05 1.9 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.825 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -146.55 87.9 1.74 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.936 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 8.5 m -128.48 -67.63 0.79 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.895 179.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 11.3 p 54.52 -169.79 0.06 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.978 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -154.5 96.35 1.89 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.866 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.587 HG22 ' H ' ' A' ' 146' ' ' GLU . 0.7 OUTLIER -110.27 -143.67 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.134 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 179.942 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.587 ' H ' HG22 ' A' ' 145' ' ' ILE . 0.3 OUTLIER -135.26 121.26 19.91 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-N 115.362 -0.835 . . . . 0.0 110.858 179.981 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.1 p-10 -96.44 142.18 28.84 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.896 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -100.43 162.94 12.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.922 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.8 t0 -156.62 -62.52 0.1 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.967 -179.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 7.1 mt-10 60.31 31.18 20.35 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.898 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -167.92 99.24 0.46 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.863 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 14.8 m -128.41 34.05 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.133 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.6 t -172.45 -63.09 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.935 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 2.2 m 60.9 31.35 19.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.857 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -161.11 104.09 1.3 Allowed 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.924 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.93 176.15 5.14 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.938 -179.994 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 14.3 ttt85 -130.08 -58.76 1.07 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.898 179.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -141.29 86.72 2.04 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.895 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.249 1.04 0 CA-C-O 118.204 -0.903 . . . . 0.0 110.883 -179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 6.8 mttt . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.758 0.313 . . . . 0.0 111.161 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.5 mtt-85 -76.01 116.13 16.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.913 -179.971 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.9 tt0 61.32 170.69 0.11 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.987 -179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 63.28 143.74 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.884 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.6 mtt180 -150.38 157.15 42.73 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.821 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -175.68 -179.54 1.24 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.967 -179.983 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 84.2 m-20 -116.34 106.45 13.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.925 -180.0 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.417 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.2 OUTLIER -77.15 -62.48 0.59 Allowed Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.014 -179.842 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.417 ' CD ' ' CB ' ' A' ' 26' ' ' LYS . 55.7 Cg_endo -70.21 159.05 54.43 Favored 'Trans proline' 0 C--N 1.345 0.365 0 C-N-CA 122.48 2.12 . . . . 0.0 112.362 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 61.57 49.33 5.16 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.919 179.906 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 5.4 t -116.51 85.28 2.28 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.91 -179.992 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -59.9 176.42 0.3 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.926 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.429 ' CD2' ' HB3' ' A' ' 53' ' ' ARG . 10.6 m-85 -80.15 -101.63 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.936 -179.891 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.534 ' N ' HG22 ' A' ' 51' ' ' THR . 0.0 OUTLIER -140.46 128.95 22.72 Favored 'General case' 0 C--N 1.334 -0.085 0 CA-C-O 120.796 0.331 . . . . 0.0 110.648 179.883 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.8 t -67.36 122.86 18.84 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.999 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.608 HD21 ' ND2' ' A' ' 93' ' ' ASN . 5.0 tp -133.29 -62.39 0.79 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.675 179.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -113.5 162.77 12.26 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.832 -0.699 . . . . 0.0 112.298 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.42 ' CD2' ' HG3' ' A' ' 49' ' ' GLU . 27.3 m80 -132.24 160.38 36.34 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.961 0.41 . . . . 0.0 111.185 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.964 HD12 HD11 ' A' ' 50' ' ' ILE . 78.9 mt -127.11 118.72 24.93 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.879 -0.6 . . . . 0.0 110.845 179.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.5 t -100.36 121.85 51.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.129 179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -89.7 125.27 35.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.888 179.967 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.7 mp -86.74 106.97 18.04 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.877 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.66 HG22 ' HD2' ' A' ' 42' ' ' PRO . 1.7 mt -124.11 141.39 37.07 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.63 179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.66 ' HD2' HG22 ' A' ' 41' ' ' ILE . 56.2 Cg_endo -72.14 -8.33 22.64 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.171 1.914 . . . . 0.0 112.489 -179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -109.29 -14.2 15.31 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.555 179.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 175.97 -165.84 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 120.705 0.288 . . . . 0.0 110.744 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -137.99 132.42 32.23 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.923 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -108.13 133.59 52.19 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.883 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.1 tttm -113.06 122.93 49.05 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.942 -179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 18.6 t -111.56 151.16 13.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.997 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.42 ' HG3' ' CD2' ' A' ' 36' ' ' HIS . 0.3 OUTLIER -104.85 119.42 38.95 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.063 -179.878 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.964 HD11 HD12 ' A' ' 37' ' ' LEU . 27.3 mm -98.37 132.09 44.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.829 179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.534 HG22 ' N ' ' A' ' 32' ' ' THR . 0.5 OUTLIER -103.2 168.03 9.44 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.063 -179.89 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.834 ' HA ' HD22 ' A' ' 82' ' ' LEU . 14.3 p30 -97.68 73.64 2.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.435 179.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.585 ' C ' ' H ' ' A' ' 55' ' ' VAL . 6.1 ptp180 -103.47 16.9 25.33 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.614 -179.666 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.426 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 13.7 m120 68.49 -29.16 0.16 Allowed 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.365 -0.235 . . . . 0.0 110.365 -179.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.585 ' H ' ' C ' ' A' ' 53' ' ' ARG . 59.4 t -137.38 131.3 44.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 CA-C-O 121.072 0.463 . . . . 0.0 111.623 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.677 HG23 ' HB3' ' A' ' 65' ' ' ASP . 45.7 m -125.29 125.86 44.2 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.66 -0.7 . . . . 0.0 109.688 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.4 ' HB ' ' CB ' ' A' ' 64' ' ' CYS . 0.1 OUTLIER -103.67 130.76 51.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.986 0.422 . . . . 0.0 111.183 -179.64 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.86 HG23 HD11 ' A' ' 68' ' ' LEU . 5.2 mp -112.23 117.17 54.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.789 -179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 172.56 -141.92 6.51 Favored Glycine 0 C--N 1.332 0.333 0 C-N-CA 120.932 -0.652 . . . . 0.0 112.357 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.541 ' HB3' ' HA ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -111.47 -23.17 10.9 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.696 0.284 . . . . 0.0 111.233 179.891 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.622 ' HB2' HG23 ' A' ' 75' ' ' THR . 0.1 OUTLIER -51.88 126.06 17.03 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.8 0.334 . . . . 0.0 111.072 -179.926 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.22 -28.61 59.01 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.049 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -74.27 -22.45 59.3 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.113 -179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.4 ' CB ' ' HB ' ' A' ' 57' ' ' THR . 94.2 m -55.76 168.14 0.47 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.493 -0.322 . . . . 0.0 110.982 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.677 ' HB3' HG23 ' A' ' 56' ' ' THR . 65.9 t0 -89.24 -51.37 5.61 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.863 0.363 . . . . 0.0 110.893 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.403 HG23 ' CG2' ' A' ' 56' ' ' THR . 21.6 t -104.22 132.02 51.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.029 -179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.4 pt -108.16 128.96 63.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.357 -179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.86 HD11 HG23 ' A' ' 58' ' ' ILE . 1.3 mp -114.3 -152.32 0.5 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.304 179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.575 ' O ' ' CB ' ' A' ' 70' ' ' GLU . 0.5 OUTLIER -42.08 -58.45 2.1 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.506 0.193 . . . . 0.0 110.753 179.779 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.702 ' HB3' ' HD3' ' A' ' 71' ' ' PRO . 0.7 OUTLIER 110.42 -56.04 0.0 OUTLIER Pre-proline 0 N--CA 1.471 0.585 0 C-N-CA 123.594 0.758 . . . . 0.0 112.209 178.708 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.702 ' HD3' ' HB3' ' A' ' 70' ' ' GLU . 16.9 Cg_exo -67.22 -40.08 11.94 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.177 1.918 . . . . 0.0 112.899 -179.385 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -107.06 23.92 13.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.828 0.347 . . . . 0.0 111.016 -179.819 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.839 HG12 HD13 ' A' ' 68' ' ' LEU . 4.8 tp -115.94 127.9 73.39 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.103 -179.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.4 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 54.7 m -67.48 131.76 46.29 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.902 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.622 HG23 ' HB2' ' A' ' 61' ' ' SER . 85.1 m -58.75 -33.12 69.91 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.574 179.824 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.442 ' O ' ' C ' ' A' ' 77' ' ' HIS . 0.1 OUTLIER -112.19 13.96 20.56 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.919 -0.582 . . . . 0.0 111.537 179.859 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.442 ' C ' ' O ' ' A' ' 76' ' ' PHE . 1.0 OUTLIER -22.03 -69.61 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 114.748 -1.115 . . . . 0.0 112.576 -179.339 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.737 ' HB3' ' CE2' ' A' ' 127' ' ' PHE . . . -159.33 164.06 35.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.101 0.477 . . . . 0.0 111.936 -179.737 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -123.74 140.23 53.2 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.405 179.514 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.672 ' CE1' HG13 ' A' ' 97' ' ' VAL . 2.3 m-85 -119.38 131.16 55.63 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.301 -0.408 . . . . 0.0 110.866 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.426 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 4.4 m-70 -95.28 116.26 28.53 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.82 0.343 . . . . 0.0 111.082 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.834 HD22 ' HA ' ' A' ' 52' ' ' ASN . 0.3 OUTLIER -106.64 109.62 21.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.853 179.588 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.462 HD12 ' C ' ' A' ' 82' ' ' LEU . 7.1 mp -122.32 140.15 52.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.978 179.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -111.92 121.02 43.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.834 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -132.37 130.09 40.24 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.929 -179.918 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.3 p-10 -107.06 128.56 54.48 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.251 -0.432 . . . . 0.0 110.936 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.6 t -129.83 136.08 59.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.953 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.0 t0 71.98 -60.67 0.52 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.308 -0.406 . . . . 0.0 110.982 -179.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -176.09 -39.69 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.767 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -81.03 131.85 35.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.731 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 66.9 mt-30 -82.96 128.14 34.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.032 -179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.9 mtt180 -112.98 143.1 44.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.783 179.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.608 ' ND2' HD21 ' A' ' 34' ' ' LEU . 27.0 m120 -114.01 129.56 56.6 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.051 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.753 HD22 HD11 ' A' ' 118' ' ' ILE . 7.9 mt -120.62 142.36 49.48 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.703 179.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.467 HG13 ' CE1' ' A' ' 135' ' ' PHE . 10.7 mm -124.26 141.17 45.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.377 -0.374 . . . . 0.0 111.245 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -113.8 138.54 50.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.743 179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.672 HG13 ' CE1' ' A' ' 80' ' ' PHE . 21.4 t -109.63 120.85 61.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.311 -179.795 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 13.9 mt -130.15 120.94 50.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.88 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.416 ' OD1' HD13 ' A' ' 112' ' ' LEU . 2.1 m-20 -115.32 126.12 54.07 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.957 -179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.05 28.38 5.35 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.056 179.95 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 58.11 106.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.05 179.998 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.21 -76.08 0.28 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.893 -179.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -125.02 27.87 6.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.254 179.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 66.79 128.14 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.673 -0.775 . . . . 0.0 112.597 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 63.1 m -131.29 123.02 27.46 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.821 0.343 . . . . 0.0 110.751 179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.414 ' CE2' ' HG3' ' A' ' 111' ' ' ARG . 62.2 m-85 -120.02 114.97 22.81 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.93 -179.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.714 ' CG2' HG22 ' A' ' 125' ' ' ILE . 2.1 pp -109.48 131.19 61.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.118 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 7.8 m-80 59.59 31.75 21.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.968 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.63 13.05 74.5 Favored Glycine 0 N--CA 1.444 -0.832 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.96 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -129.12 132.36 47.36 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.845 0.355 . . . . 0.0 110.895 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.414 ' HG3' ' CE2' ' A' ' 106' ' ' PHE . 5.4 ttt180 -68.41 142.99 55.24 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.92 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.416 HD13 ' OD1' ' A' ' 99' ' ' ASP . 0.4 OUTLIER -81.47 132.74 35.33 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.851 179.975 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.633 HG22 ' O ' ' A' ' 113' ' ' VAL . 14.7 p -144.06 32.62 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.081 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 4.1 mptt -131.12 138.18 49.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.843 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.08 -40.05 86.9 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.896 179.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -126.31 78.43 1.77 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.939 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 31.9 t80 -84.05 139.07 32.74 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.819 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.753 HD11 HD22 ' A' ' 94' ' ' LEU . 8.5 tp -98.52 119.94 47.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-O 121.011 0.434 . . . . 0.0 111.289 -179.693 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.788 HD23 ' N ' ' A' ' 120' ' ' LYS . 3.1 tt -103.18 142.37 34.27 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.965 -0.561 . . . . 0.0 111.014 -179.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.788 ' N ' HD23 ' A' ' 119' ' ' LEU . 6.3 mttt -125.42 178.03 5.85 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.072 179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.453 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 7.9 p30 -62.73 146.86 51.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.173 -179.878 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 68.92 51.86 27.0 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.7 -0.762 . . . . 0.0 112.342 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.736 ' HB2' HD21 ' A' ' 119' ' ' LEU . 0.7 OUTLIER -127.61 124.31 37.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.843 0.354 . . . . 0.0 111.191 -179.752 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.721 ' CA ' HD12 ' A' ' 134' ' ' LEU . 24.8 ttm180 -84.7 132.3 34.48 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.707 179.808 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.714 HG22 ' CG2' ' A' ' 107' ' ' ILE . 22.5 pt -129.56 128.4 65.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.212 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.534 HG13 ' O ' ' A' ' 131' ' ' CYS . 21.6 t -113.56 129.63 69.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.08 -0.509 . . . . 0.0 111.0 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.737 ' CE2' ' HB3' ' A' ' 78' ' ' ALA . 5.5 m-85 -116.77 111.96 20.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.004 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 104.76 -75.55 0.25 Allowed Glycine 0 N--CA 1.45 -0.393 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.479 179.836 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 5.6 tttt 179.42 -38.44 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.769 0.319 . . . . 0.0 110.989 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 12.0 p -104.51 -40.59 5.99 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.287 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . 0.534 ' O ' HG13 ' A' ' 126' ' ' VAL . 22.0 m -57.93 107.04 0.42 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.842 0.353 . . . . 0.0 111.079 -179.771 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 29.7 t -124.21 119.92 30.76 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.998 -0.547 . . . . 0.0 110.788 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.446 ' CD1' ' N ' ' A' ' 133' ' ' PHE . 1.1 p90 -141.9 150.32 41.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.091 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.721 HD12 ' CA ' ' A' ' 124' ' ' ARG . 0.5 OUTLIER -109.22 140.13 43.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.777 179.933 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.618 ' HD2' HD21 ' A' ' 37' ' ' LEU . 12.3 t80 -102.25 141.26 35.38 Favored 'General case' 0 CA--C 1.511 -0.538 0 CA-C-O 121.893 0.854 . . . . 0.0 111.664 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.449 ' N ' ' CD1' ' A' ' 135' ' ' PHE . 7.2 mttp -154.68 155.4 34.55 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 113.829 -1.532 . . . . 0.0 111.128 179.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.453 ' CE2' ' HB3' ' A' ' 121' ' ' ASN . 8.7 m-85 -86.16 140.0 30.58 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 121.003 0.43 . . . . 0.0 110.638 179.386 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.407 ' HB3' ' CE1' ' A' ' 36' ' ' HIS . . . -127.24 70.71 1.31 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.883 -0.599 . . . . 0.0 111.123 179.888 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 3.2 m -93.29 -52.0 4.74 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.866 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.0 t -111.57 149.12 31.9 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.857 -179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -155.09 96.92 1.88 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.946 -179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.3 m -124.8 -44.62 1.94 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.881 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.9 m -136.9 88.63 2.38 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.922 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -154.29 31.17 0.43 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.894 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.617 HG22 ' O ' ' A' ' 145' ' ' ILE . 1.8 mt -111.06 24.99 3.67 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 CA-C-O 121.611 0.72 . . . . 0.0 111.308 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -125.14 172.13 9.74 Favored 'General case' 0 C--N 1.307 -1.273 0 CA-C-N 114.606 -1.179 . . . . 0.0 110.902 -179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 75.7 m-20 -95.31 145.15 25.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.914 179.93 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -76.02 125.44 29.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.93 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -105.63 32.66 4.17 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.912 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.6 tp10 -120.63 -48.15 2.29 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.877 179.988 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.7 tppp? -88.69 -60.15 2.04 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.881 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.5 t -84.01 147.46 5.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.039 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 80.2 p -155.87 97.81 1.85 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.929 179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 18.0 m -119.65 88.81 3.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.86 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -149.13 110.72 4.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.859 179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 4.3 t -136.23 36.17 2.76 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.859 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 2.6 ttt180 -106.23 130.28 54.12 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.929 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 29.7 t -91.64 96.76 10.63 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.971 179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 10.6 t80 . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.295 -0.86 . . . . 0.0 110.844 -179.973 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.3 mmtp . . . . . 0 N--CA 1.486 1.334 0 CA-C-O 120.756 0.312 . . . . 0.0 111.254 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.38 31.73 4.02 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.842 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -112.28 -36.76 5.21 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.857 179.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.46 137.46 34.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.846 180.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -131.25 -59.65 0.97 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.877 179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -119.4 137.73 53.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.907 179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.5 m-80 -81.18 -35.75 31.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.878 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.3 mttp -107.92 104.86 54.82 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.894 179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_endo -68.17 141.51 52.6 Favored 'Trans proline' 0 C--N 1.347 0.452 0 C-N-CA 122.353 2.036 . . . . 0.0 112.364 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.7 m -105.48 165.67 10.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.965 179.941 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -117.06 160.18 21.38 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.927 -179.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -144.6 130.44 19.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.811 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.433 ' H ' HG21 ' A' ' 51' ' ' THR . 4.6 m-85 -70.08 -100.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.938 -179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.655 ' N ' HG22 ' A' ' 51' ' ' THR . 0.1 OUTLIER -140.48 137.34 33.8 Favored 'General case' 0 C--O 1.231 0.129 0 CA-C-O 120.842 0.353 . . . . 0.0 110.675 179.764 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.8 t -72.27 120.57 18.07 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.977 -179.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.585 ' O ' HD23 ' A' ' 34' ' ' LEU . 7.7 tt -119.81 -40.5 2.74 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.893 179.896 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.677 ' C ' HG22 ' A' ' 50' ' ' ILE . . . -149.25 -169.6 15.95 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.49 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 51.1 m80 -146.96 160.65 42.08 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.774 0.321 . . . . 0.0 110.919 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.574 HD11 ' HB ' ' A' ' 50' ' ' ILE . 2.4 mp -127.1 119.33 26.28 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.799 179.807 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.4 t -98.28 121.76 49.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.179 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 6.0 m120 -89.93 119.16 30.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.844 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.421 HD22 ' N ' ' A' ' 40' ' ' LEU . 3.8 mm? -75.37 106.88 7.13 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.915 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.43 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 18.9 mt -124.11 138.75 31.27 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.847 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.43 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 86.6 Cg_exo -44.46 -28.76 2.78 Favored 'Trans proline' 0 C--N 1.347 0.494 0 C-N-CA 122.48 2.12 . . . . 0.0 112.441 179.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -111.18 -143.4 9.37 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.838 -0.696 . . . . 0.0 112.268 179.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.0 mtpt -53.89 113.77 1.33 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.83 0.347 . . . . 0.0 111.134 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -59.93 168.02 1.99 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.955 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 9.8 tt0 -135.66 125.01 24.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.015 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -113.01 134.28 54.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.92 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.8 t -125.42 139.42 51.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.277 -0.419 . . . . 0.0 111.122 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -80.31 139.67 36.5 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.748 179.757 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.696 HG21 ' HE2' ' A' ' 135' ' ' PHE . 2.2 tt -116.01 130.86 70.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.895 0.378 . . . . 0.0 111.398 -179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.655 HG22 ' N ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -96.77 168.11 10.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.6 179.733 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.579 ' ND2' HG23 ' A' ' 32' ' ' THR . 0.4 OUTLIER -110.76 73.16 0.81 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.677 179.751 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.595 ' C ' ' H ' ' A' ' 55' ' ' VAL . 0.1 OUTLIER -98.65 23.36 8.76 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.115 -179.788 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 69.83 -28.3 0.17 Allowed 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.887 -0.412 . . . . 0.0 109.887 -178.827 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.595 ' H ' ' C ' ' A' ' 53' ' ' ARG . 58.6 t -137.29 134.18 47.04 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 CA-C-O 121.111 0.481 . . . . 0.0 111.506 179.868 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.697 HG23 ' HB3' ' A' ' 65' ' ' ASP . 18.0 m -125.45 125.9 44.08 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.372 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.78 133.24 49.11 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.956 0.408 . . . . 0.0 111.213 -179.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.576 ' N ' HD12 ' A' ' 58' ' ' ILE . 3.9 mp -118.35 116.73 52.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.896 179.837 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . 0.402 ' HA2' HG13 ' A' ' 73' ' ' ILE . . . 173.42 -142.37 6.58 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.652 -0.785 . . . . 0.0 112.657 -179.874 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.423 ' HB2' ' CG2' ' A' ' 73' ' ' ILE . 11.7 ttp180 -103.76 -30.94 10.08 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.777 0.322 . . . . 0.0 110.947 -179.782 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.719 ' HB2' HG23 ' A' ' 75' ' ' THR . 0.2 OUTLIER -49.17 124.46 9.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.241 -179.696 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 47.6 mtm180 -57.04 -30.32 64.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.904 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.4 m -69.99 -21.96 63.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.081 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 86.5 m -55.8 166.17 0.77 Allowed 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.995 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.697 ' HB3' HG23 ' A' ' 56' ' ' THR . 11.7 t70 -83.58 -48.13 10.55 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.816 0.341 . . . . 0.0 111.033 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.403 ' O ' ' HA ' ' A' ' 58' ' ' ILE . 21.3 t -124.93 125.43 69.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.515 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.6 pt -98.28 131.04 46.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.786 179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.661 HD22 ' HB3' ' A' ' 131' ' ' CYS . 19.9 mt -118.25 105.17 11.5 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.263 -179.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.59 ' C ' ' HD2' ' A' ' 71' ' ' PRO . 0.6 OUTLIER 68.75 -70.27 0.14 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.571 179.991 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.57 ' CB ' ' O ' ' A' ' 69' ' ' SER . 31.1 mt-10 112.18 -60.71 0.0 OUTLIER Pre-proline 0 N--CA 1.476 0.84 0 C-N-CA 123.992 0.917 . . . . 0.0 112.336 179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.59 ' HD2' ' C ' ' A' ' 69' ' ' SER . 38.1 Cg_endo -66.74 -14.15 42.73 Favored 'Trans proline' 0 C--N 1.351 0.659 0 C-N-CA 122.123 1.882 . . . . 0.0 113.367 -179.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -129.18 25.72 5.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.66 0.267 . . . . 0.0 111.269 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.45 ' HB ' ' O ' ' A' ' 68' ' ' LEU . 4.9 tp -119.89 150.61 22.45 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 CA-C-O 120.943 0.402 . . . . 0.0 111.566 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 45.0 t -94.88 129.38 41.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.993 -0.548 . . . . 0.0 111.063 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.719 HG23 ' HB2' ' A' ' 61' ' ' SER . 58.0 m -53.7 -33.39 55.33 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.157 179.959 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 63.3 m-85 -112.3 14.0 20.43 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.167 0.508 . . . . 0.0 111.838 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.47 ' HB2' ' O ' ' A' ' 74' ' ' SER . 2.0 t-160 -29.17 -70.38 0.05 OUTLIER 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.901 -1.045 . . . . 0.0 112.617 -179.161 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.652 ' HB3' ' CE2' ' A' ' 127' ' ' PHE . . . -154.96 164.15 39.3 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.08 0.467 . . . . 0.0 112.126 -179.34 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -127.79 139.23 52.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.631 -0.713 . . . . 0.0 110.206 179.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.812 ' CZ ' HG13 ' A' ' 97' ' ' VAL . 5.5 m-85 -119.42 131.33 55.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.984 -179.741 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 5.5 m-70 -94.59 116.39 28.71 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.972 0.415 . . . . 0.0 110.964 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.661 HD13 HG13 ' A' ' 95' ' ' ILE . 4.2 mm? -106.47 109.72 21.72 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.775 179.802 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.9 tp -120.79 140.0 52.33 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.065 179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -107.63 126.36 52.47 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.745 179.98 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -126.09 143.09 51.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.984 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -95.84 116.91 29.6 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.895 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.6 t -138.71 121.05 17.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.073 -179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 62.11 -176.59 0.13 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.825 179.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 22.7 t30 -50.7 -31.13 15.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.257 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -94.46 -177.53 4.28 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.922 -179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 8.8 pt20 -115.67 128.66 56.07 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.849 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -99.19 123.2 43.29 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.923 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.405 ' ND2' HD11 ' A' ' 34' ' ' LEU . 24.2 m120 -113.51 138.26 50.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.745 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.494 HD12 ' N ' ' A' ' 94' ' ' LEU . 0.5 OUTLIER -132.07 134.22 45.26 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.95 -179.957 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.661 HG13 HD13 ' A' ' 82' ' ' LEU . 3.6 mp -115.45 141.11 33.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.976 179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -113.91 137.66 51.38 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.295 -0.412 . . . . 0.0 110.844 -179.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.812 HG13 ' CZ ' ' A' ' 80' ' ' PHE . 12.1 t -105.78 126.36 61.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.222 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 33.9 mt -129.95 120.99 51.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.984 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -121.76 139.01 54.12 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.951 -179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 4.3 mmtm -99.92 6.27 45.24 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.332 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 6.6 m 58.08 101.83 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.75 0.31 . . . . 0.0 111.014 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 14.3 ttt180 -149.23 -63.72 0.23 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.889 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -96.2 -45.61 6.78 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.235 179.967 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 132.96 106.08 0.97 Allowed Glycine 0 N--CA 1.451 -0.356 0 C-N-CA 120.734 -0.746 . . . . 0.0 112.554 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 1.9 m -118.52 126.36 51.84 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.835 0.35 . . . . 0.0 110.949 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.408 ' CE2' ' HB2' ' A' ' 111' ' ' ARG . 19.3 m-85 -120.83 121.26 37.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.882 179.956 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.6 HD12 ' O ' ' A' ' 124' ' ' ARG . 2.3 tp -108.51 137.29 40.97 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 CA-C-O 121.522 0.677 . . . . 0.0 111.193 179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 61.71 28.05 17.26 Favored 'General case' 0 C--N 1.32 -0.694 0 CA-C-N 114.879 -1.055 . . . . 0.0 110.825 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.69 9.55 69.99 Favored Glycine 0 N--CA 1.444 -0.812 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.947 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 11.0 p30 -134.1 152.0 51.64 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-O 120.804 0.335 . . . . 0.0 110.862 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.408 ' HB2' ' CE2' ' A' ' 106' ' ' PHE . 0.6 OUTLIER -71.77 133.02 45.29 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.954 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 1.9 pp -88.57 134.62 33.82 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.924 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 13.0 m -110.52 -30.22 2.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.224 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.2 153.97 31.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.983 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -88.62 -36.3 16.35 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.895 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -102.93 74.62 1.33 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.917 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -83.72 139.04 32.99 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.815 -179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.505 ' O ' HG23 ' A' ' 118' ' ' ILE . 8.6 tp -98.63 118.99 46.03 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.37 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.148 -179.82 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.914 HD11 HD11 ' A' ' 125' ' ' ILE . 6.1 tt -103.04 135.88 43.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.056 -179.653 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -131.07 178.12 6.93 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.743 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.429 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 4.5 p-10 -52.95 143.77 16.34 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.091 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 68.51 44.04 74.48 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.667 -0.778 . . . . 0.0 112.475 -179.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -112.85 121.19 43.94 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.806 0.336 . . . . 0.0 110.916 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.608 ' HG3' HD12 ' A' ' 134' ' ' LEU . 1.5 mpt_? -90.51 119.03 30.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.871 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.914 HD11 HD11 ' A' ' 119' ' ' LEU . 3.6 mt -114.94 132.07 65.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.061 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.625 HG22 ' OG ' ' A' ' 132' ' ' SER . 29.6 t -116.57 131.84 67.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.174 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.652 ' CE2' ' HB3' ' A' ' 78' ' ' ALA . 8.3 m-85 -118.57 133.63 55.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.975 -179.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 80.19 -66.19 3.67 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.788 -0.72 . . . . 0.0 112.446 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 170.38 -33.73 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.814 0.34 . . . . 0.0 110.998 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.3 p -107.19 -42.76 4.77 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.287 -179.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . 0.661 ' HB3' HD22 ' A' ' 68' ' ' LEU . 59.5 m -56.4 104.78 0.16 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.874 0.369 . . . . 0.0 111.194 -179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.625 ' OG ' HG22 ' A' ' 126' ' ' VAL . 0.3 OUTLIER -124.42 125.01 43.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.922 179.906 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.445 ' CE1' HD11 ' A' ' 68' ' ' LEU . 2.1 p90 -142.15 156.12 45.35 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.93 0.395 . . . . 0.0 111.091 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.608 HD12 ' HG3' ' A' ' 124' ' ' ARG . 9.6 tt -116.25 138.97 50.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.645 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.696 ' HE2' HG21 ' A' ' 50' ' ' ILE . 25.4 t80 -103.38 141.4 36.01 Favored 'General case' 0 CA--C 1.512 -0.506 0 CA-C-O 122.029 0.919 . . . . 0.0 111.875 -179.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 11.4 mtmt -154.67 143.8 21.09 Favored 'General case' 0 C--N 1.311 -1.084 0 CA-C-N 113.787 -1.552 . . . . 0.0 110.74 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.429 ' CE2' ' HB3' ' A' ' 121' ' ' ASN . 4.0 m-85 -72.86 139.72 47.1 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 121.002 0.43 . . . . 0.0 110.72 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -119.69 103.47 9.42 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.804 -0.634 . . . . 0.0 111.092 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 35.7 p -87.95 163.65 16.23 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.951 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.3 m -111.22 -34.42 6.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.921 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.66 133.29 17.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.825 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 9.4 t -117.98 -41.55 2.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.888 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 40.8 p -94.69 179.26 5.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.907 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -132.18 128.82 38.83 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.854 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.573 HG22 ' H ' ' A' ' 146' ' ' GLU . 2.4 mt -110.4 -143.39 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.437 -1.098 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.573 ' H ' HG22 ' A' ' 145' ' ' ILE . 0.0 OUTLIER -152.96 34.31 0.48 Allowed 'General case' 0 C--N 1.306 -1.322 0 CA-C-N 115.498 -0.774 . . . . 0.0 110.913 -179.965 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 36.3 m120 61.68 56.1 2.55 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.904 -179.955 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 29.9 t0 -95.88 109.71 22.01 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.848 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -106.22 31.63 5.0 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.947 179.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -95.16 87.26 4.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.86 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 17.9 mttp -77.32 93.03 3.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.971 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 5.7 m -120.0 -41.66 2.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.056 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 4.9 p -96.49 105.11 17.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.854 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 79.7 p -171.0 165.65 7.53 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.884 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 60.74 31.7 20.14 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.816 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 8.9 m -119.74 -66.9 1.02 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.82 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -157.38 84.27 0.91 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.847 -179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.8 p -167.98 145.84 4.39 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.806 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 20.1 t80 . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.335 -0.841 . . . . 0.0 110.879 179.924 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.364 0 CA-C-O 120.8 0.333 . . . . 0.0 111.208 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.41 101.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.84 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.9 pt20 -75.04 127.03 32.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.989 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 53.7 mt-30 -149.09 -64.89 0.23 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.887 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.9 mtp180 59.89 99.48 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.944 179.979 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 83.8 p -72.38 -42.78 64.85 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.826 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -130.88 174.98 9.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.817 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.417 ' CB ' ' CD ' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -178.19 -61.95 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.055 -179.973 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.417 ' CD ' ' CB ' ' A' ' 26' ' ' LYS . 39.7 Cg_endo -67.0 145.59 74.39 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.488 2.126 . . . . 0.0 112.366 -179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -154.44 -170.43 3.53 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.803 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 3.5 m -151.37 138.07 18.83 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.903 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -60.33 160.76 8.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.771 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.441 ' H ' HG21 ' A' ' 51' ' ' THR . 5.2 m-85 -74.86 -99.84 0.01 OUTLIER 'General case' 0 CA--C 1.533 0.311 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.802 -179.887 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.582 ' N ' HG22 ' A' ' 51' ' ' THR . 1.0 OUTLIER -140.4 128.79 22.61 Favored 'General case' 0 C--O 1.232 0.137 0 CA-C-O 120.68 0.276 . . . . 0.0 110.743 179.831 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 10.6 t -69.7 114.9 8.34 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.58 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.761 HD22 HD23 ' A' ' 82' ' ' LEU . 3.1 tp -118.16 -41.95 2.83 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.28 -179.728 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.465 ' C ' HG22 ' A' ' 50' ' ' ILE . . . -148.53 -167.92 14.07 Favored Glycine 0 N--CA 1.452 -0.24 0 C-N-CA 120.233 -0.984 . . . . 0.0 113.056 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.43 ' CD2' ' HG3' ' A' ' 49' ' ' GLU . 46.1 m80 -144.58 161.04 40.13 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.862 0.363 . . . . 0.0 110.683 179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.477 ' CD1' HG21 ' A' ' 66' ' ' VAL . 23.5 mt -127.11 112.85 15.66 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.666 179.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.5 t -95.92 121.77 46.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.135 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 -90.23 125.96 35.66 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.933 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.458 HD12 ' HA ' ' A' ' 133' ' ' PHE . 4.8 mp -106.1 106.81 17.49 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.802 179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 43.8 mm -124.03 138.17 30.2 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.086 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_exo -55.78 87.11 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.4 2.067 . . . . 0.0 112.205 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 139.51 -22.55 2.86 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.647 -0.787 . . . . 0.0 112.662 179.987 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.9 mtpt 177.01 164.03 0.49 Allowed 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.861 0.363 . . . . 0.0 110.814 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -122.61 -178.19 3.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.906 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.53 134.93 16.1 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.882 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -109.03 122.7 47.81 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.854 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.3 t -122.47 151.12 26.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.211 -179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.43 ' HG3' ' CD2' ' A' ' 36' ' ' HIS . 0.4 OUTLIER -94.69 130.65 41.1 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.602 179.852 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.721 HG21 ' HE2' ' A' ' 135' ' ' PHE . 3.1 tt -116.1 128.88 73.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-O 121.084 0.469 . . . . 0.0 111.578 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.582 HG22 ' N ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -96.79 168.12 10.69 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.196 179.539 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.684 ' HA ' HD22 ' A' ' 82' ' ' LEU . 56.5 m-80 -68.51 -89.02 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.987 -0.285 . . . . 0.0 110.333 179.751 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.571 ' C ' ' H ' ' A' ' 55' ' ' VAL . 12.9 ttt-85 72.79 -1.09 3.12 Favored 'General case' 0 N--CA 1.462 0.173 0 N-CA-C 112.586 0.587 . . . . 0.0 112.586 179.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.403 ' HA ' ' O ' ' A' ' 82' ' ' LEU . 1.3 m-20 70.33 -34.06 0.28 Allowed 'General case' 0 C--N 1.331 -0.199 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.096 -179.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.571 ' H ' ' C ' ' A' ' 53' ' ' ARG . 64.1 t -137.04 134.84 47.98 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 CA-C-O 121.012 0.434 . . . . 0.0 110.949 179.749 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.807 HG23 ' CB ' ' A' ' 65' ' ' ASP . 50.6 m -125.28 132.17 52.96 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.061 179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.401 ' HB ' ' CB ' ' A' ' 64' ' ' CYS . 0.0 OUTLIER -104.33 143.84 32.44 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.843 0.354 . . . . 0.0 111.231 -179.786 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.445 ' N ' HD12 ' A' ' 58' ' ' ILE . 4.8 mp -130.76 126.72 60.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.083 -179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 164.98 -139.28 5.73 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.667 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.42 ' HB2' HG23 ' A' ' 73' ' ' ILE . 10.6 ttp180 -106.85 -26.59 11.18 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.749 0.309 . . . . 0.0 110.969 179.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.733 ' HB2' HG23 ' A' ' 75' ' ' THR . 0.1 OUTLIER -52.12 136.5 29.68 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.24 -179.741 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.74 -31.89 72.13 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.915 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 46.2 p -69.95 -23.91 63.26 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.942 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.401 ' CB ' ' HB ' ' A' ' 57' ' ' THR . 96.4 m -56.64 171.87 0.29 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.944 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.807 ' CB ' HG23 ' A' ' 56' ' ' THR . 0.7 OUTLIER -85.07 -68.16 0.75 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.002 0.429 . . . . 0.0 110.885 179.813 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.477 HG21 ' CD1' ' A' ' 37' ' ' LEU . 21.2 t -105.95 115.31 47.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.899 179.866 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.4 pt -91.94 104.97 16.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.553 -179.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.498 HD11 ' CE2' ' A' ' 133' ' ' PHE . 1.8 mp -66.85 -155.86 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.837 179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.482 ' O ' ' CB ' ' A' ' 70' ' ' GLU . 19.1 p -41.81 -96.43 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 117.592 0.178 . . . . 0.0 111.193 -179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.535 ' CB ' ' HD3' ' A' ' 71' ' ' PRO . 1.5 mt-10 159.19 -60.93 0.0 OUTLIER Pre-proline 0 N--CA 1.466 0.366 0 N-CA-C 111.857 0.317 . . . . 0.0 111.857 179.144 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.535 ' HD3' ' CB ' ' A' ' 70' ' ' GLU . 36.4 Cg_exo -57.4 -40.31 82.47 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.206 1.937 . . . . 0.0 113.241 -179.03 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 86.2 m-20 -116.53 28.86 8.3 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.698 0.285 . . . . 0.0 111.313 -179.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.469 HD11 HD22 ' A' ' 68' ' ' LEU . 4.9 tp -110.6 126.74 67.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.99 0.424 . . . . 0.0 111.293 -179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.417 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 1.5 m -79.03 134.66 36.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.194 -179.595 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.733 HG23 ' HB2' ' A' ' 61' ' ' SER . 72.0 m -61.03 -29.16 69.56 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.859 -0.609 . . . . 0.0 111.02 179.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.431 ' O ' ' C ' ' A' ' 77' ' ' HIS . 0.3 OUTLIER -106.91 14.02 27.02 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.237 0.541 . . . . 0.0 111.598 179.985 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.462 ' CE1' ' HB3' ' A' ' 127' ' ' PHE . 1.4 t-160 -24.41 -71.11 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.759 -1.109 . . . . 0.0 112.747 -179.38 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.541 ' HB3' ' HE2' ' A' ' 127' ' ' PHE . . . -163.43 164.12 24.66 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.062 0.458 . . . . 0.0 112.019 -179.539 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.5 mt-10 -124.35 140.88 52.53 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.696 -0.684 . . . . 0.0 110.342 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.656 ' CE1' HG13 ' A' ' 97' ' ' VAL . 3.2 m-85 -119.22 131.15 55.78 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.751 0.31 . . . . 0.0 110.863 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 12.8 m-70 -94.82 116.47 28.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.909 0.385 . . . . 0.0 111.038 -179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.761 HD23 HD22 ' A' ' 34' ' ' LEU . 0.1 OUTLIER -106.41 109.55 21.51 Favored 'General case' 0 C--O 1.234 0.269 0 CA-C-N 116.126 -0.488 . . . . 0.0 111.107 179.866 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.23 130.62 53.35 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.814 179.45 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 5.7 tm0? -107.0 128.12 54.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.925 -179.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 9.4 ttt -152.03 143.15 23.2 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.253 -0.431 . . . . 0.0 110.928 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 11.1 p-10 -99.89 131.13 46.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.852 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 19.8 t -137.01 134.46 47.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.112 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 61.11 39.83 15.64 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.833 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 62.26 32.67 17.05 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.856 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -145.68 157.09 43.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.882 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 11.4 pt20 -82.98 127.92 33.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.905 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -117.01 117.44 29.67 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.008 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.452 ' ND2' HD11 ' A' ' 34' ' ' LEU . 12.4 m120 -105.42 119.96 40.39 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.766 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.4 mt -118.2 125.65 50.61 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.077 -179.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.407 HG13 ' CE1' ' A' ' 135' ' ' PHE . 11.7 mm -115.0 133.3 61.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.013 179.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -113.94 143.49 44.63 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.635 179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.656 HG13 ' CE1' ' A' ' 80' ' ' PHE . 18.0 t -109.12 132.63 56.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.381 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.472 HD13 ' O ' ' A' ' 97' ' ' VAL . 25.3 mm -130.05 120.93 50.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.14 -0.482 . . . . 0.0 111.029 179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 75.0 m-20 -102.23 127.05 49.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.964 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.4 mmtp -140.69 31.54 1.85 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.886 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.6 m -123.92 178.35 5.32 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.953 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -121.95 31.25 6.29 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.951 -179.907 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -103.58 -56.29 2.24 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.186 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 138.05 120.78 1.9 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.514 179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 2.8 m -125.59 122.95 37.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.813 0.34 . . . . 0.0 110.911 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.401 ' CE2' ' HB3' ' A' ' 111' ' ' ARG . 46.1 m-85 -116.31 129.15 56.12 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.848 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.1 tp -123.08 137.24 57.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.445 0.641 . . . . 0.0 111.378 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 61.86 29.71 17.98 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.798 -1.092 . . . . 0.0 110.838 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.64 12.98 74.49 Favored Glycine 0 N--CA 1.444 -0.818 0 C-N-CA 120.762 -0.732 . . . . 0.0 112.87 179.849 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 73.3 m-80 -133.47 152.01 51.86 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.798 0.332 . . . . 0.0 110.849 -179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.401 ' HB3' ' CE2' ' A' ' 106' ' ' PHE . 0.0 OUTLIER -68.0 143.05 55.74 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.932 -179.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.457 HD21 ' HB2' ' A' ' 117' ' ' TYR . 0.3 OUTLIER -85.46 126.31 33.72 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.865 179.991 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.406 HG13 ' N ' ' A' ' 114' ' ' LYS . 11.2 p -112.16 -40.81 3.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.113 179.994 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.406 ' N ' HG13 ' A' ' 113' ' ' VAL . 7.6 tptp -76.56 163.71 26.63 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.968 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -89.68 -29.25 18.9 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.902 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -121.13 82.06 1.87 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.316 -0.402 . . . . 0.0 111.018 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.457 ' HB2' HD21 ' A' ' 112' ' ' LEU . 57.6 t80 -84.09 139.21 32.62 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.673 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.542 ' O ' HG23 ' A' ' 118' ' ' ILE . 8.7 tp -98.52 118.52 45.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.435 -179.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.714 HD11 HD11 ' A' ' 125' ' ' ILE . 7.0 tt -103.2 143.93 31.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.841 -179.931 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.3 mmtt -127.51 178.01 6.38 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.851 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.434 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 11.7 p-10 -59.94 148.07 36.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.973 -179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.529 ' HA2' HD21 ' A' ' 134' ' ' LEU . . . 64.05 43.71 96.92 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.413 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -114.69 130.74 56.86 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.774 0.321 . . . . 0.0 111.069 -179.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.54 ' HD3' HD12 ' A' ' 134' ' ' LEU . 1.2 mmm-85 -83.87 130.77 34.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.712 179.838 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.714 HD11 HD11 ' A' ' 119' ' ' LEU . 2.7 mt -126.8 128.14 70.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.356 -179.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 40.6 t -122.76 124.01 69.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.734 179.622 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.541 ' HE2' ' HB3' ' A' ' 78' ' ' ALA . 3.3 m-85 -113.47 145.98 40.32 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.969 0.414 . . . . 0.0 111.306 -179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 70.6 -65.17 0.82 Allowed Glycine 0 N--CA 1.45 -0.388 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.435 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 173.83 -50.18 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.853 0.358 . . . . 0.0 110.859 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 89.1 p -96.15 -36.15 11.07 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.203 -179.613 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . 0.488 ' SG ' HD23 ' A' ' 68' ' ' LEU . 24.7 m -57.66 104.49 0.19 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.003 0.43 . . . . 0.0 111.124 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.41 124.14 41.69 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.951 -179.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.498 ' CE2' HD11 ' A' ' 68' ' ' LEU . 8.4 p90 -142.13 153.64 44.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.379 -0.373 . . . . 0.0 110.966 179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.54 HD12 ' HD3' ' A' ' 124' ' ' ARG . 2.0 tt -112.22 133.93 54.06 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.766 179.889 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.721 ' HE2' HG21 ' A' ' 50' ' ' ILE . 48.0 t80 -106.42 141.4 37.79 Favored 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 121.958 0.885 . . . . 0.0 111.802 -179.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.55 157.44 38.29 Favored 'General case' 0 C--N 1.311 -1.099 0 CA-C-N 113.928 -1.487 . . . . 0.0 111.119 179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.434 ' CE2' ' HB3' ' A' ' 121' ' ' ASN . 6.7 m-85 -86.0 139.87 30.8 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.761 179.454 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -117.73 130.37 56.28 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.948 -0.569 . . . . 0.0 111.125 179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 33.8 t -133.2 163.14 29.95 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.93 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 75.1 p -153.34 165.2 36.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.889 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.3 m -124.76 -44.44 1.95 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.929 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -111.42 -58.54 2.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.898 -179.94 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 39.9 p -131.99 176.74 8.11 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.887 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -90.34 -28.19 18.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.984 179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 1.7 mp -144.45 118.18 3.13 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.292 0 CA-C-O 121.798 0.808 . . . . 0.0 109.556 179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -166.37 -61.11 0.03 OUTLIER 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 114.33 -1.305 . . . . 0.0 110.803 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -73.78 109.0 6.94 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.832 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -78.45 107.03 10.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.821 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 54.5 m-20 -126.57 178.29 5.98 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.816 -179.941 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 21.9 mp0 -130.94 134.46 46.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.921 179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 33.3 mttm -93.9 -35.64 12.58 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.94 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 152' ' ' VAL . 11.6 m -80.2 76.53 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.065 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.6 p -166.09 162.1 17.58 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.899 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 16.6 t -109.75 -40.56 4.78 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.87 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 7.9 tt0 60.22 32.32 20.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.937 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 3.9 m 60.63 79.59 0.24 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.887 179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -84.88 159.95 20.25 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.942 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 2.1 t -109.96 95.18 5.43 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.927 179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 . . . . . 0 C--O 1.249 1.058 0 CA-C-O 118.28 -0.867 . . . . 0.0 110.86 -179.978 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 14.2 mmtt . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.787 0.327 . . . . 0.0 111.169 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 61.19 29.43 18.76 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.891 -179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -104.19 -174.55 2.57 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.874 -179.956 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 61.19 103.35 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.931 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 2.3 mpp_? -129.17 171.86 12.0 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.877 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.9 m -62.74 137.06 58.17 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.923 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -160.38 -53.88 0.05 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.866 -179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -97.45 109.38 49.97 Favored Pre-proline 0 C--N 1.328 -0.326 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.794 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -57.92 152.9 47.61 Favored 'Trans proline' 0 C--N 1.346 0.41 0 C-N-CA 122.522 2.148 . . . . 0.0 112.202 -179.943 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 67.1 m -139.97 -64.04 0.49 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.861 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 29.3 p -155.47 88.14 1.13 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.919 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 60.04 165.54 0.07 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.876 -179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.426 ' CE2' ' HG3' ' A' ' 53' ' ' ARG . 83.2 m-85 -104.13 -121.38 0.2 Allowed 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.546 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.55 ' C ' HG22 ' A' ' 51' ' ' THR . 0.1 OUTLIER -140.25 129.32 23.55 Favored 'General case' 0 C--O 1.231 0.116 0 CA-C-O 120.776 0.322 . . . . 0.0 110.692 179.815 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 4.4 t -62.05 138.43 58.38 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.07 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 7.1 tp -142.54 -47.83 0.34 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.708 179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.721 ' C ' HG22 ' A' ' 50' ' ' ILE . . . -137.63 -174.68 13.47 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.795 -0.717 . . . . 0.0 112.287 179.886 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.413 ' ND1' ' HB2' ' A' ' 138' ' ' ALA . 50.5 m80 -144.83 163.76 33.1 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.893 0.378 . . . . 0.0 111.031 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.0 mt -126.59 131.05 51.6 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.048 -0.524 . . . . 0.0 110.683 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.1 t -105.33 121.92 58.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.094 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.412 ' CB ' HD11 ' A' ' 41' ' ' ILE . 1.1 m-20 -89.99 126.01 35.59 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.794 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -94.94 106.54 18.54 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.88 0.371 . . . . 0.0 110.782 179.845 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.543 HG23 ' HD2' ' A' ' 42' ' ' PRO . 4.3 mp -124.49 141.06 36.68 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.048 -0.523 . . . . 0.0 110.906 179.921 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.543 ' HD2' HG23 ' A' ' 41' ' ' ILE . 58.9 Cg_endo -74.44 83.31 1.72 Allowed 'Trans proline' 0 C--N 1.346 0.434 0 C-N-CA 122.102 1.868 . . . . 0.0 111.978 179.834 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 143.33 -14.3 2.29 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.92 -0.657 . . . . 0.0 112.531 -179.577 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -179.02 176.18 0.92 Allowed 'General case' 0 N--CA 1.455 -0.207 0 CA-C-O 120.716 0.293 . . . . 0.0 110.672 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -132.73 160.62 36.27 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.141 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -137.78 130.27 29.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.814 179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 33.6 tttt -106.21 127.28 53.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.007 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 23.5 t -117.47 147.73 20.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.083 179.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.402 ' CG ' ' NE2' ' A' ' 36' ' ' HIS . 3.4 mt-10 -97.26 135.72 38.78 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.844 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.721 HG22 ' C ' ' A' ' 35' ' ' GLY . 1.1 tt -115.25 132.15 65.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.093 179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.567 ' O ' HD22 ' A' ' 82' ' ' LEU . 0.7 OUTLIER -106.46 168.46 9.14 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.253 -179.653 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -85.07 68.93 10.72 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.153 0.502 . . . . 0.0 110.511 179.692 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.576 ' C ' ' H ' ' A' ' 55' ' ' VAL . 19.3 ttt-85 -87.77 4.45 44.27 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.676 -0.693 . . . . 0.0 111.814 -179.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.506 ' HB2' ' O ' ' A' ' 53' ' ' ARG . 10.3 m120 69.0 -35.08 0.29 Allowed 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 109.889 -0.412 . . . . 0.0 109.889 -178.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.576 ' H ' ' C ' ' A' ' 53' ' ' ARG . 70.5 t -137.27 135.23 47.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.599 179.287 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.669 HG23 ' HB3' ' A' ' 65' ' ' ASP . 53.4 m -125.15 126.52 45.4 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.023 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.73 131.05 51.27 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.964 0.411 . . . . 0.0 110.732 -179.79 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.856 HG23 HD13 ' A' ' 68' ' ' LEU . 5.0 mp -119.77 118.91 58.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.929 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 172.46 -137.18 4.1 Favored Glycine 0 CA--C 1.519 0.325 0 C-N-CA 120.449 -0.881 . . . . 0.0 113.201 -179.886 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.493 ' HD2' ' O ' ' A' ' 70' ' ' GLU . 11.2 ttt-85 -103.29 -38.13 7.36 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-O 120.815 0.34 . . . . 0.0 111.103 -179.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.682 ' HB2' HG23 ' A' ' 75' ' ' THR . 0.3 OUTLIER -45.8 127.52 8.07 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.583 -179.389 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -61.8 -29.1 69.93 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.737 179.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 94.2 p -69.93 -23.67 63.24 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.826 179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 87.9 m -53.3 158.15 1.73 Allowed 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.87 179.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.669 ' HB3' HG23 ' A' ' 56' ' ' THR . 8.8 t0 -74.09 -47.62 35.16 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.847 0.356 . . . . 0.0 111.008 -179.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.46 ' O ' ' HA ' ' A' ' 58' ' ' ILE . 20.8 t -125.08 133.27 69.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.559 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 4.7 pt -100.24 118.93 47.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.603 179.543 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.856 HD13 HG23 ' A' ' 58' ' ' ILE . 2.3 mp -84.83 -86.67 0.13 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.784 -179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 38.9 m -107.7 -109.77 0.31 Allowed 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 109.728 -0.471 . . . . 0.0 109.728 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.611 ' CB ' ' HD3' ' A' ' 71' ' ' PRO . 0.1 OUTLIER 168.34 -63.49 0.0 OUTLIER Pre-proline 0 CA--C 1.529 0.157 0 O-C-N 122.375 -0.203 . . . . 0.0 111.541 178.862 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.611 ' HD3' ' CB ' ' A' ' 70' ' ' GLU . 21.5 Cg_exo -64.74 -22.14 64.28 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 121.977 1.785 . . . . 0.0 112.867 -179.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 46.1 m-20 -136.32 22.07 3.2 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 121.03 -0.268 . . . . 0.0 111.684 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.468 ' CG2' ' HB2' ' A' ' 60' ' ' ARG . 4.7 tp -105.68 121.25 57.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-O 121.06 0.457 . . . . 0.0 110.957 179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.415 ' HB2' ' CA ' ' A' ' 77' ' ' HIS . 13.8 m -65.24 133.08 50.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.867 -0.606 . . . . 0.0 111.484 -179.11 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.682 HG23 ' HB2' ' A' ' 61' ' ' SER . 77.8 m -58.73 -35.34 72.52 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.974 179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.43 ' O ' ' C ' ' A' ' 77' ' ' HIS . 0.2 OUTLIER -112.01 14.14 20.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.225 0.536 . . . . 0.0 111.361 -179.939 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.43 ' C ' ' O ' ' A' ' 76' ' ' PHE . 14.8 t60 -24.88 -69.14 0.04 OUTLIER 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.648 -179.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -149.77 163.96 36.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.07 0.462 . . . . 0.0 112.056 -179.53 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -129.01 137.98 51.66 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.462 179.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.813 ' CE1' HG13 ' A' ' 97' ' ' VAL . 2.0 m-85 -119.57 125.98 50.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.848 -179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 10.1 m-70 -94.84 116.19 28.41 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.913 0.387 . . . . 0.0 111.294 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.567 HD22 ' O ' ' A' ' 51' ' ' THR . 0.1 OUTLIER -106.64 109.5 21.44 Favored 'General case' 0 C--O 1.233 0.196 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.714 179.399 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 3.9 tp -122.49 140.2 53.01 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.2 -179.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -122.82 120.95 35.06 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.807 179.71 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -115.47 126.58 54.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.985 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.0 p30 -107.07 117.56 34.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.904 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 25.3 t -133.54 125.08 49.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.015 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.5 t70 70.61 -61.55 0.47 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.048 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -176.54 -39.64 0.01 OUTLIER 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.845 179.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 46.3 m-85 -89.48 101.28 13.96 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.68 179.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -82.93 145.44 29.39 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.051 -179.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 2.8 ttp-105 -113.1 141.13 47.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.808 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -107.35 129.92 54.85 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.029 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.705 HD23 HD11 ' A' ' 118' ' ' ILE . 0.3 OUTLIER -126.7 133.9 50.81 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.718 179.883 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.623 HD13 HD23 ' A' ' 119' ' ' LEU . 3.8 mp -117.48 140.77 39.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.22 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -117.82 125.82 51.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.825 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.813 HG13 ' CE1' ' A' ' 80' ' ' PHE . 18.0 t -96.34 131.48 43.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.131 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 32.4 mt -123.0 120.95 61.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.03 179.952 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -87.48 117.88 26.57 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.93 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.04 30.06 1.82 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.885 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 18.5 m -96.04 177.71 5.65 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.825 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.9 29.58 1.87 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.093 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 34.7 p-10 -135.18 -44.85 0.71 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.964 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 157.33 117.01 0.52 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.578 -0.82 . . . . 0.0 112.739 179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.689 HG23 ' CD1' ' A' ' 127' ' ' PHE . 62.5 m -132.04 122.75 25.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.734 0.302 . . . . 0.0 110.79 179.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -121.21 139.07 53.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.188 -179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.825 HD13 HG22 ' A' ' 125' ' ' ILE . 3.3 tp -122.79 137.34 56.62 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 CA-C-O 121.443 0.639 . . . . 0.0 111.196 179.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 60.52 30.0 19.43 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.864 -1.062 . . . . 0.0 110.65 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.69 12.67 74.36 Favored Glycine 0 N--CA 1.444 -0.823 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.843 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 52.6 m-80 -134.14 152.03 51.64 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.819 0.342 . . . . 0.0 110.769 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.83 143.09 44.08 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.872 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.518 ' CD1' HG22 ' A' ' 107' ' ' ILE . 3.2 mp -74.74 131.33 40.75 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.942 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 11.3 p -114.73 -37.09 2.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.07 179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 9.9 tttt -115.38 149.77 37.42 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.871 179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.3 165.94 21.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.027 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 27.5 t70 62.48 64.73 0.91 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.988 179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 5.1 t80 -84.04 138.47 33.06 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.846 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.705 HD11 HD23 ' A' ' 94' ' ' LEU . 8.4 tp -98.7 120.28 47.82 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.226 -179.678 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.646 HD13 ' HE2' ' A' ' 80' ' ' PHE . 4.7 tt -103.07 139.06 39.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.992 -179.932 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 13.0 mmtp -129.84 178.17 6.72 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.74 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.442 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 4.8 p-10 -53.41 148.0 9.74 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.153 -179.89 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 64.08 37.5 94.68 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.565 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -109.81 127.85 54.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.821 0.343 . . . . 0.0 110.96 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.413 ' O ' HD12 ' A' ' 107' ' ' ILE . 54.2 mtt180 -93.6 132.69 37.67 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.858 179.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.825 HG22 HD13 ' A' ' 107' ' ' ILE . 0.1 OUTLIER -118.42 122.0 68.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.087 179.877 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 46.7 t -112.71 123.9 68.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.771 179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.689 ' CD1' HG23 ' A' ' 105' ' ' THR . 68.5 m-85 -120.38 148.03 44.29 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.951 0.405 . . . . 0.0 111.211 -179.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 73.79 -65.84 1.78 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.348 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 175.35 -50.16 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.807 0.337 . . . . 0.0 111.022 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -102.06 -33.13 9.82 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.681 -179.589 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 21.6 m -55.74 105.46 0.18 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.884 0.373 . . . . 0.0 110.98 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 13.7 p -124.22 136.76 54.4 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.918 179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.439 ' CZ ' ' HG ' ' A' ' 68' ' ' LEU . 15.5 m-85 -142.25 156.21 45.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.151 179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.8 tt -121.66 116.1 23.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.711 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.569 ' HE2' HG21 ' A' ' 50' ' ' ILE . 21.4 t80 -94.7 141.56 28.47 Favored 'General case' 0 CA--C 1.513 -0.478 0 CA-C-O 122.054 0.931 . . . . 0.0 111.895 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 6.8 tttt -154.62 160.4 41.43 Favored 'General case' 0 C--N 1.311 -1.092 0 CA-C-N 113.781 -1.554 . . . . 0.0 110.85 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.461 ' HE1' HD11 ' A' ' 95' ' ' ILE . 3.7 m-85 -86.07 139.98 30.66 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-O 121.051 0.453 . . . . 0.0 110.681 179.496 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.413 ' HB2' ' ND1' ' A' ' 36' ' ' HIS . . . -95.7 170.51 9.27 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.812 -0.631 . . . . 0.0 111.058 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 12.0 m -109.39 156.98 19.37 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.014 -179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 60.5 p -111.45 31.53 6.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.847 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -99.76 -170.03 1.83 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.942 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.2 m -80.42 138.64 36.65 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.986 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 18.9 p -113.28 -36.56 4.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.931 -179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 61.11 173.7 0.11 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.894 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.585 HG22 ' O ' ' A' ' 145' ' ' ILE . 19.1 mm -106.37 24.93 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.315 0 CA-C-O 121.551 0.691 . . . . 0.0 111.345 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 9.4 tt0 -105.3 110.29 22.6 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 114.623 -1.171 . . . . 0.0 110.8 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -138.17 107.5 6.12 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.846 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 23.8 p30 -88.4 167.75 13.23 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.108 -0.497 . . . . 0.0 110.941 179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 7.1 t0 -134.43 -55.37 0.85 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.905 -179.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -175.71 -41.83 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.897 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 7.5 mttp -67.86 127.96 34.75 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.908 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 10.9 p -115.43 -38.26 2.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.217 -0.447 . . . . 0.0 111.098 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 96.7 p -109.49 150.13 28.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.894 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.4 m -80.5 117.19 21.0 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.955 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -117.57 -40.91 2.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.848 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.9 m -60.07 157.64 12.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.855 179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 5.4 ptp180 -89.45 78.13 7.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.881 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.74 179.2 4.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.9 179.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 1.4 t80 . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.208 -0.901 . . . . 0.0 110.95 -179.971 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 1.5 mptt . . . . . 0 N--CA 1.486 1.349 0 CA-C-O 120.832 0.348 . . . . 0.0 111.119 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 16.7 mtt180 -75.1 169.48 17.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.808 -179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 60.24 97.04 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.88 179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 24.4 pt20 -112.98 171.7 7.38 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.885 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.45 162.4 28.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.843 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -135.93 113.79 11.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.833 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 41.9 p30 -165.36 -177.42 4.48 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.873 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.1 tmtt? -142.19 134.93 13.84 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.908 179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.85 155.47 32.67 Favored 'Trans proline' 0 C--N 1.346 0.438 0 C-N-CA 122.311 2.007 . . . . 0.0 112.325 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -169.38 -177.75 2.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.94 -179.983 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -64.35 171.74 2.95 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.945 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -172.07 -71.93 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.903 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 31.3 m-85 -71.29 -108.75 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.834 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.474 ' N ' HG22 ' A' ' 51' ' ' THR . 0.2 OUTLIER -140.28 129.03 23.1 Favored 'General case' 0 C--O 1.231 0.107 0 CA-C-O 120.868 0.366 . . . . 0.0 110.517 179.665 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 40.6 t -59.84 120.17 9.08 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.158 -179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.567 HD23 HD22 ' A' ' 52' ' ' ASN . 1.3 mm? -117.04 -34.97 4.22 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.705 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.6 ' O ' HG22 ' A' ' 50' ' ' ILE . . . -168.54 -177.9 39.84 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.961 -0.638 . . . . 0.0 112.274 179.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 23.2 m80 -138.08 166.05 25.08 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 121.084 0.468 . . . . 0.0 111.138 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.493 HD22 ' CE2' ' A' ' 133' ' ' PHE . 1.1 mt -127.28 114.73 18.0 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.614 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.426 HG22 ' HG2' ' A' ' 47' ' ' LYS . 20.0 t -95.92 121.59 46.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.129 -179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -90.37 142.04 28.13 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.939 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.6 mt -107.43 106.49 16.92 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.681 179.695 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 9.9 mt -124.39 138.67 31.41 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.983 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 57.3 Cg_exo -52.12 -25.39 22.82 Favored 'Trans proline' 0 C--N 1.346 0.416 0 C-N-CA 122.475 2.117 . . . . 0.0 112.516 179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -85.52 -34.01 15.04 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.736 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER 177.15 -174.28 0.12 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.835 0.35 . . . . 0.0 110.948 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -107.92 157.53 18.12 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.918 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 27.8 tt0 -135.41 120.26 18.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.954 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.426 ' HG2' HG22 ' A' ' 38' ' ' VAL . 1.7 mmtp -100.72 128.2 46.86 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.882 179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.1 t -122.4 139.71 48.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.156 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.9 pt-20 -92.43 127.42 37.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.724 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.6 HG22 ' O ' ' A' ' 35' ' ' GLY . 15.9 tt -116.05 132.08 66.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.04 0.448 . . . . 0.0 111.468 -179.731 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.474 HG22 ' N ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -98.81 167.87 10.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.454 179.74 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.567 HD22 HD23 ' A' ' 34' ' ' LEU . 0.7 OUTLIER -61.14 -92.18 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.684 -0.235 . . . . 0.0 110.387 179.592 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.558 ' C ' ' H ' ' A' ' 55' ' ' VAL . 8.0 ttt180 75.2 -5.77 2.1 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 112.581 0.586 . . . . 0.0 112.581 179.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.423 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 7.9 t-20 71.03 -32.97 0.26 Allowed 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.786 -0.365 . . . . 0.0 110.199 -179.137 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.558 ' H ' ' C ' ' A' ' 53' ' ' ARG . 61.6 t -135.82 138.33 47.86 Favored 'Isoleucine or valine' 0 C--O 1.232 0.14 0 CA-C-O 120.926 0.393 . . . . 0.0 110.931 179.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.762 HG23 ' CB ' ' A' ' 65' ' ' ASP . 94.0 m -125.38 130.5 52.04 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.006 -0.543 . . . . 0.0 110.579 -179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.413 ' O ' ' N ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -104.01 139.76 38.69 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.821 0.343 . . . . 0.0 111.025 -179.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.419 ' N ' HD12 ' A' ' 58' ' ' ILE . 4.7 mp -132.2 130.87 60.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.335 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 160.35 -135.31 3.99 Favored Glycine 0 C--N 1.333 0.366 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.971 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.482 ' HB2' ' CG2' ' A' ' 73' ' ' ILE . 7.5 ttt-85 -100.59 -40.9 7.18 Favored 'General case' 0 N--CA 1.462 0.13 0 CA-C-O 120.855 0.36 . . . . 0.0 110.918 -179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.607 ' HB2' HG23 ' A' ' 75' ' ' THR . 0.3 OUTLIER -44.83 118.82 1.73 Allowed 'General case' 0 N--CA 1.463 0.201 0 CA-C-N 116.057 -0.519 . . . . 0.0 111.446 -179.568 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 15.9 mtt85 -57.42 -27.42 62.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.884 179.875 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 4.7 m -69.82 -25.62 63.85 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.778 179.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 89.8 m -54.73 166.6 0.46 Allowed 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.78 179.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.762 ' CB ' HG23 ' A' ' 56' ' ' THR . 0.6 OUTLIER -73.52 -58.33 3.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.875 0.369 . . . . 0.0 111.117 -179.945 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.408 HG21 ' CD1' ' A' ' 37' ' ' LEU . 21.2 t -121.51 125.36 73.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.062 -0.517 . . . . 0.0 111.647 -179.551 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.3 pt -95.81 118.19 41.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.567 179.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.49 HD13 HD11 ' A' ' 73' ' ' ILE . 9.1 mt -77.01 -91.55 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.686 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.583 ' OG ' HD13 ' A' ' 73' ' ' ILE . 1.3 p -101.42 -102.11 0.26 Allowed 'General case' 0 C--N 1.332 -0.188 0 N-CA-C 109.579 -0.526 . . . . 0.0 109.579 179.064 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.583 ' CB ' ' HD3' ' A' ' 71' ' ' PRO . 3.6 mt-10 162.4 -63.96 0.0 OUTLIER Pre-proline 0 CA--C 1.531 0.228 0 N-CA-C 111.737 0.273 . . . . 0.0 111.737 178.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.583 ' HD3' ' CB ' ' A' ' 70' ' ' GLU . 46.8 Cg_exo -56.09 -40.13 86.86 Favored 'Trans proline' 0 C--N 1.345 0.372 0 C-N-CA 122.107 1.871 . . . . 0.0 113.355 -178.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 63.9 m-20 -124.19 25.67 7.72 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 111.748 0.277 . . . . 0.0 111.748 -179.18 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.583 HD13 ' OG ' ' A' ' 69' ' ' SER . 3.1 tp -104.31 121.93 56.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-O 121.137 0.494 . . . . 0.0 111.223 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.6 m -62.9 136.31 57.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.739 -0.664 . . . . 0.0 111.285 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.607 HG23 ' HB2' ' A' ' 61' ' ' SER . 65.8 m -64.4 -40.57 96.04 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.806 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.452 ' O ' ' C ' ' A' ' 77' ' ' HIS . 3.5 m-85 -99.24 13.86 31.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.232 0.539 . . . . 0.0 111.448 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.452 ' C ' ' O ' ' A' ' 76' ' ' PHE . 1.0 OUTLIER -20.6 -69.8 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 114.705 -1.134 . . . . 0.0 112.76 -179.346 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -156.64 164.05 38.61 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.214 0.53 . . . . 0.0 112.099 -179.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -129.52 133.78 47.42 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.536 -0.756 . . . . 0.0 110.085 179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.836 ' CE1' HG13 ' A' ' 97' ' ' VAL . 5.1 m-85 -119.2 131.22 55.81 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.975 -179.443 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.423 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 8.1 m-70 -94.67 116.33 28.62 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.991 0.424 . . . . 0.0 110.906 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.43 109.65 21.63 Favored 'General case' 0 C--O 1.235 0.294 0 CA-C-N 116.042 -0.527 . . . . 0.0 111.058 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.31 137.56 54.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.794 179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.419 ' HG3' HD11 ' A' ' 34' ' ' LEU . 2.0 tt0 -109.64 129.2 55.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.868 179.931 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.88 141.22 34.63 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.948 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 28.8 p-10 -106.95 115.95 31.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.856 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.0 m -124.95 117.41 50.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.258 -0.428 . . . . 0.0 111.3 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.7 t0 58.35 77.51 0.29 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.081 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 63.18 -80.0 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.994 179.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 88.7 m-85 -63.67 151.72 41.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.917 -179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -118.63 136.72 53.74 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.96 179.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 10.7 mtp180 -112.64 149.74 32.42 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.997 -179.904 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -112.12 125.61 54.3 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.716 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.3 mp -107.78 127.29 53.57 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.927 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.491 ' N ' HD12 ' A' ' 95' ' ' ILE . 4.1 mp -118.09 137.41 52.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.076 -179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -114.01 144.09 43.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.041 -179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.836 HG13 ' CE1' ' A' ' 80' ' ' PHE . 14.1 t -106.45 127.13 62.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.253 -179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 11.9 mt -130.03 120.91 50.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.851 179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -100.14 136.5 39.95 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.021 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.7 mmtt -133.47 30.55 3.82 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.913 179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.7 m -160.68 150.78 17.8 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.841 179.92 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 14.5 ptp180 -102.21 44.76 0.99 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.954 -179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -83.65 -31.71 26.03 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.242 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 121.33 89.21 1.03 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.51 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 67.4 m -112.36 126.09 54.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.9 0.381 . . . . 0.0 110.912 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 9.6 m-85 -121.03 118.31 29.49 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.956 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.436 HD12 ' O ' ' A' ' 124' ' ' ARG . 2.7 tp -115.49 137.33 49.41 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.288 0 CA-C-O 121.551 0.691 . . . . 0.0 111.255 179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 59.98 28.09 17.57 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.838 -1.073 . . . . 0.0 110.931 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.74 9.89 70.82 Favored Glycine 0 N--CA 1.444 -0.806 0 C-N-CA 120.825 -0.702 . . . . 0.0 112.878 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 47.2 m-80 -134.04 152.0 51.66 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.823 0.344 . . . . 0.0 110.854 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.04 136.74 43.11 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.894 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -69.91 144.96 52.29 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.866 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.534 HG22 ' O ' ' A' ' 113' ' ' VAL . 10.2 p -141.11 56.13 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.106 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -177.25 -176.4 0.64 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.835 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.41 25.84 9.2 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.024 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -166.46 72.9 0.15 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.778 179.893 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.429 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 0.7 OUTLIER -84.14 139.4 32.46 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.833 -179.974 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.543 ' O ' HG23 ' A' ' 118' ' ' ILE . 7.8 tp -98.51 117.62 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.379 0 CA-C-O 120.984 0.421 . . . . 0.0 111.242 -179.787 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.734 HD21 ' CD2' ' A' ' 135' ' ' PHE . 0.5 OUTLIER -103.1 132.54 49.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.035 -179.834 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -130.84 178.09 6.92 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.799 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.423 ' HB2' ' CE2' ' A' ' 137' ' ' TYR . 0.3 OUTLIER -54.81 141.32 33.36 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.061 -179.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 71.8 53.04 10.16 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.5 179.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -129.14 127.12 40.76 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.895 0.378 . . . . 0.0 111.009 -179.987 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.724 ' HD2' HD12 ' A' ' 134' ' ' LEU . 0.3 OUTLIER -91.13 124.38 35.3 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.747 179.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.427 HD11 HD11 ' A' ' 119' ' ' LEU . 3.2 mp -115.0 131.57 66.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.283 -179.833 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.7 t -122.71 128.14 75.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.943 179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.483 ' CB ' HD13 ' A' ' 68' ' ' LEU . 44.5 m-85 -121.77 118.22 28.5 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.983 -179.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 86.63 -8.17 76.39 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.776 -0.726 . . . . 0.0 112.84 179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 76.74 27.98 0.72 Allowed 'General case' 0 CA--C 1.522 -0.11 0 CA-C-O 120.939 0.4 . . . . 0.0 110.243 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 4.2 p -138.13 -48.24 0.54 Allowed 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.94 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . 0.465 ' HB3' HD22 ' A' ' 68' ' ' LEU . 1.8 m -88.41 112.04 22.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.865 179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 23.0 t -120.08 123.35 43.18 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.036 -179.894 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.493 ' CE2' HD22 ' A' ' 37' ' ' LEU . 3.1 p90 -142.16 156.22 45.34 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.118 179.952 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.724 HD12 ' HD2' ' A' ' 124' ' ' ARG . 7.1 tt -108.07 138.79 43.72 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.706 179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.734 ' CD2' HD21 ' A' ' 119' ' ' LEU . 56.5 t80 -105.18 141.57 36.49 Favored 'General case' 0 CA--C 1.512 -0.493 0 CA-C-O 121.992 0.901 . . . . 0.0 111.938 -179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.43 155.11 34.37 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 113.846 -1.525 . . . . 0.0 110.747 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.423 ' CE2' ' HB2' ' A' ' 121' ' ' ASN . 1.1 m-85 -85.06 139.74 31.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.945 0.403 . . . . 0.0 110.847 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -118.9 -168.6 1.58 Allowed 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.88 -0.6 . . . . 0.0 111.065 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -160.78 -46.34 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.927 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 4.9 m -74.03 132.89 42.8 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.928 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 4.3 t -119.56 -40.42 2.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.965 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 6.1 m -58.1 -48.52 79.91 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.007 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER 60.65 31.61 20.2 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.894 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -166.86 119.0 0.96 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.882 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.6 HG22 ' O ' ' A' ' 145' ' ' ILE . 19.2 mt -103.2 25.2 1.45 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 CA-C-O 121.623 0.725 . . . . 0.0 111.278 -179.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 61.99 93.47 0.05 OUTLIER 'General case' 0 C--N 1.307 -1.278 0 CA-C-N 114.656 -1.156 . . . . 0.0 110.899 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.6 t30 -128.93 112.44 14.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.908 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -116.15 -64.81 1.26 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.966 179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -129.69 -45.98 1.17 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.852 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 61.09 102.36 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.86 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -106.74 32.51 4.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.872 -179.998 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.5 t -69.95 -60.89 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.085 -179.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 26.1 t -77.16 98.18 5.0 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.842 -179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 2.1 p -114.14 140.6 48.38 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.968 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -68.45 78.85 0.27 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.907 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 3.9 m 60.07 165.52 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.907 179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 37.2 mtt-85 -73.87 115.27 13.12 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.901 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 47.9 t -117.94 89.97 3.23 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.887 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 36.5 t80 . . . . . 0 C--O 1.249 1.056 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.886 -179.984 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 13.4 mttm . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.835 0.35 . . . . 0.0 111.182 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 61.05 110.22 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.864 -179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 4.9 tt0 59.66 94.4 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.966 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 13.5 mm100 -146.75 115.85 6.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.927 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.66 -71.63 0.72 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.829 179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.01 31.43 5.27 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.863 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -103.43 111.97 24.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.874 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 7.4 mtmt -132.43 149.11 72.21 Favored Pre-proline 0 C--N 1.328 -0.351 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.859 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -68.58 140.91 48.74 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.589 2.193 . . . . 0.0 112.21 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 24.0 t -113.19 94.36 4.85 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.03 -179.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.4 p -77.94 -58.61 3.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.756 179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -178.73 -69.23 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.807 179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.422 ' HB2' ' HB ' ' A' ' 51' ' ' THR . 17.8 m-85 -97.18 -108.13 0.16 Allowed 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.865 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.478 ' C ' HG22 ' A' ' 51' ' ' THR . 0.7 OUTLIER -140.27 128.72 22.71 Favored 'General case' 0 C--O 1.231 0.099 0 CA-C-O 120.726 0.298 . . . . 0.0 110.635 179.758 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 13.2 t -76.43 114.86 15.61 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.901 0.382 . . . . 0.0 111.071 -179.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -118.19 -35.8 3.73 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.889 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.711 ' C ' HG22 ' A' ' 50' ' ' ILE . . . -141.03 -177.81 16.67 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.743 -0.742 . . . . 0.0 112.565 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.638 ' ND1' ' HB2' ' A' ' 138' ' ' ALA . 31.9 m80 -142.13 157.87 44.39 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.836 0.35 . . . . 0.0 110.832 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.494 ' O ' HD12 ' A' ' 37' ' ' LEU . 3.0 pp -127.08 123.05 35.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.722 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.3 t -105.89 121.93 58.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.279 -0.419 . . . . 0.0 111.197 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 14.8 m120 -86.3 115.16 23.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.751 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 45.1 mt -83.87 106.87 15.89 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.986 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.547 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 4.4 mt -124.25 141.5 37.55 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.806 -179.899 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.547 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 57.5 Cg_endo -73.66 84.91 1.36 Allowed 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.253 1.968 . . . . 0.0 112.018 179.99 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 141.34 -14.04 2.76 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 121.026 -0.607 . . . . 0.0 112.41 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.2 ttpt -179.03 173.68 1.15 Allowed 'General case' 0 N--CA 1.453 -0.296 0 CA-C-O 120.767 0.317 . . . . 0.0 110.628 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -139.04 160.76 39.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.376 -0.375 . . . . 0.0 111.075 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -141.5 123.35 15.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.959 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.42 ' HE2' ' CD2' ' A' ' 36' ' ' HIS . 28.4 tttt -110.68 126.17 54.24 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.819 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 38.5 t -124.05 144.67 33.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.235 -179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.442 ' HG2' ' CD2' ' A' ' 36' ' ' HIS . 48.0 mt-10 -80.87 135.64 35.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.546 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.711 HG22 ' C ' ' A' ' 35' ' ' GLY . 2.9 tt -111.65 131.99 61.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.043 0.449 . . . . 0.0 111.444 -179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.585 ' O ' HD13 ' A' ' 82' ' ' LEU . 0.9 OUTLIER -102.7 168.02 9.52 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.465 179.804 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.769 ' HA ' HD22 ' A' ' 82' ' ' LEU . 34.1 m-80 -68.43 -91.25 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.034 -0.358 . . . . 0.0 110.034 179.289 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.574 ' C ' ' H ' ' A' ' 55' ' ' VAL . 5.8 ttt85 69.75 -2.48 1.97 Allowed 'General case' 0 C--O 1.231 0.126 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 178.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.417 ' HA ' HD22 ' A' ' 83' ' ' LEU . 1.8 m-20 70.29 -32.21 0.23 Allowed 'General case' 0 C--N 1.332 -0.192 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 -179.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.574 ' H ' ' C ' ' A' ' 53' ' ' ARG . 81.6 t -136.99 143.25 35.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.822 179.638 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.499 HG23 ' CB ' ' A' ' 65' ' ' ASP . 9.2 m -125.49 131.2 52.87 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.458 -179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.446 ' O ' ' N ' ' A' ' 65' ' ' ASP . 0.1 OUTLIER -103.98 137.46 41.93 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.908 0.385 . . . . 0.0 111.087 -179.862 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.416 HD13 ' CE1' ' A' ' 80' ' ' PHE . 3.4 mp -132.1 128.47 59.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.276 -0.42 . . . . 0.0 111.096 179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 168.9 -135.27 3.53 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.718 -0.753 . . . . 0.0 112.754 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.448 ' HB3' ' HA ' ' A' ' 70' ' ' GLU . 14.8 ptt85 -108.11 -29.4 8.97 Favored 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.663 0.268 . . . . 0.0 111.022 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.713 ' CB ' HG23 ' A' ' 75' ' ' THR . 2.8 t -57.46 121.73 10.95 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.831 0.348 . . . . 0.0 110.816 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.68 -25.36 39.38 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.07 -179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -69.97 -24.63 63.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.32 -0.4 . . . . 0.0 111.0 179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 87.7 m -58.22 166.47 1.62 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.038 -179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.499 ' CB ' HG23 ' A' ' 56' ' ' THR . 0.5 OUTLIER -71.01 -57.1 4.88 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.003 0.43 . . . . 0.0 110.832 179.742 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.47 HG21 ' CD2' ' A' ' 37' ' ' LEU . 21.0 t -125.2 133.3 69.72 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.193 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.67 -179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.6 pt -101.72 125.32 55.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.722 179.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.531 HD23 ' CB ' ' A' ' 131' ' ' CYS . 4.3 mp -93.28 -85.98 0.26 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.45 -0.341 . . . . 0.0 110.944 -179.722 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.401 ' O ' ' CB ' ' A' ' 70' ' ' GLU . 10.0 t -98.33 -101.93 0.21 Allowed 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 179.671 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.531 ' CB ' ' CD ' ' A' ' 71' ' ' PRO . 0.1 OUTLIER 167.21 -70.2 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.189 0 CA-C-O 120.528 0.204 . . . . 0.0 111.299 179.369 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.531 ' CD ' ' CB ' ' A' ' 70' ' ' GLU . 47.0 Cg_endo -67.86 -38.19 13.95 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 122.56 2.173 . . . . 0.0 113.579 -179.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -105.71 10.51 32.78 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-O 120.757 0.313 . . . . 0.0 111.226 -179.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.449 ' O ' ' CG2' ' A' ' 73' ' ' ILE . 2.9 tp -105.88 117.29 51.34 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-O 121.016 0.436 . . . . 0.0 110.612 -179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.429 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 0.3 OUTLIER -67.22 135.97 54.26 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.16 -179.163 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.713 HG23 ' CB ' ' A' ' 61' ' ' SER . 64.1 m -49.33 -44.02 44.09 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.826 179.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.448 ' O ' ' C ' ' A' ' 77' ' ' HIS . 5.7 p90 -106.85 14.1 27.04 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.22 0.533 . . . . 0.0 111.327 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.448 ' C ' ' O ' ' A' ' 76' ' ' PHE . 3.9 t-160 -20.2 -58.51 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 114.609 -1.178 . . . . 0.0 112.826 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.431 ' CB ' ' CZ ' ' A' ' 127' ' ' PHE . . . -150.63 157.89 43.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.97 0.414 . . . . 0.0 111.583 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.404 ' HA ' ' O ' ' A' ' 56' ' ' THR . 16.2 pt-20 -133.06 133.49 43.1 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.796 -0.638 . . . . 0.0 110.684 179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.664 ' CE2' HG22 ' A' ' 97' ' ' VAL . 5.0 m-85 -119.3 131.33 55.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.608 -179.907 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.4 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 9.0 m-70 -94.41 116.43 28.79 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.985 0.421 . . . . 0.0 111.092 -179.688 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.769 HD22 ' HA ' ' A' ' 52' ' ' ASN . 1.8 tt -106.49 109.88 21.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.883 -0.598 . . . . 0.0 110.814 179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . 0.417 HD22 ' HA ' ' A' ' 54' ' ' ASN . 1.1 mm? -121.6 137.4 54.75 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.895 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -108.93 136.91 47.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.856 179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -126.88 131.77 51.09 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.869 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -88.54 120.17 29.67 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.904 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.5 t -139.96 139.13 37.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.133 -0.485 . . . . 0.0 111.065 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -50.1 132.86 23.58 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.078 -179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 35.6 m120 62.47 99.35 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.792 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 41.7 m-85 63.16 133.92 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.999 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 24.6 mt-30 -82.93 158.71 22.5 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.897 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.91 111.82 20.17 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.974 -179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.495 ' C ' HD12 ' A' ' 94' ' ' LEU . 11.9 m-80 -113.34 138.92 49.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.837 179.819 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.495 HD12 ' C ' ' A' ' 93' ' ' ASN . 7.9 mp -130.03 137.17 50.11 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.995 -179.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.454 ' O ' HD12 ' A' ' 118' ' ' ILE . 3.8 mp -119.59 139.02 48.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.078 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -116.88 144.13 44.88 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.688 179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.664 HG22 ' CE2' ' A' ' 80' ' ' PHE . 16.4 t -116.2 132.15 66.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.271 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.558 HD13 ' O ' ' A' ' 115' ' ' LYS . 20.5 mm -127.11 131.06 71.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.119 -179.987 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -90.22 128.35 36.36 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.861 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.5 mmmt -119.93 -35.36 3.51 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.278 -179.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.8 m -78.07 -44.84 25.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.425 -0.352 . . . . 0.0 111.117 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 59.51 21.54 10.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.904 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 25.5 p-10 -85.95 -30.51 22.73 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.855 179.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 167.36 73.37 0.03 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.506 179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.456 HG23 ' CE1' ' A' ' 127' ' ' PHE . 62.0 m -104.72 122.76 46.37 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.888 0.375 . . . . 0.0 110.869 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 75.0 m-85 -121.14 119.29 31.94 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.874 179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.789 HD13 HD12 ' A' ' 125' ' ' ILE . 2.9 tp -118.09 137.29 52.52 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.31 0 CA-C-O 121.524 0.678 . . . . 0.0 111.202 179.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 60.15 27.29 16.75 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 114.866 -1.061 . . . . 0.0 110.818 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.75 9.86 70.81 Favored Glycine 0 N--CA 1.443 -0.843 0 C-N-CA 120.918 -0.658 . . . . 0.0 112.818 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 4.0 m-80 -134.03 152.02 51.67 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.749 0.309 . . . . 0.0 110.958 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 30.1 mtm180 -65.1 142.97 58.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.902 179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.418 HD21 ' HB ' ' A' ' 105' ' ' THR . 3.1 pp -99.17 129.57 45.43 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.898 179.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 5.6 m -111.85 -30.79 2.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.189 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 16.9 mtmt -80.64 142.22 34.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.937 179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.558 ' O ' HD13 ' A' ' 98' ' ' ILE . 0.2 OUTLIER -77.73 -32.75 53.02 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.875 179.968 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -105.64 75.04 1.11 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.927 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -80.75 139.03 36.31 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.822 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.525 ' O ' HG23 ' A' ' 118' ' ' ILE . 8.6 tp -98.54 119.06 46.04 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.37 -179.738 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 7.6 tt -103.0 138.51 39.78 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.982 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.02 178.11 7.31 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.862 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.445 ' HB2' ' CE2' ' A' ' 137' ' ' TYR . 2.0 t30 -55.31 142.06 33.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.084 -179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.501 ' HA2' HD21 ' A' ' 134' ' ' LEU . . . 68.08 48.62 52.47 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.793 -0.718 . . . . 0.0 112.406 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -123.44 124.24 42.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.843 0.354 . . . . 0.0 111.072 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.473 ' O ' HD12 ' A' ' 107' ' ' ILE . 48.6 ttt-85 -90.22 122.19 32.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.801 179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.789 HD12 HD13 ' A' ' 107' ' ' ILE . 0.5 OUTLIER -120.63 136.41 57.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.933 0.397 . . . . 0.0 111.317 -179.882 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.432 HG22 ' HB3' ' A' ' 132' ' ' SER . 21.4 t -124.09 133.95 67.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.815 179.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.456 ' CE1' HG23 ' A' ' 105' ' ' THR . 9.7 m-85 -124.85 138.42 54.26 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.955 0.407 . . . . 0.0 111.142 -179.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 86.77 -69.83 3.03 Favored Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.84 -0.695 . . . . 0.0 112.343 179.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 176.67 -39.1 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.729 0.3 . . . . 0.0 111.076 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -112.38 -40.21 4.19 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.804 -179.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . 0.531 ' CB ' HD23 ' A' ' 68' ' ' LEU . 33.6 m -53.92 103.95 0.09 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.071 0.462 . . . . 0.0 111.268 -179.595 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.432 ' HB3' HG22 ' A' ' 126' ' ' VAL . 5.6 p -124.6 129.34 50.37 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.902 179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.457 ' CD1' ' N ' ' A' ' 133' ' ' PHE . 1.3 p90 -142.16 156.08 45.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.363 -0.38 . . . . 0.0 111.058 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.583 HD23 ' N ' ' A' ' 135' ' ' PHE . 3.5 tt -115.11 136.16 53.42 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.83 179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.7 ' HE2' HG21 ' A' ' 50' ' ' ILE . 21.6 t80 -105.67 141.56 36.92 Favored 'General case' 0 CA--C 1.512 -0.487 0 CA-C-O 121.95 0.881 . . . . 0.0 111.774 -179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 12.2 mttt -154.31 159.67 41.35 Favored 'General case' 0 C--N 1.312 -1.038 0 CA-C-N 113.828 -1.533 . . . . 0.0 110.756 179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.445 ' CE2' ' HB2' ' A' ' 121' ' ' ASN . 4.5 m-85 -85.29 140.11 31.08 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.059 0.457 . . . . 0.0 110.618 179.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.638 ' HB2' ' ND1' ' A' ' 36' ' ' HIS . . . -91.17 138.93 31.22 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.755 -0.657 . . . . 0.0 111.191 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -88.17 94.23 9.75 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.919 -179.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 52.9 p -139.89 48.36 1.8 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.882 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -158.76 31.94 0.22 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.803 -179.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.478 ' O ' HG22 ' A' ' 143' ' ' THR . 0.2 OUTLIER -79.43 -56.88 4.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.923 179.969 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . 0.478 HG22 ' O ' ' A' ' 142' ' ' SER . 15.0 t 45.32 -167.6 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.366 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -151.63 178.96 8.81 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.9 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.605 HG22 ' O ' ' A' ' 145' ' ' ILE . 3.3 mp -105.01 25.04 1.83 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.341 0 CA-C-O 121.707 0.765 . . . . 0.0 111.37 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 2.8 mm-40 -138.4 138.66 38.43 Favored 'General case' 0 C--N 1.307 -1.28 0 CA-C-N 114.558 -1.201 . . . . 0.0 110.941 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 10.5 p30 -166.24 -45.24 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.88 -179.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.62 -33.06 12.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.86 180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -94.89 125.96 39.89 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.872 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -84.63 151.64 24.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.906 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 20.0 mttt -85.85 174.84 9.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.952 179.928 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 152' ' ' VAL . 21.4 m -125.73 115.68 43.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.12 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 2.5 m -129.24 -57.73 1.14 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.962 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 60.73 -179.29 0.1 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.901 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 13.4 mp0 -126.04 160.75 29.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.858 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 73.3 m -153.71 78.84 1.14 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.874 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 1.8 mtp-105 -98.33 123.34 42.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.913 179.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.3 m 60.75 80.92 0.2 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.428 . . . . 0.0 110.9 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 . . . . . 0 C--O 1.249 1.033 0 CA-C-O 118.217 -0.897 . . . . 0.0 110.873 -179.953 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 17.4 mttp . . . . . 0 N--CA 1.487 1.385 0 CA-C-O 120.836 0.351 . . . . 0.0 111.195 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.89 153.39 40.8 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.762 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -126.29 177.75 6.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.92 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.444 ' O ' ' HG2' ' A' ' 23' ' ' ARG . 0.5 OUTLIER -112.62 -175.06 2.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.85 179.984 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . 0.444 ' HG2' ' O ' ' A' ' 22' ' ' GLN . 0.1 OUTLIER 34.65 50.46 0.42 Allowed 'General case' 0 N--CA 1.466 0.335 0 CA-C-N 116.001 -0.545 . . . . 0.0 111.905 179.909 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 92.8 p -84.08 -26.2 29.17 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.123 -0.49 . . . . 0.0 111.08 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.8 m120 -55.33 -71.07 0.09 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.374 -0.375 . . . . 0.0 111.037 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 16.2 mmtt -134.95 139.39 31.97 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.876 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -70.14 146.68 58.54 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.471 2.114 . . . . 0.0 112.224 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 15.8 t -75.66 85.49 2.69 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.886 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -74.9 161.15 29.79 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.892 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -142.42 -65.64 0.4 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.762 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.464 ' HB2' ' CG2' ' A' ' 51' ' ' THR . 49.0 m-85 -114.99 -118.19 0.32 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.618 179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.4 ' O ' HG22 ' A' ' 51' ' ' THR . 0.0 OUTLIER -140.18 137.42 34.35 Favored 'General case' 0 N--CA 1.457 -0.082 0 CA-C-O 120.823 0.344 . . . . 0.0 110.73 179.917 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.8 t -59.81 145.07 46.76 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.117 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.618 HD22 HD21 ' A' ' 82' ' ' LEU . 8.3 tt -152.2 -44.98 0.1 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.945 179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -157.72 172.82 35.04 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.445 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.546 ' ND1' ' HB2' ' A' ' 138' ' ' ALA . 32.1 m80 -133.47 161.19 35.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.008 0.432 . . . . 0.0 111.208 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.608 HD12 HD11 ' A' ' 50' ' ' ILE . 57.9 mt -127.19 107.92 10.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.858 -0.61 . . . . 0.0 110.596 179.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.2 t -96.78 121.74 47.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.825 0.345 . . . . 0.0 111.366 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 5.5 m-80 -90.16 119.44 30.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.836 179.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 3.5 mt -79.26 106.8 11.55 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.297 -0.411 . . . . 0.0 110.898 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 5.4 mt -124.27 139.27 32.45 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.914 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 76.3 Cg_exo -50.11 91.32 0.02 OUTLIER 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.41 2.074 . . . . 0.0 112.286 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 116.03 -105.6 1.42 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.263 -179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -56.85 -168.03 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.791 0.329 . . . . 0.0 111.023 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -155.5 141.7 18.42 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.985 179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -110.46 120.17 41.57 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.82 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -110.57 126.14 54.11 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.993 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 22.7 t -117.21 143.99 26.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.134 -0.485 . . . . 0.0 110.975 179.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -93.7 131.16 39.29 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.925 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.608 HD11 HD12 ' A' ' 37' ' ' LEU . 30.5 mm -111.33 122.38 65.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.002 179.748 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.757 ' O ' HD23 ' A' ' 82' ' ' LEU . 0.4 OUTLIER -102.48 168.2 9.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.899 179.994 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 17.2 p30 -93.19 71.38 4.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.704 179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.587 ' C ' ' H ' ' A' ' 55' ' ' VAL . 2.6 ptp180 -98.35 15.62 24.09 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.994 -0.548 . . . . 0.0 111.618 -179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 68.97 -29.26 0.17 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.706 0.289 . . . . 0.0 110.333 -179.579 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.587 ' H ' ' C ' ' A' ' 53' ' ' ARG . 59.3 t -137.09 134.64 47.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 CA-C-O 121.193 0.52 . . . . 0.0 111.548 -179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.659 HG23 ' HB3' ' A' ' 65' ' ' ASP . 39.7 m -125.06 122.53 37.49 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.635 -0.712 . . . . 0.0 109.756 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.88 133.84 48.17 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.901 0.382 . . . . 0.0 111.038 -179.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.4 mp -119.11 116.52 51.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.721 179.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 174.72 -146.09 8.32 Favored Glycine 0 C--N 1.332 0.339 0 C-N-CA 120.739 -0.743 . . . . 0.0 112.571 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.524 ' HB3' ' HA ' ' A' ' 70' ' ' GLU . 9.4 ptt180 -100.21 -27.67 13.39 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.702 0.287 . . . . 0.0 111.102 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -53.06 121.4 7.34 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.911 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 1.7 ptt85 -54.96 -28.78 54.1 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.067 -179.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.91 -24.99 63.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.836 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 99.8 m -55.36 158.8 3.0 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.001 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.659 ' HB3' HG23 ' A' ' 56' ' ' THR . 62.0 t0 -76.3 -52.89 9.05 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.905 0.383 . . . . 0.0 110.943 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 16.6 t -101.64 129.83 52.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.252 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.253 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 14.6 pt -99.82 125.84 53.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.158 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.405 ' O ' ' C ' ' A' ' 69' ' ' SER . 3.3 mp -113.71 -163.69 0.88 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.038 -0.528 . . . . 0.0 110.249 179.881 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.596 ' O ' ' CB ' ' A' ' 70' ' ' GLU . 1.2 m -35.56 -58.46 0.59 Allowed 'General case' 0 N--CA 1.466 0.33 0 CA-C-O 120.574 0.226 . . . . 0.0 110.975 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.596 ' CB ' ' O ' ' A' ' 69' ' ' SER . 9.0 tm-20 109.84 -61.74 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.529 0 CA-C-N 115.673 -0.694 . . . . 0.0 112.702 178.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.585 ' HD2' ' C ' ' A' ' 69' ' ' SER . 44.0 Cg_endo -67.75 -33.51 27.26 Favored 'Trans proline' 0 C--N 1.35 0.615 0 C-N-CA 121.888 1.726 . . . . 0.0 113.199 -179.358 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 43.0 m-20 -112.04 21.56 15.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.701 0.286 . . . . 0.0 111.301 -179.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.424 ' HA ' HD12 ' A' ' 73' ' ' ILE . 4.8 tp -117.8 128.85 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-O 120.916 0.388 . . . . 0.0 111.147 -179.699 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 11.8 m -63.55 132.78 52.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.057 -179.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 2.8 m -59.81 -33.48 71.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.897 179.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.448 ' O ' ' C ' ' A' ' 77' ' ' HIS . 14.9 m-85 -112.1 13.88 20.66 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.053 -0.521 . . . . 0.0 111.474 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.449 ' CE1' ' HB3' ' A' ' 127' ' ' PHE . 2.1 t-160 -21.62 -69.49 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.709 0 CA-C-N 114.726 -1.125 . . . . 0.0 112.574 -179.456 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.465 ' HB3' ' HE2' ' A' ' 127' ' ' PHE . . . -153.06 159.68 42.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.125 0.488 . . . . 0.0 112.045 -179.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -126.53 134.2 50.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.602 -0.726 . . . . 0.0 110.41 179.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.655 ' CZ ' HG13 ' A' ' 97' ' ' VAL . 7.5 m-85 -119.4 131.45 55.67 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.888 -179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 9.9 m-70 -94.63 116.37 28.68 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.917 0.389 . . . . 0.0 111.011 -179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.757 HD23 ' O ' ' A' ' 51' ' ' THR . 12.8 tp -106.47 109.69 21.69 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.915 179.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.1 140.08 52.96 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.889 179.892 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.1 tt0 -116.3 125.13 51.73 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.864 179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 32.6 tpp -138.84 133.39 31.96 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.912 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -107.04 133.66 51.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.93 -179.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.5 t -135.8 134.19 51.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.002 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.8 t70 75.04 -58.24 0.58 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.021 -179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.7 p30 -176.31 -39.02 0.01 OUTLIER 'General case' 0 N--CA 1.453 -0.313 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.894 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 9.9 m-85 -86.63 146.11 26.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.775 179.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -97.07 137.84 35.52 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.327 -0.397 . . . . 0.0 111.032 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 8.2 mtm-85 -114.3 144.8 42.66 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.873 179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -114.08 121.34 43.53 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.854 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.668 HD21 HG12 ' A' ' 118' ' ' ILE . 1.8 tt -115.72 132.84 56.52 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.877 179.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.528 ' N ' HD12 ' A' ' 95' ' ' ILE . 3.2 mp -122.27 140.99 44.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.146 -179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -113.94 144.0 43.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.823 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.655 HG13 ' CZ ' ' A' ' 80' ' ' PHE . 22.7 t -109.15 122.91 64.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.193 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 25.1 mt -130.1 122.32 53.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.089 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.6 p-10 -107.71 138.6 43.65 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.863 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.9 mmtp -92.65 -6.02 50.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.414 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 50.8 m 63.05 44.37 5.92 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.882 0.372 . . . . 0.0 110.877 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -95.32 -45.84 6.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.86 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -123.99 -43.59 2.09 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.244 179.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 136.34 110.61 1.04 Allowed Glycine 0 N--CA 1.451 -0.359 0 C-N-CA 120.772 -0.727 . . . . 0.0 112.504 179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 35.8 m -114.39 123.13 48.69 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.721 0.296 . . . . 0.0 110.942 179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.414 ' CE2' ' HB2' ' A' ' 111' ' ' ARG . 6.2 m-85 -121.04 120.34 35.08 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.808 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.577 HG22 HD22 ' A' ' 112' ' ' LEU . 2.8 tp -102.75 137.24 31.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.493 0.663 . . . . 0.0 111.263 179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 61.65 30.55 18.6 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.91 -1.041 . . . . 0.0 110.79 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.67 11.32 72.84 Favored Glycine 0 N--CA 1.443 -0.853 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.849 179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -134.01 150.58 51.24 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.782 0.325 . . . . 0.0 110.877 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.414 ' HB2' ' CE2' ' A' ' 106' ' ' PHE . 57.4 ttt-85 -74.97 137.89 41.91 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.902 179.934 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.577 HD22 HG22 ' A' ' 107' ' ' ILE . 0.5 OUTLIER -98.58 134.86 40.93 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.882 179.982 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 15.0 p -107.46 -37.27 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.186 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.1 tttp -61.39 151.52 32.15 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.874 179.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.14 30.91 3.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.888 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -169.76 60.25 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.783 179.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -73.25 136.46 44.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.746 179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.668 HG12 HD21 ' A' ' 94' ' ' LEU . 0.0 OUTLIER -98.83 116.71 42.5 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.491 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.817 -179.887 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.767 HD11 HD11 ' A' ' 125' ' ' ILE . 7.8 tt -101.41 145.87 28.36 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.977 -179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.511 ' HD3' HD11 ' A' ' 118' ' ' ILE . 8.4 mmmt -133.51 178.06 7.22 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.807 179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.421 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 12.6 p30 -56.19 141.65 40.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.081 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.728 ' HA2' HD21 ' A' ' 134' ' ' LEU . . . 70.11 46.45 50.93 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.523 -179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . 0.458 ' C ' HD12 ' A' ' 134' ' ' LEU . 7.6 m-20 -120.29 120.78 37.06 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.768 0.318 . . . . 0.0 110.945 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.566 ' N ' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -85.19 124.47 31.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.811 179.886 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.767 HD11 HD11 ' A' ' 119' ' ' LEU . 1.2 mp -121.49 135.16 62.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.111 -179.945 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.683 HG22 ' HB3' ' A' ' 132' ' ' SER . 21.9 t -115.84 125.42 72.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.069 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.513 ' CE1' ' CZ ' ' A' ' 133' ' ' PHE . 67.4 m-85 -116.51 113.45 22.8 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.014 -179.86 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 86.92 -8.63 75.35 Favored Glycine 0 CA--C 1.519 0.322 0 C-N-CA 120.725 -0.75 . . . . 0.0 112.918 179.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 6.0 tttm 78.82 28.54 0.41 Allowed 'General case' 0 C--O 1.232 0.142 0 CA-C-O 120.869 0.366 . . . . 0.0 110.477 -179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.37 -47.57 0.34 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.929 179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 18.7 m -96.11 109.99 22.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.871 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.683 ' HB3' HG22 ' A' ' 126' ' ' VAL . 0.2 OUTLIER -122.07 126.63 48.86 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.946 -179.902 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.551 ' CE1' HD13 ' A' ' 37' ' ' LEU . 13.5 p90 -139.22 155.93 47.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.886 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.728 HD21 ' HA2' ' A' ' 122' ' ' GLY . 3.6 tp -105.35 136.21 45.31 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.97 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.577 ' HD2' HD21 ' A' ' 37' ' ' LEU . 24.7 t80 -96.53 141.54 29.69 Favored 'General case' 0 CA--C 1.512 -0.501 0 CA-C-O 121.971 0.891 . . . . 0.0 111.604 179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 29.3 mttp -154.57 153.11 30.88 Favored 'General case' 0 C--N 1.311 -1.104 0 CA-C-N 113.885 -1.507 . . . . 0.0 110.867 179.801 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.446 ' HE1' HD11 ' A' ' 95' ' ' ILE . 3.7 m-85 -79.26 139.68 37.82 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.94 0.4 . . . . 0.0 110.696 179.561 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.546 ' HB2' ' ND1' ' A' ' 36' ' ' HIS . . . -93.0 44.58 1.15 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.932 -0.577 . . . . 0.0 111.173 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 2.1 p -97.46 59.37 1.54 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.684 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 6.1 t -57.99 156.98 8.42 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.975 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 3.2 m -152.04 72.88 1.03 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.872 179.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 98.3 p -140.76 170.71 15.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.867 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 16.1 m -148.41 -63.29 0.25 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.862 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 14.0 p-10 -153.26 -178.91 7.27 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.892 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.578 HG22 ' H ' ' A' ' 146' ' ' GLU . 2.2 mt -110.24 -143.7 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.156 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.578 ' H ' HG22 ' A' ' 145' ' ' ILE . 0.0 OUTLIER -64.88 145.96 55.57 Favored 'General case' 0 C--N 1.305 -1.35 0 CA-C-N 115.473 -0.785 . . . . 0.0 110.882 179.98 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -81.1 141.98 33.75 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.846 -179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -157.55 121.12 4.09 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.85 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -105.48 158.6 16.55 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.867 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.24 -47.79 7.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.823 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -96.51 116.83 29.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.896 179.938 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.4 t -69.19 132.86 32.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.148 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -73.89 128.62 36.01 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.898 179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 5.5 p -175.2 -53.61 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.866 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -141.23 122.23 14.58 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.909 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 24.3 p -114.37 150.6 34.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.883 -179.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 18.1 mtm180 -124.27 -64.83 1.09 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.859 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 15.3 p -78.68 -57.08 3.94 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.907 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 79.3 m-85 . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.87 179.976 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 15.6 mttt . . . . . 0 N--CA 1.487 1.411 0 CA-C-O 120.858 0.361 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.15 174.15 9.83 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.869 -179.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -63.19 174.17 1.26 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.836 -179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 60.2 90.13 0.06 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.902 -179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.55 146.08 5.75 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.912 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.1 m -67.21 88.8 0.18 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.91 179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 49.7 p30 -146.16 171.93 14.2 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.805 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -115.91 132.95 22.95 Favored Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.855 179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -70.13 157.92 58.13 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.449 2.1 . . . . 0.0 112.231 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.2 m 58.99 93.41 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.953 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 68.4 p -149.82 79.77 1.37 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.864 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -100.41 138.48 37.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.003 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.546 ' N ' HG21 ' A' ' 51' ' ' THR . 3.4 m-85 -61.78 -97.07 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.316 0 CA-C-N 116.088 -0.505 . . . . 0.0 110.921 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.583 ' N ' HG22 ' A' ' 51' ' ' THR . 0.2 OUTLIER -140.44 134.72 31.17 Favored 'General case' 0 C--N 1.334 -0.082 0 CA-C-O 120.72 0.295 . . . . 0.0 110.573 179.761 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 2.0 t -59.95 127.57 32.57 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.971 -179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.632 HD23 HD22 ' A' ' 52' ' ' ASN . 1.3 tm? -128.91 -44.1 1.33 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.713 179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.704 ' C ' HG22 ' A' ' 50' ' ' ILE . . . -157.33 -165.21 14.74 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.867 -0.682 . . . . 0.0 112.43 179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 52.9 m80 -146.18 163.9 33.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.87 0.367 . . . . 0.0 111.065 179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.524 HD11 ' HB ' ' A' ' 50' ' ' ILE . 1.7 mp -126.81 119.97 28.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.644 179.863 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.4 t -96.12 121.92 47.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.209 -179.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.429 ' HA ' ' CD1' ' A' ' 133' ' ' PHE . 4.3 m-20 -89.39 113.98 25.36 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.767 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 14.1 mt -88.59 106.51 18.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.996 -179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.55 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 1.7 mp -124.5 140.73 35.93 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.509 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.55 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 53.1 Cg_endo -72.24 80.86 1.54 Allowed 'Trans proline' 0 C--N 1.345 0.391 0 C-N-CA 122.003 1.802 . . . . 0.0 112.011 179.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 145.16 -14.47 1.89 Allowed Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.854 -0.689 . . . . 0.0 112.686 -179.751 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 2.4 tptm -178.34 164.28 1.71 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.806 0.336 . . . . 0.0 110.863 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -125.56 164.99 19.34 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.053 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -150.34 124.92 9.66 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.911 179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 2.5 mtpt -102.41 134.66 45.35 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.879 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.7 t -121.71 150.18 24.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.112 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 10.5 mt-10 -94.93 132.4 39.81 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.808 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.743 HG21 ' HE2' ' A' ' 135' ' ' PHE . 5.0 tt -115.98 132.14 66.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.212 -179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.583 HG22 ' N ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -98.98 168.1 10.31 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.925 -179.832 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.632 HD22 HD23 ' A' ' 34' ' ' LEU . 13.5 p30 -102.72 74.97 1.38 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.444 179.419 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.594 ' C ' ' H ' ' A' ' 55' ' ' VAL . 0.7 OUTLIER -99.04 23.19 9.31 Favored 'General case' 0 CA--C 1.514 -0.406 0 CA-C-N 115.929 -0.578 . . . . 0.0 111.526 -179.601 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.552 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 1.6 m-20 67.53 -28.91 0.14 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.626 -0.261 . . . . 0.0 110.487 -179.578 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.594 ' H ' ' C ' ' A' ' 53' ' ' ARG . 60.2 t -137.76 136.56 45.65 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.161 0 CA-C-O 120.964 0.412 . . . . 0.0 111.749 -179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.748 HG23 ' CB ' ' A' ' 65' ' ' ASP . 99.5 m -125.51 129.9 50.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.959 -0.564 . . . . 0.0 110.062 179.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.455 ' O ' ' N ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -104.0 138.82 39.99 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.954 0.407 . . . . 0.0 111.529 -179.448 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.612 HG22 HD11 ' A' ' 68' ' ' LEU . 4.6 mp -132.52 135.19 58.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.093 179.765 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 157.12 -137.36 5.36 Favored Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.305 -0.95 . . . . 0.0 113.227 179.64 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.473 ' HB2' ' CG2' ' A' ' 73' ' ' ILE . 21.3 ttp180 -94.89 -49.24 5.66 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 120.753 0.311 . . . . 0.0 111.22 -179.559 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.494 ' OG ' HG23 ' A' ' 75' ' ' THR . 0.0 OUTLIER -43.71 117.02 1.06 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.497 -179.373 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 4.1 mtt85 -57.37 -23.3 48.22 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.989 -0.551 . . . . 0.0 111.015 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.78 -24.19 63.47 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.76 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 96.4 m -57.42 168.25 0.83 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.824 179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.748 ' CB ' HG23 ' A' ' 56' ' ' THR . 0.5 OUTLIER -69.85 -56.62 6.62 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 120.952 0.406 . . . . 0.0 110.778 179.827 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.41 ' O ' ' HA ' ' A' ' 58' ' ' ILE . 21.3 t -125.2 132.95 70.53 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.972 -0.558 . . . . 0.0 111.594 -179.661 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 7.9 pt -102.8 128.05 55.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.816 179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.81 HD23 ' CE2' ' A' ' 133' ' ' PHE . 0.5 OUTLIER -89.19 -71.35 0.6 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.781 -179.769 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.448 ' HB3' ' HB ' ' A' ' 73' ' ' ILE . 12.8 t -121.3 -111.67 0.33 Allowed 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 116.42 -0.354 . . . . 0.0 110.076 179.379 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.442 ' HB3' ' CD ' ' A' ' 71' ' ' PRO . 9.7 tt0 170.63 -64.15 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.264 0 O-C-N 122.298 -0.251 . . . . 0.0 111.575 179.424 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.442 ' CD ' ' HB3' ' A' ' 70' ' ' GLU . 25.2 Cg_endo -62.0 -40.05 46.05 Favored 'Trans proline' 0 C--N 1.344 0.298 0 C-N-CA 122.35 2.033 . . . . 0.0 113.28 -179.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 20.0 m-20 -122.49 28.87 7.17 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.569 0.223 . . . . 0.0 111.503 -179.466 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.532 HD11 HD13 ' A' ' 68' ' ' LEU . 4.4 tp -110.8 125.94 68.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-O 120.971 0.415 . . . . 0.0 111.116 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -59.48 134.01 56.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.884 -0.598 . . . . 0.0 111.484 -179.461 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.494 HG23 ' OG ' ' A' ' 61' ' ' SER . 36.2 m -65.91 -44.21 85.87 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.85 -0.613 . . . . 0.0 110.856 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.448 ' O ' ' C ' ' A' ' 77' ' ' HIS . 2.1 m-85 -100.27 13.73 33.32 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.27 0.557 . . . . 0.0 111.153 179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.461 ' CE1' ' HB3' ' A' ' 127' ' ' PHE . 0.4 OUTLIER -15.51 -71.39 0.01 OUTLIER 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.403 -1.271 . . . . 0.0 113.175 -179.338 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.405 ' HB2' ' HE1' ' A' ' 127' ' ' PHE . . . -153.75 164.08 38.92 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.225 0.536 . . . . 0.0 112.293 -179.234 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.5 mt-10 -132.5 132.64 42.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.962 179.196 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.642 ' CE2' HG22 ' A' ' 97' ' ' VAL . 3.9 m-85 -119.39 131.08 55.61 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.781 0.324 . . . . 0.0 110.96 -179.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.552 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 24.8 m-70 -95.89 116.81 29.48 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.245 -179.796 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . . . . . . . . . 1.2 mp -106.3 109.37 21.28 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.147 -0.478 . . . . 0.0 110.669 179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -122.58 140.19 53.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.052 -0.522 . . . . 0.0 111.032 -179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -104.21 120.95 42.26 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.754 179.65 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -119.68 142.62 48.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.0 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -107.13 124.89 50.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.902 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.437 HG21 ' HE ' ' A' ' 92' ' ' ARG . 4.0 m -121.88 132.48 70.78 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.149 -179.968 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 68.45 -65.58 0.26 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.059 -179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 179.82 39.0 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.818 179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -145.94 -177.29 5.52 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.103 -0.499 . . . . 0.0 110.695 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -117.29 129.12 55.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.999 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.437 ' HE ' HG21 ' A' ' 87' ' ' VAL . 9.4 mtm180 -116.32 150.21 38.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.85 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -114.03 123.67 50.26 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.944 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.8 mp -130.05 123.84 31.44 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.825 179.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.414 ' N ' HD12 ' A' ' 95' ' ' ILE . 4.3 mp -116.25 141.07 35.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.057 -179.911 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -114.03 144.06 43.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.862 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.642 HG22 ' CE2' ' A' ' 80' ' ' PHE . 18.1 t -115.36 126.09 72.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.23 -179.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.3 mp -127.99 135.57 62.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.071 179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 17.2 p-10 -107.55 120.23 41.63 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.822 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -137.45 32.38 2.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.006 179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 21.8 m -126.85 178.78 5.74 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.898 179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 1.1 ptp85 -127.55 39.13 3.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.922 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -106.67 -60.62 1.64 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.228 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 145.06 103.36 0.4 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.827 -0.701 . . . . 0.0 112.539 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.464 ' CG2' ' CE1' ' A' ' 127' ' ' PHE . 85.5 m -117.95 124.92 49.4 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.861 0.362 . . . . 0.0 110.979 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.418 ' CD1' ' N ' ' A' ' 106' ' ' PHE . 5.0 m-85 -121.03 123.71 43.05 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.829 179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.604 ' CD1' HD13 ' A' ' 125' ' ' ILE . 3.0 tp -109.95 137.29 42.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.464 0.649 . . . . 0.0 111.391 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 60.66 29.59 19.12 Favored 'General case' 0 C--N 1.319 -0.738 0 CA-C-N 114.858 -1.065 . . . . 0.0 110.817 179.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.63 11.38 72.75 Favored Glycine 0 N--CA 1.443 -0.857 0 C-N-CA 120.846 -0.692 . . . . 0.0 112.834 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -134.02 152.06 51.69 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.759 0.314 . . . . 0.0 110.877 179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 4.0 mtt180 -63.53 142.96 58.2 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.964 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.407 HD23 ' N ' ' A' ' 113' ' ' VAL . 0.7 OUTLIER -83.95 133.11 34.71 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.769 -179.991 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.45 HG13 ' N ' ' A' ' 114' ' ' LYS . 11.8 p -120.62 -42.8 2.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.149 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.45 ' N ' HG13 ' A' ' 113' ' ' VAL . 0.0 OUTLIER -71.92 147.46 47.01 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.794 -179.975 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.89 -37.38 48.2 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.795 -179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -111.36 77.79 1.07 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.862 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -80.05 135.95 36.46 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.867 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.493 ' O ' HG23 ' A' ' 118' ' ' ILE . 8.7 tp -98.73 122.28 50.25 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.289 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.743 ' CD1' HD11 ' A' ' 125' ' ' ILE . 4.8 tt -103.06 132.78 49.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.879 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -123.78 178.07 5.42 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.838 179.906 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.417 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 8.2 p30 -60.41 138.55 57.97 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.07 -179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 74.76 56.0 5.14 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.595 179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -130.96 132.91 45.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.794 0.33 . . . . 0.0 110.981 179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -84.15 132.68 34.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.877 179.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.743 HD11 ' CD1' ' A' ' 119' ' ' LEU . 21.1 mm -117.64 121.77 68.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.302 -0.408 . . . . 0.0 111.166 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.421 HG22 ' OG ' ' A' ' 132' ' ' SER . 59.0 t -115.13 128.35 72.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.66 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.464 ' CE1' ' CG2' ' A' ' 105' ' ' THR . 15.1 m-85 -132.08 111.88 11.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.923 0.392 . . . . 0.0 111.659 -179.444 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.495 ' O ' ' HB2' ' A' ' 129' ' ' LYS . . . 108.91 -81.9 0.29 Allowed Glycine 0 N--CA 1.449 -0.486 0 CA-C-N 115.932 -0.576 . . . . 0.0 112.206 179.657 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.495 ' HB2' ' O ' ' A' ' 128' ' ' GLY . 14.1 tttp 172.22 37.03 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.887 0.375 . . . . 0.0 110.664 179.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 24.9 p 178.83 -48.82 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.95 -179.884 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . 0.405 ' O ' ' HA ' ' A' ' 126' ' ' VAL . 77.6 m -56.7 104.7 0.16 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.887 -179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.421 ' OG ' HG22 ' A' ' 126' ' ' VAL . 0.3 OUTLIER -124.3 111.94 16.41 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.149 -179.766 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.81 ' CE2' HD23 ' A' ' 68' ' ' LEU . 3.0 m-85 -120.45 156.07 32.21 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.864 179.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.41 HD23 ' N ' ' A' ' 135' ' ' PHE . 6.0 tt -111.74 140.1 46.65 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.944 -179.946 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.743 ' HE2' HG21 ' A' ' 50' ' ' ILE . 18.9 t80 -116.33 141.76 47.73 Favored 'General case' 0 CA--C 1.514 -0.429 0 CA-C-O 121.885 0.85 . . . . 0.0 111.733 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 19.6 tttt -154.44 159.74 41.23 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.06 -1.427 . . . . 0.0 111.022 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.417 ' CE2' ' HB3' ' A' ' 121' ' ' ASN . 3.3 m-85 -84.25 140.25 31.8 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.057 0.456 . . . . 0.0 110.741 179.483 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -104.05 -53.92 2.65 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.165 179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -177.4 170.31 2.11 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.956 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 43.9 m -116.51 -40.35 3.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.902 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 5.2 t 63.56 52.84 2.19 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.952 179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.1 t 59.53 -169.34 0.14 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.908 179.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 10.5 t -112.84 -176.48 2.91 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.85 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -121.92 -79.88 0.62 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.262 -0.427 . . . . 0.0 110.859 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.618 HG22 ' H ' ' A' ' 146' ' ' GLU . 0.7 OUTLIER -110.95 -143.17 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.438 -1.071 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 179.936 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.618 ' H ' HG22 ' A' ' 145' ' ' ILE . 0.4 OUTLIER -175.73 117.22 0.15 Allowed 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.865 -179.945 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 61.12 36.62 18.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.906 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -134.29 92.36 2.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.971 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -152.82 120.66 6.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.828 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -141.55 156.8 45.69 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.943 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.7 tttt -153.38 107.02 3.01 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.886 179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 152' ' ' VAL . 10.8 m -86.25 86.27 2.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.108 -0.496 . . . . 0.0 111.112 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 5.8 t -145.53 33.12 1.06 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.822 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 16.5 t -77.42 107.47 9.88 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.877 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.0 tt0 -147.58 158.28 43.93 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.925 179.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 38.8 t -78.19 126.09 30.29 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.857 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.4 121.69 15.44 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.838 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.2 m 60.43 106.11 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.895 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.163 -0.922 . . . . 0.0 110.86 -179.965 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 7.1 mmtt . . . . . 0 N--CA 1.488 1.465 0 CA-C-O 120.814 0.34 . . . . 0.0 111.173 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 3.4 mmt-85 -109.24 -60.78 1.72 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.901 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -132.31 -177.78 4.62 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.937 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 1.3 tt0 -62.31 -63.06 1.35 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.855 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER 62.19 117.19 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.926 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 66.6 p -107.87 157.77 17.89 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.93 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -170.32 141.2 1.98 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.868 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.63 99.98 7.59 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.885 179.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -67.48 140.94 53.97 Favored 'Trans proline' 0 C--N 1.346 0.412 0 C-N-CA 122.451 2.101 . . . . 0.0 112.277 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.4 t -87.48 163.83 16.49 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.943 -179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 13.6 m -113.12 168.1 9.99 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.887 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.1 tp10 -72.29 -69.11 0.42 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.897 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -90.77 -106.08 0.1 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.859 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.428 ' N ' HG22 ' A' ' 51' ' ' THR . 0.8 OUTLIER -140.39 128.88 22.74 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.801 0.334 . . . . 0.0 110.731 179.882 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 2.1 t -67.01 143.89 56.51 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.942 179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.709 HD22 HD11 ' A' ' 82' ' ' LEU . 1.5 tp -156.21 -67.65 0.11 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.902 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.403 ' HA3' ' CE1' ' A' ' 135' ' ' PHE . . . -114.13 167.09 12.23 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.816 -0.707 . . . . 0.0 112.446 -179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.42 ' CE1' ' HB3' ' A' ' 138' ' ' ALA . 33.4 m80 -136.19 160.67 37.96 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.907 0.384 . . . . 0.0 111.017 -179.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.815 ' CD1' HD11 ' A' ' 50' ' ' ILE . 97.8 mt -127.23 117.96 23.33 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.709 179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.4 t -101.8 121.59 52.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.205 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -90.26 136.97 32.72 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.891 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 19.8 mt -108.36 106.56 16.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.974 0.416 . . . . 0.0 110.848 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.548 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 4.1 mt -124.4 141.25 37.09 Favored Pre-proline 0 C--N 1.329 -0.32 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.857 179.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.548 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 56.9 Cg_endo -73.36 81.46 1.77 Allowed 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.172 1.915 . . . . 0.0 112.041 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 148.93 -18.78 1.23 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 121.028 -0.606 . . . . 0.0 112.403 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 11.9 ttmm -177.65 165.0 2.07 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.709 0.29 . . . . 0.0 110.655 179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 24.0 mt-10 -122.11 149.76 43.12 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.34 -0.391 . . . . 0.0 111.028 -179.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -121.43 134.05 55.08 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.74 179.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.95 124.88 53.65 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.137 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.547 HG11 HG13 ' A' ' 66' ' ' VAL . 31.6 t -120.15 150.52 22.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.998 179.847 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.419 ' HG3' ' CD2' ' A' ' 36' ' ' HIS . 0.0 OUTLIER -103.01 142.07 34.73 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.037 -179.867 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.815 HD11 ' CD1' ' A' ' 37' ' ' LEU . 33.1 mm -115.38 122.68 69.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.839 179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.428 HG22 ' N ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -99.87 168.16 10.06 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.144 -179.885 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 11.4 m-20 -100.11 73.87 1.74 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.079 -0.509 . . . . 0.0 110.593 179.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.577 ' C ' ' H ' ' A' ' 55' ' ' VAL . 4.0 ptp180 -107.05 22.04 16.61 Favored 'General case' 0 CA--C 1.514 -0.407 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.437 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.505 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 30.6 m-80 67.1 -27.9 0.13 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.644 -0.253 . . . . 0.0 110.659 -179.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.577 ' H ' ' C ' ' A' ' 53' ' ' ARG . 61.6 t -137.72 137.67 45.02 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.143 0 CA-C-O 121.006 0.431 . . . . 0.0 111.96 -179.962 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.49 HG22 ' CB ' ' A' ' 65' ' ' ASP . 0.4 OUTLIER -125.36 128.28 47.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.72 178.911 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.464 ' O ' ' N ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -104.06 136.22 44.11 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.976 0.417 . . . . 0.0 111.488 -179.463 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.561 HD11 ' HD2' ' A' ' 80' ' ' PHE . 4.4 mp -132.2 127.17 57.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.974 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 164.08 -142.13 7.59 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.481 -0.866 . . . . 0.0 113.074 179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.529 ' HB2' HG23 ' A' ' 73' ' ' ILE . 14.3 ttp180 -88.65 -43.19 11.51 Favored 'General case' 0 C--N 1.332 -0.175 0 CA-C-O 120.811 0.339 . . . . 0.0 111.027 -179.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.757 ' HB2' HG23 ' A' ' 75' ' ' THR . 0.4 OUTLIER -45.93 115.09 0.89 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.111 -0.495 . . . . 0.0 111.461 -179.527 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -57.04 -27.41 61.65 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.942 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 3.2 m -70.03 -24.71 63.32 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.814 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . 0.417 ' CB ' ' HB ' ' A' ' 57' ' ' THR . 98.7 m -53.08 167.93 0.15 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.284 -0.417 . . . . 0.0 110.76 179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.49 ' CB ' HG22 ' A' ' 56' ' ' THR . 0.6 OUTLIER -69.5 -53.88 16.94 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.922 0.391 . . . . 0.0 111.038 179.943 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.609 HG21 HD12 ' A' ' 37' ' ' LEU . 22.1 t -125.05 125.69 69.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.02 -0.536 . . . . 0.0 111.517 -179.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.3 pt -99.65 131.06 47.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.504 179.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.627 HD23 ' HB2' ' A' ' 131' ' ' CYS . 8.4 mp -100.89 -100.33 0.25 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.525 -0.307 . . . . 0.0 111.344 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.2 p -92.14 -103.9 0.11 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 121.224 -0.19 . . . . 0.0 110.724 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.554 ' HA ' HG22 ' A' ' 73' ' ' ILE . 3.0 mt-10 167.17 -64.78 0.0 OUTLIER Pre-proline 0 CA--C 1.529 0.136 0 CA-C-O 120.68 0.276 . . . . 0.0 111.145 179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.448 ' CD ' ' CB ' ' A' ' 70' ' ' GLU . 28.9 Cg_endo -62.89 -37.49 54.26 Favored 'Trans proline' 0 C--N 1.344 0.322 0 C-N-CA 122.359 2.039 . . . . 0.0 112.56 -179.681 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -112.04 17.06 19.96 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.419 -0.355 . . . . 0.0 111.276 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.554 HG22 ' HA ' ' A' ' 70' ' ' GLU . 4.5 tp -108.79 127.48 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.213 0 CA-C-O 120.925 0.393 . . . . 0.0 111.093 -179.824 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.42 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 0.9 OUTLIER -83.79 133.67 34.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.367 -179.578 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.757 HG23 ' HB2' ' A' ' 61' ' ' SER . 57.3 m -57.94 -30.74 66.2 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.895 -0.593 . . . . 0.0 111.078 179.782 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.414 ' O ' ' C ' ' A' ' 77' ' ' HIS . 39.6 m-85 -110.27 13.97 22.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.237 0.541 . . . . 0.0 111.536 -179.793 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.444 ' CE1' ' HB3' ' A' ' 127' ' ' PHE . 0.1 OUTLIER -25.94 -64.75 0.06 Allowed 'General case' 0 C--N 1.319 -0.73 0 CA-C-N 114.779 -1.1 . . . . 0.0 112.702 -179.277 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.45 ' HB3' ' CZ ' ' A' ' 127' ' ' PHE . . . -157.66 163.98 37.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.116 0.484 . . . . 0.0 112.027 -179.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.48 ' HA ' ' O ' ' A' ' 56' ' ' THR . 0.8 OUTLIER -134.81 141.4 46.4 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.595 -0.73 . . . . 0.0 110.319 179.405 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.561 ' HD2' HD11 ' A' ' 58' ' ' ILE . 47.0 m-85 -119.44 131.51 55.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.942 -179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.505 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 4.1 m-70 -94.63 116.53 28.87 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.832 0.349 . . . . 0.0 110.756 179.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.709 HD11 HD22 ' A' ' 34' ' ' LEU . 0.1 OUTLIER -106.28 109.89 21.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.03 -179.89 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.07 133.86 55.25 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.705 179.843 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -101.69 128.82 47.83 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.917 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 3.7 ttt -141.45 111.97 7.01 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.864 179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -79.03 116.02 19.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.953 -179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.5 t -140.0 114.3 6.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.072 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER 60.83 -165.83 0.21 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.79 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -48.92 132.4 18.49 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.225 -0.443 . . . . 0.0 111.281 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 57.1 m-85 61.11 155.04 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.904 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -85.98 139.78 30.89 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.953 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 80.1 mtt180 -109.92 122.64 48.02 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.865 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -113.04 146.73 38.6 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.84 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 1.2 mt -128.81 140.04 51.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.927 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.482 HG13 HD22 ' A' ' 82' ' ' LEU . 4.1 mp -120.97 138.48 51.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.06 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -113.94 143.31 44.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.021 -179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.558 HG22 ' HE1' ' A' ' 80' ' ' PHE . 3.9 t -104.41 135.08 43.85 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.173 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 22.6 mt -129.86 146.33 34.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.191 -0.458 . . . . 0.0 111.18 179.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.559 ' OD1' HD22 ' A' ' 112' ' ' LEU . 2.9 p-10 -119.74 123.49 43.88 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.902 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.67 -41.7 1.98 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.119 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 4.2 m -71.56 157.76 37.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.065 -179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -111.43 29.01 8.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.844 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -86.97 -42.2 13.32 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.227 -179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 136.48 100.58 0.58 Allowed Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.671 -0.775 . . . . 0.0 112.595 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.53 HG23 ' CD1' ' A' ' 127' ' ' PHE . 93.7 m -109.4 123.37 49.23 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.8 0.333 . . . . 0.0 110.735 -179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.425 ' CE1' ' HB3' ' A' ' 111' ' ' ARG . 47.2 m-85 -120.87 115.06 22.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.932 179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.403 ' CD1' HG13 ' A' ' 125' ' ' ILE . 2.6 tp -118.31 137.26 52.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-O 121.428 0.632 . . . . 0.0 111.196 179.883 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 61.77 32.2 18.26 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 114.897 -1.047 . . . . 0.0 110.798 -179.896 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.76 10.9 72.78 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.859 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -134.05 151.96 51.64 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.743 0.306 . . . . 0.0 110.851 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.425 ' HB3' ' CE1' ' A' ' 106' ' ' PHE . 6.6 ptm180 -70.95 139.05 50.51 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.894 179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.559 HD22 ' OD1' ' A' ' 99' ' ' ASP . 0.8 OUTLIER -85.49 129.3 34.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.88 -179.933 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.489 HG13 ' N ' ' A' ' 114' ' ' LYS . 12.2 p -125.58 -44.65 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.11 179.985 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.489 ' N ' HG13 ' A' ' 113' ' ' VAL . 2.6 mmmp? -66.23 172.83 3.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.908 179.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.1 ttpm? -119.03 31.38 6.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.931 179.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 5.7 t0 -162.23 57.86 0.24 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.801 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -78.98 139.09 38.29 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.84 179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.546 ' O ' HG23 ' A' ' 118' ' ' ILE . 7.8 tp -98.59 117.31 43.39 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.328 0 CA-C-O 121.004 0.43 . . . . 0.0 111.228 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.444 HD22 ' HB ' ' A' ' 95' ' ' ILE . 7.6 tt -103.07 131.23 50.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.085 -0.507 . . . . 0.0 111.057 -179.837 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.26 178.03 6.88 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.781 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.451 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 5.0 p-10 -57.72 141.29 49.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.966 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.782 ' HA2' HD21 ' A' ' 134' ' ' LEU . . . 74.86 47.66 13.77 Favored Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.763 -0.732 . . . . 0.0 112.311 -179.917 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -123.46 131.34 53.61 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.795 0.331 . . . . 0.0 111.081 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.74 122.6 41.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.65 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.54 HG21 ' HZ ' ' A' ' 80' ' ' PHE . 1.7 mp -114.97 133.56 60.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.314 -179.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.632 HG22 ' HB3' ' A' ' 132' ' ' SER . 21.2 t -124.02 123.81 67.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.968 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.53 ' CD1' HG23 ' A' ' 105' ' ' THR . 23.5 m-85 -116.27 111.92 20.83 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.85 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . 0.402 ' O ' ' CB ' ' A' ' 129' ' ' LYS . . . 88.61 -15.31 57.45 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.757 -0.735 . . . . 0.0 112.88 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . 0.402 ' CB ' ' O ' ' A' ' 128' ' ' GLY . 10.9 tttt 79.32 30.65 0.3 Allowed 'General case' 0 CA--C 1.522 -0.109 0 CA-C-O 121.002 0.43 . . . . 0.0 110.378 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 15.3 p -128.22 -50.07 1.31 Allowed 'General case' 0 N--CA 1.453 -0.276 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.99 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . 0.627 ' HB2' HD23 ' A' ' 68' ' ' LEU . 7.0 m -109.59 112.58 24.74 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.977 179.953 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.632 ' HB3' HG22 ' A' ' 126' ' ' VAL . 0.7 OUTLIER -116.8 131.06 57.05 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.931 179.95 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.409 ' CD1' HD22 ' A' ' 37' ' ' LEU . 6.0 p90 -141.25 156.04 45.94 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.074 -179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.782 HD21 ' HA2' ' A' ' 122' ' ' GLY . 7.7 tt -107.74 140.05 41.39 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.8 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.431 ' CD2' HD21 ' A' ' 119' ' ' LEU . 87.7 t80 -101.57 141.56 34.25 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 122.002 0.906 . . . . 0.0 111.933 -179.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.3 mtpt -154.37 145.87 23.13 Favored 'General case' 0 C--N 1.313 -1.016 0 CA-C-N 113.748 -1.569 . . . . 0.0 110.707 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.451 ' CE2' ' HB3' ' A' ' 121' ' ' ASN . 4.4 m-85 -73.62 139.75 45.7 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.992 0.425 . . . . 0.0 110.736 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.42 ' HB3' ' CE1' ' A' ' 36' ' ' HIS . . . -119.15 87.78 2.8 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.906 -0.588 . . . . 0.0 111.045 179.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 5.4 t -90.65 141.59 28.62 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.959 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.1 m -102.0 157.42 16.88 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.888 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 1.3 m 60.6 101.45 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.899 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 19.1 m -142.67 -61.91 0.43 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.921 179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 68.4 p -78.72 117.23 19.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.923 179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . 0.807 ' O ' HD13 ' A' ' 145' ' ' ILE . 6.2 p-10 -111.13 -25.65 9.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.114 -179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.807 HD13 ' O ' ' A' ' 144' ' ' ASP . 6.3 mm -143.46 117.38 3.66 Favored 'Isoleucine or valine' 0 N--CA 1.434 -1.257 0 CA-C-O 121.699 0.762 . . . . 0.0 109.558 179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 37.0 mt-10 -116.28 82.37 1.77 Allowed 'General case' 0 C--N 1.298 -1.66 0 CA-C-N 114.341 -1.299 . . . . 0.0 110.852 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -76.05 -41.27 51.26 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.875 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -87.21 160.9 18.32 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.909 -179.941 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -134.58 123.67 24.22 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.834 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 3.4 mt-10 -142.59 152.62 42.72 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.892 -179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -163.0 107.19 1.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.835 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.5 t -112.31 -58.95 3.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.124 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 7.3 m -134.28 32.7 3.38 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.906 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 2.6 p -104.4 170.55 7.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.883 179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 3.0 mt-10 -144.1 144.59 31.67 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.962 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.3 m -82.45 140.28 33.5 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.439 . . . . 0.0 110.899 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER 60.71 36.63 19.4 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.918 179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 58.3 m -137.66 95.69 3.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.943 179.908 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.25 1.116 0 CA-C-O 118.247 -0.882 . . . . 0.0 110.819 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 39.6 mttt . . . . . 0 N--CA 1.487 1.391 0 CA-C-O 120.796 0.331 . . . . 0.0 111.181 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 4.2 ptt85 -133.22 -46.67 0.84 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.835 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.76 143.89 40.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.837 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.5 mp0 -81.31 104.47 11.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.926 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -170.25 -62.24 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.918 -179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -82.2 95.76 7.63 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.875 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -117.31 163.56 16.16 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.845 179.977 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.87 143.36 26.5 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.789 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.01 146.25 58.1 Favored 'Trans proline' 0 C--N 1.344 0.338 0 C-N-CA 122.579 2.186 . . . . 0.0 112.316 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 75.9 p -83.58 -33.93 25.28 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.856 179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.3 t -144.71 144.37 31.18 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.928 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.454 ' C ' ' CG ' ' A' ' 31' ' ' TYR . 6.0 tt0 -107.12 164.15 12.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.923 179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.454 ' CG ' ' C ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -167.81 115.7 0.75 Allowed 'General case' 0 N--CA 1.454 -0.245 0 CA-C-O 121.237 0.542 . . . . 0.0 110.464 179.629 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.1 m -97.6 158.72 15.34 Favored 'General case' 0 C--N 1.316 -0.887 0 CA-C-N 115.327 -0.851 . . . . 0.0 110.725 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 44.9 t -59.92 137.23 58.12 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.882 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.751 HD13 HD23 ' A' ' 82' ' ' LEU . 8.4 tt -130.21 -44.98 1.13 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.971 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.622 ' C ' HG22 ' A' ' 50' ' ' ILE . . . -157.67 -167.89 19.3 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.567 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.535 ' ND1' ' HB2' ' A' ' 138' ' ' ALA . 54.2 m80 -147.0 164.06 34.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.841 0.353 . . . . 0.0 110.911 -179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.574 HD11 ' HB ' ' A' ' 50' ' ' ILE . 2.4 mp -127.03 108.0 10.55 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.809 179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.5 t -97.96 121.96 49.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.163 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -90.06 117.06 28.55 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.785 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 4.4 mt -81.14 106.53 13.21 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.332 -0.394 . . . . 0.0 110.831 179.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.54 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 4.8 mt -124.25 140.83 35.85 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.917 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.54 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 58.0 Cg_endo -74.43 81.82 1.99 Allowed 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.161 1.908 . . . . 0.0 111.867 179.829 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 145.02 -14.19 1.92 Allowed Glycine 0 CA--C 1.52 0.382 0 C-N-CA 120.903 -0.665 . . . . 0.0 112.483 -179.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -179.0 173.8 1.14 Allowed 'General case' 0 N--CA 1.455 -0.194 0 CA-C-O 120.774 0.321 . . . . 0.0 110.604 179.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 13.2 mm-40 -132.75 156.32 47.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.098 -179.874 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 24.9 tt0 -135.37 112.17 10.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.804 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -105.63 132.29 51.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.02 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 32.1 t -121.09 151.1 24.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.014 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 3.2 mt-10 -94.87 131.41 40.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.807 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.689 HG21 ' HE2' ' A' ' 135' ' ' PHE . 1.6 tt -116.05 124.67 72.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.248 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.515 ' O ' HD22 ' A' ' 82' ' ' LEU . 0.2 OUTLIER -100.93 168.14 9.82 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.959 -179.765 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 12.6 p30 -80.32 66.36 5.8 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.173 0.511 . . . . 0.0 110.313 179.539 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.555 ' C ' ' H ' ' A' ' 55' ' ' VAL . 8.8 ttt85 -79.48 1.55 25.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.622 -0.717 . . . . 0.0 111.796 -179.753 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.4 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 1.2 t-20 72.12 -36.55 0.36 Allowed 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 -178.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.555 ' H ' ' C ' ' A' ' 53' ' ' ARG . 66.5 t -137.36 132.75 46.1 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.781 179.282 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.743 HG23 ' HB3' ' A' ' 65' ' ' ASP . 21.7 m -125.22 124.32 41.46 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.933 -0.576 . . . . 0.0 109.917 179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.65 132.37 49.97 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.876 0.369 . . . . 0.0 110.777 -179.744 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.436 HD12 ' CZ ' ' A' ' 127' ' ' PHE . 34.6 mt -115.19 120.37 64.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.107 -0.497 . . . . 0.0 111.286 -179.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 170.71 -134.09 3.01 Favored Glycine 0 C--N 1.331 0.259 0 CA-C-N 115.852 -0.613 . . . . 0.0 112.235 -179.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.61 ' HB3' ' HA ' ' A' ' 70' ' ' GLU . 0.2 OUTLIER -118.76 -21.96 7.61 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.585 0.231 . . . . 0.0 111.305 179.806 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.454 ' HB2' HG23 ' A' ' 75' ' ' THR . 0.2 OUTLIER -52.01 126.48 18.54 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.864 0.364 . . . . 0.0 110.96 179.993 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.4 mmm180 -55.05 -26.25 36.23 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.104 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 5.0 m -77.3 -22.68 51.6 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.12 179.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 98.5 m -54.71 162.26 1.26 Allowed 'General case' 0 C--O 1.232 0.135 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.151 -179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.743 ' HB3' HG23 ' A' ' 56' ' ' THR . 12.9 t0 -83.69 -49.0 9.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.402 -0.363 . . . . 0.0 111.128 -179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 58' ' ' ILE . 26.7 t -123.77 116.85 49.34 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 CA-C-N 116.353 -0.385 . . . . 0.0 111.371 -179.748 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 16.5 pt -100.76 127.8 53.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.975 179.676 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.514 HD12 ' HB3' ' A' ' 131' ' ' CYS . 3.8 mm? -98.18 -92.21 0.25 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.697 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.411 ' O ' ' CB ' ' A' ' 70' ' ' GLU . 48.0 m -87.58 -108.01 0.07 Allowed 'General case' 0 CA--C 1.529 0.162 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 179.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.61 ' HA ' ' HB3' ' A' ' 60' ' ' ARG . 1.0 OUTLIER 167.48 -64.51 0.0 OUTLIER Pre-proline 0 CA--C 1.532 0.275 0 N-CA-C 111.644 0.238 . . . . 0.0 111.644 178.871 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.593 ' HD3' ' HB3' ' A' ' 70' ' ' GLU . 15.9 Cg_exo -67.61 -40.28 10.47 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 122.123 1.882 . . . . 0.0 112.998 -179.433 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -109.22 21.29 17.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.554 -0.294 . . . . 0.0 111.303 -179.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.471 ' CG2' ' HB3' ' A' ' 60' ' ' ARG . 4.8 tp -112.26 120.62 62.94 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.355 0 CA-C-O 120.905 0.384 . . . . 0.0 110.817 -179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.451 ' HB2' ' CG ' ' A' ' 77' ' ' HIS . 0.5 OUTLIER -57.92 131.48 50.54 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.075 -179.527 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.454 HG23 ' HB2' ' A' ' 61' ' ' SER . 91.5 m -59.12 -44.01 91.97 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.688 179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.473 ' O ' ' C ' ' A' ' 77' ' ' HIS . 1.6 m-85 -105.62 13.75 29.45 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.184 179.731 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.473 ' C ' ' O ' ' A' ' 76' ' ' PHE . 0.2 OUTLIER -15.0 -70.18 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 114.618 -1.174 . . . . 0.0 112.763 -179.479 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -151.21 153.3 34.66 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.065 0.459 . . . . 0.0 111.937 -179.596 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -117.21 133.8 55.56 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 115.752 -0.658 . . . . 0.0 110.255 179.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.755 ' CE2' HG22 ' A' ' 97' ' ' VAL . 8.2 m-85 -119.45 131.11 55.55 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.477 -0.329 . . . . 0.0 111.142 -179.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.4 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 17.7 m-70 -94.88 116.67 29.0 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.857 0.361 . . . . 0.0 111.107 -179.894 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.751 HD23 HD13 ' A' ' 34' ' ' LEU . 0.0 OUTLIER -106.34 109.62 21.6 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.69 179.737 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 4.6 tt -122.19 139.38 53.83 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.125 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -129.1 131.89 47.32 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.724 179.756 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.15 148.48 40.1 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.354 -0.385 . . . . 0.0 111.078 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 1.5 p30 -107.09 125.76 51.47 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.779 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.5 t -139.96 126.33 22.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.158 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 58.82 42.21 20.27 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.987 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 62.04 29.11 17.58 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.949 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -139.45 130.91 27.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.814 179.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 20.8 mm100 -85.58 132.26 34.21 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.971 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 3.2 mmp_? -111.7 124.65 52.77 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.794 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 25.0 m120 -103.81 122.56 45.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.021 -179.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.8 mt -132.08 122.96 26.25 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.727 179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.607 HD12 ' HG ' ' A' ' 82' ' ' LEU . 7.2 mm -113.16 137.25 46.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.349 -0.387 . . . . 0.0 111.02 -179.899 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -114.01 135.35 54.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.821 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.755 HG22 ' CE2' ' A' ' 80' ' ' PHE . 18.7 t -112.82 128.55 69.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.195 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 7.5 mt -129.64 120.97 51.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.004 179.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -102.32 134.01 46.3 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.937 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.6 pttp -149.73 32.17 0.7 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.835 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 1.8 m -119.94 -178.0 3.54 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.25 -0.432 . . . . 0.0 111.01 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.35 38.1 2.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.876 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -105.53 -38.32 6.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.249 -0.432 . . . . 0.0 111.278 179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 131.95 98.5 0.73 Allowed Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.521 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 71.0 m -117.54 124.13 47.95 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.846 0.355 . . . . 0.0 110.835 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 44.7 m-85 -120.98 121.79 38.75 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.956 179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.45 HD13 ' CG1' ' A' ' 125' ' ' ILE . 3.2 tp -120.57 137.1 55.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.414 0.626 . . . . 0.0 111.282 179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 9.9 m120 56.56 31.45 19.08 Favored 'General case' 0 C--N 1.32 -0.686 0 CA-C-N 114.936 -1.029 . . . . 0.0 110.892 -179.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.69 13.05 74.73 Favored Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.875 179.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 24.7 p30 -134.08 150.34 51.17 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.785 0.326 . . . . 0.0 110.912 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 3.7 ttm180 -62.83 141.82 58.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.983 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.413 HD23 ' N ' ' A' ' 113' ' ' VAL . 1.1 tt -100.06 125.7 46.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.831 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.572 HG22 ' O ' ' A' ' 113' ' ' VAL . 12.0 p -149.94 49.62 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.128 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -125.46 -177.47 3.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.827 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.3 mtpt -111.56 -33.75 6.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.908 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -137.59 76.8 1.6 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.97 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -84.0 136.38 34.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.768 179.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.519 ' O ' HG23 ' A' ' 118' ' ' ILE . 8.8 tp -98.64 118.95 45.97 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.344 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.261 -179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.479 HD23 ' C ' ' A' ' 119' ' ' LEU . 7.4 tt -103.09 145.59 29.66 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.928 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 13.6 mttt -132.1 178.06 7.08 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.84 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.404 ' HB3' ' CD2' ' A' ' 137' ' ' TYR . 15.5 p30 -58.25 138.81 56.04 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.0 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.439 ' HA2' HD21 ' A' ' 134' ' ' LEU . . . 78.13 58.04 3.28 Favored Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.764 -0.731 . . . . 0.0 112.523 -179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 52.6 m-20 -134.22 126.57 30.13 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.798 0.332 . . . . 0.0 110.889 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.425 ' N ' HD12 ' A' ' 134' ' ' LEU . 7.9 ttm180 -93.3 127.64 38.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.846 -180.0 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.45 ' CG1' HD13 ' A' ' 107' ' ' ILE . 1.7 mp -121.67 134.23 65.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.188 -179.901 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.582 HG22 ' HB3' ' A' ' 132' ' ' SER . 21.7 t -124.12 123.92 67.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.946 179.823 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.443 ' HB3' ' CE1' ' A' ' 77' ' ' HIS . 79.7 m-85 -113.98 111.89 22.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.002 -179.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 84.04 -10.27 61.05 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.846 -0.692 . . . . 0.0 113.057 179.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 77.28 30.02 0.54 Allowed 'General case' 0 CA--C 1.522 -0.133 0 CA-C-O 120.985 0.421 . . . . 0.0 110.273 -179.467 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 26.9 p -125.84 -44.06 1.81 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.99 -179.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . 0.514 ' HB3' HD12 ' A' ' 68' ' ' LEU . 1.8 m -118.6 116.92 27.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.032 -179.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.582 ' HB3' HG22 ' A' ' 126' ' ' VAL . 77.2 p -124.06 130.66 52.93 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.795 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.529 ' CE2' HD23 ' A' ' 37' ' ' LEU . 8.8 p90 -141.98 156.01 45.45 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.023 -179.885 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.439 HD21 ' HA2' ' A' ' 122' ' ' GLY . 2.2 tp -105.79 130.88 53.69 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.785 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.689 ' HE2' HG21 ' A' ' 50' ' ' ILE . 26.9 t80 -94.31 141.44 28.57 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-O 121.886 0.85 . . . . 0.0 111.729 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.3 tttp -154.7 149.85 26.99 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-N 113.938 -1.483 . . . . 0.0 111.041 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.404 ' CD2' ' HB3' ' A' ' 121' ' ' ASN . 5.6 m-85 -76.25 140.09 41.43 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.987 0.422 . . . . 0.0 110.645 179.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.535 ' HB2' ' ND1' ' A' ' 36' ' ' HIS . . . -97.25 158.89 15.23 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.882 -0.599 . . . . 0.0 111.043 -179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 4.8 m 61.6 86.33 0.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.842 -179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 67.6 m -56.85 147.18 24.08 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.023 -179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 98.8 p -128.41 117.36 21.25 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.902 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 61.51 87.2 0.1 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.905 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 25.4 p -104.28 -179.24 3.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.929 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -126.19 130.97 52.01 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.896 179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.607 HG22 ' O ' ' A' ' 145' ' ' ILE . 19.9 mm -103.23 25.1 1.48 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.332 0 CA-C-O 121.642 0.734 . . . . 0.0 111.314 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 60.81 77.41 0.33 Allowed 'General case' 0 C--N 1.307 -1.259 0 CA-C-N 114.563 -1.199 . . . . 0.0 110.89 -179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 4.0 m-20 -76.86 -65.63 0.92 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.88 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 59.79 104.03 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.825 179.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 1.6 t70 -168.03 149.24 5.18 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.861 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -131.0 -178.7 4.94 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.886 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 39.4 mttm -139.85 174.21 10.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.853 -179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.591 HG22 ' O ' ' A' ' 152' ' ' VAL . 14.8 p -117.68 38.94 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.997 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -140.78 97.74 3.26 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.953 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 22.4 m -137.53 -61.65 0.63 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.879 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 60.05 -175.88 0.1 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.899 179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.4 p -62.85 170.74 2.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.861 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 11.8 ttp180 -164.79 161.57 20.54 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.897 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 18.4 t -117.35 96.93 5.64 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.925 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 36.7 t80 . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.292 -0.861 . . . . 0.0 110.935 179.995 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.395 0 CA-C-O 120.839 0.352 . . . . 0.0 111.176 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -157.26 -46.31 0.07 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.822 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -99.7 -68.48 0.8 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.948 179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -176.04 -64.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.915 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 16.8 mtp180 -89.1 119.04 29.26 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.931 -179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 72.8 m -147.35 33.85 0.88 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.938 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -158.68 139.09 12.48 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.877 179.9 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.415 ' HA ' ' HD3' ' A' ' 27' ' ' PRO . 20.3 mttm -146.77 138.58 13.46 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.992 -179.886 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.415 ' HD3' ' HA ' ' A' ' 26' ' ' LYS . 32.4 Cg_exo -57.97 159.11 18.96 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.52 2.147 . . . . 0.0 112.212 179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 2.0 m -92.57 43.16 1.12 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.953 179.871 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 178.23 -179.34 0.29 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.747 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 60.09 69.69 0.68 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.889 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.43 ' HB2' ' CG2' ' A' ' 51' ' ' THR . 33.3 m-85 -107.29 -112.03 0.29 Allowed 'General case' 0 CA--C 1.536 0.417 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.786 -179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.21 136.32 33.27 Favored 'General case' 0 C--O 1.232 0.147 0 CA-C-O 120.833 0.349 . . . . 0.0 110.435 179.796 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 51.3 t -59.83 145.19 46.41 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.367 -179.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.508 HD13 HD22 ' A' ' 52' ' ' ASN . 2.6 tp -150.72 -44.22 0.12 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.665 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.743 ' C ' HG22 ' A' ' 50' ' ' ILE . . . -153.03 -175.57 24.61 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 121.041 -0.599 . . . . 0.0 112.127 179.844 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.41 ' CE1' ' HG3' ' A' ' 49' ' ' GLU . 40.4 m80 -147.01 166.06 27.97 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 121.012 0.434 . . . . 0.0 111.221 179.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.418 HD12 ' N ' ' A' ' 37' ' ' LEU . 4.7 mp -127.07 136.01 51.58 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.827 -0.624 . . . . 0.0 110.59 179.718 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.409 HG22 ' HE3' ' A' ' 47' ' ' LYS . 1.7 t -101.66 123.61 54.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.417 -0.356 . . . . 0.0 111.125 -179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -90.15 120.91 31.73 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.779 179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 88.3 mt -97.86 107.73 20.28 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.965 -179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.421 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 3.3 mp -116.82 138.77 24.93 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.757 179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.421 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 91.5 Cg_exo -44.42 -27.67 2.21 Favored 'Trans proline' 0 C--N 1.347 0.466 0 C-N-CA 122.623 2.215 . . . . 0.0 112.708 -179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -149.22 45.32 0.7 Allowed Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.624 -0.798 . . . . 0.0 112.601 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 20.8 tptt -179.86 164.15 1.17 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.792 0.329 . . . . 0.0 111.01 179.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -146.92 134.39 20.84 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.634 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 3.4 tp60 -129.62 145.51 51.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.352 -0.385 . . . . 0.0 111.157 -179.731 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.409 ' HE3' HG22 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -113.0 133.24 55.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.739 179.794 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 40.1 t -121.97 149.25 25.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.941 0.4 . . . . 0.0 111.237 -179.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.41 ' HG3' ' CE1' ' A' ' 36' ' ' HIS . 48.6 tt0 -107.97 128.53 54.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.655 179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.743 HG22 ' C ' ' A' ' 35' ' ' GLY . 1.2 tt -105.92 132.03 53.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.337 -0.392 . . . . 0.0 111.264 -179.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.648 ' O ' HD23 ' A' ' 82' ' ' LEU . 0.8 OUTLIER -98.55 168.42 10.19 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.044 -179.707 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.508 HD22 HD13 ' A' ' 34' ' ' LEU . 12.1 p30 -86.09 62.94 7.75 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.198 0.523 . . . . 0.0 110.17 179.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.578 ' C ' ' H ' ' A' ' 55' ' ' VAL . 23.5 ttt-85 -82.83 1.78 37.44 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.005 -179.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 71.93 -33.62 0.27 Allowed 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -178.677 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.578 ' H ' ' C ' ' A' ' 53' ' ' ARG . 74.0 t -136.79 141.33 41.07 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.372 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.428 179.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.592 HG23 ' HB3' ' A' ' 65' ' ' ASP . 51.0 m -125.18 126.79 45.79 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.336 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.79 139.1 39.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.823 0.344 . . . . 0.0 110.517 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.571 ' CG2' HD11 ' A' ' 68' ' ' LEU . 4.5 mp -130.8 132.66 63.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.063 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 164.89 -151.9 21.16 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.472 -0.871 . . . . 0.0 113.09 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.422 ' HB2' ' CG2' ' A' ' 73' ' ' ILE . 14.7 ttp180 -86.2 -45.43 11.32 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.76 0.314 . . . . 0.0 111.25 -179.7 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.833 ' HB3' HG23 ' A' ' 75' ' ' THR . 11.5 p -52.05 128.72 25.39 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.358 -179.47 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.98 -16.49 61.7 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.141 179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -69.72 -26.62 64.42 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.817 0.342 . . . . 0.0 110.708 179.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 83.1 m -59.85 156.32 14.51 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.627 179.621 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.592 ' HB3' HG23 ' A' ' 56' ' ' THR . 7.4 t70 -62.07 -46.3 89.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.913 0.387 . . . . 0.0 110.495 179.927 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 20.9 t -125.18 132.98 70.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 116.073 -0.512 . . . . 0.0 111.316 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 2.4 mt -104.35 115.2 45.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.025 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.793 HD12 HD11 ' A' ' 73' ' ' ILE . 14.5 mt -87.22 -134.92 0.08 Allowed 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.517 179.941 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.444 ' O ' ' CB ' ' A' ' 70' ' ' GLU . 17.4 m -57.04 -105.99 0.0 OUTLIER 'General case' 0 CA--C 1.533 0.318 0 O-C-N 122.404 -0.185 . . . . 0.0 110.941 -179.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.444 ' CB ' ' O ' ' A' ' 69' ' ' SER . 2.9 mt-10 163.72 -62.64 0.0 OUTLIER Pre-proline 0 N--CA 1.464 0.264 0 CA-C-O 120.597 0.236 . . . . 0.0 111.398 179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.433 ' HD2' ' N ' ' A' ' 70' ' ' GLU . 19.7 Cg_endo -58.93 -39.98 75.96 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.661 2.24 . . . . 0.0 113.009 -179.205 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -118.55 27.12 9.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.682 0.277 . . . . 0.0 111.538 -179.507 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.793 HD11 HD12 ' A' ' 68' ' ' LEU . 4.8 tp -109.7 127.65 66.36 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 120.96 0.409 . . . . 0.0 111.606 -179.869 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -72.17 134.17 45.55 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.045 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.833 HG23 ' HB3' ' A' ' 61' ' ' SER . 87.6 m -50.73 -44.06 58.22 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.271 179.934 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.494 ' O ' ' C ' ' A' ' 77' ' ' HIS . 12.1 p90 -106.69 13.86 27.57 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.081 0.467 . . . . 0.0 111.677 -179.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.494 ' C ' ' O ' ' A' ' 76' ' ' PHE . 4.2 t60 -6.38 -69.09 0.0 OUTLIER 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 114.671 -1.15 . . . . 0.0 112.979 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -152.81 164.05 38.56 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.951 0.405 . . . . 0.0 111.632 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.1 mt-10 -130.09 128.97 42.95 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.864 179.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.914 ' CZ ' HG13 ' A' ' 97' ' ' VAL . 5.6 m-85 -119.44 131.15 55.57 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.719 -179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -94.72 116.34 28.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.964 0.412 . . . . 0.0 111.266 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.712 HD22 HG12 ' A' ' 50' ' ' ILE . 22.3 tp -106.74 109.73 21.71 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.849 179.622 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -122.22 140.09 53.0 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 111.012 179.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 3.4 tm0? -106.03 137.18 44.39 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.759 179.844 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 7.6 mtt -107.03 136.76 46.35 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.841 -179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -97.87 116.48 30.18 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.035 -179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 17.5 t -139.97 139.15 37.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.943 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 -48.36 -51.61 25.55 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.188 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -53.66 -65.74 0.51 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.27 -0.423 . . . . 0.0 111.163 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.494 ' CD2' HG23 ' A' ' 145' ' ' ILE . 8.3 m-85 -162.67 163.11 27.16 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.826 179.904 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.0 128.0 34.07 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.913 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 6.3 mmm180 -108.1 129.69 55.14 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.82 -179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 17.0 m120 -114.07 120.0 39.09 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.01 -179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 3.2 mt -115.55 130.1 56.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.752 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.652 HG13 HD12 ' A' ' 82' ' ' LEU . 3.7 mp -114.66 136.04 52.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.365 -0.38 . . . . 0.0 111.275 -179.907 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -114.28 138.76 50.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.731 179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.914 HG13 ' CZ ' ' A' ' 80' ' ' PHE . 17.4 t -101.02 134.95 39.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.274 -179.799 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 32.4 mt -129.3 134.96 62.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.071 179.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.421 ' HB3' HD11 ' A' ' 112' ' ' LEU . 20.6 p-10 -105.55 118.86 37.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.849 -179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.3 mtpp -133.17 31.11 3.86 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.922 179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.2 m -144.03 174.67 10.65 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.881 179.941 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.94 30.44 4.83 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.894 -179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -85.32 -34.46 21.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.142 -179.957 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 120.94 88.79 1.04 Allowed Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.798 -0.715 . . . . 0.0 112.527 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.555 HG23 ' CD1' ' A' ' 127' ' ' PHE . 75.6 m -107.12 126.98 53.08 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.903 0.382 . . . . 0.0 110.946 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 35.2 m-85 -120.93 117.85 28.4 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.904 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.42 HD13 HG12 ' A' ' 125' ' ' ILE . 2.6 tp -113.01 137.23 46.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.449 0.643 . . . . 0.0 111.297 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 62.94 27.69 16.05 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.882 -1.054 . . . . 0.0 110.933 179.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.74 12.77 74.66 Favored Glycine 0 N--CA 1.443 -0.875 0 C-N-CA 120.819 -0.705 . . . . 0.0 112.811 179.843 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -134.02 152.05 51.69 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.82 0.343 . . . . 0.0 110.903 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.0 ttp180 -73.61 129.79 38.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.85 179.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.421 HD11 ' HB3' ' A' ' 99' ' ' ASP . 3.6 pp -88.52 144.82 26.1 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.993 179.909 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 14.2 m -143.46 32.21 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.264 -0.426 . . . . 0.0 111.112 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -147.43 149.39 32.61 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.881 179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.6 mtmm -98.63 34.84 1.94 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.942 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -152.76 50.27 0.74 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.972 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -83.89 136.63 34.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.843 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.542 ' O ' HG23 ' A' ' 118' ' ' ILE . 8.9 tp -98.56 117.27 43.29 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.382 0 CA-C-O 120.983 0.42 . . . . 0.0 111.216 -179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.75 HD11 HD11 ' A' ' 125' ' ' ILE . 10.0 tt -103.16 135.52 44.67 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.024 -179.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 35.7 mttt -131.99 178.03 7.1 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.765 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.431 ' HB3' ' CD2' ' A' ' 137' ' ' TYR . 9.9 p-10 -62.15 142.86 57.39 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.871 179.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.484 ' HA2' HD21 ' A' ' 134' ' ' LEU . . . 72.67 42.41 47.15 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.5 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -118.08 127.3 53.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.8 0.333 . . . . 0.0 110.932 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.57 118.5 23.32 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.837 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.75 HD11 HD11 ' A' ' 119' ' ' LEU . 2.9 mt -114.93 122.68 69.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.206 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 24.7 t -118.48 128.22 75.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.96 179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.555 ' CD1' HG23 ' A' ' 105' ' ' THR . 49.1 m-85 -111.4 137.16 49.54 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.963 -179.816 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 74.48 -65.85 2.03 Favored Glycine 0 N--CA 1.449 -0.435 0 C-N-CA 120.861 -0.685 . . . . 0.0 112.351 179.967 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER 174.94 -50.34 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.812 0.339 . . . . 0.0 110.95 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.2 p -91.33 -42.74 10.19 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.253 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . 0.412 ' HB3' ' CZ ' ' A' ' 133' ' ' PHE . 25.9 m -54.93 108.17 0.37 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.336 -0.393 . . . . 0.0 111.121 -179.856 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 41.5 t -123.76 129.97 51.9 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.856 -179.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.505 ' CZ ' HD22 ' A' ' 68' ' ' LEU . 1.5 m-85 -141.98 154.24 44.89 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.797 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.484 HD21 ' HA2' ' A' ' 122' ' ' GLY . 0.6 OUTLIER -120.02 139.82 51.92 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.937 179.901 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.412 ' HE2' HG21 ' A' ' 50' ' ' ILE . 28.3 t80 -112.37 141.48 46.05 Favored 'General case' 0 CA--C 1.512 -0.509 0 CA-C-O 121.964 0.887 . . . . 0.0 111.859 -179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.65 159.02 40.53 Favored 'General case' 0 C--N 1.311 -1.086 0 CA-C-N 113.853 -1.522 . . . . 0.0 110.761 179.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.431 ' CD2' ' HB3' ' A' ' 121' ' ' ASN . 3.6 m-85 -86.05 139.72 30.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.933 0.397 . . . . 0.0 110.763 179.579 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -115.28 -37.37 4.08 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.839 -0.618 . . . . 0.0 111.083 -179.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -58.39 162.95 3.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.922 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 41.4 t 60.66 162.32 0.06 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.867 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 91.5 p -61.91 106.78 0.74 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.903 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -74.05 76.78 1.72 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.879 -179.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 1.6 p -137.28 -67.85 0.48 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.984 179.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -159.01 148.88 19.12 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.824 179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.494 HG23 ' CD2' ' A' ' 90' ' ' PHE . 8.1 mt -147.02 119.83 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.432 -1.329 0 CA-C-O 121.71 0.767 . . . . 0.0 109.573 -179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -98.3 107.83 20.39 Favored 'General case' 0 C--N 1.296 -1.721 0 CA-C-N 114.414 -1.266 . . . . 0.0 110.907 179.99 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -165.83 143.89 5.78 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.914 179.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 7.3 t70 60.28 35.85 20.76 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.907 -179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 4.6 t0 -98.79 31.38 2.96 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.904 179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -113.64 -51.57 2.79 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.852 -179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 12.0 tttm 60.22 91.3 0.05 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.917 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.5 t -95.34 -60.07 2.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.138 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 18.6 p -124.82 120.21 31.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.889 179.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 22.8 p -151.0 179.74 8.0 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.896 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -127.5 143.63 51.16 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.94 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 4.0 m -167.34 179.14 5.17 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.925 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 9.2 mtt-85 -135.69 70.59 1.43 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.866 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 4.9 m -148.56 156.0 41.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.941 179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.261 -0.876 . . . . 0.0 110.854 179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 5.2 mttp . . . . . 0 N--CA 1.488 1.429 0 CA-C-O 120.867 0.365 . . . . 0.0 111.133 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 2.2 ttm-85 -132.08 104.19 6.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.928 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -132.1 30.72 4.22 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.845 -179.938 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 59.35 -176.45 0.09 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.946 179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 10.4 tpt180 -162.5 150.25 14.0 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.934 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 1.3 m -108.91 91.05 3.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.895 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 59.1 m-20 -90.55 168.21 11.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.931 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 6.2 mmtm -63.01 120.09 57.93 Favored Pre-proline 0 C--N 1.328 -0.338 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.882 179.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -70.0 144.55 53.12 Favored 'Trans proline' 0 C--N 1.347 0.487 0 C-N-CA 122.355 2.037 . . . . 0.0 112.315 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 73.4 m -66.12 174.24 2.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.904 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -150.47 84.38 1.37 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.202 -0.453 . . . . 0.0 110.832 179.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -164.17 131.51 3.3 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.064 179.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.506 ' N ' HG21 ' A' ' 51' ' ' THR . 2.1 m-85 -53.65 -96.21 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.983 179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.45 132.12 27.26 Favored 'General case' 0 N--CA 1.456 -0.13 0 N-CA-C 109.946 -0.39 . . . . 0.0 109.946 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.8 t -59.71 144.89 46.87 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 121.101 0.477 . . . . 0.0 111.341 -179.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.464 HD12 ' HB3' ' A' ' 52' ' ' ASN . 0.8 OUTLIER -151.52 -45.04 0.11 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.636 -0.711 . . . . 0.0 110.338 179.787 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -147.36 157.61 27.45 Favored Glycine 0 N--CA 1.451 -0.362 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.926 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.633 ' ND1' ' HB2' ' A' ' 138' ' ' ALA . 51.8 m80 -119.83 160.4 22.71 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.99 0.424 . . . . 0.0 111.295 -179.92 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.967 HD12 HD11 ' A' ' 50' ' ' ILE . 59.2 mt -127.09 112.77 15.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.607 179.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.867 HG22 ' HG3' ' A' ' 47' ' ' LYS . 27.2 t -99.71 121.74 50.74 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.133 -179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 25.9 m120 -90.19 114.87 26.94 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.763 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 32.0 mt -88.21 106.85 18.47 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.84 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 3.4 mt -124.11 139.27 32.29 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.187 -0.46 . . . . 0.0 111.08 179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.34 92.86 0.04 OUTLIER 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.377 2.051 . . . . 0.0 112.251 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 87.71 34.21 10.42 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.659 -0.781 . . . . 0.0 112.364 -179.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 9.7 tttt -179.94 150.55 0.39 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.806 0.336 . . . . 0.0 110.859 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 6.2 mp0 -151.22 152.0 32.66 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.991 -179.959 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -143.6 126.22 15.97 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.163 -0.472 . . . . 0.0 110.739 179.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.867 ' HG3' HG22 ' A' ' 38' ' ' VAL . 5.0 ttpt -104.65 126.07 51.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.929 -179.808 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 21.0 t -111.6 150.8 13.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.134 -0.484 . . . . 0.0 111.104 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.413 ' HG3' ' CD2' ' A' ' 36' ' ' HIS . 0.4 OUTLIER -100.46 119.95 39.26 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.97 -179.891 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.967 HD11 HD12 ' A' ' 37' ' ' LEU . 31.0 mm -96.12 132.09 41.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.07 179.906 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.506 HG21 ' N ' ' A' ' 31' ' ' TYR . 1.1 p -110.0 168.51 9.38 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.788 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.464 ' HB3' HD12 ' A' ' 34' ' ' LEU . 3.9 p30 -81.32 60.43 4.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.149 0.5 . . . . 0.0 110.291 179.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.583 ' C ' ' H ' ' A' ' 55' ' ' VAL . 20.0 ttt-85 -82.86 1.38 39.62 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.654 -0.703 . . . . 0.0 111.757 -179.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.407 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 11.9 m-20 71.54 -33.28 0.27 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 -178.696 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.583 ' H ' ' C ' ' A' ' 53' ' ' ARG . 78.8 t -137.19 140.75 41.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.58 179.379 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.697 HG23 ' HB3' ' A' ' 65' ' ' ASP . 30.5 m -125.29 128.33 48.08 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.054 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.91 130.69 51.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.809 0.338 . . . . 0.0 110.768 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.558 ' CG2' HD11 ' A' ' 68' ' ' LEU . 2.7 mp -124.06 120.94 60.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.084 -0.507 . . . . 0.0 111.09 -179.713 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 171.35 -143.11 7.41 Favored Glycine 0 C--N 1.331 0.284 0 C-N-CA 120.761 -0.733 . . . . 0.0 112.735 179.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.547 ' HB2' HG23 ' A' ' 73' ' ' ILE . 11.8 ttp180 -95.18 -32.34 13.1 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.803 0.335 . . . . 0.0 111.093 -179.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.928 ' HB2' HG23 ' A' ' 75' ' ' THR . 0.3 OUTLIER -48.79 133.91 16.95 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.331 -179.575 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 48.6 mtp85 -67.12 -31.14 71.4 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.741 179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -70.98 -22.83 62.14 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.039 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 66.9 m -52.1 146.62 8.57 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.88 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.697 ' HB3' HG23 ' A' ' 56' ' ' THR . 63.6 t0 -61.07 -43.82 98.31 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.876 0.37 . . . . 0.0 110.727 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.424 HG21 ' CD1' ' A' ' 37' ' ' LEU . 23.0 t -125.17 132.95 70.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.357 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 6.7 pt -109.86 127.16 66.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.856 179.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.592 ' CD1' HD11 ' A' ' 73' ' ' ILE . 8.0 mt -103.67 -132.76 0.3 Allowed 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.881 -179.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.405 ' O ' ' CB ' ' A' ' 70' ' ' GLU . 29.4 t -57.67 -105.67 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 O-C-N 122.336 -0.227 . . . . 0.0 111.002 -179.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.479 ' HA ' HG22 ' A' ' 73' ' ' ILE . 2.7 mt-10 167.02 -64.37 0.0 OUTLIER Pre-proline 0 N--CA 1.463 0.207 0 CA-C-O 120.605 0.24 . . . . 0.0 111.213 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.448 ' CD ' ' CB ' ' A' ' 70' ' ' GLU . 21.5 Cg_endo -61.04 -40.08 54.78 Favored 'Trans proline' 0 C--N 1.345 0.389 0 C-N-CA 122.6 2.2 . . . . 0.0 112.673 -179.609 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -110.34 20.81 17.4 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.307 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.592 HD11 ' CD1' ' A' ' 68' ' ' LEU . 4.7 tp -109.39 121.8 63.0 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.275 0 CA-C-O 121.114 0.483 . . . . 0.0 111.098 -179.807 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.41 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 45.1 t -83.4 136.23 34.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.357 -179.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.928 HG23 ' HB2' ' A' ' 61' ' ' SER . 63.6 m -61.24 -30.01 70.18 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.988 179.68 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.406 ' O ' ' C ' ' A' ' 77' ' ' HIS . 12.2 m-85 -103.92 14.23 31.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.119 -0.492 . . . . 0.0 111.731 -179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.494 ' CE1' HD12 ' A' ' 73' ' ' ILE . 0.1 OUTLIER -29.81 -72.95 0.03 OUTLIER 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.961 -1.018 . . . . 0.0 112.348 -179.232 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.718 ' HB3' ' CZ ' ' A' ' 127' ' ' PHE . . . -156.48 164.1 38.63 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.979 0.419 . . . . 0.0 111.821 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.412 ' HA ' ' O ' ' A' ' 56' ' ' THR . 0.0 OUTLIER -129.23 136.05 49.6 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.651 179.666 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.965 ' CE2' HG22 ' A' ' 97' ' ' VAL . 9.3 m-85 -119.3 127.88 53.62 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.64 179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.407 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 9.0 m-70 -94.88 116.41 28.68 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.975 0.416 . . . . 0.0 111.53 -179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.673 HD13 HG21 ' A' ' 50' ' ' ILE . 0.3 OUTLIER -106.68 109.74 21.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.551 179.386 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -122.18 140.08 53.0 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.207 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 2.4 tt0 -102.4 122.38 44.18 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.67 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -120.31 113.43 20.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.314 -0.403 . . . . 0.0 111.15 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -107.09 121.54 44.7 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.816 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.488 ' O ' HG13 ' A' ' 87' ' ' VAL . 11.4 p -139.98 120.1 13.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.26 -179.892 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 57.99 65.53 1.28 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.001 179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.8 t30 66.66 -73.69 0.07 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.998 -179.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 47.1 m-85 -60.47 122.63 15.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.864 179.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -111.17 129.14 56.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.136 -0.483 . . . . 0.0 110.919 179.995 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 1.6 mtt180 -106.64 135.52 48.03 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.942 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.524 ' C ' HD22 ' A' ' 94' ' ' LEU . 9.3 m-80 -99.97 131.29 46.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.903 -179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.524 HD22 ' C ' ' A' ' 93' ' ' ASN . 3.9 mm? -121.93 128.42 51.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.814 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.61 ' N ' HD12 ' A' ' 95' ' ' ILE . 3.5 mp -112.97 141.13 29.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.076 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -113.99 143.93 43.92 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.769 -179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.965 HG22 ' CE2' ' A' ' 80' ' ' PHE . 12.0 t -107.01 126.67 63.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.147 -0.478 . . . . 0.0 111.153 -179.966 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.451 HD12 ' N ' ' A' ' 98' ' ' ILE . 3.9 mp -128.23 120.97 54.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.125 -0.488 . . . . 0.0 111.02 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -114.17 138.75 50.04 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.941 -179.925 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -101.21 -11.05 19.83 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.208 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.0 m 65.67 102.39 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 120.825 0.345 . . . . 0.0 110.913 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 12.6 mmp_? -128.1 -69.04 0.74 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.865 179.951 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 35.7 p-10 -110.97 -32.65 6.74 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.868 179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 147.42 100.94 0.26 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.466 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.502 ' O ' HD23 ' A' ' 112' ' ' LEU . 0.9 OUTLIER -119.83 123.92 44.84 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.769 0.319 . . . . 0.0 110.93 -179.96 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . 0.406 ' CE2' ' HG3' ' A' ' 111' ' ' ARG . 4.7 m-85 -121.15 138.12 54.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.849 179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.804 HG22 ' CD2' ' A' ' 112' ' ' LEU . 3.4 tp -121.68 137.3 55.77 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.302 0 CA-C-O 121.59 0.71 . . . . 0.0 111.367 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 60.05 30.41 19.9 Favored 'General case' 0 C--N 1.319 -0.737 0 CA-C-N 114.755 -1.111 . . . . 0.0 110.69 -179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.8 13.03 75.1 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.877 -0.678 . . . . 0.0 112.782 179.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -129.53 152.05 49.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.946 0.403 . . . . 0.0 111.048 -179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.406 ' HG3' ' CE2' ' A' ' 106' ' ' PHE . 30.5 ttt180 -75.02 143.46 43.54 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.055 -0.52 . . . . 0.0 110.939 179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.804 ' CD2' HG22 ' A' ' 107' ' ' ILE . 4.0 mm? -69.71 138.25 52.74 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.188 -0.46 . . . . 0.0 111.024 -179.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.464 HG23 ' N ' ' A' ' 114' ' ' LYS . 16.8 m -134.39 -46.14 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.05 179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.464 ' N ' HG23 ' A' ' 113' ' ' VAL . 0.5 OUTLIER -88.34 162.98 16.27 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.925 179.916 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -107.16 31.93 5.0 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.912 -179.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -161.81 65.66 0.25 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.904 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -84.1 139.11 32.68 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.8 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.485 ' O ' HG23 ' A' ' 118' ' ' ILE . 8.4 tp -98.58 121.42 49.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 CA-C-N 116.26 -0.427 . . . . 0.0 111.221 -179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.647 HD21 ' CD2' ' A' ' 135' ' ' PHE . 3.4 tp -103.14 132.75 49.16 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.902 -179.842 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -126.38 178.03 6.09 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.79 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.439 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 7.1 p30 -63.05 143.13 58.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.9 -179.974 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 69.37 50.36 33.03 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.535 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -117.73 142.24 47.48 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.767 0.318 . . . . 0.0 111.025 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . . . . . . . . . 61.9 mtt85 -100.94 127.14 47.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.83 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.419 ' HB ' ' CE2' ' A' ' 133' ' ' PHE . 1.6 mp -123.37 136.91 58.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.185 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 38.1 t -124.01 124.05 68.11 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.92 179.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.718 ' CZ ' ' HB3' ' A' ' 78' ' ' ALA . 3.3 m-85 -111.8 133.03 54.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.09 -179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 82.36 -67.55 3.68 Favored Glycine 0 N--CA 1.45 -0.414 0 C-N-CA 120.848 -0.691 . . . . 0.0 112.419 179.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 178.35 -41.68 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.772 0.32 . . . . 0.0 111.118 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -107.81 -41.98 4.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.701 -179.418 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 29.1 m -51.98 105.65 0.12 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.934 0.397 . . . . 0.0 111.231 -179.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 32.4 p -124.36 134.72 53.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.909 179.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.419 ' CE2' ' HB ' ' A' ' 125' ' ' ILE . 6.8 p90 -141.97 155.03 45.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.01 179.844 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.3 tp -112.64 138.38 49.52 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.777 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.647 ' CD2' HD21 ' A' ' 119' ' ' LEU . 47.7 t80 -108.15 141.48 39.81 Favored 'General case' 0 CA--C 1.512 -0.512 0 CA-C-O 122.005 0.907 . . . . 0.0 111.802 179.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 9.2 ptpt -154.59 154.13 32.53 Favored 'General case' 0 C--N 1.311 -1.07 0 CA-C-N 113.883 -1.508 . . . . 0.0 110.873 179.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.439 ' CE2' ' HB3' ' A' ' 121' ' ' ASN . 0.8 OUTLIER -86.0 139.6 31.04 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.913 0.387 . . . . 0.0 110.734 179.643 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.633 ' HB2' ' ND1' ' A' ' 36' ' ' HIS . . . -89.48 -30.05 18.55 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.917 -0.583 . . . . 0.0 111.121 -179.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.33 160.41 31.89 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.787 179.898 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 1.6 m -134.64 169.56 17.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.911 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 55.0 p -80.25 -44.07 20.3 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.949 179.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -98.07 127.87 44.27 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.807 -179.955 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 20.2 m -114.38 89.99 3.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.846 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 13.7 m-20 -146.48 -56.63 0.28 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.851 179.928 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.596 HG22 ' O ' ' A' ' 145' ' ' ILE . 17.9 mt -103.87 25.14 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-O 121.575 0.702 . . . . 0.0 111.302 179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -114.27 160.02 19.51 Favored 'General case' 0 C--N 1.307 -1.247 0 CA-C-N 114.64 -1.164 . . . . 0.0 110.88 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 16.3 m120 -101.78 97.15 7.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.873 -179.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -120.23 -48.27 2.33 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.893 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -145.88 -49.53 0.22 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.892 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 59.24 90.45 0.05 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.941 -179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.22 87.32 2.73 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.913 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.5 t -77.08 124.95 36.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.152 179.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -93.35 166.57 12.23 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.306 -0.406 . . . . 0.0 110.847 -180.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 34.8 t -171.03 149.2 2.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.919 -179.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 2.8 pt-20 -76.93 147.38 37.0 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.899 179.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 49.6 m -149.22 -59.88 0.22 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.951 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -102.27 134.54 45.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.868 179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.4 p -119.38 -179.58 3.9 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.84 -179.946 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 . . . . . 0 C--O 1.248 1.016 0 CA-C-O 118.255 -0.878 . . . . 0.0 110.861 179.976 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 2.0 ttpt . . . . . 0 N--CA 1.485 1.313 0 CA-C-O 120.931 0.396 . . . . 0.0 111.238 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.34 176.73 4.92 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.888 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 19.3 mt-30 -60.22 104.01 0.28 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.899 -179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 2.0 mt-30 -75.89 -178.1 4.15 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.9 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -178.63 -35.8 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.026 179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 80.8 p -76.94 -51.89 10.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.896 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 96.8 m-20 -87.25 -179.69 6.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.9 -179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.73 119.61 75.79 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.776 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.06 145.49 55.56 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.385 2.056 . . . . 0.0 112.387 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.9 m -71.11 73.58 0.64 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.896 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 2.1 t -168.88 33.76 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.969 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -155.95 121.59 4.92 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.761 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 26.8 m-85 -89.4 -108.78 0.08 Allowed 'General case' 0 CA--C 1.536 0.434 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.851 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.454 ' N ' HG22 ' A' ' 51' ' ' THR . 0.0 OUTLIER -140.44 134.17 30.38 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-O 120.778 0.323 . . . . 0.0 110.613 179.742 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 49.7 t -59.88 145.02 47.26 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.3 -0.409 . . . . 0.0 111.094 -179.78 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.804 HD13 HD21 ' A' ' 82' ' ' LEU . 8.4 tt -150.96 -46.68 0.12 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.844 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.616 ' C ' HG22 ' A' ' 50' ' ' ILE . . . -151.16 -176.95 24.52 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.473 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 40.9 m80 -147.08 157.89 43.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.872 0.368 . . . . 0.0 111.041 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.575 HD23 ' N ' ' A' ' 37' ' ' LEU . 0.3 OUTLIER -127.02 129.42 48.04 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.716 179.712 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.63 HG22 ' HD2' ' A' ' 47' ' ' LYS . 21.3 t -109.03 122.0 63.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.224 -179.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.3 m-80 -90.01 119.89 30.75 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.805 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 66.3 mt -75.68 108.69 8.69 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.887 179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.408 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 14.4 mt -122.24 138.52 29.13 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.889 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.408 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 87.8 Cg_exo -46.94 -27.95 6.49 Favored 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.568 2.178 . . . . 0.0 112.529 -179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -114.15 -125.55 4.18 Favored Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.772 -0.728 . . . . 0.0 112.413 179.849 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -53.89 138.31 36.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.795 0.331 . . . . 0.0 111.129 -179.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 2.7 mt-10 -82.12 150.52 27.42 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.833 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -117.01 110.51 18.35 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.025 -179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.63 ' HD2' HG22 ' A' ' 38' ' ' VAL . 0.5 OUTLIER -113.04 121.0 43.31 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.842 179.891 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.8 t -124.53 151.06 29.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.153 -179.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.6 pt-20 -100.26 142.15 32.13 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.786 179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.616 HG22 ' C ' ' A' ' 35' ' ' GLY . 6.1 tt -116.03 132.21 66.23 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.373 -179.785 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.454 HG22 ' N ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -97.59 168.08 10.57 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.819 -179.848 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.884 ' HA ' HD22 ' A' ' 82' ' ' LEU . 11.4 p30 -85.01 62.71 7.68 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.134 0.492 . . . . 0.0 110.238 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.562 ' C ' ' H ' ' A' ' 55' ' ' VAL . 22.3 ttt-85 -81.24 2.75 26.55 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.591 -0.731 . . . . 0.0 112.051 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.404 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 0.5 OUTLIER 72.06 -35.24 0.32 Allowed 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.503 -0.555 . . . . 0.0 109.503 -178.77 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.562 ' H ' ' C ' ' A' ' 53' ' ' ARG . 73.5 t -137.18 138.43 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 CA-C-N 115.826 -0.625 . . . . 0.0 110.424 179.293 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.732 HG23 ' CB ' ' A' ' 65' ' ' ASP . 96.9 m -125.2 129.66 50.54 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.587 -179.76 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.418 ' O ' ' N ' ' A' ' 65' ' ' ASP . 0.0 OUTLIER -103.98 140.72 37.33 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.897 0.379 . . . . 0.0 110.954 -179.825 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.543 HD13 ' HE2' ' A' ' 127' ' ' PHE . 9.6 mt -132.05 123.41 50.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.964 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 171.78 -148.46 10.96 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.812 -0.708 . . . . 0.0 112.717 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.47 ' HB2' HG23 ' A' ' 73' ' ' ILE . 9.4 tpt85 -93.55 -33.11 13.88 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-O 120.754 0.311 . . . . 0.0 111.083 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.7 ' HB2' HG23 ' A' ' 75' ' ' THR . 3.5 t -53.61 139.98 30.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.287 -0.415 . . . . 0.0 111.133 -179.661 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.17 -25.41 61.68 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.03 -0.532 . . . . 0.0 111.119 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 63.6 p -69.81 -24.69 63.52 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.354 -0.384 . . . . 0.0 110.99 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 93.3 m -59.1 163.94 3.34 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.873 179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.732 ' CB ' HG23 ' A' ' 56' ' ' THR . 0.9 OUTLIER -72.16 -59.18 2.87 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.033 0.444 . . . . 0.0 110.692 179.807 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 24.8 t -109.64 122.01 63.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 115.836 -0.62 . . . . 0.0 111.111 -179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.1 pt -98.4 105.11 16.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.917 179.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.441 HD13 ' HA ' ' A' ' 68' ' ' LEU . 1.6 mm? -64.94 -25.92 68.08 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.92 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 49.1 m 62.63 26.68 15.81 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.98 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.423 ' CB ' ' HB ' ' A' ' 73' ' ' ILE . 0.0 OUTLIER -85.37 148.52 49.91 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.707 179.837 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.04 -14.05 42.12 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.678 2.252 . . . . 0.0 113.061 -179.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -135.17 23.27 3.51 Favored 'General case' 0 C--N 1.331 -0.221 0 N-CA-C 111.765 0.283 . . . . 0.0 111.765 -179.578 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.488 HG23 ' O ' ' A' ' 73' ' ' ILE . 5.2 tp -77.33 120.37 27.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.979 0.418 . . . . 0.0 110.996 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.401 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 47.0 t -62.39 133.99 55.82 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.932 -0.576 . . . . 0.0 111.311 -179.552 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.7 HG23 ' HB2' ' A' ' 61' ' ' SER . 94.3 m -57.94 -31.76 67.15 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.733 179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.465 ' O ' ' C ' ' A' ' 77' ' ' HIS . 13.5 m-85 -110.36 13.9 22.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.064 -0.516 . . . . 0.0 111.48 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.465 ' C ' ' O ' ' A' ' 76' ' ' PHE . 1.9 t60 -18.93 -67.69 0.02 OUTLIER 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 114.694 -1.139 . . . . 0.0 112.708 -179.38 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -156.34 162.29 40.09 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.0 0.428 . . . . 0.0 111.982 -179.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -128.55 132.56 48.26 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.385 179.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.813 ' CZ ' HG13 ' A' ' 97' ' ' VAL . 6.0 m-85 -119.28 129.39 54.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.437 -0.347 . . . . 0.0 110.838 -179.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.404 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 16.2 m-70 -94.88 116.19 28.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.855 0.36 . . . . 0.0 111.348 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.884 HD22 ' HA ' ' A' ' 52' ' ' ASN . 7.1 tt -106.85 109.88 21.9 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.714 179.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -121.28 139.93 52.74 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.933 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 46.2 tt0 -107.31 133.29 52.07 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.871 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -140.18 140.7 35.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.881 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 12.5 p-10 -97.33 119.68 36.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.897 179.902 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.4 t -135.74 114.53 15.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.205 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 59.59 78.1 0.28 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.944 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 6.6 m-20 64.08 -79.25 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.03 -179.979 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -69.59 159.53 33.22 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.914 179.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -111.91 140.63 46.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.921 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -104.05 148.42 26.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.824 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.435 ' HB2' ' CD1' ' A' ' 137' ' ' TYR . 14.3 m120 -114.01 120.03 39.23 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.99 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.95 HD12 HD11 ' A' ' 118' ' ' ILE . 4.1 mm? -105.37 127.52 53.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.766 179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.472 ' HB ' HD22 ' A' ' 119' ' ' LEU . 26.7 mm -113.1 141.12 29.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.266 -0.425 . . . . 0.0 111.182 -179.865 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -115.83 144.09 44.49 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.672 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.813 HG13 ' CZ ' ' A' ' 80' ' ' PHE . 22.0 t -112.32 134.3 55.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.228 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 27.7 mt -130.01 129.87 65.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.1 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.778 ' HB2' HD11 ' A' ' 112' ' ' LEU . 44.1 t0 -98.22 125.04 43.11 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.866 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 26.9 mmtp -147.42 31.37 0.9 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.893 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 20.1 m -105.42 171.68 7.2 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.878 -179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 21.1 mtt85 -110.36 -31.53 7.26 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.884 179.926 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -69.07 -73.31 0.15 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.235 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 176.36 135.41 2.14 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.596 -0.811 . . . . 0.0 112.672 179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.513 HG23 ' CD1' ' A' ' 127' ' ' PHE . 88.2 m -131.82 122.96 26.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.773 0.321 . . . . 0.0 110.536 179.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 6.7 m-85 -120.37 130.91 54.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.042 -179.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . . . . . . . . . 3.2 tp -123.02 137.35 56.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.49 0.662 . . . . 0.0 111.216 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 62.75 28.8 16.65 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-N 114.823 -1.08 . . . . 0.0 110.776 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.81 6.0 62.38 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 120.925 -0.655 . . . . 0.0 113.073 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 3.7 m-80 -134.21 144.26 48.34 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.788 0.328 . . . . 0.0 110.825 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 7.3 ttm180 -70.32 128.94 37.94 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.818 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.778 HD11 ' HB2' ' A' ' 99' ' ' ASP . 0.8 OUTLIER -76.26 139.2 41.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.29 -0.413 . . . . 0.0 110.98 -179.966 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 30.6 m -111.78 -34.85 2.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.13 -0.486 . . . . 0.0 111.028 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.2 tttt -105.99 166.0 10.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.84 179.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.43 171.47 8.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.939 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 28.9 t70 62.65 56.23 2.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.023 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.404 ' HB3' ' HB ' ' A' ' 97' ' ' VAL . 0.2 OUTLIER -79.0 137.58 37.65 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.745 179.879 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.95 HD11 HD12 ' A' ' 94' ' ' LEU . 8.5 tp -98.65 119.62 46.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-O 121.013 0.435 . . . . 0.0 111.418 -179.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.839 HD11 HD11 ' A' ' 125' ' ' ILE . 5.9 tt -103.19 132.62 49.31 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.849 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 29.5 mttt -114.63 178.09 4.41 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.875 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.442 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 5.6 p-10 -56.23 136.69 52.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.019 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 69.47 51.36 26.72 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.73 -0.747 . . . . 0.0 112.3 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -111.64 129.55 56.05 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 120.789 0.328 . . . . 0.0 111.028 -179.882 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.513 ' NH1' HD23 ' A' ' 134' ' ' LEU . 11.7 ttm-85 -88.23 123.96 33.38 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.829 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.839 HD11 HD11 ' A' ' 119' ' ' LEU . 2.1 mp -123.07 130.43 74.42 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.159 -179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 43.7 t -124.03 134.09 67.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.179 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.543 ' HE2' HD13 ' A' ' 58' ' ' ILE . 8.6 m-85 -115.78 139.32 50.28 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.92 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 71.29 -64.63 1.01 Allowed Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.863 -0.684 . . . . 0.0 112.477 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 15.0 mttt 170.34 -37.24 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.755 0.312 . . . . 0.0 111.011 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 23.8 p -99.89 -43.55 6.36 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.303 -0.408 . . . . 0.0 111.406 -179.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 76.5 m -53.17 104.47 0.1 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.936 0.398 . . . . 0.0 111.311 -179.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.56 127.71 47.81 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.963 179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.432 ' CE2' ' HB ' ' A' ' 125' ' ' ILE . 4.0 p90 -142.14 156.26 45.35 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.966 0.412 . . . . 0.0 111.283 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.513 HD23 ' NH1' ' A' ' 124' ' ' ARG . 0.3 OUTLIER -116.33 120.3 38.44 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.625 179.788 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.477 ' HE2' HG21 ' A' ' 50' ' ' ILE . 45.7 t80 -97.93 141.66 30.63 Favored 'General case' 0 CA--C 1.513 -0.462 0 CA-C-O 121.978 0.894 . . . . 0.0 111.976 -179.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.35 147.09 24.27 Favored 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 113.807 -1.542 . . . . 0.0 110.828 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.442 ' CE2' ' HB3' ' A' ' 121' ' ' ASN . 10.1 m-85 -76.56 140.01 40.93 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.037 0.446 . . . . 0.0 110.812 179.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -117.55 30.8 7.08 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.789 -0.641 . . . . 0.0 111.14 -179.992 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 3.3 m -113.18 -44.16 3.29 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.912 179.946 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.0 t -117.97 129.8 55.82 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.95 179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 94.0 p -90.04 163.0 15.08 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.874 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.7 t -160.54 79.57 0.65 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.922 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 29.0 m -105.45 88.2 2.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.872 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -131.2 67.54 1.51 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.84 179.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.624 HG22 ' O ' ' A' ' 145' ' ' ILE . 2.4 mt -106.84 24.88 2.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-O 121.72 0.771 . . . . 0.0 111.257 179.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 24.4 mt-10 -97.63 127.75 43.82 Favored 'General case' 0 C--N 1.307 -1.241 0 CA-C-N 114.576 -1.193 . . . . 0.0 110.912 179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -116.19 32.24 6.23 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.837 -179.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 5.1 t70 -89.07 147.93 23.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.908 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -132.39 143.49 49.86 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.799 -179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -113.12 170.91 7.88 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.886 179.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 19.4 mtpp 60.33 100.12 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.862 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 21.5 t 62.79 102.31 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.047 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 5.0 p -85.8 160.34 19.5 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.894 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 4.6 m -128.35 94.05 3.8 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.901 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -87.89 93.72 9.55 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.899 179.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 4.6 t -118.82 82.43 1.86 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.895 179.99 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 14.1 ptt180 -116.96 149.73 39.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.884 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 32.0 p -109.41 -28.79 8.76 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.933 179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 . . . . . 0 C--O 1.248 0.998 0 CA-C-O 118.256 -0.878 . . . . 0.0 110.872 -179.948 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.6 tptt . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.78 0.324 . . . . 0.0 111.139 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 60.79 96.74 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.908 -179.889 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 11.0 pt20 -131.21 -48.2 1.0 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.988 179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -91.71 126.98 36.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.951 -179.902 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 6.6 ptt180 -121.51 -174.77 2.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.893 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 2.2 t -127.0 -66.23 0.91 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.886 179.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.4 p30 -80.51 109.8 15.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.934 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.48 ' N ' ' CD ' ' A' ' 27' ' ' PRO . 3.0 mtpp -74.24 -46.91 6.16 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.437 . . . . 0.0 111.096 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.48 ' CD ' ' N ' ' A' ' 26' ' ' LYS . 33.0 Cg_exo -57.81 141.56 95.83 Favored 'Trans proline' 0 C--N 1.347 0.485 0 C-N-CA 122.285 1.99 . . . . 0.0 112.291 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 6.7 m 60.08 177.97 0.09 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.9 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 52.9 p -163.47 99.17 0.91 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.947 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -146.05 131.06 18.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.748 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 7.6 m-85 -77.34 -105.44 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.83 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.493 ' N ' HG22 ' A' ' 51' ' ' THR . 0.7 OUTLIER -140.64 129.04 22.54 Favored 'General case' 0 N--CA 1.457 -0.093 0 CA-C-O 120.721 0.296 . . . . 0.0 110.776 179.803 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 52.4 t -61.82 137.5 58.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.855 -179.948 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.661 HD11 ' OD1' ' A' ' 93' ' ' ASN . 5.3 tt -142.93 -50.44 0.35 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.969 179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.616 ' C ' HG22 ' A' ' 50' ' ' ILE . . . -140.3 -177.35 15.87 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.727 -0.749 . . . . 0.0 112.544 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 47.5 m80 -144.69 161.02 40.24 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.899 0.38 . . . . 0.0 110.987 -179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 4.0 mt -121.94 121.02 36.14 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.637 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.3 t -96.04 121.89 47.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.345 -179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -90.16 131.79 35.81 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.425 179.754 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' A' ' 133' ' ' PHE . 1.9 mp -113.38 106.83 15.05 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.935 0.398 . . . . 0.0 111.21 -179.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.414 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 22.0 mt -124.15 138.33 30.59 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-N 116.077 -0.51 . . . . 0.0 110.887 179.753 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.414 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 83.0 Cg_exo -45.38 -28.8 4.17 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.478 2.119 . . . . 0.0 112.639 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -85.02 -30.12 26.67 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.678 -0.772 . . . . 0.0 112.406 179.889 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 174.88 -169.54 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.879 0.371 . . . . 0.0 110.969 179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -129.37 -178.53 4.7 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.946 -179.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -162.52 151.09 14.68 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.975 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 5.7 tttt -113.01 131.53 55.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.008 -179.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 25.1 t -119.1 147.48 22.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.135 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -100.16 128.54 46.22 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.859 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.662 HG21 ' HE1' ' A' ' 135' ' ' PHE . 15.3 tt -115.93 132.3 65.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.262 -0.427 . . . . 0.0 111.247 -179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.493 HG22 ' N ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -97.99 168.11 10.48 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.125 -0.488 . . . . 0.0 110.884 -179.824 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -102.33 75.56 1.49 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.43 179.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.601 ' C ' ' H ' ' A' ' 55' ' ' VAL . 1.6 ptp85 -101.05 23.59 10.56 Favored 'General case' 0 CA--C 1.515 -0.387 0 CA-C-N 115.995 -0.548 . . . . 0.0 111.39 -179.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 68.59 -28.31 0.15 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.717 0.294 . . . . 0.0 110.216 -179.35 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.601 ' H ' ' C ' ' A' ' 53' ' ' ARG . 65.3 t -137.27 139.73 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.225 0 CA-C-O 121.087 0.47 . . . . 0.0 111.352 179.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.651 HG23 ' HB3' ' A' ' 65' ' ' ASP . 38.5 m -125.28 125.47 43.6 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.046 179.625 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.88 137.24 42.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.801 0.334 . . . . 0.0 110.806 -179.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 4.2 mp -128.53 121.28 54.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.98 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 172.68 -151.8 15.03 Favored Glycine 0 C--N 1.332 0.314 0 C-N-CA 120.668 -0.777 . . . . 0.0 112.656 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.416 ' HB2' ' CG2' ' A' ' 73' ' ' ILE . 6.3 ttp180 -87.67 -31.26 19.84 Favored 'General case' 0 C--N 1.331 -0.197 0 CA-C-O 120.775 0.321 . . . . 0.0 110.974 -179.902 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.898 ' HB2' HG23 ' A' ' 75' ' ' THR . 0.1 OUTLIER -55.53 127.54 30.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.226 -179.751 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -63.81 -25.53 68.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.915 179.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 91.0 p -69.87 -25.48 63.74 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.927 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 88.8 m -56.11 153.49 9.03 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.87 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.651 ' HB3' HG23 ' A' ' 56' ' ' THR . 10.0 t70 -62.7 -45.93 90.49 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.988 0.423 . . . . 0.0 110.664 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.5 t -120.31 129.16 75.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.958 -0.564 . . . . 0.0 110.947 179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 31.2 mt -102.6 104.87 17.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.241 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.604 HD11 ' CE2' ' A' ' 133' ' ' PHE . 1.3 tp -77.67 -154.58 0.07 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.132 179.745 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.471 ' O ' ' CB ' ' A' ' 70' ' ' GLU . 26.9 m -44.14 -97.79 0.0 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 111.262 0.097 . . . . 0.0 111.262 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.471 ' CB ' ' O ' ' A' ' 69' ' ' SER . 2.5 mt-10 158.81 -65.12 0.0 OUTLIER Pre-proline 0 N--CA 1.468 0.446 0 CA-C-O 120.704 0.287 . . . . 0.0 111.427 179.506 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.462 ' CD ' ' CB ' ' A' ' 70' ' ' GLU . 12.0 Cg_endo -55.93 -40.05 87.44 Favored 'Trans proline' 0 C--N 1.346 0.443 0 C-N-CA 122.705 2.27 . . . . 0.0 113.146 -178.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -117.97 28.4 8.42 Favored 'General case' 0 C--N 1.328 -0.354 0 N-CA-C 111.663 0.245 . . . . 0.0 111.663 -179.464 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.537 HD11 ' CD2' ' A' ' 68' ' ' LEU . 4.9 tp -112.64 125.37 69.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 121.046 0.45 . . . . 0.0 111.459 179.995 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.432 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 57.3 m -76.87 137.71 39.33 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.186 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.898 HG23 ' HB2' ' A' ' 61' ' ' SER . 52.8 m -60.09 -40.96 91.42 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.09 179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.45 ' O ' ' C ' ' A' ' 77' ' ' HIS . 14.0 m-85 -99.46 14.13 30.91 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 121.088 0.47 . . . . 0.0 111.922 -179.602 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.45 ' C ' ' O ' ' A' ' 76' ' ' PHE . 0.8 OUTLIER -22.74 -69.38 0.03 OUTLIER 'General case' 0 C--N 1.32 -0.699 0 CA-C-N 114.982 -1.008 . . . . 0.0 112.598 -179.361 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -154.61 164.1 39.23 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.054 0.455 . . . . 0.0 111.837 -179.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.6 mt-10 -131.8 130.36 41.69 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.457 179.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.887 ' CZ ' HG13 ' A' ' 97' ' ' VAL . 7.3 m-85 -119.47 131.56 55.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.949 -179.76 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . . . . . . . . . 9.6 m170 -94.3 116.41 28.79 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.937 0.399 . . . . 0.0 111.075 -179.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.448 HD13 ' O ' ' A' ' 51' ' ' THR . 3.9 tt -106.44 109.96 22.03 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.913 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 2.1 mp -117.85 139.22 51.41 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.009 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -126.57 128.74 47.31 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.905 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -140.09 146.15 38.54 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.913 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 3.2 p30 -104.66 115.92 31.17 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.85 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 3.4 m -122.96 110.95 27.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.251 -0.431 . . . . 0.0 111.262 -179.876 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 57.63 82.68 0.12 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.109 179.841 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 70.9 m-80 62.47 -79.93 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.094 179.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 37.5 m-85 -58.99 170.53 0.83 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.941 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -126.7 140.46 52.38 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.919 -179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.32 119.37 39.31 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.844 179.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.661 ' OD1' HD11 ' A' ' 34' ' ' LEU . 3.0 m-80 -108.6 123.75 49.43 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.805 -179.978 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 2.6 mt -125.68 132.6 52.39 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.981 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.543 ' N ' HD12 ' A' ' 95' ' ' ILE . 4.0 mp -114.87 141.02 33.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.026 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -113.97 144.07 43.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.998 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.887 HG13 ' CZ ' ' A' ' 80' ' ' PHE . 18.2 t -110.48 127.73 67.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.167 -0.47 . . . . 0.0 111.136 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 33.1 mt -130.01 121.0 50.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 0.0 111.146 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -113.84 117.36 31.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.786 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -102.26 24.56 10.05 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.234 -0.439 . . . . 0.0 111.099 -179.92 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 46.5 m 63.19 142.57 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.888 0.375 . . . . 0.0 110.939 179.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 6.4 tpt180 -178.71 -68.84 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.721 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -123.32 -31.01 3.61 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.249 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 128.82 120.46 2.27 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.805 -0.712 . . . . 0.0 112.281 -179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.476 HG23 ' CE1' ' A' ' 127' ' ' PHE . 90.6 m -123.27 128.47 50.02 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.847 0.355 . . . . 0.0 111.063 -179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 14.8 m-85 -120.98 114.99 22.31 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.766 179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.846 HD12 ' O ' ' A' ' 124' ' ' ARG . 2.2 tp -120.51 137.25 54.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 121.522 0.677 . . . . 0.0 111.496 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 59.18 28.16 17.38 Favored 'General case' 0 C--N 1.319 -0.742 0 CA-C-N 114.654 -1.157 . . . . 0.0 111.05 179.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.71 13.07 74.79 Favored Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.834 -0.698 . . . . 0.0 112.952 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 67.4 m-80 -133.17 150.13 52.02 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.835 0.35 . . . . 0.0 110.948 -179.951 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 19.3 ttt-85 -74.96 142.35 43.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.92 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -88.88 127.86 35.65 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.847 179.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.484 HG13 ' HG2' ' A' ' 114' ' ' LYS . 12.7 p -117.82 -40.07 2.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.155 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.484 ' HG2' HG13 ' A' ' 113' ' ' VAL . 4.4 mmmt -84.18 173.74 10.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.823 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.5 ptpt -121.2 32.86 5.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.818 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -145.94 49.55 1.2 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.9 179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -81.56 138.11 35.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.796 179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.516 ' O ' HG23 ' A' ' 118' ' ' ILE . 8.8 tp -98.56 118.93 45.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.272 -0.422 . . . . 0.0 111.195 -179.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.546 HD11 HD11 ' A' ' 125' ' ' ILE . 7.9 tt -103.1 136.21 43.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.015 -179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 1.9 mtmt -125.65 178.06 5.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.789 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.431 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 4.7 p30 -59.53 137.74 57.92 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.279 -0.418 . . . . 0.0 111.004 -179.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 74.2 55.57 5.64 Favored Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.841 -0.695 . . . . 0.0 112.444 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -117.31 139.29 51.02 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.925 0.393 . . . . 0.0 110.849 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.846 ' O ' HD12 ' A' ' 107' ' ' ILE . 3.1 ttt180 -103.18 123.62 47.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.855 -179.914 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.546 HD11 HD11 ' A' ' 119' ' ' LEU . 1.4 mp -126.75 135.7 62.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.214 -0.448 . . . . 0.0 111.184 -179.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 21.4 t -120.63 125.09 73.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.058 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.476 ' CE1' HG23 ' A' ' 105' ' ' THR . 90.1 m-85 -120.61 130.61 54.23 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.114 -179.817 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 84.07 -6.0 77.26 Favored Glycine 0 CA--C 1.519 0.3 0 C-N-CA 120.75 -0.738 . . . . 0.0 112.899 179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 12.2 mtpt 77.2 28.78 0.6 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 120.911 0.386 . . . . 0.0 110.525 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -157.29 -45.08 0.07 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.949 -0.569 . . . . 0.0 111.073 179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . 0.471 ' CB ' HD21 ' A' ' 68' ' ' LEU . 99.6 m -77.37 107.75 10.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.804 179.866 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 47.3 t -124.07 126.32 46.04 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.971 -179.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.604 ' CE2' HD11 ' A' ' 68' ' ' LEU . 12.9 p90 -142.05 155.51 45.4 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.926 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.47 140.05 39.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.773 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.662 ' HE1' HG21 ' A' ' 50' ' ' ILE . 55.6 t80 -103.52 141.66 35.62 Favored 'General case' 0 CA--C 1.513 -0.477 0 CA-C-O 121.924 0.868 . . . . 0.0 111.809 -179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.8 tttt -154.26 147.69 25.03 Favored 'General case' 0 C--N 1.311 -1.101 0 CA-C-N 113.953 -1.476 . . . . 0.0 110.932 179.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.467 ' CD1' ' N ' ' A' ' 137' ' ' TYR . 0.8 OUTLIER -79.88 139.73 37.02 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.712 179.729 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -109.98 162.91 14.07 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.975 -0.557 . . . . 0.0 111.141 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 1.4 m -127.18 -178.65 4.51 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.844 179.97 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 10.6 t -79.67 101.61 8.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.902 -179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 48.8 m -92.69 80.16 4.76 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.911 -179.976 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.3 p -73.14 87.5 1.41 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.839 -179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 56.4 p -140.95 102.94 4.38 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.869 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 60.55 87.15 0.09 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.835 179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.596 HG22 ' H ' ' A' ' 146' ' ' GLU . 0.7 OUTLIER -110.35 -143.51 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.157 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.973 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.596 ' H ' HG22 ' A' ' 145' ' ' ILE . 17.8 mt-10 -104.33 160.26 15.04 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-N 115.491 -0.777 . . . . 0.0 110.91 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 25.6 m120 -124.62 -58.22 1.51 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.867 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -67.87 145.86 54.2 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.909 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 10.4 m-20 -98.95 175.95 5.75 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.912 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -129.21 -46.98 1.21 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.938 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 4.4 mmtm -70.48 -49.32 49.75 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.903 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 30.9 m -101.61 127.94 54.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.262 -0.426 . . . . 0.0 111.095 179.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -148.39 144.68 27.66 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.842 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.8 t -160.56 -55.07 0.05 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.851 -179.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER 59.25 96.72 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.886 179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 28.2 p -171.56 116.33 0.4 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.914 -179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -129.98 86.43 2.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.913 179.926 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.1 t -175.17 91.52 0.06 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.958 -179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.195 -0.907 . . . . 0.0 110.891 -179.945 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 4.5 ttmt . . . . . 0 N--CA 1.487 1.376 0 CA-C-O 120.812 0.339 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -99.22 161.77 13.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.861 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -112.13 116.64 30.82 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.96 -179.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 48.1 tt0 -128.99 -55.09 1.2 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.853 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.31 161.47 41.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.817 -179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 14.8 m -143.38 33.27 1.32 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.873 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -92.7 -175.8 4.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.848 179.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.56 157.8 87.12 Favored Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.984 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.0 Cg_endo -69.7 143.08 49.99 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.57 2.18 . . . . 0.0 112.304 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -145.63 160.14 42.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.946 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 64.5 p -121.35 136.86 54.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.185 -0.462 . . . . 0.0 110.845 -179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.464 ' C ' ' CG ' ' A' ' 31' ' ' TYR . 21.5 mt-10 -121.1 28.99 7.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.963 -179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.464 ' CG ' ' C ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -168.37 115.84 0.69 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.29 0.567 . . . . 0.0 110.443 179.583 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.2 m -100.25 163.55 12.35 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 115.314 -0.857 . . . . 0.0 110.648 179.593 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 53.6 t -59.96 134.77 57.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.332 -0.395 . . . . 0.0 110.842 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.492 HD12 ' CG ' ' A' ' 84' ' ' GLN . 3.7 tt -133.79 -46.11 0.8 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.987 -179.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.57 ' O ' HG22 ' A' ' 50' ' ' ILE . . . -156.85 -176.66 29.17 Favored Glycine 0 N--CA 1.45 -0.397 0 C-N-CA 120.715 -0.755 . . . . 0.0 112.594 -179.897 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 36.3 m80 -142.29 166.05 25.76 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.87 0.366 . . . . 0.0 110.901 179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.651 ' CD1' HG21 ' A' ' 66' ' ' VAL . 3.8 mt -127.19 110.21 12.65 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.862 179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.598 HG22 ' HD3' ' A' ' 47' ' ' LYS . 23.2 t -102.23 121.77 53.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.281 -0.418 . . . . 0.0 111.136 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -90.08 123.78 34.23 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.863 179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 7.8 mt -83.8 106.68 15.69 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.341 -0.39 . . . . 0.0 110.82 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.708 HD12 ' HA ' ' A' ' 45' ' ' GLU . 1.5 mt -124.16 138.01 30.03 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.925 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -46.99 -27.76 6.36 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.454 2.103 . . . . 0.0 112.531 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -133.22 107.36 0.68 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.737 -0.744 . . . . 0.0 112.483 179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 36.7 mttt 63.16 129.26 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.796 0.332 . . . . 0.0 110.916 -179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.708 ' HA ' HD12 ' A' ' 41' ' ' ILE . 42.3 mt-10 -95.64 170.22 9.49 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.929 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.1 tp60 -126.32 121.94 34.04 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.897 179.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.598 ' HD3' HG22 ' A' ' 38' ' ' VAL . 1.1 mmmp? -102.97 129.07 49.58 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.936 -179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 39.2 t -121.6 130.71 74.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.065 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.12 124.2 32.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.935 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.57 HG22 ' O ' ' A' ' 35' ' ' GLY . 2.9 tt -116.02 132.14 66.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 116.209 -0.45 . . . . 0.0 111.138 -179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.517 ' O ' HD13 ' A' ' 82' ' ' LEU . 0.1 OUTLIER -99.76 168.39 9.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.245 -179.541 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.458 ' HB3' HD13 ' A' ' 34' ' ' LEU . 16.8 p30 -82.26 68.3 8.62 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.342 179.534 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.558 ' C ' ' H ' ' A' ' 55' ' ' VAL . 23.5 ttt-85 -83.01 6.58 18.31 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.653 -0.703 . . . . 0.0 112.041 -179.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.477 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 2.2 t30 71.43 -38.45 0.42 Allowed 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -178.797 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.558 ' H ' ' C ' ' A' ' 53' ' ' ARG . 75.6 t -137.64 133.49 45.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.274 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.531 179.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.919 ' OG1' HD11 ' A' ' 82' ' ' LEU . 33.0 m -125.24 131.25 53.16 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.286 -0.415 . . . . 0.0 110.178 179.767 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.91 133.86 48.17 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.892 0.377 . . . . 0.0 111.037 -179.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.581 ' N ' HD12 ' A' ' 58' ' ' ILE . 3.9 mp -118.22 123.58 71.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.201 -179.847 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 166.98 -130.08 2.05 Favored Glycine 0 C--N 1.331 0.267 0 CA-C-N 115.927 -0.579 . . . . 0.0 112.275 -179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.533 ' HB3' ' HA ' ' A' ' 70' ' ' GLU . 7.2 ptt180 -122.23 -25.96 4.77 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.55 0.214 . . . . 0.0 111.288 179.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.428 ' HB2' HG23 ' A' ' 75' ' ' THR . 0.2 OUTLIER -48.53 125.38 9.71 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-O 120.881 0.372 . . . . 0.0 110.999 -179.919 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.97 -25.47 29.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.163 -179.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 41.1 p -78.23 -23.42 47.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.993 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 93.8 m -57.16 169.27 0.59 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.967 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.8 ' CB ' HG23 ' A' ' 56' ' ' THR . 1.6 m-20 -85.91 -68.31 0.74 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.984 0.421 . . . . 0.0 110.909 179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.651 HG21 ' CD1' ' A' ' 37' ' ' LEU . 27.7 t -101.99 133.05 46.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.085 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 15.7 pt -112.78 127.82 69.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.161 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.762 HD22 ' HB3' ' A' ' 131' ' ' CYS . 13.4 mt -94.04 -84.28 0.32 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.321 -0.4 . . . . 0.0 110.487 179.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.412 ' O ' ' CB ' ' A' ' 70' ' ' GLU . 10.8 t -102.55 -104.52 0.27 Allowed 'General case' 0 C--N 1.331 -0.222 0 N-CA-C 109.771 -0.455 . . . . 0.0 109.771 179.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.639 ' CB ' ' HD3' ' A' ' 71' ' ' PRO . 0.0 OUTLIER 166.76 -64.66 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.19 0 N-CA-C 111.672 0.249 . . . . 0.0 111.672 178.937 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.639 ' HD3' ' CB ' ' A' ' 70' ' ' GLU . 15.6 Cg_exo -67.84 -40.23 9.97 Favored 'Trans proline' 0 C--N 1.346 0.44 0 C-N-CA 122.299 1.999 . . . . 0.0 113.519 -179.16 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -110.55 16.06 21.72 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 111.845 0.313 . . . . 0.0 111.845 -179.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.499 ' CG2' ' HB3' ' A' ' 60' ' ' ARG . 3.6 tp -107.15 124.72 63.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 120.865 0.364 . . . . 0.0 110.773 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . . . . . . . . . 1.5 m -57.47 131.52 50.39 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.408 -179.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.428 HG23 ' HB2' ' A' ' 61' ' ' SER . 35.2 m -63.69 -39.96 95.61 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.436 179.607 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.465 ' O ' ' C ' ' A' ' 77' ' ' HIS . 4.4 m-85 -104.99 13.74 30.48 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.164 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.488 ' CD2' ' CD1' ' A' ' 127' ' ' PHE . 1.5 t60 -16.65 -69.1 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 114.582 -1.19 . . . . 0.0 112.708 -179.276 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.581 ' HB3' ' CZ ' ' A' ' 127' ' ' PHE . . . -158.88 164.1 35.99 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.916 0.389 . . . . 0.0 111.611 -179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.5 mt-10 -124.0 140.36 53.05 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.872 179.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.933 ' CE1' HG13 ' A' ' 97' ' ' VAL . 4.8 m-85 -119.54 131.06 55.46 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.542 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.477 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 21.1 m-70 -102.91 116.11 31.9 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.691 -0.403 . . . . 0.0 111.674 -179.63 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.919 HD11 ' OG1' ' A' ' 56' ' ' THR . 0.2 OUTLIER -107.06 109.84 21.8 Favored 'General case' 0 C--O 1.233 0.234 0 CA-C-N 115.93 -0.577 . . . . 0.0 110.635 179.116 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 1.2 mt -120.67 140.05 52.15 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.405 -0.361 . . . . 0.0 110.992 -179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . 0.492 ' CG ' HD12 ' A' ' 34' ' ' LEU . 56.8 mt-30 -109.49 125.76 52.81 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.768 179.873 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 11.1 mtp -129.62 148.53 51.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.952 -179.938 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -107.07 119.92 40.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.856 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 21.4 t -129.44 110.96 21.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.138 -179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 11.8 t70 58.67 68.52 0.82 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.934 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 5.5 t-20 68.26 -68.36 0.17 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.951 179.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -64.57 146.93 53.89 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.865 179.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.91 128.04 54.28 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.985 -179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -98.54 144.68 27.6 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.832 179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . . . . . . . . . 27.1 m120 -109.14 127.01 53.83 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.988 -179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.419 ' CD2' HD11 ' A' ' 118' ' ' ILE . 1.1 mt -123.41 129.19 50.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.691 179.845 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.63 HD12 HD23 ' A' ' 82' ' ' LEU . 30.6 mm -117.93 138.01 50.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-O 120.903 0.383 . . . . 0.0 111.284 -179.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -113.9 144.08 43.64 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.745 179.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.933 HG13 ' CE1' ' A' ' 80' ' ' PHE . 18.2 t -114.65 134.8 56.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.178 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 25.4 mm -121.04 121.01 63.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.03 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -97.75 123.71 41.8 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.941 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -82.98 -26.36 31.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.97 179.916 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 2.4 m 65.28 99.02 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.909 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -169.68 -42.77 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.888 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -104.26 -55.66 2.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.228 -179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 143.6 106.65 0.56 Allowed Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.501 180.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . . . . . . . . . 90.9 m -118.39 126.86 52.97 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.71 0.29 . . . . 0.0 110.898 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 11.1 m-85 -120.93 115.03 22.42 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.921 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.728 HD12 ' O ' ' A' ' 124' ' ' ARG . 2.5 tp -114.16 137.36 47.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 121.464 0.649 . . . . 0.0 111.21 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 63.09 29.05 16.26 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 114.884 -1.053 . . . . 0.0 110.826 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.78 7.98 66.93 Favored Glycine 0 N--CA 1.445 -0.75 0 C-N-CA 120.893 -0.67 . . . . 0.0 112.974 179.818 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 9.3 p30 -134.17 144.14 48.33 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-O 120.758 0.313 . . . . 0.0 110.856 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 5.4 ttp180 -70.51 128.99 38.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.81 179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.729 HD13 ' N ' ' A' ' 113' ' ' VAL . 0.3 OUTLIER -92.2 137.97 31.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.917 -179.957 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.729 ' N ' HD13 ' A' ' 112' ' ' LEU . 6.2 m -121.51 -42.08 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.1 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 2.4 mttm -65.37 -174.55 0.19 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.852 179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 5.0 tttt -124.0 171.15 9.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.803 179.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 13.5 t70 60.48 63.42 1.36 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.872 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . 0.437 ' CZ ' HG12 ' A' ' 107' ' ' ILE . 10.7 t80 -84.2 139.13 32.59 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.785 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.534 ' O ' HG23 ' A' ' 118' ' ' ILE . 8.4 tp -98.37 118.5 45.0 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.391 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.253 -179.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.561 HD13 ' C ' ' A' ' 119' ' ' LEU . 3.2 tm? -100.84 120.0 39.49 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.767 -179.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.427 ' N ' HD13 ' A' ' 119' ' ' LEU . 0.4 OUTLIER -118.7 178.07 4.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.004 -0.543 . . . . 0.0 110.882 -179.955 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.443 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 17.8 p30 -60.06 135.79 57.82 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.264 -0.425 . . . . 0.0 111.017 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 75.04 56.32 4.86 Favored Glycine 0 N--CA 1.45 -0.402 0 C-N-CA 120.815 -0.707 . . . . 0.0 112.582 179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -123.09 135.06 54.24 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.845 0.355 . . . . 0.0 111.04 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.728 ' O ' HD12 ' A' ' 107' ' ' ILE . 0.0 OUTLIER -99.47 117.33 33.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.132 -0.486 . . . . 0.0 110.825 -179.977 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.611 HG12 HD13 ' A' ' 107' ' ' ILE . 5.1 mt -115.0 133.21 61.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.114 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.566 HG13 ' O ' ' A' ' 131' ' ' CYS . 21.4 t -124.09 127.69 73.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.134 -0.485 . . . . 0.0 111.072 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.581 ' CZ ' ' HB3' ' A' ' 78' ' ' ALA . 4.8 m-85 -116.66 126.19 52.85 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.042 -179.973 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 92.87 -71.09 1.51 Allowed Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.794 -0.717 . . . . 0.0 112.36 179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER 174.55 -43.57 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.788 0.328 . . . . 0.0 111.171 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.0 p -98.08 -41.91 7.72 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.268 -0.423 . . . . 0.0 111.545 -179.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . 0.762 ' HB3' HD22 ' A' ' 68' ' ' LEU . 25.3 m -54.13 106.17 0.18 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.955 0.407 . . . . 0.0 111.222 -179.61 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 13.9 p -124.38 122.54 37.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.949 -0.569 . . . . 0.0 110.773 179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -142.04 156.23 45.42 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.034 0.445 . . . . 0.0 111.276 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . . . . . . . . . 1.1 tp -114.37 134.44 54.97 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.66 179.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.428 ' CD1' ' N ' ' A' ' 136' ' ' LYS . 14.5 t80 -98.2 141.17 31.44 Favored 'General case' 0 CA--C 1.512 -0.494 0 CA-C-O 121.929 0.871 . . . . 0.0 111.754 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.428 ' N ' ' CD1' ' A' ' 135' ' ' PHE . 9.6 tptt -154.86 154.71 33.14 Favored 'General case' 0 C--N 1.31 -1.134 0 CA-C-N 113.878 -1.51 . . . . 0.0 111.128 179.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.443 ' CE2' ' HB3' ' A' ' 121' ' ' ASN . 13.2 m-85 -86.13 140.15 30.46 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.623 179.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -100.59 158.73 15.72 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.797 -0.638 . . . . 0.0 111.124 -179.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 46.9 m -96.82 -59.83 1.72 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.95 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 7.2 t -158.54 112.07 2.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.917 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.15 85.05 7.18 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.854 179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -134.58 -68.72 0.53 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.894 -179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 17.1 p -103.38 94.12 5.32 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.918 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -72.34 147.31 46.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.956 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.594 HG22 ' O ' ' A' ' 145' ' ' ILE . 19.5 mm -102.73 25.0 1.41 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.301 0 CA-C-O 121.599 0.714 . . . . 0.0 111.316 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 14.1 mt-10 -106.97 167.64 9.75 Favored 'General case' 0 C--N 1.307 -1.24 0 CA-C-N 114.587 -1.188 . . . . 0.0 110.898 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -86.99 173.89 9.03 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.931 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 30.2 m-20 60.71 36.79 19.35 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.924 179.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -93.67 -43.07 8.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.892 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 7.4 mt-10 -110.84 86.72 2.37 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.973 -179.993 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.41 176.38 10.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.9 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 14.5 m -140.43 -179.67 2.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.242 -0.436 . . . . 0.0 111.14 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 62.18 100.89 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.857 -179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 7.7 t -147.05 -56.48 0.25 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.874 179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -133.41 -44.08 0.84 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.149 -0.478 . . . . 0.0 111.029 179.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -176.11 -68.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.968 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 3.1 mtt85 -151.57 162.54 40.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.866 -179.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 7.1 t -175.8 175.71 1.97 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.976 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 . . . . . 0 C--O 1.248 1.023 0 CA-C-O 118.213 -0.899 . . . . 0.0 110.845 -179.939 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.486 1.36 0 CA-C-O 120.79 0.329 . . . . 0.0 111.251 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -131.09 -46.78 1.01 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.993 179.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -60.19 131.25 50.24 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.875 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -160.55 175.58 12.55 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.902 179.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 5.7 mtp85 -129.3 -179.84 5.37 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.911 179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.75 -177.12 3.23 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.246 -0.433 . . . . 0.0 110.87 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.2 m-20 -74.79 -43.52 54.35 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.904 179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 5.4 tttm -79.97 134.32 56.68 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.787 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -70.02 155.12 65.84 Favored 'Trans proline' 0 C--N 1.347 0.459 0 C-N-CA 122.477 2.118 . . . . 0.0 112.391 -179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.28 -68.41 0.48 Allowed 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.728 179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 7.2 t 60.07 110.58 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.046 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -73.16 166.39 23.22 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.702 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 9.0 m-85 -70.95 -108.35 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.717 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.457 ' O ' HG22 ' A' ' 51' ' ' THR . 0.0 OUTLIER -140.6 145.03 36.15 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-O 120.692 0.282 . . . . 0.0 110.705 179.678 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 52.6 t -64.66 144.79 56.97 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.954 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.586 HD22 ' HB3' ' A' ' 52' ' ' ASN . 10.2 tp -155.33 -46.32 0.08 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.705 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -154.67 169.69 32.94 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.853 -0.689 . . . . 0.0 112.229 179.93 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.563 ' ND1' ' HB2' ' A' ' 138' ' ' ALA . 27.2 m80 -131.52 163.62 27.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.948 0.404 . . . . 0.0 110.946 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.649 HD12 HG21 ' A' ' 66' ' ' VAL . 19.1 mt -127.06 111.07 13.61 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.801 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 21.4 t -95.92 121.88 46.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.119 179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 69.5 m-80 -89.17 120.88 30.94 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.912 -179.923 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 5.0 mp -79.71 107.05 12.18 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.888 179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.403 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 11.7 mt -123.98 138.39 30.52 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.856 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.403 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 84.4 Cg_exo -47.59 -27.47 7.73 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.494 2.129 . . . . 0.0 112.429 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . -124.96 -126.09 2.99 Favored Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.465 179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 28.9 mttt -53.1 101.72 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.824 0.345 . . . . 0.0 111.134 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 16.6 mt-10 -65.36 172.27 3.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.844 179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 15.0 mt-30 -133.61 131.1 39.23 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.906 -179.94 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -113.07 127.36 56.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.863 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.675 HG11 HG13 ' A' ' 66' ' ' VAL . 28.6 t -119.94 150.98 22.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.14 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 1.1 tt0 -103.44 138.16 40.55 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.863 179.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.665 HG22 HD22 ' A' ' 82' ' ' LEU . 26.2 mm -116.08 126.67 73.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.328 -179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.457 HG22 ' O ' ' A' ' 32' ' ' THR . 0.1 OUTLIER -98.3 168.13 10.42 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.74 179.786 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.586 ' HB3' HD22 ' A' ' 34' ' ' LEU . 26.4 p30 -100.25 66.8 1.32 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.008 0.432 . . . . 0.0 110.762 179.866 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.576 ' C ' ' H ' ' A' ' 55' ' ' VAL . 0.6 OUTLIER -97.73 21.65 10.16 Favored 'General case' 0 CA--C 1.516 -0.365 0 CA-C-N 115.957 -0.565 . . . . 0.0 111.374 179.993 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.431 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 0.6 OUTLIER 68.23 -27.87 0.14 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.601 -0.272 . . . . 0.0 110.485 -179.726 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.576 ' H ' ' C ' ' A' ' 53' ' ' ARG . 62.9 t -137.31 139.31 44.08 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 CA-C-O 121.075 0.465 . . . . 0.0 111.826 -179.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.472 HG22 ' CB ' ' A' ' 65' ' ' ASP . 0.4 OUTLIER -125.24 128.05 47.7 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.747 -0.66 . . . . 0.0 110.005 179.338 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.459 ' O ' ' N ' ' A' ' 65' ' ' ASP . 0.1 OUTLIER -103.95 138.93 39.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.971 0.415 . . . . 0.0 111.417 -179.519 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . . . . . . . . . 32.8 mt -132.3 131.24 60.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.136 -0.483 . . . . 0.0 111.13 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 162.78 -146.67 12.09 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.264 -0.969 . . . . 0.0 113.283 179.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.583 ' HB2' HG23 ' A' ' 73' ' ' ILE . 4.1 ttp-105 -87.59 -44.54 11.17 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.83 0.348 . . . . 0.0 111.392 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.564 ' HB3' HG23 ' A' ' 75' ' ' THR . 33.2 t -50.51 122.15 6.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.483 -179.272 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 8.7 mmt180 -60.43 -20.28 59.21 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.905 179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 16.3 m -69.75 -27.43 64.94 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.698 179.849 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 84.4 m -56.33 164.67 1.27 Allowed 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.671 179.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.472 ' CB ' HG22 ' A' ' 56' ' ' THR . 0.6 OUTLIER -66.94 -52.86 37.78 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.979 0.418 . . . . 0.0 110.802 179.827 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.675 HG13 HG11 ' A' ' 48' ' ' VAL . 21.3 t -125.12 126.79 71.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.989 -0.55 . . . . 0.0 111.508 -179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 3.8 mp -97.51 119.71 45.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.498 179.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.713 HD22 ' HB3' ' A' ' 131' ' ' CYS . 19.4 mt -83.4 -86.61 0.11 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.46 -0.336 . . . . 0.0 111.078 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 34.4 m -108.66 -109.88 0.32 Allowed 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 110.251 -0.278 . . . . 0.0 110.251 179.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.655 ' HA ' HG22 ' A' ' 73' ' ' ILE . 0.2 OUTLIER 169.66 -63.11 0.0 OUTLIER Pre-proline 0 CA--C 1.53 0.192 0 CA-C-O 120.496 0.188 . . . . 0.0 111.412 179.414 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.588 ' HD3' ' CB ' ' A' ' 70' ' ' GLU . 37.2 Cg_exo -60.29 -40.19 61.15 Favored 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.043 1.829 . . . . 0.0 112.899 -179.437 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -115.13 12.73 16.67 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.589 -0.278 . . . . 0.0 111.587 -179.573 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.655 HG22 ' HA ' ' A' ' 70' ' ' GLU . 2.6 tp -104.55 133.32 48.99 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 CA-C-O 120.831 0.348 . . . . 0.0 110.975 -179.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.476 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 4.1 p -98.82 131.76 44.69 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.152 -0.476 . . . . 0.0 111.546 -179.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.564 HG23 ' HB3' ' A' ' 61' ' ' SER . 19.6 m -53.48 -30.17 39.69 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.843 -0.617 . . . . 0.0 111.159 179.654 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -93.92 14.12 20.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.159 -0.473 . . . . 0.0 112.018 -179.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.476 ' HB2' ' O ' ' A' ' 74' ' ' SER . 1.4 t-160 -34.51 -66.65 0.16 Allowed 'General case' 0 C--N 1.318 -0.79 0 CA-C-N 115.262 -0.881 . . . . 0.0 112.07 -179.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.57 ' HB3' ' CE2' ' A' ' 127' ' ' PHE . . . -161.62 163.24 30.07 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.097 0.475 . . . . 0.0 111.765 -179.735 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.7 mt-10 -129.47 135.16 48.29 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.237 179.456 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.954 ' CE2' HG22 ' A' ' 97' ' ' VAL . 6.3 m-85 -119.34 131.46 55.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.999 -179.618 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.431 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 11.9 m170 -94.69 116.45 28.77 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.954 0.407 . . . . 0.0 110.928 -179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.665 HD22 HG22 ' A' ' 50' ' ' ILE . 1.6 tp -106.45 109.95 22.02 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.933 -0.576 . . . . 0.0 110.948 179.936 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.2 tp -118.57 140.09 50.45 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.89 179.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 6.4 tm0? -100.4 132.0 46.02 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.937 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -113.3 130.1 56.35 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.85 -179.99 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -95.12 130.77 41.7 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.964 -179.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . 0.465 HG21 ' HD3' ' A' ' 92' ' ' ARG . 21.4 t -140.09 138.8 37.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.135 179.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -70.35 67.38 0.33 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.797 -179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER 173.4 -52.67 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.748 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -153.03 172.24 17.15 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.856 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 9.7 mt-30 -94.78 127.94 41.14 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.942 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.465 ' HD3' HG21 ' A' ' 87' ' ' VAL . 0.8 OUTLIER -101.12 125.4 47.73 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.869 179.914 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.438 ' HB2' ' CE1' ' A' ' 137' ' ' TYR . 24.4 m120 -112.77 125.08 53.94 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.994 -179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.648 ' HG ' HD11 ' A' ' 118' ' ' ILE . 1.3 tp -122.52 129.3 51.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.694 179.89 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.476 ' N ' HD12 ' A' ' 95' ' ' ILE . 3.2 mp -122.96 141.01 44.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.204 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -116.53 144.01 44.88 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.827 -179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.954 HG22 ' CE2' ' A' ' 80' ' ' PHE . 22.0 t -112.17 124.63 69.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.193 -179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 20.4 mt -130.01 124.95 59.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.071 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . 0.449 ' HB2' HD22 ' A' ' 112' ' ' LEU . 26.7 m-20 -114.03 127.83 56.12 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.946 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -84.71 -7.47 59.21 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.372 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 21.6 m 64.25 79.02 0.27 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.779 0.324 . . . . 0.0 110.884 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -116.43 -39.95 3.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.919 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -133.19 -46.02 0.84 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.192 179.991 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 145.47 103.16 0.38 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.406 -179.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.449 HG23 ' CD1' ' A' ' 127' ' ' PHE . 28.0 m -113.46 131.57 55.98 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.788 0.328 . . . . 0.0 110.92 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -116.49 117.71 30.65 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.871 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.447 HD13 HG23 ' A' ' 125' ' ' ILE . 3.0 tp -112.5 137.32 45.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.424 0.631 . . . . 0.0 111.281 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 62.15 27.66 16.65 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 114.811 -1.086 . . . . 0.0 110.942 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.59 10.22 70.74 Favored Glycine 0 N--CA 1.443 -0.861 0 C-N-CA 120.945 -0.645 . . . . 0.0 112.94 179.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 1.9 m-80 -133.99 151.34 51.42 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.775 0.321 . . . . 0.0 110.957 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -70.58 130.0 40.68 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.859 179.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.709 HD21 ' O ' ' A' ' 114' ' ' LYS . 7.0 tt -70.19 139.28 52.3 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.818 -179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.472 HG13 ' N ' ' A' ' 114' ' ' LYS . 10.8 p -121.98 -44.66 2.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.077 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . 0.709 ' O ' HD21 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -84.61 167.45 16.25 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.946 179.97 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -108.85 28.52 8.36 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.942 -179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -158.62 62.45 0.43 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.005 0.431 . . . . 0.0 110.8 -179.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 45.3 t80 -84.06 139.11 32.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.803 179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.648 HD11 ' HG ' ' A' ' 94' ' ' LEU . 8.6 tp -98.48 120.14 47.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.307 0 CA-C-O 121.01 0.433 . . . . 0.0 111.408 -179.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.679 HD11 HD11 ' A' ' 125' ' ' ILE . 6.6 tt -103.1 142.21 34.52 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.074 -0.512 . . . . 0.0 110.923 179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 9.6 mmtp -129.76 178.13 6.73 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.817 179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.45 ' HB3' ' CE2' ' A' ' 137' ' ' TYR . 9.2 p30 -56.35 144.44 30.55 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.083 -179.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.433 ' HA2' HD21 ' A' ' 134' ' ' LEU . . . 65.51 45.49 89.65 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.721 -0.752 . . . . 0.0 112.42 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 11.3 m-20 -112.37 133.59 54.38 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.91 0.386 . . . . 0.0 110.973 -179.906 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.607 ' HG2' HD12 ' A' ' 134' ' ' LEU . 0.0 OUTLIER -91.42 130.77 37.22 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.819 179.931 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.679 HD11 HD11 ' A' ' 119' ' ' LEU . 1.8 mp -129.83 121.92 53.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.255 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.572 HG22 ' OG ' ' A' ' 132' ' ' SER . 39.2 t -113.13 130.55 66.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.033 179.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.57 ' CE2' ' HB3' ' A' ' 78' ' ' ALA . 3.3 m-85 -114.61 141.39 47.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.071 -179.776 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 71.59 -64.67 1.11 Allowed Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.872 -0.68 . . . . 0.0 112.49 179.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER 169.91 -38.2 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.884 0.373 . . . . 0.0 110.963 -179.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 82.7 p -101.75 -39.97 7.17 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.041 -179.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . 0.713 ' HB3' HD22 ' A' ' 68' ' ' LEU . 57.1 m -57.17 106.38 0.31 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.998 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . 0.572 ' OG ' HG22 ' A' ' 126' ' ' VAL . 1.3 m -124.21 123.7 40.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.889 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -142.09 156.01 45.38 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.356 -0.384 . . . . 0.0 111.111 179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.607 HD12 ' HG2' ' A' ' 124' ' ' ARG . 1.4 tt -117.89 140.02 50.31 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.717 179.889 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 20.3 t80 -104.94 141.39 36.64 Favored 'General case' 0 CA--C 1.514 -0.411 0 CA-C-O 121.945 0.879 . . . . 0.0 111.935 -179.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -154.73 159.35 40.63 Favored 'General case' 0 C--N 1.31 -1.115 0 CA-C-N 113.711 -1.586 . . . . 0.0 110.591 179.459 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.45 ' CE2' ' HB3' ' A' ' 121' ' ' ASN . 2.5 m-85 -83.83 139.81 32.43 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.021 0.438 . . . . 0.0 110.697 179.588 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.563 ' HB2' ' ND1' ' A' ' 36' ' ' HIS . . . -96.9 87.43 4.27 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.835 -0.62 . . . . 0.0 111.131 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.11 175.12 5.59 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.98 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.9 127.1 35.74 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.902 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 23.3 t -153.42 -61.05 0.14 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.907 -179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.21 31.02 1.38 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.969 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 24.7 p -106.56 22.71 15.41 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.035 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -117.47 -30.65 5.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.396 -0.366 . . . . 0.0 111.084 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.609 HG22 ' O ' ' A' ' 145' ' ' ILE . 17.8 mt -100.94 25.04 1.13 Allowed 'Isoleucine or valine' 0 CA--C 1.517 -0.323 0 CA-C-O 121.628 0.727 . . . . 0.0 111.415 -179.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 6.1 tt0 -152.8 33.14 0.49 Allowed 'General case' 0 C--N 1.307 -1.26 0 CA-C-N 114.699 -1.137 . . . . 0.0 110.881 179.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 2.7 m-20 -87.89 91.51 8.79 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.829 179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -99.12 149.54 22.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.951 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -148.97 -47.51 0.14 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.923 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 13.8 mt-10 -58.9 132.91 55.37 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.923 -179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 60.89 87.57 0.09 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.85 -179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 14.2 m -90.02 149.12 4.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.115 179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -63.37 -174.07 0.08 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.838 -179.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.2 m -128.82 -70.31 0.68 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.917 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -64.12 -177.62 0.28 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.862 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 6.9 m 60.78 -170.81 0.15 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.918 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.36 -39.46 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.902 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 62.66 177.48 0.14 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.91 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 23.4 t80 . . . . . 0 C--O 1.25 1.096 0 CA-C-O 118.197 -0.906 . . . . 0.0 110.937 179.981 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 3.8 mtpm? . . . . . 0 N--CA 1.486 1.329 0 CA-C-O 120.847 0.356 . . . . 0.0 111.183 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.4 164.63 12.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.837 179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.38 117.97 3.53 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.92 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 3.4 tt0 -151.52 159.82 43.97 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.961 179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 9.7 ttt-85 -111.06 -31.87 6.98 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.938 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 48.2 p -94.17 162.15 13.98 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.889 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 32.2 m-20 60.16 54.8 3.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.882 179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . 0.427 ' N ' ' HD2' ' A' ' 27' ' ' PRO . 0.0 OUTLIER -70.35 -61.4 2.72 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.036 -179.989 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . 0.427 ' HD2' ' N ' ' A' ' 26' ' ' LYS . 36.9 Cg_endo -65.67 156.42 63.95 Favored 'Trans proline' 0 C--N 1.347 0.481 0 C-N-CA 122.472 2.115 . . . . 0.0 112.283 -179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 60.2 p -89.32 56.64 3.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.921 -179.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -114.77 85.02 2.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.918 179.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 9.7 pm0 -136.6 -175.35 3.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.96 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -110.3 -119.39 0.28 Allowed 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.588 -179.911 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -140.1 130.15 24.9 Favored 'General case' 0 C--O 1.232 0.134 0 CA-C-O 120.797 0.332 . . . . 0.0 110.554 179.706 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.8 t -60.71 145.05 50.81 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.254 -0.43 . . . . 0.0 111.063 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.551 HD22 ' OD1' ' A' ' 93' ' ' ASN . 9.6 mt -147.76 -53.68 0.2 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.908 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.689 ' C ' HG22 ' A' ' 50' ' ' ILE . . . -140.65 -175.28 14.48 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.69 -0.767 . . . . 0.0 112.564 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 50.4 m80 -146.07 166.05 27.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.904 0.383 . . . . 0.0 110.936 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.7 mp -125.69 107.85 10.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.539 179.625 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.65 HG22 ' HG2' ' A' ' 47' ' ' LYS . 27.6 t -96.13 121.98 47.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.167 -179.838 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -89.98 113.98 25.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.86 179.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -87.65 106.75 18.24 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.878 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.542 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 18.9 mt -124.17 141.0 36.12 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.835 -179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.542 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 50.2 Cg_endo -72.59 83.95 1.26 Allowed 'Trans proline' 0 C--N 1.346 0.43 0 C-N-CA 122.078 1.852 . . . . 0.0 111.967 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 118.0 25.98 2.88 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.982 -0.628 . . . . 0.0 112.372 -179.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 170.58 155.31 0.06 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 120.691 0.282 . . . . 0.0 110.555 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -142.47 151.91 42.19 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.466 -0.334 . . . . 0.0 110.975 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 2.3 mt-30 -140.29 128.79 22.77 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.176 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.65 ' HG2' HG22 ' A' ' 38' ' ' VAL . 0.0 OUTLIER -113.04 131.24 55.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.806 179.82 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 41.8 t -125.46 151.02 31.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.29 -179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 -104.24 132.92 49.97 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.626 179.787 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.689 HG22 ' C ' ' A' ' 35' ' ' GLY . 2.3 tt -116.07 132.02 66.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.01 0.433 . . . . 0.0 111.492 -179.743 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.01 168.05 9.44 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.007 -0.542 . . . . 0.0 111.033 -179.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.482 ' HB3' HD12 ' A' ' 34' ' ' LEU . 6.7 p30 -76.28 63.39 1.91 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.307 179.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.542 ' C ' ' H ' ' A' ' 55' ' ' VAL . 11.1 ttt-85 -80.88 0.12 36.58 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.818 -0.628 . . . . 0.0 112.013 -179.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.451 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 8.3 m120 71.51 -35.88 0.34 Allowed 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 -178.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.542 ' H ' ' C ' ' A' ' 53' ' ' ARG . 68.0 t -137.37 134.14 46.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.061 179.515 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.653 HG23 ' HB3' ' A' ' 65' ' ' ASP . 51.8 m -125.29 124.19 41.08 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.942 -0.572 . . . . 0.0 109.893 179.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.66 127.34 51.12 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.952 0.406 . . . . 0.0 111.11 -179.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.725 ' CG2' HD11 ' A' ' 68' ' ' LEU . 4.6 mp -107.98 117.74 54.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.003 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 172.95 -144.96 8.14 Favored Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 121.024 -0.608 . . . . 0.0 112.405 -179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . . . . . . . . . 3.3 ttm105 -111.15 -19.93 12.53 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.715 0.293 . . . . 0.0 111.245 179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.449 ' HB2' HG22 ' A' ' 75' ' ' THR . 0.1 OUTLIER -50.27 151.67 2.03 Favored 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 120.895 0.379 . . . . 0.0 111.141 -179.859 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 2.5 tpt180 -72.91 -38.74 66.78 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.93 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 6.0 m -70.1 -19.62 63.24 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.209 179.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 48.8 m -53.91 149.25 9.16 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.544 -0.298 . . . . 0.0 111.028 -179.88 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.653 ' HB3' HG23 ' A' ' 56' ' ' THR . 10.4 t70 -75.16 -53.68 8.43 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.904 0.383 . . . . 0.0 110.836 -179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . . . . . . . . . 21.5 t -114.83 116.99 54.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.216 -179.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 20.0 pt -99.15 131.05 47.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.155 -0.475 . . . . 0.0 111.061 -179.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.834 HD13 HG12 ' A' ' 73' ' ' ILE . 5.0 mp -86.45 -175.93 5.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.911 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.2 t -118.34 34.61 5.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.98 -179.954 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.419 ' HB3' ' HB ' ' A' ' 73' ' ' ILE . 5.4 tp10 -109.68 118.51 50.12 Favored Pre-proline 0 C--N 1.329 -0.309 0 CA-C-N 116.324 -0.398 . . . . 0.0 110.667 179.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . . . . . . . . . 35.0 Cg_exo -57.74 -16.11 23.79 Favored 'Trans proline' 0 C--N 1.346 0.439 0 C-N-CA 122.566 2.177 . . . . 0.0 112.804 -179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -119.8 36.61 4.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.765 0.317 . . . . 0.0 111.029 -179.779 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.834 HG12 HD13 ' A' ' 68' ' ' LEU . 7.3 tp -82.45 147.7 5.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.27 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.427 ' HB3' ' CG ' ' A' ' 77' ' ' HIS . 2.5 t -77.17 129.91 36.6 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.103 -179.825 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.449 HG22 ' HB2' ' A' ' 61' ' ' SER . 1.8 m -65.37 -39.21 92.01 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.726 179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.434 ' O ' ' C ' ' A' ' 77' ' ' HIS . 1.1 m-85 -103.8 13.94 31.93 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.295 179.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.434 ' C ' ' O ' ' A' ' 76' ' ' PHE . 0.3 OUTLIER -22.31 -71.87 0.02 OUTLIER 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 114.647 -1.161 . . . . 0.0 112.595 -179.349 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.601 ' HB3' ' CE2' ' A' ' 127' ' ' PHE . . . -158.6 164.03 36.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.074 0.464 . . . . 0.0 111.928 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.58 ' HG3' HD12 ' A' ' 98' ' ' ILE . 11.1 pt-20 -129.09 136.49 50.3 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.471 179.484 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.883 ' CZ ' HG13 ' A' ' 97' ' ' VAL . 6.1 m-85 -119.54 131.17 55.49 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.385 -0.371 . . . . 0.0 110.887 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.451 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 6.3 m-70 -94.87 116.38 28.64 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.89 0.376 . . . . 0.0 111.049 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.498 HD12 HG12 ' A' ' 95' ' ' ILE . 0.4 OUTLIER -106.51 109.58 21.54 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.711 179.57 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 8.4 mp -122.2 140.14 52.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.166 -179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 10.0 tm0? -108.97 133.34 53.09 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.892 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -141.89 122.69 14.38 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.939 -179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 21.5 p-10 -97.05 116.1 28.65 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.944 179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 4.2 m -119.68 110.92 30.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.243 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 20.6 m-20 59.25 72.82 0.51 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.072 -0.513 . . . . 0.0 111.004 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 66.08 -74.54 0.06 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.236 -0.438 . . . . 0.0 111.042 179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -52.85 144.41 14.61 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.152 -179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -108.83 130.95 55.41 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.94 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -116.5 125.61 52.18 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.796 179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.551 ' OD1' HD22 ' A' ' 34' ' ' LEU . 5.1 m120 -106.98 135.37 48.66 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.939 179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -126.66 139.62 53.03 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.773 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.498 HG12 HD12 ' A' ' 82' ' ' LEU . 4.0 mp -127.79 138.29 55.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.205 -179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -113.88 140.62 48.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.772 -179.926 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.883 HG13 ' CZ ' ' A' ' 80' ' ' PHE . 16.9 t -103.99 121.99 56.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.156 -179.958 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . 0.58 HD12 ' HG3' ' A' ' 79' ' ' GLU . 28.6 mt -114.21 124.2 70.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.046 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -87.78 138.23 31.64 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.941 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -100.1 -25.68 14.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.013 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 15.1 m 65.47 81.37 0.21 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.943 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -137.07 -47.07 0.58 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.883 179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -124.74 -48.83 1.77 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.157 -179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 154.32 129.39 1.29 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.783 -0.723 . . . . 0.0 112.547 179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.493 HG23 ' CE1' ' A' ' 127' ' ' PHE . 1.7 m -131.94 123.7 27.94 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.758 0.314 . . . . 0.0 110.954 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 51.3 m-85 -121.16 123.28 41.91 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.809 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.479 HD12 ' O ' ' A' ' 124' ' ' ARG . 2.9 tp -119.01 137.32 53.36 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.232 0 CA-C-O 121.426 0.631 . . . . 0.0 111.337 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 62.38 27.97 16.62 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 114.899 -1.046 . . . . 0.0 110.859 -179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.66 9.82 70.33 Favored Glycine 0 N--CA 1.444 -0.801 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.971 179.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -133.99 152.04 51.69 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.825 0.345 . . . . 0.0 110.859 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.02 129.21 39.29 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.88 -179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.474 HD21 ' HB ' ' A' ' 105' ' ' THR . 4.1 pp -71.44 140.13 49.95 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.954 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 12.0 m -135.02 31.41 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.171 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 23.9 mmtt -145.93 149.09 33.56 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.931 179.925 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 17.9 ttpp -98.77 31.13 3.04 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.813 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 6.2 t70 -166.57 66.93 0.1 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.862 -179.981 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -82.81 139.03 33.76 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.941 -179.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.633 HD13 ' C ' ' A' ' 118' ' ' ILE . 0.0 OUTLIER -98.73 117.61 44.02 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.525 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.749 -179.841 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.779 HD11 HD11 ' A' ' 125' ' ' ILE . 7.7 tt -103.0 136.89 41.98 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.186 -179.777 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . 0.542 ' N ' HD23 ' A' ' 119' ' ' LEU . 3.1 mmmm -136.14 178.15 7.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.764 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.433 ' HB3' ' CZ ' ' A' ' 137' ' ' TYR . 12.7 p30 -55.48 139.31 44.14 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.034 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . . . . . . . . . . . 71.27 52.93 11.36 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.706 -0.759 . . . . 0.0 112.479 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -124.8 125.25 43.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.794 0.33 . . . . 0.0 110.974 -179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.613 ' HG3' HD12 ' A' ' 134' ' ' LEU . 11.2 mtp180 -93.67 131.81 38.62 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.818 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.779 HD11 HD11 ' A' ' 119' ' ' LEU . 2.7 mt -125.74 137.95 56.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.123 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 22.9 t -120.36 123.98 71.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.065 179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.601 ' CE2' ' HB3' ' A' ' 78' ' ' ALA . 3.6 m-85 -119.22 128.97 54.7 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.199 -0.455 . . . . 0.0 111.139 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 80.97 -3.38 76.42 Favored Glycine 0 CA--C 1.518 0.252 0 C-N-CA 120.821 -0.704 . . . . 0.0 113.072 179.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 8.6 tttt 76.31 24.5 1.09 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.861 0.362 . . . . 0.0 110.511 -179.567 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.88 -52.63 0.13 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.012 179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 91.1 m -77.48 107.76 10.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.671 179.786 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 79.8 p -121.99 133.33 54.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.992 -179.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.423 ' CE1' ' HB ' ' A' ' 125' ' ' ILE . 2.8 p90 -142.01 155.69 45.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.905 179.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.613 HD12 ' HG3' ' A' ' 124' ' ' ARG . 7.9 tt -112.35 139.98 47.45 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.774 179.833 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.558 ' HE1' HG21 ' A' ' 50' ' ' ILE . 74.1 t80 -101.5 141.5 34.28 Favored 'General case' 0 CA--C 1.513 -0.456 0 CA-C-O 121.944 0.878 . . . . 0.0 111.838 -179.815 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.31 154.11 32.82 Favored 'General case' 0 C--N 1.311 -1.096 0 CA-C-N 113.864 -1.516 . . . . 0.0 110.784 179.805 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.479 ' CD1' ' N ' ' A' ' 137' ' ' TYR . 0.6 OUTLIER -85.53 139.72 31.24 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.992 0.425 . . . . 0.0 110.752 179.74 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . . . . . . . . . . . -115.19 107.74 15.69 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.097 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 3.2 m -137.35 31.45 2.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.937 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 3.1 m -83.98 78.14 9.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.88 -179.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -95.7 90.76 5.8 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.889 -179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.1 p -111.27 155.28 23.24 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.898 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 2.3 t -135.96 -50.29 0.7 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.875 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -168.86 87.17 0.18 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.897 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.6 HG22 ' H ' ' A' ' 146' ' ' GLU . 0.8 OUTLIER -110.89 -143.44 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.435 -1.176 0 N-CA-C 109.568 -0.53 . . . . 0.0 109.568 179.847 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . 0.6 ' H ' HG22 ' A' ' 145' ' ' ILE . 5.6 tp10 -102.04 152.44 20.97 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.924 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER 60.64 177.5 0.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.874 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.52 128.18 35.36 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.921 179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -119.76 164.84 15.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.871 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 60.44 -178.83 0.1 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.811 179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.93 134.8 36.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.114 -0.493 . . . . 0.0 110.87 -179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.514 ' O ' HG13 ' A' ' 152' ' ' VAL . 11.3 p -148.81 57.89 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.061 179.981 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 16.7 p -93.0 -31.76 14.76 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.871 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 1.4 t -105.39 -45.64 4.41 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.896 -179.923 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -158.73 158.82 34.39 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.865 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -95.68 -169.02 1.87 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.926 179.938 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -94.22 46.71 1.17 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.862 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 1.9 m 60.86 107.82 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.909 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 26.3 t80 . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.205 -0.902 . . . . 0.0 110.868 179.932 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 12.7 mttt . . . . . 0 N--CA 1.486 1.365 0 CA-C-O 120.861 0.362 . . . . 0.0 111.187 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 60.28 92.71 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.967 179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.9 mm-40 59.18 30.62 20.42 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.971 179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -143.35 84.04 1.8 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.89 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.02 -47.48 0.23 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.803 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' SER . . . . . . . . . . . . . 88.5 p -90.85 170.46 10.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.929 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -116.46 160.58 20.38 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.869 -179.942 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LYS . . . . . . . . . . . . . 4.2 mtpp -135.94 83.05 35.52 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.927 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -57.94 159.05 19.02 Favored 'Trans proline' 0 C--N 1.345 0.357 0 C-N-CA 122.576 2.184 . . . . 0.0 112.28 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 23.0 t -108.74 -61.19 1.64 Allowed 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.916 179.99 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' SER . . . . . 0.401 ' O ' ' CZ ' ' A' ' 31' ' ' TYR . 67.2 m -88.5 151.68 22.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.919 -179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . 0.446 ' C ' ' CG ' ' A' ' 31' ' ' TYR . 7.3 mm-40 -95.03 167.41 11.41 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.842 179.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.446 ' CG ' ' C ' ' A' ' 30' ' ' GLU . 0.0 OUTLIER -168.48 115.78 0.68 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.247 0.546 . . . . 0.0 110.413 179.602 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 2.4 m -102.01 152.51 20.87 Favored 'General case' 0 C--N 1.318 -0.8 0 CA-C-N 115.265 -0.88 . . . . 0.0 110.749 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 1.8 t -60.07 135.21 57.64 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.423 . . . . 0.0 110.868 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.667 HD22 ' ND2' ' A' ' 52' ' ' ASN . 4.9 tp -136.65 -63.61 0.61 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.97 -179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . -139.6 178.25 19.82 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.677 -0.773 . . . . 0.0 112.498 -179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.43 ' ND1' ' HB2' ' A' ' 138' ' ' ALA . 31.0 m80 -133.52 166.0 23.58 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.788 0.328 . . . . 0.0 110.911 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.656 HD22 ' HD2' ' A' ' 133' ' ' PHE . 18.9 mt -126.5 113.71 17.17 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.96 -179.9 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.462 HG22 ' HD3' ' A' ' 47' ' ' LYS . 28.5 t -96.24 121.89 47.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.948 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 10.0 m-20 -90.0 113.85 25.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.892 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LEU . . . . . 0.555 HD13 HH12 ' A' ' 124' ' ' ARG . 2.9 mt -77.76 106.75 9.78 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.785 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.523 ' CG2' ' HD2' ' A' ' 42' ' ' PRO . 1.6 mp -124.15 140.26 34.47 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.97 -179.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' PRO . . . . . 0.523 ' HD2' ' CG2' ' A' ' 41' ' ' ILE . 67.9 Cg_endo -76.13 83.84 1.92 Allowed 'Trans proline' 0 C--N 1.347 0.477 0 C-N-CA 122.304 2.003 . . . . 0.0 112.029 179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 115.62 24.04 4.18 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.906 -0.664 . . . . 0.0 112.382 -179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.6 tttp -179.5 166.96 1.45 Allowed 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.794 0.33 . . . . 0.0 110.612 179.729 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -144.41 128.27 17.36 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.362 -0.381 . . . . 0.0 111.045 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -116.17 118.82 33.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.835 179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.462 ' HD3' HG22 ' A' ' 38' ' ' VAL . 1.1 mmmp? -108.82 124.83 51.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.909 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.617 HG11 HG13 ' A' ' 66' ' ' VAL . 26.2 t -120.36 137.64 53.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.096 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -85.75 132.84 34.05 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.84 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.541 HD11 HD12 ' A' ' 37' ' ' LEU . 33.4 mm -108.76 116.25 51.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.264 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.566 ' O ' HD23 ' A' ' 82' ' ' LEU . 0.2 OUTLIER -100.88 167.77 10.06 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.016 -0.538 . . . . 0.0 110.66 179.729 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASN . . . . . 0.667 ' ND2' HD22 ' A' ' 34' ' ' LEU . 2.1 m-80 -61.68 -95.65 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.324 179.684 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . 0.564 ' C ' ' H ' ' A' ' 55' ' ' VAL . 3.9 ttt-85 70.79 -4.41 1.71 Allowed 'General case' 0 C--O 1.232 0.15 0 N-CA-C 112.339 0.496 . . . . 0.0 112.339 179.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' ASN . . . . . 0.4 ' O ' ' HA ' ' A' ' 81' ' ' HIS . 0.1 OUTLIER 70.24 -32.93 0.25 Allowed 'General case' 0 C--N 1.331 -0.226 0 O-C-N 122.156 -0.34 . . . . 0.0 110.247 -179.035 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' VAL . . . . . 0.564 ' H ' ' C ' ' A' ' 53' ' ' ARG . 65.7 t -136.72 140.72 42.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 CA-C-O 121.082 0.468 . . . . 0.0 111.055 179.784 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.816 HG23 ' HB3' ' A' ' 65' ' ' ASP . 14.2 m -125.35 130.19 51.44 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.745 -0.661 . . . . 0.0 110.101 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -103.98 135.48 45.41 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.818 0.342 . . . . 0.0 110.684 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ILE . . . . . 0.74 ' CG2' HD23 ' A' ' 68' ' ' LEU . 5.9 mt -128.5 124.07 61.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.342 -179.625 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLY . . . . . . . . . . . . . . . 166.55 -134.48 3.29 Favored Glycine 0 C--N 1.332 0.316 0 C-N-CA 120.47 -0.872 . . . . 0.0 113.068 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ARG . . . . . 0.466 ' HB2' HG23 ' A' ' 73' ' ' ILE . 8.2 ttp180 -99.99 -40.12 7.8 Favored 'General case' 0 C--N 1.333 -0.132 0 CA-C-O 120.886 0.374 . . . . 0.0 111.158 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' SER . . . . . 0.804 ' HB2' HG23 ' A' ' 75' ' ' THR . 0.3 OUTLIER -46.18 118.11 1.79 Allowed 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.481 -179.52 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.85 -28.37 56.11 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.76 179.812 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -69.93 -22.96 63.14 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.88 179.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' CYS . . . . . . . . . . . . . 86.8 m -54.33 154.27 4.69 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.774 179.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.816 ' HB3' HG23 ' A' ' 56' ' ' THR . 64.1 t0 -65.88 -46.25 79.07 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.823 0.344 . . . . 0.0 110.957 -179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' VAL . . . . . 0.617 HG13 HG11 ' A' ' 48' ' ' VAL . 21.3 t -125.18 133.24 69.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.436 -179.8 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.8 pt -106.16 122.43 59.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.69 179.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . 0.74 HD23 ' CG2' ' A' ' 58' ' ' ILE . 2.7 mm? -94.15 -88.35 0.24 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.94 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 28.0 t -104.79 -115.64 0.23 Allowed 'General case' 0 C--N 1.331 -0.239 0 N-CA-C 110.139 -0.319 . . . . 0.0 110.139 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.584 ' HA ' HG22 ' A' ' 73' ' ' ILE . 3.4 tt0 171.79 -62.1 0.0 OUTLIER Pre-proline 0 CA--C 1.533 0.327 0 O-C-N 122.372 -0.205 . . . . 0.0 111.117 179.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PRO . . . . . 0.524 ' HD3' ' CB ' ' A' ' 70' ' ' GLU . 38.8 Cg_exo -59.44 -40.17 69.49 Favored 'Trans proline' 0 C--N 1.345 0.393 0 C-N-CA 121.924 1.749 . . . . 0.0 112.86 -179.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -118.73 19.85 13.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.545 -0.298 . . . . 0.0 111.507 -179.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.584 HG22 ' HA ' ' A' ' 70' ' ' GLU . 4.6 tp -103.97 122.2 56.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.078 0.466 . . . . 0.0 110.942 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' SER . . . . . 0.429 ' O ' ' HB2' ' A' ' 77' ' ' HIS . 2.6 p -71.81 134.87 46.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.406 -179.291 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.804 HG23 ' HB2' ' A' ' 61' ' ' SER . 91.4 m -61.99 -30.35 70.88 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.899 -0.592 . . . . 0.0 110.716 179.63 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' PHE . . . . . 0.422 ' O ' ' C ' ' A' ' 77' ' ' HIS . 0.4 OUTLIER -108.77 14.08 24.57 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.044 -0.525 . . . . 0.0 111.514 -179.939 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' HIS . . . . . 0.504 ' CD2' ' CD1' ' A' ' 127' ' ' PHE . 1.1 t60 -25.68 -68.73 0.04 OUTLIER 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 114.796 -1.093 . . . . 0.0 112.668 -179.345 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . 0.569 ' HB3' ' CZ ' ' A' ' 127' ' ' PHE . . . -157.09 164.1 38.25 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.017 0.437 . . . . 0.0 111.647 -179.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -131.67 137.95 48.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.822 179.773 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' PHE . . . . . 0.898 ' CE2' HG22 ' A' ' 97' ' ' VAL . 7.0 m-85 -119.28 130.14 55.26 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.534 179.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' HIS . . . . . 0.4 ' HA ' ' O ' ' A' ' 54' ' ' ASN . 4.4 m-70 -94.78 116.17 28.41 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.802 0.334 . . . . 0.0 111.14 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LEU . . . . . 0.566 HD23 ' O ' ' A' ' 51' ' ' THR . 11.1 tp -106.54 109.49 21.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.156 -0.474 . . . . 0.0 110.718 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -122.46 140.23 52.97 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.92 -0.582 . . . . 0.0 111.035 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -98.45 134.89 40.79 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.682 179.767 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.02 122.94 47.45 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.984 -179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -96.97 119.53 35.61 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.002 -179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' VAL . . . . . . . . . . . . . 18.4 t -140.05 139.15 37.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.098 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 13.3 m-20 -48.59 -56.44 8.41 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.198 -179.901 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' ASN . . . . . . . . . . . . . 12.0 m-20 -51.08 -75.11 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.152 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -147.65 155.27 41.6 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.801 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -82.92 127.93 33.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.967 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.04 134.93 54.13 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.984 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' ASN . . . . . 0.631 HD21 HD11 ' A' ' 34' ' ' LEU . 20.1 m-20 -111.43 140.62 45.87 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.733 179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LEU . . . . . 0.619 ' HG ' HD11 ' A' ' 118' ' ' ILE . 4.6 tp -132.02 139.47 48.6 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.054 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ILE . . . . . 0.641 HD13 HD23 ' A' ' 119' ' ' LEU . 2.6 mp -125.02 134.31 67.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.178 -0.465 . . . . 0.0 111.049 179.883 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -114.04 144.01 43.81 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.817 -179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' VAL . . . . . 0.898 HG22 ' CE2' ' A' ' 80' ' ' PHE . 16.3 t -108.78 131.61 58.99 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.187 -179.832 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ILE . . . . . . . . . . . . . 3.8 mp -130.05 121.31 51.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.985 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' ASP . . . . . . . . . . . . . 21.1 p30 -84.88 139.09 32.12 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.93 -179.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.2 mmtt -143.6 30.48 1.35 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.959 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' SER . . . . . . . . . . . . . 3.6 m -153.97 152.2 30.28 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.829 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 11.7 mmt180 -106.18 34.6 3.27 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.987 -179.95 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -89.19 -31.22 18.03 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.268 -0.424 . . . . 0.0 111.207 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 121.19 115.99 2.43 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.452 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' THR . . . . . 0.463 ' CG2' ' CE1' ' A' ' 127' ' ' PHE . 99.5 m -131.72 128.45 38.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.811 0.338 . . . . 0.0 110.886 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 -121.05 114.96 22.24 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.746 179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ILE . . . . . 0.639 HD12 ' O ' ' A' ' 124' ' ' ARG . 2.8 tp -111.56 137.29 44.74 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.329 0 CA-C-O 121.435 0.636 . . . . 0.0 111.342 -179.893 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ASN . . . . . . . . . . . . . 1.2 m-80 61.93 26.53 16.05 Favored 'General case' 0 C--N 1.319 -0.749 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.739 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLY . . . . . . . . . . . . . . . 71.72 8.95 69.01 Favored Glycine 0 N--CA 1.445 -0.761 0 C-N-CA 120.876 -0.678 . . . . 0.0 112.858 179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ASN . . . . . . . . . . . . . 51.9 m-80 -134.11 151.99 51.63 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.792 0.33 . . . . 0.0 110.901 -179.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 10.5 mtm105 -74.96 132.82 41.69 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.739 179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.432 HD23 ' H ' ' A' ' 112' ' ' LEU . 0.6 OUTLIER -83.05 143.5 30.56 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.231 -0.441 . . . . 0.0 110.95 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.636 HG22 ' O ' ' A' ' 113' ' ' VAL . 14.5 p -128.75 14.56 2.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.206 -0.452 . . . . 0.0 111.39 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -121.85 -178.56 3.87 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.806 0.336 . . . . 0.0 110.768 179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.3 mttt -110.2 -29.64 8.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.95 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ASP . . . . . . . . . . . . . 3.6 t0 -112.63 78.87 1.16 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.899 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -80.79 139.33 36.09 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.903 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.619 HD11 ' HG ' ' A' ' 94' ' ' LEU . 7.5 tp -98.46 115.98 40.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 121.035 0.445 . . . . 0.0 111.241 -179.617 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.641 HD23 HD13 ' A' ' 95' ' ' ILE . 0.7 OUTLIER -103.12 132.85 49.07 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.964 -179.862 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LYS . . . . . . . . . . . . . 19.4 mttm -135.99 178.23 7.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.76 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ASN . . . . . 0.46 ' ND2' ' CD2' ' A' ' 137' ' ' TYR . 3.2 t-20 -50.93 139.99 16.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.315 -0.402 . . . . 0.0 111.176 -179.899 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' GLY . . . . . 0.508 ' HA2' HD21 ' A' ' 134' ' ' LEU . . . 70.75 51.46 19.78 Favored Glycine 0 N--CA 1.45 -0.401 0 C-N-CA 120.745 -0.74 . . . . 0.0 112.497 179.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.46 130.07 53.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.918 0.39 . . . . 0.0 110.952 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ARG . . . . . 0.639 ' O ' HD12 ' A' ' 107' ' ' ILE . 1.4 ttm-85 -98.15 124.11 42.55 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.918 179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ILE . . . . . 0.529 HD11 HD11 ' A' ' 119' ' ' LEU . 1.9 mp -115.53 134.71 57.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.17 -179.855 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 29.2 t -124.1 133.95 67.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.209 -0.451 . . . . 0.0 111.104 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' PHE . . . . . 0.569 ' CZ ' ' HB3' ' A' ' 78' ' ' ALA . 7.5 m-85 -131.84 134.33 45.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.301 -0.409 . . . . 0.0 111.055 -179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLY . . . . . . . . . . . . . . . 81.02 -2.23 81.72 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.746 -0.74 . . . . 0.0 112.95 179.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LYS . . . . . . . . . . . . . 2.8 mtpp 75.47 27.77 1.02 Allowed 'General case' 0 C--N 1.333 -0.142 0 CA-C-O 120.914 0.388 . . . . 0.0 110.424 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 63.9 p -154.01 -60.03 0.13 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.834 179.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . 0.71 ' HB3' HD12 ' A' ' 68' ' ' LEU . 55.6 m -61.91 109.05 1.14 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.727 179.761 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' SER . . . . . . . . . . . . . 3.0 p -120.51 128.0 52.71 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.004 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' PHE . . . . . 0.656 ' HD2' HD22 ' A' ' 37' ' ' LEU . 2.1 p90 -142.06 155.99 45.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.953 -179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' LEU . . . . . 0.508 HD21 ' HA2' ' A' ' 122' ' ' GLY . 3.9 tt -113.37 140.11 48.31 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.834 179.987 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . 0.507 ' HE2' HG21 ' A' ' 50' ' ' ILE . 26.4 t80 -104.54 141.48 36.32 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-O 121.984 0.897 . . . . 0.0 111.81 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 8.7 pttt -154.71 158.97 40.37 Favored 'General case' 0 C--N 1.311 -1.076 0 CA-C-N 113.914 -1.494 . . . . 0.0 110.867 179.585 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' TYR . . . . . 0.46 ' CD2' ' ND2' ' A' ' 121' ' ' ASN . 3.2 m-85 -86.07 139.74 30.87 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.381 -0.372 . . . . 0.0 110.716 179.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' ALA . . . . . 0.43 ' HB2' ' ND1' ' A' ' 36' ' ' HIS . . . -106.39 35.6 2.9 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.22 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -127.37 31.6 5.18 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.942 179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 60.5 90.68 0.06 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.863 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -130.21 123.4 30.12 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.817 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.1 p -94.85 147.98 22.79 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.953 179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' THR . . . . . . . . . . . . . 6.9 t -126.57 125.2 41.59 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.933 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -107.37 -174.88 2.64 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.853 179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . 0.579 HG22 ' O ' ' A' ' 145' ' ' ILE . 20.2 mm -101.6 25.04 1.23 Allowed 'Isoleucine or valine' 0 CA--C 1.516 -0.336 0 CA-C-O 121.699 0.762 . . . . 0.0 111.375 -179.973 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -163.51 98.12 0.89 Allowed 'General case' 0 C--N 1.308 -1.223 0 CA-C-N 114.603 -1.18 . . . . 0.0 110.858 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -59.6 -37.43 78.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.969 -179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -73.74 153.56 39.98 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.931 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -151.73 131.84 13.52 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.879 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -175.54 -40.84 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.896 -179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . . . . . . . . . 1.3 ttpt -73.06 116.94 14.19 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.886 179.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 152' ' ' VAL . 28.6 m -122.02 120.05 60.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.196 -0.456 . . . . 0.0 111.127 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -75.29 -59.88 2.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.908 179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' SER . . . . . . . . . . . . . 94.8 p -119.65 168.64 10.84 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.863 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -68.5 113.3 5.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.152 -0.477 . . . . 0.0 110.907 179.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' SER . . . . . . . . . . . . . 16.3 m -153.97 86.49 1.18 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.827 179.987 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ARG . . . . . . . . . . . . . 1.4 mtt180 -121.1 97.73 5.66 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.855 179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 62.3 m 60.29 -178.42 0.1 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.843 179.923 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' TYR . . . . . . . . . . . . . 20.8 t80 . . . . . 0 C--O 1.249 1.036 0 CA-C-O 118.297 -0.859 . . . . 0.0 110.875 -179.947 . . . . . . . . 0 0 . 1 stop_ save_